diff --git "a/data/train.conll" "b/data/train.conll"
deleted file mode 100644--- "a/data/train.conll"
+++ /dev/null
@@ -1,41071 +0,0 @@
-For ADP B-O
-this DET B-O
-purpose NOUN B-O
-the DET B-O
-Gothenburg PROPN B-LF
-Young PROPN I-LF
-Persons PROPN I-LF
-Empowerment PROPN I-LF
-Scale PROPN I-LF
-( PUNCT B-O
-GYPES PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-developed VERB B-O
-. PUNCT B-O
-
-The DET B-O
-following ADJ B-O
-physiological ADJ B-O
-traits NOUN B-O
-were AUX B-O
-measured VERB B-O
-: PUNCT B-O
-stomatal ADJ B-LF
-conductance NOUN I-LF
-( PUNCT B-O
-gs PROPN B-AC
-, PUNCT B-O
-mol NOUN B-O
-H2O NOUN B-O
-m-2 NOUN B-O
-s-1 NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-transpiration NOUN B-LF
-rate NOUN I-LF
-( PUNCT B-O
-E PROPN B-AC
-, PUNCT B-O
-mmol NOUN B-O
-H2O NOUN B-O
-m-2 NOUN B-O
-s-1 NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-net ADJ B-LF
-photosynthetic ADJ I-LF
-rate NOUN I-LF
-( PUNCT B-O
-PN PROPN B-AC
-, PUNCT B-O
-μmol NOUN B-O
-m-2 NOUN B-O
-s-1 NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-intercellular ADJ B-LF
-CO2 NOUN I-LF
-concentration NOUN I-LF
-CO2 PROPN B-AC
-( PUNCT B-O
-Ci PROPN B-AC
-, PUNCT B-O
-μmol NOUN B-O
-m-2 NOUN B-O
-s-1 NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Minor ADJ B-O
-H PROPN B-AC
-antigen NOUN B-O
-alloimmune ADJ B-O
-responses NOUN B-O
-readily ADV B-O
-occur VERB B-O
-in ADP B-O
-the DET B-O
-setting NOUN B-O
-of ADP B-O
-human ADJ B-LF
-leukocyte NOUN I-LF
-antigen NOUN I-LF
-( PUNCT B-O
-HLA)–matched PROPN B-AC
-allogeneic ADJ B-O
-solid ADJ B-O
-organ NOUN B-O
-and CCONJ B-O
-stem NOUN B-LF
-cell NOUN I-LF
-transplantation NOUN I-LF
-( PUNCT B-O
-SCT PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-3,4 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-EPI PROPN B-AC
-= PUNCT B-O
-Echo NOUN B-LF
-planar NOUN I-LF
-imaging NOUN I-LF
-. PUNCT B-O
-
-Furthermore ADV B-O
-, PUNCT B-O
-eNOS PROPN B-AC
-- PUNCT B-O
-derived VERB B-O
-NO PROPN B-AC
-S NOUN B-O
-- PUNCT B-O
-nitrosylated VERB B-O
-β PUNCT B-O
-- PUNCT B-O
-actin NOUN B-O
-on ADP B-O
-Cys374 PROPN B-O
-and CCONJ B-O
-impaired VERB B-O
-actin NOUN B-O
-binding VERB B-O
-to ADP B-O
-profilin-1 NOUN B-LF
-( PUNCT B-O
-PFN1 PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-as SCONJ B-O
-confirmed VERB B-O
-with ADP B-O
-the DET B-O
-transnitrosylating NOUN B-O
-agent NOUN B-O
-S NOUN B-LF
-- PUNCT I-LF
-nitroso NOUN I-LF
-- PUNCT I-LF
-L NOUN I-LF
-- PUNCT I-LF
-cysteine NOUN I-LF
-( PUNCT B-O
-Cys-NO PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-The PROPN B-AC
-importance NOUN B-O
-of ADP B-O
-NO PROPN B-AC
-and CCONJ B-O
-the DET B-O
-formation NOUN B-O
-of ADP B-O
-PFN1 PROPN B-AC
-- PUNCT B-O
-actin NOUN B-O
-complexes NOUN B-O
-on ADP B-O
-the DET B-O
-regulation NOUN B-O
-of ADP B-O
-PKC PROPN B-AC
-was AUX B-O
-corroborated VERB B-O
-by ADP B-O
-overexpression NOUN B-O
-of ADP B-O
--θPFN1- PROPN B-AC
-and CCONJ B-O
-actin NOUN B-O
-- PUNCT B-O
-binding VERB B-O
-defective ADJ B-O
-mutants NOUN B-O
-of ADP B-O
-β PUNCT B-O
-- PUNCT B-O
-actin NOUN B-O
-( PUNCT B-O
-C374S PROPN B-O
-) PUNCT B-O
-and CCONJ B-O
-PFN1 PROPN B-AC
-( PUNCT B-O
-H119E PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-respectively ADV B-O
-, PUNCT B-O
-which PRON B-O
-reduced VERB B-O
-the DET B-O
-coalescence NOUN B-O
-of ADP B-O
-PKC PROPN B-AC
-at ADP B-O
-the DET B-O
--θc-SMAC PROPN B-AC
-. PUNCT B-O
-
-These DET B-O
-findings NOUN B-O
-unveil VERB B-O
-a DET B-O
-novel ADJ B-O
-NO PROPN B-AC
-- PUNCT B-O
-dependent ADJ B-O
-mechanism NOUN B-O
-by ADP B-O
-which PRON B-O
-the DET B-O
-actin NOUN B-O
-cytoskeleton NOUN B-O
-controls VERB B-O
-the DET B-O
-organization NOUN B-O
-and CCONJ B-O
-activation NOUN B-O
-of ADP B-O
-signaling NOUN B-O
-microclusters NOUN B-O
-at ADP B-O
-the DET B-O
-IS PROPN B-AC
-. PUNCT B-O
-
-Both DET B-O
-Mekk3 PROPN B-O
-cKO PROPN B-AC
-and CCONJ B-O
-their PRON B-O
-wild ADJ B-LF
-- PUNCT I-LF
-type NOUN I-LF
-( PUNCT B-O
-WT PROPN B-AC
-) PUNCT B-O
-littermates NOUN B-O
-were AUX B-O
-labeled VERB B-O
-at ADP B-O
-E16.5 NUM B-O
-with ADP B-O
-5 NUM B-LF
-- PUNCT I-LF
-bromo-2’-deoxyuridine NOUN I-LF
-( PUNCT B-O
-BrdU PROPN B-AC
-) PUNCT B-O
-to PART B-O
-track VERB B-O
-cells NOUN B-O
-undergoing VERB B-O
-DNA NOUN B-O
-synthesis NOUN B-O
-. PUNCT B-O
-
-Recent ADJ B-O
-work NOUN B-O
-by ADP B-O
-us PRON B-O
-and CCONJ B-O
-others NOUN B-O
-suggests VERB B-O
-that SCONJ B-O
-the DET B-O
-host NOUN B-O
-’s PART B-O
-heat NOUN B-LF
-shock NOUN I-LF
-protein NOUN I-LF
-90 NUM I-LF
-( PUNCT B-O
-Hsp90 PROPN B-AC
-) PUNCT B-O
-chaperone NOUN B-O
-can AUX B-O
-modulate VERB B-O
-the DET B-O
-evolutionary ADJ B-O
-paths NOUN B-O
-traversed VERB B-O
-by ADP B-O
-viruses NOUN B-O
-[ PUNCT B-O
-18 NUM B-O
-, PUNCT B-O
-19 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-We PRON B-O
-performed VERB B-O
-a DET B-O
-linear ADJ B-O
-regression NOUN B-O
-model NOUN B-O
-of ADP B-O
-the DET B-O
-effect NOUN B-O
-of ADP B-O
-PCL PROPN B-AC
-on ADP B-O
-Dizziness PROPN B-LF
-Handicap PROPN I-LF
-Inventory PROPN I-LF
-( PUNCT B-O
-DHI PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-DHI PROPN B-AC
-was AUX B-O
-significantly ADV B-O
-correlated VERB B-O
-to ADP B-O
-PCL PROPN B-AC
-scores NOUN B-O
-, PUNCT B-O
-suggesting VERB B-O
-that SCONJ B-O
-Veterans NOUN B-O
-with ADP B-O
-more ADJ B-O
-severe ADJ B-O
-PTSD PROPN B-AC
-symptoms NOUN B-O
-also ADV B-O
-had VERB B-O
-more ADJ B-O
-dizziness NOUN B-O
-handicap NOUN B-O
-as SCONJ B-O
-illustrated VERB B-O
-in ADP B-O
-Fig NUM B-O
-2 NUM B-O
-( PUNCT B-O
-r2 NOUN B-O
-= SYM B-O
-0.28 NUM B-O
-, PUNCT B-O
-p NOUN B-O
-< SYM B-O
-0.0001 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Correlation NOUN B-O
-of ADP B-O
-( PUNCT B-O
-a X B-O
-) PUNCT B-O
-rate NOUN B-O
-of ADP B-O
-seed NOUN B-O
-mass NOUN B-O
-evolution NOUN B-O
-and CCONJ B-O
-( PUNCT B-O
-b X B-O
-) PUNCT B-O
-seed NOUN B-O
-mass NOUN B-O
-with ADP B-O
-speciation NOUN B-O
-rate NOUN B-O
-( PUNCT B-O
-λ PUNCT B-O
-) PUNCT B-O
-estimated VERB B-O
-by ADP B-O
-using VERB B-O
-R PROPN B-LF
-: PUNCT I-LF
-Phylogenetic PROPN I-LF
-ANalyses PROPN I-LF
-of ADP I-LF
-DiversificAtion PROPN I-LF
-( PUNCT B-O
-RPANDA PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-clade NOUN B-O
-- PUNCT B-O
-based VERB B-O
-analysis NOUN B-O
-. PUNCT B-O
-
-Typically ADV B-O
-, PUNCT B-O
-at ADP B-O
-low ADJ B-O
-inspiratory ADJ B-LF
-positive ADJ I-LF
-airway NOUN I-LF
-pressure NOUN I-LF
-( PUNCT B-O
-IPAP PROPN B-AC
-) PUNCT B-O
-values NOUN B-O
-, PUNCT B-O
-short ADJ B-O
-PLBD PROPN B-AC
-and CCONJ B-O
-low ADJ B-O
-PLBP PROPN B-AC
-are AUX B-O
-set VERB B-O
-, PUNCT B-O
-at ADP B-O
-higher ADJ B-O
-IPAP PROPN B-AC
-values NOUN B-O
-, PUNCT B-O
-longer ADJ B-O
-PLBD PROPN B-AC
-and CCONJ B-O
-higher ADJ B-O
-PLBP PROPN B-AC
-are AUX B-O
-set VERB B-O
-. PUNCT B-O
-
-When SCONJ B-O
-considering VERB B-O
-the DET B-O
-appropriateness NOUN B-O
-of ADP B-O
-introducing VERB B-O
-an DET B-O
-ACP PROPN B-AC
-protocol NOUN B-O
-at ADP B-O
-KCMC PROPN B-AC
-, PUNCT B-O
-it PRON B-O
-was AUX B-O
-evident ADJ B-O
-that SCONJ B-O
-there PRON B-O
-was AUX B-O
-a DET B-O
-literature NOUN B-O
-deficit NOUN B-O
-on ADP B-O
-the DET B-O
-cultural ADJ B-O
-views NOUN B-O
-of ADP B-O
-quality NOUN B-LF
-of ADP I-LF
-death NOUN I-LF
-( PUNCT B-O
-QoD PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-Tanzania PROPN B-O
-but CCONJ B-O
-two NUM B-O
-previous ADJ B-O
-studies NOUN B-O
-from ADP B-O
-northern ADJ B-O
-Tanzania PROPN B-O
-had AUX B-O
-indicated VERB B-O
-that SCONJ B-O
-QoD PROPN B-AC
-was AUX B-O
-an DET B-O
-existing VERB B-O
-concept NOUN B-O
-in ADP B-O
-northern ADJ B-O
-Tanzania PROPN B-O
-. PUNCT B-O
-
-Positive ADJ B-O
-cells NOUN B-O
-from ADP B-O
-each DET B-O
-specimen NOUN B-O
-were AUX B-O
-counted VERB B-O
-from ADP B-O
-a DET B-O
-minimum NOUN B-O
-of ADP B-O
-four NUM B-O
-randomly ADV B-O
-selected VERB B-O
-fields NOUN B-O
-per ADP B-O
-high ADJ B-LF
-power NOUN I-LF
-field NOUN I-LF
-( PUNCT B-O
-HPF PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-compared VERB B-O
-with ADP B-O
-the DET B-O
-control NOUN B-O
-by ADP B-O
-calculating VERB B-O
-the DET B-O
-average ADJ B-O
-number NOUN B-O
-of ADP B-O
-cells NOUN B-O
-. PUNCT B-O
-
-FSC PROPN B-O
-, PUNCT B-O
-Fourier PROPN B-O
-Shell PROPN B-O
-Correlation PROPN B-O
-; PUNCT B-O
-MrNV PROPN B-AC
-, PUNCT B-O
-M. PROPN B-O
-rosenbergii PROPN B-O
-nodavirus NOUN B-O
-; PUNCT B-O
-3D PROPN B-AC
-, PUNCT B-O
-three NUM B-LF
-- PUNCT I-LF
-dimensional ADJ I-LF
-. PUNCT B-O
-
-In ADP B-O
-rodent ADJ B-O
-taste NOUN B-O
-cells NOUN B-O
-, PUNCT B-O
-expression NOUN B-O
-of ADP B-O
-insulin NOUN B-O
-and CCONJ B-O
-the DET B-O
-insulin NOUN B-LF
-receptor NOUN I-LF
-subunit NOUN I-LF
-α PUNCT I-LF
-( PUNCT B-O
-IRα PROPN B-AC
-) PUNCT B-O
-has AUX B-O
-been AUX B-O
-proposed VERB B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-[ PUNCT B-O
-2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-To PART B-O
-test VERB B-O
-this PRON B-O
-, PUNCT B-O
-we PRON B-O
-exposed VERB B-O
-the DET B-O
-mouse NOUN B-O
-intestine NOUN B-O
-to ADP B-O
-two NUM B-O
-conditions NOUN B-O
-: PUNCT B-O
-1 X B-O
-) PUNCT B-O
-30 NUM B-O
-min NOUN B-O
-of ADP B-O
-ischemia NOUN B-O
-followed VERB B-O
-by ADP B-O
-30 NUM B-O
-min NOUN B-O
-of ADP B-O
-reperfusion NOUN B-O
-stress NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-2 X B-O
-) PUNCT B-O
-ischemia NOUN B-LF
-/ SYM I-LF
-reperfusion NOUN I-LF
-( PUNCT B-O
-I/R PROPN B-AC
-) PUNCT B-O
-stress NOUN B-O
-coupled VERB B-O
-with ADP B-O
-luminal ADJ B-O
-inoculation NOUN B-O
-with ADP B-O
-P. NOUN B-O
-aeruginosa NOUN B-O
-( PUNCT B-O
-I PROPN B-AC
-+ CCONJ B-O
-Pa PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-localization NOUN B-O
-of ADP B-O
-motility NOUN B-O
-complexes NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-thereby ADV B-O
-the DET B-O
-direction NOUN B-O
-of ADP B-O
-movement NOUN B-O
-, PUNCT B-O
-is AUX B-O
-determined VERB B-O
-by ADP B-O
-an DET B-O
-oscillatory ADJ B-O
-system NOUN B-O
-, PUNCT B-O
-which PRON B-O
-includes VERB B-O
-Mutual PROPN B-LF
-gliding NOUN I-LF
-motility NOUN I-LF
-A NOUN I-LF
-( PUNCT B-O
-MglA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-small ADJ B-O
-Ras PROPN B-O
-- PUNCT B-O
-like ADJ B-O
-GTPase NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-Mutual PROPN B-LF
-gliding NOUN I-LF
-motility NOUN I-LF
-B NOUN I-LF
-( PUNCT B-O
-MglB PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-its PRON B-O
-GTPase NOUN B-LF
-activating VERB I-LF
-protein NOUN I-LF
-( PUNCT B-O
-GAP PROPN B-AC
-) PUNCT B-O
-as ADP B-O
-major ADJ B-O
-components NOUN B-O
-[ X B-O
-1,4,5 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Using VERB B-O
-chemical NOUN B-O
-cross NOUN B-O
-- PUNCT B-O
-linking NOUN B-O
-/ SYM B-O
-MS PROPN B-AC
-, PUNCT B-O
-we PRON B-O
-had AUX B-O
-been AUX B-O
-able ADJ B-O
-to PART B-O
-monitor VERB B-O
-conformational ADJ B-O
-changes NOUN B-O
-in ADP B-O
-the DET B-O
-ligand NOUN B-LF
-- PUNCT I-LF
-binding VERB I-LF
-domain NOUN I-LF
-( PUNCT B-O
-LBD PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-PPAR PROPN B-AC
-- PUNCT B-O
-α PUNCT B-O
-upon SCONJ B-O
-ligand NOUN B-O
-binding.[8 NOUN B-O
-] PUNCT B-O
-Inbred ADJ B-O
-line NOUN B-O
-L8 PROPN B-O
-was AUX B-O
-about ADV B-O
-the DET B-O
-most ADV B-O
-distant ADJ B-O
-line NOUN B-O
-to ADP B-O
-the DET B-O
-three NUM B-O
-testers NOUN B-O
-based VERB B-O
-on ADP B-O
-both DET B-O
-GDs PROPN B-AC
-. PUNCT B-O
-
-As SCONJ B-O
-shown VERB B-O
-in ADP B-O
-Fig NOUN B-O
-1 NUM B-O
-, PUNCT B-O
-the DET B-O
-genetic ADJ B-LF
-distance NOUN I-LF
-estimates NOUN B-O
-between ADP B-O
-the DET B-O
-Striga PROPN B-O
-resistant ADJ B-O
-lines NOUN B-O
-and CCONJ B-O
-the DET B-O
-resistant ADJ B-O
-tester NOUN B-O
-were AUX B-O
-broader ADJ B-O
-in ADP B-O
-the DET B-O
-range NOUN B-O
-of ADP B-O
-GD PROPN B-AC
-values NOUN B-O
-than ADP B-O
-those PRON B-O
-between ADP B-O
-the DET B-O
-Striga PROPN B-O
-- PUNCT B-O
-resistant ADJ B-O
-and CCONJ B-O
-susceptible ADJ B-O
-tester NOUN B-O
-, PUNCT B-O
-indicating VERB B-O
-the DET B-O
-resistant ADJ B-O
-tester NOUN B-O
-was AUX B-O
-considered VERB B-O
-as ADP B-O
-a DET B-O
-suitable ADJ B-O
-tester NOUN B-O
-. PUNCT B-O
-
-Cardiac ADJ B-O
-inflammation NOUN B-O
-induced VERB B-O
-by ADP B-O
-B. PROPN B-O
-burgdorferi PROPN B-O
-is AUX B-O
-dependent ADJ B-O
-on ADP B-O
-the DET B-O
-interaction NOUN B-O
-of ADP B-O
-the DET B-O
-spirochete NOUN B-O
-with ADP B-O
-macrophages NOUN B-O
-and CCONJ B-O
-other ADJ B-O
-cell NOUN B-O
-types NOUN B-O
-, PUNCT B-O
-such ADJ B-O
-as ADP B-O
-invariant ADJ B-LF
-NKT NOUN I-LF
-( PUNCT B-O
-iNKT PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
-T NOUN B-O
-cells NOUN B-O
-[ PUNCT B-O
-35 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Data NOUN B-O
-are AUX B-O
-expressed VERB B-O
-as ADP B-O
-mean NOUN B-O
-± ADP B-O
-SEM PROPN B-AC
-, PUNCT B-O
-n NOUN B-O
-= SYM B-O
-3 NUM B-O
-from ADP B-O
-at ADV B-O
-least ADV B-O
-three NUM B-O
-independent ADJ B-O
-experiments NOUN B-O
-; PUNCT B-O
-nd PROPN B-AC
-: PUNCT B-O
-not PART B-LF
-detected VERB I-LF
-or CCONJ B-O
-below ADP B-O
-the DET B-O
-limit NOUN B-O
-of ADP B-O
-quantitation NOUN B-O
-. PUNCT B-O
-
-BMI NOUN B-O
-: PUNCT B-O
-body NOUN B-O
-mass NOUN B-O
-index NOUN B-O
-; PUNCT B-O
-CE PROPN B-AC
-: PUNCT B-O
-cholesteryl ADJ B-O
-ester NOUN B-O
-; PUNCT B-O
-ELF PROPN B-AC
-: PUNCT B-O
-epithelial ADJ B-LF
-lining NOUN I-LF
-fluid NOUN I-LF
-; PUNCT B-O
-FEV1 PROPN B-AC
-: PUNCT B-O
-forced VERB B-LF
-expiratory ADJ I-LF
-volume NOUN I-LF
-in ADP I-LF
-1 NUM I-LF
-second NOUN I-LF
-; PUNCT B-O
-FVC PROPN B-AC
-: PUNCT B-O
-forced VERB B-LF
-vital ADJ I-LF
-capacity NOUN I-LF
-; PUNCT B-O
-IL PROPN B-O
-: PUNCT B-O
-Interleukin NOUN B-O
-; PUNCT B-O
-LABA PROPN B-O
-: PUNCT B-O
-long VERB B-O
-acting VERB B-O
-beta NOUN B-O
-agonists NOUN B-O
-; PUNCT B-O
-LAMA PROPN B-O
-: PUNCT B-O
-long VERB B-O
-acting VERB B-O
-muscarinic ADJ B-O
-antagonists NOUN B-O
-; PUNCT B-O
-MCP-1 NOUN B-O
-: PUNCT B-O
-macrophage NOUN B-O
-chemotactic ADJ B-O
-protein-1 NOUN B-O
-; PUNCT B-O
-TG PROPN B-AC
-: PUNCT B-O
-triglyceride NOUN B-O
-. PUNCT B-O
-
-DEFF PROPN B-AC
-: PUNCT B-O
-Design NOUN B-LF
-effect NOUN I-LF
-; PUNCT B-O
-ICC PROPN B-AC
-: PUNCT B-O
-Intracluster ADJ B-LF
-correlation NOUN I-LF
-coefficient NOUN I-LF
-; PUNCT B-O
-SD PROPN B-AC
-: PUNCT B-O
-Standard ADJ B-LF
-deviation NOUN I-LF
-; PUNCT B-O
-IQR PROPN B-AC
-: PUNCT B-O
-Interquartile ADJ B-LF
-range NOUN I-LF
-. PUNCT B-O
-
-The DET B-O
-leading VERB B-O
-causes NOUN B-O
-of ADP B-O
-death NOUN B-O
-and CCONJ B-O
-morbidity NOUN B-O
-worldwide ADV B-O
-are AUX B-O
-noncommunicable ADJ B-LF
-diseases NOUN I-LF
-( PUNCT B-O
-NCDs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-such ADJ B-O
-as ADP B-O
-chronic ADJ B-O
-respiratory ADJ B-O
-disease NOUN B-O
-, PUNCT B-O
-cancer NOUN B-O
-, PUNCT B-O
-diabetes NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-, PUNCT B-O
-in ADP B-O
-particular ADJ B-O
-, PUNCT B-O
-ischemic ADJ B-O
-heart NOUN B-O
-disease NOUN B-O
-and CCONJ B-O
-stroke NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-slope NOUN B-O
-of ADP B-O
-field NOUN B-LF
-excitatory ADJ I-LF
-postsynaptic ADJ I-LF
-potentials NOUN I-LF
-( PUNCT B-O
-fEPSPs PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-Fig NOUN B-O
-6B NUM B-O
-) PUNCT B-O
-was AUX B-O
-measured VERB B-O
-to PART B-O
-monitor VERB B-O
-synaptic ADJ B-O
-activation NOUN B-O
-of ADP B-O
-the DET B-O
-CA1 NOUN B-O
-pyramidal ADJ B-O
-neurons NOUN B-O
-. PUNCT B-O
-
-BAZ PROPN B-AC
-, PUNCT B-O
-BMI NOUN B-LF
-- PUNCT I-LF
-BMI PROPN B-AC
-for ADP I-LF
-- PUNCT I-LF
-age NOUN I-LF
-z- NOUN B-O
-score NOUN B-O
-; PUNCT B-O
-T PROPN B-AC
-, PUNCT B-O
-triene NOUN B-O
-- PUNCT B-O
-to ADP B-O
-- PUNCT B-O
-tetraene NOUN B-O
-These DET B-O
-supercomplexes NOUN B-O
-are AUX B-O
-associations NOUN B-O
-of ADP B-O
-oxidase NOUN B-O
-with ADP B-O
-either CCONJ B-O
-respiratory ADJ B-O
-complexIII PROPN B-AC
-and CCONJ B-O
-cytochrome NOUN B-LF
-c552 NOUN I-LF
-( PUNCT B-O
-Sc NOUN B-O
-: PUNCT B-O
-III4IV2 NUM B-O
-, PUNCT B-O
-Sb NOUN B-O
-: PUNCT B-O
-III4IV4 NUM B-O
-) PUNCT B-O
-or CCONJ B-O
-of ADP B-O
-complex PROPN B-AC
-, PUNCT B-O
-IIIcomplexI PROPN B-AC
-and CCONJ B-O
-cyt PROPN B-AC
-( PUNCT B-O
-Sa NOUN B-O
-: PUNCT B-O
-I1III4IV4 NOUN B-O
-; PUNCT B-O
-S1 NOUN B-O
-, PUNCT B-O
-S3 PROPN B-O
-and CCONJ B-O
-S4 PROPN B-O
-Figs NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-Ct PROPN B-AC
-, PUNCT B-O
-cycle NOUN B-LF
-threshold NOUN I-LF
-; PUNCT B-O
-n NOUN B-O
-/ SYM B-O
-a NOUN B-O
-, PUNCT B-O
-not PART B-O
-applicable ADJ B-O
-; PUNCT B-O
-N1 PROPN B-AC
-, PUNCT B-O
-SARS PROPN B-LF
-- PUNCT I-LF
-SARS PROPN B-AC
-CoV-2 NOUN I-LF
-nucleocapsid NOUN I-LF
-gene NOUN I-LF
-region NOUN I-LF
-1 NUM I-LF
-; PUNCT B-O
--CoV-2SARS PROPN B-AC
-, PUNCT B-O
-severe ADJ B-LF
-acute ADJ I-LF
-respiratory ADJ I-LF
-syndrome NOUN I-LF
-coronavirus NOUN I-LF
-2 NUM I-LF
-; PUNCT B-O
-Unk PROPN B-O
-, PUNCT B-O
-Unknown ADJ B-O
-To PART B-O
-further ADV B-O
-identify VERB B-O
-significant ADJ B-O
-correlations NOUN B-O
-between ADP B-O
-phenotypes NOUN B-O
-and CCONJ B-O
-GO PROPN B-AC
-concepts NOUN B-O
-, PUNCT B-O
-we PRON B-O
-used VERB B-O
-a DET B-O
-GO PROPN B-AC
-term NOUN B-O
-finder NOUN B-O
-software NOUN B-O
-[ X B-O
-49 X B-O
-] X B-O
-to ADP B-O
-correlate VERB B-O
-phenotypes NOUN B-O
-with ADP B-O
-GO PROPN B-AC
-using VERB B-O
-the DET B-O
-Pfam PROPN B-AC
-to ADP B-O
-GO PROPN B-AC
-mapping NOUN B-O
-data NOUN B-O
-from ADP B-O
-the DET B-O
-Gene PROPN B-LF
-Ontology PROPN I-LF
-Consortium PROPN B-O
-. PUNCT B-O
-
-Crude ADJ B-LF
-lipid NOUN I-LF
-extract NOUN I-LF
-( PUNCT B-O
-CLE PROPN B-AC
-in ADP B-O
-mg NOUN B-O
-) PUNCT B-O
-was AUX B-O
-estimated VERB B-O
-following VERB B-O
-Cointet PROPN B-O
-et PROPN B-O
-al PROPN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-2019 NUM B-O
-) PUNCT B-O
-and CCONJ B-O
-lipid NOUN B-O
-content NOUN B-O
-( PUNCT B-O
-LC NOUN B-O
-) PUNCT B-O
-was AUX B-O
-estimated VERB B-O
-in ADP B-O
-mg NOUN B-O
-. PUNCT B-O
-
-L-1 NOUN B-O
-. PUNCT B-O
-
-One NUM B-O
-day NOUN B-O
-after ADP B-O
-the DET B-O
-preparation NOUN B-O
-, PUNCT B-O
-slice NOUN B-O
-cultures NOUN B-O
-were AUX B-O
-transduced VERB B-O
-with ADP B-O
-adeno NOUN B-LF
-- NOUN I-LF
-associated VERB I-LF
-virus NOUN I-LF
-( PUNCT B-O
-AAV PROPN B-AC
-) PUNCT B-O
-serotype NOUN B-O
-9 NUM B-O
-particles NOUN B-O
-encoding VERB B-O
-CaMKII.iGluu NOUN B-O
-. PUNCT B-O
-
-WPRE NOUN B-O
-- NOUN B-O
-hGH NOUN B-O
-[ PUNCT B-O
-30 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Potato NOUN B-LF
-dextrose NOUN I-LF
-agar NOUN I-LF
-( PUNCT B-O
-PDA PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-potato NOUN B-LF
-dextrose NOUN I-LF
-broth NOUN I-LF
-( PUNCT B-O
-PDB PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-purchased VERB B-O
-from ADP B-O
-Difco PROPN B-O
-( PUNCT B-O
-BD PROPN B-O
-, PUNCT B-O
-USA PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Calcium NOUN B-LF
-carbonate NOUN I-LF
-( PUNCT B-O
-CaCO3 PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-ethanol NOUN B-O
-were AUX B-O
-purchased VERB B-O
-from ADP B-O
-Systerm PROPN B-O
-( PUNCT B-O
-Selangor PROPN B-O
-, PUNCT B-O
-Malaysia PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Estimated VERB B-LF
-glomerular ADJ I-LF
-filtration NOUN I-LF
-rates NOUN I-LF
-( PUNCT B-O
-eGFRs PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-calculated VERB B-O
-using VERB B-O
-the DET B-O
-four NUM B-O
-- PUNCT B-O
-variable NOUN B-O
-equation NOUN B-O
-derived VERB B-O
-from ADP B-O
-the DET B-O
-Modification PROPN B-LF
-of ADP I-LF
-Diet PROPN I-LF
-in ADP I-LF
-Renal PROPN I-LF
-Disease PROPN I-LF
-( PUNCT B-O
-MDRD PROPN B-AC
-) PUNCT B-O
-Study PROPN B-O
-. PUNCT B-O
-
-We PRON B-O
-used VERB B-O
-the DET B-O
-cross ADJ B-O
-- PUNCT B-O
-sectional ADJ B-O
-data NOUN B-O
-including VERB B-O
-6,160 NUM B-O
-oldest ADJ B-O
-old ADJ B-O
-( PUNCT B-O
-aged ADJ B-O
-80 NUM B-O
-years NOUN B-O
-old ADJ B-O
-or CCONJ B-O
-older ADJ B-O
-) PUNCT B-O
-from ADP B-O
-the DET B-O
-genetic ADJ B-O
-substudy NOUN B-O
-of ADP B-O
-the DET B-O
-Chinese PROPN B-LF
-Longitudinal PROPN I-LF
-Healthy PROPN I-LF
-Longevity PROPN I-LF
-Survey PROPN I-LF
-( PUNCT B-O
-CLHLS PROPN B-AC
-) PUNCT B-O
-which PRON B-O
-is AUX B-O
-a DET B-O
-national ADJ B-O
-wide ADJ B-O
-cohort NOUN B-O
-study NOUN B-O
-that PRON B-O
-began VERB B-O
-in ADP B-O
-1998 NUM B-O
-with ADP B-O
-follow VERB B-O
-- PUNCT B-O
-up ADP B-O
-surveys NOUN B-O
-every DET B-O
-2–3 NUM B-O
-years NOUN B-O
-. PUNCT B-O
-
-Surprisingly ADV B-O
-, PUNCT B-O
-although SCONJ B-O
-IL-22 PROPN B-AC
-activates VERB B-O
-signal NOUN B-LF
-transducer NOUN I-LF
-and CCONJ I-LF
-activator NOUN I-LF
-of ADP I-LF
-transcription NOUN I-LF
-3 NUM I-LF
-( PUNCT B-O
-STAT3 PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-APC PROPN B-O
-- PUNCT B-O
-mutant ADJ B-O
-cells NOUN B-O
-, PUNCT B-O
-STAT3 PROPN B-AC
-target NOUN B-O
-genes NOUN B-O
-were AUX B-O
-not PART B-O
-induced VERB B-O
-. PUNCT B-O
-
-Hh PROPN B-AC
-, PUNCT B-O
-hedgehog NOUN B-LF
-; PUNCT B-O
-NRF2 PROPN B-AC
-, PUNCT B-O
-nuclear ADJ B-LF
-factor NOUN I-LF
-- PUNCT I-LF
-erythroid NOUN I-LF
-2 NUM I-LF
-- PUNCT I-LF
-like NOUN I-LF
-2 NUM I-LF
-IMCD3 PROPN B-AC
-, PUNCT B-O
-inner ADJ B-LF
-medullary NOUN I-LF
-collecting VERB I-LF
-duct NOUN I-LF
-; PUNCT B-O
-Nb PROPN B-AC
-, PUNCT B-O
-nanobody NOUN B-LF
-; PUNCT B-O
-SMO PROPN B-O
-, PUNCT B-O
-Smoothened VERB B-O
-. PUNCT B-O
-
-Specifically ADV B-O
-, PUNCT B-O
-the DET B-O
-non ADJ B-O
-- ADJ B-O
-HCC PROPN B-AC
-participants NOUN B-O
-included VERB B-O
-123 NUM B-O
-with ADP B-O
-gastrointestinal ADJ B-O
-tumour NOUN B-O
-( PUNCT B-O
-GIT PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-73 NUM B-O
-with ADP B-O
-benign ADJ B-O
-liver NOUN B-O
-tumour NOUN B-O
-( PUNCT B-O
-BLT PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-453 NUM B-O
-with ADP B-O
-liver NOUN B-O
-cirrhosis NOUN B-O
-, PUNCT B-O
-27 NUM B-O
-with ADP B-O
-chronic ADJ B-LF
-hepatitis NOUN I-LF
-C NOUN I-LF
-( PUNCT B-O
-CHC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-86 NUM B-O
-with ADP B-O
-chronic ADJ B-LF
-hepatitis NOUN I-LF
-B NOUN I-LF
-( PUNCT B-O
-CHB PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-50 NUM B-O
-with ADP B-O
-benign ADJ B-LF
-gastrointestinal ADJ I-LF
-disease NOUN I-LF
-( PUNCT B-O
-BGID PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-295 NUM B-O
-healthy ADJ B-O
-people NOUN B-O
-. PUNCT B-O
-
-To PART B-O
-generate VERB B-O
-null ADJ B-O
-alleles NOUN B-O
-, PUNCT B-O
-we PRON B-O
-sought VERB B-O
-to PART B-O
-create VERB B-O
-mutants NOUN B-O
-with ADP B-O
-large ADJ B-O
-fragment NOUN B-O
-deletions NOUN B-O
-by ADP B-O
-designing VERB B-O
-2 NUM B-O
-single ADJ B-LF
-guide NOUN I-LF
-RNAs NOUN I-LF
-( PUNCT B-O
-sgRNAs PROPN B-AC
-) PUNCT B-O
-within ADP B-O
-or CCONJ B-O
-flanking VERB B-O
-the DET B-O
-stem NOUN B-O
-- PUNCT B-O
-loop NOUN B-O
-region NOUN B-O
-( PUNCT B-O
-Fig PROPN B-O
-1B NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Using VERB B-O
-PCR NOUN B-O
-genotyping NOUN B-O
-, PUNCT B-O
-we PRON B-O
-successfully ADV B-O
-identified VERB B-O
-plants NOUN B-O
-carrying VERB B-O
-mutations NOUN B-O
-in ADP B-O
-every DET B-O
-MIR172 PROPN B-O
-family NOUN B-O
-member NOUN B-O
-in ADP B-O
-the DET B-O
-T1 PROPN B-O
-generation NOUN B-O
-( PUNCT B-O
-Fig PROPN B-O
-1B NUM B-O
-; PUNCT B-O
-S1 PROPN B-O
-Fig PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-GP PROPN B-AC
-, PUNCT B-O
-EBOV NOUN B-LF
-envelope NOUN I-LF
-EBOV PROPN B-AC
-glycoprotein NOUN I-LF
-. PUNCT B-O
-
-We PRON B-O
-used VERB B-O
-a DET B-O
-specific ADJ B-O
-antibody NOUN B-O
-against ADP B-O
-the DET B-O
-promyelocytic ADJ B-LF
-leukemia NOUN I-LF
-( PUNCT B-O
-PML PROPN B-AC
-) PUNCT B-O
-protein NOUN B-O
-to PART B-O
-study VERB B-O
-the DET B-O
-fate NOUN B-O
-of ADP B-O
-the DET B-O
-PML PROPN B-AC
-nuclear ADJ B-O
-bodies NOUN B-O
-, PUNCT B-O
-which PRON B-O
-are AUX B-O
-well ADV B-O
-- PUNCT B-O
-characterized VERB B-O
-subnuclear ADJ B-O
-structures NOUN B-O
-[ PUNCT B-O
-22 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-parallel NOUN B-O
-, PUNCT B-O
-the DET B-O
-rate NOUN B-O
-of ADP B-O
-Caesarean ADJ B-LF
-section NOUN I-LF
-( PUNCT B-O
-C-Section PROPN B-AC
-) PUNCT B-O
-deliveries NOUN B-O
-has AUX B-O
-also ADV B-O
-increased VERB B-O
-dramatically ADV B-O
-over ADP B-O
-the DET B-O
-last ADJ B-O
-decades NOUN B-O
-. PUNCT B-O
-
-• PUNCT B-O
-RLS PROPN B-AC
-diagnosis NOUN B-O
-was AUX B-O
-made VERB B-O
-on ADP B-O
-the DET B-O
-diagnostic ADJ B-O
-criteria NOUN B-O
-of ADP B-O
-the DET B-O
-International PROPN B-O
-Restless PROPN B-LF
-Legs PROPN I-LF
-Syndrome PROPN I-LF
-Study PROPN B-O
-Group PROPN B-O
-( PUNCT B-O
-2010 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-IQR PROPN B-AC
-: PUNCT B-O
-interquartile ADJ B-LF
-range NOUN I-LF
-Similarly ADV B-O
-, PUNCT B-O
-assessment NOUN B-O
-of ADP B-O
-other ADJ B-O
-quantitative ADJ B-O
-variables NOUN B-O
-is AUX B-O
-essential ADJ B-O
-in ADP B-O
-pre- ADJ B-O
-and CCONJ B-O
-post ADJ B-O
-- ADJ B-O
-MI PROPN B-AC
-conditions NOUN B-O
-which PRON B-O
-primarily ADV B-O
-includes VERB B-O
-, PUNCT B-O
-plasma NOUN B-O
-glucose NOUN B-O
-levels NOUN B-O
-, PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-( PUNCT B-O
-BMI PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-high ADJ B-LF
-density NOUN I-LF
-lipid NOUN I-LF
-( PUNCT B-O
-HDL PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-low ADJ B-LF
-density NOUN I-LF
-lipid NOUN I-LF
-( PUNCT B-O
-LDL PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-triglycerides NOUN B-O
-levels NOUN B-O
-. PUNCT B-O
-
-Fresh ADJ B-O
-IBM PROPN B-O
-suspended VERB B-O
-in ADP B-O
-0.1 NUM B-O
-% PUNCT B-O
-AKRB PROPN B-AC
-were AUX B-O
-centrifuged VERB B-O
-for ADP B-O
-15 NUM B-O
-min NOUN B-O
-at ADP B-O
-800 NUM B-O
-rpm NOUN B-O
-and CCONJ B-O
-immediately ADV B-O
-suspended VERB B-O
-in ADP B-O
-2ml NUM B-O
-of ADP B-O
-Dulbecco PROPN B-LF
-'s PART I-LF
-Modified PROPN I-LF
-Eagle PROPN I-LF
-'s PART I-LF
-( PUNCT B-O
-DMEM PROPN B-AC
-) PUNCT B-O
-+ SYM B-O
-BSA0.1 NUM B-O
-% PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-addition NOUN B-O
-, PUNCT B-O
-Tem PROPN B-AC
-effects NOUN B-O
-on ADP B-O
-LC3-II PROPN B-AC
-levels NOUN B-O
-were AUX B-O
-also ADV B-O
-preserved VERB B-O
-in ADP B-O
-5 NUM B-LF
-' NOUN I-LF
-adenosine NOUN I-LF
-monophosphate NOUN I-LF
-- PUNCT I-LF
-activated VERB I-LF
-protein NOUN I-LF
-kinase NOUN I-LF
-( PUNCT B-O
-AMPK PROPN B-AC
-) PUNCT B-O
-α1 NUM B-O
-/ SYM B-O
-α2 NUM B-O
-double ADJ B-O
-KO PROPN B-AC
-MEFs PROPN B-AC
-( PUNCT B-O
-S6B PROPN B-O
-Fig PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Chronic ADJ B-O
-HBV PROPN B-AC
-infection NOUN B-O
-was AUX B-O
-classified VERB B-O
-according VERB B-O
-to ADP B-O
-the DET B-O
-latest ADJ B-O
-European PROPN B-LF
-Association PROPN I-LF
-for ADP I-LF
-the DET I-LF
-Study PROPN I-LF
-of ADP I-LF
-the DET I-LF
-Liver PROPN I-LF
-( PUNCT B-O
-EASL PROPN B-AC
-) PUNCT B-O
-Clinical PROPN B-LF
-Practice PROPN I-LF
-Guidelines PROPN I-LF
-( PUNCT B-O
-CPG PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-CI PROPN B-AC
-, PUNCT B-O
-confidence NOUN B-LF
-interval NOUN I-LF
-; PUNCT B-O
-TBI PROPN B-AC
-, PUNCT B-O
-traumatic ADJ B-LF
-brain NOUN I-LF
-injury NOUN I-LF
-. PUNCT B-O
-
-This DET B-O
-study NOUN B-O
-is AUX B-O
-reported VERB B-O
-as ADP B-O
-per ADP B-O
-the DET B-O
-CONsolidated PROPN B-LF
-Standards PROPN I-LF
-of ADP I-LF
-Reporting PROPN I-LF
-Trials PROPN I-LF
-( PUNCT B-O
-CONSORT PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-S1 PROPN B-O
-CONSORT PROPN B-AC
-Checklist PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-risk NOUN B-O
-of ADP B-O
-ID PROPN B-AC
-increases VERB B-O
-during ADP B-O
-pregnancy NOUN B-O
-due ADP B-O
-to PART B-O
-an DET B-O
-increase NOUN B-O
-in ADP B-O
-maternal ADJ B-O
-iron NOUN B-O
-requirements NOUN B-O
-to PART B-O
-accommodate VERB B-O
-the DET B-O
-expansion NOUN B-O
-of ADP B-O
-maternal ADJ B-O
-red ADJ B-LF
-blood NOUN I-LF
-cell NOUN I-LF
-( PUNCT B-O
-RBC PROPN B-AC
-) PUNCT B-O
-mass NOUN B-O
-, PUNCT B-O
-development NOUN B-O
-of ADP B-O
-the DET B-O
-placenta NOUN B-O
-and CCONJ B-O
-fetus NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-loss NOUN B-O
-of ADP B-O
-blood NOUN B-O
-associated VERB B-O
-with ADP B-O
-labor NOUN B-O
-and CCONJ B-O
-delivery NOUN B-O
-[ PUNCT B-O
-2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-This DET B-O
-study NOUN B-O
-is AUX B-O
-reported VERB B-O
-according VERB B-O
-to ADP B-O
-the DET B-O
-Strengthening VERB B-LF
-the DET I-LF
-Reporting PROPN I-LF
-of ADP I-LF
-Observational PROPN I-LF
-Studies PROPN I-LF
-in ADP I-LF
-Epidemiology PROPN I-LF
-( PUNCT B-O
-STROBE PROPN B-AC
-) PUNCT B-O
-statement NOUN B-O
-( PUNCT B-O
-S1 PROPN B-O
-STROBE PROPN B-AC
-Checklist PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Schematic ADJ B-O
-pressure NOUN B-O
-curve NOUN B-O
-of ADP B-O
-a DET B-O
-BiPAP PROPN B-AC
-ventilation NOUN B-O
-( PUNCT B-O
-A NOUN B-O
-) PUNCT B-O
-compared VERB B-O
-to ADP B-O
-ventilation NOUN B-O
-in ADP B-O
-PLBV PROPN B-AC
-mode NOUN B-O
-( PUNCT B-O
-B NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-BiPAP PROPN B-AC
-: PUNCT B-O
-Bilevel NOUN B-LF
-positive ADJ I-LF
-airway NOUN I-LF
-pressure NOUN I-LF
-; PUNCT B-O
-IPAP PROPN B-AC
-: PUNCT B-O
-inspiratory ADJ B-LF
-positive ADJ I-LF
-airway NOUN I-LF
-pressure NOUN I-LF
-; PUNCT B-O
-EPAP PROPN B-AC
-: PUNCT B-O
-expiratory ADJ B-LF
-positive ADJ I-LF
-airway NOUN I-LF
-pressure NOUN I-LF
-; PUNCT B-O
-PLBV PROPN B-AC
-: PUNCT B-O
-pursed ADJ B-LF
-lips NOUN I-LF
-breathing VERB I-LF
-ventilation NOUN I-LF
-. PUNCT B-O
-
-Sodium PROPN B-LF
-Calcium PROPN I-LF
-exchangers NOUN I-LF
-( PUNCT B-O
-NCX PROPN B-AC
-) PUNCT B-O
-are AUX B-O
-low ADJ B-O
-affinity NOUN B-O
-high ADJ B-O
-capacity NOUN B-O
-( PUNCT B-O
-kcat NOUN B-O
-2000–5000 NUM B-O
-s−1 NUM B-O
-) PUNCT B-O
-antiporters NOUN B-O
-that PRON B-O
-can AUX B-O
-rapidly ADV B-O
-move VERB B-O
-Ca2 NOUN B-O
-+ NOUN B-O
-ions NOUN B-O
-across ADP B-O
-the DET B-O
-plasma NOUN B-O
-membrane NOUN B-O
-. PUNCT B-O
-
-Cells NOUN B-O
-were AUX B-O
-left VERB B-O
-to PART B-O
-expand VERB B-O
-for ADP B-O
-3–4 NUM B-O
-consecutive ADJ B-O
-days NOUN B-O
-to PART B-O
-form VERB B-O
-a DET B-O
-confluent ADJ B-O
-monolayer NOUN B-O
-( PUNCT B-O
-unless SCONJ B-O
-stated VERB B-O
-otherwise ADV B-O
-) PUNCT B-O
-before SCONJ B-O
-fixation NOUN B-O
-with ADP B-O
-4 NUM B-O
-% NOUN B-O
-paraformaldehyde NOUN B-LF
-( PUNCT B-O
-PFA PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-performed VERB B-O
-. PUNCT B-O
-
-Moreover ADV B-O
-, PUNCT B-O
-HIF-2α PROPN B-AC
-– PUNCT B-O
-dependent ADJ B-O
-up NOUN B-O
-- PUNCT B-O
-regulation NOUN B-O
-of ADP B-O
-interleukin NOUN B-LF
-( PUNCT B-O
-IL)-6 PROPN B-AC
-in ADP B-O
-FLS PROPN B-AC
-stimulated VERB B-O
-differentiation NOUN B-O
-of ADP B-O
-TH17 NOUN B-O
-cells NOUN B-O
-— PUNCT B-O
-crucial ADJ B-O
-effectors NOUN B-O
-of ADP B-O
-RA PROPN B-AC
-pathogenesis NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-tested VERB B-O
-2 NUM B-O
-low ADJ B-O
-- PUNCT B-O
-intensity NOUN B-O
-versions NOUN B-O
-of ADP B-O
-CBT PROPN B-AC
-in ADP B-O
-a DET B-O
-trial NOUN B-O
-( PUNCT B-O
-guided VERB B-O
-self NOUN B-O
-- PUNCT B-O
-help NOUN B-O
-and CCONJ B-O
-supported VERB B-O
-computerised ADJ B-LF
-cognitive ADJ I-LF
-- PUNCT I-LF
-behaviour NOUN I-LF
-therapy NOUN I-LF
-[ PUNCT B-O
-cCBT PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-, PUNCT B-O
-testing VERB B-O
-their PRON B-O
-impact NOUN B-O
-on ADP B-O
-patients NOUN B-O
-with ADP B-O
-OCD PROPN B-AC
-when SCONJ B-O
-provided VERB B-O
-prior ADV B-O
-to ADP B-O
-CBT PROPN B-AC
-with ADP B-O
-a DET B-O
-therapist NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-pelvic ADJ B-O
-inlet NOUN B-O
-anterior ADJ B-LF
-- PUNCT I-LF
-posterior ADJ I-LF
-diameter NOUN I-LF
-( PUNCT B-O
-APD PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-also ADV B-O
-called VERB B-O
-the DET B-O
-obstetric ADJ B-O
-conjugate NOUN B-O
-, PUNCT B-O
-was AUX B-O
-measured VERB B-O
-from ADP B-O
-the DET B-O
-anterior ADJ B-O
-cortical ADJ B-O
-surface NOUN B-O
-of ADP B-O
-the DET B-O
-sacrovertebral ADJ B-O
-angel NOUN B-O
-( PUNCT B-O
-promontory NOUN B-O
-) PUNCT B-O
-to ADP B-O
-the DET B-O
-closest ADJ B-O
-point NOUN B-O
-on ADP B-O
-the DET B-O
-convex ADJ B-O
-posterior ADJ B-O
-- PUNCT B-O
-superior ADJ B-O
-aspect NOUN B-O
-of ADP B-O
-the DET B-O
-pubis NOUN B-O
-symphysis NOUN B-O
-. PUNCT B-O
-
-By ADP B-O
-contrast NOUN B-O
-, PUNCT B-O
-enhanced VERB B-O
-green ADJ B-O
-- PUNCT B-O
-fusion NOUN B-O
-protein NOUN B-O
-- PUNCT B-O
-maximakinin NOUN B-LF
-( PUNCT B-O
-EGFP PROPN B-AC
-- PUNCT B-O
-MK PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-a DET B-O
-much ADV B-O
-brighter ADJ B-O
-, PUNCT B-O
-nanomolar ADJ B-O
-affinity NOUN B-O
-agonist NOUN B-O
-of ADP B-O
-the DET B-O
-rabbit NOUN B-O
-B2R PROPN B-AC
-that PRON B-O
-does AUX B-O
-not PART B-O
-bind VERB B-O
-to ADP B-O
-ACE PROPN B-AC
-[ PUNCT B-O
-9 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Currently ADV B-O
-there PRON B-O
-is VERB B-O
-no DET B-O
-standard ADJ B-O
-second ADJ B-O
-- PUNCT B-O
-line NOUN B-O
-treatment NOUN B-O
-for ADP B-O
-steroid NOUN B-LF
-- PUNCT I-LF
-refractory ADJ I-LF
-aGVHD PROPN B-AC
-( PUNCT B-O
-SR PROPN B-AC
-- PUNCT B-O
-aGVHD PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Numerous ADJ B-O
-strategies NOUN B-O
-to PART B-O
-treat VERB B-O
-SR PROPN B-AC
-- PUNCT B-O
-aGVHD PROPN B-AC
-have AUX B-O
-been AUX B-O
-reported VERB B-O
-, PUNCT B-O
-but CCONJ B-O
-results NOUN B-O
-have AUX B-O
-been AUX B-O
-disappointing ADJ B-O
-with ADP B-O
-varying VERB B-O
-response NOUN B-O
-rates NOUN B-O
-and CCONJ B-O
-long ADJ B-O
-term NOUN B-O
-overall ADJ B-LF
-survival NOUN I-LF
-( PUNCT B-O
-OS PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-only ADV B-O
-20–30 NUM B-O
-% NOUN B-O
-[ PUNCT B-O
-2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Raw ADJ B-O
-data NOUN B-O
-for ADP B-O
-panels NOUN B-O
-A NOUN B-O
-and CCONJ B-O
-B NOUN B-O
-can AUX B-O
-be AUX B-O
-found VERB B-O
-in ADP B-O
-the DET B-O
-Supporting NOUN B-O
-Information NOUN B-O
-section NOUN B-O
-S2 NOUN B-O
-Data NOUN B-O
-file NOUN B-O
-. PUNCT B-O
-
-fMLP PROPN B-AC
-, PUNCT B-O
-N NOUN B-LF
-- PUNCT I-LF
-formylMethionyl NOUN I-LF
-- PUNCT I-LF
-Leucyl NOUN I-LF
-- PUNCT I-LF
-Phenylalanine NOUN I-LF
-; PUNCT B-O
-KD PROPN B-AC
-, PUNCT B-O
-knockdown NOUN B-LF
-; PUNCT B-O
-NSshRNA PROPN B-AC
-, PUNCT B-O
-nonspecific ADJ B-LF
-shRNA NOUN I-LF
-shRNA PROPN B-AC
-. PUNCT B-O
-
-To PART B-O
-determine VERB B-O
-whether SCONJ B-O
-this DET B-O
-inflammatory ADJ B-O
-response NOUN B-O
-is AUX B-O
-reflected VERB B-O
-by ADP B-O
-up NOUN B-O
-- ADJ B-O
-regulation NOUN B-O
-of ADP B-O
-pro ADJ B-O
-- ADJ B-O
-inflammatory ADJ B-O
-markers NOUN B-O
-, PUNCT B-O
-we PRON B-O
-performed VERB B-O
-reverse ADJ B-LF
-transcription NOUN I-LF
-PCR NOUN I-LF
-( PUNCT B-O
-RT-PCR PROPN B-AC
-) PUNCT B-O
-on ADP B-O
-larvae NOUN B-O
-carrying VERB B-O
-a DET B-O
-transformed VERB B-O
-goblet NOUN B-O
-cell NOUN B-O
-burden NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-indeed ADV B-O
-we PRON B-O
-see VERB B-O
-increased VERB B-O
-levels NOUN B-O
-of ADP B-O
-tnfα NOUN B-O
-, PUNCT B-O
-cxcl1 NOUN B-O
-, PUNCT B-O
-il8 NOUN B-O
-, PUNCT B-O
-ifn1 NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-il1β NOUN B-O
-in ADP B-O
-these DET B-O
-larvae NOUN B-O
-( PUNCT B-O
-Figure NOUN B-O
-S1A NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Moreover ADV B-O
-, PUNCT B-O
-if SCONJ B-O
-we PRON B-O
-look VERB B-O
-by ADP B-O
-quantitative ADJ B-LF
-PCR NOUN I-LF
-( PUNCT B-O
-qPCR PROPN B-AC
-) PUNCT B-O
-at ADP B-O
-levels NOUN B-O
-of ADP B-O
-two NUM B-O
-of ADP B-O
-these DET B-O
-genes NOUN B-O
-, PUNCT B-O
-il1β NOUN B-O
-and CCONJ B-O
-cxcl1 NOUN B-O
-, PUNCT B-O
-we PRON B-O
-see VERB B-O
-their PRON B-O
-clear ADJ B-O
-induction NOUN B-O
-in ADP B-O
-larvae NOUN B-O
-where SCONJ B-O
-V12RAS NOUN B-O
-expression NOUN B-O
-is AUX B-O
-induced VERB B-O
-by ADP B-O
-heat NOUN B-O
-shock NOUN B-O
-only ADV B-O
-6 NUM B-O
-h NOUN B-O
-before ADP B-O
-RNA NOUN B-O
-extraction NOUN B-O
-, PUNCT B-O
-suggesting VERB B-O
-that SCONJ B-O
-pro ADJ B-O
-- ADJ B-O
-inflammatory ADJ B-O
-gene NOUN B-O
-expression NOUN B-O
-is AUX B-O
-a DET B-O
-rapid ADJ B-O
-response NOUN B-O
-to ADP B-O
-V12RAS NOUN B-O
-expression NOUN B-O
-( PUNCT B-O
-Figure NOUN B-O
-S1B NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Replacing VERB B-O
-NNRTIs PROPN B-AC
-by ADP B-O
-dolutegravir PROPN B-LF
-( PUNCT B-O
-DTG PROPN B-AC
-) PUNCT B-O
-may AUX B-O
-curb VERB B-O
-the DET B-O
-spread NOUN B-O
-of ADP B-O
-resistance NOUN B-O
-, PUNCT B-O
-but CCONJ B-O
-it PRON B-O
-is AUX B-O
-unclear ADJ B-O
-how SCONJ B-O
-effective ADJ B-O
-this DET B-O
-switch NOUN B-O
-will AUX B-O
-be AUX B-O
-and CCONJ B-O
-which DET B-O
-patient NOUN B-O
-groups NOUN B-O
-should AUX B-O
-be AUX B-O
-switched VERB B-O
-from ADP B-O
-NNRTI PROPN B-AC
-to ADP B-O
-DTG PROPN B-AC
-. PUNCT B-O
-
-Transcriptome ADJ B-O
-sequencing NOUN B-O
-analysis NOUN B-O
-detected VERB B-O
-106 NUM B-O
-differentially ADV B-LF
-expressed VERB I-LF
-genes NOUN I-LF
-( PUNCT B-O
-DEGs PROPN B-AC
-) PUNCT B-O
-related VERB B-O
-to ADP B-O
-oxidative ADJ B-O
-stress NOUN B-O
-. PUNCT B-O
-
-Finally ADV B-O
-, PUNCT B-O
-demographic ADJ B-O
-information NOUN B-O
-was AUX B-O
-collected VERB B-O
-, PUNCT B-O
-including VERB B-O
-the DET B-O
-Integrated PROPN B-LF
-Systematic PROPN I-LF
-Care PROPN I-LF
-for ADP I-LF
-Older PROPN I-LF
-People PROPN I-LF
-( PUNCT B-O
-ISCOPE PROPN B-AC
-) PUNCT B-O
-questionnaire NOUN B-O
-, PUNCT B-O
-to PART B-O
-determine VERB B-O
-complex ADJ B-O
-health NOUN B-O
-problems NOUN B-O
-in ADP B-O
-the DET B-O
-participants NOUN B-O
-[ PUNCT B-O
-35 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-chicken NOUN B-O
-appears VERB B-O
-to PART B-O
-lack VERB B-O
-the DET B-O
-ortholog NOUN B-O
-for ADP B-O
-the DET B-O
-human ADJ B-O
-GABABR PROPN B-AC
-( PUNCT B-O
-gamma NOUN B-LF
-aminobutyric ADJ I-LF
-acid NOUN I-LF
-– PUNCT I-LF
-binding VERB I-LF
-receptor NOUN I-LF
-) PUNCT B-O
-1 NUM B-O
-. PUNCT B-O
-
-Mice NOUN B-O
-8–10 NUM B-O
-weeks NOUN B-O
-old ADJ B-O
-infected VERB B-O
-intraperitoneally ADV B-O
-with ADP B-O
-102 NUM B-O
-( PUNCT B-O
-A&E NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-103 NUM B-O
-( PUNCT B-O
-B&F NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-104 NUM B-O
-( PUNCT B-O
-C&G NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-or CCONJ B-O
-106 NUM B-O
-( PUNCT B-O
-D&H NOUN B-O
-) PUNCT B-O
-plaque NOUN B-O
-forming VERB B-O
-units NOUN B-O
-( PUNCT B-O
-pfu NOUN B-O
-) PUNCT B-O
-Smith PROPN B-O
-strain NOUN B-O
-mCMV PROPN B-AC
-had VERB B-O
-peripheral ADJ B-LF
-blood NOUN I-LF
-mononuclear ADJ I-LF
-cells NOUN I-LF
-( PUNCT B-O
-PBMC PROPN B-AC
-) PUNCT B-O
-evaluated VERB B-O
-16 NUM B-O
-weeks NOUN B-O
-after ADP B-O
-infection NOUN B-O
-for ADP B-O
-inflationary ADJ B-O
-mCMV PROPN B-AC
-- PUNCT B-O
-specific ADJ B-O
-T NOUN B-O
-- PUNCT B-O
-cells NOUN B-O
-. PUNCT B-O
-
-Error NOUN B-O
-bars NOUN B-O
-were AUX B-O
-equal ADJ B-O
-to ADP B-O
-the DET B-O
-standard ADJ B-LF
-error NOUN I-LF
-of ADP I-LF
-the DET I-LF
-mean NOUN I-LF
-( PUNCT B-O
-SEM PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-a DET B-O
-subset NOUN B-O
-of ADP B-O
-the DET B-O
-local ADJ B-O
-UIs PROPN B-AC
-. PUNCT B-O
-
-The DET B-O
-subset NOUN B-O
-was AUX B-O
-chosen VERB B-O
-so SCONJ B-O
-that SCONJ B-O
-no DET B-O
-two NUM B-O
-triangles NOUN B-O
-shared VERB B-O
-an DET B-O
-edge NOUN B-O
-, PUNCT B-O
-ensuring VERB B-O
-that SCONJ B-O
-local ADJ B-O
-correlations NOUN B-O
-in ADP B-O
-the DET B-O
-UI PROPN B-AC
-did AUX B-O
-not PART B-O
-artificially ADV B-O
-reduce VERB B-O
-the DET B-O
-SEM PROPN B-AC
-. PUNCT B-O
-
-The DET B-O
-SEM PROPN B-AC
-was AUX B-O
-validated VERB B-O
-using VERB B-O
-a DET B-O
-bootstrap NOUN B-O
-simulation NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-find VERB B-O
-that SCONJ B-O
-parasites NOUN B-O
-undergoing VERB B-O
-delayed VERB B-O
-death NOUN B-O
-exhibited VERB B-O
-disrupted VERB B-O
-prenylation NOUN B-O
-of ADP B-O
-proteins NOUN B-O
-required VERB B-O
-for ADP B-O
-haemoglobin NOUN B-O
-uptake NOUN B-O
-and CCONJ B-O
-the DET B-O
-biogenesis NOUN B-O
-of ADP B-O
-the DET B-O
-digestive ADJ B-LF
-vacuole NOUN I-LF
-( PUNCT B-O
-DV PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-We PRON B-O
-further ADV B-O
-demonstrate VERB B-O
-defective ADJ B-O
-localisation NOUN B-O
-of ADP B-O
-prenylated VERB B-O
-trafficking NOUN B-O
-mediators NOUN B-O
-, PUNCT B-O
-defective ADJ B-O
-uptake NOUN B-O
-of ADP B-O
-haemoglobin NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-a DET B-O
-disrupted VERB B-O
-DV PROPN B-AC
-in ADP B-O
-these DET B-O
-parasites NOUN B-O
-. PUNCT B-O
-
-Tuberculosis NOUN B-LF
-( PUNCT B-O
-TB PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-one NUM B-O
-of ADP B-O
-the DET B-O
-leading VERB B-O
-causes NOUN B-O
-of ADP B-O
-death NOUN B-O
-from ADP B-O
-infectious ADJ B-O
-disease NOUN B-O
-worldwide ADV B-O
-, PUNCT B-O
-and CCONJ B-O
-it PRON B-O
-kills VERB B-O
-around ADV B-O
-1.7 NUM B-O
-million NUM B-O
-people NOUN B-O
-each DET B-O
-year NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-brief NOUN B-O
-, PUNCT B-O
-a DET B-O
-simplified ADJ B-O
-form NOUN B-O
-of ADP B-O
-sepsis NOUN B-LF
-- PUNCT I-LF
-related VERB I-LF
-organ NOUN B-LF
-failure NOUN I-LF
-assessment NOUN I-LF
-( PUNCT B-O
-SOFA PROPN B-AC
-) PUNCT B-O
-score NOUN B-O
-[ PUNCT B-O
-23]-based VERB B-O
-scoring NOUN B-O
-system NOUN B-O
-, PUNCT B-O
-the DET B-O
-CLIF-C PROPN B-AC
-OF PROPN B-AC
-score NOUN B-O
-, PUNCT B-O
-was AUX B-O
-used VERB B-O
-to PART B-O
-evaluate VERB B-O
-OF PROPN B-AC
-. PUNCT B-O
-
-The DET B-O
-CLIF PROPN B-AC
--CACLF PROPN B-AC
-score NOUN B-O
-was AUX B-O
-developed VERB B-O
-by ADP B-O
-combining VERB B-O
-the DET B-O
-CLIF PROPN B-AC
--COF PROPN B-AC
-score NOUN B-O
-and CCONJ B-O
-two NUM B-O
-other ADJ B-O
-independent ADJ B-O
-prognostic ADJ B-O
-factors NOUN B-O
-, PUNCT B-O
-age NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-white ADJ B-LF
-blood NOUN I-LF
-cell NOUN I-LF
-( PUNCT B-O
-WBC PROPN B-AC
-) PUNCT B-O
-count NOUN B-O
-[ PUNCT B-O
-22 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-three NUM B-O
-- ADJ B-O
-parameter NOUN B-O
-model NOUN B-O
-that PRON B-O
-did AUX B-O
-not PART B-O
-incorporate VERB B-O
-inter ADJ B-O
-- ADJ B-O
-item ADJ B-O
-homogeneity NOUN B-O
-( PUNCT B-O
-as SCONJ B-O
-shown VERB B-O
-in ADP B-O
-Figure NOUN B-O
-8A NUM B-O
-) PUNCT B-O
-accounted VERB B-O
-for ADP B-O
-only ADV B-O
-51 NUM B-O
-% NOUN B-O
-of ADP B-O
-the DET B-O
-variance NOUN B-O
-( PUNCT B-O
-r NOUN B-O
-2 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-had VERB B-O
-an DET B-O
-Akaike PROPN B-LF
-information NOUN I-LF
-criterion NOUN I-LF
-( PUNCT B-O
-AIC PROPN B-AC
-) PUNCT B-O
-value NOUN B-O
-( PUNCT B-O
-see VERB B-O
-Methods NOUN B-O
-) PUNCT B-O
-of ADP B-O
-1,010 NUM B-O
-( PUNCT B-O
-higher ADJ B-O
-AIC PROPN B-AC
-values NOUN B-O
-indicate VERB B-O
-worse ADJ B-O
-fit NOUN B-O
-[ X B-O
-27 NUM B-O
-] PUNCT B-O
-) PUNCT B-O
-. PUNCT B-O
-
-D13 NOUN B-O
-, PUNCT B-O
-diploid ADJ B-O
-cycle NOUN B-O
-13 NUM B-O
-embryos NOUN B-O
-; PUNCT B-O
-eve2 PROPN B-AC
-, PUNCT B-O
-even ADV B-LF
-skipped VERB I-LF
-stripe NOUN I-LF
-2 NUM I-LF
-; PUNCT B-O
-Frs PROPN B-AC
-, PUNCT B-O
-Frühstart NOUN B-LF
-; PUNCT B-O
-H14 NOUN B-O
-, PUNCT B-O
-haploid ADJ B-O
-cycle NOUN B-O
-14 NUM B-O
-embryos NOUN B-O
-; PUNCT B-O
-kni PROPN B-AC
-, PUNCT B-O
-knirps NOUN B-LF
-; PUNCT B-O
-N PROPN B-AC
-, PUNCT B-O
-ratio NOUN B-LF
-of ADP I-LF
-nuclei NOUN I-LF
-to ADP I-LF
-cytoplasm NOUN I-LF
-; PUNCT B-O
-PCNA PROPN B-O
-, PUNCT B-O
-proliferating VERB B-O
-cell NOUN B-O
-nuclear ADJ B-O
-antigen NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-ectopically ADV B-O
-expressed VERB B-O
-N. PROPN B-O
-crassa NOUN B-O
-Puf3 PROPN B-O
-protein NOUN B-O
-fused VERB B-O
-to ADP B-O
-a DET B-O
-tandem NOUN B-LF
-affinity NOUN I-LF
-purification NOUN I-LF
-tag NOUN I-LF
-( PUNCT B-O
-TAP-tag PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-a DET B-O
-S. PROPN B-O
-cerevisiae NOUN B-O
-strain NOUN B-O
-missing VERB B-O
-endogenous ADJ B-O
-Puf PROPN B-AC
-proteins NOUN B-O
-, PUNCT B-O
-Puf1 PROPN B-O
-- PUNCT B-O
-5 NUM B-O
-( PUNCT B-O
-derived VERB B-O
-from ADP B-O
-5Δpufs NOUN B-O
-strain NOUN B-O
-[ PUNCT B-O
-47 NUM B-O
-] PUNCT B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-we PRON B-O
-identified VERB B-O
-the DET B-O
-RNAs NOUN B-O
-bound VERB B-O
-by ADP B-O
-N. PROPN B-O
-crassa NOUN B-O
-Puf3 PROPN B-O
-( PUNCT B-O
-Materials NOUN B-O
-and CCONJ B-O
-Methods PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-This DET B-O
-periodicity NOUN B-O
-was AUX B-O
-evident ADJ B-O
-when SCONJ B-O
-we PRON B-O
-aligned VERB B-O
-all DET B-O
-coding VERB B-O
-regions NOUN B-O
-to ADP B-O
-the DET B-O
-first ADJ B-O
-nucleosome NOUN B-O
-downstream ADV B-O
-of ADP B-O
-the DET B-O
-TSS PROPN B-AC
-and CCONJ B-O
-ranked VERB B-O
-all DET B-O
-these DET B-O
-genes NOUN B-O
-by ADP B-O
-a DET B-O
-nucleosome NOUN B-LF
-positioning NOUN I-LF
-periodicity NOUN I-LF
-( PUNCT B-O
-NPP PROPN B-AC
-) PUNCT B-O
-score NOUN B-O
-applied VERB B-O
-to ADP B-O
-the DET B-O
-coding VERB B-O
-region NOUN B-O
-( PUNCT B-O
-Figure NOUN B-O
-3A NUM B-O
-; PUNCT B-O
-Materials NOUN B-O
-and CCONJ B-O
-Methods NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Therefore ADV B-O
-, PUNCT B-O
-the DET B-O
-study NOUN B-O
-aimed VERB B-O
-to ADP B-O
-suggest VERB B-O
-the DET B-O
-chemical ADJ B-O
-composition NOUN B-O
-of ADP B-O
-C. PROPN B-O
-obtusa PROPN B-O
-leaf NOUN B-O
-extract NOUN B-O
-using VERB B-O
-LC PROPN B-O
-- PUNCT B-O
-MS PROPN B-O
-. PUNCT B-O
-
-To PART B-O
-assess VERB B-O
-if SCONJ B-O
-, PUNCT B-O
-besides SCONJ B-O
-the DET B-O
-antioxidant ADJ B-O
-activity NOUN B-O
-, PUNCT B-O
-C. PROPN B-O
-obtusa PROPN B-O
-would AUX B-O
-exhibit VERB B-O
-an DET B-O
-anti ADJ B-O
-aging ADJ B-O
-effect NOUN B-O
-and CCONJ B-O
-which DET B-O
-mechanisms NOUN B-O
-would AUX B-O
-be AUX B-O
-involved VERB B-O
-in ADP B-O
-it PRON B-O
-, PUNCT B-O
-we PRON B-O
-evaluated VERB B-O
-the DET B-O
-effect NOUN B-O
-of ADP B-O
-the DET B-O
-extract NOUN B-O
-on ADP B-O
-keratinocytes NOUN B-O
-and CCONJ B-O
-fibroblasts NOUN B-O
-exposed VERB B-O
-to ADP B-O
-UV PROPN B-AC
-radiation NOUN B-O
-and CCONJ B-O
-analyzed VERB B-O
-protein NOUN B-O
-carbonyl NOUN B-O
-, PUNCT B-O
-collagen NOUN B-O
-, PUNCT B-O
-hyaluronic ADJ B-LF
-acid NOUN I-LF
-( PUNCT B-O
-HA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-metalloproteinase-1 NOUN B-O
-( PUNCT B-O
-MMP-1 PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-IL-1 NOUN B-O
-β PUNCT B-O
-and CCONJ B-O
-IL-6 NOUN B-O
-contents NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-first ADV B-O
-analyzed VERB B-O
-differences NOUN B-O
-between ADP B-O
-wards NOUN B-O
-on ADP B-O
-the DET B-O
-activity NOUN B-O
-categories NOUN B-O
-: PUNCT B-O
-Direct PROPN B-LF
-Patient PROPN I-LF
-Care PROPN I-LF
-( PUNCT B-O
-DPC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Collective PROPN B-LF
-Patient PROPN I-LF
-Care PROPN I-LF
-( PUNCT B-O
-CPC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-General PROPN B-LF
-Tasks PROPN I-LF
-( PUNCT B-O
-GT PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-Other ADJ B-LF
-Tasks PROPN I-LF
-( PUNCT B-O
-OT PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Compositional ADJ B-O
-analysis NOUN B-O
-dictates VERB B-O
-that SCONJ B-O
-one NUM B-O
-variable NOUN B-O
-needs VERB B-O
-to PART B-O
-be AUX B-O
-chosen VERB B-O
-as ADP B-O
-a DET B-O
-reference NOUN B-O
-variable NOUN B-O
-, PUNCT B-O
-to PART B-O
-compare VERB B-O
-the DET B-O
-others NOUN B-O
-against ADP B-O
-. PUNCT B-O
-
-Specifically ADV B-O
-, PUNCT B-O
-we PRON B-O
-loaded VERB B-O
-retinas NOUN B-O
-using VERB B-O
-the DET B-O
-acetoxymethyl NOUN B-LF
-ester NOUN I-LF
-( PUNCT B-O
-AM-ester PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-this DET B-O
-dye NOUN B-O
-( PUNCT B-O
-see VERB B-O
-Methods NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-then ADV B-O
-we PRON B-O
-mechanically ADV B-O
-dissociated VERB B-O
-individual ADJ B-O
-rod NOUN B-O
-photoreceptors NOUN B-O
-and/or CCONJ B-O
-OSs PROPN B-AC
-. PUNCT B-O
-
-We PRON B-O
-viewed VERB B-O
-the DET B-O
-preparation NOUN B-O
-using VERB B-O
-IR PROPN B-AC
-illumination NOUN B-O
-at ADP B-O
-750 NUM B-O
-nm NOUN B-O
-and CCONJ B-O
-an DET B-O
-IR PROPN B-AC
-- PUNCT B-O
-sensitive ADJ B-O
-video NOUN B-O
-camera NOUN B-O
-attached VERB B-O
-to ADP B-O
-the DET B-O
-microscope NOUN B-O
-. PUNCT B-O
-
-For ADP B-O
-some DET B-O
-years NOUN B-O
-, PUNCT B-O
-the DET B-O
-maximum ADJ B-LF
-relaxation NOUN I-LF
-rate NOUN I-LF
-( PUNCT B-O
-MRR PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-the DET B-O
-inspiratory ADJ B-O
-muscles NOUN B-O
-has AUX B-O
-been AUX B-O
-used VERB B-O
-as ADP B-O
-an DET B-O
-indirect ADJ B-O
-marker NOUN B-O
-of ADP B-O
-fatigue NOUN B-O
-and CCONJ B-O
-overload NOUN B-O
-of ADP B-O
-the DET B-O
-inspiratory ADJ B-O
-muscles NOUN B-O
-. PUNCT B-O
-
-Zhang PROPN B-O
-et PROPN B-O
-al NOUN B-O
-. PUNCT B-O
-
-[ X B-O
-16 X B-O
-] X B-O
-demonstrated VERB B-O
-that SCONJ B-O
-Shp2 PROPN B-O
-controls VERB B-O
-phosphorylation NOUN B-O
-and CCONJ B-O
-activation NOUN B-O
-of ADP B-O
-Src PROPN B-LF
-family NOUN I-LF
-kinases NOUN I-LF
-( PUNCT B-O
-SFKs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-in ADP B-O
-that SCONJ B-O
-SFK PROPN B-AC
-activity NOUN B-O
-is AUX B-O
-reduced VERB B-O
-in ADP B-O
-the DET B-O
-absence NOUN B-O
-of ADP B-O
-Shp2 PROPN B-O
-, PUNCT B-O
-due ADP B-O
-to ADP B-O
-hyperphosphorylation NOUN B-O
-of ADP B-O
-the DET B-O
-inhibitory ADJ B-O
-phosphorylation NOUN B-O
-site NOUN B-O
-. PUNCT B-O
-
-PAM PROPN B-AC
-, PUNCT B-O
-protospacer NOUN B-LF
-adjacent ADJ I-LF
-motif NOUN I-LF
-; PUNCT B-O
-SpCas9 PROPN B-AC
-, PUNCT B-O
-Streptococcus NOUN B-LF
-pyogenes NOUN I-LF
-Cas9 PROPN I-LF
-; PUNCT B-O
-WT PROPN B-AC
-, PUNCT B-O
-wild ADJ B-LF
-- PUNCT I-LF
-type NOUN I-LF
-. PUNCT B-O
-
-Anthranilic ADJ B-LF
-acid NOUN I-LF
-( PUNCT B-O
-AA PROPN B-AC
-) PUNCT B-O
-supplementation NOUN B-O
-rescues VERB B-O
-gut NOUN B-O
-granule NOUN B-O
-and CCONJ B-O
-DF PROPN B-AC
-. PUNCT B-O
-
-( PUNCT B-O
-A X B-O
-, PUNCT B-O
-B NOUN B-O
-) PUNCT B-O
-Incubation NOUN B-O
-of ADP B-O
-tdo-2(RNAi NOUN B-O
-) PUNCT B-O
-worms NOUN B-O
-in ADP B-O
-5 NUM B-O
-mM PROPN B-O
-AA PROPN B-AC
-leads VERB B-O
-to ADP B-O
-gut NOUN B-O
-granule NOUN B-O
-fluorescence NOUN B-O
-similar ADJ B-O
-to ADP B-O
-wild ADJ B-O
-type NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-A X B-O
-) PUNCT B-O
-Effect NOUN B-O
-on ADP B-O
-gut NOUN B-O
-granule NOUN B-O
-fluorescence NOUN B-O
-of ADP B-O
-incubation NOUN B-O
-in ADP B-O
-a DET B-O
-range NOUN B-O
-of ADP B-O
-AA PROPN B-AC
-concentrations NOUN B-O
-. PUNCT B-O
-
-5 NUM B-O
-mM PROPN B-O
-AA PROPN B-AC
-gives VERB B-O
-fluorescence NOUN B-O
-levels NOUN B-O
-similar ADJ B-O
-to ADP B-O
-wild ADJ B-O
-type NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-B NOUN B-O
-) PUNCT B-O
-Epifluorescence NOUN B-O
-microscopy NOUN B-O
-reveals VERB B-O
-restoration NOUN B-O
-of ADP B-O
-gut NOUN B-O
-granule NOUN B-O
-fluorescence NOUN B-O
-by ADP B-O
-incubation NOUN B-O
-in ADP B-O
-5 NUM B-O
-mM PROPN B-O
-AA PROPN B-AC
-. PUNCT B-O
-
-( PUNCT B-O
-C X B-O
-, PUNCT B-O
-D NOUN B-O
-) PUNCT B-O
-Incubation NOUN B-O
-of ADP B-O
-tdo-2(RNAi NOUN B-O
-) PUNCT B-O
-worms NOUN B-O
-in ADP B-O
-5 NUM B-O
-mM PROPN B-O
-AA PROPN B-AC
-leads VERB B-O
-to ADP B-O
-DF PROPN B-AC
-similar ADJ B-O
-to ADP B-O
-wild ADJ B-O
-type NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-C X B-O
-) PUNCT B-O
-Effects NOUN B-O
-of ADP B-O
-tdo-2(RNAi NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-AA PROPN B-AC
-supplementation NOUN B-O
-on ADP B-O
-peak ADJ B-O
-DF PROPN B-AC
-. PUNCT B-O
-
-( PUNCT B-O
-D NOUN B-O
-) PUNCT B-O
-Similar ADJ B-O
-kinetics NOUN B-O
-of ADP B-O
-DF PROPN B-AC
-in ADP B-O
-control NOUN B-O
-worms NOUN B-O
-and CCONJ B-O
-tdo-2(RNAi NOUN B-O
-) PUNCT B-O
-worms NOUN B-O
-with ADP B-O
-AA PROPN B-AC
-- PUNCT B-O
-replenished VERB B-O
-gut NOUN B-O
-granules NOUN B-O
-, PUNCT B-O
-even ADV B-O
-though SCONJ B-O
-only ADV B-O
-the DET B-O
-former ADJ B-O
-can AUX B-O
-synthesize VERB B-O
-AA PROPN B-AC
-. PUNCT B-O
-
-Signal ADJ B-LF
-transducer NOUN I-LF
-and CCONJ I-LF
-activator NOUN I-LF
-of ADP I-LF
-transcription NOUN I-LF
-5b NOUN I-LF
-( PUNCT B-O
-STAT5b PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-one NUM B-O
-of ADP B-O
-seven NUM B-O
-mammalian ADJ B-O
-STAT PROPN B-O
-transcription NOUN B-O
-factors NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-, PUNCT B-O
-2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Oxidative ADJ B-O
-stress NOUN B-O
-refers VERB B-O
-to PART B-O
-the DET B-O
-imbalance NOUN B-O
-between ADP B-O
-the DET B-O
-products NOUN B-O
-of ADP B-O
-reactive ADJ B-LF
-oxygen NOUN I-LF
-species NOUN I-LF
-( PUNCT B-O
-ROS PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-the DET B-O
-biological ADJ B-O
-ability NOUN B-O
-to PART B-O
-detoxify VERB B-O
-them PRON B-O
-[ PUNCT B-O
-2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-U5 PROPN B-O
-is AUX B-O
-identical ADJ B-O
-to ADP B-O
-U3 PROPN B-O
-except SCONJ B-O
-that SCONJ B-O
-it PRON B-O
-lacks VERB B-O
-the DET B-O
-third ADJ B-O
-randomized VERB B-O
-ankyrin NOUN B-LF
-repeat NOUN I-LF
-( PUNCT B-O
-AR PROPN B-AC
-) PUNCT B-O
-domain NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-used VERB B-O
-an DET B-O
-iterative ADJ B-O
-immuno ADJ B-O
-- PUNCT B-O
-FISH PROPN B-AC
-( PUNCT B-O
-fluorescence NOUN B-LF
-in ADP I-LF
-situ NOUN I-LF
-hybridization NOUN I-LF
-) PUNCT B-O
-approach NOUN B-O
-[ X B-O
-41 X B-O
-] X B-O
-to ADP B-O
-investigate VERB B-O
-the DET B-O
-organization NOUN B-O
-of ADP B-O
-the DET B-O
-chromosome NOUN B-O
-loops NOUN B-O
-associated VERB B-O
-with ADP B-O
-pairs NOUN B-O
-of ADP B-O
-sister NOUN B-O
-chromatids NOUN B-O
-, PUNCT B-O
-both PRON B-O
-relative ADJ B-O
-to ADP B-O
-each DET B-O
-other ADJ B-O
-and CCONJ B-O
-in ADP B-O
-relationship NOUN B-O
-to ADP B-O
-the DET B-O
-chromosome NOUN B-O
-axis NOUN B-O
-. PUNCT B-O
-
-Historically ADV B-O
-, PUNCT B-O
-PJP PROPN B-AC
-affects VERB B-O
-mostly ADV B-O
-patients NOUN B-O
-with ADP B-O
-human ADJ B-LF
-immunodeficiency NOUN I-LF
-virus NOUN I-LF
-( PUNCT B-O
-HIV PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-However ADV B-O
-, PUNCT B-O
-prevalence NOUN B-O
-of ADP B-O
-patients NOUN B-O
-with ADP B-O
-HIV PROPN B-AC
-- PUNCT B-O
-related VERB B-O
-PJP PROPN B-AC
-has AUX B-O
-decreased VERB B-O
-with ADP B-O
-the DET B-O
-use NOUN B-O
-of ADP B-O
-highly ADV B-O
-active ADJ B-O
-antiretroviral ADJ B-O
-therapy NOUN B-O
-and CCONJ B-O
-routine ADJ B-O
-PJP PROPN B-AC
-prophylaxis NOUN B-O
-[ X B-O
-1,2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-AID PROPN B-AC
-, PUNCT B-O
-auxin X B-LF
-- PUNCT I-LF
-inducible NOUN I-LF
-degron PROPN I-LF
-. PUNCT B-O
-
-We PRON B-O
-calculated VERB B-O
-the DET B-O
-GSCORR PROPN B-AC
-under ADP B-O
-three NUM B-O
-procedures NOUN B-O
-of ADP B-O
-noise NOUN B-O
-regression NOUN B-O
-: PUNCT B-O
-( PUNCT B-O
-1 X B-O
-) PUNCT B-O
-without ADP B-O
-any DET B-O
-noise NOUN B-O
-regression NOUN B-O
-, PUNCT B-O
-( PUNCT B-O
-2 NUM B-O
-) PUNCT B-O
-regressors NOUN B-O
-including VERB B-O
-head NOUN B-O
-motion NOUN B-O
-and CCONJ B-O
-signals NOUN B-O
-from ADP B-O
-the DET B-O
-ventricle NOUN B-O
-and CCONJ B-O
-white ADJ B-O
-matter NOUN B-O
-as SCONJ B-O
-well ADV B-O
-as SCONJ B-O
-their PRON B-O
-first ADJ B-O
-order NOUN B-O
-derivatives NOUN B-O
-, PUNCT B-O
-( PUNCT B-O
-3 X B-O
-) PUNCT B-O
-regressors NOUN B-O
-including VERB B-O
-those PRON B-O
-in ADP B-O
-( PUNCT B-O
-2 NUM B-O
-) PUNCT B-O
-plus CCONJ B-O
-the DET B-O
-RVT PROPN B-AC
-and CCONJ B-O
-heart NOUN B-LF
-rate NOUN I-LF
-( PUNCT B-O
-HR PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-If SCONJ B-O
-the DET B-O
-task NOUN B-O
-modulation NOUN B-O
-of ADP B-O
-GSCORR PROPN B-AC
-( PUNCT B-O
-i.e. X B-O
-, PUNCT B-O
-ΔGSCORR NOUN B-O
-) PUNCT B-O
-was AUX B-O
-driven VERB B-O
-merely ADV B-O
-by ADP B-O
-noise NOUN B-O
-, PUNCT B-O
-then ADV B-O
-its PRON B-O
-spatial ADJ B-O
-pattern NOUN B-O
-, PUNCT B-O
-as SCONJ B-O
-calculated VERB B-O
-without ADP B-O
-noise NOUN B-O
-, PUNCT B-O
-should AUX B-O
-show VERB B-O
-low ADJ B-O
-degrees NOUN B-O
-of ADP B-O
-spatial ADJ B-O
-similarity NOUN B-O
-with ADP B-O
-the DET B-O
-one NUM B-O
-after ADP B-O
-noise NOUN B-O
-regression NOUN B-O
-. PUNCT B-O
-
-To PART B-O
-overcome VERB B-O
-the DET B-O
-effects NOUN B-O
-of ADP B-O
-heterogeneous ADJ B-O
-ELF5 PROPN B-O
-induction NOUN B-O
-( PUNCT B-O
-Fig PROPN B-O
-1A NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-we PRON B-O
-performed VERB B-O
-intraductal ADJ B-O
-allografts NOUN B-O
-of ADP B-O
-Fluorescence PROPN B-LF
-- PUNCT I-LF
-Activated VERB I-LF
-Cell PROPN I-LF
-Sorting PROPN I-LF
-( PUNCT B-O
-FACS)-sorted PROPN B-AC
-( PUNCT B-O
-Lin- PROPN B-O
-and CCONJ B-O
-CD24 PROPN B-O
-+ PUNCT B-O
-) PUNCT B-O
-tumor NOUN B-O
-cells NOUN B-O
-that PRON B-O
-were AUX B-O
-either CCONJ B-O
-EGFP PROPN B-O
-( PUNCT B-O
-ELF5 PROPN B-O
-) PUNCT B-O
-positive ADJ B-O
-or CCONJ B-O
-negative ADJ B-O
-. PUNCT B-O
-
-Recently ADV B-O
-, PUNCT B-O
-Anaplastic ADJ B-LF
-Lymphoma PROPN I-LF
-Kinase PROPN I-LF
-( PUNCT B-O
-ALK PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-receptor NOUN B-O
-kinase NOUN B-O
-involved VERB B-O
-in ADP B-O
-pro ADJ B-O
-- ADJ B-O
-survival ADJ B-O
-signaling NOUN B-O
-, PUNCT B-O
-was AUX B-O
-shown VERB B-O
-to PART B-O
-be AUX B-O
-upregulated ADJ B-O
-in ADP B-O
-advanced ADJ B-O
-/ SYM B-O
-metastatic ADJ B-O
-neuroblastomas NOUN B-O
-[ PUNCT B-O
-13 NUM B-O
-, PUNCT B-O
-14 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-the DET B-O
-one NUM B-O
-- PUNCT B-O
-stage NOUN B-O
-approach NOUN B-O
-, PUNCT B-O
-we PRON B-O
-added VERB B-O
-a DET B-O
-second ADJ B-O
-sensitivity NOUN B-O
-analysis NOUN B-O
-to PART B-O
-compare VERB B-O
-our PRON B-O
-results NOUN B-O
-against ADP B-O
-those PRON B-O
-of ADP B-O
-a DET B-O
-procedure NOUN B-O
-applying VERB B-O
-multiple ADJ B-O
-imputation NOUN B-O
-to PART B-O
-include VERB B-O
-all DET B-O
-participants NOUN B-O
-( PUNCT B-O
-an DET B-O
-intention NOUN B-LF
-- PUNCT I-LF
-to PART I-LF
-- PUNCT I-LF
-treat VERB I-LF
-[ X B-O
-ITT PROPN B-AC
-] X B-O
-analysis NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Previous ADJ B-O
-work NOUN B-O
-by ADP B-O
-our PRON B-O
-group NOUN B-O
-reported VERB B-O
-that SCONJ B-O
-long ADJ B-O
-- PUNCT B-O
-term NOUN B-O
-, PUNCT B-O
-ambient ADJ B-O
-PM PROPN B-AC
-exposure NOUN B-O
-induces VERB B-O
-hepatic ADJ B-O
-fibrosis NOUN B-O
-and CCONJ B-O
-increased VERB B-O
-ROS NOUN B-O
-production NOUN B-O
-in ADP B-O
-the DET B-O
-liver NOUN B-O
-in ADP B-O
-mice NOUN B-O
-; PUNCT B-O
-the DET B-O
-combination NOUN B-O
-of ADP B-O
-PM PROPN B-AC
-exposure NOUN B-O
-and CCONJ B-O
-a DET B-O
-high ADJ B-LF
-- PUNCT I-LF
-fat NOUN I-LF
-diet NOUN I-LF
-( PUNCT B-O
-HFD PROPN B-AC
-) PUNCT B-O
-aggravates VERB B-O
-hepatic ADJ B-O
-fibrosis NOUN B-O
-[ PUNCT B-O
-11 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-subsidy NOUN B-O
-level NOUN B-O
-of ADP B-O
-30 NUM B-O
-% NOUN B-O
-was AUX B-O
-based VERB B-O
-on ADP B-O
-the DET B-O
-subsidy NOUN B-O
-level NOUN B-O
-used VERB B-O
-in ADP B-O
-the DET B-O
-US PROPN B-O
-Department PROPN B-O
-of ADP B-O
-Agriculture PROPN B-O
-’s PART B-O
-( PUNCT B-O
-USDA PROPN B-AC
-’s PART B-O
-) PUNCT B-O
-Healthy PROPN B-LF
-Incentives PROPN I-LF
-Pilot PROPN I-LF
-( PUNCT B-O
-HIP PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-randomized ADJ B-O
-controlled ADJ B-O
-trial NOUN B-O
-implemented VERB B-O
-among ADP B-O
-Supplemental PROPN B-LF
-Nutrition PROPN I-LF
-Assistant PROPN I-LF
-Program PROPN I-LF
-( PUNCT B-O
-SNAP PROPN B-AC
-) PUNCT B-O
-participants NOUN B-O
-to PART B-O
-incentivize VERB B-O
-F&V PROPN B-AC
-consumption NOUN B-O
-[ PUNCT B-O
-37 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-This PRON B-O
-is AUX B-O
-of ADP B-O
-particular ADJ B-O
-relevance NOUN B-O
-because SCONJ B-O
-obesity NOUN B-O
-is AUX B-O
-a DET B-O
-risk NOUN B-O
-factor NOUN B-O
-for ADP B-O
-a DET B-O
-number NOUN B-O
-of ADP B-O
-cancer NOUN B-O
-types NOUN B-O
-, PUNCT B-O
-including VERB B-O
-multiple ADJ B-LF
-myeloma NOUN I-LF
-( PUNCT B-O
-MM PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-5 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-During ADP B-O
-the DET B-O
-past NOUN B-O
-decade NOUN B-O
-, PUNCT B-O
-large ADJ B-O
-- PUNCT B-O
-scale NOUN B-O
-implementation NOUN B-O
-of ADP B-O
-long ADV B-LF
-- PUNCT I-LF
-lasting VERB I-LF
-insecticidal ADJ I-LF
-nets NOUN I-LF
-( PUNCT B-O
-LLINs PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-indoor ADJ B-LF
-residual ADJ I-LF
-spraying NOUN I-LF
-( PUNCT B-O
-IRS PROPN B-AC
-) PUNCT B-O
-has AUX B-O
-played VERB B-O
-a DET B-O
-major ADJ B-O
-role NOUN B-O
-in ADP B-O
-reducing VERB B-O
-malaria NOUN B-O
-morbidity NOUN B-O
-and CCONJ B-O
-mortality NOUN B-O
-in ADP B-O
-Africa PROPN B-O
-south ADV B-O
-of ADP B-O
-the DET B-O
-Sahara PROPN B-O
-[ PUNCT B-O
-2 NUM B-O
-, PUNCT B-O
-3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Data NOUN B-O
-represent VERB B-O
-the DET B-O
-concentrations NOUN B-O
-of ADP B-O
-cytokines NOUN B-O
-IL-1α PROPN B-AC
-, PUNCT B-O
-IL-1β PROPN B-AC
-, PUNCT B-O
-IL-6 PROPN B-AC
-and CCONJ B-O
-IL-10 PROPN B-AC
-in ADP B-O
-infants NOUN B-O
-with ADP B-O
-confirmed VERB B-O
-late ADJ B-LF
-- PUNCT I-LF
-onset NOUN I-LF
-sepsis NOUN I-LF
-( PUNCT B-O
-LOS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-possible ADJ B-O
-LOS PROPN B-AC
-and CCONJ B-O
-no DET B-O
-LOS PROPN B-AC
-. PUNCT B-O
-
-The DET B-O
-box NOUN B-O
-plots NOUN B-O
-show VERB B-O
-the DET B-O
-median ADJ B-O
-and CCONJ B-O
-interquartile ADJ B-O
-range NOUN B-O
-and CCONJ B-O
-statistically ADV B-O
-significant ADJ B-O
-differences NOUN B-O
-based VERB B-O
-on ADP B-O
-the DET B-O
-Mann PROPN B-O
-- PUNCT B-O
-Whitney PROPN B-O
-Test PROPN B-O
-( PUNCT B-O
-* PUNCT B-O
-, PUNCT B-O
-p<0.05 NUM B-O
-and CCONJ B-O
-* PUNCT B-O
-* PUNCT B-O
-, PUNCT B-O
-p<0.005 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-From ADP B-O
-a DET B-O
-societal ADJ B-O
-perspective NOUN B-O
-including VERB B-O
-informal ADJ B-O
-healthcare NOUN B-O
-costs NOUN B-O
-and CCONJ B-O
-lost VERB B-O
-productivity NOUN B-O
-, PUNCT B-O
-respective ADJ B-O
-ICERs PROPN B-AC
-were AUX B-O
-$ SYM B-O
-14,576 NUM B-O
-/ SYM B-O
-QALY PROPN B-AC
-and CCONJ B-O
-$ SYM B-O
-9,497 NUM B-O
-/ SYM B-O
-QALY PROPN B-AC
-. PUNCT B-O
-
-Results NOUN B-O
-were AUX B-O
-robust ADJ B-O
-in ADP B-O
-probabilistic ADJ B-O
-sensitivity NOUN B-O
-analyses NOUN B-O
-and CCONJ B-O
-a DET B-O
-range NOUN B-O
-of ADP B-O
-one NUM B-O
-- PUNCT B-O
-way NOUN B-O
-sensitivity NOUN B-O
-and CCONJ B-O
-subgroup NOUN B-O
-analyses NOUN B-O
-, PUNCT B-O
-including VERB B-O
-by ADP B-O
-different ADJ B-O
-durations NOUN B-O
-of ADP B-O
-the DET B-O
-intervention NOUN B-O
-( PUNCT B-O
-5 NUM B-O
-, PUNCT B-O
-10 NUM B-O
-, PUNCT B-O
-and CCONJ B-O
-20 NUM B-O
-years NOUN B-O
-and CCONJ B-O
-lifetime NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-food NOUN B-O
-subsidy NOUN B-O
-levels NOUN B-O
-( PUNCT B-O
-20 NUM B-O
-% PUNCT B-O
-, PUNCT B-O
-50 NUM B-O
-% PUNCT B-O
-) PUNCT B-O
-, PUNCT B-O
-insurance NOUN B-O
-groups NOUN B-O
-( PUNCT B-O
-Medicare PROPN B-O
-, PUNCT B-O
-Medicaid PROPN B-O
-, PUNCT B-O
-and CCONJ B-O
-dual ADJ B-O
-- PUNCT B-O
-eligible ADJ B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-beneficiary NOUN B-O
-characteristics NOUN B-O
-within ADP B-O
-each DET B-O
-insurance NOUN B-O
-group NOUN B-O
-( PUNCT B-O
-age NOUN B-O
-, PUNCT B-O
-race NOUN B-O
-/ SYM B-O
-ethnicity NOUN B-O
-, PUNCT B-O
-education NOUN B-O
-, PUNCT B-O
-income NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-Supplemental PROPN B-LF
-Nutrition PROPN I-LF
-Assistant PROPN I-LF
-Program PROPN I-LF
-[ PUNCT B-O
-SNAP PROPN B-AC
-] PUNCT B-O
-status NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-t NOUN B-O
-: PUNCT B-O
-endoscopic ADJ B-LF
-papillary ADJ I-LF
-balloon NOUN I-LF
-dilatation NOUN I-LF
-duration NOUN B-O
-time NOUN B-O
-, PUNCT B-O
-N NOUN B-O
-: PUNCT B-O
-number NOUN B-O
-, PUNCT B-O
-BMI PROPN B-O
-: PUNCT B-O
-body NOUN B-O
-mass NOUN B-O
-index NOUN B-O
-, PUNCT B-O
-BW PROPN B-O
-: PUNCT B-O
-body NOUN B-O
-weight NOUN B-O
-, PUNCT B-O
-CV PROPN B-O
-: PUNCT B-O
-cardiovascular ADJ B-O
-, PUNCT B-O
-CM PROPN B-O
-: PUNCT B-O
-chest NOUN B-O
-, PUNCT B-O
-DM PROPN B-O
-: PUNCT B-O
-diabetes NOUN B-O
-mellitus NOUN B-O
-, PUNCT B-O
-SBP PROPN B-O
-: PUNCT B-O
-systolic ADJ B-O
-blood NOUN B-O
-pressure NOUN B-O
-, PUNCT B-O
-BT PROPN B-O
-: PUNCT B-O
-body NOUN B-O
-temperature NOUN B-O
-, PUNCT B-O
-HR NOUN B-O
-: PUNCT B-O
-heart NOUN B-O
-rate NOUN B-O
-, PUNCT B-O
-RR PROPN B-O
-: PUNCT B-O
-respiratory ADJ B-O
-rate NOUN B-O
-, PUNCT B-O
-WBC PROPN B-O
-: PUNCT B-O
-white ADJ B-O
-blood NOUN B-O
-cell NOUN B-O
-count NOUN B-O
-, PUNCT B-O
-Hb PROPN B-O
-: PUNCT B-O
-hemoglobin NOUN B-O
-, PUNCT B-O
-PLT PROPN B-O
-: PUNCT B-O
-platelet NOUN B-O
-, PUNCT B-O
-INR PROPN B-O
-: PUNCT B-O
-international ADJ B-O
-normalized VERB B-O
-ratio NOUN B-O
-, PUNCT B-O
-ALT PROPN B-O
-: PUNCT B-O
-alanine NOUN B-O
-aminotransferase NOUN B-O
-, PUNCT B-O
-AST PROPN B-O
-: PUNCT B-O
-aspartate NOUN B-O
-aminotransferase NOUN B-O
-, PUNCT B-O
-BUN PROPN B-O
-: PUNCT B-O
-blood NOUN B-O
-urea NOUN B-O
-nitrogen NOUN B-O
-, PUNCT B-O
-Cr PROPN B-O
-: PUNCT B-O
-creatinine NOUN B-O
-, PUNCT B-O
-ALP PROPN B-O
-: PUNCT B-O
-alkaline NOUN B-O
-phosphatase NOUN B-O
-, PUNCT B-O
-rGT PROPN B-O
-: PUNCT B-O
-gamma NOUN B-O
-- PUNCT B-O
-glutamyl NOUN B-O
-transpeptidase NOUN B-O
-, PUNCT B-O
-Amy PROPN B-O
-: PUNCT B-O
-amylase NOUN B-O
-, PUNCT B-O
-Tbili PROPN B-O
-: PUNCT B-O
-total NOUN B-O
-bilirubin NOUN B-O
-, PUNCT B-O
-CRP PROPN B-O
-: PUNCT B-O
-c NOUN B-O
-- PUNCT B-O
-reactive ADJ B-O
-protein NOUN B-O
-, PUNCT B-O
-BD PROPN B-O
-: PUNCT B-O
-bile NOUN B-O
-duct NOUN B-O
-, PUNCT B-O
-CBD PROPN B-AC
-: PUNCT B-O
-common ADJ B-LF
-bile NOUN I-LF
-duct NOUN I-LF
-, PUNCT B-O
-PTCD PROPN B-O
-: PUNCT B-O
-percutaneous ADJ B-O
-transhepatic ADJ B-O
-cholangiography NOUN B-O
-and CCONJ B-O
-drainage NOUN B-O
-, PUNCT B-O
-PTGBD PROPN B-O
-: PUNCT B-O
-percutaneous ADJ B-O
-transhepatic ADJ B-O
-gallbladder NOUN B-O
-drainage NOUN B-O
-, PUNCT B-O
-EST PROPN B-AC
-: PUNCT B-O
-endoscopic ADJ B-LF
-sphincterotomy NOUN I-LF
-, PUNCT B-O
-EPBD PROPN B-AC
-: PUNCT B-O
-endoscopic ADJ B-LF
-papillary ADJ I-LF
-balloon NOUN I-LF
-dilatation NOUN I-LF
-. PUNCT B-O
-
-Here ADV B-O
-, PUNCT B-O
-we PRON B-O
-analyse VERB B-O
-a DET B-O
-newly ADV B-O
-created VERB B-O
-dataset NOUN B-O
-of ADP B-O
-trade NOUN B-O
-challenges NOUN B-O
-about ADP B-O
-food NOUN B-O
-, PUNCT B-O
-beverage NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-tobacco NOUN B-O
-regulations NOUN B-O
-among ADP B-O
-122 NUM B-O
-World PROPN B-LF
-Trade PROPN I-LF
-Organization PROPN I-LF
-( PUNCT B-O
-WTO PROPN B-AC
-) PUNCT B-O
-members NOUN B-O
-from ADP B-O
-January PROPN B-O
-1 NUM B-O
-, PUNCT B-O
-1995 NUM B-O
-to ADP B-O
-December PROPN B-O
-31 NUM B-O
-, PUNCT B-O
-2016 NUM B-O
-. PUNCT B-O
-
-Severe ADJ B-O
-abdominal ADJ B-LF
-aortic ADJ I-LF
-calcification NOUN I-LF
-( PUNCT B-O
-AAC PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-associated VERB B-O
-with ADP B-O
-higher ADJ B-O
-risk NOUN B-O
-of ADP B-O
-cardiovascular ADJ B-O
-event NOUN B-O
-and CCONJ B-O
-of ADP B-O
-fragility NOUN B-O
-fracture NOUN B-O
-. PUNCT B-O
-
-Oxidative ADJ B-O
-stress NOUN B-O
-results VERB B-O
-in ADP B-O
-the DET B-O
-generation NOUN B-O
-of ADP B-O
-excessive ADJ B-O
-reactive ADJ B-LF
-oxygen NOUN I-LF
-species NOUN I-LF
-( PUNCT B-O
-ROS PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-reactive ADJ B-LF
-nitrogen NOUN I-LF
-species NOUN I-LF
-( PUNCT B-O
-RNS PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-9–12 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-promotes VERB B-O
-the DET B-O
-formation NOUN B-O
-of ADP B-O
-lipid NOUN B-O
-peroxides NOUN B-O
-and CCONJ B-O
-damages VERB B-O
-the DET B-O
-RNA NOUN B-O
-, PUNCT B-O
-DNA PROPN B-O
-, PUNCT B-O
-and CCONJ B-O
-proteins NOUN B-O
-. PUNCT B-O
-
-Further ADV B-O
-, PUNCT B-O
-biological ADJ B-O
-samples NOUN B-O
-were AUX B-O
-often ADV B-O
-analyzed VERB B-O
-using VERB B-O
-nuclear ADJ B-LF
-magnetic ADJ I-LF
-resonance NOUN I-LF
-spectroscopy NOUN B-O
-( PUNCT B-O
-NMR PROPN B-AC
-) PUNCT B-O
-as ADP B-O
-the DET B-O
-only ADJ B-O
-analytical ADJ B-O
-method NOUN B-O
-, PUNCT B-O
-data NOUN B-O
-analysis NOUN B-O
-was AUX B-O
-mainly ADV B-O
-based VERB B-O
-on ADP B-O
-principle ADJ B-O
-component NOUN B-O
-analysis NOUN B-O
-( PUNCT B-O
-PCA PROPN B-O
-) PUNCT B-O
-and CCONJ B-O
-partial ADJ B-LF
-least ADJ I-LF
-squares NOUN I-LF
-discriminant ADJ B-O
-analysis NOUN B-O
-( PUNCT B-O
-PLS PROPN B-AC
-- PUNCT B-O
-DA PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-thus ADV B-O
-results NOUN B-O
-have AUX B-O
-been AUX B-O
-rather ADV B-O
-descriptive ADJ B-O
-[ PUNCT B-O
-2 NUM B-O
-, PUNCT B-O
-5 NUM B-O
-, PUNCT B-O
-16 NUM B-O
-, PUNCT B-O
-18 NUM B-O
-, PUNCT B-O
-22 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-UHDRS PROPN B-AC
-motor NOUN B-O
-score NOUN B-O
-( PUNCT B-O
-A NOUN B-O
-) PUNCT B-O
-; PUNCT B-O
-UHDRS PROPN B-AC
-behavioral ADJ B-O
-( PUNCT B-O
-B NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-IS PROPN B-AC
-: PUNCT B-O
-Independence PROPN B-O
-Score PROPN B-O
-( PUNCT B-O
-C PROPN B-O
-) PUNCT B-O
-; PUNCT B-O
-FAS PROPN B-AC
-: PUNCT B-O
-Functional PROPN B-LF
-Assessment PROPN I-LF
-Scale PROPN I-LF
-( PUNCT B-O
-D NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-cognitive ADJ B-O
-( PUNCT B-O
-letter NOUN B-O
-fluency NOUN B-O
-1 NUM B-O
-’ PUNCT B-O
-: PUNCT B-O
-at ADP B-O
-1 NUM B-O
-minute NOUN B-O
-( PUNCT B-O
-E NOUN B-O
-) PUNCT B-O
-; PUNCT B-O
-letter NOUN B-O
-fluency NOUN B-O
-2 NUM B-O
-’ PUNCT B-O
-: PUNCT B-O
-at ADP B-O
-2 NUM B-O
-minutes NOUN B-O
-( PUNCT B-O
-F NOUN B-O
-) PUNCT B-O
-; PUNCT B-O
-SDMT PROPN B-AC
-: PUNCT B-O
-symbol NOUN B-O
-digit NOUN B-O
-modalities NOUN B-O
-test NOUN B-O
-( PUNCT B-O
-G NOUN B-O
-) PUNCT B-O
-; PUNCT B-O
-Stroop NOUN B-O
-C PROPN B-O
-: PUNCT B-O
-Stroop NOUN B-O
-color NOUN B-O
-( PUNCT B-O
-H NOUN B-O
-) PUNCT B-O
-; PUNCT B-O
-Stroop NOUN B-O
-W PROPN B-O
-: PUNCT B-O
-Stroop NOUN B-O
-word NOUN B-O
-( PUNCT B-O
-I NOUN B-O
-) PUNCT B-O
-; PUNCT B-O
-Stroop NOUN B-O
-W PROPN B-O
-/ SYM B-O
-C PROPN B-O
-: PUNCT B-O
-Stroop NOUN B-O
-interference NOUN B-O
-( PUNCT B-O
-J NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-RR PROPN B-AC
-, PUNCT B-O
-relative ADJ B-LF
-risk NOUN I-LF
-. PUNCT B-O
-
-Dpp PROPN B-AC
-, PUNCT B-O
-Decapentaplegic PROPN B-LF
-; PUNCT B-O
-GMR PROPN B-AC
-, PUNCT B-O
-glass NOUN B-LF
-multiple ADJ I-LF
-reporter NOUN I-LF
-; PUNCT B-O
-MF PROPN B-AC
-, PUNCT B-O
-morphogenetic ADJ B-LF
-furrow NOUN I-LF
-; PUNCT B-O
-rpr PROPN B-O
-, PUNCT B-O
-reaper NOUN B-O
-. PUNCT B-O
-
-Since SCONJ B-O
-a DET B-O
-down ADJ B-O
-- ADJ B-O
-stream NOUN B-O
-integrator NOUN B-O
-of ADP B-O
-metabolic ADJ B-O
-alterations NOUN B-O
-, PUNCT B-O
-mammalian ADJ B-LF
-target NOUN I-LF
-of ADP I-LF
-rapamycin NOUN I-LF
-( PUNCT B-O
-mTOR PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-is AUX B-O
-responsible ADJ B-O
-for ADP B-O
-controlling VERB B-O
-the DET B-O
-balance NOUN B-O
-between ADP B-O
-pro ADJ B-O
-- ADJ B-O
-inflammatory ADJ B-O
-interleukin NOUN B-LF
-( PUNCT B-O
-IL)-12 PROPN B-AC
-and CCONJ B-O
-anti ADJ B-O
-- ADJ B-O
-inflammatory ADJ B-O
-IL-10 PROPN B-AC
-, PUNCT B-O
-we PRON B-O
-investigated VERB B-O
-the DET B-O
-effect NOUN B-O
-of ADP B-O
-upstream ADJ B-O
-interference NOUN B-O
-using VERB B-O
-metabolic ADJ B-O
-modulators NOUN B-O
-on ADP B-O
-the DET B-O
-production NOUN B-O
-of ADP B-O
-pro- ADJ B-O
-and CCONJ B-O
-anti ADJ B-O
-- ADJ B-O
-inflammatory ADJ B-O
-cytokines NOUN B-O
-. PUNCT B-O
-
-E NOUN B-O
-: PUNCT B-O
-Representative ADJ B-O
-images NOUN B-O
-of ADP B-O
-hepatic ADJ B-O
-hematoxylin NOUN B-O
-and CCONJ B-O
-eosin NOUN B-O
-( PUNCT B-O
-H&E PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-Oil PROPN B-O
-Red PROPN B-O
-O NOUN B-O
-and CCONJ B-O
-chloroacetate NOUN B-LF
-esterase NOUN I-LF
-( PUNCT B-O
-CAE PROPN B-AC
-) PUNCT B-O
-staining NOUN B-O
-. PUNCT B-O
-
-DOTS PROPN B-AC
-( PUNCT B-O
-directly ADV B-LF
-observed VERB I-LF
-treatment NOUN I-LF
-, PUNCT I-LF
-short ADJ I-LF
-course NOUN I-LF
-) PUNCT B-O
-is AUX B-O
-the DET B-O
-internationally ADV B-O
-recommended VERB B-O
-control NOUN B-O
-strategy NOUN B-O
-for ADP B-O
-TB PROPN B-AC
-[ PUNCT B-O
-3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Logistic ADJ B-O
-regression NOUN B-O
-was AUX B-O
-used VERB B-O
-to ADP B-O
-estimate VERB B-O
-the DET B-O
-odds NOUN B-LF
-ratio NOUN I-LF
-( PUNCT B-O
-OR PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-O
-interval NOUN B-O
-for ADP B-O
-the DET B-O
-relation NOUN B-O
-of ADP B-O
-diabetes NOUN B-O
-to ADP B-O
-the DET B-O
-IDE PROPN B-O
-genes NOUN B-O
-. PUNCT B-O
-
-Continuous ADJ B-O
-variables NOUN B-O
-with ADP B-O
-normal ADJ B-O
-distribution NOUN B-O
-are AUX B-O
-reported VERB B-O
-as ADP B-O
-mean NOUN B-O
-and CCONJ B-O
-standard ADJ B-O
-deviation NOUN B-O
-and CCONJ B-O
-compared VERB B-O
-using VERB B-O
-analysis NOUN B-LF
-of ADP I-LF
-variance NOUN I-LF
-( PUNCT B-O
-ANOVA PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Variables NOUN B-O
-without ADP B-O
-normal ADJ B-O
-distribution NOUN B-O
-are AUX B-O
-reported VERB B-O
-as ADP B-O
-median ADJ B-O
-and CCONJ B-O
-interquartile ADJ B-O
-range NOUN B-O
-( PUNCT B-O
-IQR PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-compared VERB B-O
-with ADP B-O
-Kruskal PROPN B-O
-- PUNCT B-O
-Wallis PROPN B-O
-test NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-contrast NOUN B-O
-, PUNCT B-O
-significant ADJ B-O
-progress NOUN B-O
-has AUX B-O
-been AUX B-O
-made VERB B-O
-in ADP B-O
-reconstituting VERB B-O
-purely ADV B-O
-chemical ADJ B-O
-reactions NOUN B-O
-that PRON B-O
-self NOUN B-O
-- PUNCT B-O
-organise VERB B-O
-, PUNCT B-O
-such ADJ B-O
-as ADP B-O
-the DET B-O
-Belousov PROPN B-O
-- PUNCT B-O
-Zhabotinski PROPN B-O
-reactions NOUN B-O
-[ PUNCT B-O
-13,14,15 NUM B-O
-] PUNCT B-O
-and CCONJ B-O
-Turing PROPN B-O
-- PUNCT B-O
-type NOUN B-O
-, PUNCT B-O
-Meinhardt PROPN B-LF
-- PUNCT I-LF
-Gierer PROPN I-LF
-( PUNCT B-O
-M-G PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-oscillatory ADJ B-O
-reactions NOUN B-O
-[ PUNCT B-O
-16,17,18,19,20 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-BMI PROPN B-AC
-, PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-; PUNCT B-O
-CI PROPN B-AC
-, PUNCT B-O
-confidence NOUN B-LF
-interval NOUN I-LF
-; PUNCT B-O
-HR PROPN B-AC
-, PUNCT B-O
-hazard NOUN B-LF
-ratio NOUN I-LF
-; PUNCT B-O
-Ref PROPN B-O
-. PUNCT B-O
-
-, PUNCT B-O
-Reference PROPN B-O
-category NOUN B-O
-We PRON B-O
-therefore ADV B-O
-aimed VERB B-O
-at ADV B-O
-exploring VERB B-O
-the DET B-O
-repertoire NOUN B-O
-of ADP B-O
-mRNAs NOUN B-O
-bound VERB B-O
-by ADP B-O
-aaRSs PROPN B-AC
-. PUNCT B-O
-
-To ADP B-O
-this DET B-O
-end NOUN B-O
-, PUNCT B-O
-we PRON B-O
-utilized VERB B-O
-yeast NOUN B-O
-strains NOUN B-O
-expressing VERB B-O
-endogenously ADV B-O
-, PUNCT B-O
-C PROPN B-O
-- PUNCT B-O
-terminally ADV B-O
-Tandem PROPN B-LF
-Affinity PROPN I-LF
-Purification PROPN I-LF
-( PUNCT B-O
-methionyl NOUN B-LF
-TAP)-tagged PROPN B-AC
-- PUNCT I-LF
-tRNA NOUN I-LF
-synthetase NOUN I-LF
-( PUNCT B-O
-MetRS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-glutamyl NOUN B-LF
-- PUNCT I-LF
-tRNA NOUN I-LF
-synthetase NOUN I-LF
-( PUNCT B-O
-GluRS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-valyl NOUN B-LF
-- PUNCT I-LF
-tRNA NOUN I-LF
-synthetase NOUN I-LF
-( PUNCT B-O
-ValRS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-HisRS PROPN B-AC
-or CCONJ B-O
-green ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-( PUNCT B-O
-GFP)-tagged PROPN B-AC
-HisRS PROPN B-AC
-and CCONJ B-O
-glutamine NOUN B-LF
-- PUNCT I-LF
-tRNA NOUN I-LF
-synthetase NOUN I-LF
-( PUNCT B-O
-GlnRS PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-These DET B-O
-aaRSs PROPN B-AC
-appeared VERB B-O
-to PART B-O
-be AUX B-O
-associated VERB B-O
-with ADP B-O
-mRNA NOUN B-O
-in ADP B-O
-at ADV B-O
-least ADV B-O
-two NUM B-O
-of ADP B-O
-the DET B-O
-yeast NOUN B-O
-interactome NOUN B-O
-studies NOUN B-O
-( PUNCT B-O
-S1 PROPN B-O
-Table PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-contrast NOUN B-O
-to ADP B-O
-other ADJ B-O
-XP PROPN B-AC
-patients NOUN B-O
-, PUNCT B-O
-those PRON B-O
-with ADP B-O
-the DET B-O
-variant NOUN B-O
-form NOUN B-O
-( PUNCT B-O
-XPV PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-Xeroderma PROPN B-LF
-Pigmentosum PROPN I-LF
-have VERB B-O
-no DET B-O
-defect NOUN B-O
-in ADP B-O
-excision NOUN B-O
-repair NOUN B-O
-[ PUNCT B-O
-8 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-but CCONJ B-O
-are AUX B-O
-deficient ADJ B-O
-in ADP B-O
-post ADJ B-O
-- ADJ B-O
-replication ADJ B-O
-repair NOUN B-O
-[ PUNCT B-O
-23 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Then ADV B-O
-, PUNCT B-O
-we PRON B-O
-selected VERB B-O
-the DET B-O
-compounds NOUN B-O
-library NOUN B-O
-which PRON B-O
-included VERB B-O
-those DET B-O
-drug NOUN B-O
-classes NOUN B-O
-( PUNCT B-O
-ZINC15 PROPN B-O
-FDA PROPN B-O
-- PUNCT B-O
-approved VERB B-O
-drugs NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-carried VERB B-O
-out ADP B-O
-the DET B-O
-virtual ADJ B-LF
-screening NOUN I-LF
-( PUNCT B-O
-VS PROPN B-AC
-) PUNCT B-O
-study NOUN B-O
-against ADP B-O
-that DET B-O
-library NOUN B-O
-using VERB B-O
-structures NOUN B-O
-of ADP B-O
-incretin NOUN B-O
-receptors NOUN B-O
-. PUNCT B-O
-
-Analytical ADJ B-LF
-ultracentrifugation NOUN I-LF
-( PUNCT B-O
-AUC PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-sedimentation NOUN B-LF
-velocity NOUN I-LF
-( PUNCT B-O
-SV PROPN B-AC
-) PUNCT B-O
-mode NOUN B-O
-was AUX B-O
-performed VERB B-O
-on ADP B-O
-the DET B-O
-wild ADJ B-O
-- PUNCT B-O
-type NOUN B-O
-protein NOUN B-O
-and CCONJ B-O
-all PRON B-O
-of ADP B-O
-the DET B-O
-mutated VERB B-O
-proteins NOUN B-O
-. PUNCT B-O
-
-Virus NOUN B-O
-titers NOUN B-O
-were AUX B-O
-determined VERB B-O
-by ADP B-O
-endpoint NOUN B-O
-dilution NOUN B-O
-assay NOUN B-O
-and CCONJ B-O
-calculated VERB B-O
-by ADP B-O
-the DET B-O
-method NOUN B-O
-of ADP B-O
-Reed PROPN B-O
-and CCONJ B-O
-Muench PROPN B-O
-and CCONJ B-O
-expressed VERB B-O
-as ADP B-O
-50 NUM B-LF
-% NOUN I-LF
-tissue NOUN I-LF
-culture NOUN I-LF
-infectious ADJ I-LF
-dose NOUN I-LF
-( PUNCT B-O
-TCID50 PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-53 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Examples NOUN B-O
-include VERB B-O
-statine NOUN B-LF
-( PUNCT B-O
-Sta)-containing PROPN B-AC
-inhibitors NOUN B-O
-and CCONJ B-O
-several ADJ B-O
-are AUX B-O
-now ADV B-O
-in ADP B-O
-clinical ADJ B-O
-use NOUN B-O
-[ PUNCT B-O
-21 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Consistently ADV B-O
-, PUNCT B-O
-in ADP B-O
-pollen NOUN B-O
-tubes NOUN B-O
-tip NOUN B-O
-, PUNCT B-O
-ROP PROPN B-AC
-/ SYM B-O
-RAC PROPN B-O
-proteins NOUN B-O
-were AUX B-O
-shown VERB B-O
-to PART B-O
-physically ADV B-O
-associate VERB B-O
-with ADP B-O
-a DET B-O
-phosphatidylinositol NOUN B-LF
-monophosphate NOUN I-LF
-kinase NOUN I-LF
-( PUNCT B-O
-PtdInsP-K PROPN B-AC
-) PUNCT B-O
-activity NOUN B-O
-[ PUNCT B-O
-46 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-PtdIns PROPN B-O
-- PUNCT B-O
-P2 PROPN B-O
-, PUNCT B-O
-the DET B-O
-product NOUN B-O
-of ADP B-O
-PtdIns PROPN B-AC
-, PUNCT B-O
-had VERB B-O
-similar ADJ B-O
-distribution NOUN B-O
-[ PUNCT B-O
-46],[47 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-FLPe PROPN B-O
-( PUNCT B-O
-Flip)-mediated NOUN B-O
-recombination NOUN B-O
-resulted VERB B-O
-in ADP B-O
-a DET B-O
-continuous ADJ B-O
-reading NOUN B-O
-frame NOUN B-O
-from ADP B-O
-the DET B-O
-authentic ADJ B-O
-Mll2 NOUN B-O
-initiating VERB B-O
-codon NOUN B-O
-, PUNCT B-O
-through ADP B-O
-eYFP NOUN B-O
-and CCONJ B-O
-the DET B-O
-residual ADJ B-O
-FRT NOUN B-O
-to PART B-O
-the DET B-O
-second ADJ B-O
-amino NOUN B-O
-acid NOUN B-O
-of ADP B-O
-Mll2 NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-B NOUN B-O
-) PUNCT B-O
-Mice NOUN B-O
-carrying VERB B-O
-a DET B-O
-single ADJ B-O
-copy NOUN B-O
-of ADP B-O
-Mll2 NOUN B-O
-tm2 NOUN B-O
-( PUNCT B-O
-Mll2 NOUN B-O
-tm2/+ NOUN B-O
-) PUNCT B-O
-were AUX B-O
-intercrossed VERB B-O
-to PART B-O
-obtain VERB B-O
-control NOUN B-O
-( PUNCT B-O
-Mll2 NOUN B-O
-+ X B-O
-/+and CCONJ B-O
-Mll2 NOUN B-O
-tm2/+ NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-experimental ADJ B-O
-Mll2 NOUN B-O
-tm2 NOUN B-O
-/ SYM B-O
-tm2 NOUN B-O
-mice NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-C X B-O
-) PUNCT B-O
-Southern PROPN B-O
-blot NOUN B-O
-analysis NOUN B-O
-of ADP B-O
-tail NOUN B-O
-genomic ADJ B-O
-DNA NOUN B-O
-: PUNCT B-O
-a DET B-O
-3.8 NUM B-O
-kb NOUN B-O
-band NOUN B-O
-denotes VERB B-O
-the DET B-O
-Mll2 NOUN B-O
-tm2 NOUN B-O
-/ SYM B-O
-tm2 NOUN B-O
-allele NOUN B-O
-, PUNCT B-O
-whereas SCONJ B-O
-a DET B-O
-3.0 NUM B-O
-kb NOUN B-O
-band NOUN B-O
-denotes VERB B-O
-the DET B-O
-wild ADJ B-LF
-type NOUN I-LF
-( PUNCT B-O
-WT PROPN B-AC
-) PUNCT B-O
-allele NOUN B-O
-. PUNCT B-O
-
-Fewer ADJ B-O
-falls NOUN B-O
-( PUNCT B-O
-incidence NOUN B-LF
-rate NOUN I-LF
-ratio NOUN I-LF
-[ PUNCT B-O
-IRR PROPN B-AC
-] PUNCT B-O
-: PUNCT B-O
-0.65 NUM B-O
-, PUNCT B-O
-0.43–0.99 NUM B-O
-; PUNCT B-O
-P NOUN B-O
-= SYM B-O
-0.042 NUM B-O
-) PUNCT B-O
-were AUX B-O
-observed VERB B-O
-in ADP B-O
-the DET B-O
-RESPOND NOUN B-O
-group NOUN B-O
-compared VERB B-O
-with ADP B-O
-the DET B-O
-control NOUN B-O
-( PUNCT B-O
-Table PROPN B-O
-3 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Cancer NOUN B-O
-development NOUN B-O
-and CCONJ B-O
-tumor NOUN B-O
-growth NOUN B-O
-are AUX B-O
-driven VERB B-O
-by ADP B-O
-specific ADJ B-O
-types NOUN B-O
-of ADP B-O
-cells NOUN B-O
-— PUNCT B-O
-stem NOUN B-LF
-cell NOUN I-LF
-- PUNCT I-LF
-like ADJ I-LF
-cancer NOUN I-LF
-cells NOUN I-LF
-( PUNCT B-O
-SCLCCs)—which PROPN B-AC
-are AUX B-O
-also ADV B-O
-responsible ADJ B-O
-for ADP B-O
-metastatic ADJ B-O
-spread NOUN B-O
-and CCONJ B-O
-drug NOUN B-O
-resistance NOUN B-O
-. PUNCT B-O
-
-Under ADP B-O
-some DET B-O
-conditions NOUN B-O
-, PUNCT B-O
-the DET B-O
-C262 PROPN B-O
-- PUNCT B-O
-S PROPN B-AC
-P NOUN B-O
-ribozyme NOUN B-LF
-E·S·G PROPN B-AC
-ternary ADJ B-O
-complex NOUN B-O
-must AUX B-O
-undergo VERB B-O
-a DET B-O
-rate NOUN B-O
-- PUNCT B-O
-limiting VERB B-O
-conformational ADJ B-O
-change NOUN B-O
-en ADP B-O
-route NOUN B-O
-to ADP B-O
-the DET B-O
-chemical ADJ B-O
-transition NOUN B-O
-state NOUN B-O
-. PUNCT B-O
-
-To PART B-O
-address VERB B-O
-these DET B-O
-concerns NOUN B-O
-, PUNCT B-O
-we PRON B-O
-propose VERB B-O
-a DET B-O
-new ADJ B-O
-generic ADJ B-O
-approach NOUN B-O
-for ADP B-O
-estimating VERB B-O
-the DET B-O
-distribution NOUN B-O
-of ADP B-O
-incident NOUN B-O
-infections NOUN B-O
-acquired VERB B-O
-according VERB B-O
-to PART B-O
-identifiable ADJ B-O
-determinants NOUN B-O
-of ADP B-O
-risk NOUN B-O
-in ADP B-O
-the DET B-O
-generalised VERB B-O
-epidemics NOUN B-O
-of ADP B-O
-SSA PROPN B-AC
-. PUNCT B-O
-
-The DET B-O
-objectives NOUN B-O
-of ADP B-O
-this DET B-O
-study NOUN B-O
-were AUX B-O
-to PART B-O
-( PUNCT B-O
-1 X B-O
-) PUNCT B-O
-describe VERB B-O
-the DET B-O
-Incidence PROPN B-LF
-Patterns PROPN I-LF
-Model PROPN I-LF
-( PUNCT B-O
-IPM PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-SSA PROPN B-AC
-, PUNCT B-O
-( PUNCT B-O
-2 X B-O
-) PUNCT B-O
-validate VERB B-O
-and CCONJ B-O
-train VERB B-O
-the DET B-O
-IPM PROPN B-AC
-using VERB B-O
-data NOUN B-O
-from ADP B-O
-cohort NOUN B-O
-studies NOUN B-O
-in ADP B-O
-four NUM B-O
-countries NOUN B-O
-, PUNCT B-O
-( PUNCT B-O
-3 X B-O
-) PUNCT B-O
-apply VERB B-O
-the DET B-O
-IPM PROPN B-AC
-to PART B-O
-six NUM B-O
-different ADJ B-O
-countries NOUN B-O
-to PART B-O
-show VERB B-O
-the DET B-O
-predicted VERB B-O
-distributions NOUN B-O
-of ADP B-O
-newly ADV B-O
-acquired VERB B-O
-HIV PROPN B-O
-infections NOUN B-O
-in ADP B-O
-different ADJ B-O
-population NOUN B-O
-groups NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-( PUNCT B-O
-4 X B-O
-) PUNCT B-O
-use VERB B-O
-the DET B-O
-IPM PROPN B-AC
-outputs NOUN B-O
-to PART B-O
-infer VERB B-O
-the DET B-O
-distributions NOUN B-O
-of ADP B-O
-the DET B-O
-groups NOUN B-O
-transmitting VERB B-O
-HIV PROPN B-O
-. PUNCT B-O
-
-The DET B-O
-accumulation NOUN B-O
-of ADP B-O
-TAG PROPN B-AC
-- PUNCT B-O
-containing VERB B-O
-lipid NOUN B-O
-droplets NOUN B-O
-in ADP B-O
-multiple ADJ B-O
-tissues NOUN B-O
-characteristic ADJ B-O
-of ADP B-O
-CDS PROPN B-O
-has AUX B-O
-been AUX B-O
-linked VERB B-O
-to ADP B-O
-impaired ADJ B-O
-lipolysis NOUN B-O
-caused VERB B-O
-by ADP B-O
-mutations NOUN B-O
-in ADP B-O
-comparative ADJ B-LF
-gene NOUN I-LF
-identification NOUN I-LF
-58 NUM I-LF
-( PUNCT B-O
-CGI-58 PROPN B-AC
-; PUNCT B-O
-also ADV B-O
-called VERB B-O
-ABHD5 NOUN B-O
-) PUNCT B-O
-[ PUNCT B-O
-5 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Hepatorenal PROPN B-LF
-syndrome NOUN I-LF
-( PUNCT B-O
-HRS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-most ADV B-O
-severe ADJ B-O
-form NOUN B-O
-of ADP B-O
-AKI PROPN B-AC
-in ADP B-O
-cirrhosis NOUN B-O
-, PUNCT B-O
-develops VERB B-O
-in ADP B-O
-more ADJ B-O
-than ADP B-O
-50 NUM B-O
-% NOUN B-O
-of ADP B-O
-patients NOUN B-O
-with ADP B-O
-cirrhosis NOUN B-O
-who PRON B-O
-die VERB B-O
-[ PUNCT B-O
-3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-PCA PROPN B-AC
-, PUNCT B-O
-principal ADJ B-LF
-component NOUN I-LF
-analysis NOUN I-LF
-. PUNCT B-O
-
-BHIS PROPN B-AC
-, PUNCT B-O
-brain NOUN B-LF
-heart NOUN I-LF
-infusion NOUN I-LF
-plus CCONJ I-LF
-yeast NOUN I-LF
-; PUNCT B-O
-c PROPN B-AC
-, PUNCT B-O
-cyclic ADJ B-LF
-diguanosine NOUN I-LF
-monophosphate NOUN I-LF
-; PUNCT B-O
-cmr NOUN B-O
-, PUNCT B-O
-colony NOUN B-O
-morphology NOUN B-O
-regulators NOUN B-O
-; PUNCT B-O
--di-GMPDccA PROPN B-AC
-, PUNCT B-O
-diguanylate NOUN B-LF
-cyclase NOUN I-LF
-A NOUN I-LF
-; PUNCT B-O
-erm PROPN B-AC
-, PUNCT B-O
-erythromycin NOUN B-LF
-resistance NOUN I-LF
-cassette NOUN I-LF
-; PUNCT B-O
-mut NOUN B-O
-, PUNCT B-O
-mutant NOUN B-O
-; PUNCT B-O
-R NOUN B-O
-, PUNCT B-O
-rough ADJ B-O
-; PUNCT B-O
-S NOUN B-O
-, PUNCT B-O
-smooth NOUN B-O
-; PUNCT B-O
-qPCR PROPN B-AC
-, PUNCT B-O
-quantitative ADJ B-LF
-PCR NOUN I-LF
-; PUNCT B-O
-qRT PROPN B-AC
-, PUNCT B-O
-quantitative ADJ B-LF
-real ADJ I-LF
-- PUNCT I-LF
-time NOUN I-LF
-PCR NOUN I-LF
-; PUNCT B-O
-sigD NOUN B-O
-, PUNCT B-O
-sigma NOUN B-O
-factor NOUN B-O
-D PROPN B-O
-gene NOUN B-O
-; PUNCT B-O
--PCRTFP PROPN B-AC
-, PUNCT B-O
-type NOUN B-LF
-IV NUM I-LF
-pilus NOUN I-LF
-. PUNCT B-O
-
-Interferon PROPN B-LF
-( PUNCT B-O
-IFN PROPN B-AC
-) PUNCT B-O
-therapy NOUN B-O
-has AUX B-O
-been AUX B-O
-proved VERB B-O
-to PART B-O
-achieve VERB B-O
-sustained ADJ B-LF
-virologic ADJ I-LF
-response NOUN I-LF
-( PUNCT B-O
-SVR PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-patients NOUN B-O
-with ADP B-O
-chronic ADJ B-O
-HCV PROPN B-AC
-infection NOUN B-O
-and CCONJ B-O
-can AUX B-O
-prevent VERB B-O
-progression NOUN B-O
-of ADP B-O
-liver NOUN B-O
-fibrosis NOUN B-O
-. PUNCT B-O
-
-Thus ADV B-O
-, PUNCT B-O
-we PRON B-O
-expressed VERB B-O
-carnitine NOUN B-O
-palmitoyltransferase NOUN B-O
-1AM PROPN B-O
-( PUNCT B-O
-CPT1AM PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-permanently ADV B-LF
-active ADJ I-LF
-mutant ADJ I-LF
-form NOUN I-LF
-of ADP I-LF
-CPT1A PROPN I-LF
-CPT1A PROPN B-AC
-( PUNCT B-O
-the DET B-O
-rate NOUN B-O
-- PUNCT B-O
-limiting VERB B-O
-enzyme NOUN B-O
-in ADP B-O
-FAO PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-in ADP B-O
-a DET B-O
-rat NOUN B-O
-brown ADJ B-O
-adipocyte NOUN B-O
-( PUNCT B-O
-rBA PROPN B-AC
-) PUNCT B-O
-cell NOUN B-O
-line NOUN B-O
-through ADP B-O
-adenoviral ADJ B-O
-infection NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-neurons NOUN B-O
-, PUNCT B-O
-the DET B-O
-gp120 PROPN B-O
-interaction NOUN B-O
-with ADP B-O
-CXCR4 PROPN B-AC
-enhances VERB B-O
-Ca2 NOUN B-O
-+ NOUN B-O
--regulating VERB B-O
-systems NOUN B-O
-through ADP B-O
-NMDA PROPN B-O
-receptors NOUN B-O
-( PUNCT B-O
-NMDARs PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-synaptic ADJ B-O
-membrane NOUN B-O
-and CCONJ B-O
-inositol NOUN B-O
-trisphosphate NOUN B-O
-receptors NOUN B-O
-( PUNCT B-O
-IP3Rs PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-endoplasmic ADJ B-LF
-reticulum NOUN I-LF
-( PUNCT B-O
-ER PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-resulting VERB B-O
-in ADP B-O
-apoptosis NOUN B-O
-[ PUNCT B-O
-28–34 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Brain NOUN B-LF
-– PUNCT I-LF
-machine NOUN I-LF
-interfaces NOUN I-LF
-( PUNCT B-O
-BMIs PROPN B-AC
-) PUNCT B-O
-have VERB B-O
-the DET B-O
-potential NOUN B-O
-to PART B-O
-revolutionize VERB B-O
-the DET B-O
-care NOUN B-O
-of ADP B-O
-neurologically ADV B-O
-impaired ADJ B-O
-patients NOUN B-O
-. PUNCT B-O
-
-Antimicrobial ADJ B-LF
-peptides NOUN I-LF
-( PUNCT B-O
-AMPs PROPN B-AC
-) PUNCT B-O
-play VERB B-O
-a DET B-O
-key ADJ B-O
-role NOUN B-O
-in ADP B-O
-innate ADJ B-O
-immune ADJ B-O
-response NOUN B-O
-against ADP B-O
-bacteria NOUN B-O
-, PUNCT B-O
-viruses NOUN B-O
-, PUNCT B-O
-fungi NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-parasites NOUN B-O
-[ PUNCT B-O
-20,21 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-FFR PROPN B-AC
-, PUNCT B-O
-fractional ADJ B-LF
-flow NOUN I-LF
-reserve NOUN I-LF
-. PUNCT B-O
-
-Co ADJ B-O
-- PUNCT B-O
-primary ADJ B-O
-short- ADJ B-O
-and CCONJ B-O
-long ADJ B-O
-- PUNCT B-O
-term NOUN B-O
-outcomes NOUN B-O
-were AUX B-O
-1 NUM B-O
-- PUNCT B-O
-year NOUN B-O
-total ADJ B-LF
-kidney NOUN I-LF
-volume NOUN I-LF
-( PUNCT B-O
-TKV PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-computed ADJ B-O
-tomography NOUN B-O
-scan NOUN B-O
-) PUNCT B-O
-growth NOUN B-O
-and CCONJ B-O
-3 NUM B-O
-- PUNCT B-O
-year NOUN B-O
-GFR PROPN B-AC
-( PUNCT B-O
-iohexol NOUN B-O
-plasma NOUN B-O
-clearance NOUN B-O
-) PUNCT B-O
-decline NOUN B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-BMI PROPN B-AC
-, PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-; PUNCT B-O
-HEI PROPN B-AC
-, PUNCT B-O
-Healthy PROPN B-LF
-Eating PROPN I-LF
-Index PROPN I-LF
-; PUNCT B-O
-Q NOUN B-O
-, PUNCT B-O
-quartile NOUN B-O
-. PUNCT B-O
-
-Indeed ADV B-O
-, PUNCT B-O
-discrimination NOUN B-O
-of ADP B-O
-the DET B-O
-mother NOUN B-O
-and CCONJ B-O
-daughter NOUN B-O
-using VERB B-O
-CEP164 PROPN B-O
-immunostaining NOUN B-O
-showed VERB B-O
-that SCONJ B-O
-roots NOUN B-O
-are AUX B-O
-nucleated VERB B-O
-symmetrically ADV B-O
-on ADP B-O
-both CCONJ B-O
-mother NOUN B-O
-and CCONJ B-O
-daughter NOUN B-O
-( PUNCT B-O
-Fig NOUN B-O
-4B NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-A DET B-O
-similar ADJ B-O
-comparison NOUN B-O
-of ADP B-O
-PCM PROPN B-AC
-structure NOUN B-O
-with ADP B-O
-the DET B-O
-PCM PROPN B-AC
-resident NOUN B-O
-Pericentrin PROPN B-LF
-( PUNCT B-O
-PCNT PROPN B-AC
-) PUNCT B-O
-showed VERB B-O
-similarly ADV B-O
-that SCONJ B-O
-both CCONJ B-O
-mother NOUN B-O
-and CCONJ B-O
-daughter NOUN B-O
-centrioles NOUN B-O
-individually ADV B-O
-nucleate VERB B-O
-PCM PROPN B-AC
-when SCONJ B-O
-split VERB B-O
-( PUNCT B-O
-Fig NOUN B-O
-4C NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-something PRON B-O
-also ADV B-O
-evident ADJ B-O
-in ADP B-O
-the DET B-O
-live ADJ B-O
-- PUNCT B-O
-cell NOUN B-O
-imaging NOUN B-O
-of ADP B-O
-NEDD1 PROPN B-AC
-- PUNCT B-O
-mRuby3 PROPN B-O
-( PUNCT B-O
-Fig NOUN B-O
-3H–3 NUM B-O
-K NUM B-O
-) PUNCT B-O
-and CCONJ B-O
-previous ADJ B-O
-work NOUN B-O
-[ X B-O
-24,32,34 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Water NOUN B-O
-deficit NOUN B-O
-was AUX B-O
-initiated VERB B-O
-when SCONJ B-O
-seedlings NOUN B-O
-were AUX B-O
-almost ADV B-O
-20 NUM B-O
-day NOUN B-O
-- PUNCT B-O
-old ADJ B-O
-, PUNCT B-O
-attaining VERB B-O
-2–3 NUM B-O
-true ADJ B-O
-leaves NOUN B-O
-and CCONJ B-O
-it PRON B-O
-was AUX B-O
-applied VERB B-O
-by ADP B-O
-maintaining VERB B-O
-the DET B-O
-soil NOUN B-O
-moisture NOUN B-O
-at ADP B-O
-40 NUM B-O
-% NOUN B-O
-of ADP B-O
-substrate NOUN B-O
-field NOUN B-LF
-capacity NOUN I-LF
-( PUNCT B-O
-FC PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-the DET B-O
-stressed VERB B-O
-plants NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-80 NUM B-O
-% NOUN B-O
-FC PROPN B-AC
-for ADP B-O
-the DET B-O
-well ADV B-O
-- PUNCT B-O
-watered VERB B-O
-plants NOUN B-O
-. PUNCT B-O
-
-It PRON B-O
-would AUX B-O
-be AUX B-O
-worth ADJ B-O
-noting VERB B-O
-that PRON B-O
-the DET B-O
-clustered VERB B-O
-lysine NOUN B-O
-residues NOUN B-O
-that PRON B-O
-we PRON B-O
-found VERB B-O
-as ADP B-O
-TMP195 NOUN B-O
-- ADJ B-O
-sensitive ADJ B-O
-acetylation NOUN B-O
-sites NOUN B-O
-were AUX B-O
-located VERB B-O
-in ADP B-O
-the DET B-O
-N NOUN B-O
-- ADJ B-O
-terminal ADJ B-O
-intrinsically ADV B-LF
-disordered VERB I-LF
-region NOUN I-LF
-( PUNCT B-O
-IDR PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-NCL PROPN B-AC
-( PUNCT B-O
-S7C PROPN B-O
-Fig PROPN B-O
-) PUNCT B-O
-[ PUNCT B-O
-87 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-They PRON B-O
-recognize VERB B-O
-bacterial ADJ B-O
-surface NOUN B-O
-molecules NOUN B-O
-, PUNCT B-O
-such ADJ B-O
-as ADP B-O
-lipopolysaccharides NOUN B-O
-( PUNCT B-O
-LPS PROPN B-AC
-) PUNCT B-O
-from ADP B-O
-the DET B-O
-outer ADJ B-O
-wall NOUN B-O
-of ADP B-O
-Gram NOUN B-O
-- PUNCT B-O
-negative ADJ B-O
-bacteria NOUN B-O
-and CCONJ B-O
-flagellin NOUN B-LF
-( PUNCT B-O
-FLG PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-is AUX B-O
-a DET B-O
-structural ADJ B-O
-protein NOUN B-O
-of ADP B-O
-flagellum NOUN B-O
-, PUNCT B-O
-a DET B-O
-bacterial ADJ B-O
-locomotive NOUN B-O
-organelle NOUN B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-OR PROPN B-AC
-: PUNCT B-O
-odds NOUN B-LF
-ratio NOUN I-LF
-; PUNCT B-O
-CI PROPN B-AC
-: PUNCT B-O
-confidence NOUN B-O
-interval NOUN B-O
-. PUNCT B-O
-
-MOI PROPN B-AC
-represents VERB B-O
-the DET B-O
-multiplicity NOUN B-LF
-of ADP I-LF
-infection NOUN I-LF
-. PUNCT B-O
-
-Both DET B-O
-domains NOUN B-O
-share VERB B-O
-approximately ADV B-O
-9 NUM B-O
-% NOUN B-O
-sequence NOUN B-O
-identity NOUN B-O
-and CCONJ B-O
-can AUX B-O
-be AUX B-O
-superimposed VERB B-O
-with ADP B-O
-a DET B-O
-root NOUN B-LF
-mean ADJ I-LF
-square ADJ I-LF
-( PUNCT B-O
-rms PROPN B-AC
-) PUNCT B-O
-deviation NOUN B-O
-of ADP B-O
-2.4 NUM B-O
-Å NOUN B-O
-using VERB B-O
-101 NUM B-O
-Cα NOUN B-O
-- NOUN B-O
-atoms NOUN B-O
-out ADP B-O
-of ADP B-O
-153 NUM B-O
-from ADP B-O
-domain NOUN B-O
-1 NUM B-O
-, PUNCT B-O
-and CCONJ B-O
-201 NUM B-O
-from ADP B-O
-domain NOUN B-O
-4 NUM B-O
-, PUNCT B-O
-respectively ADV B-O
-. PUNCT B-O
-
-The DET B-O
-study NOUN B-O
-was AUX B-O
-carried VERB B-O
-out ADP B-O
-in ADP B-O
-collaboration NOUN B-O
-with ADP B-O
-the DET B-O
-Swiss PROPN B-LF
-Childhood PROPN I-LF
-Cancer PROPN I-LF
-Registry PROPN I-LF
-( PUNCT B-O
-SCCR PROPN B-AC
-, PUNCT B-O
-www.childhoodcancerregistry.ch X B-O
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-, PUNCT B-O
-since SCONJ B-O
-1976 NUM B-O
-, PUNCT B-O
-has AUX B-O
-included VERB B-O
-all DET B-O
-children NOUN B-O
-and CCONJ B-O
-adolescents NOUN B-O
-in ADP B-O
-Switzerland PROPN B-O
-diagnosed VERB B-O
-with ADP B-O
-leukemia NOUN B-O
-, PUNCT B-O
-lymphoma NOUN B-O
-, PUNCT B-O
-central ADJ B-LF
-nervous ADJ I-LF
-system NOUN I-LF
-( PUNCT B-O
-CNS PROPN B-AC
-) PUNCT B-O
-tumors NOUN B-O
-, PUNCT B-O
-malignant ADJ B-O
-solid ADJ B-O
-tumors NOUN B-O
-and CCONJ B-O
-Langerhans PROPN B-LF
-cell NOUN I-LF
-histiocytosis NOUN I-LF
-( PUNCT B-O
-LCH PROPN B-AC
-) PUNCT B-O
-before SCONJ B-O
-they PRON B-O
-were AUX B-O
-21 NUM B-O
-[ PUNCT B-O
-17 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Yunnan PROPN B-O
-province NOUN B-O
-itself PRON B-O
-has VERB B-O
-a DET B-O
-large ADJ B-O
-population NOUN B-O
-of ADP B-O
-people NOUN B-LF
-who PRON I-LF
-inject VERB I-LF
-drugs NOUN I-LF
-( PUNCT B-O
-PWID PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-15 NUM B-O
-, PUNCT B-O
-16 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-possibly ADV B-O
-due ADP B-O
-to ADP B-O
-Yunnan PROPN B-O
-’s PART B-O
-position NOUN B-O
-along ADP B-O
-key ADJ B-O
-heroin NOUN B-O
-trafficking NOUN B-O
-routes NOUN B-O
-into ADP B-O
-China PROPN B-O
-[ PUNCT B-O
-17 NUM B-O
-, PUNCT B-O
-18 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-A3A PROPN B-AC
-, PUNCT B-O
-APOBEC3A. PROPN B-LF
-Serial ADJ B-O
-10 NUM B-O
-- PUNCT B-O
-fold ADJ B-O
-dilution NOUN B-O
-from ADP B-O
-indicated VERB B-O
-strains NOUN B-O
-spotted VERB B-O
-onto ADP B-O
-media NOUN B-O
-containing VERB B-O
-indicated VERB B-O
-hydroxyurea NOUN B-LF
-( PUNCT B-O
-HU PROPN B-AC
-, PUNCT B-O
-top ADJ B-O
-panel NOUN B-O
-) PUNCT B-O
-or CCONJ B-O
-camptothecin NOUN B-LF
-( PUNCT B-O
-CPT PROPN B-AC
-, PUNCT B-O
-bottom ADJ B-O
-panel NOUN B-O
-) PUNCT B-O
-concentration NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-complete ADJ B-O
-results NOUN B-O
-for ADP B-O
-two NUM B-O
-distinct ADJ B-O
-diplococci NOUN B-O
-( PUNCT B-O
-no NOUN B-O
-. PUNCT B-O
-
-109 NUM B-O
-and CCONJ B-O
-no NOUN B-O
-. PUNCT B-O
-
-110 NUM B-O
-) PUNCT B-O
-are AUX B-O
-presented VERB B-O
-in ADP B-O
-Figure PROPN B-O
-S3 NUM B-O
-. PUNCT B-O
-
-The DET B-O
-position NOUN B-O
-coordinates NOUN B-O
-of ADP B-O
-individual ADJ B-O
-diplococci NOUN B-O
-mounted VERB B-O
-on ADP B-O
-formvar NOUN B-O
-- NOUN B-O
-coated VERB B-O
-gold NOUN B-O
-TEM PROPN B-AC
-grids NOUN B-O
-were AUX B-O
-determined VERB B-O
-by ADP B-O
-light NOUN B-LF
-microscopy NOUN I-LF
-( PUNCT B-O
-LM PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-TEM PROPN B-AC
-grids NOUN B-O
-were AUX B-O
-subsequently ADV B-O
-placed VERB B-O
-in ADP B-O
-the DET B-O
-focal ADJ B-O
-plane NOUN B-O
-of ADP B-O
-the DET B-O
-X NOUN B-O
-- NOUN B-O
-ray NOUN B-O
-optic NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-grid NOUN B-O
-markers NOUN B-O
-were AUX B-O
-used VERB B-O
-to PART B-O
-locate VERB B-O
-the DET B-O
-targeted VERB B-O
-cells NOUN B-O
-. PUNCT B-O
-
-Because SCONJ B-O
-PMNs PROPN B-AC
-adhere VERB B-O
-to ADP B-O
-plates NOUN B-O
-after ADP B-O
-activation NOUN B-O
-, PUNCT B-O
-the DET B-O
-use NOUN B-O
-of ADP B-O
-counting NOUN B-O
-by ADP B-O
-flow NOUN B-O
-cytometry NOUN B-O
-was AUX B-O
-ineffective ADJ B-O
-for ADP B-O
-determining VERB B-O
-viability NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-instead ADV B-O
-viability NOUN B-O
-was AUX B-O
-assessed VERB B-O
-using VERB B-O
-cytosolic ADJ B-O
-mammalian ADJ B-O
-- PUNCT B-O
-specific ADJ B-O
-lactate NOUN B-LF
-dehydrogenase NOUN I-LF
-( PUNCT B-O
-LDH PROPN B-AC
-) PUNCT B-O
-detection NOUN B-O
-in ADP B-O
-supernatants NOUN B-O
-using VERB B-O
-the DET B-O
-CytoTox PROPN B-O
-- PUNCT B-O
-One NUM B-O
-homogeneous ADJ B-O
-membrane NOUN B-O
-integrity NOUN B-O
-assay NOUN B-O
-( PUNCT B-O
-Promega PROPN B-O
-, PUNCT B-O
-Madison PROPN B-O
-, PUNCT B-O
-WI PROPN B-O
-) PUNCT B-O
-as SCONJ B-O
-described VERB B-O
-[ PUNCT B-O
-27 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Data NOUN B-O
-on ADP B-O
-sow NOUN B-O
-, PUNCT B-O
-piglet NOUN B-O
-, PUNCT B-O
-weaner NOUN B-O
-and CCONJ B-O
-fattening NOUN B-O
-pig NOUN B-O
-holdings NOUN B-O
-were AUX B-O
-described VERB B-O
-separately ADV B-O
-, PUNCT B-O
-using VERB B-O
-the DET B-O
-semi ADJ B-O
-- ADJ B-O
-annual ADJ B-O
-treatment NOUN B-LF
-frequency NOUN I-LF
-( PUNCT B-O
-TF PROPN B-AC
-) PUNCT B-O
-to PART B-O
-measure VERB B-O
-antibiotic ADJ B-O
-consumption NOUN B-O
-. PUNCT B-O
-
-MHC PROPN B-AC
-, PUNCT B-O
-major ADJ B-LF
-histocompatibility NOUN I-LF
-complex NOUN I-LF
-. PUNCT B-O
-
-Many ADJ B-O
-activation NOUN B-O
-events NOUN B-O
-downstream ADV B-O
-of ADP B-O
-the DET B-O
-T NOUN B-LF
-- PUNCT I-LF
-cell NOUN I-LF
-antigen NOUN I-LF
-receptor NOUN I-LF
-( PUNCT B-O
-TCR PROPN B-AC
-) PUNCT B-O
-are AUX B-O
-up ADV B-O
-- PUNCT B-O
-regulated VERB B-O
-by ADP B-O
-the DET B-O
-nuclear ADJ B-LF
-factor NOUN I-LF
-of ADP I-LF
-activated VERB I-LF
-T NOUN I-LF
-cells NOUN I-LF
-( PUNCT B-O
-NFAT PROPN B-AC
-) PUNCT B-O
-transcription NOUN B-O
-factor NOUN B-O
-family NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-addition NOUN B-O
-, PUNCT B-O
-copy NOUN B-LF
-number NOUN I-LF
-variation NOUN I-LF
-( PUNCT B-O
-CNV PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-well ADV B-O
-- ADJ B-O
-established VERB B-O
-source NOUN B-O
-of ADP B-O
-inter ADJ B-O
-- ADJ B-O
-individual ADJ B-O
-genetic ADJ B-O
-variation NOUN B-O
-[ X B-O
-5 NUM B-O
-, PUNCT B-O
-13 NUM B-O
-, PUNCT B-O
-14 NUM B-O
-] PUNCT B-O
-has AUX B-O
-also ADV B-O
-been AUX B-O
-reported VERB B-O
-to PART B-O
-target VERB B-O
-several ADJ B-O
-FcγR PROPN B-AC
-genes NOUN B-O
-and CCONJ B-O
-can AUX B-O
-alter VERB B-O
-surface NOUN B-O
-FcγR PROPN B-AC
-protein NOUN B-O
-expression NOUN B-O
-and CCONJ B-O
-cellular ADJ B-O
-function NOUN B-O
-[ X B-O
-2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Humoral ADJ B-O
-allo ADJ B-O
-- PUNCT B-O
-immune ADJ B-O
-responses NOUN B-O
-mediated VERB B-O
-by ADP B-O
-donor NOUN B-LF
-- PUNCT I-LF
-specific ADJ I-LF
-antibodies NOUN I-LF
-( PUNCT B-O
-DSA PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-now ADV B-O
-well ADV B-O
-recognized VERB B-O
-as ADP B-O
-a DET B-O
-detrimental ADJ B-O
-determinant NOUN B-O
-of ADP B-O
-graft NOUN B-O
-outcome NOUN B-O
-after ADP B-O
-solid ADJ B-O
-organ NOUN B-O
-transplantation NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-USP6 PROPN B-O
-transgenic VERB B-O
-mice NOUN B-O
-exhibited VERB B-O
-enhanced ADJ B-O
-learning NOUN B-O
-and CCONJ B-O
-memory NOUN B-O
-behavior NOUN B-O
-in ADP B-O
-Morris PROPN B-LF
-water PROPN I-LF
-maze PROPN I-LF
-( PUNCT B-O
-MWM PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-novel ADJ B-LF
-object NOUN I-LF
-recognition NOUN I-LF
-( PUNCT B-O
-NOR PROPN B-AC
-) PUNCT B-O
-tests NOUN B-O
-. PUNCT B-O
-
-Tether NOUN B-O
-proteins NOUN B-O
-attach VERB B-O
-the DET B-O
-endoplasmic ADJ B-LF
-reticulum NOUN I-LF
-( PUNCT B-O
-ER PROPN B-AC
-) PUNCT B-O
-to PART B-O
-other ADJ B-O
-cellular ADJ B-O
-membranes NOUN B-O
-, PUNCT B-O
-thereby ADV B-O
-creating VERB B-O
-contact NOUN B-O
-sites NOUN B-O
-that PRON B-O
-are AUX B-O
-proposed VERB B-O
-to PART B-O
-form VERB B-O
-platforms NOUN B-O
-for ADP B-O
-regulating VERB B-O
-lipid NOUN B-O
-homeostasis NOUN B-O
-and CCONJ B-O
-facilitating VERB B-O
-non ADJ B-O
-- ADJ B-O
-vesicular ADJ B-O
-lipid NOUN B-O
-exchange NOUN B-O
-. PUNCT B-O
-
-Oral ADJ B-LF
-cholera NOUN I-LF
-vaccine NOUN I-LF
-( PUNCT B-O
-OCV PROPN B-AC
-) PUNCT B-O
-plays VERB B-O
-a DET B-O
-key ADJ B-O
-role NOUN B-O
-in ADP B-O
-reducing VERB B-O
-the DET B-O
-near ADJ B-O
-- PUNCT B-O
-term NOUN B-O
-risk NOUN B-O
-of ADP B-O
-cholera NOUN B-O
-, PUNCT B-O
-although SCONJ B-O
-global ADJ B-O
-supplies NOUN B-O
-are AUX B-O
-limited ADJ B-O
-. PUNCT B-O
-
-Emitted VERB B-O
-photons NOUN B-O
-were AUX B-O
-detected VERB B-O
-with ADP B-O
-a DET B-O
-single ADJ B-LF
-- PUNCT I-LF
-photon NOUN I-LF
-avalanche NOUN I-LF
-diode NOUN I-LF
-( PUNCT B-O
-SPAD PROPN B-AC
-) PUNCT B-O
-detector NOUN B-O
-( PUNCT B-O
-SPCM PROPN B-O
-CD3516H PROPN B-O
-; PUNCT B-O
-Excelitas PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-a DET B-O
-time NOUN B-O
-- PUNCT B-O
-correlated VERB B-O
-single ADJ B-O
-- PUNCT B-O
-photon NOUN B-O
-counting VERB B-O
-unit NOUN B-O
-( PUNCT B-O
-HydraHarp PROPN B-O
-400 NUM B-O
-; PUNCT B-O
-PicoQuant PROPN B-O
-) PUNCT B-O
-was AUX B-O
-used VERB B-O
-to PART B-O
-generate VERB B-O
-picosecond NOUN B-O
-histograms NOUN B-O
-( PUNCT B-O
-16 NUM B-O
-ps NOUN B-O
-resolution NOUN B-O
-) PUNCT B-O
-from ADP B-O
-the DET B-O
-photon NOUN B-O
-arrival NOUN B-O
-times NOUN B-O
-. PUNCT B-O
-
-TBB PROPN B-AC
-is AUX B-O
-a DET B-O
-selective ADJ B-O
-, PUNCT B-O
-cell NOUN B-O
-- PUNCT B-O
-permeable ADJ B-O
-, PUNCT B-O
-ATP PROPN B-O
-/ SYM B-O
-GTP NOUN B-O
-- PUNCT B-O
-competitive ADJ B-O
-inhibitor NOUN B-O
-of ADP B-O
-casein NOUN B-LF
-kinase NOUN I-LF
-II NUM I-LF
-( PUNCT B-O
-CKII PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-IC50 NUM B-O
-= SYM B-O
-900 NUM B-O
-nM NOUN B-O
-for ADP B-O
-rat ADJ B-O
-liver NOUN B-O
-) PUNCT B-O
-[ PUNCT B-O
-124 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Berberine PROPN B-LF
-( PUNCT B-O
-BBR PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-an DET B-O
-isoquinoline NOUN B-O
-alkaloid NOUN B-O
-isolated VERB B-O
-from ADP B-O
-many ADJ B-O
-medicinal ADJ B-O
-herbs NOUN B-O
-, PUNCT B-O
-is AUX B-O
-one NUM B-O
-of ADP B-O
-the DET B-O
-widely ADV B-O
-used VERB B-O
-traditional ADJ B-O
-Chinese ADJ B-O
-medicines NOUN B-O
-and CCONJ B-O
-has AUX B-O
-been AUX B-O
-used VERB B-O
-to PART B-O
-treat VERB B-O
-various ADJ B-O
-infectious ADJ B-O
-disorders NOUN B-O
-for ADP B-O
-more ADJ B-O
-than ADP B-O
-3,000 NUM B-O
-years NOUN B-O
-[ PUNCT B-O
-9 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Lower ADJ B-LF
-limit NOUN I-LF
-of ADP I-LF
-quantitation NOUN I-LF
-( PUNCT B-O
-LLoQ PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-limit NOUN B-LF
-of ADP I-LF
-detection NOUN I-LF
-( PUNCT B-O
-LoD PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-determined VERB B-O
-by ADP B-O
-measurement NOUN B-O
-precision NOUN B-O
-using VERB B-O
-serial ADJ B-O
-dilutions NOUN B-O
-of ADP B-O
-LAM PROPN B-AC
-extracts NOUN B-O
-obtained VERB B-O
-from ADP B-O
-M. PROPN B-O
-bovis PROPN B-O
-Bacillus PROPN B-O
-Calmette PROPN B-O
-- PUNCT B-O
-Guérin PROPN B-O
-Tokyo PROPN B-O
-( PUNCT B-O
-BCG PROPN B-AC
-) PUNCT B-O
-culture NOUN B-O
-. PUNCT B-O
-
-Before ADP B-O
-dissociation NOUN B-O
-of ADP B-O
-C120 PROPN B-O
-from ADP B-O
-Z775mAG PROPN B-O
-, PUNCT B-O
-the DET B-O
-head NOUN B-LF
-- PUNCT I-LF
-to ADP I-LF
-- PUNCT I-LF
-head NOUN I-LF
-distance NOUN I-LF
-( PUNCT B-O
-i.e. X B-O
-, PUNCT B-O
-the DET B-O
-distance NOUN B-O
-between ADP B-O
-the DET B-O
-centers NOUN B-O
-of ADP B-O
-mass NOUN B-O
-of ADP B-O
-ZEN-4 NOUN B-O
-motor NOUN B-O
-domains NOUN B-O
-[ X B-O
-DH-H PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-was AUX B-O
-12 NUM B-O
-± SYM B-O
-3 NUM B-O
-nm NOUN B-O
-( PUNCT B-O
-mean ADJ B-O
-± SYM B-O
-SD NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-whereas SCONJ B-O
-, PUNCT B-O
-after ADP B-O
-dissociation NOUN B-O
-, PUNCT B-O
-the DET B-O
-mean ADJ B-O
-DH PROPN B-AC
-increased VERB B-O
-to ADP B-O
-16 NUM B-O
-nm NOUN B-O
-, PUNCT B-O
-with ADP B-O
-a DET B-O
-larger ADJ B-O
-standard ADJ B-O
-deviation NOUN B-O
-of ADP B-O
-6 NUM B-O
-nm NOUN B-O
-( PUNCT B-O
-Fig PROPN B-O
-6D NUM B-O
-and CCONJ B-O
-6E NUM B-O
-; PUNCT B-O
-for ADP B-O
-additional ADJ B-O
-movies NOUN B-O
-and CCONJ B-O
-head NOUN B-LF
-- PUNCT I-LF
-to ADP I-LF
-- PUNCT I-LF
-head NOUN I-LF
-distance NOUN I-LF
-measurements NOUN B-O
-, PUNCT B-O
-S11 PROPN B-O
-Movie PROPN B-O
-and CCONJ B-O
-S4A PROPN B-O
-– PUNCT B-O
-S4C PROPN B-O
-Fig PROPN B-O
-, PUNCT B-O
-respectively ADV B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Of ADP B-O
-855,046 NUM B-O
-sequences NOUN B-O
-, PUNCT B-O
-417,953 NUM B-O
-with ADP B-O
-useable ADJ B-O
-reads NOUN B-O
-were AUX B-O
-assignable ADJ B-O
-to ADP B-O
-93 NUM B-O
-operational ADJ B-LF
-taxonomic ADJ I-LF
-units NOUN I-LF
-( PUNCT B-O
-OTUs PROPN B-AC
-) PUNCT B-O
-consisting VERB B-O
-of ADP B-O
-80 NUM B-O
-OTUs PROPN B-AC
-of ADP B-O
-bacteria NOUN B-O
-, PUNCT B-O
-12 NUM B-O
-OTUs PROPN B-AC
-of ADP B-O
-hamster NOUN B-O
-DNA NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-one NUM B-O
-OTU PROPN B-AC
-of ADP B-O
-plant NOUN B-O
-origin NOUN B-O
-. PUNCT B-O
-
-A DET B-O
-1.0 NUM B-O
-m NOUN B-O
-above ADP B-LF
-- PUNCT I-LF
-ground NOUN I-LF
-biomass NOUN I-LF
-( PUNCT B-O
-AGBM PROPN B-AC
-) PUNCT B-O
-sample NOUN B-O
-was AUX B-O
-cut VERB B-O
-from ADP B-O
-the DET B-O
-center NOUN B-O
-row NOUN B-O
-of ADP B-O
-each DET B-O
-plot NOUN B-O
-at ADP B-O
-harvest NOUN B-O
-maturity NOUN B-O
-( PUNCT B-O
-grain NOUN B-O
-moisture NOUN B-O
-concentration NOUN B-O
-≤ PUNCT B-O
-160 NUM B-O
-g NOUN B-O
-kg-1 NUM B-O
-) PUNCT B-O
-in ADP B-O
-all DET B-O
-testing NOUN B-O
-environments NOUN B-O
-. PUNCT B-O
-
-Cathepsin PROPN B-LF
-D PROPN I-LF
-( PUNCT B-O
-CD PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-a DET B-O
-lysosomal ADJ B-O
-protease NOUN B-O
-previously ADV B-O
-demonstrated VERB B-O
-to PART B-O
-cleave VERB B-O
-α PUNCT B-O
-- NOUN B-O
-syn NOUN B-O
-and CCONJ B-O
-decrease VERB B-O
-its PRON B-O
-toxicity NOUN B-O
-in ADP B-O
-cell NOUN B-O
-lines NOUN B-O
-[ PUNCT B-O
-18 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-This PRON B-O
-is AUX B-O
-promising ADJ B-O
-especially ADV B-O
-concerning VERB B-O
-cardiomyocyte NOUN B-O
-damage NOUN B-O
-following VERB B-O
-myocardial ADJ B-LF
-infarction NOUN I-LF
-( PUNCT B-O
-MI PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
-heart NOUN B-O
-failure NOUN B-O
-in ADP B-O
-CVD PROPN B-AC
-patients NOUN B-O
-. PUNCT B-O
-
-Liver PROPN B-O
-disease NOUN B-O
-severity NOUN B-O
-was AUX B-O
-assessed VERB B-O
-using VERB B-O
-the DET B-O
-Child PROPN B-LF
-Pugh PROPN I-LF
-Score PROPN I-LF
-( PUNCT B-O
-CPS PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-Model PROPN B-LF
-for ADP I-LF
-End PROPN I-LF
-- PUNCT I-LF
-stage NOUN I-LF
-Liver PROPN I-LF
-Disease PROPN I-LF
-( PUNCT B-O
-MELD PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-medical ADJ B-O
-comorbidities NOUN B-O
-were AUX B-O
-assessed VERB B-O
-using VERB B-O
-the DET B-O
-Charlson PROPN B-LF
-Comorbidity PROPN I-LF
-Index PROPN I-LF
-( PUNCT B-O
-CCI PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-11 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-An DET B-O
-analysis NOUN B-O
-of ADP B-O
-microtubule NOUN B-LF
-associated VERB I-LF
-protein NOUN I-LF
-2 NUM I-LF
-( PUNCT B-O
-MAP2)- PROPN B-AC
-and CCONJ B-O
-Nissl PROPN B-O
-- ADJ B-O
-stained VERB B-O
-Ngl3−/− PROPN B-O
-slices NOUN B-O
-revealed VERB B-O
-that SCONJ B-O
-the DET B-O
-gross ADJ B-O
-morphology NOUN B-O
-of ADP B-O
-the DET B-O
-Ngl3−/−(Hyb PROPN B-O
-) PUNCT B-O
-brain NOUN B-O
-was AUX B-O
-largely ADV B-O
-normal ADJ B-O
-, PUNCT B-O
-except SCONJ B-O
-for ADP B-O
-an DET B-O
-apparent ADJ B-O
-decrease NOUN B-O
-in ADP B-O
-the DET B-O
-size NOUN B-O
-of ADP B-O
-the DET B-O
-thalamus NOUN B-O
-( PUNCT B-O
-Fig PROPN B-O
-1F NUM B-O
-and CCONJ B-O
-1 NUM B-O
-G NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Levels NOUN B-O
-of ADP B-O
-NGL-3 PROPN B-AC
-relatives NOUN B-O
-( PUNCT B-O
-NGL-1 PROPN B-O
-and CCONJ B-O
-NGL-2 PROPN B-O
-) PUNCT B-O
-were AUX B-O
-normal ADJ B-O
-in ADP B-O
-the DET B-O
-Ngl3−/−(Hyb PROPN B-O
-) PUNCT B-O
-brains NOUN B-O
-( PUNCT B-O
-3 NUM B-O
-and CCONJ B-O
-10 NUM B-O
-weeks NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-although SCONJ B-O
-levels NOUN B-O
-of ADP B-O
-PTPδ PROPN B-AC
-, PUNCT B-O
-a DET B-O
-trans ADJ B-O
-- ADJ B-O
-synaptic ADJ B-O
-partner NOUN B-O
-of ADP B-O
-NGL-3 PROPN B-AC
-, PUNCT B-O
-were AUX B-O
-reduced VERB B-O
-( PUNCT B-O
-S2 PROPN B-O
-Fig PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-IFOF PROPN B-AC
-, PUNCT B-O
-inferior ADJ B-LF
-fronto ADJ I-LF
-- PUNCT I-LF
-occipital ADJ I-LF
-fascicle NOUN I-LF
-; PUNCT B-O
-ILF PROPN B-AC
-, PUNCT B-O
-inferior ADJ B-LF
-longitudinal ADJ I-LF
-fascicle NOUN I-LF
-; PUNCT B-O
-ILFlat PROPN B-AC
-, PUNCT B-O
-inferior ADJ B-LF
-longitudinal ADJ I-LF
-fascicle NOUN I-LF
-lateral ADJ B-O
-; PUNCT B-O
-ILFmed PROPN B-AC
-, PUNCT B-O
-inferior ADJ B-LF
-longitudinal ADJ I-LF
-fascicle NOUN I-LF
-medial ADJ B-O
-; PUNCT B-O
-MdLF PROPN B-AC
-, PUNCT B-O
-middle ADJ B-LF
-longitudinal ADJ I-LF
-fascicle NOUN I-LF
-; PUNCT B-O
-PRIME PROPN B-O
-- PUNCT B-O
-DE PROPN B-O
-, PUNCT B-O
-Primate PROPN B-O
-Data PROPN B-O
-Exchange PROPN B-O
-. PUNCT B-O
-
-Recent ADJ B-O
-work NOUN B-O
-suggests VERB B-O
-that SCONJ B-O
-a DET B-O
-T NOUN B-O
-cell NOUN B-O
-- PUNCT B-O
-based VERB B-O
-assay NOUN B-O
-for ADP B-O
-interferon NOUN B-O
-gamma NOUN B-O
-, PUNCT B-O
-the DET B-O
-enzyme NOUN B-LF
-- PUNCT I-LF
-linked VERB I-LF
-immunosorbent ADJ I-LF
-spot NOUN I-LF
-test NOUN I-LF
-( PUNCT B-O
-ELISPOT PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-has VERB B-O
-promise NOUN B-O
-in ADP B-O
-the DET B-O
-diagnosis NOUN B-O
-of ADP B-O
-Mycobacterium PROPN B-O
-tuberculosis NOUN B-LF
-infection NOUN B-O
-after ADP B-O
-exposure NOUN B-O
-to ADP B-O
-a DET B-O
-known VERB B-O
-tuberculosis NOUN B-LF
-( PUNCT B-O
-TB PROPN B-AC
-) PUNCT B-O
-patient NOUN B-O
-[ X B-O
-1–3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-NB PROPN B-O
-: PUNCT B-O
-GLIA PROPN B-AC
-: PUNCT B-O
-Guideline PROPN B-LF
-Implementability PROPN I-LF
-Appraisal PROPN I-LF
-, PUNCT B-O
-SD PROPN B-O
-: PUNCT B-O
-standard ADJ B-O
-deviation NOUN B-O
-, PUNCT B-O
-% NOUN B-O
-age NOUN B-O
-score NOUN B-O
-: PUNCT B-O
-percentage NOUN B-O
-score NOUN B-O
-EF PROPN B-O
-– PUNCT B-O
-Ejection PROPN B-O
-Fraction PROPN B-O
-, PUNCT B-O
-EDV PROPN B-O
-– PUNCT B-O
-End PROPN B-O
-diastolic ADJ B-O
-volume NOUN B-O
-index NOUN B-O
-, PUNCT B-O
-ESVI PROPN B-O
-– PUNCT B-O
-End PROPN B-O
-systolic ADJ B-O
-volume NOUN B-O
-index NOUN B-O
-, PUNCT B-O
-LV PROPN B-AC
-– PUNCT B-O
-left ADJ B-LF
-ventricle NOUN I-LF
-, PUNCT B-O
-RV NOUN B-O
-– PUNCT B-O
-right ADJ B-O
-ventricle NOUN B-O
-, PUNCT B-O
-SVI NOUN B-O
-– PUNCT B-O
-stroke NOUN B-O
-volume NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-surface NOUN B-O
-- PUNCT B-O
-exposed VERB B-O
-P2 NOUN B-O
-subdomain NOUN B-O
-( PUNCT B-O
-residues NOUN B-O
-279–405 NUM B-O
-) PUNCT B-O
-[ X B-O
-17 X B-O
-] PUNCT B-O
-interacts VERB B-O
-with ADP B-O
-histoblood NOUN B-LF
-group NOUN I-LF
-antigens NOUN I-LF
-( PUNCT B-O
-HBGAs PROPN B-AC
-) PUNCT B-O
-expressed VERB B-O
-on ADP B-O
-gut ADJ B-O
-epithelial ADJ B-O
-cells NOUN B-O
-, PUNCT B-O
-facilitating VERB B-O
-virus NOUN B-O
-binding NOUN B-O
-and CCONJ B-O
-entry NOUN B-O
-resulting VERB B-O
-in ADP B-O
-infection NOUN B-O
-[ X B-O
-18 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Within ADP B-O
-the DET B-O
-ALs PROPN B-AC
-, PUNCT B-O
-the DET B-O
-olfactory ADJ B-O
-information NOUN B-O
-is AUX B-O
-processed VERB B-O
-by ADP B-O
-a DET B-O
-complex ADJ B-O
-network NOUN B-O
-of ADP B-O
-neurons NOUN B-O
-, PUNCT B-O
-including VERB B-O
-OSNs PROPN B-AC
-, PUNCT B-O
-local ADJ B-LF
-interneurons NOUN I-LF
-( PUNCT B-O
-LNs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-projection NOUN B-LF
-neurons NOUN I-LF
-( PUNCT B-O
-PNs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-centrifugal ADJ B-LF
-neurons NOUN I-LF
-( PUNCT B-O
-CNs PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-21 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Genetic ADJ B-O
-- PUNCT B-O
-variation NOUN B-O
-studies NOUN B-O
-have AUX B-O
-primarily ADV B-O
-been AUX B-O
-focused VERB B-O
-on ADP B-O
-tumor NOUN B-O
-somatic ADJ B-O
-mutations NOUN B-O
-or CCONJ B-O
-on ADP B-O
-germline ADJ B-O
-single ADJ B-LF
-- PUNCT I-LF
-nucleotide NOUN I-LF
-polymorphisms NOUN I-LF
-( PUNCT B-O
-SNPs PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-AID PROPN B-AC
-, PUNCT B-O
-auxin NOUN B-LF
-- PUNCT I-LF
-inducible ADJ I-LF
-degron NOUN I-LF
-; PUNCT B-O
-CENP PROPN B-AC
-, PUNCT B-O
-centromere NOUN B-LF
-protein NOUN I-LF
-A NOUN I-LF
-; PUNCT B-O
--AFL PROPN B-AC
-, PUNCT B-O
-full ADJ B-LF
-- PUNCT I-LF
-length NOUN I-LF
-; PUNCT B-O
-IF PROPN B-AC
-, PUNCT B-O
-immunofluorescence NOUN B-LF
-; PUNCT B-O
-RNAi PROPN B-AC
-, PUNCT B-O
-RNA NOUN B-LF
-interference NOUN I-LF
-; PUNCT B-O
-WT PROPN B-O
-, PUNCT B-O
-wild ADJ B-O
-- PUNCT B-O
-type NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-order NOUN B-O
-to PART B-O
-delineate VERB B-O
-the DET B-O
-complex ADJ B-O
-relationship NOUN B-O
-among ADP B-O
-chain NOUN B-O
-connectivity NOUN B-O
-, PUNCT B-O
-protein NOUN B-O
-folding NOUN B-O
-, PUNCT B-O
-coupled VERB B-O
-networks NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-catalysis NOUN B-O
-by ADP B-O
-DHFR PROPN B-AC
-, PUNCT B-O
-we PRON B-O
-have AUX B-O
-carried VERB B-O
-out ADP B-O
-a DET B-O
-systematic ADJ B-O
-network NOUN B-O
-analysis NOUN B-O
-and CCONJ B-O
-molecular ADJ B-LF
-dynamics NOUN I-LF
-( PUNCT B-O
-MD PROPN B-AC
-) PUNCT B-O
-simulations NOUN B-O
-of ADP B-O
-the DET B-O
-native ADJ B-O
-( PUNCT B-O
-closed ADJ B-O
-state NOUN B-O
-) PUNCT B-O
-DHFR PROPN B-AC
-and CCONJ B-O
-19 NUM B-O
-of ADP B-O
-its PRON B-O
-circularly ADV B-O
-permuted ADJ B-O
-variants NOUN B-O
-. PUNCT B-O
-
-Cervical ADJ B-O
-cancer NOUN B-O
-is AUX B-O
-mainly ADV B-O
-caused VERB B-O
-by ADP B-O
-sexually ADV B-O
-transmitted VERB B-O
-Human PROPN B-LF
-Papilloma PROPN I-LF
-Virus PROPN I-LF
-( PUNCT B-O
-HPV PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-is AUX B-O
-the DET B-O
-most ADV B-O
-common ADJ B-O
-viral ADJ B-O
-infection NOUN B-O
-of ADP B-O
-the DET B-O
-female ADJ B-O
-reproductive ADJ B-O
-tract NOUN B-O
-. PUNCT B-O
-
-Combining VERB B-O
-sensitivity NOUN B-O
-and CCONJ B-O
-specificity NOUN B-O
-, PUNCT B-O
-we PRON B-O
-calculated VERB B-O
-likelihood NOUN B-LF
-ratios NOUN I-LF
-( PUNCT B-O
-LR PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-different ADJ B-O
-cut VERB B-O
-- PUNCT B-O
-off ADP B-O
-points NOUN B-O
-. PUNCT B-O
-
-MDA PROPN B-AC
-levels NOUN B-O
-in ADP B-O
-cell NOUN B-O
-lysates NOUN B-O
-were AUX B-O
-determined VERB B-O
-by ADP B-O
-high ADJ B-LF
-- PUNCT I-LF
-performance NOUN I-LF
-liquid NOUN I-LF
-chromatography NOUN I-LF
-( PUNCT B-O
-HPLC PROPN B-AC
-) PUNCT B-O
-as SCONJ B-O
-shown VERB B-O
-previously ADV B-O
-[ X B-O
-31 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-At ADP B-O
-the DET B-O
-end NOUN B-O
-of ADP B-O
-the DET B-O
-study NOUN B-O
-, PUNCT B-O
-CO NOUN B-O
-concentration NOUN B-O
-in ADP B-O
-the DET B-O
-exhaled VERB B-O
-gas NOUN B-O
-of ADP B-O
-each DET B-O
-participant NOUN B-O
-was AUX B-O
-measured VERB B-O
-, PUNCT B-O
-and CCONJ B-O
-indoor ADJ B-O
-air NOUN B-O
-pollutants NOUN B-O
-( PUNCT B-O
-i.e. X B-O
-, PUNCT B-O
-SO2 NOUN B-O
-, PUNCT B-O
-CO NOUN B-O
-, PUNCT B-O
-CO2 NOUN B-O
-, PUNCT B-O
-NO2 NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-particulate NOUN B-LF
-matter NOUN I-LF
-with ADP I-LF
-an DET I-LF
-aerodynamic ADJ I-LF
-diameter NOUN I-LF
-of ADP I-LF
-10 NUM I-LF
-µm NOUN I-LF
-or CCONJ I-LF
-less ADJ I-LF
-[ PUNCT B-O
-PM10 PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-were AUX B-O
-measured VERB B-O
-for ADP B-O
-one NUM B-O
-- PUNCT B-O
-third NOUN B-O
-of ADP B-O
-the DET B-O
-participants NOUN B-O
-' PART B-O
-homes NOUN B-O
-, PUNCT B-O
-which PRON B-O
-were AUX B-O
-randomly ADV B-O
-selected VERB B-O
-through ADP B-O
-a DET B-O
-systematic ADJ B-O
-random ADJ B-O
-process NOUN B-O
-as SCONJ B-O
-previously ADV B-O
-described VERB B-O
-for ADP B-O
-the DET B-O
-baseline NOUN B-O
-survey NOUN B-O
-[ PUNCT B-O
-3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Here ADV B-O
-, PUNCT B-O
-we PRON B-O
-used VERB B-O
-RNA NOUN B-LF
-interference NOUN I-LF
-( PUNCT B-O
-RNAi PROPN B-AC
-) PUNCT B-O
-to PART B-O
-systematically ADV B-O
-investigate VERB B-O
-the DET B-O
-roles NOUN B-O
-of ADP B-O
-Acps PROPN B-AC
-in ADP B-O
-inducing VERB B-O
-changes NOUN B-O
-in ADP B-O
-egg NOUN B-O
-laying NOUN B-O
-, PUNCT B-O
-fertility NOUN B-O
-, PUNCT B-O
-receptivity NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-sperm NOUN B-O
-storage NOUN B-O
-. PUNCT B-O
-
-Over ADP B-O
-recent ADJ B-O
-years NOUN B-O
-, PUNCT B-O
-the DET B-O
-use NOUN B-O
-of ADP B-O
-novel ADJ B-O
-agents NOUN B-O
-( PUNCT B-O
-immunomodulatory ADJ B-O
-drugs NOUN B-O
-[ X B-O
-lenalidomide NOUN B-O
-, PUNCT B-O
-thalidomide NOUN B-O
-and CCONJ B-O
-pomalidomide NOUN B-O
-] PUNCT B-O
-and CCONJ B-O
-the DET B-O
-proteasome NOUN B-O
-inhibitor NOUN B-O
-[ X B-O
-bortezomib NOUN B-O
-] PUNCT B-O
-) PUNCT B-O
-and CCONJ B-O
-autologous ADJ B-LF
-stem NOUN I-LF
-cell NOUN I-LF
-transplant NOUN I-LF
-( PUNCT B-O
-ASCT PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-patients NOUN B-O
-eligible ADJ B-O
-for ADP B-O
-transplant NOUN B-O
-has AUX B-O
-improved VERB B-O
-the DET B-O
-outcomes NOUN B-O
-of ADP B-O
-patients NOUN B-O
-with ADP B-O
-MM PROPN B-AC
-around ADP B-O
-the DET B-O
-world NOUN B-O
-[ X B-O
-2–6 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Apnea NOUN B-LF
-- NOUN I-LF
-Hypopnea NOUN I-LF
-index NOUN I-LF
-( PUNCT B-O
-AHI PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
-oxygen NOUN B-LF
-de NOUN I-LF
-- NOUN I-LF
-saturation NOUN I-LF
-index NOUN I-LF
-( PUNCT B-O
-ODI PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-also ADV B-O
-independent ADJ B-O
-factors NOUN B-O
-of ADP B-O
-DNA NOUN B-O
-methylation NOUN B-O
-levels NOUN B-O
-of ADP B-O
-the DET B-O
-TLR2 NOUN B-O
-promoter NOUN B-O
-region NOUN B-O
-, PUNCT B-O
-TLR6 NOUN B-O
-gene NOUN B-O
-body NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-protein NOUN B-O
-expressions NOUN B-O
-of ADP B-O
-TLR6 NOUN B-O
-( PUNCT B-O
-S4 PROPN B-O
-and CCONJ B-O
-S5 PROPN B-O
-Tables NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Subgroup NOUN B-O
-comparisons NOUN B-O
-of ADP B-O
-the DET B-O
-weighted VERB B-O
-mean ADJ B-O
-difference NOUN B-O
-of ADP B-O
-diastolic ADJ B-O
-blood NOUN B-O
-pressure NOUN B-O
-between ADP B-O
-South PROPN B-LF
-Asians PROPN I-LF
-( PUNCT B-O
-SA PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-European ADJ B-O
-participants NOUN B-O
-( PUNCT B-O
-EU PROPN B-AC
-) PUNCT B-O
-by ADP B-O
-country NOUN B-O
-of ADP B-O
-origin NOUN B-O
-. PUNCT B-O
-
-Quantitative ADJ B-O
-measurement NOUN B-O
-of ADP B-O
-lipid NOUN B-O
-peroxidation NOUN B-O
-was AUX B-O
-performed VERB B-O
-in ADP B-O
-cell NOUN B-O
-homogenates NOUN B-O
-according VERB B-O
-to ADP B-O
-the DET B-O
-methods NOUN B-O
-of ADP B-O
-Tappel PROPN B-O
-and CCONJ B-O
-Zalkin PROPN B-O
-, PUNCT B-O
-1959 NUM B-O
-[ PUNCT B-O
-33 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-is AUX B-O
-based VERB B-O
-on ADP B-O
-the DET B-O
-formation NOUN B-O
-of ADP B-O
-thiobarbituric NOUN B-LF
-acid NOUN I-LF
-reactive ADJ I-LF
-substances NOUN I-LF
-( PUNCT B-O
-TBARS PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-expressed VERB B-O
-as ADP B-O
-the DET B-O
-extent NOUN B-O
-of ADP B-O
-malondialdehyde NOUN B-LF
-( PUNCT B-O
-MDA PROPN B-AC
-) PUNCT B-O
-production NOUN B-O
-. PUNCT B-O
-
-All DET B-O
-villages NOUN B-O
-were AUX B-O
-Primary PROPN B-LF
-Health PROPN I-LF
-Care PROPN I-LF
-Programme PROPN I-LF
-( PUNCT B-O
-PHC PROPN B-AC
-) PUNCT B-O
-villages NOUN B-O
-and CCONJ B-O
-had AUX B-O
-a DET B-O
-male ADJ B-O
-village NOUN B-LF
-health NOUN I-LF
-worker NOUN I-LF
-( PUNCT B-O
-VHW PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-a DET B-O
-traditional ADJ B-LF
-birth NOUN I-LF
-attendant NOUN I-LF
-( PUNCT B-O
-TBA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-both PRON B-O
-of ADP B-O
-whom PRON B-O
-had AUX B-O
-completed VERB B-O
-a DET B-O
-4 NUM B-O
-- PUNCT B-O
-week NOUN B-O
-Gambian ADJ B-O
-Ministry PROPN B-O
-of ADP B-O
-Health PROPN B-O
-( PUNCT B-O
-MoH PROPN B-O
-) PUNCT B-O
-training NOUN B-O
-programme NOUN B-O
-. PUNCT B-O
-
-E10.5 PROPN B-AC
-, PUNCT B-O
-embryonic ADJ B-LF
-day NOUN I-LF
-10.5 NUM I-LF
-; PUNCT B-O
-E11.5 PROPN B-AC
-, PUNCT B-O
-embryonic ADJ B-LF
-day NOUN I-LF
-11.5 NUM I-LF
-; PUNCT B-O
-EP PROPN B-O
-, PUNCT B-O
-embryo NOUN B-O
-proper ADJ B-O
-; PUNCT B-O
-HM PROPN B-O
-Ripk1D325A PROPN B-O
-/ SYM B-O
-D325A NOUN B-O
-homozygotes NOUN B-O
-; PUNCT B-O
-NF PROPN B-AC
-, PUNCT B-O
-nuclear ADJ B-LF
-factor NOUN I-LF
-- PUNCT I-LF
-kappa NOUN I-LF
-B NOUN I-LF
-; PUNCT B-O
--κBWT PROPN B-AC
-, PUNCT B-O
-wild ADJ B-LF
-- PUNCT I-LF
-type NOUN I-LF
-; PUNCT B-O
-YS NOUN B-O
-, PUNCT B-O
-yolk NOUN B-O
-sac NOUN B-O
-. PUNCT B-O
-
-These DET B-O
-PRRs PROPN B-AC
-include VERB B-O
-Toll NOUN B-LF
-- PUNCT I-LF
-like ADJ I-LF
-receptors NOUN I-LF
-( PUNCT B-O
-TLRs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-receptor NOUN B-LF
-for ADP I-LF
-advanced ADJ I-LF
-glycation NOUN I-LF
-end NOUN I-LF
-products NOUN I-LF
-( PUNCT B-O
-RAGE PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-scavenger NOUN B-O
-receptors NOUN B-O
-[ PUNCT B-O
-59–61 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-B. PROPN B-O
-malayi NOUN B-O
-microfilaria NOUN B-O
-worms NOUN B-O
-were AUX B-O
-purchased VERB B-O
-from ADP B-O
-TRS PROPN B-O
-Labs PROPN B-O
-( PUNCT B-O
-Athens PROPN B-O
-, PUNCT B-O
-GA PROPN B-O
-, PUNCT B-O
-United PROPN B-O
-States PROPN B-O
-) PUNCT B-O
-for ADP B-O
-preparation NOUN B-O
-of ADP B-O
-DNA NOUN B-O
-. PUNCT B-O
-
-Because SCONJ B-O
-of ADP B-O
-the DET B-O
-difficulties NOUN B-O
-in ADP B-O
-obtaining VERB B-O
-purified ADJ B-O
-Wolbachia PROPN B-O
-DNA NOUN B-O
-from ADP B-O
-the DET B-O
-B. PROPN B-O
-malayi NOUN B-O
-host NOUN B-O
-, PUNCT B-O
-bacterial ADJ B-LF
-artificial ADJ I-LF
-chromosome NOUN I-LF
-( PUNCT B-O
-BAC PROPN B-AC
-) PUNCT B-O
-libraries NOUN B-O
-were AUX B-O
-created VERB B-O
-[ PUNCT B-O
-114 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-treatment NOUN B-O
-regimen NOUN B-O
-developed VERB B-O
-from ADP B-O
-this DET B-O
-dose NOUN B-O
-- ADJ B-O
-finding VERB B-O
-study NOUN B-O
-has AUX B-O
-now ADV B-O
-been AUX B-O
-carried VERB B-O
-forward ADV B-O
-into ADP B-O
-the DET B-O
-DIABIL-2 PROPN B-O
-clinical ADJ B-O
-trial NOUN B-O
-to PART B-O
-assess VERB B-O
-the DET B-O
-efficacy NOUN B-O
-and CCONJ B-O
-safety NOUN B-O
-of ADP B-O
-ultra ADJ B-O
-- ADJ B-O
-low ADJ B-O
-doses NOUN B-O
-of ADP B-O
-recombinant ADJ B-LF
-human ADJ I-LF
-IL-2 NOUN I-LF
-( PUNCT B-O
-rhIL-2 PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-children NOUN B-O
-and CCONJ B-O
-adults NOUN B-O
-with ADP B-O
-T1D PROPN B-AC
-[ PUNCT B-O
-37 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-516 NUM B-O
-conceptus NOUN B-O
-cells NOUN B-O
-consist VERB B-O
-of ADP B-O
-cells NOUN B-O
-of ADP B-O
-EPI PROPN B-AC
-, PUNCT B-O
-primitive ADJ B-LF
-endoderm NOUN I-LF
-( PUNCT B-O
-PE PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-TE PROPN B-AC
-lineages NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-wild ADJ B-O
-- PUNCT B-O
-type NOUN B-O
-animals NOUN B-O
-, PUNCT B-O
-mutation NOUN B-O
-or CCONJ B-O
-RNA NOUN B-LF
-interference NOUN I-LF
-( PUNCT B-O
-RNAi PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-individual ADJ B-O
-Wnt PROPN B-O
-genes NOUN B-O
-did AUX B-O
-not PART B-O
-reduce VERB B-O
-the DET B-O
-normal ADJ B-O
-frequency NOUN B-O
-of ADP B-O
-vulval ADJ B-O
-fates NOUN B-O
-( PUNCT B-O
-Table PROPN B-O
-2 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Beyond ADP B-O
-JIA PROPN B-AC
-, PUNCT B-O
-our PRON B-O
-approach NOUN B-O
-may AUX B-O
-be AUX B-O
-a DET B-O
-transferrable ADJ B-O
-template NOUN B-O
-for ADP B-O
-application NOUN B-O
-in ADP B-O
-rheumatoid ADJ B-LF
-arthritis NOUN I-LF
-( PUNCT B-O
-RA PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-spondyloarthropathies NOUN B-O
-( PUNCT B-O
-SpAs PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Error NOUN B-O
-bars NOUN B-O
-indicated VERB B-O
-SEM PROPN B-O
-. PUNCT B-O
-
-AAV PROPN B-AC
-, PUNCT B-O
-adeno NOUN B-LF
-- PUNCT I-LF
-associated VERB I-LF
-virus NOUN I-LF
-; PUNCT B-O
-ANOVA PROPN B-AC
-, PUNCT B-O
-Analysis PROPN B-LF
-of ADP I-LF
-Variance NOUN I-LF
-; PUNCT B-O
-DHPG PROPN B-AC
-, PUNCT B-O
-( PUNCT B-O
-S)-3,5 NOUN B-O
-- PUNCT B-O
-Dihydroxyphenylglycine NOUN B-O
-; PUNCT B-O
-GFP PROPN B-AC
-, PUNCT B-O
-green ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-; PUNCT B-O
-GlyR PROPN B-AC
-, PUNCT B-O
-glycine NOUN B-LF
-receptor NOUN I-LF
-; PUNCT B-O
-IPSC PROPN B-AC
-, PUNCT B-O
-inhibitory ADJ B-LF
-postsynaptic ADJ I-LF
-current NOUN I-LF
-; PUNCT B-O
-mIPSC PROPN B-AC
-, PUNCT B-O
-miniature ADJ B-LF
-IPSC NOUN I-LF
-IPSC PROPN B-AC
-; PUNCT B-O
-NC PROPN B-AC
-, PUNCT B-O
-negative ADJ B-LF
-control NOUN I-LF
-shRNA NOUN I-LF
-shRNA PROPN B-AC
-; PUNCT B-O
-RPM PROPN B-AC
-, PUNCT B-O
-rounds NOUN B-LF
-per ADP I-LF
-minute NOUN I-LF
-; PUNCT B-O
-shRNA PROPN B-AC
-, PUNCT B-O
-short ADJ B-LF
-hairpin NOUN I-LF
-RNA NOUN I-LF
-. PUNCT B-O
-
-The DET B-O
-WHO PROPN B-O
-group NOUN B-O
-wanted VERB B-O
-to ADP B-O
-know VERB B-O
-how SCONJ B-O
-these DET B-O
-treatments NOUN B-O
-affected VERB B-O
-the DET B-O
-virus NOUN B-O
-outside ADP B-O
-the DET B-O
-body NOUN B-O
-( PUNCT B-O
-“ PUNCT B-O
-in ADP B-O
-vitro X B-O
-” PUNCT B-O
-) PUNCT B-O
-and CCONJ B-O
-whether SCONJ B-O
-it PRON B-O
-helped VERB B-O
-the DET B-O
-condition NOUN B-O
-of ADP B-O
-patients NOUN B-O
-and CCONJ B-O
-reduced VERB B-O
-the DET B-O
-death NOUN B-O
-rate NOUN B-O
-, PUNCT B-O
-particularly ADV B-O
-in ADP B-O
-those DET B-O
-patients NOUN B-O
-who PRON B-O
-developed VERB B-O
-the DET B-O
-dangerous ADJ B-O
-complication NOUN B-O
-called VERB B-O
-acute ADJ B-LF
-respiratory ADJ I-LF
-distress NOUN I-LF
-syndrome NOUN I-LF
-( PUNCT B-O
-ARDS PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-This DET B-O
-study NOUN B-O
-is AUX B-O
-a DET B-O
-systematic ADJ B-O
-review NOUN B-O
-conducted VERB B-O
-in ADP B-O
-response NOUN B-O
-to ADP B-O
-the DET B-O
-WHO PROPN B-O
-request NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-A X B-O
-) PUNCT B-O
-Hippo PROPN B-O
-signaling NOUN B-O
-pathway NOUN B-O
-, PUNCT B-O
-( PUNCT B-O
-B X B-O
-) PUNCT B-O
-Focal ADJ B-O
-adhesion NOUN B-O
-and CCONJ B-O
-( PUNCT B-O
-C X B-O
-) PUNCT B-O
-Cell NOUN B-LF
-adhesion NOUN I-LF
-molecules NOUN I-LF
-( PUNCT B-O
-CAMs PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Fluorescence NOUN B-LF
-recovery NOUN I-LF
-after ADP I-LF
-photobleaching NOUN I-LF
-( PUNCT B-O
-FRAP PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-performed VERB B-O
-to PART B-O
-compare VERB B-O
-the DET B-O
-mobility NOUN B-O
-and CCONJ B-O
-dynamics NOUN B-O
-of ADP B-O
-the DET B-O
-mutant ADJ B-O
-variants NOUN B-O
-with ADP B-O
-wild ADJ B-O
-- PUNCT B-O
-type NOUN B-O
-myotilin NOUN B-O
-( PUNCT B-O
-Fig NOUN B-O
-5A NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Wild ADJ B-O
-- PUNCT B-O
-type NOUN B-O
-myotilin NOUN B-O
-showed VERB B-O
-rapid ADJ B-O
-dynamics NOUN B-O
-with ADP B-O
-80 NUM B-O
-% NOUN B-O
-fluorescence NOUN B-O
-recovery NOUN B-O
-after ADP B-O
-300 NUM B-O
-s NOUN B-O
-( PUNCT B-O
-median ADJ B-O
-half ADJ B-O
-- PUNCT B-O
-time NOUN B-O
-t1/2 NUM B-O
-of ADP B-O
-72.4 NUM B-O
-s NOUN B-O
-) PUNCT B-O
-( PUNCT B-O
-Fig NOUN B-O
-5B NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-is AUX B-O
-in ADP B-O
-excellent ADJ B-O
-agreement NOUN B-O
-with ADP B-O
-previously ADV B-O
-published VERB B-O
-reports NOUN B-O
-[ PUNCT B-O
-50,51 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-ability NOUN B-O
-of ADP B-O
-α PUNCT B-LF
-- PUNCT I-LF
-methyl NOUN I-LF
-- PUNCT I-LF
-p NOUN I-LF
-- PUNCT I-LF
-tyrosine NOUN I-LF
-( PUNCT B-O
-αMT PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-potent ADJ B-O
-irreversible ADJ B-O
-inhibitor NOUN B-O
-of ADP B-O
-TH PROPN B-AC
-[ PUNCT B-O
-29,45,46 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-to PART B-O
-impede VERB B-O
-production NOUN B-O
-of ADP B-O
-brain NOUN B-O
-DA PROPN B-AC
-suggests VERB B-O
-a DET B-O
-simple ADJ B-O
-, PUNCT B-O
-but CCONJ B-O
-straightforward ADJ B-O
-, PUNCT B-O
-strategy NOUN B-O
-for ADP B-O
-producing VERB B-O
-an DET B-O
-acute ADJ B-O
-PD PROPN B-AC
-mouse NOUN B-O
-model NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-this DET B-O
-context NOUN B-O
-, PUNCT B-O
-adult NOUN B-O
-bone NOUN B-O
-marrow NOUN B-O
-derived VERB B-O
-mesenchymal ADJ B-LF
-stem NOUN I-LF
-cells NOUN I-LF
-( PUNCT B-O
-BM-MSCs PROPN B-AC
-) PUNCT B-O
-represent VERB B-O
-the DET B-O
-most ADV B-O
-studied ADJ B-O
-cell NOUN B-O
-type NOUN B-O
-for ADP B-O
-cardiac ADJ B-O
-repair NOUN B-O
-due ADP B-O
-to ADP B-O
-their PRON B-O
-unique ADJ B-O
-features NOUN B-O
-including VERB B-O
-the DET B-O
-ease NOUN B-O
-in ADP B-O
-their PRON B-O
-isolation NOUN B-O
-/ SYM B-O
-expansion NOUN B-O
-, PUNCT B-O
-their PRON B-O
-paracrine NOUN B-O
-activity NOUN B-O
-to ADP B-O
-induce VERB B-O
-neovascularization ADJ B-O
-post ADJ B-O
-ischemic ADJ B-O
-injury NOUN B-O
-and CCONJ B-O
-most ADV B-O
-importantly ADV B-O
-due ADP B-O
-to ADP B-O
-their PRON B-O
-immunomodulatory ADJ B-O
-properties NOUN B-O
-[ X B-O
-1–5 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Arrow NOUN B-O
-indicates VERB B-O
-BRCA2 PROPN B-O
-deficiency NOUN B-O
-threshold NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-C X B-O
-) PUNCT B-O
-Number NOUN B-O
-of ADP B-O
-silent ADJ B-O
-or CCONJ B-O
-non ADJ B-O
-- PUNCT B-O
-silent ADJ B-O
-mutations NOUN B-O
-, PUNCT B-O
-mutation NOUN B-O
-signatures NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-BRCA PROPN B-O
-deficiency NOUN B-O
-in ADP B-O
-TCGA PROPN B-AC
-TNBCs PROPN B-AC
-. PUNCT B-O
-
-BRCA-D PROPN B-AC
-, PUNCT B-O
-BRCA PROPN B-LF
-- PUNCT I-LF
-deficient ADJ I-LF
-; PUNCT B-O
-BRCA PROPN B-AC
-, PUNCT B-O
-BRCA PROPN B-LF
-- PUNCT I-LF
-normal ADJ I-LF
-; PUNCT B-O
-CNV PROPN B-O
-, PUNCT B-O
-copy NOUN B-O
-number NOUN B-O
-variation NOUN B-O
-; PUNCT B-O
-MMR PROPN B-O
-, PUNCT B-O
-mismatch NOUN B-O
-repair NOUN B-O
-; PUNCT B-O
-Mut PROPN B-O
-, PUNCT B-O
-mutation NOUN B-O
-; PUNCT B-O
-SNV PROPN B-O
-, PUNCT B-O
-single ADJ B-O
-nucleotide NOUN B-O
-variant NOUN B-O
-; PUNCT B-O
--NTCGA PROPN B-AC
-, PUNCT B-O
-The PRON B-LF
-Cancer PROPN I-LF
-Genome PROPN I-LF
-Atlas PROPN I-LF
-; PUNCT B-O
-TNBC PROPN B-AC
-, PUNCT B-O
-triple ADV B-LF
-negative ADJ I-LF
-breast NOUN I-LF
-cancer NOUN I-LF
-; PUNCT B-O
-WT PROPN B-AC
-, PUNCT B-O
-wild ADJ B-LF
-- PUNCT I-LF
-type NOUN I-LF
-. PUNCT B-O
-
-The DET B-O
-Circumplex PROPN B-LF
-of ADP I-LF
-Interpersonal PROPN I-LF
-Problems PROPN I-LF
-( PUNCT B-O
-CIP PROPN B-AC
-) PUNCT B-O
-[ X B-O
-64 X B-O
-] X B-O
-was AUX B-O
-used VERB B-O
-to PART B-O
-assess VERB B-O
-interpersonal ADJ B-O
-personal ADJ B-O
-problems NOUN B-O
-. PUNCT B-O
-
-Data NOUN B-O
-can AUX B-O
-be AUX B-O
-made VERB B-O
-available ADJ B-O
-by ADP B-O
-the DET B-O
-Health PROPN B-LF
-Informatics PROPN I-LF
-Centre PROPN I-LF
-, PUNCT B-O
-University PROPN B-O
-of ADP B-O
-Dundee PROPN B-O
-( PUNCT B-O
-contact VERB B-O
-via ADP B-O
-hicsupport@dundee.ac.uk X B-O
-) PUNCT B-O
-with ADP B-O
-the DET B-O
-HIC PROPN B-AC
-Safe PROPN B-O
-Haven PROPN B-O
-for ADP B-O
-researchers NOUN B-O
-who PRON B-O
-meet VERB B-O
-the DET B-O
-criteria NOUN B-O
-for ADP B-O
-access NOUN B-O
-to ADP B-O
-confidential ADJ B-O
-data NOUN B-O
-and CCONJ B-O
-subject ADJ B-O
-to ADP B-O
-a DET B-O
-data NOUN B-O
-access NOUN B-O
-fee NOUN B-O
-. PUNCT B-O
-
-Indeed ADV B-O
-, PUNCT B-O
-we PRON B-O
-found VERB B-O
-that SCONJ B-O
-sperm NOUN B-O
-enter VERB B-O
-preferentially ADV B-O
-into ADP B-O
-the DET B-O
-polar ADJ B-LF
-body NOUN I-LF
-( PUNCT B-O
-pb PROPN B-AC
-) PUNCT B-O
-half NOUN B-O
-, PUNCT B-O
-except SCONJ B-O
-for ADP B-O
-the DET B-O
-microvilli NOUN B-O
-- ADJ B-O
-free ADJ B-O
-area NOUN B-O
-directly ADV B-O
-above ADP B-O
-the DET B-O
-metaphase NOUN B-O
-chromosomes NOUN B-O
-[ PUNCT B-O
-11 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-whereas SCONJ B-O
-an DET B-O
-earlier ADJ B-O
-study NOUN B-O
-reported VERB B-O
-that SCONJ B-O
-more ADJ B-O
-sperm NOUN B-O
-enter VERB B-O
-in ADP B-O
-the DET B-O
-“ PUNCT B-O
-vegetal ADJ B-O
-” PUNCT B-O
-area NOUN B-O
-[ PUNCT B-O
-10 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-WGV PROPN B-AC
-; PUNCT B-O
-weight NOUN B-LF
-growth NOUN I-LF
-velocity NOUN I-LF
-, PUNCT B-O
-SD PROPN B-AC
-; PUNCT B-O
-standard ADJ B-LF
-deviation NOUN I-LF
-, PUNCT B-O
-PROM PROPN B-AC
-; PUNCT B-O
-preterm ADJ B-LF
-rupture NOUN I-LF
-of ADP I-LF
-membrane NOUN I-LF
-, PUNCT B-O
-SGA PROPN B-AC
-; PUNCT B-O
-small ADJ B-LF
-for ADP I-LF
-gestational ADJ I-LF
-age NOUN I-LF
-, PUNCT B-O
-AS PROPN B-AC
-; PUNCT B-O
-Apgar PROPN B-LF
-score NOUN I-LF
-, PUNCT B-O
-RDS PROPN B-AC
-; PUNCT B-O
-respiratory ADJ B-LF
-distress NOUN I-LF
-syndrome NOUN I-LF
-, PUNCT B-O
-CLD PROPN B-AC
-; PUNCT B-O
-chronic ADJ B-LF
-lung NOUN I-LF
-disease NOUN I-LF
-, PUNCT B-O
-PDA PROPN B-AC
-; PUNCT B-O
-patent NOUN B-LF
-ductus NOUN I-LF
-arteriosus NOUN I-LF
-, PUNCT B-O
-NEC PROPN B-AC
-; PUNCT B-O
-necrotizing VERB B-LF
-enterocolitis NOUN I-LF
-, PUNCT B-O
-IVH PROPN B-AC
-; PUNCT B-O
-intraventricular ADJ B-LF
-hemorrhage NOUN I-LF
-. PUNCT B-O
-
-Other ADJ B-O
-information NOUN B-O
-available ADJ B-O
-in ADP B-O
-MMBNT PROPN B-AC
-’s PART B-O
-dataset NOUN B-O
-includes VERB B-O
-: PUNCT B-O
-Donor PROPN B-O
-ID PROPN B-O
-, PUNCT B-O
-Baby PROPN B-O
-Date NOUN B-LF
-of ADP I-LF
-Birth PROPN I-LF
-( PUNCT B-O
-DOB PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Baby PROPN B-O
-Term PROPN B-O
-( PUNCT B-O
-full ADJ B-O
-term NOUN B-O
-, PUNCT B-O
-preterm ADJ B-O
-, PUNCT B-O
-or CCONJ B-O
-deceased ADJ B-O
-) PUNCT B-O
-, PUNCT B-O
-Deposit NOUN B-O
-Receipt PROPN B-O
-Date NOUN B-O
-, PUNCT B-O
-Deposit NOUN B-O
-Expiration NOUN B-O
-Date NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-Deposit NOUN B-O
-Volume NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-care NOUN B-O
-provided VERB B-O
-by ADP B-O
-skilled ADJ B-O
-health NOUN B-O
-care NOUN B-O
-professionals NOUN B-O
-to PART B-O
-pregnant ADJ B-O
-women NOUN B-O
-and CCONJ B-O
-adolescent ADJ B-O
-girls NOUN B-O
-in ADP B-O
-order NOUN B-O
-to PART B-O
-ensure VERB B-O
-the DET B-O
-best ADJ B-O
-health NOUN B-O
-conditions NOUN B-O
-for ADP B-O
-both CCONJ B-O
-mother NOUN B-O
-and CCONJ B-O
-baby NOUN B-O
-during ADP B-O
-pregnancy NOUN B-O
-is AUX B-O
-considered VERB B-O
-Antenatal ADJ B-LF
-care NOUN I-LF
-( PUNCT B-O
-ANC PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Tau PROPN B-O
-belongs VERB B-O
-to ADP B-O
-the DET B-O
-class NOUN B-O
-of ADP B-O
-natively ADV B-O
-unfolded VERB B-O
-proteins NOUN B-O
-, PUNCT B-O
-binds VERB B-O
-to ADP B-O
-and CCONJ B-O
-stabilizes VERB B-O
-microtubules NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-partially ADV B-O
-folds VERB B-O
-into ADP B-O
-an DET B-O
-ordered ADJ B-O
-β PUNCT B-O
-- NOUN B-O
-structure NOUN B-O
-during NOUN B-O
-aggregation NOUN B-O
-to ADP B-O
-Alzheimer PROPN B-O
-paired VERB B-LF
-helical ADJ I-LF
-filaments NOUN I-LF
-( PUNCT B-O
-PHFs PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-insoluble ADJ B-O
-pellet NOUN B-O
-or CCONJ B-O
-acid NOUN B-LF
-insoluble ADJ I-LF
-matrix NOUN I-LF
-( PUNCT B-O
-AIM PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-washed VERB B-O
-with ADP B-O
-MilliQ PROPN B-O
-water NOUN B-O
-several ADJ B-O
-times NOUN B-O
-. PUNCT B-O
-
-Our PRON B-O
-ongoing ADJ B-O
-investigations NOUN B-O
-and CCONJ B-O
-recently ADV B-O
-published VERB B-O
-reports NOUN B-O
-indicated VERB B-O
-that SCONJ B-O
-IV NOUN B-O
-formulation NOUN B-O
-of ADP B-O
-HET0016 PROPN B-O
-with ADP B-O
-2 NUM B-LF
-- PUNCT I-LF
-Hydroxypropyl NOUN I-LF
-Beta PROPN I-LF
-Cyclodextrin PROPN I-LF
-( PUNCT B-O
-HPßCD PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-HPßCD PROPN B-AC
-- PUNCT B-O
-HET0016 PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-20 PROPN B-AC
-synthesis NOUN B-O
-inhibitor NOUN B-O
-, PUNCT B-O
-not PART B-O
-only ADV B-O
-decreased VERB B-O
-the DET B-O
-tumor NOUN B-O
-size NOUN B-O
-but CCONJ B-O
-also ADV B-O
-inhibited VERB B-O
-the DET B-O
-invasiveness NOUN B-O
-of ADP B-O
-these DET B-O
-cancer NOUN B-O
-cells NOUN B-O
-in ADP B-O
-animal NOUN B-O
-models NOUN B-O
-of ADP B-O
-human ADJ B-O
-glioma NOUN B-O
-[ PUNCT B-O
-9 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-addition NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-consistent ADJ B-O
-with ADP B-O
-the DET B-O
-recruitment NOUN B-O
-of ADP B-O
-attention NOUN B-O
-, PUNCT B-O
-functional ADJ B-LF
-MRI NOUN I-LF
-( PUNCT B-O
-fMRI PROPN B-AC
-) PUNCT B-O
-analyses NOUN B-O
-of ADP B-O
-late ADJ B-O
-learning NOUN B-O
-stages NOUN B-O
-showed VERB B-O
-left ADJ B-O
-parietal ADJ B-O
-activity NOUN B-O
-within ADP B-O
-a DET B-O
-broad ADJ B-O
-bilateral ADJ B-O
-dorsal ADJ B-O
-frontoparietal ADJ B-O
-network NOUN B-O
-. PUNCT B-O
-
-Body NOUN B-LF
-surface NOUN I-LF
-area NOUN I-LF
-( PUNCT B-O
-BSA PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-calculated VERB B-O
-using VERB B-O
-the DET B-O
-formula NOUN B-O
-: PUNCT B-O
-0.0001 NUM B-O
-x NOUN B-O
-71.84 NUM B-O
-x NOUN B-O
-( PUNCT B-O
-weight NOUN B-O
-[ PUNCT B-O
-kg])0.425 NUM B-O
-x NOUN B-O
-( PUNCT B-O
-height NOUN B-O
-[ PUNCT B-O
-cm])0.725 NUM B-O
-. PUNCT B-O
-
-The DET B-O
-PMTCT PROPN B-LF
-Effectiveness PROPN I-LF
-PMTCT PROPN B-AC
-in ADP I-LF
-Africa PROPN I-LF
-: PUNCT I-LF
-Research PROPN I-LF
-and CCONJ I-LF
-Linkages PROPN I-LF
-to ADP I-LF
-Care PROPN I-LF
-Study PROPN I-LF
-( PUNCT B-O
-PEARLStudy PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-a DET B-O
-multi ADJ B-O
-- ADJ B-O
-country ADJ B-O
-evaluation NOUN B-O
-of ADP B-O
-the DET B-O
-effectiveness NOUN B-O
-of ADP B-O
-PMTCT PROPN B-AC
-services NOUN B-O
-at ADP B-O
-the DET B-O
-community NOUN B-O
-and CCONJ B-O
-facility NOUN B-O
-level NOUN B-O
-. PUNCT B-O
-
-R NOUN B-O
-- PUNCT B-O
-loops NOUN B-O
-can AUX B-O
-recruit VERB B-O
-their PRON B-O
-reader NOUN B-O
-( PUNCT B-O
-growth NOUN B-LF
-arrest NOUN I-LF
-and CCONJ I-LF
-DNA NOUN I-LF
-damage NOUN I-LF
-protein NOUN I-LF
-45A NOUN I-LF
-[ PUNCT B-O
-GADD45A PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-to PART B-O
-promote VERB B-O
-the DET B-O
-demethylation NOUN B-O
-pathway NOUN B-O
-at ADP B-O
-promoter NOUN B-O
-cytosine NOUN B-LF
-- PUNCT I-LF
-phosphate NOUN I-LF
-- PUNCT I-LF
-guanine NOUN I-LF
-( PUNCT B-O
-CpG PROPN B-AC
-) PUNCT B-O
-islands NOUN B-O
-in ADP B-O
-human ADJ B-O
-cells NOUN B-O
-[ PUNCT B-O
-44 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-We PRON B-O
-utilized VERB B-O
-multiple ADJ B-O
-publicly ADV B-O
-available ADJ B-O
-data NOUN B-O
-sources NOUN B-O
-to PART B-O
-evaluate VERB B-O
-the DET B-O
-association NOUN B-O
-between ADP B-O
-introduction NOUN B-O
-of ADP B-O
-PMI PROPN B-AC
-and CCONJ B-O
-child NOUN B-O
-mortality NOUN B-O
-rates NOUN B-O
-in ADP B-O
-sub ADJ B-LF
-- ADJ I-LF
-Saharan ADJ I-LF
-Africa PROPN I-LF
-( PUNCT B-O
-SSA PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-To PART B-O
-test VERB B-O
-whether SCONJ B-O
-hemoglobin NOUN B-O
-levels NOUN B-O
-were AUX B-O
-significantly ADV B-O
-different ADJ B-O
-between ADP B-O
-the DET B-O
-groups NOUN B-O
-we PRON B-O
-used VERB B-O
-a DET B-O
-mixed VERB B-O
-linear ADJ B-O
-model NOUN B-O
-that PRON B-O
-adjusts VERB B-O
-for ADP B-O
-repeated VERB B-O
-measures NOUN B-O
-over ADP B-O
-the DET B-O
-period NOUN B-O
-of ADP B-O
-observation NOUN B-O
-and CCONJ B-O
-also ADV B-O
-adjusts VERB B-O
-for ADP B-O
-coinfections NOUN B-O
-with ADP B-O
-schistosomiasis NOUN B-O
-, PUNCT B-O
-lymphatic ADJ B-O
-filariasis NOUN B-O
-and/or CCONJ B-O
-hookworm NOUN B-O
-, PUNCT B-O
-as ADP B-O
-well ADV B-O
-as ADP B-O
-height NOUN B-O
-and CCONJ B-O
-weight NOUN B-O
-measurements NOUN B-O
-( PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-[ PUNCT B-O
-BMI PROPN B-AC
-] PUNCT B-O
-, PUNCT B-O
-a DET B-O
-surrogate NOUN B-O
-for ADP B-O
-nutritional ADJ B-O
-status NOUN B-O
-) PUNCT B-O
-from ADP B-O
-each DET B-O
-follow NOUN B-O
-- PUNCT B-O
-up NOUN B-O
-. PUNCT B-O
-
-CD59 NOUN B-O
-is AUX B-O
-a DET B-O
-membrane NOUN B-O
-complement NOUN B-O
-regulatory ADJ B-O
-protein NOUN B-O
-that PRON B-O
-is AUX B-O
-attached VERB B-O
-to ADP B-O
-the DET B-O
-cell NOUN B-O
-membrane NOUN B-O
-via ADP B-O
-a DET B-O
-glycosylphosphatidylinositol NOUN B-LF
-( PUNCT B-O
-GPI PROPN B-AC
-) PUNCT B-O
-anchor NOUN B-O
-. PUNCT B-O
-
-Leptin NOUN B-O
-receptors NOUN B-O
-have AUX B-O
-been AUX B-O
-found VERB B-O
-on ADP B-O
-paraventricular ADJ B-LF
-nucleus NOUN I-LF
-( PUNCT B-O
-PVN PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-lateral ADJ B-LF
-hypothalamic ADJ I-LF
-( PUNCT B-O
-LHA PROPN B-AC
-) PUNCT B-O
-neurons NOUN B-O
-, PUNCT B-O
-implicating VERB B-O
-them PRON B-O
-as ADP B-O
-direct ADJ B-O
-targets NOUN B-O
-for ADP B-O
-regulation NOUN B-O
-by ADP B-O
-circulating VERB B-O
-adiposity NOUN B-O
-signals NOUN B-O
-. PUNCT B-O
-
-Cadmium NOUN B-LF
-( PUNCT B-O
-Cd PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-a DET B-O
-developmental ADJ B-O
-toxicant NOUN B-O
-that PRON B-O
-induces VERB B-O
-fetal ADJ B-LF
-growth NOUN I-LF
-restriction NOUN I-LF
-( PUNCT B-O
-FGR PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Placental ADJ B-O
-endoplasmic ADJ B-O
-reticulum NOUN B-O
-( PUNCT B-O
-ER PROPN B-O
-) PUNCT B-O
-stress NOUN B-O
-is AUX B-O
-associated VERB B-O
-with ADP B-O
-FGR PROPN B-AC
-. PUNCT B-O
-
-This DET B-O
-study NOUN B-O
-investigated VERB B-O
-the DET B-O
-effects NOUN B-O
-of ADP B-O
-N NOUN B-LF
-- PUNCT I-LF
-acetylcysteine NOUN I-LF
-( PUNCT B-O
-NAC PROPN B-AC
-) PUNCT B-O
-on ADP B-O
-Cd PROPN B-AC
-- PUNCT B-O
-induced VERB B-O
-placental ADJ B-O
-ER PROPN B-AC
-and CCONJ B-O
-stressFGR PROPN B-AC
-. PUNCT B-O
-
-Pregnant ADJ B-O
-mice NOUN B-O
-were AUX B-O
-intraperitoneally ADV B-O
-injected VERB B-O
-with ADP B-O
-CdCl2 PROPN B-O
-daily ADV B-O
-from ADP B-O
-gestational ADJ B-LF
-day NOUN I-LF
-( PUNCT B-O
-GD)13 PROPN B-AC
-to ADP B-O
-GD17 NUM B-O
-. PUNCT B-O
-
-Reviewer#2 NOUN B-O
-: PUNCT B-O
-This DET B-O
-manuscript NOUN B-O
-describes VERB B-O
-a DET B-O
-novel ADJ B-O
-matrix NOUN B-LF
-- PUNCT I-LF
-assisted VERB I-LF
-laser NOUN I-LF
-desorption NOUN I-LF
-/ SYM I-LF
-ionization NOUN I-LF
-time NOUN I-LF
-- PUNCT I-LF
-of ADP I-LF
-- PUNCT I-LF
-flight NOUN I-LF
-mass NOUN I-LF
-spectrometry NOUN I-LF
-( PUNCT B-O
-MALDI-TOF-MS PROPN B-AC
-) PUNCT B-O
-analysis NOUN B-O
-of ADP B-O
-the DET B-O
-extracted VERB B-O
-peptides NOUN B-O
-obtained VERB B-O
-from ADP B-O
-Streptococcus PROPN B-O
-suis PROPN B-O
-, PUNCT B-O
-and CCONJ B-O
-in ADP B-O
-particularly ADV B-O
-S. PROPN B-O
-suis PROPN B-O
-serotype NOUN B-O
-( PUNCT B-O
-SS2 NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Replicated VERB B-O
-hybridisation NOUN B-O
-to ADP B-O
-genomic ADJ B-O
-DNA NOUN B-O
-tiling NOUN B-O
-arrays NOUN B-O
-generated VERB B-O
-a DET B-O
-dataset NOUN B-O
-( PUNCT B-O
-Dataset PROPN B-O
-S1 PROPN B-O
-) PUNCT B-O
-with ADP B-O
-mean ADJ B-LF
-enrichments NOUN I-LF
-( PUNCT B-O
-Mn PROPN B-AC
-) PUNCT B-O
-equivalent ADJ B-O
-to ADP B-O
-log2 NUM B-O
-3.8 NUM B-O
-( PUNCT B-O
-14 NUM B-O
-- ADJ B-O
-fold ADJ B-O
-) PUNCT B-O
-observed VERB B-O
-. PUNCT B-O
-
-Therefore ADV B-O
-, PUNCT B-O
-our PRON B-O
-estimates NOUN B-O
-at ADP B-O
-such ADJ B-O
-high ADJ B-O
-thresholds NOUN B-O
-might AUX B-O
-be AUX B-O
-approximately ADV B-O
-correct ADJ B-O
-; PUNCT B-O
-if SCONJ B-O
-so ADV B-O
-, PUNCT B-O
-the DET B-O
-accuracy NOUN B-O
-of ADP B-O
-homology NOUN B-O
-transfer NOUN B-O
-for ADP B-O
-high ADJ B-O
-similarity NOUN B-O
-( PUNCT B-O
-HVAL PROPN B-AC
-> SYM B-O
-40 NUM B-O
-, PUNCT B-O
-Percentage NOUN B-LF
-sequence NOUN I-LF
-IDEntity NOUN I-LF
-( PUNCT B-O
-PIDE PROPN B-AC
-) PUNCT B-O
-> SYM B-O
-70 NUM B-O
-) PUNCT B-O
-were AUX B-O
-just ADV B-O
-over ADP B-O
-10 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-Figure PROPN B-O
-2 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-FGC PROPN B-AC
-, PUNCT B-O
-female ADJ B-LF
-genital ADJ I-LF
-cutting NOUN I-LF
-; PUNCT B-O
-MoH PROPN B-AC
-, PUNCT B-O
-Ministry PROPN B-LF
-of ADP I-LF
-Health PROPN I-LF
-However ADV B-O
-, PUNCT B-O
-type NOUN B-O
-D NOUN B-O
-is AUX B-O
-a DET B-O
-limited ADJ B-O
-and CCONJ B-O
-specific ADJ B-O
-aspect NOUN B-O
-of ADP B-O
-personality NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-currently ADV B-O
-the DET B-O
-Five NUM B-LF
-Factor PROPN I-LF
-Model PROPN I-LF
-( PUNCT B-O
-FFM PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-a DET B-O
-more ADV B-O
-accepted ADJ B-O
-, PUNCT B-O
-widely ADV B-O
-used VERB B-O
-and CCONJ B-O
-comprehensive ADJ B-O
-means NOUN B-O
-of ADP B-O
-categorization NOUN B-O
-[ PUNCT B-O
-21 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-presence NOUN B-O
-of ADP B-O
-ITPase PROPN B-AC
-deficiency NOUN B-O
-was AUX B-O
-not PART B-O
-statistically ADV B-O
-associated VERB B-O
-with ADP B-O
-a DET B-O
-lower ADJ B-O
-hazard NOUN B-LF
-ratio NOUN I-LF
-( PUNCT B-O
-HR PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-RBV PROPN B-AC
-dose NOUN B-O
-reductions NOUN B-O
-( PUNCT B-O
-HR PROPN B-AC
-0.80 NUM B-O
-, PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-0.35–1.71 NUM B-O
-, PUNCT B-O
-p NOUN B-O
-= SYM B-O
-0.57 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-BMP PROPN B-AC
-, PUNCT B-O
-Bone PROPN B-LF
-Morphogenetic PROPN I-LF
-Protein PROPN I-LF
-; PUNCT B-O
-FISH PROPN B-AC
-, PUNCT B-O
-fluorescent ADJ B-LF
-in ADP I-LF
-situ NOUN I-LF
-hybridization NOUN I-LF
-; PUNCT B-O
-hpf PROPN B-AC
-, PUNCT B-O
-hours NOUN B-LF
-post ADP I-LF
-fertilization NOUN I-LF
-; PUNCT B-O
-pSmad5 PROPN B-AC
-, PUNCT B-O
-phosphorylated VERB B-LF
-Smad5 NOUN I-LF
-; PUNCT B-O
-WT PROPN B-O
-, PUNCT B-O
-wild ADJ B-O
-- PUNCT B-O
-type NOUN B-O
-. PUNCT B-O
-
-NF-κB PROPN B-AC
-dimers NOUN B-O
-are AUX B-O
-sequestered VERB B-O
-in ADP B-O
-the DET B-O
-cytoplasm NOUN B-O
-by ADP B-O
-an DET B-O
-inhibitory ADJ B-O
-protein NOUN B-O
-IκBα PROPN B-O
-, PUNCT B-O
-which PRON B-O
-masks VERB B-O
-the DET B-O
-conserved VERB B-O
-nuclear ADJ B-LF
-localization NOUN I-LF
-sequence NOUN I-LF
-( PUNCT B-O
-NLS PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-RelA PROPN B-O
-/ SYM B-O
-p65 NOUN B-O
-to PART B-O
-prevent VERB B-O
-nuclear ADJ B-O
-translocation NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-AMPK PROPN B-AC
-, PUNCT B-O
-AMP NOUN B-O
-- PUNCT B-O
-activated VERB B-O
-protein NOUN B-O
-kinase NOUN B-O
-; PUNCT B-O
-AUC PROPN B-AC
-, PUNCT B-O
-area NOUN B-LF
-under ADP I-LF
-the DET I-LF
-curve NOUN I-LF
-; PUNCT B-O
-Glut2 PROPN B-AC
-, PUNCT B-O
-glucose NOUN B-LF
-transporter NOUN I-LF
-2 NUM I-LF
-; PUNCT B-O
-GTT PROPN B-AC
-, PUNCT B-O
-glucose NOUN B-LF
-tolerance NOUN I-LF
-test NOUN I-LF
-; PUNCT B-O
-GS PROPN B-AC
-, PUNCT B-O
-glycogen NOUN B-LF
-synthase NOUN I-LF
-; PUNCT B-O
-GS PROPN B-AC
-- PUNCT B-O
-p641 NOUN B-O
-, PUNCT B-O
-phospho NOUN B-O
-- PUNCT B-O
-glycogen NOUN B-LF
-synthase NOUN I-LF
-at ADP B-O
-S641 NUM B-O
-; PUNCT B-O
-ITT PROPN B-AC
-, PUNCT B-O
-insulin NOUN B-LF
-tolerance NOUN I-LF
-test NOUN I-LF
-; PUNCT B-O
-Oct1 PROPN B-O
-, PUNCT B-O
-organic ADJ B-O
-cation NOUN B-O
-transporter NOUN B-O
-1 NUM B-O
-; PUNCT B-O
-pACC NOUN B-O
-, PUNCT B-O
-phosphorylate NOUN B-O
-acetyl NOUN B-O
-- PUNCT B-O
-CoA NOUN B-O
-carboxylase NOUN B-O
-; PUNCT B-O
-pAMPK PROPN B-O
-, PUNCT B-O
-phosphorylate NOUN B-O
-5 NUM B-O
-' NOUN B-O
-adenosine NOUN B-O
-monophosphate NOUN B-O
-- PUNCT B-O
-activated VERB B-O
-protein NOUN B-O
-kinase NOUN B-O
-; PUNCT B-O
-PDH PROPN B-AC
-, PUNCT B-O
-pyruvate NOUN B-LF
-dehydrogenase NOUN I-LF
-; PUNCT B-O
-PDH PROPN B-AC
-- PUNCT B-O
-p NOUN B-O
-, PUNCT B-O
-phospho NOUN B-O
-- PUNCT B-O
-pyruvate NOUN B-LF
-dehydrogenase NOUN I-LF
-; PUNCT B-O
-PTT PROPN B-AC
-, PUNCT B-O
-pyruvate NOUN B-LF
-tolerance NOUN I-LF
-test NOUN I-LF
-; PUNCT B-O
-PYGL PROPN B-AC
-; PUNCT B-O
-glycogen NOUN B-LF
-phosphorylase NOUN I-LF
-. PUNCT B-O
-
-Using VERB B-O
-ChIP-qPCR PROPN B-AC
-, PUNCT B-O
-we PRON B-O
-analysed VERB B-O
-levels NOUN B-O
-of ADP B-O
-the DET B-O
-active ADJ B-O
-- PUNCT B-O
-promoter NOUN B-O
-– PUNCT B-O
-associated VERB B-O
-H3K4Me3 PROPN B-AC
-mark NOUN B-O
-and CCONJ B-O
-the DET B-O
-polycomb NOUN B-LF
-repressor NOUN I-LF
-complex NOUN I-LF
-( PUNCT B-O
-PRC)-associated PROPN B-AC
-repressive ADJ B-O
-H3K27Me3 PROPN B-AC
-mark NOUN B-O
-across ADP B-O
-the DET B-O
-HPV18 PROPN B-O
-genome NOUN B-O
-. PUNCT B-O
-
-Criteria NOUN B-O
-for ADP B-O
-discharge NOUN B-O
-were AUX B-O
-the DET B-O
-absence NOUN B-O
-of ADP B-O
-fever NOUN B-O
-and CCONJ B-O
-significant ADJ B-O
-symptoms NOUN B-O
-for ADP B-O
-four NUM B-O
-consecutive ADJ B-O
-days NOUN B-O
-, PUNCT B-O
-ability NOUN B-O
-to PART B-O
-feed VERB B-O
-and CCONJ B-O
-walk VERB B-O
-independently ADV B-O
-, PUNCT B-O
-and CCONJ B-O
-two NUM B-O
-consecutive ADJ B-O
-negative ADJ B-O
-blood NOUN B-O
-reverse ADJ B-LF
-EBOV PROPN B-AC
-transcription NOUN I-LF
-PCR NOUN I-LF
-( PUNCT B-O
-RT PROPN B-AC
-) PUNCT B-O
-tests NOUN B-O
-. PUNCT B-O
-
-p NOUN B-LF
-- NOUN I-LF
-p PROPN B-AC
-value NOUN I-LF
-Statistical PROPN B-LF
-Package PROPN I-LF
-for ADP I-LF
-the DET I-LF
-Social PROPN I-LF
-Sciences PROPN I-LF
-( PUNCT B-O
-SPSS PROPN B-AC
-17.0 NUM B-O
-) PUNCT B-O
-was AUX B-O
-used VERB B-O
-for ADP B-O
-all DET B-O
-analyses NOUN B-O
-. PUNCT B-O
-
-Length NOUN B-LF
-of ADP I-LF
-stay NOUN I-LF
-( PUNCT B-O
-LOS PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-calculated VERB B-O
-as ADP B-O
-the DET B-O
-time NOUN B-O
-the DET B-O
-disposition NOUN B-O
-was AUX B-O
-set VERB B-O
-to ADP B-O
-admit VERB B-O
-to ADP B-O
-the DET B-O
-time NOUN B-O
-the DET B-O
-subject NOUN B-O
-met VERB B-O
-the DET B-O
-clinical ADJ B-O
-criteria NOUN B-O
-for ADP B-O
-discharge NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-order NOUN B-O
-to PART B-O
-define VERB B-O
-a DET B-O
-putative ADJ B-O
-olfactory ADJ B-O
-space NOUN B-O
-for ADP B-O
-the DET B-O
-honeybee NOUN B-O
-, PUNCT B-O
-we PRON B-O
-performed VERB B-O
-a DET B-O
-principal ADJ B-LF
-component NOUN I-LF
-analysis NOUN I-LF
-( PUNCT B-O
-PCA PROPN B-AC
-) PUNCT B-O
-on ADP B-O
-our PRON B-O
-data NOUN B-O
-to PART B-O
-represent VERB B-O
-in ADP B-O
-a DET B-O
-limited ADJ B-O
-number NOUN B-O
-of ADP B-O
-dimensions NOUN B-O
-the DET B-O
-relative ADJ B-O
-relationships NOUN B-O
-between ADP B-O
-odorants NOUN B-O
-in ADP B-O
-a DET B-O
-16 NUM B-O
-- PUNCT B-O
-dimension NOUN B-O
-perceptual ADJ B-O
-space NOUN B-O
-( PUNCT B-O
-Figure PROPN B-O
-6A NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-first ADJ B-O
-three NUM B-O
-factors NOUN B-O
-represented VERB B-O
-31 NUM B-O
-% PUNCT B-O
-, PUNCT B-O
-29 NUM B-O
-% PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-15 NUM B-O
-% PUNCT B-O
-of ADP B-O
-overall ADJ B-O
-variance NOUN B-O
-in ADP B-O
-the DET B-O
-data NOUN B-O
-( PUNCT B-O
-total NOUN B-O
-of ADP B-O
-the DET B-O
-first ADJ B-O
-three NUM B-O
-factors NOUN B-O
-: PUNCT B-O
-75 NUM B-O
-% PUNCT B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-HIV PROPN B-O
-epidemic NOUN B-O
-is AUX B-O
-rapidly ADV B-O
-growing VERB B-O
-among ADP B-O
-men NOUN B-LF
-who PRON I-LF
-have VERB I-LF
-sex NOUN I-LF
-with ADP I-LF
-men NOUN I-LF
-( PUNCT B-O
-MSM PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-China PROPN B-O
-, PUNCT B-O
-yet CCONJ B-O
-HIV PROPN B-O
-testing NOUN B-O
-remains VERB B-O
-suboptimal ADJ B-O
-. PUNCT B-O
-
-Quality NOUN B-LF
-of ADP I-LF
-care NOUN I-LF
-was AUX B-O
-assessed VERB B-O
-using VERB B-O
-context NOUN B-O
-based VERB B-O
-validated VERB B-O
-indicators NOUN B-O
-which PRON B-O
-provide VERB B-O
-a DET B-O
-more ADV B-O
-detailed ADJ B-O
-picture NOUN B-O
-of ADP B-O
-the DET B-O
-state NOUN B-O
-of ADP B-O
-QoC PROPN B-AC
-in ADP B-O
-the DET B-O
-process NOUN B-O
-of ADP B-O
-childbirth NOUN B-O
-. PUNCT B-O
-
-To PART B-O
-understand VERB B-O
-the DET B-O
-source NOUN B-O
-of ADP B-O
-ROS PROPN B-AC
-and CCONJ B-O
-to PART B-O
-determine VERB B-O
-the DET B-O
-association NOUN B-O
-of ADP B-O
-AngII PROPN B-AC
-signaling NOUN B-O
-, PUNCT B-O
-Klf5 PROPN B-AC
-, PUNCT B-O
-and CCONJ B-O
-eIF5α NOUN B-O
-with ADP B-O
-NOX PROPN B-AC
-expression NOUN B-O
-, PUNCT B-O
-mouse NOUN B-O
-VSMCs PROPN B-AC
-were AUX B-O
-transfected VERB B-O
-with ADP B-O
-expression NOUN B-O
-vectors NOUN B-O
-for ADP B-O
-Klf5 PROPN B-AC
-and CCONJ B-O
-eIF5α NOUN B-O
-or CCONJ B-O
-small ADJ B-LF
-interfering VERB I-LF
-RNA NOUN I-LF
-( PUNCT B-O
-siRNA PROPN B-AC
-) PUNCT B-O
-against ADP B-O
-Klf5 PROPN B-AC
-and CCONJ B-O
-eIF5α NOUN B-O
-, PUNCT B-O
-respectively ADV B-O
-, PUNCT B-O
-and CCONJ B-O
-then ADV B-O
-treated VERB B-O
-with ADP B-O
-Ang PROPN B-AC
-for ADP B-O
-0 NUM B-O
-, PUNCT B-O
-1 NUM B-O
-, PUNCT B-O
-3 NUM B-O
-, PUNCT B-O
-and CCONJ B-O
-5 NUM B-O
-days NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-expression NOUN B-O
-of ADP B-O
-NOX1 NOUN B-O
-and CCONJ B-O
-NOX4 NOUN B-O
-was AUX B-O
-detected VERB B-O
-by ADP B-O
-RT NOUN B-O
-- PUNCT B-O
-qPCR NOUN B-O
-. PUNCT B-O
-
-As SCONJ B-O
-shown VERB B-O
-in ADP B-O
-S17A PROPN B-O
-– PUNCT B-O
-S17D PROPN B-O
-Fig PROPN B-O
-, PUNCT B-O
-IIAng PROPN B-AC
-treatment NOUN B-O
-increased VERB B-O
-NOX1 NOUN B-O
-expression NOUN B-O
-, PUNCT B-O
-peaked VERB B-O
-at ADP B-O
-24 NUM B-O
-hours NOUN B-O
-after ADP B-O
-treatment NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-gradually ADV B-O
-declined VERB B-O
-thereafter ADV B-O
-. PUNCT B-O
-
-terminal ADJ B-LF
-λz PROPN B-AC
-slope NOUN I-LF
-; PUNCT B-O
-AUC0-∞ NOUN B-O
-area NOUN B-O
-under ADP B-O
-the DET B-O
-curve NOUN B-O
-from ADP B-O
-0 NUM B-O
-to ADP B-O
-infinitive ADJ B-O
-; PUNCT B-O
-mean ADJ B-LF
-MTT PROPN B-AC
-transit NOUN I-LF
-time NOUN I-LF
-; PUNCT B-O
-Tmax PROPN B-AC
-time NOUN B-O
-at ADP B-O
-maximum ADJ B-LF
-concentration NOUN I-LF
-; PUNCT B-O
-maximum ADJ B-LF
-Cmax PROPN B-AC
-concentration NOUN I-LF
-; PUNCT B-O
-F NOUN B-O
-bioavailability NOUN B-O
-, PUNCT B-O
-was AUX B-O
-calculated VERB B-O
-by ADP B-O
-dividing VERB B-O
-the DET B-O
-ratio NOUN B-O
-of ADP B-O
-AUC0-∞ NOUN B-O
-oral ADJ B-O
-by ADP B-O
-the DET B-O
-dose NOUN B-O
-and CCONJ B-O
-by ADP B-O
-ratio NOUN B-O
-total ADJ B-O
-PTA PROPN B-AC
-AUC0-∞ NOUN B-O
-IV NOUN B-O
-by ADP B-O
-respective ADJ B-O
-dose NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-figure NOUN B-O
-illustrates VERB B-O
-ErbB PROPN B-O
-signaling NOUN B-O
-pathway NOUN B-O
-that PRON B-O
-contain VERB B-O
-genes NOUN B-O
-that PRON B-O
-are AUX B-O
-targeted VERB B-O
-by ADP B-O
-miRNAs PROPN B-AC
-which PRON B-O
-regulate VERB B-O
-NMT PROPN B-AC
-gene NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-EGF PROPN B-O
-, PUNCT B-O
-epidermal ADJ B-O
-growth NOUN B-O
-factor NOUN B-O
-; PUNCT B-O
-TGF PROPN B-O
-, PUNCT B-O
-transforming VERB B-O
-growth NOUN B-O
-factor NOUN B-O
-; PUNCT B-O
-BTC PROPN B-O
-, PUNCT B-O
-betacellulin NOUN B-O
-; PUNCT B-O
-HB PROPN B-O
-- PUNCT B-O
-EGF PROPN B-O
-, PUNCT B-O
-heparin NOUN B-O
-- PUNCT B-O
-binding VERB B-O
-epidermal ADJ B-O
-growth NOUN B-O
-factor NOUN B-O
-( PUNCT B-O
-EGF)-like PROPN B-O
-growth NOUN B-O
-factor NOUN B-O
-; PUNCT B-O
-EREG PROPN B-O
-, PUNCT B-O
-epiregulin NOUN B-O
-; PUNCT B-O
-NRG1 PROPN B-O
-, PUNCT B-O
-neuregulin-1 NOUN B-O
-; PUNCT B-O
-NRG2 PROPN B-O
-, PUNCT B-O
-neuregulin-2 NOUN B-O
-; PUNCT B-O
-NRG3 PROPN B-O
-, PUNCT B-O
-neuregulin-3 NOUN B-O
-; PUNCT B-O
-NRG4 PROPN B-O
-, PUNCT B-O
-neuregulin-4 NOUN B-O
-; PUNCT B-O
-PLCγ PROPN B-O
-, PUNCT B-O
-phospholipase NOUN B-O
-C PROPN B-O
-type NOUN B-O
-gamma NOUN B-O
-; PUNCT B-O
-CAMK2B PROPN B-O
-, PUNCT B-O
-calcium NOUN B-O
-/ SYM B-O
-calmodulin NOUN B-O
-dependent ADJ B-O
-protein NOUN B-O
-kinase NOUN B-O
-; PUNCT B-O
-PRKCB PROPN B-O
-, PUNCT B-O
-Protein PROPN B-O
-kinase NOUN B-O
-C PROPN B-O
-- PUNCT B-O
-beta NOUN B-O
-; PUNCT B-O
-STAT5 PROPN B-O
-, PUNCT B-O
-Signal NOUN B-O
-transducer NOUN B-O
-and CCONJ B-O
-activator NOUN B-O
-of ADP B-O
-transcription NOUN B-O
-5 NUM B-O
-; PUNCT B-O
-src PROPN B-O
-, PUNCT B-O
-Rous PROPN B-O
-sarcoma NOUN B-O
-virus NOUN B-O
-gene NOUN B-O
-; PUNCT B-O
-CRK PROPN B-O
-, PUNCT B-O
-C PROPN B-O
-T10 NOUN B-O
-regulator NOUN B-O
-of ADP B-O
-a DET B-O
-tyrosine NOUN B-O
-kinase NOUN B-O
-; PUNCT B-O
-NCL PROPN B-O
-, PUNCT B-O
-NCK PROPN B-O
-Adaptor PROPN B-O
-Protein PROPN B-O
-2 NUM B-O
-; PUNCT B-O
-PTK2 PROPN B-O
-, PUNCT B-O
-PTK2 PROPN B-O
-protein NOUN B-O
-tyrosine NOUN B-O
-kinase NOUN B-O
-2 NUM B-O
-; PUNCT B-O
-ABL2 PROPN B-O
-, PUNCT B-O
-V PROPN B-O
-- PUNCT B-O
-Abl PROPN B-O
-Abelson PROPN B-O
-Murine PROPN B-O
-Leukemia PROPN B-O
-Viral PROPN B-O
-Oncogene PROPN B-O
-Homolog PROPN B-O
-2 NUM B-O
-; PUNCT B-O
-PAK2 PROPN B-O
-, PUNCT B-O
-P21 PROPN B-O
-( PUNCT B-O
-RAC1 PROPN B-O
-) PUNCT B-O
-Activated PROPN B-O
-Kinase PROPN B-O
-2 NUM B-O
-; PUNCT B-O
-MAP2K4 PROPN B-O
-, PUNCT B-O
-Mitogen PROPN B-O
-- PUNCT B-O
-Activated PROPN B-O
-Protein PROPN B-O
-Kinase PROPN B-O
-Kinase PROPN B-O
-4 NUM B-O
-; PUNCT B-O
-MAPK10 PROPN B-O
-, PUNCT B-O
-Mitogen PROPN B-O
-- PUNCT B-O
-Activated PROPN B-O
-Protein PROPN B-O
-Kinase PROPN B-O
-10 NUM B-O
-; PUNCT B-O
-SOS1 PROPN B-O
-, PUNCT B-O
-SOS PROPN B-O
-Ras PROPN B-O
-/ SYM B-O
-Rac NOUN B-O
-Guanine NOUN B-O
-Nucleotide PROPN B-O
-Exchange PROPN B-O
-Factor PROPN B-O
-1 NUM B-O
-; PUNCT B-O
-Grb2 PROPN B-O
-, PUNCT B-O
-Growth NOUN B-O
-Factor PROPN B-O
-Receptor NOUN B-O
-Bound PROPN B-O
-Protein PROPN B-O
-2 NUM B-O
-; PUNCT B-O
-SHC4 PROPN B-O
-, PUNCT B-O
-Src NOUN B-O
-Homology NOUN B-O
-2 NUM B-O
-Domain NOUN B-O
-- PUNCT B-O
-Containing VERB B-O
-- PUNCT B-O
-Transforming VERB B-O
-Protein PROPN B-O
-C4 PROPN B-O
-; PUNCT B-O
-PIK3C4 PROPN B-O
-, PUNCT B-O
-Phosphatidylinositol-4,5 NOUN B-O
-- PUNCT B-O
-Bisphosphate NOUN B-O
-3 NUM B-O
-- PUNCT B-O
-Kinase PROPN B-O
-Catalytic PROPN B-O
-Subunit PROPN B-O
-; PUNCT B-O
-AKT3 PROPN B-O
-, PUNCT B-O
-KT PROPN B-O
-Serine NOUN B-O
-/ SYM B-O
-Threonine NOUN B-O
-Kinase PROPN B-O
-3 NUM B-O
-; PUNCT B-O
-mTOR NOUN B-O
-, PUNCT B-O
-Mechanistic ADJ B-O
-Target NOUN B-O
-Of ADP B-O
-Rapamycin NOUN B-O
-Kinase PROPN B-O
-; PUNCT B-O
-BCL2 PROPN B-O
-, PUNCT B-O
-BCL2 PROPN B-O
-Associated ADJ B-O
-Agonist NOUN B-O
-Of ADP B-O
-Cell NOUN B-O
-Death NOUN B-O
-; PUNCT B-O
-GSK3B PROPN B-AC
-, PUNCT B-O
-Glycogen NOUN B-LF
-Synthase NOUN I-LF
-Kinase PROPN I-LF
-3 NUM I-LF
-Beta PROPN I-LF
-; PUNCT B-O
-CDKN1A PROPN B-O
-, PUNCT B-O
-Cyclin NOUN B-O
-Dependent PROPN B-O
-Kinase PROPN B-O
-Inhibitor PROPN B-O
-1A PROPN B-O
-; PUNCT B-O
-EIF4EBP1 PROPN B-O
-, PUNCT B-O
-Eukaryotic ADJ B-O
-Translation NOUN B-O
-Initiation PROPN B-O
-Factor PROPN B-O
-4E NUM B-O
-Binding PROPN B-O
-Protein PROPN B-O
-1 NUM B-O
-; PUNCT B-O
-BRAF PROPN B-AC
-, PUNCT B-O
-B PROPN B-LF
-- PUNCT I-LF
-Raf PROPN I-LF
-Proto PROPN I-LF
-- PUNCT I-LF
-Oncogene PROPN I-LF
-, PUNCT B-O
-Serine NOUN B-O
-/ SYM B-O
-Threonine NOUN B-O
-Kinase PROPN B-O
-; PUNCT B-O
-RPS6KB1 PROPN B-O
-, PUNCT B-O
-Ribosomal PROPN B-O
-Protein PROPN B-O
-S6 PROPN B-O
-Kinase PROPN B-O
-B1 PROPN B-O
-; PUNCT B-O
-KRAS PROPN B-O
-, PUNCT B-O
-KRAS PROPN B-O
-Proto PROPN B-O
-- PUNCT B-O
-Oncogene PROPN B-O
-, PUNCT B-O
-GTPase PROPN B-O
-; PUNCT B-O
-JUN PROPN B-O
-, PUNCT B-O
-Jun PROPN B-O
-Proto PROPN B-O
-- PUNCT B-O
-Oncogene PROPN B-O
-, PUNCT B-O
-AP-1 PROPN B-O
-Transcription PROPN B-O
-Factor PROPN B-O
-Subunit PROPN B-O
-; PUNCT B-O
-ELK PROPN B-O
-, PUNCT B-O
-ETS PROPN B-O
-Transcription PROPN B-O
-Factor PROPN B-O
-; PUNCT B-O
-Myc PROPN B-O
-, PUNCT B-O
-MYC PROPN B-O
-Proto PROPN B-O
-- PUNCT B-O
-Oncogene PROPN B-O
-, PUNCT B-O
-BHLH PROPN B-O
-Transcription PROPN B-O
-Factor PROPN B-O
-; PUNCT B-O
-ER PROPN B-O
-, PUNCT B-O
-endoplasmic ADJ B-O
-reticulum NOUN B-O
-. PUNCT B-O
-
-To PART B-O
-determine VERB B-O
-whether SCONJ B-O
-such ADJ B-O
-target NOUN B-O
-proteins NOUN B-O
-could AUX B-O
-be AUX B-O
-identified VERB B-O
-for ADP B-O
-Ginir PROPN B-AC
-RNA NOUN B-O
-, PUNCT B-O
-we PRON B-O
-followed VERB B-O
-the DET B-O
-approach NOUN B-O
-of ADP B-O
-using VERB B-O
-biotin NOUN B-O
-- PUNCT B-O
-labelled VERB B-O
-RNA NOUN B-O
-affinity NOUN B-O
-pull VERB B-O
-- PUNCT B-O
-down NOUN B-O
-and CCONJ B-O
-RNA NOUN B-LF
-- PUNCT I-LF
-immunoprecipitation NOUN I-LF
-( PUNCT B-O
-RIP PROPN B-AC
-) PUNCT B-O
-assays NOUN B-O
-. PUNCT B-O
-
-This DET B-O
-hyperphosphorylation NOUN B-O
-causes VERB B-O
-light NOUN B-O
-- PUNCT B-O
-dependent ADJ B-O
-retinal ADJ B-O
-degeneration NOUN B-O
-and CCONJ B-O
-premature ADJ B-O
-entrance NOUN B-O
-into ADP B-O
-the DET B-O
-prolonged VERB B-LF
-depolarizing VERB I-LF
-afterpotential NOUN I-LF
-( PUNCT B-O
-PDA PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-1–3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Sirius PROPN B-O
-red ADJ B-O
-staining NOUN B-O
-revealed VERB B-O
-significantly ADV B-O
-more ADJ B-O
-collagen NOUN B-O
-deposition NOUN B-O
-in ADP B-O
-the DET B-O
-F-BCA PROPN B-AC
-adipose ADJ B-O
-tissues NOUN B-O
-, PUNCT B-O
-particularly ADV B-O
-around ADP B-O
-the DET B-O
-SVF PROPN B-AC
-zones NOUN B-O
-( PUNCT B-O
-Fig NUM B-O
-6A NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-More ADV B-O
-abundant ADJ B-O
-type NOUN B-LF
-I NOUN I-LF
-collagen NOUN I-LF
-( PUNCT B-O
-ColI PROPN B-AC
-) PUNCT B-O
-expression NOUN B-O
-was AUX B-O
-detected VERB B-O
-in ADP B-O
-the DET B-O
-F PROPN B-AC
--BCASVF PROPN B-AC
-cells NOUN B-O
-( PUNCT B-O
-Fig NUM B-O
-6B NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-although SCONJ B-O
-the DET B-O
-mRNA NOUN B-O
-levels NOUN B-O
-were AUX B-O
-unchanged ADJ B-O
-upon SCONJ B-O
-activation NOUN B-O
-of ADP B-O
-canonical ADJ B-O
-Wnt NOUN B-O
-signaling NOUN B-O
-in ADP B-O
-the DET B-O
-FSP1 PROPN B-AC
-+ NOUN B-O
-fibroblasts NOUN B-O
-( PUNCT B-O
-Fig NUM B-O
-6C NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-matrix NOUN B-LF
-metalloproteinase NOUN I-LF
-( PUNCT B-O
-MMP PROPN B-AC
-) PUNCT B-O
-family NOUN B-O
-is AUX B-O
-primarily ADV B-O
-responsible ADJ B-O
-for ADP B-O
-the DET B-O
-degradation NOUN B-O
-and CCONJ B-O
-remodeling NOUN B-O
-of ADP B-O
-extracellular ADJ B-O
-matrix NOUN B-O
-[ PUNCT B-O
-6,21 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-After ADP B-O
-heat NOUN B-O
-antigen NOUN B-O
-retrieval NOUN B-O
-using VERB B-O
-sodium NOUN B-O
-citrate NOUN B-O
-buffer NOUN B-O
-, PUNCT B-O
-brain NOUN B-O
-sections NOUN B-O
-were AUX B-O
-incubated VERB B-O
-with ADP B-O
-blocking VERB B-O
-buffer NOUN B-O
-( PUNCT B-O
-10 NUM B-O
-% NOUN B-O
-Normal PROPN B-O
-Goat PROPN B-O
-Serum PROPN B-O
-, PUNCT B-O
-1 NUM B-O
-% NOUN B-O
-BSA PROPN B-O
-, PUNCT B-O
-and CCONJ B-O
-3 NUM B-O
-M NOUN B-O
-Glycine PROPN B-O
-in ADP B-O
-TBS-0.1 NUM B-O
-% NOUN B-O
-Triton PROPN B-O
-- PUNCT B-O
-X PROPN B-O
-) PUNCT B-O
-for ADP B-O
-1 NUM B-O
-hour NOUN B-O
-at ADP B-O
-room NOUN B-LF
-temperature NOUN I-LF
-( PUNCT B-O
-RT PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-After ADP B-O
-blocking VERB B-O
-, PUNCT B-O
-antibodies NOUN B-O
-were AUX B-O
-diluted VERB B-O
-in ADP B-O
-blocking VERB B-O
-buffer NOUN B-O
-and CCONJ B-O
-incubated VERB B-O
-overnight ADV B-O
-at ADP B-O
-4 NUM B-O
-° NOUN B-O
-C NOUN B-O
-. PUNCT B-O
-
-Healthy ADJ B-LF
-controls NOUN I-LF
-( PUNCT B-O
-HC PROPN B-AC
-): PUNCT B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-59 NUM B-O
-) PUNCT B-O
-21 NUM B-O
-adult NOUN B-O
-healthy ADJ B-LF
-controls NOUN I-LF
-and CCONJ B-O
-38 NUM B-O
-children NOUN B-O
-older ADJ B-O
-than ADP B-O
-4 NUM B-O
-were AUX B-O
-included VERB B-O
-in ADP B-O
-Study NOUN B-O
-2 NUM B-O
-. PUNCT B-O
-
-Primaquine PROPN B-LF
-( PUNCT B-O
-PQ PROPN B-AC
-) PUNCT B-O
-has AUX B-O
-been AUX B-O
-used VERB B-O
-for ADP B-O
-over ADP B-O
-65 NUM B-O
-years NOUN B-O
-and CCONJ B-O
-is AUX B-O
-currently ADV B-O
-the DET B-O
-only ADJ B-O
-widely ADV B-O
-available ADJ B-O
-hypnozoitocidal ADJ B-O
-drug NOUN B-O
-for ADP B-O
-P. PROPN B-O
-vivax PROPN B-O
-and CCONJ B-O
-P. PROPN B-O
-ovale PROPN B-O
-. PUNCT B-O
-
-A DET B-O
-recent ADJ B-O
-report NOUN B-O
-suggests VERB B-O
-that SCONJ B-O
-SDF-1 PROPN B-O
-promotes VERB B-O
-epidermal ADJ B-LF
-stem NOUN I-LF
-cell NOUN I-LF
-( PUNCT B-O
-ESC PROPN B-AC
-) PUNCT B-O
-migration NOUN B-O
-and CCONJ B-O
-accelerates VERB B-O
-wound NOUN B-O
-healing NOUN B-O
-in ADP B-O
-vivo ADV B-O
-[ PUNCT B-O
-22 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Extracted VERB B-O
-peptides NOUN B-O
-were AUX B-O
-analysed VERB B-O
-by ADP B-O
-liquid NOUN B-LF
-chromatography NOUN I-LF
-– PUNCT I-LF
-tandem NOUN I-LF
-mass NOUN I-LF
-spectrometry NOUN I-LF
-( PUNCT B-O
-LC–MS/MS PROPN B-AC
-) PUNCT B-O
-with ADP B-O
-the DET B-O
-Orbitrap PROPN B-O
-Fusion PROPN B-O
-mass NOUN B-O
-spectrometer NOUN B-O
-and CCONJ B-O
-nanoflow NOUN B-O
-- PUNCT B-O
-HPLC NOUN B-O
-system NOUN B-O
-U3000 PROPN B-O
-( PUNCT B-O
-Thermo PROPN B-O
-Fisher PROPN B-O
-Scientific PROPN B-O
-, PUNCT B-O
-UK PROPN B-O
-) PUNCT B-O
-[ PUNCT B-O
-48,50 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-This DET B-O
-study NOUN B-O
-aimed VERB B-O
-to PART B-O
-assess VERB B-O
-the DET B-O
-comparability NOUN B-O
-among ADP B-O
-assays NOUN B-O
-using VERB B-O
-freshly ADV B-O
-frozen VERB B-O
-human ADJ B-O
-sera NOUN B-O
-and CCONJ B-O
-external ADJ B-LF
-quality NOUN I-LF
-assessment NOUN I-LF
-( PUNCT B-O
-EQA PROPN B-AC
-) PUNCT B-O
-data NOUN B-O
-in ADP B-O
-China PROPN B-O
-. PUNCT B-O
-
-The DET B-O
-“ PUNCT B-O
-gold NOUN B-O
-standard NOUN B-O
-” PUNCT B-O
-for ADP B-O
-NACT PROPN B-AC
-response NOUN B-O
-was AUX B-O
-the DET B-O
-5 NUM B-O
-- PUNCT B-O
-years NOUN B-O
-relapse NOUN B-LF
-free ADJ I-LF
-survival NOUN I-LF
-( PUNCT B-O
-RFS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-as SCONJ B-O
-it PRON B-O
-provides VERB B-O
-a DET B-O
-reasonable ADJ B-O
-threshold NOUN B-O
-to ADP B-O
-capture VERB B-O
-all DET B-O
-relapses NOUN B-O
-related VERB B-O
-to ADP B-O
-NACT PROPN B-AC
-response NOUN B-O
-[ PUNCT B-O
-11 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-ATP PROPN B-LF
-- PUNCT I-LF
-binding VERB I-LF
-cassette NOUN I-LF
-transporter NOUN I-LF
-A1 NOUN I-LF
-( PUNCT B-O
-ABCA1 PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-a DET B-O
-cholesterol NOUN B-O
-and CCONJ B-O
-phospholipid NOUN B-O
-transporter NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-mutations NOUN B-O
-in ADP B-O
-ABCA1 PROPN B-AC
-cause VERB B-O
-Tangier PROPN B-LF
-disease NOUN I-LF
-( PUNCT B-O
-TD PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-1–3 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-a DET B-O
-rare ADJ B-O
-disorder NOUN B-O
-characterized VERB B-O
-by ADP B-O
-reduced VERB B-O
-levels NOUN B-O
-of ADP B-O
-plasma NOUN B-O
-high ADJ B-LF
-density NOUN I-LF
-lipoprotein NOUN I-LF
-( PUNCT B-O
-HDL PROPN B-AC
-) PUNCT B-O
-cholesterol NOUN B-O
-and CCONJ B-O
-increased VERB B-O
-risk NOUN B-O
-for ADP B-O
-coronary ADJ B-O
-artery NOUN B-O
-disease NOUN B-O
-[ PUNCT B-O
-4 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-neonatal ADJ B-LF
-mortality NOUN I-LF
-rate NOUN I-LF
-( PUNCT B-O
-NMR PROPN B-AC
-) PUNCT B-O
-has AUX B-O
-declined VERB B-O
-markedly ADV B-O
-in ADP B-O
-recent ADJ B-O
-years NOUN B-O
-in ADP B-O
-Tanzania PROPN B-O
-but CCONJ B-O
-varies VERB B-O
-widely ADV B-O
-across ADP B-O
-the DET B-O
-country NOUN B-O
-. PUNCT B-O
-
-HSV-2 PROPN B-AC
-, PUNCT B-O
-herpes NOUN B-LF
-simplex NOUN I-LF
-virus NOUN I-LF
-type NOUN I-LF
-2 NUM I-LF
-; PUNCT B-O
-STI PROPN B-AC
-, PUNCT B-O
-sexually ADV B-LF
-transmitted VERB I-LF
-infection NOUN I-LF
-. PUNCT B-O
-
-Eight NUM B-O
-databases NOUN B-O
-, PUNCT B-O
-PubMed PROPN B-O
-, PUNCT B-O
-GWAS PROPN B-AC
-, PUNCT B-O
-Embase PROPN B-O
-, PUNCT B-O
-Lochrane PROPN B-O
-, PUNCT B-O
-Ebsco PROPN B-O
-, PUNCT B-O
-CNKI PROPN B-AC
-( PUNCT B-O
-Chinese PROPN B-LF
-National PROPN I-LF
-Knowledge PROPN I-LF
-Infrastructure PROPN I-LF
-) PUNCT B-O
-, PUNCT B-O
-VIP PROPN B-AC
-( PUNCT B-O
-Viper PROPN B-LF
-Database PROPN I-LF
-) PUNCT B-O
-and CCONJ B-O
-ChinaInfo PROPN B-O
-were AUX B-O
-searched VERB B-O
-, PUNCT B-O
-and CCONJ B-O
-a DET B-O
-meta NOUN B-O
-- NOUN B-O
-analysis NOUN B-O
-of ADP B-O
-susceptibility NOUN B-O
-was AUX B-O
-conducted VERB B-O
-between ADP B-O
-SNP45 NOUN B-O
-, PUNCT B-O
-SNP276 NOUN B-O
-polymorphisms NOUN B-O
-and CCONJ B-O
-T2DM PROPN B-AC
-. PUNCT B-O
-
-Furthermore ADV B-O
-, PUNCT B-O
-HWE PROPN B-AC
-test NOUN B-O
-was AUX B-O
-conducted VERB B-O
-to PART B-O
-assess VERB B-O
-the DET B-O
-genetic ADJ B-O
-balance NOUN B-O
-of ADP B-O
-the DET B-O
-study NOUN B-O
-, PUNCT B-O
-evaluate VERB B-O
-the DET B-O
-quality NOUN B-O
-of ADP B-O
-Newcastle PROPN B-LF
-– PUNCT I-LF
-Ottawa PROPN I-LF
-quality NOUN I-LF
-assessment NOUN I-LF
-scale NOUN I-LF
-( PUNCT B-O
-NOS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-establishing VERB B-O
-allelic ADJ B-O
-, PUNCT B-O
-dominant ADJ B-O
-, PUNCT B-O
-recessive ADJ B-O
-, PUNCT B-O
-heterozygous ADJ B-O
-, PUNCT B-O
-and CCONJ B-O
-homozygous ADJ B-O
-gene NOUN B-O
-models NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-carbohydrate NOUN B-O
-composition NOUN B-O
-of ADP B-O
-the DET B-O
-extracts NOUN B-O
-was AUX B-O
-analysed VERB B-O
-using VERB B-O
-polysaccharide NOUN B-LF
-analysis NOUN I-LF
-by ADP I-LF
-carbohydrate NOUN I-LF
-gel NOUN I-LF
-electrophoresis NOUN I-LF
-( PUNCT B-O
-PACE PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-high ADJ B-O
-- NOUN B-O
-performance NOUN B-O
-anion NOUN B-O
-- NOUN B-O
-exchange NOUN B-O
-chromatography NOUN B-O
-( PUNCT B-O
-HPAEC PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Whether SCONJ B-O
-there PRON B-O
-were VERB B-O
-any DET B-O
-proteinaceous ADJ B-O
-moieties NOUN B-O
-linked VERB B-O
-to ADP B-O
-β PUNCT B-O
-- NOUN B-O
-glucan NOUN B-O
-was AUX B-O
-also ADV B-O
-examined VERB B-O
-. PUNCT B-O
-
-Wild ADJ B-O
-- PUNCT B-O
-type NOUN B-O
-( PUNCT B-O
-WT PROPN B-AC
-) PUNCT B-O
-Salmonella NOUN B-O
-was AUX B-O
-electroporated VERB B-O
-with ADP B-O
-6 NUM B-O
-μM PROPN B-O
-I NOUN B-O
-- PUNCT B-O
-switch NOUN B-O
-and CCONJ B-O
-recovered VERB B-O
-in ADP B-O
-SOC PROPN B-O
-for ADP B-O
-1 NUM B-O
-h NOUN B-O
-at ADP B-O
-37 NUM B-O
-° NOUN B-O
-C NOUN B-O
-, PUNCT B-O
-followed VERB B-O
-by ADP B-O
-three NUM B-O
-washes NOUN B-O
-with ADP B-O
-PBS PROPN B-O
-. PUNCT B-O
-
-Bacteria NOUN B-O
-were AUX B-O
-then ADV B-O
-clamped VERB B-O
-at ADP B-O
-various ADJ B-O
-pH NOUN B-O
-values NOUN B-O
-in ADP B-O
-K+-rich NOUN B-O
-buffer NOUN B-O
-containing VERB B-O
-40 NUM B-O
-μM PROPN B-O
-nigericin NOUN B-O
-for ADP B-O
-1 NUM B-O
-h NOUN B-O
-at ADP B-O
-room NOUN B-LF
-temperature NOUN I-LF
-( PUNCT B-O
-RT PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-imaged VERB B-O
-on ADP B-O
-an DET B-O
-Applied PROPN B-O
-Precision PROPN B-O
-Delta PROPN B-O
-Vision PROPN B-O
-inverted VERB B-O
-wide ADJ B-O
-- PUNCT B-O
-field NOUN B-O
-fluorescence NOUN B-O
-microscope NOUN B-O
-. PUNCT B-O
-
-Protein NOUN B-O
-export NOUN B-O
-via ADP B-O
-both DET B-O
-fT3SS PROPN B-AC
-and CCONJ B-O
-vT3SS PROPN B-AC
-is AUX B-O
-primarily ADV B-O
-dependent ADJ B-O
-on ADP B-O
-the DET B-O
-proton NOUN B-LF
-motive NOUN I-LF
-force NOUN I-LF
-( PUNCT B-O
-pmf PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-5–9 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-CPM PROPN B-AC
-, PUNCT B-O
-counts NOUN B-LF
-per ADP I-LF
-minute NOUN I-LF
-; PUNCT B-O
-CRF PROPN B-AC
-, PUNCT B-O
-cardiorespiratory ADJ B-LF
-fitness NOUN I-LF
-; PUNCT B-O
-CI PROPN B-O
-, PUNCT B-O
-confidence NOUN B-O
-interval NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-standard ADJ B-O
-test NOUN B-O
-for ADP B-O
-infection NOUN B-O
-is AUX B-O
-the DET B-O
-tuberculin NOUN B-LF
-skin NOUN I-LF
-test NOUN I-LF
-( PUNCT B-O
-TST PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-this PRON B-O
-, PUNCT B-O
-bacterial ADJ B-O
-antigens NOUN B-O
-( PUNCT B-O
-proteins NOUN B-O
-that PRON B-O
-the DET B-O
-immune ADJ B-O
-system NOUN B-O
-recognize VERB B-O
-as ADP B-O
-foreign ADJ B-O
-) PUNCT B-O
-are AUX B-O
-injected VERB B-O
-under ADP B-O
-the DET B-O
-skin NOUN B-O
-. PUNCT B-O
-
-No PROPN B-O
-, PUNCT B-O
-core NOUN B-O
-number NOUN B-O
-; PUNCT B-O
-Dx NOUN B-O
-, PUNCT B-O
-diagnosis NOUN B-O
-; PUNCT B-O
-ILC PROPN B-AC
-, PUNCT B-O
-invasive ADJ B-LF
-lobular ADJ I-LF
-carcinoma NOUN I-LF
-; PUNCT B-O
-ITC PROPN B-AC
-, PUNCT B-O
-invasive ADJ B-LF
-tubular ADJ I-LF
-carcinoma NOUN I-LF
-; PUNCT B-O
-+ NUM B-O
-, PUNCT B-O
-positive ADJ B-O
-; PUNCT B-O
-EXP PROPN B-AC
-, PUNCT B-O
-expression NOUN B-LF
-; PUNCT B-O
-INTPN PROPN B-AC
-, PUNCT B-O
-interpretation NOUN B-LF
-after ADP B-O
-considering VERB B-O
-the DET B-O
-1 NUM B-O
-+ NUM B-O
-intensity NOUN B-O
-( PUNCT B-O
-2a NUM B-O
-) PUNCT B-O
-as ADP B-O
-negative ADJ B-O
-; PUNCT B-O
-LC PROPN B-AC
-, PUNCT B-O
-lymphocyte NOUN B-LF
-; PUNCT B-O
-NS PROPN B-AC
-, PUNCT B-O
-no DET B-LF
-lymphocytes NOUN B-LF
-seen VERB I-LF
-Ab PROPN B-AC
-, PUNCT B-O
-antibody NOUN B-LF
-; PUNCT B-O
-Iso PROPN B-O
-, PUNCT B-O
-Isotype PROPN B-O
-control NOUN B-O
-. PUNCT B-O
-
-STAT3 PROPN B-AC
-decoy NOUN B-O
-was AUX B-O
-loaded VERB B-O
-on ADP B-O
-cationic ADJ B-O
-lipid NOUN B-O
-microbubbles NOUN B-LF
-( PUNCT B-O
-STAT3 PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
-loaded VERB B-O
-on ADP B-O
-liposome NOUN B-O
-- PUNCT B-O
-conjugated VERB B-O
-lipid NOUN B-O
-microbubbles NOUN B-LF
-to PART B-O
-form VERB B-O
--MBSTAT3 PROPN B-AC
-- PUNCT B-O
-loaded VERB B-O
-liposome NOUN B-O
-- PUNCT B-O
-microbubble NOUN B-LF
-complexes NOUN B-O
-( PUNCT B-O
-STAT3 PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
--LPXUTMC PROPN B-AC
-treatment NOUN B-O
-efficacy NOUN B-O
-with ADP B-O
-these DET B-O
-two NUM B-O
-formulations NOUN B-O
-was AUX B-O
-evaluated VERB B-O
-in ADP B-O
-vitro ADV B-O
-using VERB B-O
-viability NOUN B-O
-and CCONJ B-O
-apoptosis NOUN B-O
-assays NOUN B-O
-in ADP B-O
-CAL33 PROPN B-O
-( PUNCT B-O
-human ADJ B-O
-HNSCC PROPN B-AC
-) PUNCT B-O
-cells NOUN B-O
-. PUNCT B-O
-
-BF PROPN B-O
-, PUNCT B-O
-Burkina PROPN B-O
-Faso PROPN B-O
-; PUNCT B-O
-DRC PROPN B-AC
-, PUNCT B-O
-Democratic PROPN B-LF
-Republic PROPN I-LF
-of ADP I-LF
-the DET I-LF
-Congo PROPN I-LF
-; PUNCT B-O
-EMEP PROPN B-O
-, PUNCT B-O
-Evaluation NOUN B-O
-of ADP B-O
-Medications NOUN B-O
-used VERB B-O
-in ADP B-O
-Early PROPN B-O
-Pregnancy NOUN B-O
-; PUNCT B-O
-GA PROPN B-O
-, PUNCT B-O
-gestational ADJ B-O
-age NOUN B-O
-; PUNCT B-O
-IPTp PROPN B-AC
-, PUNCT B-O
-intermittent ADJ B-LF
-preventive ADJ I-LF
-treatment NOUN I-LF
-in ADP I-LF
-pregnancy NOUN I-LF
-; PUNCT B-O
-ITN PROPN B-O
-, PUNCT B-O
-insecticide NOUN B-O
-- PUNCT B-O
-treated VERB B-O
-bed NOUN B-O
-nets NOUN B-O
-; PUNCT B-O
-M3 PROPN B-AC
-, PUNCT B-O
-Maternal PROPN B-LF
-Malaria NOUN I-LF
-and CCONJ I-LF
-Malnutrition PROPN I-LF
-; PUNCT B-O
-PNG PROPN B-AC
-, PUNCT B-O
-Papua PROPN B-LF
-New PROPN I-LF
-Guinea PROPN I-LF
-; PUNCT B-O
-STOPPAM PROPN B-O
-, PUNCT B-O
-Strategies NOUN B-O
-to PART B-O
-Prevent VERB B-O
-Pregnancy NOUN B-O
-- PUNCT B-O
-Associated VERB B-O
-Malaria NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-prognostic ADJ B-O
-values NOUN B-O
-of ADP B-O
-left ADJ B-LF
-ventricular ADJ I-LF
-ejection NOUN I-LF
-fraction NOUN I-LF
-( PUNCT B-O
-LVEF PROPN B-AC
-) PUNCT B-O
-during ADP B-O
-heart NOUN B-LF
-failure NOUN I-LF
-( PUNCT B-O
-HF PROPN B-AC
-) PUNCT B-O
-with ADP B-O
-acute ADJ B-O
-decompensation NOUN B-O
-or CCONJ B-O
-after ADP B-O
-optimal ADJ B-O
-treatment NOUN B-O
-have AUX B-O
-not PART B-O
-been AUX B-O
-extensively ADV B-O
-studied VERB B-O
-. PUNCT B-O
-
-( PUNCT B-O
-Photo- ADJ B-O
-) PUNCT B-O
-chemical ADJ B-O
-cross ADJ B-O
-- ADJ B-O
-linking ADJ B-O
-combined VERB B-O
-with ADP B-O
-mass NOUN B-LF
-spectrometry NOUN I-LF
-( PUNCT B-O
-MS PROPN B-AC
-) PUNCT B-O
-has AUX B-O
-evolved VERB B-O
-as ADP B-O
-an DET B-O
-alternative ADJ B-O
-method NOUN B-O
-to PART B-O
-obtain VERB B-O
-low ADJ B-O
-- ADJ B-O
-resolution NOUN B-O
-three NUM B-O
-- ADJ B-O
-dimensional ADJ B-O
-( PUNCT B-O
-3D ADJ B-O
-) PUNCT B-O
-structural ADJ B-O
-information NOUN B-O
-of ADP B-O
-proteins NOUN B-O
-and CCONJ B-O
-protein NOUN B-O
-complexes.[1–9 NUM B-O
-] PUNCT B-O
-The DET B-O
-cross ADJ B-O
-- ADJ B-O
-linking ADJ B-O
-/ SYM B-O
-MS PROPN B-AC
-approach NOUN B-O
-allows VERB B-O
-deriving VERB B-O
-structural ADJ B-O
-information NOUN B-O
-by ADP B-O
-covalently ADV B-O
-connecting VERB B-O
-pairs NOUN B-O
-of ADP B-O
-functional ADJ B-O
-groups NOUN B-O
-in ADP B-O
-the DET B-O
-protein(s NOUN B-O
-) PUNCT B-O
-under ADP B-O
-investigation NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-widespread ADJ B-O
-presence NOUN B-O
-of ADP B-O
-overweight NOUN B-O
-and CCONJ B-O
-obesity NOUN B-O
-increases VERB B-O
-with ADP B-O
-every DET B-O
-decade NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-number NOUN B-O
-of ADP B-O
-people NOUN B-O
-with ADP B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-( PUNCT B-O
-BMI PROPN B-AC
-) PUNCT B-O
-> ADP B-O
-30 NUM B-O
-kg NOUN B-O
-/ SYM B-O
-m2 NOUN B-O
-has AUX B-O
-doubled VERB B-O
-in ADP B-O
-the DET B-O
-last ADJ B-O
-30 NUM B-O
-years NOUN B-O
-. PUNCT B-O
-
-Effect NOUN B-O
-of ADP B-O
-mitoCCCP PROPN B-AC
-and CCONJ B-O
-CCCP PROPN B-AC
-on ADP B-O
-the DET B-O
-pH NOUN B-O
-gradient NOUN B-O
-across ADP B-O
-the DET B-O
-membranes NOUN B-O
-of ADP B-O
-submitochondrial ADJ B-LF
-particles NOUN I-LF
-( PUNCT B-O
-SMP PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-as SCONJ B-O
-measured VERB B-O
-by ADP B-O
-ACMA PROPN B-AC
-( PUNCT B-O
-0.5 NUM B-O
-μg NOUN B-O
-/ SYM B-O
-ml NOUN B-O
-) PUNCT B-O
-fluorescence NOUN B-O
-. PUNCT B-O
-
-Within ADP B-O
-the DET B-O
-DOT PROPN B-AC
-- PUNCT B-O
-group NOUN B-O
-, PUNCT B-O
-SVR12 PROPN B-O
-was AUX B-O
-achieved VERB B-O
-in ADP B-O
-99.1 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-: PUNCT B-O
-95.0–100 NUM B-O
-; PUNCT B-O
-n NOUN B-O
-= SYM B-O
-109/110 NUM B-O
-) PUNCT B-O
-with ADP B-O
-one NUM B-O
-patient NOUN B-O
-experiencing VERB B-O
-treatment NOUN B-O
-failure NOUN B-O
-, PUNCT B-O
-while SCONJ B-O
-n NOUN B-O
-= SYM B-O
-12/122 NUM B-O
-( PUNCT B-O
-9.8 NUM B-O
-% NOUN B-O
-) PUNCT B-O
-patients NOUN B-O
-were AUX B-O
-excluded VERB B-O
-due ADP B-O
-to ADP B-O
-loss NOUN B-O
-of ADP B-O
-follow NOUN B-LF
-- PUNCT I-LF
-up NOUN I-LF
-( PUNCT B-O
-FU PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-5 NUM B-O
-patients NOUN B-O
-showed VERB B-O
-HCV PROPN B-AC
-reinfection NOUN B-O
-after ADP B-O
-achieving VERB B-O
-SVR12 PROPN B-O
-. PUNCT B-O
-
-We PRON B-O
-assumed VERB B-O
-that PRON B-O
-lung NOUN B-O
-tissues NOUN B-O
-are AUX B-O
-protected VERB B-O
-from ADP B-O
-overactive ADJ B-O
-immune ADJ B-O
-cells NOUN B-O
-by ADP B-O
-the DET B-O
-same ADJ B-O
-hypoxia NOUN B-O
-- PUNCT B-O
-driven VERB B-O
-mechanism NOUN B-O
-and CCONJ B-O
-immunosuppressive ADJ B-O
-adenosine NOUN B-LF
-A2A NOUN I-LF
-receptor NOUN I-LF
-( PUNCT B-O
-A2AR)-mediated PROPN B-AC
-mechanism NOUN B-O
-that PRON B-O
-was AUX B-O
-recently ADV B-O
-shown VERB B-O
-to PART B-O
-play VERB B-O
-a DET B-O
-critical ADJ B-O
-role NOUN B-O
-in ADP B-O
-the DET B-O
-down NOUN B-O
-- PUNCT B-O
-regulation NOUN B-O
-of ADP B-O
-inflammation NOUN B-O
-and CCONJ B-O
-tissue NOUN B-O
-damage NOUN B-O
-in ADP B-O
-different ADJ B-O
-models NOUN B-O
-[ PUNCT B-O
-4–7 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-false ADJ B-LF
-discovery NOUN I-LF
-rate NOUN I-LF
-( PUNCT B-O
-FDR PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-controlled VERB B-O
-by ADP B-O
-adjusting VERB B-O
-the DET B-O
-p NOUN B-O
-value NOUN B-O
-using VERB B-O
-the DET B-O
-Benjamini PROPN B-O
-- PUNCT B-O
-Hochberg PROPN B-O
-algorithm NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-used VERB B-O
-the DET B-O
-three NUM B-O
-Ethiopian ADJ B-LF
-demographic ADJ I-LF
-and CCONJ I-LF
-health NOUN I-LF
-surveys NOUN I-LF
-( PUNCT B-O
-EDHSs PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-2005 NUM B-O
-, PUNCT B-O
-2011 NUM B-O
-, PUNCT B-O
-and CCONJ B-O
-2016 NUM B-O
-) PUNCT B-O
-data NOUN B-O
-, PUNCT B-O
-which PRON B-O
-are AUX B-O
-the DET B-O
-nationally ADV B-O
-representative ADJ B-O
-surveys NOUN B-O
-performed VERB B-O
-in ADP B-O
-Ethiopia PROPN B-O
-. PUNCT B-O
-
-Acquiring VERB B-O
-and CCONJ B-O
-sharing VERB B-O
-large ADJ B-O
-amounts NOUN B-O
-of ADP B-O
-neuroimaging NOUN B-O
-data NOUN B-O
-have AUX B-O
-recently ADV B-O
-become VERB B-O
-critical ADJ B-O
-for ADP B-O
-bridging VERB B-O
-the DET B-O
-gap NOUN B-O
-between ADP B-O
-basic ADJ B-O
-neuroscience NOUN B-O
-research NOUN B-O
-and CCONJ B-O
-clinical ADJ B-O
-applications NOUN B-O
-, PUNCT B-O
-such ADJ B-O
-as ADP B-O
-the DET B-O
-diagnosis NOUN B-O
-and CCONJ B-O
-treatment NOUN B-O
-of ADP B-O
-psychiatric ADJ B-O
-disorders NOUN B-O
-( PUNCT B-O
-Human PROPN B-LF
-Connectome PROPN I-LF
-Project PROPN I-LF
-[ PUNCT B-O
-HCP PROPN B-AC
-] PUNCT B-O
-[ PUNCT B-O
-1 X B-O
-] PUNCT B-O
-[ PUNCT B-O
-http://www.humanconnectomeproject.org/ X B-O
-] PUNCT B-O
-; PUNCT B-O
-Human PROPN B-O
-Brain PROPN B-O
-Project PROPN B-O
-[ PUNCT B-O
-https://www.humanbrainproject.eu/en/ X B-O
-] PUNCT B-O
-; PUNCT B-O
-UK PROPN B-O
-Biobank PROPN B-O
-[ PUNCT B-O
-http://www.ukbiobank.ac.uk/ X B-O
-] PUNCT B-O
-; PUNCT B-O
-and CCONJ B-O
-Strategic PROPN B-LF
-Research PROPN I-LF
-Program PROPN I-LF
-for ADP I-LF
-Brain PROPN I-LF
-Sciences PROPN I-LF
-[ PUNCT B-O
-SRPBS PROPN B-AC
-] PUNCT B-O
-[ PUNCT B-O
-2 X B-O
-] PUNCT B-O
-[ PUNCT B-O
-https://bicr.atr.jp/decnefpro/ X B-O
-] PUNCT B-O
-) PUNCT B-O
-[ PUNCT B-O
-3–5 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Analysis NOUN B-O
-of ADP B-O
-the DET B-O
-molecular ADJ B-LF
-dynamics NOUN I-LF
-( PUNCT B-O
-MD PROPN B-AC
-) PUNCT B-O
-trajectories NOUN B-O
-and CCONJ B-O
-binding VERB B-O
-free ADJ B-O
-energy NOUN B-O
-components NOUN B-O
-shed VERB B-O
-light NOUN B-O
-into ADP B-O
-understanding VERB B-O
-the DET B-O
-mechanism NOUN B-O
-of ADP B-O
-the DET B-O
-binding VERB B-O
-specificity NOUN B-O
-of ADP B-O
-the DET B-O
-Abl PROPN B-O
-SH3 PROPN B-AC
-domain NOUN B-O
-. PUNCT B-O
-
-HCVcc PROPN B-AC
-was AUX B-O
-produced VERB B-O
-and CCONJ B-O
-50 NUM B-LF
-% NOUN I-LF
-tissue NOUN I-LF
-culture NOUN I-LF
-infective ADJ I-LF
-dose NOUN I-LF
-( PUNCT B-O
-TCID50 PROPN B-AC
-) PUNCT B-O
-determined VERB B-O
-as SCONJ B-O
-described VERB B-O
-[ PUNCT B-O
-37 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Data NOUN B-O
-are AUX B-O
-presented VERB B-O
-with ADP B-O
-counts NOUN B-O
-unless SCONJ B-O
-otherwise ADV B-O
-stated VERB B-O
-. PUNCT B-O
-
-95%CI PROPN B-AC
-: PUNCT B-O
-95 NUM B-LF
-% NOUN I-LF
-confidence NOUN I-LF
-interval NOUN I-LF
-; PUNCT B-O
-BSI PROPN B-AC
-: PUNCT B-O
-Bronchiectasis PROPN B-LF
-Severity PROPN I-LF
-Index PROPN I-LF
-. PUNCT B-O
-
-To PART B-O
-separate VERB B-O
-the DET B-O
-active ADJ B-O
-compounds NOUN B-O
-, PUNCT B-O
-preparative ADJ B-LF
-high ADJ I-LF
-performance NOUN I-LF
-liquid NOUN I-LF
-chromatography NOUN I-LF
-( PUNCT B-O
-PHPLC PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-conducted VERB B-O
-on ADP B-O
-a DET B-O
-Waters PROPN B-O
-2545 NUM B-O
-series NOUN B-O
-instrument NOUN B-O
-( PUNCT B-O
-Waters PROPN B-O
-, PUNCT B-O
-USA PROPN B-O
-) PUNCT B-O
-equipped VERB B-O
-with ADP B-O
-a DET B-O
-OBD PROPN B-O
-- PUNCT B-O
-C18 NUM B-O
-column NOUN B-O
-( PUNCT B-O
-19 NUM B-O
-mm NOUN B-O
-×150 NUM B-O
-mm NOUN B-O
-, PUNCT B-O
-10 NUM B-O
-μm NOUN B-O
-, PUNCT B-O
-Waters PROPN B-O
-, PUNCT B-O
-USA PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-mobile ADJ B-O
-phase NOUN B-O
-used VERB B-O
-for ADP B-O
-PHPLC PROPN B-AC
-was AUX B-O
-methanol NOUN B-O
-/ SYM B-O
-H2O NOUN B-O
-( PUNCT B-O
-1:4 NOUN B-O
-, PUNCT B-O
-v NOUN B-O
-/ SYM B-O
-v NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-applied VERB B-O
-with ADP B-O
-a DET B-O
-flow NOUN B-O
-rate NOUN B-O
-of ADP B-O
-8 NUM B-O
-mL NOUN B-O
-/ SYM B-O
-min NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-ultraviolet ADJ B-O
-detection NOUN B-O
-was AUX B-O
-a DET B-O
-210 NUM B-O
-nm NOUN B-O
-. PUNCT B-O
-
-Enhanced VERB B-O
-mean ADJ B-O
-intensity NOUN B-O
-images NOUN B-O
-are AUX B-O
-shown VERB B-O
-to ADP B-O
-demonstrate VERB B-O
-the DET B-O
-alignment NOUN B-O
-procedure NOUN B-O
-between ADP B-O
-a DET B-O
-recording NOUN B-O
-in ADP B-O
-Iso PROPN B-AC
-( PUNCT B-O
-A NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-one NUM B-O
-during ADP B-O
-wakefulness NOUN B-O
-( PUNCT B-O
-B NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-( PUNCT B-O
-C NOUN B-O
-) PUNCT B-O
-Mean ADJ B-O
-intensity NOUN B-O
-image NOUN B-O
-of ADP B-O
-the DET B-O
-awake ADJ B-O
-recording NOUN B-O
-aligned VERB B-O
-to ADP B-O
-the DET B-O
-anesthesia NOUN B-O
-condition NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-D NOUN B-O
-) PUNCT B-O
-Overlaid VERB B-O
-, PUNCT B-O
-enhanced VERB B-O
-mean ADJ B-O
-intensity NOUN B-O
-images NOUN B-O
-before ADP B-O
-and CCONJ B-O
-after SCONJ B-O
-( PUNCT B-O
-E NOUN B-O
-) PUNCT B-O
-the DET B-O
-alignment NOUN B-O
-algorithm NOUN B-O
-was AUX B-O
-applied VERB B-O
-. PUNCT B-O
-
-( PUNCT B-O
-F NOUN B-O
-) PUNCT B-O
-ROIs PROPN B-AC
-of ADP B-O
-active ADJ B-O
-neurons NOUN B-O
-during ADP B-O
-wakefulness NOUN B-O
-( PUNCT B-O
-pink NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-Iso PROPN B-AC
-anesthesia NOUN B-O
-( PUNCT B-O
-cyan NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-their PRON B-O
-overlap NOUN B-O
-( PUNCT B-O
-black NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-( PUNCT B-O
-G NOUN B-O
-– PUNCT B-O
-I NOUN B-O
-) PUNCT B-O
-Magnified VERB B-O
-views NOUN B-O
-of ADP B-O
-a DET B-O
-randomly ADV B-O
-selected VERB B-O
-sections NOUN B-O
-from ADP B-O
-panels NOUN B-O
-( PUNCT B-O
-D)–(F NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Iso PROPN B-AC
-, PUNCT B-O
-isoflurane NOUN B-LF
-; PUNCT B-O
-ROI PROPN B-AC
-, PUNCT B-O
-region NOUN B-LF
-of ADP I-LF
-interest NOUN I-LF
-. PUNCT B-O
-
-For ADP B-O
-example NOUN B-O
-, PUNCT B-O
-the DET B-O
-depletion NOUN B-O
-of ADP B-O
-CpG NOUN B-O
-dinucleotides NOUN B-O
-in ADP B-O
-vertebrate NOUN B-O
-- PUNCT B-O
-infecting VERB B-O
-RNA NOUN B-O
-virus NOUN B-O
-genomes NOUN B-O
-may AUX B-O
-have AUX B-O
-arisen VERB B-O
-to PART B-O
-evade VERB B-O
-zinc NOUN B-LF
-- PUNCT I-LF
-finger NOUN I-LF
-antiviral ADJ I-LF
-protein NOUN I-LF
-( PUNCT B-O
-ZAP PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-an DET B-O
-interferon NOUN B-LF
-- PUNCT I-LF
-stimulated VERB I-LF
-gene NOUN I-LF
-( PUNCT B-O
-ISG PROPN B-AC
-) PUNCT B-O
-that PRON B-O
-initiates VERB B-O
-the DET B-O
-degradation NOUN B-O
-of ADP B-O
-CpG NOUN B-O
-- PUNCT B-O
-rich ADJ B-O
-RNA NOUN B-O
-molecules NOUN B-O
-[ PUNCT B-O
-12 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-All DET B-O
-participants NOUN B-O
-in ADP B-O
-the DET B-O
-training NOUN B-O
-program NOUN B-O
-were AUX B-O
-key ADJ B-O
-persons NOUN B-O
-, PUNCT B-O
-recruited VERB B-O
-among ADP B-O
-93 NUM B-O
-eligible ADJ B-O
-baggage NOUN B-O
-handlers NOUN B-O
-identified VERB B-O
-to ADP B-O
-have VERB B-O
-key ADJ B-O
-roles NOUN B-O
-in ADP B-O
-the DET B-O
-company NOUN B-O
-( PUNCT B-O
-Table NOUN B-O
-1 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-i.e. X B-O
-safety NOUN B-LF
-officers NOUN I-LF
-( PUNCT B-O
-SO PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-16 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-instructors NOUN B-O
-teaching VERB B-O
-the DET B-O
-use NOUN B-O
-of ADP B-O
-technical ADJ B-O
-devices NOUN B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-26 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-coordinators NOUN B-O
-allocating VERB B-O
-tasks NOUN B-O
-to ADP B-O
-baggage NOUN B-O
-handlers NOUN B-O
-during ADP B-O
-the DET B-O
-shift NOUN B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-42 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-managers NOUN B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-9 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-ChIP PROPN B-O
-, PUNCT B-O
-chromatin NOUN B-O
-immunoprecipitation NOUN B-O
-; PUNCT B-O
-CREB PROPN B-AC
-, PUNCT B-O
-cAMP NOUN B-LF
-responsive ADJ I-LF
-element NOUN I-LF
-binding VERB I-LF
-protein NOUN I-LF
-; PUNCT B-O
-DHS PROPN B-AC
-, PUNCT B-O
-DNase NOUN B-LF
-hypersensitive ADJ I-LF
-site NOUN I-LF
-; PUNCT B-O
-FDR PROPN B-AC
-, PUNCT B-O
-false ADJ B-LF
-discovery NOUN I-LF
-rate NOUN I-LF
-; PUNCT B-O
-FOXO1 PROPN B-AC
-, PUNCT B-O
-Forkhead PROPN B-LF
-box NOUN I-LF
-O1 NOUN I-LF
-; PUNCT B-O
-GR PROPN B-AC
-, PUNCT B-O
-glucocorticoid NOUN B-LF
-receptor NOUN I-LF
-; PUNCT B-O
-H3K27Ac PROPN B-O
-, PUNCT B-O
-Histone NOUN B-O
-3 NUM B-O
-lysine NOUN B-O
-27 NUM B-O
-acetylation NOUN B-O
-; PUNCT B-O
-ROC PROPN B-AC
-, PUNCT B-O
-receiver NOUN B-LF
-operating NOUN I-LF
-characteristic NOUN I-LF
-; PUNCT B-O
-TSS PROPN B-AC
-, PUNCT B-O
-transcription NOUN B-LF
-start NOUN I-LF
-site NOUN I-LF
-. PUNCT B-O
-
-In ADP B-O
-the DET B-O
-Mexican ADJ B-O
-cohort NOUN B-O
-, PUNCT B-O
-the DET B-O
-fibrotic ADJ B-O
-non ADJ B-O
-- NOUN B-O
-IPF PROPN B-AC
-group NOUN B-O
-consisted VERB B-O
-of ADP B-O
-patients NOUN B-O
-with ADP B-O
-Rheumatoid PROPN B-LF
-Arthritis PROPN I-LF
-interstitial ADJ B-LF
-lung NOUN I-LF
-disease NOUN I-LF
-( PUNCT B-O
-RA PROPN B-AC
--ILD PROPN B-AC
-n NOUN B-O
-= SYM B-O
-18 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-Sjögren PROPN B-O
-Syndrome PROPN B-O
-interstitial ADJ B-LF
-lung NOUN I-LF
-disease NOUN I-LF
-( PUNCT B-O
-SS NOUN B-O
-- NOUN B-O
-ILD PROPN B-AC
-n NOUN B-O
-= SYM B-O
-5 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-or CCONJ B-O
-chronic ADJ B-LF
-hypersensitivity ADJ I-LF
-pneumonitis NOUN I-LF
-( PUNCT B-O
-cHP PROPN B-AC
-n NOUN B-O
-= SYM B-O
-46 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-BChl PROPN B-AC
-, PUNCT B-O
-bacteriochlorophyll NOUN B-LF
-; PUNCT B-O
-CD PROPN B-AC
-, PUNCT B-O
-circular ADJ B-LF
-dichroism NOUN I-LF
-; PUNCT B-O
-LD PROPN B-AC
-, PUNCT B-O
-linear ADJ B-LF
-dichroism NOUN I-LF
-; PUNCT B-O
-LH1 PROPN B-AC
-, PUNCT B-O
-light NOUN B-LF
-- PUNCT I-LF
-harvesting NOUN I-LF
-complex NOUN I-LF
-1 NUM I-LF
-; PUNCT B-O
-mdeg NOUN B-O
-, PUNCT B-O
-millidegree NOUN B-O
-; PUNCT B-O
-NIR PROPN B-AC
-, PUNCT B-O
-near ADJ B-LF
-infrared ADJ I-LF
-region NOUN I-LF
-; PUNCT B-O
-rel NOUN B-O
-. PUNCT B-O
-
-u. PROPN B-O
-, PUNCT B-O
-relative ADJ B-O
-units NOUN B-O
-. PUNCT B-O
-
-MPoRT PROPN B-AC
-parameters NOUN B-O
-, PUNCT B-O
-including VERB B-O
-variable ADJ B-O
-description NOUN B-O
-, PUNCT B-O
-derivation NOUN B-O
-and CCONJ B-O
-calibration NOUN B-O
-are AUX B-O
-available ADJ B-O
-as ADP B-O
-Predictive PROPN B-LF
-Modelling PROPN I-LF
-Markup PROPN I-LF
-Language NOUN I-LF
-( PUNCT B-O
-PMML PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-Lime PROPN B-O
-questionnaire NOUN B-O
-files NOUN B-O
-( PUNCT B-O
-See VERB B-O
-: PUNCT B-O
-S2 PROPN B-O
-Text PROPN B-O
-, PUNCT B-O
-S3 PROPN B-O
-Text PROPN B-O
-, PUNCT B-O
-https://github.com/Ottawa-mHealth/predictive-algorithms X B-O
-) PUNCT B-O
-[ PUNCT B-O
-41,42 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-components NOUN B-O
-related VERB B-O
-to ADP B-O
-blood NOUN B-LF
-pressure NOUN I-LF
-and CCONJ B-O
-the DET B-O
-metabolism NOUN B-O
-of ADP B-O
-glucose NOUN B-O
-— PUNCT B-O
-high ADJ B-O
-- PUNCT B-O
-normal ADJ B-O
-BP PROPN B-AC
-, PUNCT B-O
-DM2 PROPN B-AC
-, PUNCT B-O
-hypertension NOUN B-O
-and CCONJ B-O
-impaired ADJ B-O
-fasting VERB B-O
-glucose NOUN B-O
-— PUNCT B-O
-were AUX B-O
-, PUNCT B-O
-in ADP B-O
-this DET B-O
-order NOUN B-O
-, PUNCT B-O
-those PRON B-O
-that PRON B-O
-, PUNCT B-O
-when SCONJ B-O
-they PRON B-O
-appear VERB B-O
-first ADV B-O
-, PUNCT B-O
-determine VERB B-O
-having VERB B-O
-a DET B-O
-first ADV B-O
-episode NOUN B-O
-of ADP B-O
-MS PROPN B-AC
-, PUNCT B-O
-whereas SCONJ B-O
-the DET B-O
-components NOUN B-O
-related VERB B-O
-to ADP B-O
-dyslipidaemia NOUN B-O
-were AUX B-O
-associated VERB B-O
-with ADP B-O
-a DET B-O
-lower ADJ B-O
-risk NOUN B-O
-when SCONJ B-O
-they PRON B-O
-appear VERB B-O
-first ADV B-O
-. PUNCT B-O
-
-SIS PROPN B-AC
-- PUNCT B-O
-ECM PROPN B-AC
-; PUNCT B-O
-Small ADJ B-LF
-intestinal ADJ I-LF
-submucosa NOUN I-LF
-- PUNCT B-O
-extra ADJ B-LF
-cellular ADJ I-LF
-matrix NOUN I-LF
-, PUNCT B-O
-TE PROPN B-AC
-; PUNCT B-O
-Tissue NOUN B-LF
-engineering NOUN I-LF
-. PUNCT B-O
-
-Among ADP B-O
-women NOUN B-O
-, PUNCT B-O
-food NOUN B-O
-insufficiency NOUN B-O
-was AUX B-O
-associated VERB B-O
-with ADP B-O
-approximately ADV B-O
-70 NUM B-O
-% NOUN B-O
-higher ADJ B-O
-odds NOUN B-O
-of ADP B-O
-inconsistent ADJ B-O
-condom NOUN B-O
-use NOUN B-O
-with ADP B-O
-a DET B-O
-nonprimary ADJ B-O
-partner NOUN B-O
-after ADP B-O
-adjusting VERB B-O
-for ADP B-O
-other ADJ B-O
-covariates NOUN B-O
-in ADP B-O
-a DET B-O
-multivariate ADJ B-O
-model NOUN B-O
-( PUNCT B-O
-adjusted VERB B-LF
-odds NOUN I-LF
-ratio NOUN I-LF
-[ X B-O
-AOR PROPN B-AC
-] X B-O
-1.73 NUM B-O
-, PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-LF
-interval NOUN I-LF
-[ X B-O
-CI PROPN B-AC
-] X B-O
-1.27–2.36 NUM B-O
-) PUNCT B-O
-( PUNCT B-O
-Table PROPN B-O
-2 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-ASA PROPN B-AC
-, PUNCT B-O
-American PROPN B-LF
-Society PROPN I-LF
-of ADP I-LF
-Anaesthesiologists PROPN I-LF
-; PUNCT B-O
-BMI PROPN B-AC
-, PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-; PUNCT B-O
-OKS PROPN B-AC
-, PUNCT B-O
-Oxford PROPN B-LF
-Knee PROPN I-LF
-Score PROPN I-LF
-; PUNCT B-O
-TKR PROPN B-AC
-, PUNCT B-O
-total ADJ B-LF
-knee NOUN I-LF
-replacement NOUN I-LF
-. PUNCT B-O
-
-Manuscript NOUN B-O
-, PUNCT B-O
-page NOUN B-O
-5 NUM B-O
-, PUNCT B-O
-line NOUN B-O
-70 NUM B-O
-- PUNCT B-O
-76 NUM B-O
-: PUNCT B-O
-In ADP B-O
-our PRON B-O
-previous ADJ B-O
-work NOUN B-O
-, PUNCT B-O
-we PRON B-O
-integrated VERB B-O
-EBV NOUN B-LF
-- PUNCT I-LF
-EBV PROPN B-AC
-encoded VERB I-LF
-small ADJ I-LF
-RNA NOUN I-LF
-in ADP I-LF
-situ NOUN I-LF
-hybridization NOUN I-LF
-( PUNCT B-O
-EBER PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-immunohistochemistry NOUN B-O
-of ADP B-O
-DNA NOUN B-O
-mismatch NOUN B-O
-proteins NOUN B-O
-( PUNCT B-O
--ISHMMR PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-Lauren NOUN B-O
-histotyping NOUN B-O
-to ADP B-O
-design VERB B-O
-a DET B-O
-practical ADJ B-O
--IHCGC PROPN B-AC
-subtyping NOUN B-O
-algorithm NOUN B-O
-, PUNCT B-O
-parallel ADJ B-O
-to ADP B-O
-the DET B-O
-TCGA PROPN B-AC
-classification NOUN B-O
-[ PUNCT B-O
-3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-2002–2016 NUM B-O
-Nationwide PROPN B-LF
-Inpatient PROPN I-LF
-Sample PROPN I-LF
-( PUNCT B-O
-NIS PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-analyzed VERB B-O
-. PUNCT B-O
-
-Here ADV B-O
-, PUNCT B-O
-we PRON B-O
-have AUX B-O
-performed VERB B-O
-flat ADJ B-O
-panel NOUN B-O
-- PUNCT B-O
-based VERB B-O
-volume NOUN B-O
-computed VERB B-O
-tomography NOUN B-O
-( PUNCT B-O
-fpVCT PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-rapid ADJ B-O
-high ADJ B-O
-- PUNCT B-O
-resolution NOUN B-O
-imaging NOUN B-O
-of ADP B-O
-bone NOUN B-O
-structures NOUN B-O
-in ADP B-O
-combination NOUN B-O
-with ADP B-O
-artificial ADJ B-LF
-neuronal ADJ I-LF
-networks NOUN I-LF
-( PUNCT B-O
-ANNs PROPN B-AC
-) PUNCT B-O
-that PRON B-O
-are AUX B-O
-complex ADJ B-O
-nonlinear ADJ B-O
-computational ADJ B-O
-models NOUN B-O
-, PUNCT B-O
-designed VERB B-O
-much ADV B-O
-like ADP B-O
-the DET B-O
-neuronal ADJ B-O
-organization NOUN B-O
-of ADP B-O
-a DET B-O
-brain NOUN B-O
-[ X B-O
-10–15 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Physical ADJ B-O
-exercise NOUN B-O
-has VERB B-O
-a DET B-O
-neuromodulatory ADJ B-O
-effect NOUN B-O
-on ADP B-O
-the DET B-O
-central ADJ B-LF
-nervous ADJ I-LF
-system NOUN I-LF
-( PUNCT B-O
-CNS PROPN B-AC
-) PUNCT B-O
-partially ADV B-O
-by ADP B-O
-modifying VERB B-O
-expression NOUN B-O
-of ADP B-O
-neuropeptides NOUN B-O
-produced VERB B-O
-and CCONJ B-O
-secreted VERB B-O
-by ADP B-O
-neurons NOUN B-O
-and CCONJ B-O
-glial ADJ B-O
-cells NOUN B-O
-, PUNCT B-O
-among ADP B-O
-which PRON B-O
-the DET B-O
-best ADV B-O
-examined VERB B-O
-are AUX B-O
-brain NOUN B-LF
-- PUNCT I-LF
-derived VERB I-LF
-neurotrophic ADJ I-LF
-factor NOUN I-LF
-( PUNCT B-O
-BDNF PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-glial ADJ B-LF
-cell NOUN I-LF
-line NOUN I-LF
-- PUNCT I-LF
-derived VERB I-LF
-neurotrophic ADJ I-LF
-factor NOUN I-LF
-( PUNCT B-O
-GDNF PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Because SCONJ B-O
-both DET B-O
-neurotrophins NOUN B-O
-can AUX B-O
-cross VERB B-O
-the DET B-O
-brain NOUN B-O
-- PUNCT B-O
-blood NOUN B-O
-barrier NOUN B-O
-( PUNCT B-O
-BBB PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-their PRON B-O
-blood NOUN B-O
-levels NOUN B-O
-indirectly ADV B-O
-reflect VERB B-O
-their PRON B-O
-production NOUN B-O
-in ADP B-O
-the DET B-O
-CNS PROPN B-AC
-. PUNCT B-O
-
-Moreover ADV B-O
-, PUNCT B-O
-both DET B-O
-neuropeptides NOUN B-O
-are AUX B-O
-involved VERB B-O
-in ADP B-O
-modulation NOUN B-O
-of ADP B-O
-dopaminergic ADJ B-O
-and CCONJ B-O
-serotoninergic ADJ B-O
-system NOUN B-O
-function NOUN B-O
-. PUNCT B-O
-
-Trypsin NOUN B-O
-- PUNCT B-O
-EDTA PROPN B-O
-( PUNCT B-O
-0.05 NUM B-O
-% NOUN B-O
-) PUNCT B-O
-was AUX B-O
-prepared VERB B-O
-by ADP B-O
-diluting VERB B-O
-trypsin NOUN B-O
-- PUNCT B-O
-EDTA PROPN B-O
-( PUNCT B-O
-0.5 NUM B-O
-% NOUN B-O
-) PUNCT B-O
-in ADP B-O
-phosphate NOUN B-LF
-- PUNCT I-LF
-buffered VERB I-LF
-saline NOUN I-LF
-( PUNCT B-O
-PBS PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-All DET B-O
-cell NOUN B-O
-culture NOUN B-O
-materials NOUN B-O
-were AUX B-O
-obtained VERB B-O
-from ADP B-O
-Gibco PROPN B-O
-( PUNCT B-O
-Life PROPN B-O
-Technologies PROPN B-O
-, PUNCT B-O
-Breda PROPN B-O
-, PUNCT B-O
-The DET B-O
-Netherlands PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Despite SCONJ B-O
-the DET B-O
-significance NOUN B-O
-of ADP B-O
-insertions NOUN B-LF
-and CCONJ I-LF
-deletions NOUN I-LF
-( PUNCT B-O
-indels PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-human ADJ B-O
-genetic ADJ B-O
-disease NOUN B-O
-[ PUNCT B-O
-1 X B-O
-] PUNCT B-O
-and CCONJ B-O
-genome NOUN B-O
-evolution NOUN B-O
-[ PUNCT B-O
-2–5 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-the DET B-O
-mechanisms NOUN B-O
-of ADP B-O
-their PRON B-O
-mutagenesis NOUN B-O
-are AUX B-O
-not PART B-O
-completely ADV B-O
-understood VERB B-O
-. PUNCT B-O
-
-Further ADJ B-O
-kinetic ADJ B-O
-studies NOUN B-O
-allow VERB B-O
-the DET B-O
-first ADJ B-O
-snapshot NOUN B-O
-on ADP B-O
-how SCONJ B-O
-silver NOUN B-LF
-kills VERB B-O
-E. PROPN B-O
-coli NOUN B-O
-to PART B-O
-be AUX B-O
-captured VERB B-O
-at ADP B-O
-the DET B-O
-molecular ADJ B-O
-level NOUN B-O
-( PUNCT B-O
-Fig PROPN B-O
-4C NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Ag+ PROPN B-AC
-, PUNCT B-O
-once ADV B-O
-uptaken VERB B-O
-inside ADP B-O
-E. PROPN B-O
-coli NOUN B-O
-cell NOUN B-O
-, PUNCT B-O
-primarily ADV B-O
-targets VERB B-O
-glycolysis NOUN B-O
-and CCONJ B-O
-the DET B-O
-oxidative ADJ B-O
-branch NOUN B-O
-of ADP B-O
-the DET B-O
-TCA PROPN B-AC
-cycle NOUN B-O
-( PUNCT B-O
-or CCONJ B-O
-pyruvate NOUN B-O
-cycle NOUN B-O
-) PUNCT B-O
-via ADP B-O
-functional ADJ B-O
-disruption NOUN B-O
-of ADP B-O
-the DET B-O
-key ADJ B-O
-enzymes NOUN B-O
-, PUNCT B-O
-followed VERB B-O
-by ADP B-O
-adaptive ADJ B-O
-glyoxylate NOUN B-O
-cycle NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-then ADV B-O
-abolishes VERB B-O
-bacterial ADJ B-O
-oxidative ADJ B-O
-defense NOUN B-O
-capability NOUN B-O
-through ADP B-O
-binding NOUN B-O
-and CCONJ B-O
-inactivation NOUN B-O
-of ADP B-O
-key ADJ B-O
-antioxidant ADJ B-O
-enzymes NOUN B-O
-. PUNCT B-O
-
-Second X B-O
-, PUNCT B-O
-we PRON B-O
-defined VERB B-O
-people NOUN B-O
-receiving VERB B-O
-long ADJ B-O
-- PUNCT B-O
-term NOUN B-O
-opioid NOUN B-LF
-pain NOUN I-LF
-therapy NOUN I-LF
-( PUNCT B-O
-OPT PROPN B-AC
-) PUNCT B-O
-as ADP B-O
-those PRON B-O
-who PRON B-O
-had VERB B-O
-90 NUM B-O
-unique ADJ B-O
-days NOUN B-O
-of ADP B-O
-therapy NOUN B-O
-with ADP B-O
-opioids NOUN B-O
-indicated VERB B-O
-to ADP B-O
-treat VERB B-O
-pain NOUN B-O
-in ADP B-O
-the DET B-O
-100 NUM B-O
-days NOUN B-O
-prior ADV B-O
-to ADP B-O
-or CCONJ B-O
-including VERB B-O
-enrolment NOUN B-O
-termination NOUN B-O
-. PUNCT B-O
-
-Despite SCONJ B-O
-more ADJ B-O
-than ADP B-O
-two NUM B-O
-decades NOUN B-O
-of ADP B-O
-research NOUN B-O
-on ADP B-O
-adherence NOUN B-O
-to ADP B-O
-antiretroviral ADJ B-LF
-therapy NOUN I-LF
-( PUNCT B-O
-ART PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-more ADJ B-O
-than ADP B-O
-17 NUM B-O
-million NUM B-O
-HIV PROPN B-O
-- PUNCT B-O
-positive ADJ B-O
-individuals NOUN B-O
-on ADP B-O
-treatment NOUN B-O
-, PUNCT B-O
-adherence NOUN B-O
-to ADP B-O
-ART PROPN B-AC
-remains VERB B-O
-a DET B-O
-major ADJ B-O
-challenge NOUN B-O
-. PUNCT B-O
-
-To PART B-O
-further ADV B-O
-evaluate VERB B-O
-the DET B-O
-inhibitory ADJ B-O
-effects NOUN B-O
-of ADP B-O
-these DET B-O
-two NUM B-O
-compounds NOUN B-O
-on ADP B-O
-bacterial ADJ B-O
-growth NOUN B-O
-, PUNCT B-O
-the DET B-O
-compounds NOUN B-O
-were AUX B-O
-supplemented VERB B-O
-into ADP B-O
-the DET B-O
-culture NOUN B-O
-medium NOUN B-O
-of ADP B-O
-H. NOUN B-O
-pylori PROPN B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-pH NOUN B-O
-of ADP B-O
-brucella NOUN B-O
-broth NOUN B-O
-medium NOUN B-O
-was AUX B-O
-then ADV B-O
-adjusted VERB B-O
-to ADP B-O
-5.0 NUM B-O
-with ADP B-O
-sterile ADJ B-O
-dilute ADJ B-O
-hydrochloric ADJ B-LF
-acid NOUN I-LF
-( PUNCT B-O
-HCl PROPN B-AC
-) PUNCT B-O
-; PUNCT B-O
-inoculum NOUN B-O
-was AUX B-O
-added VERB B-O
-to ADP B-O
-an DET B-O
-initial ADJ B-O
-optical ADJ B-O
-density NOUN B-O
-at ADP B-O
-600 NUM B-O
-nm NOUN B-O
-( PUNCT B-O
-OD600 NUM B-O
-) PUNCT B-O
-of ADP B-O
-ca X B-O
-. PUNCT B-O
-
-0.1 NUM B-O
-. PUNCT B-O
-
-The DET B-O
-authors NOUN B-O
-, PUNCT B-O
-in ADP B-O
-a DET B-O
-previous ADJ B-O
-article NOUN B-O
-“ PUNCT B-O
-Recommendation NOUN B-O
-for ADP B-O
-ISTH PROPN B-O
-/ SYM B-O
-SSC PROPN B-O
-Criterion NOUN B-O
-2015 NUM B-O
-for ADP B-O
-autoimmune ADJ B-LF
-acquired VERB I-LF
-factor NOUN I-LF
-XIII/13 NUM I-LF
-deficiency NOUN I-LF
-” PUNCT B-O
-( PUNCT B-O
-Thromb PROPN B-O
-Haemost PROPN B-O
-2016 NUM B-O
-; PUNCT B-O
-116:772 NUM B-O
-- NUM B-O
-774 NUM B-O
-) PUNCT B-O
-refer VERB B-O
-to ADP B-O
-this DET B-O
-deficiency NOUN B-O
-as ADP B-O
-AAXIII/13D PROPN B-AC
-instead ADV B-O
-of ADP B-O
-AiF13D. NOUN B-O
-Children NOUN B-O
-were AUX B-O
-defined VERB B-O
-as ADP B-O
-being AUX B-O
-lost VERB B-LF
-to PART I-LF
-follow NOUN I-LF
-- PUNCT I-LF
-up ADP I-LF
-( PUNCT B-O
-LTFU PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-were AUX B-O
-censored VERB B-O
-if SCONJ B-O
-they PRON B-O
-had VERB B-O
-no DET B-O
-contact NOUN B-O
-with ADP B-O
-their PRON B-O
-health NOUN B-O
-care NOUN B-O
-facility NOUN B-O
-for ADP B-O
-9 NUM B-O
-mo NOUN B-O
-before ADP B-O
-database NOUN B-O
-closure NOUN B-O
-( PUNCT B-O
-visits NOUN B-O
-are AUX B-O
-scheduled VERB B-O
-up ADP B-O
-to PART B-O
-6 NUM B-O
-mo NOUN B-O
-apart ADV B-O
-and CCONJ B-O
-clinic NOUN B-O
-visits NOUN B-O
-being AUX B-O
-delayed VERB B-O
-for ADP B-O
-up ADP B-O
-to PART B-O
-3 NUM B-O
-mo NOUN B-O
-are AUX B-O
-possible ADJ B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-DDD PROPN B-AC
-, PUNCT B-O
-defined VERB B-LF
-daily ADJ I-LF
-dose NOUN I-LF
-. PUNCT B-O
-
-NP PROPN B-AC
-, PUNCT B-O
-normal ADJ B-LF
-pregnancy NOUN I-LF
-group NOUN B-O
-. PUNCT B-O
-
-Furthermore ADV B-O
-, PUNCT B-O
-observational ADJ B-O
-studies NOUN B-O
-of ADP B-O
-ITN PROPN B-AC
-use NOUN B-O
-have AUX B-O
-consistently ADV B-O
-shown VERB B-O
-findings NOUN B-O
-similar ADJ B-O
-to ADP B-O
-those PRON B-O
-of ADP B-O
-randomized VERB B-LF
-controlled VERB I-LF
-trials NOUN I-LF
-( PUNCT B-O
-RCTs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-suggesting VERB B-O
-that SCONJ B-O
-within ADP B-O
-specific ADJ B-O
-communities NOUN B-O
-confounding VERB B-O
-is AUX B-O
-not PART B-O
-pronounced VERB B-O
-[ PUNCT B-O
-29 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-On ADP B-O
-the DET B-O
-other ADJ B-O
-hand NOUN B-O
-, PUNCT B-O
-5-HT PROPN B-AC
-concentration NOUN B-O
-was AUX B-O
-significantly ADV B-O
-decreased VERB B-O
-in ADP B-O
-the DET B-O
-platelets NOUN B-O
-in ADP B-O
-patients NOUN B-O
-with ADP B-O
-AD PROPN B-AC
-[ X B-O
-54 X B-O
-] PUNCT B-O
-and CCONJ B-O
-selective ADJ B-O
-serotonin NOUN B-LF
-reuptake NOUN B-O
-inhibitors NOUN B-O
-improve VERB B-O
-decreased VERB B-O
-cognitive ADJ B-O
-performance NOUN B-O
-and CCONJ B-O
-BPSD PROPN B-AC
-seen VERB B-O
-in ADP B-O
-patients NOUN B-O
-with ADP B-O
-AD PROPN B-AC
-[ X B-O
-55 NUM B-O
-, PUNCT B-O
-56 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Pre X B-O
-= PUNCT B-O
-Precision NOUN B-O
-score NOUN B-O
-, PUNCT B-O
-Rec NOUN B-O
-= PUNCT B-O
-Recall NOUN B-O
-score NOUN B-O
-, PUNCT B-O
-F1 PROPN B-AC
-= PUNCT B-O
-F1 NOUN B-LF
-- PUNCT I-LF
-F1 PROPN B-AC
-score NOUN I-LF
-, PUNCT B-O
-AUC PROPN B-AC
-= PUNCT B-O
-AUC PROPN B-AC
-score NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-A(i NOUN B-O
-) PUNCT B-O
-= PUNCT B-O
-{ PUNCT B-O
-Prei NOUN B-O
-, PUNCT B-O
-Reci PROPN B-O
-, PUNCT B-O
-F1i X B-O
-, PUNCT B-O
-AUCi PROPN B-O
-} PUNCT B-O
-; PUNCT B-O
-w(i NOUN B-O
-) PUNCT B-O
-is AUX B-O
-the DET B-O
-weight NOUN B-O
-generated VERB B-O
-for ADP B-O
-the DET B-O
-ith PROPN B-O
-base NOUN B-O
-learner NOUN B-O
-to PART B-O
-compute VERB B-O
-the DET B-O
-ensemble NOUN B-O
-, PUNCT B-O
-pj(i NOUN B-O
-) PUNCT B-O
-is AUX B-O
-the DET B-O
-probability NOUN B-O
-score NOUN B-O
-for ADP B-O
-the DET B-O
-jth ADJ B-O
-sample NOUN B-O
-by ADP B-O
-the DET B-O
-ith PROPN B-O
-classifier NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-ensj NOUN B-O
-is AUX B-O
-the DET B-O
-fused VERB B-O
-probability NOUN B-O
-score NOUN B-O
-for ADP B-O
-the DET B-O
-jth ADJ B-O
-sample NOUN B-O
-; PUNCT B-O
-and CCONJ B-O
-the DET B-O
-argmax NOUN B-O
-function NOUN B-O
-returns VERB B-O
-the DET B-O
-position NOUN B-O
-having VERB B-O
-the DET B-O
-highest ADJ B-O
-value NOUN B-O
-in ADP B-O
-a DET B-O
-1D ADJ B-O
-array NOUN B-O
-, PUNCT B-O
-i.e. X B-O
-, PUNCT B-O
-in ADP B-O
-this DET B-O
-case NOUN B-O
-it PRON B-O
-generates VERB B-O
-the DET B-O
-predicted VERB B-O
-class NOUN B-O
-of ADP B-O
-the DET B-O
-sample NOUN B-O
-. PUNCT B-O
-
-This PRON B-O
-indicates VERB B-O
-that SCONJ B-O
-a DET B-O
-Chromosome NOUN B-O
-4 NUM B-O
-bivalent ADJ B-O
-experiences VERB B-O
-on ADP B-O
-average ADJ B-O
-1.76 NUM B-O
-CO PROPN B-AC
-in ADP B-O
-male ADJ B-LF
-meiosis NOUN B-O
-, PUNCT B-O
-but CCONJ B-O
-only ADV B-O
-1.05 NUM B-O
-CO PROPN B-AC
-in ADP B-O
-female ADJ B-LF
-meiosis NOUN B-O
-( PUNCT B-O
-M PROPN B-AC
-/ SYM B-O
-F PROPN B-AC
-ratio NOUN B-O
-1.68 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-results NOUN B-O
-in ADP B-O
-this DET B-O
-section NOUN B-O
-were AUX B-O
-confirmed VERB B-O
-by ADP B-O
-NCBI PROPN B-O
-’s PART B-O
-Conserved PROPN B-LF
-Domain PROPN I-LF
-Database PROPN I-LF
-( PUNCT B-O
-CDD PROPN B-AC
-) PUNCT B-O
-[ X B-O
-93 X B-O
-] X B-O
-matches NOUN B-O
-obtained VERB B-O
-using VERB B-O
-rpsblast PROPN B-O
-with ADP B-O
-composition NOUN B-O
-- PUNCT B-O
-based VERB B-O
-statistics NOUN B-O
-and CCONJ B-O
-masking VERB B-O
-low ADJ B-O
-- PUNCT B-O
-information NOUN B-O
-regions NOUN B-O
-. PUNCT B-O
-
-A X B-O
-range NOUN B-O
-of ADP B-O
-virulence NOUN B-O
-assays NOUN B-O
-were AUX B-O
-performed VERB B-O
-on ADP B-O
-a DET B-O
-subset NOUN B-O
-of ADP B-O
-10 NUM B-O
-high- ADJ B-O
-and CCONJ B-O
-10 NUM B-O
-low ADJ B-O
-- PUNCT B-O
-toxicity NOUN B-O
-isolates NOUN B-O
-from ADP B-O
-the DET B-O
-USA300 PROPN B-O
-collection NOUN B-O
-to PART B-O
-identify VERB B-O
-the DET B-O
-biological ADJ B-O
-feature NOUN B-O
-that PRON B-O
-explains VERB B-O
-the DET B-O
-observed VERB B-O
-inverse ADJ B-O
-correlation NOUN B-O
-between ADP B-O
-toxicity NOUN B-O
-and CCONJ B-O
-disease NOUN B-O
-severity NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-A X B-O
-) PUNCT B-O
-The DET B-O
-toxicity NOUN B-O
-of ADP B-O
-the DET B-O
-subset NOUN B-O
-of ADP B-O
-isolates NOUN B-O
-is AUX B-O
-provided VERB B-O
-for ADP B-O
-comparison NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-B NOUN B-O
-) PUNCT B-O
-The DET B-O
-ability NOUN B-O
-of ADP B-O
-the DET B-O
-bacteria NOUN B-O
-to PART B-O
-invade VERB B-O
-EA.hy926 NOUN B-O
-endothelial ADJ B-O
-cells NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-C X B-O
-) PUNCT B-O
-The DET B-O
-ability NOUN B-O
-of ADP B-O
-the DET B-O
-bacteria NOUN B-O
-to PART B-O
-induce VERB B-O
-the DET B-O
-release NOUN B-O
-of ADP B-O
-neutrophil NOUN B-LF
-extracellular ADJ I-LF
-traps NOUN I-LF
-( PUNCT B-O
-NETs PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-( PUNCT B-O
-D X B-O
-) PUNCT B-O
-The DET B-O
-release NOUN B-O
-of ADP B-O
-proteases NOUN B-O
-by ADP B-O
-the DET B-O
-bacteria NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-E X B-O
-) PUNCT B-O
-Resistance NOUN B-O
-of ADP B-O
-the DET B-O
-bacteria NOUN B-O
-to PART B-O
-human ADJ B-O
-neutrophil NOUN B-O
-defensin-1 NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-F X B-O
-) PUNCT B-O
-The DET B-O
-ability NOUN B-O
-of ADP B-O
-the DET B-O
-bacteria NOUN B-O
-to PART B-O
-form VERB B-O
-biofilms NOUN B-O
-. PUNCT B-O
-
-Although SCONJ B-O
-the DET B-O
-percentage NOUN B-O
-of ADP B-O
-women NOUN B-O
-attending VERB B-O
-Focused PROPN B-LF
-Antenatal PROPN I-LF
-Care PROPN I-LF
-( PUNCT B-O
-FANC PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-at ADP B-O
-least ADV B-O
-once ADV B-O
-generally ADV B-O
-tends VERB B-O
-to PART B-O
-be AUX B-O
-satisfactory ADJ B-O
-even ADV B-O
-in ADP B-O
-low ADJ B-O
-- PUNCT B-O
-income NOUN B-O
-countries NOUN B-O
-, PUNCT B-O
-maternal ADJ B-O
-and CCONJ B-O
-neonatal ADJ B-O
-mortality NOUN B-O
-remain VERB B-O
-high ADJ B-O
-. PUNCT B-O
-
-Cycloheximide NOUN B-O
-was AUX B-O
-added VERB B-O
-at ADP B-O
-time NOUN B-O
-= CCONJ B-O
-0 NUM B-O
-and CCONJ B-O
-the DET B-O
-amount NOUN B-O
-of ADP B-O
-Gal80 NOUN B-O
-protein NOUN B-O
-remaining VERB B-O
-in ADP B-O
-the DET B-O
-cells NOUN B-O
-after ADP B-O
-the DET B-O
-indicated VERB B-O
-number NOUN B-O
-of ADP B-O
-hours NOUN B-O
-was AUX B-O
-determined VERB B-O
-by ADP B-O
-Western ADJ B-O
-blot NOUN B-O
-with ADP B-O
-the DET B-O
-help NOUN B-O
-of ADP B-O
-an DET B-O
-anti ADJ B-O
-- ADJ B-O
-hemagglutinin ADJ B-LF
-( PUNCT B-O
-HA PROPN B-AC
-) PUNCT B-O
-antibody NOUN B-O
-( PUNCT B-O
-upper ADJ B-O
-panels NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Dpp PROPN B-AC
-, PUNCT B-O
-Decapentaplegic PROPN B-LF
-; PUNCT B-O
-Hh PROPN B-AC
-, PUNCT B-O
-Hedgehog PROPN B-LF
-. PUNCT B-O
-
-The DET B-O
-most ADV B-O
-common ADJ B-O
-alternative ADJ B-O
-infectious ADJ B-LF
-disease NOUN I-LF
-( PUNCT B-O
-ID)—diagnoses PROPN B-AC
-were AUX B-O
-pneumonia NOUN B-O
-( PUNCT B-O
-n NOUN B-O
-= PUNCT B-O
-30 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-infection NOUN B-O
-of ADP B-O
-totally ADV B-O
-implantable ADJ B-O
-venous ADJ B-O
-access NOUN B-O
-device NOUN B-O
-( PUNCT B-O
-port NOUN B-O
-, PUNCT B-O
-n NOUN B-O
-= PUNCT B-O
-9 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-skin NOUN B-LF
-and CCONJ I-LF
-soft ADJ I-LF
-tissue NOUN I-LF
-infection NOUN I-LF
-( PUNCT B-O
-SSTI PROPN B-AC
-, PUNCT B-O
-n NOUN B-O
-= PUNCT B-O
-9 NUM B-O
-) PUNCT B-O
-and CCONJ B-O
-influenza NOUN B-O
-( PUNCT B-O
-n NOUN B-O
-= PUNCT B-O
-4 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Lysates NOUN B-O
-derived VERB B-O
-from ADP B-O
-virions NOUN B-O
-containing VERB B-O
-HA PROPN B-O
-- PUNCT B-O
-tagged VERB B-O
-A3G PROPN B-AC
-were AUX B-O
-size NOUN B-O
-- PUNCT B-O
-fractionated VERB B-O
-by ADP B-O
-fast ADJ B-LF
-protein NOUN I-LF
-liquid NOUN I-LF
-chromatography NOUN I-LF
-( PUNCT B-O
-FPLC PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Each DET B-O
-fraction NOUN B-O
-was AUX B-O
-then ADV B-O
-analyzed VERB B-O
-by ADP B-O
-SDS PROPN B-O
-- PUNCT B-O
-PAGE PROPN B-O
-and CCONJ B-O
-immunoblotting VERB B-O
-with ADP B-O
-anti ADJ B-O
-- PUNCT B-O
-HA PROPN B-O
-monoclonal ADJ B-O
-antibodies NOUN B-O
-( PUNCT B-O
-Figure PROPN B-O
-3A NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Surprisingly ADV B-O
-, PUNCT B-O
-virion NOUN B-O
-- PUNCT B-O
-incorporated VERB B-O
-HA PROPN B-O
-- PUNCT B-O
-A3 PROPN B-AC
-was AUX B-O
-detected VERB B-O
-almost ADV B-O
-exclusively ADV B-O
-in ADP B-O
-the DET B-O
-GHMM PROPN B-AC
-region NOUN B-O
-, PUNCT B-O
-eluting VERB B-O
-in ADP B-O
-the DET B-O
-void ADJ B-O
-volume NOUN B-O
-of ADP B-O
-the DET B-O
-Superose PROPN B-O
-6 NUM B-O
-column NOUN B-O
-( PUNCT B-O
-Figure PROPN B-O
-3A NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-This DET B-O
-result NOUN B-O
-was AUX B-O
-not PART B-O
-due ADJ B-O
-to ADP B-O
-incomplete ADJ B-O
-lysis NOUN B-O
-of ADP B-O
-the DET B-O
-virion NOUN B-O
-cores NOUN B-O
-since SCONJ B-O
-the DET B-O
-p24 NOUN B-O
-viral ADJ B-O
-capsid NOUN B-LF
-( PUNCT B-O
-p24 NOUN B-O
-- PUNCT B-O
-CA PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-detected VERB B-O
-only ADV B-O
-in ADP B-O
-the DET B-O
-expected VERB B-O
-LMM PROPN B-AC
-fractions NOUN B-O
-. PUNCT B-O
-
-Inward ADJ B-LF
-rectifier NOUN I-LF
-potassium NOUN I-LF
-current NOUN I-LF
-( PUNCT B-O
-IK1 PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-measured VERB B-O
-by ADP B-O
-determining VERB B-O
-the DET B-O
-steady ADJ B-O
-- PUNCT B-O
-state NOUN B-O
-current NOUN B-O
-at ADP B-O
-the DET B-O
-end NOUN B-O
-of ADP B-O
-300 NUM B-O
-ms NOUN B-O
-long ADJ B-O
-pulses NOUN B-O
-clamped VERB B-O
-to ADP B-O
-potentials NOUN B-O
-ranging VERB B-O
-from ADP B-O
--80 NUM B-O
-to ADP B-O
-0 NUM B-O
-mV. NOUN B-O
-FFS PROPN B-AC
-, PUNCT B-O
-Medicare PROPN B-LF
-fee NOUN I-LF
-- PUNCT I-LF
-for ADP I-LF
-- PUNCT I-LF
-service NOUN I-LF
-; PUNCT B-O
-IPTW PROPN B-AC
-, PUNCT B-O
-inverse ADJ B-LF
-probability NOUN I-LF
-of ADP I-LF
-treatment NOUN I-LF
-weighting NOUN I-LF
-; PUNCT B-O
-MA PROPN B-AC
-, PUNCT B-O
-Medicare PROPN B-LF
-Advantage PROPN I-LF
-; PUNCT B-O
-SNF PROPN B-AC
-, PUNCT B-O
-skilled ADJ B-LF
-nursing NOUN I-LF
-facility NOUN I-LF
-. PUNCT B-O
-
-Weak ADJ B-O
-CGIs PROPN B-AC
-may AUX B-O
-be AUX B-O
-depleted VERB B-O
-because SCONJ B-O
-they PRON B-O
-are AUX B-O
-heavily ADV B-O
-methylated VERB B-O
-and CCONJ B-O
-therefore ADV B-O
-not PART B-O
-enriched VERB B-O
-by ADP B-O
-CAP PROPN B-AC
-. PUNCT B-O
-
-Indeed ADV B-O
-, PUNCT B-O
-22 NUM B-O
-methylated VERB B-O
-weak ADJ B-O
-CpG NOUN B-LF
-islands NOUN I-LF
-[ X B-O
-14 X B-O
-] X B-O
-were AUX B-O
-not PART B-O
-detected VERB B-O
-in ADP B-O
-our PRON B-O
-library NOUN B-O
-. PUNCT B-O
-
-Thus ADV B-O
-, PUNCT B-O
-it PRON B-O
-is AUX B-O
-necessary ADJ B-O
-to PART B-O
-test VERB B-O
-our PRON B-O
-hypothesis NOUN B-O
-that SCONJ B-O
-the DET B-O
-treatment NOUN B-O
-of ADP B-O
-stroke NOUN B-O
-with ADP B-O
-BMSC PROPN B-AC
-has AUX B-O
-therapeutic ADJ B-O
-efficacy NOUN B-O
-in ADP B-O
-the DET B-O
-most ADV B-O
-common ADJ B-O
-form NOUN B-O
-of ADP B-O
-diabetes NOUN B-O
-, PUNCT B-O
-type NOUN B-LF
-2 NUM I-LF
-diabetes NOUN I-LF
-mellitus NOUN I-LF
-( PUNCT B-O
-T2DM PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-T2DM PROPN B-AC
-was AUX B-O
-induced VERB B-O
-in ADP B-O
-adult ADJ B-O
-male ADJ B-O
-Wistar PROPN B-O
-rats NOUN B-O
-by ADP B-O
-administration NOUN B-O
-of ADP B-O
-a DET B-O
-high ADJ B-O
-fat NOUN B-O
-diet NOUN B-O
-in ADP B-O
-combination NOUN B-O
-with ADP B-O
-a DET B-O
-single ADJ B-O
-intraperitoneal ADJ B-O
-injection NOUN B-O
-( PUNCT B-O
-35mg NUM B-O
-/ SYM B-O
-kg NOUN B-O
-) PUNCT B-O
-of ADP B-O
-streptozotocin NOUN B-O
-. PUNCT B-O
-
-There PRON B-O
-are AUX B-O
-eight NUM B-O
-mammalian ADJ B-O
-IAPs NOUN B-O
-. PUNCT B-O
-
-Some DET B-O
-IAPs NOUN B-O
-also ADV B-O
-contain VERB B-O
-a DET B-O
-RING NOUN B-O
-motif NOUN B-O
-that PRON B-O
-confers VERB B-O
-ubiquitin NOUN B-O
-protein NOUN B-O
-ligase NOUN B-O
-( PUNCT B-O
-E3 NOUN B-O
-) PUNCT B-O
-activity NOUN B-O
-. PUNCT B-O
-
-c NOUN B-O
-- PUNCT B-O
-IAP1 PROPN B-O
-and CCONJ B-O
-c NOUN B-O
-- PUNCT B-O
-IAP2 PROPN B-O
-are AUX B-O
-such ADJ B-O
-RING NOUN B-O
-- PUNCT B-O
-containing VERB B-O
-proteins NOUN B-O
-that PRON B-O
-bind VERB B-O
-caspase-7 NOUN B-O
-or CCONJ B-O
--9 NUM B-O
-but CCONJ B-O
-, PUNCT B-O
-unlike ADP B-O
-XIAP PROPN B-O
-, PUNCT B-O
-do AUX B-O
-not PART B-O
-inhibit VERB B-O
-their PRON B-O
-enzymatic ADJ B-O
-activities NOUN B-O
-[ PUNCT B-O
-2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-c NOUN B-O
-- PUNCT B-O
-IAP1 PROPN B-O
-and CCONJ B-O
-c NOUN B-O
-- PUNCT B-O
-IAP2 PROPN B-O
-also ADV B-O
-bind VERB B-O
-the DET B-O
-adaptor NOUN B-O
-protein NOUN B-O
-TNF PROPN B-LF
-Receptor PROPN I-LF
-Associated PROPN I-LF
-Factor PROPN I-LF
-2 NUM I-LF
-( PUNCT B-O
-TRAF2 PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-are AUX B-O
-components NOUN B-O
-of ADP B-O
-the DET B-O
-Tumor PROPN B-LF
-Necrosis PROPN I-LF
-Factor PROPN I-LF
-Receptor PROPN I-LF
-1 NUM I-LF
-( PUNCT B-O
-TNF-R1 PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-2 NUM B-O
-signaling NOUN B-O
-complexes NOUN B-O
-[ PUNCT B-O
-3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Fig NOUN B-O
-1A–1C NOUN B-O
-shows VERB B-O
-that SCONJ B-O
-hearts NOUN B-O
-exposed VERB B-O
-to ADP B-O
-40 NUM B-O
-minutes NOUN B-O
-of ADP B-O
-ischemia NOUN B-O
-and CCONJ B-O
-60 NUM B-O
-minutes NOUN B-O
-of ADP B-O
-reperfusion NOUN B-O
-( PUNCT B-O
-I/R PROPN B-AC
-) PUNCT B-O
-suffered VERB B-O
-a DET B-O
-significant ADJ B-O
-decrease NOUN B-O
-in ADP B-O
-the DET B-O
-left ADJ B-LF
-ventricular ADJ I-LF
-developed VERB I-LF
-pressure NOUN I-LF
-( PUNCT B-O
-LVDP PROPN B-AC
-) PUNCT B-O
-as ADP B-O
-well ADV B-O
-as ADP B-O
-in ADP B-O
-the DET B-O
-positive ADJ B-O
-and CCONJ B-O
-negative ADJ B-O
-maximum ADJ B-O
-derivative NOUN B-LF
-of ADP I-LF
-left ADJ I-LF
-ventricular ADJ I-LF
-pressure NOUN I-LF
-( PUNCT B-O
-±dP NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-indicating VERB B-O
-significant ADJ B-O
-loss NOUN B-O
-in ADP B-O
-heart NOUN B-O
-function NOUN B-O
-. PUNCT B-O
-
-CK-666 PROPN B-AC
-, PUNCT B-O
-Arp2/3 NOUN B-LF
-complex NOUN I-LF
-Arp2/3 PROPN B-AC
-inhibitor NOUN I-LF
-I. NOUN I-LF
-Data NOUN B-O
-are AUX B-O
-shown VERB B-O
-as ADP B-O
-mean NOUN B-O
-± ADJ B-O
-SEM NOUN B-O
-. PUNCT B-O
-
-AAV PROPN B-O
-, PUNCT B-O
-adeno NOUN B-O
-- PUNCT B-O
-associated VERB B-O
-virus NOUN B-O
-; PUNCT B-O
-ARC PROPN B-AC
-, PUNCT B-O
-arcuate ADJ B-LF
-nucleus NOUN I-LF
-of ADP I-LF
-the DET I-LF
-hypothalamus NOUN I-LF
-; PUNCT B-O
-cap NOUN B-O
-, PUNCT B-O
-capsaicin NOUN B-O
-; PUNCT B-O
-CNO PROPN B-AC
-, PUNCT B-O
-clozapine NOUN B-LF
-- PUNCT I-LF
-N NOUN I-LF
-- PUNCT I-LF
-oxide NOUN I-LF
-; PUNCT B-O
-Cre PROPN B-AC
-, PUNCT B-O
-Cre PROPN B-LF
-recombinase NOUN I-LF
-Cre PROPN B-AC
-; PUNCT B-O
-DREADD PROPN B-AC
-, PUNCT B-O
-designer NOUN B-LF
-receptor NOUN I-LF
-exclusively ADV I-LF
-activated VERB I-LF
-by ADP I-LF
-designer NOUN I-LF
-drugs NOUN I-LF
-; PUNCT B-O
-hSyn PROPN B-AC
-, PUNCT B-O
-human ADJ B-LF
-synapsin NOUN I-LF
-I NUM I-LF
-promoter NOUN I-LF
-; PUNCT B-O
-i.p NOUN B-O
-. PUNCT B-O
-
-, PUNCT B-O
-Intraperitoneal NOUN B-O
-; PUNCT B-O
-mCherry PROPN B-AC
-, PUNCT B-O
-monomeric ADJ B-LF
-cherry NOUN I-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-; PUNCT B-O
-MC3/4 PROPN B-O
-, PUNCT B-O
-melanocortin NOUN B-O
-3/4 NUM B-O
-; PUNCT B-O
-POMC PROPN B-AC
-, PUNCT B-O
-proopiomelanocortin NOUN B-LF
-; PUNCT B-O
-RTX PROPN B-AC
-, PUNCT B-O
-resiniferatoxin NOUN B-LF
-; PUNCT B-O
-sal NOUN B-O
-, PUNCT B-O
-saline NOUN B-O
-; PUNCT B-O
-TRPV1 PROPN B-AC
-, PUNCT B-O
-transient ADJ B-LF
-receptor NOUN I-LF
-potential ADJ I-LF
-vanilloid NOUN I-LF
-1 NUM I-LF
-receptor NOUN I-LF
-. PUNCT B-O
-
-Targeted VERB B-LF
-radionuclide NOUN I-LF
-therapy NOUN I-LF
-( PUNCT B-O
-TRNT PROPN B-AC
-) PUNCT B-O
-with ADP B-O
-alpha NOUN B-O
-particles NOUN B-O
-is AUX B-O
-thus ADV B-O
-complementary ADJ B-O
-to ADP B-O
-TRNT PROPN B-AC
-with ADP B-O
-beta NOUN B-O
-particles NOUN B-O
-, PUNCT B-O
-whose DET B-O
-millimetric ADJ B-O
-path NOUN B-O
-is AUX B-O
-better ADV B-O
-suited ADJ B-O
-to ADP B-O
-bulky ADJ B-O
-tumour NOUN B-O
-treatment NOUN B-O
-. PUNCT B-O
-
-One NUM B-O
-part NOUN B-O
-is AUX B-O
-called VERB B-O
-GP PROPN B-AC
-( PUNCT B-O
-which PRON B-O
-stands VERB B-O
-for ADP B-O
-glycoprotein NOUN B-LF
-) PUNCT B-O
-and CCONJ B-O
-is AUX B-O
-from ADP B-O
-the DET B-O
-outer ADJ B-O
-coat NOUN B-O
-of ADP B-O
-the DET B-O
-virus NOUN B-O
-; PUNCT B-O
-the DET B-O
-other ADJ B-O
-, PUNCT B-O
-NP PROPN B-AC
-( PUNCT B-O
-nucleoprotein NOUN B-LF
-) PUNCT B-O
-, PUNCT B-O
-is AUX B-O
-from ADP B-O
-its PRON B-O
-inside NOUN B-O
-. PUNCT B-O
-
-Bioreactors NOUN B-O
-were AUX B-O
-filled VERB B-O
-with ADP B-O
-different ADJ B-O
-mixtures NOUN B-O
-of ADP B-O
-WAS PROPN B-AC
-substrate NOUN B-O
-and CCONJ B-O
-a DET B-O
-co NOUN B-O
-- NOUN B-O
-substrate NOUN B-O
-( PUNCT B-O
-FW PROPN B-AC
-or CCONJ B-O
-GG PROPN B-AC
-) PUNCT B-O
-prepared VERB B-O
-in ADP B-O
-different ADJ B-O
-proportions NOUN B-O
-of ADP B-O
-grams NOUN B-O
-of ADP B-O
-chemical ADJ B-LF
-oxygen NOUN I-LF
-demand NOUN I-LF
-( PUNCT B-O
-COD PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-These DET B-O
-proportions NOUN B-O
-consisted VERB B-O
-of ADP B-O
-0/100 NUM B-O
-, PUNCT B-O
-25/75 NUM B-O
-, PUNCT B-O
-50/50 NUM B-O
-, PUNCT B-O
-75/25 NUM B-O
-, PUNCT B-O
-and CCONJ B-O
-100/0 NUM B-O
-gCOD NOUN B-O
-WAS PROPN B-AC
-/ SYM B-O
-gCOD NOUN B-O
-co NOUN B-O
-- NOUN B-O
-substrate NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-appraised VERB B-O
-the DET B-O
-certainty NOUN B-O
-of ADP B-O
-the DET B-O
-key ADJ B-O
-elements NOUN B-O
-according VERB B-O
-to ADP B-O
-the DET B-O
-Grading PROPN B-LF
-of ADP I-LF
-Recommendations PROPN I-LF
-Assessment PROPN I-LF
-, PUNCT I-LF
-Development PROPN I-LF
-and CCONJ I-LF
-Evaluation PROPN I-LF
-( PUNCT B-O
-GRADE PROPN B-AC
-) PUNCT B-O
-tool NOUN B-O
-[ PUNCT B-O
-29–31 NUM B-O
-] X B-O
-( PUNCT B-O
-S3 PROPN B-O
-Table NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-H PROPN B-AC
-’s PART B-O
-Byproduct NOUN B-LF
-B PROPN B-AC
-is AUX B-O
-required VERB B-O
-by ADP B-O
-Manufacturer NOUN B-LF
-FISH PROPN B-AC
-, PUNCT B-O
-fluorescence NOUN B-LF
-in ADP I-LF
-situ ADJ I-LF
-hybridization NOUN I-LF
-; PUNCT B-O
-SIM PROPN B-AC
-, PUNCT B-O
-structured ADJ B-LF
-illumination NOUN I-LF
-microscopy NOUN I-LF
-; PUNCT B-O
-WT PROPN B-AC
-, PUNCT B-O
-wild ADJ B-LF
-type NOUN I-LF
-. PUNCT B-O
-
-AMP NOUN B-LF
-- PUNCT I-LF
-activated VERB I-LF
-protein NOUN I-LF
-kinase NOUN I-LF
-( PUNCT B-O
-AMPK PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-an DET B-O
-evolutionarily ADV B-O
-- PUNCT B-O
-conserved VERB B-O
-fuel NOUN B-O
-- PUNCT B-O
-sensitive ADJ B-O
-serine NOUN B-O
-/ SYM B-O
-threonine NOUN B-O
-protein NOUN B-O
-kinase NOUN B-O
-and CCONJ B-O
-cellular ADJ B-O
-nutrient NOUN B-O
-sensor NOUN B-O
-implicated VERB B-O
-in ADP B-O
-the DET B-O
-regulation NOUN B-O
-of ADP B-O
-energy NOUN B-O
-homeostasis NOUN B-O
-[ PUNCT B-O
-19 X B-O
-] PUNCT B-O
-[ PUNCT B-O
-20 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Such ADJ B-O
-measurement NOUN B-O
-results VERB B-O
-in ADP B-O
-various ADJ B-O
-coupling NOUN B-O
-metrics NOUN B-O
-, PUNCT B-O
-which PRON B-O
-can AUX B-O
-be AUX B-O
-considered VERB B-O
-as ADP B-O
-assessor NOUN B-O
-of ADP B-O
-design NOUN B-O
-stability NOUN B-O
-of ADP B-O
-classes NOUN B-O
-, PUNCT B-O
-such ADJ B-O
-as ADP B-O
-Coupling NOUN B-LF
-Between ADP I-LF
-Object PROPN I-LF
-( PUNCT B-O
-CBO PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-Response NOUN B-LF
-For ADP I-LF
-a DET I-LF
-Class NOUN I-LF
-( PUNCT B-O
-RFC PROPN B-AC
-) PUNCT B-O
-from ADP B-O
-Chidamber PROPN B-O
-and CCONJ B-O
-Kemerer PROPN B-O
-’s PART B-O
-metrics NOUN B-O
-suit VERB B-O
-[ PUNCT B-O
-9 NUM B-O
-, PUNCT B-O
-11 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-Data PROPN B-LF
-Abstraction NOUN I-LF
-Coupling NOUN I-LF
-( PUNCT B-O
-DAC PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-Measure NOUN B-LF
-of ADP I-LF
-Aggregation NOUN I-LF
-( PUNCT B-O
-MOA PROPN B-AC
-) PUNCT B-O
-from ADP B-O
-QMOOD PROPN B-O
-[ PUNCT B-O
-10 NUM B-O
-] PUNCT B-O
-and CCONJ B-O
-Message NOUN B-LF
-Passing NOUN I-LF
-Coupling NOUN I-LF
-( PUNCT B-O
-MPC PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-12 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Peripheral ADJ B-O
-blood NOUN B-O
-mononuclear ADJ B-O
-cells NOUN B-O
-from ADP B-O
-intensive ADJ B-LF
-care NOUN I-LF
-unit NOUN I-LF
-( PUNCT B-O
-ICU PROPN B-AC
-) PUNCT B-O
-patients NOUN B-O
-with ADP B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-30 NUM B-O
-) PUNCT B-O
-and CCONJ B-O
-without ADP B-O
-sepsis NOUN B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-10 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-healthy ADJ B-O
-volunteers NOUN B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-15 NUM B-O
-) PUNCT B-O
-were AUX B-O
-isolated VERB B-O
-using VERB B-O
-Ficoll PROPN B-O
-density NOUN B-O
-gradient NOUN B-O
-centrifugation NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-data NOUN B-O
-were AUX B-O
-then ADV B-O
-separated VERB B-O
-into ADP B-O
-local ADJ B-LF
-field NOUN I-LF
-potentials NOUN I-LF
-( PUNCT B-O
-LFPs PROPN B-AC
-; PUNCT B-O
-1–150 NUM B-O
-Hz NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-isolated VERB B-O
-single ADJ B-O
-- PUNCT B-O
-unit NOUN B-O
-activity NOUN B-O
-( PUNCT B-O
-0.5–10 NUM B-O
-kHz NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Prostate ADJ B-LF
-cancer NOUN I-LF
-( PUNCT B-O
-PCa PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-the DET B-O
-most ADV B-O
-common ADJ B-O
-malignancy NOUN B-O
-in ADP B-O
-men NOUN B-O
-and CCONJ B-O
-is AUX B-O
-the DET B-O
-second ADJ B-O
-leading VERB B-O
-cause NOUN B-O
-of ADP B-O
-cancer NOUN B-O
-deaths NOUN B-O
-worldwide ADV B-O
-. PUNCT B-O
-
-Whereas SCONJ B-O
-the DET B-O
-impact NOUN B-O
-of ADP B-O
-the DET B-O
-G PROPN B-O
-allele NOUN B-O
-on ADP B-O
-the DET B-O
-liver NOUN B-O
-fibrosis NOUN B-O
-progression NOUN B-O
-in ADP B-O
-chronic ADJ B-O
-hepatitis NOUN B-O
-C PROPN B-O
-seems VERB B-O
-to PART B-O
-be AUX B-O
-well ADV B-O
-known VERB B-O
-, PUNCT B-O
-its PRON B-O
-impact NOUN B-O
-on ADP B-O
-chronic ADJ B-LF
-liver NOUN I-LF
-failure NOUN I-LF
-( PUNCT B-O
-CLF PROPN B-AC
-) PUNCT B-O
-progression NOUN B-O
-and CCONJ B-O
-the DET B-O
-need NOUN B-O
-of ADP B-O
-LT PROPN B-AC
-has AUX B-O
-not PART B-O
-been AUX B-O
-described VERB B-O
-so ADV B-O
-far ADV B-O
-. PUNCT B-O
-
-First ADV B-O
-, PUNCT B-O
-S PROPN B-AC
-forms VERB B-O
-Watson PROPN B-O
-– PUNCT B-O
-Crick PROPN B-O
-base NOUN B-O
-pairs NOUN B-O
-with ADP B-O
-the DET B-O
-ribozyme NOUN B-LF
-'s PART B-O
-internal ADJ B-O
-guide NOUN B-O
-sequence NOUN B-O
-( PUNCT B-O
-see VERB B-O
-Figure PROPN B-O
-2A NUM B-O
-) PUNCT B-O
-to PART B-O
-give VERB B-O
-the DET B-O
-open ADJ B-O
-complex NOUN B-O
-( PUNCT B-O
-In ADP B-O
-total NOUN B-O
-, PUNCT B-O
-these DET B-O
-US PROPN B-O
-healthcare NOUN B-O
-- PUNCT B-O
-related VERB B-O
-emissions NOUN B-O
-result VERB B-O
-in ADP B-O
-an DET B-O
-estimated VERB B-O
-annual ADJ B-O
-loss NOUN B-O
-of ADP B-O
-614,000 NUM B-O
-disability NOUN B-LF
-- PUNCT I-LF
-adjusted VERB I-LF
-life NOUN I-LF
-years NOUN I-LF
-( PUNCT B-O
-DALYs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-only ADJ B-O
-such ADJ B-O
-national ADJ B-O
-damage NOUN B-O
-estimate NOUN B-O
-to ADP B-O
-date NOUN B-O
-[ PUNCT B-O
-7,24 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-For ADP B-O
-example NOUN B-O
-, PUNCT B-O
-one NUM B-O
-pair NOUN B-O
-from ADP B-O
-this DET B-O
-region NOUN B-O
-is AUX B-O
-shown VERB B-O
-to ADP B-O
-be AUX B-O
-expressed VERB B-O
-from ADP B-O
-chromosome NOUN B-O
-8q24.21 NUM B-O
-, PUNCT B-O
-and CCONJ B-O
-it PRON B-O
-forms VERB B-O
-a DET B-O
-stable ADJ B-O
-ndsRNA PROPN B-AC
-molecule NOUN B-O
-( PUNCT B-O
-nds-2a NOUN B-O
-) PUNCT B-O
-that PRON B-O
-binds VERB B-O
-to ADP B-O
-regulator NOUN B-LF
-of ADP I-LF
-chromosome NOUN I-LF
-condensation NOUN I-LF
-1 NUM I-LF
-( PUNCT B-O
-RCC1 PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-ras NOUN B-LF
-- PUNCT I-LF
-related VERB I-LF
-nuclear ADJ I-LF
-protein NOUN I-LF
-( PUNCT B-O
-RAN PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-through ADP B-O
-the DET B-O
-latter ADJ B-O
-, PUNCT B-O
-with ADP B-O
-the DET B-O
-mitotic ADJ B-O
-RANGAP1 NOUN B-O
-- PUNCT B-O
-SUMO1 NOUN B-O
-- PUNCT B-O
-RANBP2 NOUN B-O
-complex NOUN B-O
-[ PUNCT B-O
-64 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-gene NOUN B-O
-expression NOUN B-O
-of ADP B-O
-FA PROPN B-AC
-synthase NOUN B-O
-( PUNCT B-O
-FASN PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-lipoprotein NOUN B-LF
-lipase NOUN I-LF
-( PUNCT B-O
-LPL PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-stearoyl NOUN B-O
-- PUNCT B-O
-CoA NOUN B-O
-desaturase NOUN B-O
-( PUNCT B-O
-SCD PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-FA PROPN B-AC
-desaturase NOUN B-O
-1 NUM B-O
-( PUNCT B-O
-FADS1 PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-FA PROPN B-AC
-elongase NOUN B-O
-5 NUM B-O
-( PUNCT B-O
-ELOVL5 PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-measured VERB B-O
-in ADP B-O
-muscle NOUN B-O
-. PUNCT B-O
-
-Interactions NOUN B-O
-of ADP B-O
-MYPT1 PROPN B-AC
-and CCONJ B-O
-its PRON B-O
-mutants NOUN B-O
-with ADP B-O
-SNAP-25 PROPN B-AC
-were AUX B-O
-analysed VERB B-O
-by ADP B-O
-surface NOUN B-LF
-plasmon NOUN I-LF
-resonance NOUN I-LF
-( PUNCT B-O
-SPR PROPN B-AC
-) PUNCT B-O
-using VERB B-O
-a DET B-O
-Biacore PROPN B-O
-3000 NUM B-O
-instrument NOUN B-O
-( PUNCT B-O
-GE PROPN B-O
-Healthcare PROPN B-O
-, PUNCT B-O
-Little PROPN B-O
-Chalfont PROPN B-O
-, PUNCT B-O
-UK PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Anti NOUN B-O
-- PUNCT B-O
-GST PROPN B-O
-was AUX B-O
-coupled VERB B-O
-on ADP B-O
-the DET B-O
-surface NOUN B-O
-of ADP B-O
-a DET B-O
-CM5 PROPN B-O
-chip NOUN B-O
-by ADP B-O
-amine NOUN B-O
-- PUNCT B-O
-coupling NOUN B-O
-, PUNCT B-O
-then ADV B-O
-full ADJ B-O
-- PUNCT B-O
-length ADJ B-O
-GST PROPN B-O
-- PUNCT B-O
-MYPT1WT NOUN B-O
-or CCONJ B-O
-its PRON B-O
-C NOUN B-O
-- PUNCT B-O
-terminal NOUN B-O
-fragment NOUN B-O
-( PUNCT B-O
-GST PROPN B-O
-- PUNCT B-O
-MYPT1667–1004 PROPN B-O
-) PUNCT B-O
-was AUX B-O
-captured VERB B-O
-on ADP B-O
-the DET B-O
-surface NOUN B-O
-. PUNCT B-O
-
-Our PRON B-O
-estimates NOUN B-O
-( PUNCT B-O
-black ADJ B-O
-) PUNCT B-O
-of ADP B-O
-the DET B-O
-excess ADJ B-LF
-hazard NOUN I-LF
-- PUNCT I-LF
-months NOUN I-LF
-attributable ADJ I-LF
-to ADP I-LF
-the DET I-LF
-acute ADJ I-LF
-phase NOUN I-LF
-( PUNCT B-O
-EHMacute PROPN B-AC
-) PUNCT B-O
-based VERB B-O
-on ADP B-O
-( PUNCT B-O
-A NOUN B-O
-) PUNCT B-O
-viral ADJ B-O
-load NOUN B-O
-trajectories NOUN B-O
-( PUNCT B-O
-Fig NOUN B-O
-. PUNCT B-O
-
-2 NUM B-O
-) PUNCT B-O
-and CCONJ B-O
-( PUNCT B-O
-B NOUN B-O
-) PUNCT B-O
-our PRON B-O
-fit NOUN B-O
-of ADP B-O
-a DET B-O
-couples NOUN B-O
-transmission NOUN B-O
-model NOUN B-O
-to ADP B-O
-the DET B-O
-Rakai PROPN B-O
-retrospective ADJ B-O
-cohort NOUN B-O
-. PUNCT B-O
-
-These PRON B-O
-comprise VERB B-O
-: PUNCT B-O
-release NOUN B-O
-from ADP B-O
-chaperones NOUN B-O
-and CCONJ B-O
-co NOUN B-O
-- PUNCT B-O
-chaperones NOUN B-O
-, PUNCT B-O
-trimerization NOUN B-O
-via ADP B-O
-an DET B-O
-unmasked ADJ B-O
-coiled VERB B-O
-- PUNCT B-O
-coil NOUN B-O
-domain NOUN B-O
-, PUNCT B-O
-binding NOUN B-O
-to ADP B-O
-its PRON B-O
-cognate NOUN B-O
-DNA NOUN B-O
-sequences NOUN B-O
-in ADP B-O
-regulatory ADJ B-O
-regions NOUN B-O
-of ADP B-O
-target NOUN B-O
-genes NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-stimulation NOUN B-O
-of ADP B-O
-the DET B-O
-transactivation NOUN B-O
-potential NOUN B-O
-via ADP B-O
-the DET B-O
-calcium NOUN B-LF
-/ SYM I-LF
-calmodulin NOUN I-LF
-- PUNCT I-LF
-dependent ADJ I-LF
-kinase NOUN I-LF
-II NUM I-LF
-( PUNCT B-O
-CAMKII)-mediated PROPN B-AC
-phosphorylation NOUN B-O
-of ADP B-O
-a DET B-O
-serine NOUN B-O
-residue NOUN B-O
-within ADP B-O
-the DET B-O
-HSF1 PROPN B-O
-regulatory ADJ B-O
-domain NOUN B-O
-[ PUNCT B-O
-38 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Patients NOUN B-O
-with ADP B-O
-hepatocellular ADJ B-LF
-carcinoma NOUN I-LF
-( PUNCT B-O
-HCC PROPN B-AC
-) PUNCT B-O
-submitted VERB B-O
-to ADP B-O
-orthotopic ADJ B-LF
-liver NOUN I-LF
-transplantation NOUN I-LF
-( PUNCT B-O
-OLT PROPN B-AC
-) PUNCT B-O
-have VERB B-O
-a DET B-O
-variable ADJ B-O
-5 NUM B-O
-- PUNCT B-O
-year NOUN B-O
-survival NOUN B-O
-rate NOUN B-O
-limited VERB B-O
-mostly ADV B-O
-by ADP B-O
-tumor NOUN B-O
-recurrence NOUN B-O
-. PUNCT B-O
-
-All DET B-O
-data NOUN B-O
-in ADP B-O
-this DET B-O
-study NOUN B-O
-are AUX B-O
-computed VERB B-O
-with ADP B-O
-their PRON B-O
-95 NUM B-O
-% NOUN B-O
-uncertainty NOUN B-LF
-intervals NOUN I-LF
-( PUNCT B-O
-UIs PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-13–17 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-oxidative ADJ B-O
-fluorescent ADJ B-O
-dye NOUN B-O
-, PUNCT B-O
-DHE PROPN B-AC
-, PUNCT B-O
-was AUX B-O
-freely ADV B-O
-permeable ADJ B-O
-to ADP B-O
-cells NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-in ADP B-O
-the DET B-O
-presence NOUN B-O
-of ADP B-O
-O2- NOUN B-O
-was AUX B-O
-oxidized VERB B-O
-to ADP B-O
-ethidium NOUN B-LF
-bromide NOUN I-LF
-( PUNCT B-O
-EtBr PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-was AUX B-O
-trapped VERB B-O
-by ADP B-O
-intercalation NOUN B-O
-with ADP B-O
-DNA PROPN B-O
-. PUNCT B-O
-
-EtBr PROPN B-AC
-was AUX B-O
-excited VERB B-O
-at ADP B-O
-488 NUM B-O
-nm NOUN B-O
-with ADP B-O
-an DET B-O
-emission NOUN B-O
-spectrum NOUN B-O
-of ADP B-O
-610 NUM B-O
-nm NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-physiological ADJ B-O
-factors NOUN B-O
-which PRON B-O
-affect VERB B-O
-left ADJ B-LF
-ventricular ADJ I-LF
-( PUNCT B-O
-LV PROPN B-AC
-) PUNCT B-O
-long ADJ B-O
-- PUNCT B-O
-axis NOUN B-O
-function NOUN B-O
-are AUX B-O
-not PART B-O
-fully ADV B-O
-defined VERB B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-AM PROPN B-AC
-, PUNCT B-O
-acute ADJ B-LF
-malnutrition NOUN I-LF
-; PUNCT B-O
-BCC PROPN B-AC
-, PUNCT B-O
-behavior NOUN B-LF
-change NOUN I-LF
-communication NOUN I-LF
-; PUNCT B-O
-CMAM PROPN B-AC
-, PUNCT B-O
-community NOUN B-O
-management NOUN B-O
-of ADP B-O
-AM PROPN B-AC
-; PUNCT B-O
-CNS PROPN B-AC
-, PUNCT B-O
-well ADJ B-O
-- PUNCT B-O
-baby NOUN B-O
-consultation NOUN B-O
-; PUNCT B-O
-MAM PROPN B-AC
-, PUNCT B-O
-moderate ADJ B-O
-AM PROPN B-AC
-; PUNCT B-O
-MUAC PROPN B-AC
-, PUNCT B-O
-mid ADJ B-LF
-- PUNCT I-LF
-upper ADJ I-LF
-arm NOUN I-LF
-circumference NOUN I-LF
-; PUNCT B-O
-SAM PROPN B-AC
-, PUNCT B-O
-severe ADJ B-O
-AM PROPN B-AC
-; PUNCT B-O
-SQ PROPN B-AC
-, PUNCT B-O
-small ADJ B-O
-- PUNCT B-O
-quantity NOUN B-O
-lipid NOUN B-O
-- PUNCT B-O
-based VERB B-O
-nutrition NOUN B-O
-supplement NOUN B-O
-; PUNCT B-O
--LNSWLZ PROPN B-AC
-, PUNCT B-O
-weight NOUN B-LF
-- PUNCT I-LF
-for ADP I-LF
-- PUNCT I-LF
-length NOUN I-LF
-z NOUN I-LF
-- PUNCT I-LF
-score NOUN I-LF
-A DET B-O
-candidate NOUN B-O
-target NOUN B-O
-pathway NOUN B-O
-is AUX B-O
-quorum NOUN B-LF
-sensing NOUN I-LF
-( PUNCT B-O
-QS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-many ADJ B-O
-bacterial ADJ B-O
-pathogens NOUN B-O
-use VERB B-O
-to PART B-O
-coordinately ADV B-O
-regulate VERB B-O
-virulence NOUN B-O
-determinants NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-order NOUN B-O
-to PART B-O
-understand VERB B-O
-how SCONJ B-O
-p84 NOUN B-O
-could AUX B-O
-mask VERB B-O
-Ser582 NOUN B-O
-phosphorylation NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-to PART B-O
-map VERB B-O
-the DET B-O
-p110γ NOUN B-O
-- PUNCT B-O
-p84 NOUN B-O
-contact NOUN B-O
-interface NOUN B-O
-, PUNCT B-O
-hydrogen NOUN B-LF
-deuterium NOUN I-LF
-exchange NOUN I-LF
-mass NOUN I-LF
-spectrometry NOUN I-LF
-( PUNCT B-O
-HDX-MS PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-used VERB B-O
-. PUNCT B-O
-
-In ADP B-O
-more ADJ B-O
-than ADP B-O
-400 NUM B-O
-studies NOUN B-O
-compiled VERB B-O
-in ADP B-O
-the DET B-O
-GWAS PROPN B-AC
-catalog NOUN B-O
-[ PUNCT B-O
-108 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-only ADV B-O
-a DET B-O
-small ADJ B-O
-minority NOUN B-O
-of ADP B-O
-the DET B-O
-trait NOUN B-LF
-/ SYM I-LF
-disease NOUN I-LF
-- PUNCT I-LF
-associated VERB I-LF
-SNPs NOUN I-LF
-( PUNCT B-O
-TASs PROPN B-AC
-) NOUN B-O
-occur VERB B-O
-in ADP B-O
-protein NOUN B-O
-- PUNCT B-O
-coding VERB B-O
-regions NOUN B-O
-; PUNCT B-O
-the DET B-O
-large ADJ B-O
-majority NOUN B-O
-( PUNCT B-O
-89 NUM B-O
-% NOUN B-O
-) NOUN B-O
-are AUX B-O
-in ADP B-O
-noncoding ADJ B-O
-regions NOUN B-O
-. PUNCT B-O
-
-Statistical ADJ B-O
-comparisons NOUN B-O
-were AUX B-O
-performed VERB B-O
-with ADP B-O
-a DET B-O
-2 NUM B-O
-- PUNCT B-O
-way NOUN B-O
-ANOVA NOUN B-O
-using VERB B-O
-time NOUN B-O
-and CCONJ B-O
-genotype NOUN B-O
-as ADP B-O
-factors NOUN B-O
-, PUNCT B-O
-followed VERB B-O
-by ADP B-O
-post ADJ B-O
-hoc ADJ B-O
-pairwise ADJ B-O
-comparisons NOUN B-O
-at ADP B-O
-each DET B-O
-time NOUN B-O
-point NOUN B-O
-to ADP B-O
-obtain VERB B-O
-nominal ADJ B-O
-p NOUN B-O
-- PUNCT B-O
-values NOUN B-O
-, PUNCT B-O
-which PRON B-O
-were AUX B-O
-subjected VERB B-O
-to ADP B-O
-a DET B-O
-Tukey PROPN B-O
-correction NOUN B-O
-for ADP B-O
-multiple ADJ B-O
-comparisons NOUN B-O
-( PUNCT B-O
-S1 PROPN B-O
-Data PROPN B-O
-, PUNCT B-O
-Sheet PROPN B-O
-1 NUM B-O
-G PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-AMPK PROPN B-AC
-, PUNCT B-O
-adenosine NOUN B-LF
-monophosphate NOUN I-LF
-regulated VERB I-LF
-protein NOUN I-LF
-kinase NOUN I-LF
-; PUNCT B-O
-DTS PROPN B-AC
-, PUNCT B-O
-developmentally ADV B-LF
-timed VERB I-LF
-sleep NOUN I-LF
-; PUNCT B-O
-L1 PROPN B-AC
-stage NOUN B-O
-, PUNCT B-O
-first ADJ B-LF
-larval ADJ I-LF
-stage NOUN I-LF
-; PUNCT B-O
-ns PROPN B-AC
-, PUNCT B-O
-not PART B-LF
-significant ADJ I-LF
-; PUNCT B-O
-p PROPN B-AC
--AMPK PROPN B-AC
-, PUNCT B-O
-phosphorylated VERB B-LF
-AMPK NOUN I-LF
-AMPK PROPN B-AC
-; PUNCT B-O
-SIS PROPN B-AC
-, PUNCT B-O
-stress NOUN B-LF
-- PUNCT I-LF
-induced VERB I-LF
-sleep NOUN I-LF
-; PUNCT B-O
-UVC PROPN B-AC
-, PUNCT B-O
-ultraviolet ADJ B-LF
-C NOUN I-LF
-; PUNCT B-O
-WT PROPN B-O
-, PUNCT B-O
-wild ADJ B-O
-type NOUN B-O
-. PUNCT B-O
-
-Logistic ADJ B-O
-regression NOUN B-O
-analysis NOUN B-O
-showed VERB B-O
-that SCONJ B-O
-the DET B-O
-independent ADJ B-O
-factors NOUN B-O
-associated VERB B-O
-with ADP B-O
-mortality NOUN B-O
-were AUX B-O
-postoperative ADJ B-O
-lactate ADJ B-O
-level NOUN B-O
-( PUNCT B-O
-odds NOUN B-LF
-ratio NOUN I-LF
-[ X B-O
-OR PROPN B-AC
-] X B-O
-1.926 NUM B-O
-, PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-LF
-interval NOUN I-LF
-[ X B-O
-CI PROPN B-AC
-] X B-O
-1.101–3.089 NUM B-O
-, PUNCT B-O
-p NOUN B-O
-= SYM B-O
-0.007 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-postoperative ADJ B-O
-sequential ADJ B-O
-organ NOUN B-O
-failure NOUN B-O
-assessment NOUN B-O
-score NOUN B-O
-( PUNCT B-O
-OR PROPN B-AC
-1.593 NUM B-O
-, PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-1.160–2.187 NUM B-O
-, PUNCT B-O
-p NOUN B-O
-= SYM B-O
-0.004 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-DNI PROPN B-AC
-on ADP B-O
-POD1 PROPN B-O
-( PUNCT B-O
-OR PROPN B-AC
-1.118 NUM B-O
-, PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-1.028–1.215 NUM B-O
-, PUNCT B-O
-p NOUN B-O
-= SYM B-O
-0.009 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Missing VERB B-O
-values NOUN B-O
-in ADP B-O
-NSDUH PROPN B-AC
-are AUX B-O
-imputed VERB B-O
-by ADP B-O
-SAMHSA PROPN B-AC
-prior ADV B-O
-to ADP B-O
-release NOUN B-O
-of ADP B-O
-the DET B-O
-dataset NOUN B-O
-using VERB B-O
-a DET B-O
-predictive ADJ B-LF
-mean ADJ I-LF
-neighborhood NOUN I-LF
-( PUNCT B-O
-PMN PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-a DET B-O
-modified VERB B-O
-PMN PROPN B-AC
-as SCONJ B-O
-detailed VERB B-O
-in ADP B-O
-the DET B-O
-NSDUH PROPN B-AC
-codebook NOUN B-O
-[ PUNCT B-O
-26 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Mutation NOUN B-O
-of ADP B-O
-serine NOUN B-LF
-( PUNCT B-O
-S PROPN B-AC
-) PUNCT B-O
-424 NUM B-O
-to ADP B-O
-alanine NOUN B-LF
-( PUNCT B-O
-A PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-mimics NOUN B-O
-dephosphorylation NOUN B-O
-) PUNCT B-O
-inhibits VERB B-O
-HDAC3 PROPN B-AC
-enzyme NOUN B-O
-activity NOUN B-O
-without ADP B-O
-affecting VERB B-O
-its PRON B-O
-expression NOUN B-O
-or CCONJ B-O
-subcellular ADJ B-O
-localization NOUN B-O
-[ PUNCT B-O
-38 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-data NOUN B-O
-from ADP B-O
-the DET B-O
-fatty ADJ B-O
-acid NOUN B-O
-compositions NOUN B-O
-were AUX B-O
-used VERB B-O
-to ADP B-O
-investigate VERB B-O
-the DET B-O
-nutritional ADJ B-O
-lipid NOUN B-O
-quality NOUN B-O
-indices NOUN B-O
-from ADP B-O
-the DET B-O
-five NUM B-O
-evaluated VERB B-O
-freshwater NOUN B-O
-fish NOUN B-O
-species NOUN B-O
-through ADP B-O
-three NUM B-O
-important ADJ B-O
-indicators NOUN B-O
-, PUNCT B-O
-namely ADV B-O
-, PUNCT B-O
-index NOUN B-LF
-of ADP I-LF
-atherogenicity NOUN I-LF
-( PUNCT B-O
-IA PROPN B-AC
-) X B-O
-and CCONJ B-O
-index NOUN B-LF
-of ADP I-LF
-thrombogenicity NOUN I-LF
-( PUNCT B-O
-IT PROPN B-AC
-) X B-O
-, PUNCT B-O
-according VERB B-O
-to ADP B-O
-Ulbricht PROPN B-O
-and CCONJ B-O
-Southgate PROPN B-O
-[ X B-O
-37 NUM B-O
-] PUNCT B-O
-with ADP B-O
-modifications NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-hypocholesterolemic ADJ B-LF
-/ SYM I-LF
-hypercholesterolemic ADJ I-LF
-ratio NOUN I-LF
-( PUNCT B-O
-h PROPN B-AC
-) X B-O
-according VERB B-O
-to ADP B-O
-Santos PROPN B-O
-- PUNCT B-O
-Silva PROPN B-O
-, PUNCT B-O
-Bessa PROPN B-O
-, PUNCT B-O
-and CCONJ B-O
-Santos PROPN B-O
-- PUNCT B-O
-Silva PROPN B-O
-[ X B-O
-38 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-as SCONJ B-O
-follows VERB B-O
-: PUNCT B-O
-/HIA=(4×C14:0+C16:0)/(∑MUFA+∑(n–6)+∑(n–3))IT=(C14:0+C16:0+C18:0)/(0.5×∑MUFA+0.5×∑(n–6)+3×∑(n–3)+100×∑(n–3)/∑(n–6))h PROPN B-AC
-+ X B-O
-16:0 NUM B-O
-) X B-O
-A DET B-O
-retrospective ADJ B-O
-cross ADJ B-O
-- ADJ B-O
-sectional ADJ B-O
-study NOUN B-O
-was AUX B-O
-conducted VERB B-O
-on ADP B-O
-medical ADJ B-O
-records NOUN B-O
-of ADP B-O
-patients NOUN B-O
-admitted VERB B-O
-from ADP B-O
-August PROPN B-O
-1 NUM B-O
-, PUNCT B-O
-2013‒July NUM B-O
-31 NUM B-O
-, PUNCT B-O
-2018 NUM B-O
-in ADP B-O
-Ayder PROPN B-LF
-Comprehensive PROPN I-LF
-Specialized PROPN I-LF
-Hospital PROPN I-LF
-( PUNCT B-O
-ACSH PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-found VERB B-O
-in ADP B-O
-Mekelle PROPN B-O
-, PUNCT B-O
-the DET B-O
-capital NOUN B-O
-city NOUN B-O
-of ADP B-O
-Tigray PROPN B-O
-regional ADJ B-O
-state NOUN B-O
-, PUNCT B-O
-783 NUM B-O
-Kilometers NOUN B-O
-away ADV B-O
-from ADP B-O
-Addis PROPN B-O
-Ababa PROPN B-O
-, PUNCT B-O
-Ethiopia PROPN B-O
-. PUNCT B-O
-
-U2OS PROPN B-O
-reporter NOUN B-O
-cell NOUN B-O
-lines NOUN B-O
-specifically ADV B-O
-designed VERB B-O
-to PART B-O
-repair NOUN B-O
-DNA NOUN B-O
-damage NOUN B-O
-through ADP B-O
-nonhomologous ADJ B-LF
-end NOUN I-LF
-joining NOUN I-LF
-( PUNCT B-O
-NHEJ PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-homology NOUN B-LF
-- PUNCT I-LF
-directed VERB I-LF
-repair NOUN I-LF
-( PUNCT B-O
-HDR PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-were AUX B-O
-transfected VERB B-O
-with ADP B-O
-nonspecific ADJ B-O
-control NOUN B-O
-( PUNCT B-O
-si PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
--NCSam68 PROPN B-AC
-- PUNCT B-O
-specific ADJ B-O
-( PUNCT B-O
-si NOUN B-O
-- PUNCT B-O
-Sam68 PROPN B-AC
-) PUNCT B-O
-small ADJ B-O
-interference NOUN B-O
-RNA NOUN B-O
-, PUNCT B-O
-together ADV B-O
-with ADP B-O
-( PUNCT B-O
-+ PUNCT B-O
-) PUNCT B-O
-or CCONJ B-O
-without ADP B-O
-( PUNCT B-O
-− PUNCT B-O
-) PUNCT B-O
-I NOUN B-O
-- PUNCT B-O
-SceI PROPN B-O
-plasmid NOUN B-O
-, PUNCT B-O
-or CCONJ B-O
-green ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-( PUNCT B-O
-GFP PROPN B-AC
-) PUNCT B-O
-control NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-carboxysome NOUN B-O
-is AUX B-O
-a DET B-O
-bacterial ADJ B-O
-organelle NOUN B-O
-that PRON B-O
-functions VERB B-O
-to PART B-O
-enhance VERB B-O
-the DET B-O
-efficiency NOUN B-O
-of ADP B-O
-CO2 NOUN B-O
-fixation NOUN B-O
-by ADP B-O
-encapsulating VERB B-O
-the DET B-O
-enzymes NOUN B-O
-ribulose NOUN B-LF
-bisphosphate NOUN I-LF
-carboxylase NOUN I-LF
-/ SYM I-LF
-oxygenase NOUN I-LF
-( PUNCT B-O
-RuBisCO PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-carbonic ADJ B-O
-anhydrase NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-following ADJ B-O
-ELISA PROPN B-O
-kits NOUN B-O
-were AUX B-O
-used VERB B-O
-: PUNCT B-O
-LRG1 PROPN B-AC
-ELISA PROPN B-O
-kit NOUN B-O
-( PUNCT B-O
-Cosmic PROPN B-O
-Corporation PROPN B-O
-, PUNCT B-O
-Tokyo PROPN B-O
-, PUNCT B-O
-Japan PROPN B-O
-, PUNCT B-O
-product NOUN B-O
-number NOUN B-O
-; PUNCT B-O
-T131C100 NUM B-O
-) PUNCT B-O
-and CCONJ B-O
-Human PROPN B-O
-Total PROPN B-O
-Angiotensinogen PROPN B-LF
-( PUNCT B-O
-AGT PROPN B-AC
-) PUNCT B-O
-Assay PROPN B-O
-Kit PROPN B-O
-( PUNCT B-O
-Immuno PROPN B-O
-- PUNCT B-O
-Biological PROPN B-O
-Laboratories PROPN B-O
-, PUNCT B-O
-Gunma PROPN B-O
-, PUNCT B-O
-Japan PROPN B-O
-, PUNCT B-O
-product NOUN B-O
-number NOUN B-O
-; PUNCT B-O
-27412 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-We PRON B-O
-prospectively ADV B-O
-collected VERB B-O
-peripheral ADJ B-LF
-blood NOUN I-LF
-mononuclear ADJ I-LF
-cells NOUN I-LF
-( PUNCT B-O
-PBMCs PROPN B-AC
-) PUNCT B-O
-by ADP B-O
-leukapheresis NOUN B-O
-from ADP B-O
-a DET B-O
-55 NUM B-O
-- PUNCT B-O
-year NOUN B-O
-- PUNCT B-O
-old ADJ B-O
-man NOUN B-O
-with ADP B-O
-chronic ADJ B-O
-HIV PROPN B-O
-infection NOUN B-O
-before ADP B-O
-and CCONJ B-O
-after ADP B-O
-allo-SCT PROPN B-AC
-to PART B-O
-measure VERB B-O
-the DET B-O
-size NOUN B-O
-of ADP B-O
-the DET B-O
-HIV-1 PROPN B-O
-reservoir NOUN B-O
-and CCONJ B-O
-characterize VERB B-O
-viral ADJ B-O
-phylogeny NOUN B-O
-and CCONJ B-O
-phenotypic ADJ B-O
-changes NOUN B-O
-in ADP B-O
-immune ADJ B-O
-cells NOUN B-O
-. PUNCT B-O
-
-Outcome NOUN B-O
-measures NOUN B-O
-were AUX B-O
-deaths NOUN B-O
-, PUNCT B-O
-along ADP B-O
-with ADP B-O
-nonfatal ADJ B-O
-myocardial ADJ B-LF
-infarction NOUN I-LF
-( PUNCT B-O
-MI PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-stroke NOUN B-O
-, PUNCT B-O
-congestive ADJ B-LF
-heart NOUN I-LF
-failure NOUN I-LF
-( PUNCT B-O
-CHF PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-transient ADJ B-LF
-ischemic ADJ I-LF
-attack NOUN I-LF
-( PUNCT B-O
-TIA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-antihypertensive ADJ B-O
-treatment NOUN B-O
-recorded VERB B-O
-from ADP B-O
-structured VERB B-O
-interviews NOUN B-O
-at ADP B-O
-scheduled VERB B-O
-intervals NOUN B-O
-. PUNCT B-O
-
-At ADP B-O
-GW PROPN B-O
-15–26 NUM B-O
-, PUNCT B-O
-a DET B-O
-standard ADJ B-LF
-deviation NOUN I-LF
-( PUNCT B-O
-SD PROPN B-AC
-) PUNCT B-O
-increase NOUN B-O
-in ADP B-O
-total ADJ B-O
-n-3 NOUN B-O
-PUFAs PROPN B-AC
-and CCONJ B-O
-individual ADJ B-O
-n-3 NOUN B-O
-DPA PROPN B-AC
-was AUX B-O
-associated VERB B-O
-with ADP B-O
-a DET B-O
-36 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-adjusted VERB B-O
-odds NOUN B-O
-ratio NOUN B-O
-0.64 NUM B-O
-; PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI NOUN B-O
-0.42–0.96 NUM B-O
-; PUNCT B-O
-P NOUN B-O
-= SYM B-O
-0.042 NUM B-O
-) PUNCT B-O
-and CCONJ B-O
-33 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-0.67 NUM B-O
-; PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI NOUN B-O
-0.45–0.99 NUM B-O
-; PUNCT B-O
-P NOUN B-O
-= SYM B-O
-0.047 NUM B-O
-) PUNCT B-O
-lower ADJ B-O
-risk NOUN B-O
-of ADP B-O
-GDM PROPN B-AC
-, PUNCT B-O
-respectively ADV B-O
-; PUNCT B-O
-however ADV B-O
-, PUNCT B-O
-the DET B-O
-significance NOUN B-O
-did AUX B-O
-not PART B-O
-persist VERB B-O
-after ADP B-O
-post X B-O
-hoc X B-O
-false ADJ B-O
-- PUNCT B-O
-discovery NOUN B-O
-rate NOUN B-O
-( PUNCT B-O
-FDR PROPN B-AC
-) PUNCT B-O
-correction NOUN B-O
-( PUNCT B-O
-FDR PROPN B-AC
-- PUNCT B-O
-corrected VERB B-O
-P NOUN B-O
-values NOUN B-O
-> SYM B-O
-0.05 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Terminal ADJ B-O
-hypertrophic ADJ B-O
-differentiation NOUN B-O
-is AUX B-O
-accompanied VERB B-O
-by ADP B-O
-a DET B-O
-massive ADJ B-O
-increase NOUN B-O
-in ADP B-O
-cell NOUN B-O
-volume NOUN B-O
-and CCONJ B-O
-expression NOUN B-O
-of ADP B-O
-alkaline ADJ B-LF
-phosphatase NOUN I-LF
-( PUNCT B-O
-ALP PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-an DET B-O
-enzyme NOUN B-O
-required VERB B-O
-for ADP B-O
-mineralization NOUN B-O
-of ADP B-O
-cartilage NOUN B-O
-[ PUNCT B-O
-20 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-is AUX B-O
-the DET B-O
-first ADJ B-O
-step NOUN B-O
-in ADP B-O
-cartilage NOUN B-O
-remodeling NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-next ADV B-O
-asked VERB B-O
-whether SCONJ B-O
-the DET B-O
-surface NOUN B-O
-polarization NOUN B-O
-of ADP B-O
-other ADJ B-O
-axonal ADJ B-O
-membrane NOUN B-O
-proteins NOUN B-O
-was AUX B-O
-affected VERB B-O
-in ADP B-O
-the DET B-O
-absence NOUN B-O
-of ADP B-O
-SorCS1 PROPN B-AC
-. PUNCT B-O
-
-The DET B-O
-cell NOUN B-O
-adhesion NOUN B-O
-molecules NOUN B-O
-neuron NOUN B-LF
-- PUNCT I-LF
-glia NOUN I-LF
-cell NOUN I-LF
-adhesion NOUN I-LF
-molecule NOUN I-LF
-L1 NOUN I-LF
-( PUNCT B-O
-L1/NgCAM PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-contactin NOUN B-LF
-- PUNCT I-LF
-associated VERB I-LF
-protein NOUN I-LF
-- PUNCT I-LF
-like ADJ I-LF
-2 NUM I-LF
-( PUNCT B-O
-Caspr2 PROPN B-AC
-) PUNCT B-O
-are AUX B-O
-both PRON B-O
-targeted VERB B-O
-to ADP B-O
-the DET B-O
-axonal ADJ B-O
-surface NOUN B-O
-but CCONJ B-O
-via ADP B-O
-distinct ADJ B-O
-trafficking NOUN B-O
-routes NOUN B-O
-. PUNCT B-O
-
-These DET B-O
-CRMs PROPN B-AC
-act VERB B-O
-as ADP B-O
-neurogenic ADJ B-LF
-ectoderm NOUN I-LF
-enhancers NOUN I-LF
-( PUNCT B-O
-NEEs PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-function VERB B-O
-to PART B-O
-drive VERB B-O
-gene NOUN B-O
-expression NOUN B-O
-in ADP B-O
-the DET B-O
-early ADJ B-O
-embryonic ADJ B-O
-neuroectoderm NOUN B-O
-before SCONJ B-O
-gastrulation NOUN B-O
-has AUX B-O
-commenced VERB B-O
-[ PUNCT B-O
-36 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-autoxidation NOUN B-O
-of ADP B-O
-intracellular ADJ B-O
-oxyHb NOUN B-O
-and CCONJ B-O
-downstream ADJ B-O
-free ADJ B-O
-radical NOUN B-O
-formation NOUN B-O
-is AUX B-O
-prevented VERB B-O
-mainly ADV B-O
-by ADP B-O
-superoxide NOUN B-LF
-dismutase NOUN I-LF
-( PUNCT B-O
-SOD PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-catalase NOUN B-O
-and CCONJ B-O
-glutathione NOUN B-LF
-peroxidase NOUN I-LF
-( PUNCT B-O
-GPx PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-18,19 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-This DET B-O
-paper NOUN B-O
-examines VERB B-O
-whether SCONJ B-O
-practices NOUN B-O
-regarding VERB B-O
-consent NOUN B-O
-, PUNCT B-O
-confidentiality NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-referral NOUN B-O
-vary VERB B-O
-depending VERB B-O
-on ADP B-O
-whether SCONJ B-O
-testing NOUN B-O
-is AUX B-O
-provided VERB B-O
-through ADP B-O
-voluntary ADJ B-LF
-counseling NOUN I-LF
-and CCONJ I-LF
-testing NOUN I-LF
-( PUNCT B-O
-VCT PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
-provider NOUN B-O
-- PUNCT B-O
-initiated VERB B-O
-testing NOUN B-O
-. PUNCT B-O
-
-Mice NOUN B-O
-that PRON B-O
-need VERB B-O
-to ADP B-O
-be AUX B-O
-perfused VERB B-O
-with ADP B-O
-PBS PROPN B-AC
-and/or CCONJ B-O
-4 NUM B-O
-% NOUN B-O
-paraformaldehyde NOUN B-LF
-( PUNCT B-O
-PFA PROPN B-AC
-) PUNCT B-O
-prior ADV B-O
-to ADP B-O
-tissue NOUN B-O
-harvest NOUN B-O
-were AUX B-O
-anesthetized VERB B-O
-with ADP B-O
-a DET B-O
-combination NOUN B-O
-of ADP B-O
-ketamine NOUN B-O
-( PUNCT B-O
-20 NUM B-O
-mg NOUN B-O
-/ SYM B-O
-kg NOUN B-O
-body NOUN B-O
-weight NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-xylazine NOUN B-O
-( PUNCT B-O
-2 NUM B-O
-mg NOUN B-O
-/ SYM B-O
-kg NOUN B-O
-body NOUN B-O
-weight NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Mild ADJ B-LF
-cognitive ADJ I-LF
-impairment NOUN I-LF
-( PUNCT B-O
-MCI PROPN B-AC
-) PUNCT B-O
-refers VERB B-O
-to ADP B-O
-a DET B-O
-transitional ADJ B-O
-zone NOUN B-O
-between ADP B-O
-normal ADJ B-O
-ageing NOUN B-O
-and CCONJ B-O
-dementia NOUN B-O
-. PUNCT B-O
-
-Quantitative ADJ B-O
-data NOUN B-O
-were AUX B-O
-to ADP B-O
-analyze VERB B-O
-completeness NOUN B-O
-and CCONJ B-O
-timeliness NOUN B-O
-of ADP B-O
-surveillance NOUN B-O
-system NOUN B-O
-performance NOUN B-O
-from ADP B-O
-national ADJ B-O
-District PROPN B-LF
-Health PROPN I-LF
-Information PROPN I-LF
-System PROPN I-LF
-2 NUM I-LF
-( PUNCT B-O
-DHIS2 PROPN B-AC
-) PUNCT B-O
-during ADP B-O
-October PROPN B-O
-2014 NUM B-O
-to ADP B-O
-September PROPN B-O
-2016 NUM B-O
-. PUNCT B-O
-
-Importantly ADV B-O
-, PUNCT B-O
-the DET B-O
-mice NOUN B-O
-are AUX B-O
-resistant ADJ B-O
-to ADP B-O
-the DET B-O
-autoimmune ADJ B-O
-disease NOUN B-O
-models NOUN B-O
-collagen NOUN B-O
-- PUNCT B-O
-induced VERB B-O
-arthritis NOUN B-O
-and CCONJ B-O
-experimental ADJ B-LF
-autoimmune ADJ I-LF
-encephalomyelitis NOUN I-LF
-( PUNCT B-O
-EAE PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-20 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-have VERB B-O
-less ADV B-O
-aggressive ADJ B-O
-Kras PROPN B-O
-- PUNCT B-O
-induced VERB B-O
-inflammatory ADJ B-O
-pancreatic ADJ B-O
-cancer NOUN B-O
-[ PUNCT B-O
-21 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-fail VERB B-O
-to ADP B-O
-mount VERB B-O
-an DET B-O
-effective ADJ B-O
-IL-17A PROPN B-AC
-- PUNCT B-O
-dependent ADJ B-O
-immune ADJ B-O
-response NOUN B-O
-to ADP B-O
-Citrobacter PROPN B-O
-rodentium NOUN B-O
-infection NOUN B-O
-[ PUNCT B-O
-22 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-surgically ADV B-O
-removed VERB B-O
-tissue NOUN B-O
-was AUX B-O
-cut VERB B-O
-to PART B-O
-smaller ADJ B-O
-pieces NOUN B-O
-with ADP B-O
-scissors NOUN B-O
-under ADP B-O
-sterile ADJ B-O
-conditions NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-then ADV B-O
-incubated VERB B-O
-for ADP B-O
-15 NUM B-O
-min NOUN B-O
-at ADP B-O
-room NOUN B-LF
-temperature NOUN I-LF
-( PUNCT B-O
-RT PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-dithiothreitol PROPN B-O
-: PUNCT B-O
-Hank´s PART B-O
-balanced ADJ B-O
-salt NOUN B-O
-solution NOUN B-O
-( PUNCT B-O
-HBSS PROPN B-O
-) PUNCT B-O
-( PUNCT B-O
-Biosera PROPN B-O
-, PUNCT B-O
-Nuaille PROPN B-O
-, PUNCT B-O
-France PROPN B-O
-) PUNCT B-O
-mix NOUN B-O
-( PUNCT B-O
-1:9 NUM B-O
-v NOUN B-O
-/ SYM B-O
-v NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-in ADP B-O
-order NOUN B-O
-to PART B-O
-remove VERB B-O
-potential ADJ B-O
-contamination NOUN B-O
-. PUNCT B-O
-
-OR PROPN B-AC
-, PUNCT B-O
-odds NOUN B-LF
-ratio NOUN I-LF
-; PUNCT B-O
-ref NOUN B-O
-. PUNCT B-O
-
-, PUNCT B-O
-reference NOUN B-O
-; PUNCT B-O
-R1 NOUN B-O
-, PUNCT B-O
-positive ADJ B-O
-; PUNCT B-O
-R0 NOUN B-O
-, PUNCT B-O
-negative ADJ B-O
-resection NOUN B-O
-margins NOUN B-O
-Malondialdehyde NOUN B-LF
-acetaldehyde NOUN I-LF
-- PUNCT B-O
-modified VERB B-O
-LDL PROPN B-AC
-( PUNCT B-O
-MAA PROPN B-AC
-- PUNCT B-O
-LDL PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-copper NOUN B-O
-- PUNCT B-O
-oxidized VERB B-O
-LDL PROPN B-AC
-( PUNCT B-O
-CuOx-LDL PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-prepared VERB B-O
-as SCONJ B-O
-described VERB B-O
-[ PUNCT B-O
-21 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Then ADV B-O
-, PUNCT B-O
-the DET B-O
-specimens NOUN B-O
-were AUX B-O
-washed VERB B-O
-twice ADV B-O
-with ADP B-O
-stain NOUN B-O
-buffer NOUN B-O
-and CCONJ B-O
-subsequently ADV B-O
-mounted VERB B-O
-with ADP B-O
-fluoroGel PROPN B-O
-mounting NOUN B-O
-medium NOUN B-O
-( PUNCT B-O
-GeneTex PROPN B-O
-, PUNCT B-O
-Inc PROPN B-O
-, PUNCT B-O
-Irvine PROPN B-O
-, PUNCT B-O
-CA PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Stained VERB B-O
-specimens NOUN B-O
-were AUX B-O
-examined VERB B-O
-and CCONJ B-O
-captured VERB B-O
-with ADP B-O
-Leica PROPN B-O
-TCS PROPN B-O
-SPII PROPN B-O
-confocal ADJ B-LF
-laser NOUN I-LF
-scanning VERB I-LF
-microscopy NOUN I-LF
-system NOUN B-O
-( PUNCT B-O
-CLSM PROPN B-AC
-, PUNCT B-O
-; PUNCT B-O
-Leica PROPN B-O
-Microsystem PROPN B-O
-, PUNCT B-O
-GmbH PROPN B-O
-, PUNCT B-O
-Germany PROPN B-O
-) PUNCT B-O
-with ADP B-O
-LAS PROPN B-O
-AF PROPN B-O
-Lite PROPN B-O
-software NOUN B-O
-( PUNCT B-O
-Leica PROPN B-O
-Microsystems PROPN B-O
-, PUNCT B-O
-Mannheim PROPN B-O
-, PUNCT B-O
-Germany PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-HEK PROPN B-AC
-, PUNCT B-O
-human ADJ B-LF
-embryonic ADJ I-LF
-kidney NOUN I-LF
-cell NOUN I-LF
-; PUNCT B-O
-ns PROPN B-O
-, PUNCT B-O
-not PART B-O
-significant ADJ B-O
-; PUNCT B-O
-WT PROPN B-AC
-, PUNCT B-O
-wild ADJ B-LF
-type NOUN I-LF
-. PUNCT B-O
-
-Malondialdehyde NOUN B-LF
-( PUNCT B-O
-MDA PROPN B-AC
-) PUNCT B-O
-content NOUN B-O
-was AUX B-O
-measured VERB B-O
-by ADP B-O
-the DET B-O
-procedures NOUN B-O
-described VERB B-O
-by ADP B-O
-Wang PROPN B-O
-et PROPN B-O
-al NOUN B-O
-. PUNCT B-O
-
-[ PUNCT B-O
-22 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Ischaemia NOUN B-O
-- PUNCT B-O
-reperfusion NOUN B-O
-injury NOUN B-O
-in ADP B-O
-kidney NOUN B-O
-transplantation NOUN B-O
-leads VERB B-O
-to ADP B-O
-delayed VERB B-LF
-graft NOUN I-LF
-function NOUN I-LF
-( PUNCT B-O
-DGF PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-is AUX B-O
-associated VERB B-O
-with ADP B-O
-reduced VERB B-O
-long ADJ B-O
-term NOUN B-O
-graft NOUN B-O
-function NOUN B-O
-. PUNCT B-O
-
-Opaque NOUN B-O
-a DET B-O
-and CCONJ B-O
-α PUNCT B-O
-cells NOUN B-O
-secrete VERB B-O
-a DET B-O
-sex NOUN B-O
-- PUNCT B-O
-specific ADJ B-O
-pheromone NOUN B-O
-and CCONJ B-O
-induce VERB B-O
-the DET B-O
-formation NOUN B-O
-of ADP B-O
-mating NOUN B-O
-projections NOUN B-O
-in ADP B-O
-cells NOUN B-O
-with ADP B-O
-an DET B-O
-opposite ADJ B-O
-Mating NOUN B-LF
-type NOUN I-LF
-locus NOUN I-LF
-( PUNCT B-O
-MTL PROPN B-AC
-) PUNCT B-O
-type NOUN B-O
-, PUNCT B-O
-thus ADV B-O
-initiating VERB B-O
-cell NOUN B-O
-fusion NOUN B-O
-and CCONJ B-O
-mating NOUN B-O
-[ PUNCT B-O
-9 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Heart NOUN B-LF
-rate NOUN I-LF
-( PUNCT B-O
-HR PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-velocity NOUN B-O
-, PUNCT B-O
-left ADJ B-LF
-ventricle NOUN I-LF
-( PUNCT B-O
-LV PROPN B-AC
-) PUNCT B-O
-mass NOUN B-O
-, PUNCT B-O
-LV PROPN B-LF
-internal ADJ I-LF
-LV PROPN B-AC
-diameter NOUN I-LF
-at ADP I-LF
-end NOUN I-LF
-- PUNCT I-LF
-diastole NOUN I-LF
-( PUNCT B-O
-LVID PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-LV PROPN B-LF
-posterior ADJ I-LF
-,dLV PROPN B-AC
-wall NOUN I-LF
-thickness NOUN I-LF
-at ADP I-LF
-end NOUN I-LF
-- PUNCT I-LF
-diastole NOUN I-LF
-( PUNCT B-O
-LVPW PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-LV PROPN B-LF
-anterior ADJ I-LF
-,dLV PROPN B-AC
-wall NOUN I-LF
-thickness NOUN I-LF
-at ADP I-LF
-end NOUN I-LF
-- PUNCT I-LF
-diastole NOUN I-LF
-( PUNCT B-O
-LVAW PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-ejection NOUN B-LF
-fraction NOUN I-LF
-( PUNCT B-O
-,dEF PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-fractional ADJ B-LF
-shortening NOUN I-LF
-( PUNCT B-O
-FS PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-the DET B-O
-LV PROPN B-AC
-were AUX B-O
-measured VERB B-O
-. PUNCT B-O
-
-The DET B-O
-generation NOUN B-O
-of ADP B-O
-type NOUN B-LF
-2 NUM I-LF
-( PUNCT B-O
-Th2 PROPN B-AC
-) PUNCT B-O
-cytokines NOUN B-O
-, PUNCT B-O
-particularly ADV B-O
-interleukins NOUN B-LF
-( PUNCT B-O
-IL)-13 PROPN B-AC
-and CCONJ B-O
-IL-4 PROPN B-AC
-, PUNCT B-O
-is AUX B-O
-associated VERB B-O
-with ADP B-O
-parasite NOUN B-O
-expulsion NOUN B-O
-through ADP B-O
-increased VERB B-O
-epithelial ADJ B-O
-cell NOUN B-O
-turnover NOUN B-O
-, PUNCT B-O
-mucus NOUN B-O
-production NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-muscle NOUN B-O
-hypercontractility NOUN B-O
-[ PUNCT B-O
-28 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Photographs NOUN B-O
-showing VERB B-O
-double ADJ B-O
-- PUNCT B-O
-labeling NOUN B-O
-for ADP B-O
-galanin NOUN B-LF
-receptor NOUN I-LF
-type NOUN I-LF
-2 NUM I-LF
-( PUNCT B-O
-GalR2 PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-A PROPN B-O
-, PUNCT B-O
-D PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-NF200 PROPN B-O
-( PUNCT B-O
-B NOUN B-O
-, PUNCT B-O
-E NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-merged VERB B-O
-images NOUN B-O
-( PUNCT B-O
-C PROPN B-O
-, PUNCT B-O
-F PROPN B-O
-) PUNCT B-O
-in ADP B-O
-dorsal ADJ B-LF
-root NOUN I-LF
-ganglion NOUN I-LF
-( PUNCT B-O
-DRG PROPN B-AC
-) PUNCT B-O
-neurons NOUN B-O
-of ADP B-O
-the DET B-O
-naïve ADJ B-O
-( PUNCT B-O
-A PROPN B-O
-- PUNCT B-O
-C PROPN B-O
-) PUNCT B-O
-and CCONJ B-O
-chronic ADJ B-O
-constriction NOUN B-O
-injury NOUN B-O
-1 NUM B-O
-week NOUN B-O
-( PUNCT B-O
-CCI1W PROPN B-O
-) PUNCT B-O
-( PUNCT B-O
-D PROPN B-O
-- PUNCT B-O
-F PROPN B-O
-) PUNCT B-O
-groups NOUN B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-PRS PROPN B-AC
-, PUNCT B-O
-postreperfusion NOUN B-LF
-syndrome NOUN I-LF
-; PUNCT B-O
-PS PROPN B-O
-, PUNCT B-O
-propensity NOUN B-O
-score NOUN B-O
-. PUNCT B-O
-
-ABR PROPN B-AC
-, PUNCT B-O
-auditory ADJ B-LF
-brainstem NOUN I-LF
-response NOUN I-LF
-; PUNCT B-O
-DFNA PROPN B-O
-, PUNCT B-O
-non ADJ B-O
-- ADJ B-O
-syndromic ADJ B-O
-deafness NOUN B-O
-with ADP B-O
-dominant ADJ B-O
-inheritance NOUN B-O
-; PUNCT B-O
-DFNB PROPN B-O
-, PUNCT B-O
-non ADJ B-O
-- ADJ B-O
-syndromic ADJ B-O
-deafness NOUN B-O
-with ADP B-O
-recessive ADJ B-O
-inheritance NOUN B-O
-; PUNCT B-O
-DFNX PROPN B-O
-, PUNCT B-O
-non ADJ B-O
-- ADJ B-O
-syndromic ADJ B-O
-deafness NOUN B-O
-with ADP B-O
-X NOUN B-O
-- ADJ B-O
-linked VERB B-O
-inheritance NOUN B-O
-; PUNCT B-O
-Hemi PROPN B-O
-, PUNCT B-O
-hemizygote NOUN B-O
-; PUNCT B-O
-Het PROPN B-O
-, PUNCT B-O
-heterozygote NOUN B-O
-; PUNCT B-O
-Hom PROPN B-O
-, PUNCT B-O
-homozygote NOUN B-O
-; PUNCT B-O
-MGP PROPN B-AC
-, PUNCT B-O
-Mouse PROPN B-LF
-Genetics PROPN I-LF
-Project PROPN I-LF
-; PUNCT B-O
-tm PROPN B-AC
-, PUNCT B-O
-targeted VERB B-LF
-mutation NOUN I-LF
-. PUNCT B-O
-
-Phosphatidylcholine NOUN B-O
-( PUNCT B-O
-PC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-phosphatidic NOUN B-LF
-acid NOUN I-LF
-( PUNCT B-O
-PA PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-cholesterol NOUN B-O
-( PUNCT B-O
-CH NOUN B-O
-) PUNCT B-O
-( PUNCT B-O
-Avanti PROPN B-O
-Polar PROPN B-O
-Lipids PROPN B-O
-, PUNCT B-O
-Alabaster PROPN B-O
-, PUNCT B-O
-AL PROPN B-O
-) PUNCT B-O
-were AUX B-O
-dissolved VERB B-O
-in ADP B-O
-chloroform NOUN B-O
-under ADP B-O
-argon NOUN B-O
-, PUNCT B-O
-mixed VERB B-O
-in ADP B-O
-3:1:1 NUM B-O
-proportion NOUN B-O
-, PUNCT B-O
-respectively ADV B-O
-( PUNCT B-O
-w NOUN B-O
-/ SYM B-O
-w NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-chloroform NOUN B-O
-was AUX B-O
-evaporated VERB B-O
-. PUNCT B-O
-
-Prior ADV B-O
-to ADP B-O
-data NOUN B-O
-collection NOUN B-O
-, PUNCT B-O
-a DET B-O
-two NUM B-O
-- NOUN B-O
-day NOUN B-O
-intensive ADJ B-O
-training NOUN B-O
-was AUX B-O
-given VERB B-O
-to ADP B-O
-data NOUN B-O
-collectors NOUN B-O
-( PUNCT B-O
-physiotherapist NOUN B-O
-) PUNCT B-O
-by ADP B-O
-the DET B-O
-principal ADJ B-O
-investigator NOUN B-O
-( PUNCT B-O
-KS PROPN B-O
-) PUNCT B-O
-and CCONJ B-O
-clinical ADJ B-O
-neurologist NOUN B-O
-of ADP B-O
-UOGH PROPN B-O
-following VERB B-O
-which PRON B-O
-a DET B-O
-pre NOUN B-O
-- NOUN B-O
-test NOUN B-O
-of ADP B-O
-data NOUN B-O
-collection NOUN B-O
-was AUX B-O
-carried VERB B-O
-out ADP B-O
-with ADP B-O
-15 NUM B-O
-PLHIV PROPN B-AC
-. PUNCT B-O
-
-Brief ADJ B-O
-peripheral ADJ B-O
-neuropathy NOUN B-O
-screening NOUN B-O
-tool NOUN B-O
-validated VERB B-O
-by ADP B-O
-the DET B-O
-AIDS PROPN B-LF
-Clinical PROPN I-LF
-trial PROPN I-LF
-Group PROPN I-LF
-( PUNCT B-O
-ACTG PROPN B-AC
-) PUNCT B-O
-[ X B-O
-20 X B-O
-] X B-O
-was AUX B-O
-administered VERB B-O
-by ADP B-O
-a DET B-O
-trained VERB B-O
-physiotherapist NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-objective NOUN B-O
-of ADP B-O
-this DET B-O
-study NOUN B-O
-was AUX B-O
-to ADP B-O
-assess VERB B-O
-whether SCONJ B-O
-SAM PROPN B-AC
-treatment NOUN B-O
-delivered VERB B-O
-by ADP B-O
-CHWs PROPN B-AC
-close ADJ B-O
-to ADP B-O
-families NOUN B-O
-’ PUNCT B-O
-locations NOUN B-O
-may AUX B-O
-improve VERB B-O
-the DET B-O
-early ADJ B-O
-identification NOUN B-O
-of ADP B-O
-cases NOUN B-O
-compared VERB B-O
-to ADP B-O
-outpatient NOUN B-O
-treatment NOUN B-O
-at ADP B-O
-health NOUN B-LF
-facilities NOUN I-LF
-( PUNCT B-O
-HFs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-with ADP B-O
-a DET B-O
-decreased VERB B-O
-number NOUN B-O
-complicated ADJ B-O
-cases NOUN B-O
-referred VERB B-O
-to ADP B-O
-stabilization NOUN B-O
-centers NOUN B-O
-, PUNCT B-O
-increased VERB B-O
-anthropometric ADJ B-O
-measurements NOUN B-O
-at ADP B-O
-admission NOUN B-O
-( PUNCT B-O
-closer ADJ B-O
-to ADP B-O
-the DET B-O
-admission NOUN B-O
-threshold NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-similarity NOUN B-O
-in ADP B-O
-clinical ADJ B-O
-outcomes NOUN B-O
-( PUNCT B-O
-cure NOUN B-O
-, PUNCT B-O
-death NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-default NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Patients NOUN B-O
-are AUX B-O
-triaged VERB B-O
-to ADP B-O
-three NUM B-O
-sections NOUN B-O
-of ADP B-O
-the DET B-O
-ED PROPN B-AC
-( PUNCT B-O
-High ADJ B-O
-Acuity NOUN B-O
-, PUNCT B-O
-Low ADJ B-O
-Acuity NOUN B-O
-and CCONJ B-O
-Pediatrics NOUN B-O
-) PUNCT B-O
-based VERB B-O
-on ADP B-O
-the DET B-O
-Emergency PROPN B-LF
-Severity PROPN I-LF
-Index PROPN I-LF
-( PUNCT B-O
-ESI PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-age NOUN B-O
-. PUNCT B-O
-
-AP1 PROPN B-AC
-, PUNCT B-O
-activator NOUN B-LF
-protein NOUN I-LF
-1 NUM I-LF
-; PUNCT B-O
-bHLH PROPN B-O
-, PUNCT B-O
-basic ADJ B-O
-helix NOUN B-O
-- PUNCT B-O
-loop NOUN B-O
-- PUNCT B-O
-helix NOUN B-O
-; PUNCT B-O
-ChIP PROPN B-AC
-, PUNCT B-O
-chromatin NOUN B-LF
-immunoprecipitation NOUN I-LF
-and CCONJ I-LF
-sequencing NOUN I-LF
-; PUNCT B-O
--SeqdnIκBα PROPN B-AC
-, PUNCT B-O
-dominant ADJ B-O
-negative ADJ B-O
-NFKB PROPN B-O
-inhibitor NOUN B-O
-alpha NOUN B-O
-; PUNCT B-O
-FDR PROPN B-AC
-, PUNCT B-O
-false ADJ B-LF
-discovery NOUN I-LF
-rate NOUN I-LF
-; PUNCT B-O
-GO PROPN B-AC
-, PUNCT B-O
-Gene PROPN B-LF
-Ontology PROPN I-LF
-; PUNCT B-O
-NF PROPN B-AC
-, PUNCT B-O
-nuclear ADJ B-LF
-factor NOUN I-LF
-kappa NOUN I-LF
-B NOUN I-LF
-; PUNCT B-O
-PPARG PROPN B-O
-, PUNCT B-O
-peroxisome NOUN B-O
-proliferator NOUN B-O
-– PUNCT B-O
-activated VERB B-O
-receptor NOUN B-O
-gamma NOUN B-O
-; PUNCT B-O
--κBRNA PROPN B-AC
-, PUNCT B-O
-RNA NOUN B-LF
-sequencing NOUN I-LF
-; PUNCT B-O
-SOX8 PROPN B-O
-, PUNCT B-O
-SRY NOUN B-O
-- PUNCT B-O
-box NOUN B-O
-8 NUM B-O
-; PUNCT B-O
--SeqTet PROPN B-AC
-, PUNCT B-O
-tetracycline NOUN B-LF
-. PUNCT B-O
-
-Antibodies NOUN B-O
-were AUX B-O
-used VERB B-O
-at ADP B-O
-dilutions NOUN B-O
-recommended VERB B-O
-by ADP B-O
-the DET B-O
-manufacturers NOUN B-O
-. PUNCT B-O
-
-1 NUM B-O
-- PUNCT B-O
-methyl-4 NOUN B-O
-- PUNCT B-O
-phenylpyridinium NOUN B-O
-( PUNCT B-O
-MPP+ NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-adenosine NOUN B-LF
-- PUNCT I-LF
-triphosphate NOUN I-LF
-( PUNCT B-O
-ATP PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-obtained VERB B-O
-from ADP B-O
-Sigma PROPN B-O
-- PUNCT B-O
-Aldrich PROPN B-O
-. PUNCT B-O
-
-Another DET B-O
-example NOUN B-O
-is AUX B-O
-the DET B-O
-World PROPN B-O
-Bank PROPN B-O
-and CCONJ B-O
-UNICEF PROPN B-O
-– PUNCT B-O
-funded VERB B-O
-Child PROPN B-LF
-Survival PROPN I-LF
-and CCONJ I-LF
-Safe PROPN I-LF
-Motherhood PROPN I-LF
-( PUNCT B-O
-CSSM PROPN B-AC
-) PUNCT B-O
-Program PROPN B-O
-, PUNCT B-O
-which PRON B-O
-was AUX B-O
-implemented VERB B-O
-from ADP B-O
-1992–93 NUM B-O
-to ADP B-O
-1997–98 NUM B-O
-and CCONJ B-O
-later ADV B-O
-merged VERB B-O
-into ADP B-O
-the DET B-O
-Reproductive PROPN B-LF
-and CCONJ I-LF
-Child PROPN I-LF
-Health PROPN I-LF
-( PUNCT B-O
-RCH PROPN B-AC
-) PUNCT B-O
-program NOUN B-O
-in ADP B-O
-1997–98 NUM B-O
-( PUNCT B-O
-http://mohfw.nic.in/dofw%20website/Child%20healthrti.pdf X B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Following VERB B-O
-24 NUM B-O
-h NOUN B-O
-to ADP B-O
-48h NUM B-O
-of ADP B-O
-transfection NOUN B-O
-( PUNCT B-O
-Lipofectamine PROPN B-O
-2000 NUM B-O
-, PUNCT B-O
-Invitrogen PROPN B-O
-) PUNCT B-O
-of ADP B-O
-3μg ADP B-O
-of ADP B-O
-expression NOUN B-O
-plasmid(s NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-100 NUM B-O
-mm NOUN B-O
-diameter NOUN B-O
-plates NOUN B-O
-of ADP B-O
-HEK293 NOUN B-O
-T NOUN B-O
-cells NOUN B-O
-were AUX B-O
-washed VERB B-O
-in ADP B-O
-cold ADJ B-O
-PBS PROPN B-O
-, PUNCT B-O
-lysed VERB B-O
-in ADP B-O
-1ml NUM B-O
-of ADP B-O
-TX100 PROPN B-AC
-lysis NOUN B-O
-buffer NOUN B-O
-containing VERB B-O
-Tris PROPN B-O
-50mM PROPN B-O
-PH:7.5 NUM B-O
-, PUNCT B-O
-NaCl PROPN B-O
-150 NUM B-O
-mM NOUN B-O
-1 NUM B-O
-% NOUN B-O
-of ADP B-O
-Triton PROPN B-LF
-X100 NUM I-LF
-and CCONJ B-O
-a DET B-O
-complete ADJ B-O
-protease NOUN B-O
-inhibitor NOUN B-O
-cocktail NOUN B-O
-( PUNCT B-O
-Roche PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Baseline ADJ B-O
-categorical ADJ B-O
-data NOUN B-O
-are AUX B-O
-presented VERB B-O
-as ADP B-O
-frequency NOUN B-O
-( PUNCT B-O
-percent NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-continuous ADJ B-O
-data NOUN B-O
-are AUX B-O
-presented VERB B-O
-as ADP B-O
-median NOUN B-O
-( PUNCT B-O
-interquartile ADJ B-LF
-range NOUN I-LF
-[ X B-O
-IQR PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-the DET B-O
-present ADJ B-O
-study NOUN B-O
-, PUNCT B-O
-we PRON B-O
-have AUX B-O
-examined VERB B-O
-the DET B-O
-possibility NOUN B-O
-that SCONJ B-O
-the DET B-O
-Fat1 PROPN B-AC
-cadherin NOUN B-O
-, PUNCT B-O
-a DET B-O
-planar NOUN B-LF
-cell NOUN I-LF
-polarity NOUN I-LF
-( PUNCT B-O
-PCP PROPN B-AC
-) PUNCT B-O
-molecule NOUN B-O
-involved VERB B-O
-in ADP B-O
-tissue NOUN B-O
-morphogenesis NOUN B-O
-, PUNCT B-O
-could AUX B-O
-contribute VERB B-O
-to PART B-O
-coordinate NOUN B-O
-muscular ADJ B-O
-and CCONJ B-O
-neuronal ADJ B-O
-morphogenesis NOUN B-O
-. PUNCT B-O
-
-TheRe PROPN B-AC
-is AUX B-O
-calculated VERB B-O
-by ADP B-O
-: PUNCT B-O
-Re PROPN B-AC
-= ADP B-O
-uwdbνw(18 NUM B-O
-) PUNCT B-O
-where SCONJ B-O
-uw PROPN B-AC
-( PUNCT B-O
-m PROPN B-AC
-/ NOUN B-O
-s PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-the DET B-O
-velocity NOUN B-O
-of ADP B-O
-water NOUN B-O
-, PUNCT B-O
-db PROPN B-AC
-( PUNCT B-O
-m PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-the DET B-O
-diameter NOUN B-O
-of ADP B-O
-heat NOUN B-O
-exchange NOUN B-O
-borehole NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-νw PROPN B-AC
-( PUNCT B-O
-m2 PROPN B-AC
-/ NOUN B-O
-s PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-the DET B-O
-dynamic ADJ B-LF
-viscosity NOUN I-LF
-of ADP I-LF
-water NOUN I-LF
-. PUNCT B-O
-
-Similarly ADV B-O
-, PUNCT B-O
-this DET B-O
-study NOUN B-O
-found VERB B-O
-HIV PROPN B-AC
-testing NOUN B-O
-as SCONJ B-O
-part NOUN B-O
-of ADP B-O
-the DET B-O
-requirements NOUN B-O
-of ADP B-O
-focused VERB B-O
-antenatal ADJ B-LF
-care NOUN I-LF
-package NOUN B-O
-to PART B-O
-be AUX B-O
-a DET B-O
-barrier NOUN B-O
-for SCONJ B-O
-both DET B-O
-men NOUN B-O
-and CCONJ B-O
-women NOUN B-O
-to PART B-O
-attend VERB B-O
-at ADP B-O
-ANC PROPN B-AC
-. PUNCT B-O
-
-It PRON B-O
-was AUX B-O
-noted VERB B-O
-that SCONJ B-O
-men NOUN B-O
-felt VERB B-O
-obligated ADJ B-O
-to PART B-O
-attend VERB B-O
-ANC PROPN B-AC
-with ADP B-O
-their PRON B-O
-partners NOUN B-O
-on ADP B-O
-the DET B-O
-first ADJ B-O
-ANC PROPN B-AC
-visit NOUN B-O
-so SCONJ B-O
-that SCONJ B-O
-their PRON B-O
-partners NOUN B-O
-may AUX B-O
-not PART B-O
-be AUX B-O
-denied VERB B-O
-services NOUN B-O
-when SCONJ B-O
-unaccompanied ADJ B-O
-, PUNCT B-O
-even ADV B-O
-as SCONJ B-O
-some PRON B-O
-dreaded VERB B-O
-HIV PROPN B-AC
-testing NOUN B-O
-. PUNCT B-O
-
-As SCONJ B-O
-the DET B-O
-Thai ADJ B-O
-Ministry PROPN B-LF
-of ADP I-LF
-Public PROPN I-LF
-Health PROPN I-LF
-( PUNCT B-O
-MoPH PROPN B-AC
-) NOUN B-O
-policy NOUN B-O
-requires VERB B-O
-insecticide NOUN B-O
-spraying NOUN B-O
-both CCONJ B-O
-upon SCONJ B-O
-identification NOUN B-O
-of ADP B-O
-a DET B-O
-dengue NOUN B-O
-case NOUN B-O
-and CCONJ B-O
-7 NUM B-O
-d NOUN B-O
-later ADV B-O
-, NOUN B-O
-the DET B-O
-study NOUN B-O
-team NOUN B-O
-provided VERB B-O
-the DET B-O
-initial ADJ B-O
-spraying NOUN B-O
-and CCONJ B-O
-the DET B-O
-Thai ADJ B-O
-MoPH PROPN B-AC
-provided VERB B-O
-the DET B-O
-day NOUN B-O
-7 NUM B-O
-spraying NOUN B-O
-( PUNCT B-O
-deltamethrin NOUN B-O
-or CCONJ B-O
-permethrin NOUN B-O
-10 NUM B-O
-% NOUN B-O
-) NOUN B-O
-, NOUN B-O
-regardless ADV B-O
-of ADP B-O
-the DET B-O
-dengue NOUN B-O
-PCR PROPN B-AC
-status NOUN B-O
-of ADP B-O
-the DET B-O
-index NOUN B-O
-case NOUN B-O
-for ADP B-O
-that DET B-O
-cluster NOUN B-O
-. PUNCT B-O
-
-EM PROPN B-O
-, PUNCT B-O
-electron NOUN B-O
-microscopy NOUN B-O
-; PUNCT B-O
-Fab PROPN B-AC
-, PUNCT B-O
-fragment NOUN B-LF
-antigen NOUN I-LF
-binding VERB I-LF
-; PUNCT B-O
-HA PROPN B-AC
-, PUNCT B-O
-hemagglutinin NOUN B-LF
-; PUNCT B-O
-nsEM PROPN B-AC
-, PUNCT B-O
-negative ADJ B-O
-- PUNCT B-O
-stain NOUN B-O
-EM PROPN B-O
-; PUNCT B-O
-PDB PROPN B-AC
-, PUNCT B-O
-Protein PROPN B-LF
-Data PROPN I-LF
-Bank PROPN I-LF
-. PUNCT B-O
-
-FI PROPN B-AC
-, PUNCT B-O
-RpfF NOUN B-LF
-interaction NOUN I-LF
-RpfF PROPN B-AC
-; PUNCT B-O
-PAS PROPN B-AC
-, PUNCT B-O
-Per PROPN B-LF
-- PUNCT I-LF
-Arnt PROPN I-LF
-- PUNCT I-LF
-Sim PROPN I-LF
-; PUNCT B-O
-RpfF PROPN B-AC
-, PUNCT B-O
-regulation NOUN B-LF
-of ADP I-LF
-pathogenicity NOUN I-LF
-factor NOUN I-LF
-F PROPN I-LF
-; PUNCT B-O
-RpfR PROPN B-AC
-, PUNCT B-O
-regulation NOUN B-LF
-of ADP I-LF
-pathogenicity NOUN I-LF
-factor NOUN I-LF
-R NOUN I-LF
-; PUNCT B-O
-SUMO PROPN B-AC
-, PUNCT B-O
-small ADJ B-LF
-ubiquitin NOUN I-LF
-- PUNCT I-LF
-like ADJ I-LF
-modifier NOUN I-LF
-. PUNCT B-O
-
-Effect NOUN B-O
-of ADP B-O
-non ADJ B-O
-- ADJ B-O
-Darcy ADJ B-O
-flow NOUN B-O
-can AUX B-O
-be PROPN B-AC
-considered VERB B-O
-by ADP B-O
-adjusting VERB B-O
-the DET B-O
-slip NOUN B-LF
-coefficient NOUN I-LF
-which PRON B-O
-appereas VERB B-O
-in ADP B-O
-Eq NOUN B-O
-( PUNCT B-O
-30 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-To PART B-O
-observe VERB B-O
-the DET B-O
-location NOUN B-O
-of ADP B-O
-P. PROPN B-O
-berghei PROPN B-O
-proteins NOUN B-O
-, PUNCT B-O
-the DET B-O
-C NOUN B-O
-- PUNCT B-O
-terminus NOUN B-O
-of ADP B-O
-the DET B-O
-gene NOUN B-O
-was AUX B-O
-tagged VERB B-O
-with ADP B-O
-green ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-( PUNCT B-O
-GFP PROPN B-AC
-) PUNCT B-O
-sequence NOUN B-O
-by ADP B-O
-single ADJ B-O
-crossover NOUN B-O
-homologous ADJ B-O
-recombination NOUN B-O
-. PUNCT B-O
-
-Gestational ADJ B-LF
-diabetes NOUN I-LF
-mellitus NOUN I-LF
-( PUNCT B-O
-GDM PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-defined VERB B-O
-as ADP B-O
-any DET B-O
-degree NOUN B-O
-of ADP B-O
-glucose NOUN B-O
-intolerance NOUN B-O
-with ADP B-O
-onset NOUN B-O
-or CCONJ B-O
-first ADJ B-O
-recognition NOUN B-O
-during ADP B-O
-pregnancy NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Furthermore ADV B-O
-induction NOUN B-O
-of ADP B-O
-diabetes NOUN B-O
-type NOUN B-O
-1 NUM B-O
-induced VERB B-O
-a DET B-O
-decrease NOUN B-O
-in ADP B-O
-major ADJ B-O
-angiogenic ADJ B-O
-growth NOUN B-O
-factor NOUN B-O
-in ADP B-O
-the DET B-O
-skeletal ADJ B-O
-muscle NOUN B-O
-capillary ADJ B-O
-bed NOUN B-O
-of ADP B-O
-mice.[6 NOUN B-O
-] PUNCT B-O
-In ADP B-O
-a DET B-O
-chicken NOUN B-O
-model NOUN B-O
-of ADP B-O
-neoangiogenesis NOUN B-O
-, PUNCT B-O
-hyperglycemia NOUN B-O
-was AUX B-O
-shown VERB B-O
-to ADP B-O
-impair VERB B-O
-angiogenesis NOUN B-O
-through ADP B-O
-induction NOUN B-O
-of ADP B-O
-apoptosis NOUN B-O
-and CCONJ B-O
-decreases VERB B-O
-proliferation NOUN B-O
-of ADP B-O
-endothelial ADJ B-O
-cells.[7 NOUN B-O
-] PUNCT B-O
-In ADP B-O
-a DET B-O
-diabetic ADJ B-O
-mouse NOUN B-O
-model NOUN B-O
-with ADP B-O
-hindlimb NOUN B-O
-- ADJ B-O
-induced VERB B-O
-ischemia NOUN B-O
-, PUNCT B-O
-restoration NOUN B-O
-of ADP B-O
-perfusion NOUN B-O
-in ADP B-O
-the DET B-O
-ischemic ADJ B-O
-limb NOUN B-O
-was AUX B-O
-impaired VERB B-O
-and CCONJ B-O
-capillary ADJ B-O
-density NOUN B-O
-reduced.[8 VERB B-O
-] PUNCT B-O
-Goligorsky PROPN B-O
-and CCONJ B-O
-colleagues NOUN B-O
-demonstrated VERB B-O
-an DET B-O
-angiogenic ADJ B-O
-switch NOUN B-O
-during ADP B-O
-natural ADJ B-O
-history NOUN B-O
-of ADP B-O
-type NOUN B-LF
-2 NUM I-LF
-diabetes NOUN I-LF
-mellitus NOUN I-LF
-( PUNCT B-O
-T2DM PROPN B-AC
-) PUNCT B-O
-from ADP B-O
-pro ADJ B-O
-- ADJ B-O
-angiogenic ADJ B-O
-phenotype NOUN B-O
-at ADP B-O
-the DET B-O
-early ADJ B-O
-pre ADJ B-O
-- ADJ B-O
-diabetic ADJ B-O
-stages NOUN B-O
-to ADP B-O
-the DET B-O
-profound ADJ B-O
-inhibition NOUN B-O
-of ADP B-O
-ex ADJ B-O
-- ADJ B-O
-vivo ADJ B-O
-angiogenesis NOUN B-O
-and CCONJ B-O
-microvascular ADJ B-O
-rarefaction NOUN B-O
-in ADP B-O
-the DET B-O
-kidneys NOUN B-O
-of ADP B-O
-obese ADJ B-O
-zucker PROPN B-O
-diabetic ADJ B-O
-fat ADJ B-O
-rats.[5 NOUN B-O
-] PUNCT B-O
-Peritubular ADJ B-O
-capillary ADJ B-O
-rarefaction NOUN B-O
-is VERB B-O
-a DET B-O
-major ADJ B-O
-hallmark NOUN B-O
-of ADP B-O
-chronic ADJ B-O
-kidney NOUN B-O
-disease NOUN B-O
-and CCONJ B-O
-predicts VERB B-O
-renal ADJ B-O
-outcome NOUN B-O
-in ADP B-O
-diabetic ADJ B-O
-nephropathy.[9 NOUN B-O
-] PUNCT B-O
-There PRON B-O
-is VERB B-O
-evidence NOUN B-O
-from ADP B-O
-animal NOUN B-O
-models NOUN B-O
-that SCONJ B-O
-endothelial ADJ B-O
-dysfunction NOUN B-O
-, PUNCT B-O
-oxidative ADJ B-O
-stress NOUN B-O
-, PUNCT B-O
-interstitial ADJ B-O
-hypoxia NOUN B-O
-due ADP B-O
-to ADP B-O
-arteriolar ADJ B-O
-vasoconstriction NOUN B-O
-and CCONJ B-O
-pericyte NOUN B-O
-detachment NOUN B-O
-from ADP B-O
-the DET B-O
-vasculature NOUN B-O
-are AUX B-O
-involved VERB B-O
-in ADP B-O
-this DET B-O
-pathophysiological ADJ B-O
-process.[9 NOUN B-O
-] PUNCT B-O
-Initially ADV B-O
-thought VERB B-O
-to PART B-O
-be AUX B-O
-absent ADJ B-O
-in ADP B-O
-mammals NOUN B-O
-, PUNCT B-O
-small ADJ B-O
-quantities NOUN B-O
-of ADP B-O
-α PUNCT B-O
-- PUNCT B-O
-linked VERB B-O
-monoglycosylceramides NOUN B-O
-( PUNCT B-O
-e.g. X B-O
-, PUNCT B-O
-α PUNCT B-LF
-- PUNCT I-LF
-galactosylceramide NOUN I-LF
-[ PUNCT B-O
-α-GalCer PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-that PRON B-O
-may AUX B-O
-act VERB B-O
-as ADP B-O
-iNKT PROPN B-AC
-cell NOUN B-O
-self NOUN B-O
-- PUNCT B-O
-Ags PROPN B-AC
-have AUX B-O
-been AUX B-O
-identified VERB B-O
-[ PUNCT B-O
-14 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-effect NOUN B-O
-size NOUN B-O
-for ADP B-O
-the DET B-O
-primary ADJ B-O
-and CCONJ B-O
-secondary ADJ B-O
-outcomes NOUN B-O
-was AUX B-O
-evaluated VERB B-O
-as ADP B-O
-the DET B-O
-standardized ADJ B-LF
-mean NOUN I-LF
-difference NOUN I-LF
-( PUNCT B-O
-SMD PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-testing VERB B-O
-frequency NOUN B-O
-between ADP B-O
-intervention NOUN B-O
-and CCONJ B-O
-control NOUN B-O
-arms NOUN B-O
-. PUNCT B-O
-
-Activation NOUN B-O
-of ADP B-O
-MET PROPN B-AC
-signaling NOUN B-O
-cascade NOUN B-O
-by ADP B-O
-its PRON B-O
-ligand NOUN B-O
-HGF PROPN B-O
-results VERB B-O
-in ADP B-O
-colony NOUN B-O
-dispersal NOUN B-O
-, PUNCT B-O
-epithelial ADJ B-LF
-- PUNCT I-LF
-mesenchymal NOUN I-LF
-transition NOUN I-LF
-( PUNCT B-O
-EMT PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-increased VERB B-O
-motility NOUN B-O
-[ PUNCT B-O
-40 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-When SCONJ B-O
-DCs PROPN B-AC
-mature VERB B-O
-, PUNCT B-O
-they PRON B-O
-synthesize VERB B-O
-high ADJ B-O
-levels NOUN B-O
-of ADP B-O
-NO PROPN B-AC
-, PUNCT B-O
-interleukin NOUN B-LF
-( PUNCT B-O
-IL PROPN B-AC
-) PUNCT B-O
-12 NUM B-O
-, PUNCT B-O
-and CCONJ B-O
-RANTES PROPN B-AC
-, PUNCT B-O
-and CCONJ B-O
-express VERB B-O
-more ADV B-O
-costimulatory ADJ B-O
-molecules NOUN B-O
-such ADJ B-O
-as ADP B-O
-CD86 PROPN B-O
-and CCONJ B-O
-major ADJ B-LF
-histocompatibility NOUN I-LF
-complex NOUN I-LF
-( PUNCT B-O
-MHC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-all PRON B-O
-of ADP B-O
-which PRON B-O
-can AUX B-O
-induce VERB B-O
-T NOUN B-O
-cells NOUN B-O
-to ADP B-O
-become VERB B-O
-fully ADV B-O
-activated ADJ B-O
-to ADP B-O
-initial ADJ B-O
-immune ADJ B-O
-response NOUN B-O
-[ PUNCT B-O
-19 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Clot NOUN B-O
-formation NOUN B-O
-inside ADP B-O
-one NUM B-O
-of ADP B-O
-the DET B-O
-veins NOUN B-O
-deep ADJ B-O
-in ADP B-O
-the DET B-O
-body NOUN B-O
-( PUNCT B-O
-usually ADV B-O
-in ADP B-O
-a DET B-O
-leg NOUN B-O
-) PUNCT B-O
-is AUX B-O
-called VERB B-O
-deep ADJ B-LF
-vein NOUN I-LF
-thrombosis NOUN I-LF
-( PUNCT B-O
-DVT PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-DVT PROPN B-AC
-, PUNCT B-O
-which PRON B-O
-can AUX B-O
-cause VERB B-O
-pain NOUN B-O
-, PUNCT B-O
-swelling NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-redness NOUN B-O
-in ADP B-O
-the DET B-O
-affected VERB B-O
-limb NOUN B-O
-, PUNCT B-O
-is AUX B-O
-treated VERB B-O
-with ADP B-O
-anticoagulants NOUN B-O
-, PUNCT B-O
-drugs NOUN B-O
-that PRON B-O
-stop VERB B-O
-the DET B-O
-clot NOUN B-O
-growing VERB B-O
-. PUNCT B-O
-
-This DET B-O
-complex NOUN B-O
-is AUX B-O
-mainly ADV B-O
-composed VERB B-O
-of ADP B-O
-four NUM B-O
-subunits NOUN B-O
-: PUNCT B-O
-a DET B-O
-heterodimer NOUN B-O
-of ADP B-O
-two NUM B-O
-structural ADJ B-LF
-maintenance NOUN I-LF
-of ADP I-LF
-chromosome NOUN I-LF
-proteins NOUN I-LF
-( PUNCT B-O
-SMC1 PROPN B-O
-and CCONJ B-O
-SMC3 PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-associated VERB B-O
-with ADP B-O
-two NUM B-O
-non ADJ B-O
-- ADJ B-O
-SMC PROPN B-AC
-components NOUN B-O
-corresponding VERB B-O
-to ADP B-O
-sister NOUN B-O
-chromatid NOUN B-O
-cohesion NOUN B-O
-proteins NOUN B-O
-( PUNCT B-O
-SCC1 PROPN B-O
-and CCONJ B-O
-SCC3 PROPN B-O
-) PUNCT B-O
-[ X B-O
-3–6 NUM B-O
-] PUNCT B-O
-; PUNCT B-O
-and CCONJ B-O
-for ADP B-O
-review NOUN B-O
-see VERB B-O
-[ X B-O
-7,8 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Using VERB B-O
-liquid NOUN B-LF
-chromatography NOUN I-LF
-high ADJ I-LF
-- PUNCT I-LF
-resolution NOUN I-LF
-mass NOUN I-LF
-spectrometry NOUN I-LF
-( PUNCT B-O
-LC-HR-MS/MS PROPN B-AC
-) PUNCT B-O
-analysis NOUN B-O
-, PUNCT B-O
-we PRON B-O
-discovered VERB B-O
-1,360 NUM B-O
-differentially ADV B-O
-expressed VERB B-O
-proteins NOUN B-O
-in ADP B-O
-CLL PROPN B-AC
-patients NOUN B-O
-compared VERB B-O
-to PART B-O
-healthy ADJ B-O
-donors NOUN B-O
-, PUNCT B-O
-several ADJ B-O
-of ADP B-O
-which PRON B-O
-had AUX B-O
-been AUX B-O
-previously ADV B-O
-reported VERB B-O
-to PART B-O
-be AUX B-O
-associated VERB B-O
-with ADP B-O
-cancer NOUN B-O
-, PUNCT B-O
-yet CCONJ B-O
-four NUM B-O
-of ADP B-O
-which PRON B-O
-were AUX B-O
-identified VERB B-O
-as ADP B-O
-being AUX B-O
-associated VERB B-O
-with ADP B-O
-any DET B-O
-cancer NOUN B-O
-, PUNCT B-O
-including VERB B-O
-CLL PROPN B-AC
-, PUNCT B-O
-for ADP B-O
-the DET B-O
-first ADJ B-O
-time NOUN B-O
-. PUNCT B-O
-
-Similar ADJ B-O
-improvements NOUN B-O
-in ADP B-O
-systolic ADJ B-O
-and CCONJ B-O
-diastolic ADJ B-O
-BP PROPN B-AC
-to ADP B-O
-those PRON B-O
-observed VERB B-O
-in ADP B-O
-this DET B-O
-trial NOUN B-O
-of ADP B-O
-3.3 NUM B-O
-and CCONJ B-O
-1.4 NUM B-O
-mmHg NOUN B-O
-were AUX B-O
-reported VERB B-O
-in ADP B-O
-the DET B-O
-Heart PROPN B-LF
-Outcome PROPN I-LF
-Prevention PROPN I-LF
-Evaluation PROPN I-LF
-( PUNCT B-O
-HOPE PROPN B-AC
-) PUNCT B-O
-study NOUN B-O
-and CCONJ B-O
-were AUX B-O
-associated VERB B-O
-with ADP B-O
-a DET B-O
-22 NUM B-O
-% NOUN B-O
-reduction NOUN B-O
-in ADP B-O
-relative ADJ B-O
-risk NOUN B-O
-of ADP B-O
-cardiovascular ADJ B-O
-mortality NOUN B-O
-, PUNCT B-O
-myocardial ADJ B-O
-infarction NOUN B-O
-, PUNCT B-O
-or CCONJ B-O
-stroke NOUN B-O
-[ PUNCT B-O
-23 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-expression NOUN B-O
-of ADP B-O
-the DET B-O
-major ADJ B-O
-inflammatory ADJ B-O
-cytokines NOUN B-O
-, PUNCT B-O
-IL-6 PROPN B-AC
-, PUNCT B-O
-IL-1β NOUN B-O
-and CCONJ B-O
-TNF PROPN B-AC
-, PUNCT B-O
-in ADP B-O
-spinal ADJ B-O
-cords NOUN B-O
-of ADP B-O
-these DET B-O
-SOD1 NOUN B-O
-transgenic ADJ B-LF
-( PUNCT B-O
--αTG PROPN B-AC
-) PUNCT B-O
-mice NOUN B-O
-were AUX B-O
-assessed VERB B-O
-by ADP B-O
-real ADJ B-O
-time NOUN B-O
-PCR NOUN B-O
-. PUNCT B-O
-
-Mice NOUN B-O
-were AUX B-O
-then ADV B-O
-crossed VERB B-O
-with ADP B-O
-IL-6(-/- PROPN B-AC
-) PUNCT B-O
-mice NOUN B-O
-to PART B-O
-generate VERB B-O
-SOD1TG NOUN B-O
-/ SYM B-O
-IL-6(-/- PROPN B-AC
-) PUNCT B-O
-mice NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-female ADJ B-O
-mouse NOUN B-LF
-embryo NOUN I-LF
-fibroblasts NOUN I-LF
-( PUNCT B-O
-MEFs PROPN B-AC
-) PUNCT B-O
-exhibiting VERB B-O
-DD NOUN B-O
-signals NOUN B-O
-for ADP B-O
-Pgk1 NOUN B-O
-, PUNCT B-O
-the DET B-O
-distribution NOUN B-O
-of ADP B-O
-D PROPN B-AC
-/ SYM B-O
-D PROPN B-AC
-intensity NOUN B-O
-ratios NOUN B-O
-centered VERB B-O
-around ADP B-O
-1 NUM B-O
-( PUNCT B-O
-Figure PROPN B-O
-1E NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-demonstrating VERB B-O
-that SCONJ B-O
-two NUM B-O
-replicated VERB B-O
-alleles NOUN B-O
-display VERB B-O
-equal ADJ B-O
-signal NOUN B-O
-intensities NOUN B-O
-. PUNCT B-O
-
-There PRON B-O
-is VERB B-O
-no DET B-O
-dignity NOUN B-O
-… PUNCT B-O
-. PUNCT B-O
-
-” PUNCT B-O
-Account NOUN B-O
-told VERB B-O
-by ADP B-O
-a DET B-O
-16 NUM B-O
-- PUNCT B-O
-year NOUN B-O
-- PUNCT B-O
-old ADJ B-O
-Sudanese ADJ B-O
-boy NOUN B-O
-to ADP B-O
-Médecins PROPN B-LF
-Sans PROPN I-LF
-Frontières PROPN I-LF
-( PUNCT B-O
-MSF PROPN B-AC
-) PUNCT B-O
-staff NOUN B-O
-, PUNCT B-O
-after ADP B-O
-being AUX B-O
-rescued VERB B-O
-on ADP B-O
-the DET B-O
-Mediterranean PROPN B-O
-Sea PROPN B-O
-in ADP B-O
-August PROPN B-O
-2019 NUM B-O
-. PUNCT B-O
-
-To PART B-O
-examine VERB B-O
-and CCONJ B-O
-compare VERB B-O
-changes NOUN B-O
-in ADP B-O
-strength NOUN B-O
-and CCONJ B-O
-physical ADJ B-O
-function NOUN B-O
-from ADP B-O
-pre- ADJ B-O
-to ADP B-O
-post ADJ B-O
-- ADJ B-O
-diagnosis NOUN B-O
-among ADP B-O
-men NOUN B-O
-with ADP B-O
-prostate NOUN B-LF
-cancer ADJ I-LF
-( PUNCT B-O
-PC PROPN B-AC
-, PUNCT B-O
-[ X B-O
-cases NOUN B-O
-] PUNCT B-O
-) PUNCT B-O
-and CCONJ B-O
-matched VERB B-O
-non ADJ B-O
-- ADJ B-O
-cancer ADJ B-O
-controls NOUN B-O
-identified VERB B-O
-from ADP B-O
-the DET B-O
-Health PROPN B-O
-, PUNCT B-O
-Aging PROPN B-O
-and CCONJ B-O
-Body PROPN B-O
-Composition PROPN B-O
-( PUNCT B-O
-HealthABC PROPN B-AC
-) PUNCT B-O
-study NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-specific ADJ B-O
-expression NOUN B-O
-of ADP B-O
-desatF NOUN B-O
-in ADP B-O
-D. PROPN B-O
-melanogaster NOUN B-O
-females NOUN B-O
-was AUX B-O
-due ADJ B-O
-to ADP B-O
-a DET B-O
-special ADJ B-O
-cis ADJ B-LF
-- PUNCT I-LF
-regulatory ADJ I-LF
-element NOUN I-LF
-( PUNCT B-O
-CRE PROPN B-AC
-) PUNCT B-O
-located VERB B-O
-upstream ADV B-O
-of ADP B-O
-desatF NOUN B-O
-in ADP B-O
-D. PROPN B-O
-melanogaster NOUN B-O
-; PUNCT B-O
-the DET B-O
-CRE PROPN B-AC
-presented VERB B-O
-a DET B-O
-doublesex PROPN B-O
-protein NOUN B-O
-( PUNCT B-O
-Doublesx PROPN B-LF
-, PUNCT B-O
-Dsx PROPN B-AC
-) PUNCT B-O
-binding NOUN B-O
-site NOUN B-O
-that PRON B-O
-could AUX B-O
-be AUX B-O
-recognized VERB B-O
-by ADP B-O
-the DET B-O
-female NOUN B-O
-- PUNCT B-O
-specific ADJ B-O
-isoform NOUN B-O
-of ADP B-O
-Dsx PROPN B-AC
-( PUNCT B-O
-Dsx PROPN B-AC
-- PUNCT B-O
-F PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-binding NOUN B-O
-of ADP B-O
-Dsx PROPN B-AC
-- PUNCT B-O
-F PROPN B-O
-activated VERB B-O
-the DET B-O
-transcription NOUN B-O
-of ADP B-O
-desatF NOUN B-O
-, PUNCT B-O
-whereas SCONJ B-O
-male NOUN B-O
-- PUNCT B-O
-specific ADJ B-O
-Dsx PROPN B-AC
-showed VERB B-O
-no DET B-O
-regulatory ADJ B-O
-activity NOUN B-O
-, PUNCT B-O
-resulting VERB B-O
-in ADP B-O
-sexual ADJ B-O
-dimorphism NOUN B-O
-of ADP B-O
-desatF NOUN B-O
-expression NOUN B-O
-[ PUNCT B-O
-42 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-DEG PROPN B-AC
-, PUNCT B-O
-differentially ADV B-LF
-expressed VERB I-LF
-gene NOUN I-LF
-; PUNCT B-O
-IL-4 PROPN B-AC
-, PUNCT B-O
-interleukin-4 NOUN B-LF
-. PUNCT B-O
-
-This PRON B-O
-included VERB B-O
-the DET B-O
-integration NOUN B-O
-of ADP B-O
-principles NOUN B-O
-from ADP B-O
-Self PROPN B-LF
-- PUNCT I-LF
-Determination PROPN I-LF
-Theory PROPN I-LF
-( PUNCT B-O
-SDT PROPN B-AC
-) PUNCT B-O
-as ADP B-O
-a DET B-O
-means NOUN B-O
-to PART B-O
-strengthen VERB B-O
-the DET B-O
-quality NOUN B-O
-, PUNCT B-O
-quantity NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-longevity NOUN B-O
-of ADP B-O
-motivation NOUN B-O
-to PART B-O
-change VERB B-O
-health NOUN B-O
-behaviours NOUN B-O
-[ PUNCT B-O
-25 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-PAM2 PROPN B-O
-Off PROPN B-O
-- PUNCT B-O
-Target NOUN B-O
-# NOUN B-O
-2 NUM B-O
-template NOUN B-O
-( PUNCT B-O
-accession NOUN B-O
-XM_021073251.1 NOUN B-O
-) PUNCT B-O
-is AUX B-O
-predicted VERB B-O
-to ADP B-O
-encode VERB B-O
-for ADP B-O
-an DET B-O
-mRNA NOUN B-O
-transcript NOUN B-O
-for ADP B-O
-aminoadipate NOUN B-LF
-aminotransferase NOUN I-LF
-( PUNCT B-O
-AADAT PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-AADAT PROPN B-AC
-is AUX B-O
-an DET B-O
-enzyme NOUN B-O
-found VERB B-O
-primarily ADV B-O
-in ADP B-O
-the DET B-O
-brain NOUN B-O
-and CCONJ B-O
-known VERB B-O
-to ADP B-O
-catalyze VERB B-O
-the DET B-O
-transamination NOUN B-O
-of ADP B-O
-kynurenine NOUN B-O
-to ADP B-O
-kynurenic NOUN B-O
-acid NOUN B-O
-; PUNCT B-O
-AADAT PROPN B-AC
-is AUX B-O
-also ADV B-O
-responsible ADJ B-O
-for ADP B-O
-the DET B-O
-transamination NOUN B-O
-of ADP B-O
-aminoapidate NOUN B-O
-to ADP B-O
-alpha NOUN B-O
-- PUNCT B-O
-oxoadipate[17 NOUN B-O
-] PUNCT B-O
-. PUNCT B-O
-
-DIC PROPN B-AC
-, PUNCT B-O
-differential ADJ B-LF
-interference NOUN I-LF
-contrast NOUN I-LF
-; PUNCT B-O
-EXP1 PROPN B-AC
-, PUNCT B-O
-exported VERB B-LF
-protein NOUN I-LF
-1 NUM I-LF
-; PUNCT B-O
-HA PROPN B-O
-, PUNCT B-O
-triple ADJ B-O
-hemagglutinin NOUN B-O
-tag NOUN B-O
-; PUNCT B-O
-KAHRP PROPN B-AC
-, PUNCT B-O
-knob NOUN B-LF
-- PUNCT I-LF
-associated VERB I-LF
-histidine NOUN I-LF
-- PUNCT I-LF
-rich ADJ I-LF
-protein NOUN I-LF
-; PUNCT B-O
-pA NOUN B-O
-, PUNCT B-O
-Picoampere NOUN B-O
-; PUNCT B-O
-PSAC PROPN B-AC
-, PUNCT B-O
-parasite NOUN B-LF
-surface NOUN I-LF
-anion NOUN I-LF
-channel NOUN I-LF
-; PUNCT B-O
-PVM PROPN B-AC
-, PUNCT B-O
-parasitophorous ADJ B-LF
-vacuolar ADJ I-LF
-membrane NOUN I-LF
-; PUNCT B-O
-RBC PROPN B-AC
-, PUNCT B-O
-red ADJ B-LF
-blood NOUN I-LF
-cell NOUN I-LF
-; PUNCT B-O
-SBP1 PROPN B-AC
-, PUNCT B-O
-skeleton NOUN B-LF
-binding VERB I-LF
-protein NOUN I-LF
-1 NUM I-LF
-. PUNCT B-O
-
-However ADV B-O
-, PUNCT B-O
-insufficient ADJ B-O
-information NOUN B-O
-is AUX B-O
-available ADJ B-O
-on ADP B-O
-the DET B-O
-effects NOUN B-O
-of ADP B-O
-fluoride NOUN B-O
-on ADP B-O
-human ADJ B-LF
-embryonic ADJ I-LF
-stem NOUN I-LF
-cells NOUN I-LF
-( PUNCT B-O
-hESCs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-is AUX B-O
-a DET B-O
-novel ADJ B-O
-in ADP B-O
-vitro X B-O
-humanized VERB B-O
-model NOUN B-O
-for ADP B-O
-analyzing VERB B-O
-the DET B-O
-embryotoxicities NOUN B-O
-of ADP B-O
-chemical ADJ B-O
-compounds NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-first ADJ B-O
-source NOUN B-O
-is AUX B-O
-the DET B-O
-Human PROPN B-LF
-Mortality PROPN I-LF
-Database PROPN I-LF
-( PUNCT B-O
-HMD PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-consists VERB B-O
-of ADP B-O
-high ADJ B-O
-- PUNCT B-O
-quality NOUN B-O
-life NOUN B-O
-tables NOUN B-O
-mostly ADV B-O
-from ADP B-O
-Western ADJ B-O
-countries NOUN B-O
-. PUNCT B-O
-
-CsINV5 PROPN B-AC
-expression NOUN B-O
-in ADP B-O
-cultivar NOUN B-O
-SCZ PROPN B-AC
-increased VERB B-O
-by ADP B-O
-three NUM B-O
-folds NOUN B-O
-at ADP B-O
-CA2 NOUN B-O
-compared VERB B-O
-with ADP B-O
-less ADJ B-O
-than ADP B-O
-one NUM B-O
-fold NOUN B-O
-in ADP B-O
-YH9 PROPN B-AC
-( PUNCT B-O
-Fig NOUN B-O
-6B NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Raffinose NOUN B-LF
-synthase NOUN I-LF
-gene NOUN I-LF
-CsRS2 PROPN B-AC
-, PUNCT B-O
-responsible ADJ B-O
-for ADP B-O
-synthesizing NOUN B-O
-of ADP B-O
-raffinose NOUN B-O
-, PUNCT B-O
-expression NOUN B-O
-was AUX B-O
-also ADV B-O
-increased VERB B-O
-during ADP B-O
-CA PROPN B-AC
-in ADP B-O
-variety NOUN B-O
-SCZ PROPN B-AC
-and CCONJ B-O
-then ADV B-O
-decreased VERB B-O
-following VERB B-O
-DA PROPN B-AC
-, PUNCT B-O
-while SCONJ B-O
-it PRON B-O
-had VERB B-O
-no DET B-O
-distinct ADJ B-O
-changes NOUN B-O
-during ADP B-O
-CA PROPN B-AC
-in ADP B-O
-YH9 PROPN B-AC
-( PUNCT B-O
-Fig NOUN B-O
-6B NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-This PRON B-O
-suggested VERB B-O
-that SCONJ B-O
-the DET B-O
-genes NOUN B-O
-responsible ADJ B-O
-for ADP B-O
-sucrose NOUN B-O
-and CCONJ B-O
-raffinose NOUN B-O
-accumulation NOUN B-O
-acted VERB B-O
-positively ADV B-O
-to PART B-O
-regulate VERB B-O
-the DET B-O
-corresponding VERB B-O
-sugar NOUN B-O
-accumulation NOUN B-O
-in ADP B-O
-cold ADJ B-O
-treatment NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-did AUX B-O
-not PART B-O
-observe VERB B-O
-any DET B-O
-association NOUN B-O
-between ADP B-O
-the DET B-O
-grandmother NOUN B-O
-’s PART B-O
-smoking NOUN B-O
-during ADP B-O
-her PRON B-O
-pregnancy NOUN B-O
-and CCONJ B-O
-unilateral ADJ B-O
-retinoblastoma NOUN B-O
-risk NOUN B-O
-in ADP B-O
-the DET B-O
-grandchild NOUN B-O
-( PUNCT B-O
-OR PROPN B-AC
-, PUNCT B-O
-1.1 NUM B-O
-; PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-, PUNCT B-O
-0.5–2.1 NUM B-O
-) PUNCT B-O
-with ADP B-O
-a DET B-O
-slightly ADV B-O
-increased VERB B-O
-risk NOUN B-O
-estimate NOUN B-O
-for ADP B-O
-bilateral ADJ B-O
-retinoblastoma NOUN B-O
-development NOUN B-O
-, PUNCT B-O
-but CCONJ B-O
-confidence NOUN B-LF
-intervals NOUN I-LF
-crossed VERB B-O
-the DET B-O
-null ADJ B-O
-( PUNCT B-O
-OR PROPN B-AC
-, PUNCT B-O
-1.3 NUM B-O
-; PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-, PUNCT B-O
-0.5–3.1 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-Poisson PROPN B-LF
-generalized ADJ I-LF
-likelihood NOUN I-LF
-ratio NOUN I-LF
-( PUNCT B-O
-GLR PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-calculated VERB B-O
-for ADP B-O
-each DET B-O
-window NOUN B-O
-of ADP B-O
-observed VERB B-O
-and CCONJ B-O
-expected VERB B-O
-number NOUN B-O
-of ADP B-O
-cases NOUN B-O
-in SCONJ B-O
-order NOUN B-O
-to PART B-O
-identify VERB B-O
-statistically ADV B-O
-significant ADJ B-O
-high ADJ B-O
-risk NOUN B-O
-periods NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-experimentally ADV B-O
-addressed VERB B-O
-this DET B-O
-issue NOUN B-O
-by ADP B-O
-studying VERB B-O
-the DET B-O
-maternal ADJ B-O
-transmission NOUN B-O
-of ADP B-O
-random ADJ B-O
-mtDNA PROPN B-AC
-mutations NOUN B-O
-in ADP B-O
-mtDNA PROPN B-AC
-mutator NOUN B-O
-mice NOUN B-O
-expressing VERB B-O
-a DET B-O
-proofreading NOUN B-O
-- PUNCT B-O
-deficient VERB B-O
-mitochondrial ADJ B-LF
-DNA NOUN I-LF
-polymerase NOUN B-O
-. PUNCT B-O
-
-SE PROPN B-O
-: PUNCT B-O
-standard ADJ B-O
-error NOUN B-O
-, PUNCT B-O
-CI PROPN B-O
-: PUNCT B-O
-confidence NOUN B-O
-interval NOUN B-O
-, PUNCT B-O
-ANC PROPN B-AC
-: PUNCT B-O
-antenatal ADJ B-LF
-care NOUN I-LF
-, PUNCT B-O
-SHP PROPN B-O
-: PUNCT B-O
-skilled ADJ B-O
-health NOUN B-O
-professionals NOUN B-O
-Dichotomous ADJ B-O
-events NOUN B-O
-or CCONJ B-O
-odds NOUN B-LF
-ratios NOUN I-LF
-( PUNCT B-O
-ORs PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-suicide NOUN B-O
-, PUNCT B-O
-suicide NOUN B-O
-attempt NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-suicidal ADJ B-O
-ideation NOUN B-O
-were AUX B-O
-analyzed VERB B-O
-using VERB B-O
-multilevel ADJ B-O
-meta NOUN B-O
-- NOUN B-O
-analyses NOUN B-O
-to PART B-O
-accommodate VERB B-O
-the DET B-O
-non NOUN B-O
-- NOUN B-O
-independence NOUN B-O
-of ADP B-O
-effect NOUN B-O
-sizes NOUN B-O
-. PUNCT B-O
-
-DON PROPN B-AC
-, PUNCT B-O
-6 NUM B-LF
-- PUNCT I-LF
-Diazo-5 NOUN I-LF
-- PUNCT I-LF
-oxo NOUN I-LF
-- PUNCT I-LF
-L NOUN I-LF
-- PUNCT I-LF
-norleucine NOUN I-LF
-; PUNCT B-O
-IHC PROPN B-AC
-, PUNCT B-O
-immunohistochemistry NOUN B-LF
-; PUNCT B-O
-MEF PROPN B-AC
-, PUNCT B-O
-mouse NOUN B-LF
-embryonic ADJ I-LF
-fibroblast NOUN I-LF
-. PUNCT B-O
-
-We PRON B-O
-observed VERB B-O
-a DET B-O
-significant ADJ B-O
-drop NOUN B-O
-in ADP B-O
-the DET B-O
-level NOUN B-O
-of ADP B-O
-postoperative ADJ B-LF
-sVEGFR1 PROPN B-O
-than ADP B-O
-that PRON B-O
-of ADP B-O
-the DET B-O
-preoperative ADJ B-LF
-( PUNCT B-O
-median ADJ B-O
-sVEGFR1 PROPN B-O
-: PUNCT B-O
-PREOP PROPN B-AC
-, PUNCT B-O
-189.6 NUM B-O
-pg NOUN B-O
-/ SYM B-O
-ml NOUN B-O
-; PUNCT B-O
-POST PROPN B-AC
-, PUNCT B-O
-124.3 NUM B-O
-pg NOUN B-O
-/ SYM B-O
-ml NOUN B-O
-; PUNCT B-O
-P NOUN B-O
-< SYM B-O
-0.0001 NUM B-O
-; PUNCT B-O
-Fig NUM B-O
-5A NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Unlike ADP B-O
-sVEGFR1 PROPN B-O
-, PUNCT B-O
-we PRON B-O
-did AUX B-O
-not PART B-O
-observe VERB B-O
-significant ADJ B-O
-difference NOUN B-O
-in ADP B-O
-the DET B-O
-level NOUN B-O
-of ADP B-O
-serum NOUN B-O
-sVEGFR2 NOUN B-O
-between ADP B-O
-the DET B-O
-two NUM B-O
-events NOUN B-O
-( PUNCT B-O
-median ADJ B-O
-sVEGFR2 NOUN B-O
-: PUNCT B-O
-OPPRE PROPN B-AC
-, PUNCT B-O
-7773 NUM B-O
-pg NOUN B-O
-/ SYM B-O
-ml NOUN B-O
-; PUNCT B-O
-OPPOST PROPN B-AC
-, PUNCT B-O
-8306 NUM B-O
-pg NOUN B-O
-/ SYM B-O
-ml NOUN B-O
-; PUNCT B-O
-P NOUN B-O
-= SYM B-O
-0.976 NUM B-O
-; PUNCT B-O
-Fig NUM B-O
-5B NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-No DET B-O
-direct ADJ B-O
-association NOUN B-O
-between ADP B-O
-soluble ADJ B-O
-VEGF PROPN B-O
-receptors NOUN B-O
-and CCONJ B-O
-OPIPVEGF-A PROPN B-AC
-was AUX B-O
-noted VERB B-O
-. PUNCT B-O
-
-For ADP B-O
-mortality NOUN B-O
-, PUNCT B-O
-we PRON B-O
-examined VERB B-O
-deaths NOUN B-O
-from ADP B-O
-respiratory ADJ B-LF
-and CCONJ I-LF
-circulatory ADJ I-LF
-( PUNCT B-O
-R&C PROPN B-AC
-) PUNCT B-O
-conditions NOUN B-O
-as ADP B-O
-a DET B-O
-more ADV B-O
-specific ADJ B-O
-outcome NOUN B-O
-for ADP B-O
-influenza NOUN B-O
-. PUNCT B-O
-
-Although SCONJ B-O
-the DET B-O
-Preferred PROPN B-LF
-Reporting PROPN I-LF
-Items PROPN I-LF
-for ADP I-LF
-Systematic ADJ I-LF
-reviews NOUN I-LF
-and CCONJ I-LF
-Meta PROPN I-LF
-- PUNCT I-LF
-Analyses PROPN I-LF
-( PUNCT B-O
-PRISMA PROPN B-AC
-) PUNCT B-O
-guidelines NOUN B-O
-have AUX B-O
-been AUX B-O
-critical ADJ B-O
-to ADP B-O
-the DET B-O
-proper ADJ B-O
-reporting VERB B-O
-of ADP B-O
-systematic ADJ B-O
-reviews NOUN B-O
-[ PUNCT B-O
-7,8 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-they PRON B-O
-lack VERB B-O
-specificity NOUN B-O
-for ADP B-O
-reporting VERB B-O
-systematic ADJ B-O
-reviews NOUN B-O
-of ADP B-O
-preclinical ADJ B-O
-research NOUN B-O
-. PUNCT B-O
-
-Differing VERB B-O
-in ADP B-O
-allele NOUN B-O
-frequency NOUN B-O
-across ADP B-O
-three NUM B-O
-population NOUN B-O
-comparisons NOUN B-O
-and CCONJ B-O
-associated VERB B-O
-with ADP B-O
-the DET B-O
-abundance NOUN B-O
-of ADP B-O
-Clostridiales NOUN B-O
-, NOUN B-O
-the DET B-O
-genetic ADJ B-O
-variant NOUN B-O
-rs7587067 NOUN B-O
-has VERB B-O
-a DET B-O
-significantly ADV B-O
-higher ADJ B-O
-frequency NOUN B-O
-in ADP B-O
-African ADJ B-O
-( PUNCT B-O
-minor ADJ B-LF
-allele NOUN I-LF
-frequency NOUN I-LF
-[ X B-O
-MAF PROPN B-AC
-] X B-O
-= PUNCT B-O
-0.802 NUM B-O
-) PUNCT B-O
-versus ADP B-O
-East ADJ B-O
-Asian ADJ B-O
-( PUNCT B-O
-MAF PROPN B-AC
-= PUNCT B-O
-0.190 NUM B-O
-, NOUN B-O
-FST PROPN B-AC
-= PUNCT B-O
-0.54 NUM B-O
-, NOUN B-O
-Chromosome NOUN B-O
-= PUNCT B-O
-98.7 NUM B-O
-% PUNCT B-O
-, NOUN B-O
-Genome NOUN B-O
-- PUNCT B-O
-Wide ADJ B-O
-= PUNCT B-O
-98.9 NUM B-O
-% PUNCT B-O
-) PUNCT B-O
-, NOUN B-O
-admixed ADJ B-O
-American PROPN B-O
-( PUNCT B-O
-MAF PROPN B-AC
-= PUNCT B-O
-0.278 NUM B-O
-, NOUN B-O
-FST PROPN B-AC
-= PUNCT B-O
-0.44 NUM B-O
-, NOUN B-O
-Chromosome NOUN B-O
-= PUNCT B-O
-99.0 NUM B-O
-% PUNCT B-O
-, NOUN B-O
-Genome NOUN B-O
-- PUNCT B-O
-Wide ADJ B-O
-= PUNCT B-O
-99.1 NUM B-O
-% PUNCT B-O
-) PUNCT B-O
-, NOUN B-O
-and CCONJ B-O
-European ADJ B-O
-populations NOUN B-O
-( PUNCT B-O
-MAF PROPN B-AC
-= PUNCT B-O
-0.267 NUM B-O
-, NOUN B-O
-FST PROPN B-AC
-= PUNCT B-O
-0.45 NUM B-O
-, NOUN B-O
-Chromosome NOUN B-O
-= PUNCT B-O
-98.7.3 NUM B-O
-% PUNCT B-O
-, NOUN B-O
-Genome NOUN B-O
-- PUNCT B-O
-Wide ADJ B-O
-= PUNCT B-O
-98.7 NUM B-O
-% PUNCT B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Utilizing VERB B-O
-2 NUM B-O
-bulk ADJ B-O
-RNA-Seq PROPN B-AC
-datasets NOUN B-O
-( PUNCT B-O
-GSE63142 NUM B-O
-and CCONJ B-O
-GSE130499 PROPN B-O
-) PUNCT B-O
-of ADP B-O
-asthma NOUN B-O
-patients NOUN B-O
-compared VERB B-O
-to ADP B-O
-healthy ADJ B-O
-controls NOUN B-O
-, PUNCT B-O
-we PRON B-O
-identified VERB B-O
-that SCONJ B-O
-IRAK3 PROPN B-O
-and CCONJ B-O
-ADRB2 PROPN B-O
-had VERB B-O
-significantly ADV B-O
-elevated VERB B-O
-expression NOUN B-O
-( PUNCT B-O
-false ADJ B-LF
-discovery NOUN I-LF
-rate NOUN I-LF
-[ X B-O
-FDR PROPN B-AC
-] X B-O
-< ADP B-O
-0.05 NUM B-O
-) PUNCT B-O
-in ADP B-O
-asthma NOUN B-O
-patients NOUN B-O
-. PUNCT B-O
-
-As ADP B-O
-a DET B-O
-robust ADJ B-O
-fiduciary ADJ B-O
-marker NOUN B-O
-for ADP B-O
-CCPs PROPN B-AC
-, PUNCT B-O
-clathrin PROPN B-LF
-light PROPN I-LF
-chain NOUN I-LF
-a DET I-LF
-( PUNCT B-O
-CLCa PROPN B-AC
-) PUNCT B-O
-carrying VERB B-O
-an DET B-O
-N NOUN B-O
-- PUNCT B-O
-terminal ADJ B-O
-SNAP PROPN B-O
-- PUNCT B-O
-fusion NOUN B-O
-tag NOUN B-O
-was AUX B-O
-stably ADV B-O
-introduced VERB B-O
-in ADP B-O
-parallel ADJ B-O
-into ADP B-O
-both DET B-O
-cell NOUN B-O
-lines NOUN B-O
-via ADP B-O
-a DET B-O
-lentiviral ADJ B-O
-vector NOUN B-O
-with ADP B-O
-puromycin NOUN B-O
-selection NOUN B-O
-of ADP B-O
-SNAP PROPN B-O
-- PUNCT B-O
-CLCa PROPN B-AC
-expressing VERB B-O
-cells NOUN B-O
-. PUNCT B-O
-
-From ADP B-O
-S6 PROPN B-O
-Fig NOUN B-O
-, PUNCT B-O
-it PRON B-O
-can AUX B-O
-also ADV B-O
-be AUX B-O
-seen VERB B-O
-that SCONJ B-O
-upon SCONJ B-O
-binding VERB B-O
-to ADP B-O
-dabrafenib NOUN B-O
-, PUNCT B-O
-radius NOUN B-LF
-of ADP I-LF
-gyration NOUN I-LF
-value NOUN B-O
-( PUNCT B-O
-Rg PROPN B-AC
-) PUNCT B-O
-significantly ADV B-O
-decreased VERB B-O
-. PUNCT B-O
-
-CHD PROPN B-AC
-, PUNCT B-O
-coronary ADJ B-LF
-heart NOUN I-LF
-disease NOUN I-LF
-; PUNCT B-O
-FMD PROPN B-AC
-, PUNCT B-O
-flow NOUN B-LF
-- PUNCT I-LF
-mediated VERB I-LF
-dilation NOUN I-LF
-; PUNCT B-O
-HCAEC PROPN B-AC
-, PUNCT B-O
-human ADJ B-LF
-coronary ADJ I-LF
-artery NOUN I-LF
-endothelial ADJ I-LF
-cell NOUN I-LF
-; PUNCT B-O
-PCNA PROPN B-O
-, PUNCT B-O
-proliferating VERB B-O
-cell NOUN B-O
-nuclear ADJ B-O
-antigen NOUN B-O
-. PUNCT B-O
-
-Previous ADJ B-O
-connectivity NOUN B-O
-studies NOUN B-O
-using VERB B-O
-EEG PROPN B-AC
-have AUX B-O
-found VERB B-O
-synchronized VERB B-O
-beta NOUN B-O
-frequency NOUN B-O
-oscillations NOUN B-O
-in ADP B-O
-the DET B-O
-basal ADJ B-LF
-ganglia NOUN I-LF
-( PUNCT B-O
-BG PROPN B-AC
-) PUNCT B-O
-including VERB B-O
-cortical ADJ B-O
-- PUNCT B-O
-thalamic ADJ B-O
-, PUNCT B-O
-EGP NOUN B-O
-/ SYM B-O
-IGP NOUN B-O
-- PUNCT B-O
-thalamic ADJ B-O
-, PUNCT B-O
-cortical ADJ B-O
-- PUNCT B-O
-striatal ADJ B-O
-, PUNCT B-O
-striatal ADJ B-O
-- PUNCT B-O
-EGP NOUN B-O
-/ SYM B-O
-IGP NOUN B-O
-and CCONJ B-O
-cortical ADJ B-O
-- PUNCT B-O
-SN NOUN B-O
-pars NOUN B-O
-reticulata NOUN B-O
-connections NOUN B-O
-[ X B-O
-68 NUM B-O
-, PUNCT B-O
-69 NUM B-O
-] PUNCT B-O
-indicating VERB B-O
-increased VERB B-O
-functional ADJ B-O
-coupling NOUN B-O
-between ADP B-O
-these DET B-O
-brain NOUN B-O
-structures NOUN B-O
-in ADP B-O
-6-OHDA PROPN B-AC
-rats NOUN B-O
-. PUNCT B-O
-
-DIC PROPN B-AC
-, PUNCT B-O
-differential ADJ B-LF
-interference NOUN I-LF
-contrast NOUN I-LF
-; PUNCT B-O
-dsRNA PROPN B-AC
-, PUNCT B-O
-double ADJ B-LF
-- PUNCT I-LF
-stranded ADJ I-LF
-RNA NOUN I-LF
-; PUNCT B-O
-GFP PROPN B-AC
-, PUNCT B-O
-green ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-; PUNCT B-O
-Oo NOUN B-O
-, PUNCT B-O
-oocyte NOUN B-O
-; PUNCT B-O
-Sp NOUN B-O
-, PUNCT B-O
-sperm NOUN B-O
-; PUNCT B-O
-RNAi PROPN B-AC
-, PUNCT B-O
-RNA NOUN B-LF
-interference NOUN I-LF
-; PUNCT B-O
-RT PROPN B-AC
-, PUNCT B-O
-Reverse ADJ B-LF
-transcription NOUN I-LF
-polymerase NOUN I-LF
-chain NOUN I-LF
-reaction NOUN I-LF
-. PUNCT B-O
-
-Population NOUN B-O
-density NOUN B-O
-is AUX B-O
-measured VERB B-O
-using VERB B-O
-light NOUN B-O
-scattering NOUN B-O
-( PUNCT B-O
-optical ADJ B-LF
-density NOUN I-LF
-[ PUNCT B-O
-OD PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-drug NOUN B-O
-concentration NOUN B-O
-can AUX B-O
-be AUX B-O
-adjusted VERB B-O
-in ADP B-O
-real ADJ B-O
-time NOUN B-O
-in ADP B-O
-response NOUN B-O
-to ADP B-O
-population NOUN B-O
-dynamics NOUN B-O
-or CCONJ B-O
-predetermined VERB B-O
-protocols NOUN B-O
-( PUNCT B-O
-S1 NUM B-O
-Fig NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Esophageal ADJ B-LF
-adenocarcinoma NOUN I-LF
-( PUNCT B-O
-EAC PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-predominantly ADV B-O
-a DET B-O
-disease NOUN B-O
-of ADP B-O
-the DET B-O
-distal ADJ B-O
-esophagus NOUN B-O
-and CCONJ B-O
-gastroesophageal ADJ B-O
-junction NOUN B-O
-. PUNCT B-O
-
-Atherosclerosis NOUN B-O
-is AUX B-O
-the DET B-O
-major ADJ B-O
-cause NOUN B-O
-for ADP B-O
-developing VERB B-O
-vascular ADJ B-O
-events NOUN B-O
-[ PUNCT B-O
-2,13–18 NUM B-O
-] PUNCT B-O
-including VERB B-O
-ischemic ADJ B-O
-heart NOUN B-O
-disease NOUN B-O
-, PUNCT B-O
-heart NOUN B-O
-failure NOUN B-O
-, PUNCT B-O
-stroke NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-peripheral ADJ B-LF
-arterial ADJ I-LF
-occlusive ADJ I-LF
-disease NOUN I-LF
-( PUNCT B-O
-PAOD PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-A DET B-O
-genetic ADJ B-O
-manipulation NOUN B-O
-study NOUN B-O
-comparing VERB B-O
-double ADJ B-O
-( PUNCT B-O
-apolipoprotein NOUN B-O
-E NOUN B-O
-and CCONJ B-O
-eNOS PROPN B-AC
-) PUNCT B-O
-knockout NOUN B-O
-with ADP B-O
-single ADJ B-O
-( PUNCT B-O
-apolipoprotein NOUN B-O
-E NOUN B-O
-) PUNCT B-O
-knockout NOUN B-O
-model NOUN B-O
-demonstrate VERB B-O
-that SCONJ B-O
-eNOS PROPN B-AC
-deficiency NOUN B-O
-increases VERB B-O
-atherosclerosis NOUN B-O
-in ADP B-O
-Western ADJ B-O
-- PUNCT B-O
-type NOUN B-O
-diet NOUN B-O
-- PUNCT B-O
-fed VERB B-O
-single ADJ B-O
-( PUNCT B-O
-apolipoprotein NOUN B-O
-E NOUN B-O
-) PUNCT B-O
-knockout NOUN B-O
-mice NOUN B-O
-and CCONJ B-O
-introduces VERB B-O
-an DET B-O
-array NOUN B-O
-of ADP B-O
-cardiovascular ADJ B-O
-complications NOUN B-O
-, PUNCT B-O
-including VERB B-O
-myocardial ADJ B-O
-infarction NOUN B-O
-, PUNCT B-O
-heart NOUN B-O
-failure NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-spontaneous ADJ B-O
-aortic ADJ B-O
-aneurysm NOUN B-O
-and CCONJ B-O
-dissection NOUN B-O
-[ PUNCT B-O
-18 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Five NUM B-O
-different ADJ B-O
-tissues NOUN B-O
-and CCONJ B-O
-organs NOUN B-O
-of ADP B-O
-P. NOUN B-O
-tepidariorum NOUN B-O
-– PUNCT B-O
-the DET B-O
-midgut NOUN B-LF
-glands NOUN I-LF
-with ADP I-LF
-midgut NOUN I-LF
-( PUNCT B-O
-MG PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-neuroendocrine ADJ B-LF
-and CCONJ I-LF
-nervous ADJ I-LF
-system NOUN I-LF
-( PUNCT B-O
-NS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-ovaries NOUN B-LF
-( PUNCT B-O
-OV PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-hindgut NOUN B-LF
-( PUNCT B-O
-HG PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-integument NOUN B-LF
-( PUNCT B-O
-INT)–were PROPN B-AC
-used VERB B-O
-for ADP B-O
-the DET B-O
-analysis NOUN B-O
-. PUNCT B-O
-
-SDMA PROPN B-AC
-concentrations NOUN B-O
-were AUX B-O
-determined VERB B-O
-using VERB B-O
-liquid NOUN B-LF
-chromatography NOUN I-LF
-- PUNCT I-LF
-mass NOUN I-LF
-spectroscopy NOUN I-LF
-( PUNCT B-O
-LC-MS PROPN B-AC
-) PUNCT B-O
-as SCONJ B-O
-previously ADV B-O
-described VERB B-O
-[ PUNCT B-O
-6 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-BMI PROPN B-AC
-, PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-; PUNCT B-O
-HR PROPN B-AC
-, PUNCT B-O
-hazard NOUN B-LF
-ratio NOUN I-LF
-; PUNCT B-O
-SD PROPN B-AC
-, PUNCT B-O
-standard ADJ B-LF
-deviation NOUN I-LF
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-RE PROPN B-AC
--ZINB PROPN B-AC
-, PUNCT B-O
-random ADJ B-LF
-- PUNCT I-LF
-effects NOUN I-LF
-zero NUM B-LF
-- PUNCT I-LF
-inflated VERB I-LF
-negative ADJ I-LF
-binomial NOUN I-LF
-; PUNCT B-O
-IRR PROPN B-AC
-, PUNCT B-O
-incidence NOUN B-LF
-rate NOUN I-LF
-ratio NOUN I-LF
-; PUNCT B-O
-CI NOUN B-O
-, PUNCT B-O
-confidence NOUN B-O
-interval NOUN B-O
-; PUNCT B-O
-OR PROPN B-AC
-, PUNCT B-O
-odds NOUN B-LF
-ratio NOUN I-LF
-; PUNCT B-O
-LLIN PROPN B-AC
-, PUNCT B-O
-long ADV B-LF
-- PUNCT I-LF
-lasting VERB I-LF
-insecticidal ADJ I-LF
-bed NOUN I-LF
-net NOUN I-LF
-; PUNCT B-O
-IRS PROPN B-AC
-, PUNCT B-O
-indoor ADJ B-LF
-residual ADJ I-LF
-spraying NOUN I-LF
-. PUNCT B-O
-
-Trajectories NOUN B-O
-of ADP B-O
-HAQ PROPN B-AC
-scores NOUN B-O
-over ADP B-O
-follow NOUN B-O
-- PUNCT B-O
-up NOUN B-O
-were AUX B-O
-assessed VERB B-O
-using VERB B-O
-latent ADJ B-LF
-class NOUN I-LF
-growth NOUN I-LF
-models NOUN I-LF
-( PUNCT B-O
-LCGMs PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-multivariate ADJ B-O
-logistic ADJ B-O
-regression NOUN B-O
-model NOUN B-O
-was AUX B-O
-fit ADJ B-O
-to PART B-O
-determine VERB B-O
-the DET B-O
-association NOUN B-O
-between ADP B-O
-the DET B-O
-patient NOUN B-O
-specific ADJ B-O
-factors NOUN B-O
-and CCONJ B-O
-the DET B-O
-occurrence NOUN B-O
-of ADP B-O
-the DET B-O
-different ADJ B-O
-types NOUN B-O
-of ADP B-O
-DTPs PROPN B-AC
-. PUNCT B-O
-
-Comparison NOUN B-O
-of ADP B-O
-factors NOUN B-O
-contributing VERB B-O
-for ADP B-O
-drug NOUN B-LF
-therapy NOUN I-LF
-problems NOUN I-LF
-were AUX B-O
-shown VERB B-O
-using VERB B-O
-odd ADJ B-O
-ratios NOUN B-O
-. PUNCT B-O
-
-Because SCONJ B-O
-loss NOUN B-O
-of ADP B-O
-CG6866 NOUN B-O
-function NOUN B-O
-de VERB B-O
-- PUNCT B-O
-silences VERB B-O
-both CCONJ B-O
-endogenous ADJ B-O
-silencing NOUN B-O
-and CCONJ B-O
-reporter NOUN B-O
-expression NOUN B-O
-in ADP B-O
-vivo ADV B-O
-( PUNCT B-O
-below ADV B-O
-) PUNCT B-O
-, PUNCT B-O
-we PRON B-O
-named VERB B-O
-the DET B-O
-gene NOUN B-O
-loquacious ADJ B-O
-( PUNCT B-O
-loqs PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-loqs PROPN B-O
-is AUX B-O
-located VERB B-O
-on ADP B-O
-the DET B-O
-left ADJ B-O
-arm NOUN B-O
-of ADP B-O
-Chromosome NOUN B-O
-2 NUM B-O
-at ADP B-O
-polytene NOUN B-O
-band NOUN B-O
-34B9 NUM B-O
-. PUNCT B-O
-
-loqs PROPN B-O
-produces VERB B-O
-at ADP B-O
-least ADV B-O
-three NUM B-O
-different ADJ B-O
-mRNA NOUN B-O
-isoforms NOUN B-O
-through ADP B-O
-alternative ADJ B-O
-splicing NOUN B-O
-( PUNCT B-O
-Figure PROPN B-O
-1B NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-shortest ADJ B-O
-transcript NOUN B-O
-, PUNCT B-O
-loqs PROPN B-O
-RNA NOUN B-LF
-splice NOUN I-LF
-variant NOUN I-LF
-A PROPN I-LF
-( PUNCT B-O
-RA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-encodes VERB B-O
-a DET B-O
-419 NUM B-O
-- PUNCT B-O
-amino NOUN B-O
-- PUNCT B-O
-acid NOUN B-O
-protein NOUN B-O
-, PUNCT B-O
-Loqs PROPN B-O
-protein NOUN B-LF
-isoform NOUN I-LF
-A PROPN I-LF
-( PUNCT B-O
-PA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-with ADP B-O
-a DET B-O
-predicted VERB B-O
-molecular ADJ B-O
-mass NOUN B-O
-of ADP B-O
-45 NUM B-O
-kDa NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-transcript NOUN B-O
-loqs PROPN B-O
-RNA NOUN B-LF
-splice NOUN I-LF
-variant NOUN I-LF
-B PROPN I-LF
-( PUNCT B-O
-RB PROPN B-AC
-) PUNCT B-O
-contains VERB B-O
-one NUM B-O
-additional ADJ B-O
-exon NOUN B-O
-and CCONJ B-O
-encodes VERB B-O
-a DET B-O
-protein NOUN B-O
-of ADP B-O
-465 NUM B-O
-amino NOUN B-O
-acids NOUN B-O
-, PUNCT B-O
-Loqs PROPN B-O
-protein NOUN B-LF
-isoform NOUN I-LF
-B PROPN I-LF
-( PUNCT B-O
-PB PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-with ADP B-O
-a DET B-O
-predicted VERB B-O
-molecular ADJ B-O
-mass NOUN B-O
-of ADP B-O
-50 NUM B-O
-kDa NOUN B-O
-. PUNCT B-O
-
-These DET B-O
-two NUM B-O
-mRNA NOUN B-O
-species NOUN B-O
-were AUX B-O
-identified VERB B-O
-as ADP B-O
-cDNAs NOUN B-O
-in ADP B-O
-the DET B-O
-Drosophila PROPN B-O
-genome NOUN B-O
-sequencing NOUN B-O
-project NOUN B-O
-and CCONJ B-O
-annotated VERB B-O
-in ADP B-O
-FlyBase PROPN B-O
-[ X B-O
-38 NUM B-O
-] X B-O
-among ADP B-O
-the DET B-O
-Drosophila PROPN B-O
-proteins NOUN B-O
-that PRON B-O
-contain VERB B-O
-dsRBDs PROPN B-AC
-. PUNCT B-O
-
-Using VERB B-O
-non ADJ B-O
-- PUNCT B-O
-quantitative ADJ B-O
-RT NOUN B-O
-- PUNCT B-O
-PCR NOUN B-O
-, PUNCT B-O
-we PRON B-O
-detected VERB B-O
-a DET B-O
-third ADJ B-O
-splice NOUN B-O
-variant NOUN B-O
-, PUNCT B-O
-loqs PROPN B-O
-RNA NOUN B-LF
-splice NOUN I-LF
-variant NOUN I-LF
-C PROPN I-LF
-( PUNCT B-O
-RC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-in ADP B-O
-which PRON B-O
-an DET B-O
-alternative ADJ B-O
-splice NOUN B-O
-acceptor NOUN B-O
-site NOUN B-O
-for ADP B-O
-exon NOUN B-O
-4 NUM B-O
-is AUX B-O
-used VERB B-O
-( PUNCT B-O
-Figure PROPN B-O
-1B NUM B-O
-, PUNCT B-O
-C PROPN B-O
-, PUNCT B-O
-and CCONJ B-O
-D NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Use NOUN B-O
-of ADP B-O
-the DET B-O
-alternative ADJ B-O
-splice NOUN B-O
-site NOUN B-O
-creates VERB B-O
-a DET B-O
-5′-extended ADJ B-O
-fourth ADJ B-O
-exon NOUN B-O
-and CCONJ B-O
-changes VERB B-O
-the DET B-O
-reading NOUN B-O
-frame NOUN B-O
-, PUNCT B-O
-resulting VERB B-O
-in ADP B-O
-a DET B-O
-truncated VERB B-O
-protein NOUN B-O
-, PUNCT B-O
-Loqs PROPN B-O
-protein NOUN B-LF
-isoform NOUN I-LF
-C PROPN I-LF
-( PUNCT B-O
-PC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-383 NUM B-O
-amino NOUN B-O
-acids NOUN B-O
-long ADJ B-O
-( PUNCT B-O
-Figure PROPN B-O
-1C NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Loqs PROPN B-O
-PC PROPN B-AC
-has VERB B-O
-a DET B-O
-predicted VERB B-O
-molecular ADJ B-O
-mass NOUN B-O
-of ADP B-O
-41 NUM B-O
-kDa NOUN B-O
-and CCONJ B-O
-lacks VERB B-O
-the DET B-O
-entire ADJ B-O
-third ADJ B-O
-dsRBD PROPN B-AC
-of ADP B-O
-Loqs PROPN B-O
-PA PROPN B-AC
-and CCONJ B-O
-PB PROPN B-AC
-( PUNCT B-O
-Figure PROPN B-O
-1B NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-loqs PROPN B-O
-RA PROPN B-AC
-is AUX B-O
-the DET B-O
-predominant ADJ B-O
-mRNA NOUN B-O
-species NOUN B-O
-in ADP B-O
-dissected ADJ B-O
-testes NOUN B-O
-, PUNCT B-O
-whereas SCONJ B-O
-loqs PROPN B-O
-RB PROPN B-AC
-is AUX B-O
-the DET B-O
-most ADV B-O
-abundant ADJ B-O
-species NOUN B-O
-in ADP B-O
-ovaries NOUN B-O
-. PUNCT B-O
-
-Autotaxin PROPN B-LF
-( PUNCT B-O
-ATX PROPN B-AC
-) PUNCT B-O
-has VERB B-O
-a DET B-O
-profibrotic ADJ B-O
-effect NOUN B-O
-resulting VERB B-O
-from ADP B-O
-lysophosphatidic ADJ B-O
-acid NOUN B-O
-activity NOUN B-O
-. PUNCT B-O
-
-Only ADV B-O
-markers NOUN B-O
-with ADP B-O
-known VERB B-O
-map NOUN B-O
-positions NOUN B-O
-were AUX B-O
-used VERB B-O
-to PART B-O
-perform VERB B-O
-linkage NOUN B-LF
-disequilibrium NOUN I-LF
-( PUNCT B-O
-LD PROPN B-AC
-) PUNCT B-O
-analysis NOUN B-O
-with ADP B-O
-TASSEL PROPN B-O
-3.0 NUM B-O
-[ PUNCT B-O
-37 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Response NOUN B-O
-: PUNCT B-O
-Sucrose NOUN B-O
-in ADP B-O
-full ADJ B-O
-form NOUN B-O
-in ADP B-O
-heading NOUN B-O
-or CCONJ B-O
-subheadings NOUN B-O
-has AUX B-O
-been AUX B-O
-mentioned VERB B-O
-, PUNCT B-O
-and CCONJ B-O
-“ PUNCT B-O
-Determination PROPN B-O
-of ADP B-O
-Chl PROPN B-AC
-Precursors NOUN B-O
-” PUNCT B-O
-has AUX B-O
-been AUX B-O
-replaced VERB B-O
-by ADP B-O
-“ PUNCT B-O
-Determination PROPN B-O
-of ADP B-O
-Chlorophyll PROPN B-LF
-Precursors NOUN B-O
-” PUNCT B-O
-. PUNCT B-O
-
-This DET B-O
-study NOUN B-O
-was AUX B-O
-approved VERB B-O
-by ADP B-O
-the DET B-O
-institutional ADJ B-O
-review NOUN B-O
-boards NOUN B-O
-of ADP B-O
-Kyoto PROPN B-LF
-Prefectural PROPN I-LF
-University PROPN I-LF
-of ADP I-LF
-Medicine PROPN I-LF
-( PUNCT B-O
-KPUM PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-the DET B-O
-National PROPN B-O
-Institute PROPN B-O
-of ADP B-O
-Health PROPN B-O
-Sciences PROPN B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-ITH PROPN B-AC
-( PUNCT B-O
-intra ADJ B-LF
-- PUNCT I-LF
-tumour ADJ I-LF
-heterogeneity NOUN I-LF
-) PUNCT B-O
-, PUNCT B-O
-OC PROPN B-AC
-( PUNCT B-O
-ovarian ADJ B-O
-carcinoma NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-BRCA PROPN B-AC
-( PUNCT B-O
-breast ADJ B-LF
-cancer NOUN I-LF
-invasive ADJ I-LF
-carcinoma NOUN I-LF
-) PUNCT B-O
-. PUNCT B-O
-
-Data NOUN B-O
-are AUX B-O
-available ADJ B-O
-from ADP B-O
-the DET B-O
-Ethical PROPN B-O
-Review PROPN B-O
-Committee PROPN B-O
-and/or CCONJ B-O
-Research PROPN B-O
-Administration PROPN B-O
-of ADP B-O
-International PROPN B-LF
-Centre PROPN I-LF
-for ADP I-LF
-Diarrhoeal PROPN I-LF
-Disease PROPN I-LF
-Research PROPN I-LF
-, X I-LF
-Bangladesh PROPN I-LF
-( PUNCT B-O
-icddr,b PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-researchers NOUN B-O
-who PRON B-O
-meet VERB B-O
-the DET B-O
-criteria NOUN B-O
-for ADP B-O
-access NOUN B-O
-to ADP B-O
-confidential ADJ B-O
-data NOUN B-O
-. PUNCT B-O
-
-Results NOUN B-O
-are AUX B-O
-presented VERB B-O
-as ADP B-O
-adjusted VERB B-LF
-odds NOUN I-LF
-ratios NOUN I-LF
-( PUNCT B-O
-aOR PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-LF
-intervals NOUN I-LF
-( PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-their PRON B-O
-p NOUN B-O
-- PUNCT B-O
-values NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-A X B-O
-) PUNCT B-O
-Gene NOUN B-O
-induction NOUN B-O
-determined VERB B-O
-by ADP B-O
-qRT-PCR PROPN B-AC
-with ADP B-O
-parental ADJ B-O
-( PUNCT B-O
-S2-/- PROPN B-O
-) PUNCT B-O
-and CCONJ B-O
-stably ADV B-O
-STAT2 PROPN B-O
-- PUNCT B-O
-reconstituted VERB B-O
-( PUNCT B-O
-S2 PROPN B-O
-WT PROPN B-AC
-or CCONJ B-O
-S2 PROPN B-O
-L82A NOUN B-O
-) PUNCT B-O
-human ADJ B-O
-U6A PROPN B-O
-cells NOUN B-O
-after ADP B-O
-treatment NOUN B-O
-with ADP B-O
-IFN PROPN B-AC
-- PUNCT B-O
-β PUNCT B-O
-( PUNCT B-O
-500 NUM B-O
-U NOUN B-O
-/ NOUN B-O
-ml NOUN B-O
-) PUNCT B-O
-for ADP B-O
-4 NUM B-O
-h. NOUN B-O
-( PUNCT B-O
-B X B-O
-) PUNCT B-O
-STAT1 PROPN B-O
-- PUNCT B-O
-CFP PROPN B-AC
-and CCONJ B-O
-YFP PROPN B-AC
-- PUNCT B-O
-tagged VERB B-O
-wild ADJ B-LF
-type NOUN I-LF
-( PUNCT B-O
-top ADJ B-O
-panels NOUN B-O
-) PUNCT B-O
-or CCONJ B-O
-L82A NOUN B-O
-mutated VERB B-O
-STAT2 PROPN B-O
-( PUNCT B-O
-bottom ADJ B-O
-panels NOUN B-O
-) PUNCT B-O
-were AUX B-O
-co VERB B-O
-- PUNCT B-O
-expressed VERB B-O
-in ADP B-O
-HeLa PROPN B-O
-cells NOUN B-O
-and CCONJ B-O
-their PRON B-O
-subcellular ADJ B-O
-localization NOUN B-O
-was AUX B-O
-observed VERB B-O
-by ADP B-O
-deconvolution NOUN B-O
-microscopy NOUN B-O
-after ADP B-O
-1 NUM B-O
-h NOUN B-O
-in ADP B-O
-the DET B-O
-presence NOUN B-O
-of ADP B-O
-IFN PROPN B-AC
-- PUNCT B-O
-β PUNCT B-O
-. PUNCT B-O
-
-1Treatments NOUN B-O
-: PUNCT B-O
-CON PROPN B-AC
-= PUNCT B-O
-Piglets NOUN B-O
-drenched VERB B-O
-with ADP B-O
-2 NUM B-O
-mL NOUN B-O
-tap NOUN B-O
-water NOUN B-O
-until ADP B-O
-d NOUN B-O
-7 NUM B-O
-; PUNCT B-O
-T1 NOUN B-O
-= PUNCT B-O
-Piglets NOUN B-O
-drenched VERB B-O
-with ADP B-O
-1 NUM B-O
-g NOUN B-O
-short ADJ B-LF
-- PUNCT I-LF
-chain NOUN I-LF
-fructo NOUN I-LF
-- PUNCT I-LF
-oligosaccharides NOUN I-LF
-( PUNCT B-O
-scFOS PROPN B-AC
-, PUNCT B-O
-Profeed PROPN B-O
-P95 PROPN B-O
-, PUNCT B-O
-Beghin PROPN B-O
-- PUNCT B-O
-Meiji PROPN B-O
-) PUNCT B-O
-dissolved VERB B-O
-in ADP B-O
-2 NUM B-O
-mL NOUN B-O
-tap NOUN B-O
-water NOUN B-O
-until ADP B-O
-d NOUN B-O
-7 NUM B-O
-; PUNCT B-O
-T2 NOUN B-O
-= PUNCT B-O
-Piglets NOUN B-O
-drenched VERB B-O
-with ADP B-O
-1 NUM B-O
-g NOUN B-O
-scFOS PROPN B-AC
-dissolved VERB B-O
-in ADP B-O
-2 NUM B-O
-mL NOUN B-O
-tap NOUN B-O
-water NOUN B-O
-until ADP B-O
-d NOUN B-O
-21.5 NUM B-O
-( PUNCT B-O
-weaning NOUN B-O
-age NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Safety NOUN B-O
-assessments NOUN B-O
-were AUX B-O
-performed VERB B-O
-in ADP B-O
-a DET B-O
-standardized ADJ B-O
-method NOUN B-O
-at ADP B-O
-each DET B-O
-study NOUN B-O
-visit NOUN B-O
-and CCONJ B-O
-included VERB B-O
-the DET B-O
-evaluation NOUN B-O
-of ADP B-O
-adverse ADJ B-LF
-events NOUN I-LF
-( PUNCT B-O
-AEs PROPN B-AC
-): PUNCT B-O
-serious ADJ B-O
-AEs PROPN B-AC
-( PUNCT B-O
-SAEs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-severe ADJ B-O
-AEs PROPN B-AC
-, PUNCT B-O
-treatment NOUN B-O
-- PUNCT B-O
-related VERB B-O
-AEs PROPN B-AC
-, PUNCT B-O
-procedure NOUN B-O
-- PUNCT B-O
-related VERB B-O
-AEs PROPN B-AC
-( PUNCT B-O
-i.e. X B-O
-The DET B-O
-second ADJ B-O
-objective NOUN B-O
-was AUX B-O
-to PART B-O
-evaluate VERB B-O
-the DET B-O
-utility NOUN B-O
-of ADP B-O
-‘ PUNCT B-O
-TB PROPN B-AC
-Transport NOUN B-O
-’ PUNCT B-O
-( PUNCT B-O
-containing VERB B-O
-Trans-Filter PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-‘ PUNCT B-O
-TB PROPN B-AC
-DNA NOUN B-O
-Extraction NOUN B-O
-’ PUNCT B-O
-kits NOUN B-O
-for ADP B-O
-sputum NOUN B-O
-transport NOUN B-O
-, PUNCT B-O
-tuberculosis NOUN B-LF
-M.tuberculosis PROPN B-AC
-DNA NOUN B-O
-isolation NOUN B-O
-and CCONJ B-O
-Mol-DST PROPN B-AC
-assay NOUN B-O
-, PUNCT B-O
-taking VERB B-O
-phenotypic ADJ B-O
-DST NOUN B-O
-as ADP B-O
-the DET B-O
-reference NOUN B-O
-standard NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-here ADV B-O
-show VERB B-O
-that SCONJ B-O
-cell NOUN B-O
-- PUNCT B-O
-type NOUN B-O
-– AUX B-O
-specific ADJ B-O
-reduction NOUN B-O
-of ADP B-O
-cyclin NOUN B-LF
-- PUNCT I-LF
-dependent ADJ I-LF
-kinase NOUN I-LF
-5 NUM I-LF
-( PUNCT B-O
-cdk5 PROPN B-AC
-) PUNCT B-O
-activity NOUN B-O
-in ADP B-O
-newborn ADJ B-O
-neurons NOUN B-O
-results VERB B-O
-in ADP B-O
-impaired VERB B-O
-neuronal ADJ B-O
-migration NOUN B-O
-and CCONJ B-O
-leads VERB B-O
-to ADP B-O
-the DET B-O
-extension NOUN B-O
-of ADP B-O
-incorrectly ADV B-O
-targeted VERB B-O
-neuronal ADJ B-O
-processes NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-addition NOUN B-O
-, PUNCT B-O
-we PRON B-O
-performed VERB B-O
-disuccinimidyl NOUN B-LF
-sulfoxide NOUN I-LF
-( PUNCT B-O
-DSSO PROPN B-AC
-: PUNCT B-O
-a DET B-O
-mass NOUN B-LF
-spectrometry NOUN I-LF
-- PUNCT B-O
-cleavable ADJ B-O
-crosslinker NOUN B-O
-) PUNCT B-O
-crosslinking NOUN B-O
-of ADP B-O
-kindlin-3 NOUN B-O
-monomer NOUN B-O
-and CCONJ B-O
-trimer NOUN B-O
-followed VERB B-O
-by ADP B-O
-analytical ADJ B-O
-gel NOUN B-O
-filtration NOUN B-O
-and CCONJ B-O
-mass NOUN B-LF
-spectrometry NOUN I-LF
-( PUNCT B-O
-MS PROPN B-AC
-) PUNCT B-O
-analysis NOUN B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-ART PROPN B-AC
-, PUNCT B-O
-antiretroviral ADJ B-LF
-therapy NOUN I-LF
-; PUNCT B-O
-CI PROPN B-AC
-, PUNCT B-O
-confidence NOUN B-LF
-interval NOUN I-LF
-; PUNCT B-O
-HAZ PROPN B-AC
-, PUNCT B-O
-WHO PROPN B-AC
-height NOUN B-O
-- PUNCT B-O
-for ADP B-O
-- PUNCT B-O
-age NOUN B-O
-Z NOUN B-O
-- PUNCT B-O
-score NOUN B-O
-; PUNCT B-O
-IQR PROPN B-AC
-, PUNCT B-O
-interquartile ADJ B-LF
-range NOUN I-LF
-; PUNCT B-O
-LTFU PROPN B-AC
-, PUNCT B-O
-loss NOUN B-O
-to PART B-O
-follow VERB B-O
-- PUNCT B-O
-up ADP B-O
-. PUNCT B-O
-
-Since SCONJ B-O
-fructose NOUN B-O
-metabolism NOUN B-O
-is VERB B-O
-insulin NOUN B-O
-- PUNCT B-O
-independent ADJ B-O
-[ PUNCT B-O
-2 X B-O
-] PUNCT B-O
-, PUNCT B-O
-there PRON B-O
-is VERB B-O
-less ADJ B-O
-uptake NOUN B-O
-and CCONJ B-O
-catabolism NOUN B-O
-of ADP B-O
-triglyceride NOUN B-LF
-( PUNCT B-O
-TG)-rich PROPN B-AC
-lipoproteins NOUN B-O
-by ADP B-O
-tissues NOUN B-O
-, PUNCT B-O
-ultimately ADV B-O
-resulting VERB B-O
-in ADP B-O
-increased VERB B-O
-postprandial ADJ B-O
-plasma NOUN B-O
-TG PROPN B-AC
-levels NOUN B-O
-[ PUNCT B-O
-8 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-CONSORT PROPN B-AC
-has AUX B-O
-been AUX B-O
-endorsed VERB B-O
-by ADP B-O
-the DET B-O
-World PROPN B-LF
-Association PROPN I-LF
-of ADP I-LF
-Medical PROPN I-LF
-Editors PROPN I-LF
-( PUNCT B-O
-WAME PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-International PROPN B-LF
-Committee PROPN I-LF
-of ADP I-LF
-Medical PROPN I-LF
-Journal PROPN I-LF
-Editors PROPN I-LF
-( PUNCT B-O
-ICMJE PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-Council PROPN B-LF
-of ADP I-LF
-Science PROPN I-LF
-Editors PROPN I-LF
-( PUNCT B-O
-CSE PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Currently ADV B-O
-, PUNCT B-O
-however ADV B-O
-, PUNCT B-O
-the DET B-O
-CONSORT PROPN B-AC
-Statement PROPN B-O
-provides VERB B-O
-limited ADJ B-O
-guidance NOUN B-O
-about ADP B-O
-preparing VERB B-O
-abstracts NOUN B-O
-and CCONJ B-O
-, PUNCT B-O
-while SCONJ B-O
-it PRON B-O
-encourages VERB B-O
-the DET B-O
-use NOUN B-O
-of ADP B-O
-a DET B-O
-structured ADJ B-O
-format NOUN B-O
-, PUNCT B-O
-this PRON B-O
-is AUX B-O
-not PART B-O
-a DET B-O
-formal ADJ B-O
-requirement NOUN B-O
-. PUNCT B-O
-
-To PART B-O
-correlate VERB B-O
-responsiveness NOUN B-O
-of ADP B-O
-ccRCC PROPN B-AC
-cell NOUN B-O
-lines NOUN B-O
-to ADP B-O
-established VERB B-O
-forms NOUN B-O
-of ADP B-O
-treatments NOUN B-O
-with ADP B-O
-extent NOUN B-O
-of ADP B-O
-genomic ADJ B-O
-aberrations NOUN B-O
-, PUNCT B-O
-we PRON B-O
-analyzed VERB B-O
-a DET B-O
-subset NOUN B-O
-of ADP B-O
-malignant ADJ B-O
-clear ADJ B-O
-cell NOUN B-O
-renal ADJ B-O
-cell NOUN B-O
-lines NOUN B-O
-, PUNCT B-O
-via ADP B-O
-The DET B-LF
-Cancer PROPN I-LF
-Genome PROPN I-LF
-Atlas PROPN I-LF
-( PUNCT B-O
-TCGA PROPN B-AC
-: PUNCT B-O
-[ X B-O
-28 NUM B-O
-, PUNCT B-O
-29 NUM B-O
-] PUNCT B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Data NOUN B-O
-are AUX B-O
-means NOUN B-O
-± SYM B-O
-s.d NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-* PUNCT B-O
-p NOUN B-O
-= X B-O
-0.06 NUM B-O
-, PUNCT B-O
-* PUNCT B-O
-* PUNCT B-O
-p NOUN B-O
-= X B-O
-0.0012 NUM B-O
-, PUNCT B-O
-* PUNCT B-O
-* PUNCT B-O
-* PUNCT B-O
-p NOUN B-O
-= X B-O
-0.0005 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-β PUNCT B-O
-- PUNCT B-O
-Galactosidase NOUN B-O
-( PUNCT B-O
-puc-lacZ PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-purple ADJ B-O
-; PUNCT B-O
-Ptc PROPN B-AC
-, PUNCT B-O
-green NOUN B-O
-; PUNCT B-O
-DAPI NOUN B-O
-, PUNCT B-O
-turquoise NOUN B-O
-; PUNCT B-O
-En PROPN B-AC
-, PUNCT B-O
-red NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-A NOUN B-O
-– PUNCT B-O
-C PROPN B-O
-) PUNCT B-O
-( PUNCT B-O
-right ADJ B-O
-panels NOUN B-O
-) PUNCT B-O
-Scheme NOUN B-O
-of ADP B-O
-the DET B-O
-phenotype NOUN B-O
-and CCONJ B-O
-expression NOUN B-O
-patterns NOUN B-O
-of ADP B-O
-Wg PROPN B-AC
-and CCONJ B-O
-En PROPN B-AC
-; PUNCT B-O
-PS PROPN B-AC
-is AUX B-O
-for ADP B-O
-parasegment NOUN B-LF
-boundary NOUN B-O
-and CCONJ B-O
-S PROPN B-O
-for ADP B-O
-segment NOUN B-O
-boundary NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-D X B-O
-) PUNCT B-O
-Model NOUN B-O
-of ADP B-O
-JNK PROPN B-O
-induced VERB B-O
-reprogramming NOUN B-O
-at ADP B-O
-the DET B-O
-segment NOUN B-O
-boundary NOUN B-O
-and CCONJ B-O
-Wg PROPN B-AC
-inhibition NOUN B-O
-at ADP B-O
-the DET B-O
-parasegment NOUN B-LF
-boundary NOUN B-O
-. PUNCT B-O
-
-More ADV B-O
-recently ADV B-O
-, PUNCT B-O
-several ADJ B-O
-PCP PROPN B-AC
-pathway NOUN B-O
-components NOUN B-O
-, PUNCT B-O
-like ADP B-O
-the DET B-O
-Wnt NOUN B-O
-receptor NOUN B-O
-Frizzled PROPN B-LF
-( PUNCT B-O
-Fz PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Flamingo PROPN B-LF
-( PUNCT B-O
-Fmi PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Strabismus PROPN B-O
-( PUNCT B-O
-Stbm PROPN B-O
-or CCONJ B-O
-Vang PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-Dsh PROPN B-AC
-, PUNCT B-O
-have AUX B-O
-been AUX B-O
-shown VERB B-O
-to PART B-O
-play VERB B-O
-a DET B-O
-role NOUN B-O
-in ADP B-O
-the DET B-O
-correct ADJ B-O
-targeting NOUN B-O
-and CCONJ B-O
-bifurcation NOUN B-O
-of ADP B-O
-MB PROPN B-AC
-axons NOUN B-O
-[ PUNCT B-O
-4],[30],[31 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Error NOUN B-O
-bars NOUN B-O
-denote VERB B-O
-standard ADJ B-LF
-errors NOUN I-LF
-of ADP I-LF
-means NOUN I-LF
-( PUNCT B-O
-SEM PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Underlying VERB B-O
-data NOUN B-O
-can AUX B-O
-be AUX B-O
-found VERB B-O
-in ADP B-O
-S1 PROPN B-O
-Data PROPN B-O
-. PUNCT B-O
-
-Thus ADV B-O
-, PUNCT B-O
-we PRON B-O
-here ADV B-O
-decided VERB B-O
-to PART B-O
-perform VERB B-O
-all DET B-O
-reactions NOUN B-O
-in ADP B-O
-DMSO NOUN B-O
-- PUNCT B-O
-free ADJ B-O
-aqueous ADJ B-O
-buffers NOUN B-O
-using VERB B-O
-N NOUN B-LF
-, PUNCT I-LF
-N NOUN I-LF
-, PUNCT I-LF
-N’,N’,N”-pentamethyldiethylenetriamine NOUN I-LF
-( PUNCT B-O
-PMDETA PROPN B-AC
-) PUNCT B-O
-as ADP B-O
-a DET B-O
-Cu NOUN B-O
-( PUNCT B-O
-I NOUN B-O
-) PUNCT B-O
-stabilizing VERB B-O
-agent NOUN B-O
-for ADP B-O
-the DET B-O
-conjugation NOUN B-O
-of ADP B-O
-the DET B-O
-RNA NOUN B-O
-aptamer NOUN B-O
-Gint4.T PROPN B-O
-to PART B-O
-MP PROPN B-AC
-. PUNCT B-O
-
-The DET B-O
-advantage NOUN B-O
-of ADP B-O
-PMDETA PROPN B-AC
-is AUX B-O
-its PRON B-O
-water NOUN B-O
-solubility NOUN B-O
-and CCONJ B-O
-ease NOUN B-O
-to PART B-O
-separate VERB B-O
-from ADP B-O
-the DET B-O
-reaction NOUN B-O
-mixture NOUN B-O
-upon SCONJ B-O
-purification NOUN B-O
-of ADP B-O
-the DET B-O
-conjugate NOUN B-O
-[ PUNCT B-O
-27 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Human ADJ B-LF
-papillomavirus NOUN I-LF
-( PUNCT B-O
-HPV PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-the DET B-O
-name NOUN B-O
-of ADP B-O
-a DET B-O
-group NOUN B-O
-of ADP B-O
-viruses NOUN B-O
-that PRON B-O
-includes VERB B-O
-more ADJ B-O
-than ADP B-O
-100 NUM B-O
-different ADJ B-O
-strains NOUN B-O
-or CCONJ B-O
-types NOUN B-O
-; PUNCT B-O
-more ADJ B-O
-than ADP B-O
-30 NUM B-O
-of ADP B-O
-these DET B-O
-viruses NOUN B-O
-are AUX B-O
-sexually ADV B-O
-transmitted VERB B-O
-. PUNCT B-O
-
-From ADP B-O
-those DET B-O
-predictive ADJ B-O
-models NOUN B-O
-the DET B-O
-performance NOUN B-O
-( PUNCT B-O
-i.e. X B-O
-, PUNCT B-O
-ROCAUC PROPN B-AC
-; PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-LF
-interval NOUN I-LF
-, PUNCT B-O
-CI PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-classifying VERB B-O
-the DET B-O
-input NOUN B-O
-phenotypic ADJ B-O
-groups NOUN B-O
-( PUNCT B-O
-e.g. X B-O
-, PUNCT B-O
-cases NOUN B-O
-versus ADP B-O
-controls NOUN B-O
-) PUNCT B-O
-are AUX B-O
-provided VERB B-O
-. PUNCT B-O
-
-Flow NOUN B-O
-cytometry NOUN B-O
-analysis NOUN B-O
-of ADP B-O
-uterine ADJ B-O
-implantation NOUN B-O
-sites NOUN B-O
-following VERB B-O
-removal NOUN B-O
-of ADP B-O
-the DET B-O
-placenta NOUN B-O
-/ SYM B-O
-embryo NOUN B-O
-demonstrated VERB B-O
-that SCONJ B-O
-the DET B-O
-percentage NOUN B-O
-of ADP B-O
-BM PROPN B-AC
-- NOUN B-O
-derived VERB B-O
-GFP+ PROPN B-AC
-cells NOUN B-O
-in ADP B-O
-the DET B-O
-implantation NOUN B-O
-site NOUN B-O
-increased VERB B-O
-as SCONJ B-O
-pregnancy NOUN B-O
-progressed VERB B-O
-to ADP B-O
-mid NOUN B-O
-- NOUN B-O
-gestation NOUN B-O
-; PUNCT B-O
-it PRON B-O
-increased VERB B-O
-significantly ADV B-O
-on ADP B-O
-the DET B-O
-day NOUN B-O
-of ADP B-O
-implantation NOUN B-O
-( PUNCT B-O
-E5.5 NUM B-O
-) PUNCT B-O
-( PUNCT B-O
-15.8 NUM B-O
-% NOUN B-O
-) PUNCT B-O
-as SCONJ B-O
-compared VERB B-O
-with ADP B-O
-the DET B-O
-nonpregnant ADJ B-O
-state NOUN B-O
-( PUNCT B-O
-9.2 NUM B-O
-% NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-peaking VERB B-O
-on ADP B-O
-E9.5 NUM B-O
-( PUNCT B-O
-24.1 NUM B-O
-% NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-followed VERB B-O
-by ADP B-O
-a DET B-O
-gradual ADJ B-O
-decrease NOUN B-O
-on ADP B-O
-E13.5 NUM B-O
-( PUNCT B-O
-16.7 NUM B-O
-% NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-peripartum NOUN B-O
-( PUNCT B-O
-E17.5 NUM B-O
-) PUNCT B-O
-( PUNCT B-O
-13.1 NUM B-O
-% NOUN B-O
-) PUNCT B-O
-( PUNCT B-O
-Fig NOUN B-O
-1D NUM B-O
-and CCONJ B-O
-1F NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-As SCONJ B-O
-the DET B-O
-observed VERB B-O
-increase NOUN B-O
-in ADP B-O
-GFP+ PROPN B-AC
-cells NOUN B-O
-in ADP B-O
-the DET B-O
-decidua NOUN B-O
-during ADP B-O
-pregnancy NOUN B-O
-could AUX B-O
-be AUX B-O
-due ADJ B-O
-to ADP B-O
-local ADJ B-O
-proliferation NOUN B-O
-of ADP B-O
-BMDCs PROPN B-AC
-and CCONJ B-O
-not PART B-O
-only ADV B-O
-to ADP B-O
-increased VERB B-O
-recruitment NOUN B-O
-, PUNCT B-O
-we PRON B-O
-assessed VERB B-O
-cell NOUN B-O
-proliferation NOUN B-O
-using VERB B-O
-proliferating VERB B-LF
-cell NOUN I-LF
-nuclear ADJ I-LF
-antigen NOUN I-LF
-( PUNCT B-O
-PCNA PROPN B-AC
-) PUNCT B-O
-staining NOUN B-O
-. PUNCT B-O
-
-To PART B-O
-characterize VERB B-O
-its PRON B-O
-carbohydrate NOUN B-O
-utilization NOUN B-O
-capabilities NOUN B-O
-, PUNCT B-O
-we PRON B-O
-defined VERB B-O
-its PRON B-O
-growth NOUN B-O
-in ADP B-O
-minimal ADJ B-LF
-medium NOUN I-LF
-( PUNCT B-O
-MM PROPN B-AC
-) PUNCT B-O
-supplemented VERB B-O
-with ADP B-O
-one NUM B-O
-of ADP B-O
-46 NUM B-O
-different ADJ B-O
-carbohydrates NOUN B-O
-[ PUNCT B-O
-25 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Col-0 PROPN B-AC
-, PUNCT B-O
-Columbia-0 PROPN B-LF
-; PUNCT B-O
-CTL1 PROPN B-AC
-, PUNCT B-O
-choline NOUN B-LF
-transporter NOUN I-LF
-- PUNCT I-LF
-like ADJ I-LF
-1 NUM I-LF
-; PUNCT B-O
-GFP PROPN B-AC
-, PUNCT B-O
-green ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-; PUNCT B-O
-FM4 PROPN B-AC
-, PUNCT B-O
-N-(3 NOUN B-LF
-- PUNCT I-LF
-Triethylammoniumpropyl)-4-(6-(4-(diethylamino)phenyl)hexatrienyl)pyridinium NOUN I-LF
-dibromide NOUN I-LF
-; PUNCT B-O
--64NRAMP1 PROPN B-AC
-, PUNCT B-O
-natural ADJ B-LF
-resistance NOUN I-LF
-- PUNCT I-LF
-associated VERB I-LF
-macrophage NOUN I-LF
-protein NOUN I-LF
-1 NUM I-LF
-; PUNCT B-O
-PDCB PROPN B-AC
-, PUNCT B-O
-plasmodesmata NOUN B-LF
-callose NOUN I-LF
-- PUNCT I-LF
-binding VERB I-LF
-protein NOUN I-LF
-; PUNCT B-O
-sic1 PROPN B-AC
-, PUNCT B-O
-significant ADJ B-LF
-ionome NOUN I-LF
-changes NOUN I-LF
-1 NUM I-LF
-. PUNCT B-O
-
-Line NOUN B-O
-156 NUM B-O
-: PUNCT B-O
-‘ PUNCT B-O
-Clustering VERB B-O
-bootstrapping NOUN B-O
-was AUX B-O
-performed VERB B-O
-to PART B-O
-evaluate VERB B-O
-the DET B-O
-significance NOUN B-O
-of ADP B-O
-patient NOUN B-O
-- NOUN B-O
-specific ADJ B-O
-clusters NOUN B-O
-using VERB B-O
-the DET B-O
-pvclust NOUN B-O
-R NOUN B-O
-package NOUN B-O
-( PUNCT B-O
-1000 NUM B-O
-repetitions NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-significance NOUN B-O
-were AUX B-O
-estimated VERB B-O
-by ADP B-O
-Approximately ADV B-LF
-Unbiased ADJ I-LF
-( PUNCT B-O
-AU PROPN B-AC
-) PUNCT B-O
-p NOUN B-O
-- NOUN B-O
-values NOUN B-O
-: PUNCT B-O
-Clusters NOUN B-O
-were AUX B-O
-considered VERB B-O
-significant ADJ B-O
-for ADP B-O
-AU PROPN B-AC
-values NOUN B-O
-≥95 NUM B-O
-, PUNCT B-O
-which PRON B-O
-indicates VERB B-O
-a DET B-O
-significance NOUN B-O
-p NOUN B-O
-- NOUN B-O
-value NOUN B-O
-≤0.05 NUM B-O
-[ PUNCT B-O
-30 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-’ PUNCT B-O
-B X B-O
-, PUNCT B-O
-Anti ADJ B-O
-- ADJ B-O
-FXIII PROPN B-AC
-autoantibody NOUN B-O
-levels NOUN B-O
-measured VERB B-O
-using VERB B-O
-ICT PROPN B-AC
-( PUNCT B-O
-arbitrary ADJ B-LF
-unit NOUN I-LF
-; PUNCT B-O
-AU PROPN B-AC
-) PUNCT B-O
-as SCONJ B-O
-described VERB B-O
-in ADP B-O
-“ PUNCT B-O
-Materials PROPN B-O
-and CCONJ B-O
-Methods PROPN B-O
-” PUNCT B-O
-in ADP B-O
-reference NOUN B-O
-allele NOUN B-O
-( PUNCT B-O
-T NOUN B-O
-/ SYM B-O
-T NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-heterozygous ADJ B-O
-allele NOUN B-O
-( PUNCT B-O
-T NOUN B-O
-/ SYM B-O
-C NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-homozygous ADJ B-O
-allele NOUN B-O
-( PUNCT B-O
-C NOUN B-O
-/ SYM B-O
-C NOUN B-O
-) PUNCT B-O
-at ADP B-O
-chromosome NOUN B-O
-6 NUM B-O
-; PUNCT B-O
-32363816 NUM B-O
-in ADP B-O
-BTNL2 NOUN B-O
-( PUNCT B-O
-rs2076530 NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Moreover ADV B-O
-, PUNCT B-O
-Tau PROPN B-O
-, PUNCT B-O
-which PRON B-O
-is AUX B-O
-also ADV B-O
-known VERB B-O
-as ADP B-O
-microtubule NOUN B-LF
-- PUNCT I-LF
-associated VERB I-LF
-protein NOUN I-LF
-tau NOUN I-LF
-( PUNCT B-O
-Mapt PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-is AUX B-O
-abundant ADJ B-O
-in ADP B-O
-neurons NOUN B-O
-and CCONJ B-O
-plays VERB B-O
-a DET B-O
-critical ADJ B-O
-role NOUN B-O
-in ADP B-O
-neurodegenerative ADJ B-O
-diseases NOUN B-O
-. PUNCT B-O
-
-HDN PROPN B-AC
-, PUNCT B-O
-human NOUN B-LF
-- PUNCT I-LF
-baited VERB I-LF
-double ADJ I-LF
-net NOUN I-LF
-trap NOUN B-O
-; PUNCT B-O
-HLC PROPN B-AC
-, PUNCT B-O
-human NOUN B-O
-landing NOUN B-O
-catch NOUN B-O
-method NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-therapeutic ADJ B-O
-strategies NOUN B-O
-for ADP B-O
-RA PROPN B-AC
-have AUX B-O
-developed VERB B-O
-remarkably ADV B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-treat VERB B-LF
-- PUNCT I-LF
-to PART I-LF
-- PUNCT I-LF
-target NOUN I-LF
-( PUNCT B-O
-T2 PROPN B-AC
-) PUNCT B-O
-strategy NOUN B-O
-described VERB B-O
-in ADP B-O
-the DET B-O
-European PROPN B-LF
-League PROPN I-LF
-Against ADP I-LF
-Rheumatism PROPN I-LF
-( PUNCT B-O
-TEULAR PROPN B-AC
-) PUNCT B-O
-recommendations NOUN B-O
-is AUX B-O
-to PART B-O
-aim VERB B-O
-for ADP B-O
-remission NOUN B-O
-or CCONJ B-O
-low ADJ B-LF
-disease NOUN I-LF
-activity NOUN I-LF
-( PUNCT B-O
-LDA PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Fluid NOUN B-LF
-- PUNCT I-LF
-attenuated VERB I-LF
-inversion NOUN I-LF
-recovery NOUN I-LF
-( PUNCT B-O
-FLAIR PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-the DET B-O
-principle ADJ B-O
-imaging NOUN B-O
-sequence NOUN B-O
-for ADP B-O
-assessment NOUN B-O
-of ADP B-O
-growth NOUN B-O
-of ADP B-O
-low ADJ B-O
-- PUNCT B-O
-grade NOUN B-O
-gliomas NOUN B-O
-[ PUNCT B-O
-4 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-the DET B-O
-present ADJ B-O
-study NOUN B-O
-, PUNCT B-O
-by ADP B-O
-generating VERB B-O
-new ADJ B-O
-recombinant ADJ B-O
-chromosomes NOUN B-LF
-, PUNCT B-O
-we PRON B-O
-have AUX B-O
-been AUX B-O
-able ADJ B-O
-to PART B-O
-locate VERB B-O
-the DET B-O
-genetic ADJ B-O
-element NOUN B-O
-responsible ADJ B-O
-for ADP B-O
-Psmb9 NOUN B-O
-activity NOUN B-O
-within ADP B-O
-6.7 NUM B-O
-Mb NOUN B-O
-on ADP B-O
-Chr PROPN B-AC
-17 NUM B-O
-. PUNCT B-O
-
-We PRON B-O
-found VERB B-O
-that SCONJ B-O
-each DET B-O
-point NOUN B-O
-increase NOUN B-O
-in ADP B-O
-QFPC PROPN B-AC
-, PUNCT B-O
-including VERB B-O
-increasing VERB B-O
-quality NOUN B-O
-of ADP B-O
-counselling NOUN B-O
-, PUNCT B-O
-is AUX B-O
-associated VERB B-O
-with ADP B-O
-higher ADJ B-O
-odds NOUN B-O
-of ADP B-O
-clients NOUN B-O
-selecting VERB B-O
-an DET B-O
-intrauterine ADJ B-LF
-device NOUN I-LF
-( PUNCT B-O
-IUD PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-aRR:1.03 PROPN B-AC
-; PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI:1.01–1.05 PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-sterilization NOUN B-O
-( PUNCT B-O
-aRR:1.06 PROPN B-AC
-; PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI:1.03–1.08 PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-compared VERB B-O
-to ADP B-O
-no DET B-O
-method NOUN B-O
-selected VERB B-O
-. PUNCT B-O
-
-The DET B-O
-aim NOUN B-O
-of ADP B-O
-the DET B-O
-present ADJ B-O
-study NOUN B-O
-was AUX B-O
-to PART B-O
-investigate VERB B-O
-the DET B-O
-association NOUN B-O
-between ADP B-O
-the DET B-O
-functional ADJ B-O
-ITPA PROPN B-AC
-variants NOUN B-O
-and CCONJ B-O
-hematological ADJ B-O
-side NOUN B-O
-effects NOUN B-O
-during ADP B-O
-antiviral ADJ B-O
-therapy NOUN B-O
-with ADP B-O
-pegylated ADJ B-LF
-interferon NOUN I-LF
-( PUNCT B-O
-PegIFN PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-RBV PROPN B-AC
-. PUNCT B-O
-
-Ressing PROPN B-O
-, PUNCT B-O
-Leiden PROPN B-O
-University PROPN B-O
-Medical PROPN B-O
-Center PROPN B-O
-, PUNCT B-O
-the DET B-O
-Netherlands PROPN B-O
-[ PUNCT B-O
-35 NUM B-O
-] PUNCT B-O
-) PUNCT B-O
-were AUX B-O
-cultured VERB B-O
-in ADP B-O
-Roswell PROPN B-LF
-Park PROPN I-LF
-Memorial PROPN I-LF
-Institute PROPN I-LF
-( PUNCT B-O
-RPMI PROPN B-AC
-) PUNCT B-O
-medium NOUN B-O
-( PUNCT B-O
-Gibco PROPN B-O
-) PUNCT B-O
-supplemented VERB B-O
-with ADP B-O
-10 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-v NOUN B-O
-/ SYM B-O
-v NOUN B-O
-) PUNCT B-O
-FBS PROPN B-AC
-, PUNCT B-O
-2 NUM B-O
-mM PROPN B-O
-GlutaMAX PROPN B-O
-, PUNCT B-O
-1 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-v NOUN B-O
-/ SYM B-O
-v NOUN B-O
-) PUNCT B-O
-Pen PROPN B-O
-- PUNCT B-O
-Strep PROPN B-O
-, PUNCT B-O
-and CCONJ B-O
-0.3 NUM B-O
-mg NOUN B-O
-/ SYM B-O
-mL NOUN B-O
-hygromycin NOUN B-O
-B. NOUN B-O
-A DET B-O
-new ADJ B-O
-release NOUN B-O
-of ADP B-O
-XPDF PROPN B-AC
-( PUNCT B-O
-a DET B-LF
-PDF NOUN I-LF
-viewer NOUN I-LF
-for ADP I-LF
-X PROPN I-LF
-; PUNCT B-O
-http://www.foolabs.com/xpdf/ X B-O
-) PUNCT B-O
-eases VERB B-O
-this DET B-O
-problem NOUN B-O
-considerably ADV B-O
-( PUNCT B-O
-see VERB B-O
-Materials PROPN B-O
-and CCONJ B-O
-Methods PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-rodent NOUN B-O
-models NOUN B-O
-of ADP B-O
-chronic ADJ B-O
-inflammatory ADJ B-O
-and CCONJ B-O
-neuropathic ADJ B-O
-pain NOUN B-O
-, PUNCT B-O
-there PRON B-O
-is VERB B-O
-a DET B-O
-male NOUN B-O
-- PUNCT B-O
-specific ADJ B-O
-activation NOUN B-O
-of ADP B-O
-microglial ADJ B-O
-signaling NOUN B-O
-in ADP B-O
-the DET B-O
-spinal ADJ B-O
-cord NOUN B-O
-, PUNCT B-O
-which PRON B-O
-includes VERB B-O
-the DET B-O
-up NOUN B-O
-- PUNCT B-O
-regulation NOUN B-O
-of ADP B-O
-P2X4 NOUN B-O
-receptors NOUN B-O
-[ PUNCT B-O
-38 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-phosphorylation NOUN B-O
-of ADP B-O
-p38−mitogen NOUN B-O
-- PUNCT I-LF
-activated VERB I-LF
-protein NOUN I-LF
-kinase NOUN I-LF
-( PUNCT B-O
-MAPK PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-39 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-subsequent ADJ B-O
-synthesis NOUN B-O
-and CCONJ B-O
-release NOUN B-O
-of ADP B-O
-BDNF PROPN B-AC
-[ PUNCT B-O
-20 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-This DET B-O
-newly ADV B-O
-evolved VERB B-O
-cell NOUN B-O
-type NOUN B-O
-is AUX B-O
-rigidly ADV B-O
-specified VERB B-O
-early ADV B-O
-in ADP B-O
-development NOUN B-O
-through ADP B-O
-the DET B-O
-activity NOUN B-O
-of ADP B-O
-localized VERB B-O
-maternal ADJ B-O
-factors NOUN B-O
-and CCONJ B-O
-deploys VERB B-O
-a DET B-O
-well ADV B-O
-- PUNCT B-O
-characterized VERB B-O
-gene NOUN B-LF
-regulatory ADJ I-LF
-network NOUN I-LF
-( PUNCT B-O
-GRN PROPN B-AC
-) PUNCT B-O
-that PRON B-O
-controls VERB B-O
-the DET B-O
-morphogenetic ADJ B-O
-behaviors NOUN B-O
-and CCONJ B-O
-biomineral NOUN B-O
-- PUNCT B-O
-forming VERB B-O
-properties NOUN B-O
-of ADP B-O
-PMCs PROPN B-AC
-[ X B-O
-1–3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Calreticulin NOUN B-LF
-( PUNCT B-O
-CRT PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-a DET B-O
-multifunctional ADJ B-O
-stress NOUN B-O
-- PUNCT B-O
-response NOUN B-O
-chaperone NOUN B-O
-residing VERB B-O
-mainly ADV B-O
-in ADP B-O
-the DET B-O
-lumen NOUN B-O
-of ADP B-O
-the DET B-O
-endoplasmic ADJ B-LF
-reticulum NOUN I-LF
-( PUNCT B-O
-ER PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-cell NOUN B-O
-with ADP B-O
-the DET B-O
-ability NOUN B-O
-to PART B-O
-control VERB B-O
-proper ADJ B-O
-protein NOUN B-O
-folding NOUN B-O
-and CCONJ B-O
-regulate VERB B-O
-cellular ADJ B-O
-adhesion NOUN B-O
-[ PUNCT B-O
-1–6 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-We PRON B-O
-have AUX B-O
-previously ADV B-O
-reported VERB B-O
-that SCONJ B-O
-the DET B-O
-structure NOUN B-O
-and CCONJ B-O
-composition NOUN B-O
-of ADP B-O
-HF PROPN B-AC
-- PUNCT B-O
-released VERB B-O
-secondary ADJ B-LF
-cell NOUN I-LF
-wall NOUN I-LF
-polysaccharides NOUN I-LF
-( PUNCT B-O
-HF PROPN B-AC
-) PUNCT B-O
-from ADP B-O
-Ba PROPN B-O
-vegetative ADJ B-O
-cells NOUN B-O
-are AUX B-O
-not PART B-O
-dependent ADJ B-O
-on ADP B-O
-plasmid NOUN B-O
-content NOUN B-O
-[ X B-O
-11 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-are AUX B-O
-specific ADJ B-O
-for ADP B-O
-Ba PROPN B-O
-and CCONJ B-O
-antigenic ADJ B-O
-[ X B-O
-12–14 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-PDCD10 PROPN B-AC
-complexes NOUN B-O
-with ADP B-O
-CCM1 PROPN B-O
-( PUNCT B-O
-Krev PROPN B-LF
-/ SYM I-LF
-Rap1 PROPN I-LF
-Interacting PROPN I-LF
-Trapped PROPN I-LF
-1 NUM I-LF
-[ PUNCT B-O
-KRIT1 PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-and CCONJ B-O
-CCM2 PROPN B-O
-( PUNCT B-O
-osmosensing VERB B-LF
-scaffold NOUN I-LF
-for ADP I-LF
-mitogen NOUN I-LF
-- PUNCT I-LF
-activated VERB I-LF
-protein NOUN I-LF
-kinase NOUN I-LF
-kinase NOUN I-LF
-kinase-3 NOUN I-LF
-[ PUNCT B-O
-OSM PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-to PART B-O
-control VERB B-O
-the DET B-O
-onset NOUN B-O
-of ADP B-O
-a DET B-O
-detrimental ADJ B-O
-disease NOUN B-O
-named VERB B-O
-CCM PROPN B-AC
-. PUNCT B-O
-
-CCM PROPN B-AC
-is AUX B-O
-characterized VERB B-O
-by ADP B-O
-vascular ADJ B-O
-lesions NOUN B-O
-in ADP B-O
-the DET B-O
-central ADJ B-O
-nervous ADJ B-O
-system NOUN B-O
-[ PUNCT B-O
-14 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-Simes PROPN B-O
-multiple ADJ B-O
-- NOUN B-O
-test NOUN B-O
-procedure NOUN B-O
-was AUX B-O
-used VERB B-O
-for ADP B-O
-controlling VERB B-O
-the DET B-O
-false ADJ B-LF
-discovery NOUN I-LF
-rate NOUN I-LF
-( PUNCT B-O
-FDR PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-SNP PROPN B-AC
-rs848 NUM B-O
-in ADP B-O
-the DET B-O
-IL13 NUM B-O
-gene NOUN B-O
-region NOUN B-O
-( PUNCT B-O
-IL5 NOUN B-O
-/ SYM B-O
-RAD50 NOUN B-O
-/ SYM B-O
-IL13 NUM B-O
-/ SYM B-O
-IL4 NUM B-O
-) PUNCT B-O
-was AUX B-O
-associated VERB B-O
-with ADP B-O
-STS PROPN B-AC
-( PUNCT B-O
-TG NOUN B-O
-/ SYM B-O
-GG NOUN B-O
-vs ADP B-O
-TT PROPN B-O
-genotype NOUN B-O
-: PUNCT B-O
-uncorrected ADJ B-O
-p NOUN B-O
-- NOUN B-O
-value NOUN B-O
-= SYM B-O
-0.00006 NUM B-O
-, PUNCT B-O
-FDR PROPN B-AC
-- NOUN B-O
-corrected VERB B-O
-p NOUN B-O
-- NOUN B-O
-value NOUN B-O
-= SYM B-O
-0.04 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-whereas SCONJ B-O
-rs20541 NOUN B-O
-in ADP B-O
-the DET B-O
-same ADJ B-O
-gene NOUN B-O
-region NOUN B-O
-, PUNCT B-O
-in ADP B-O
-linkage NOUN B-O
-disequilibrium NOUN B-O
-with ADP B-O
-rs848 NUM B-O
-( PUNCT B-O
-r2 NOUN B-O
-= SYM B-O
-0.94 NUM B-O
-) PUNCT B-O
-in ADP B-O
-our PRON B-O
-sample NOUN B-O
-, PUNCT B-O
-did AUX B-O
-not PART B-O
-reach VERB B-O
-the DET B-O
-statistical ADJ B-O
-significance NOUN B-O
-after ADP B-O
-adjusting VERB B-O
-for ADP B-O
-multiple ADJ B-O
-testing NOUN B-O
-( PUNCT B-O
-TC NOUN B-O
-/ SYM B-O
-CC NOUN B-O
-vs ADP B-O
-TT PROPN B-O
-: PUNCT B-O
-uncorrected ADJ B-O
-p NOUN B-O
-- NOUN B-O
-value NOUN B-O
-= SYM B-O
-0.0003 NUM B-O
-, PUNCT B-O
-FDR PROPN B-AC
-- NOUN B-O
-corrected VERB B-O
-p NOUN B-O
-- NOUN B-O
-value NOUN B-O
-= SYM B-O
-0.09 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Eukaryotic ADJ B-O
-genomes NOUN B-O
-contain VERB B-O
-large ADJ B-O
-quantities NOUN B-O
-of ADP B-O
-transposable ADJ B-LF
-elements NOUN I-LF
-( PUNCT B-O
-TEs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-short ADJ B-O
-self NOUN B-O
-- PUNCT B-O
-replicating VERB B-O
-DNA NOUN B-O
-sequences NOUN B-O
-that PRON B-O
-can AUX B-O
-move VERB B-O
-within ADP B-O
-the DET B-O
-genome NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-addition NOUN B-O
-, PUNCT B-O
-criteria NOUN B-O
-aPL PROPN B-AC
-( PUNCT B-O
-aCL PROPN B-AC
-and CCONJ B-O
-aβ2-GPI PROPN B-AC
-IgG NOUN B-O
-and CCONJ B-O
-IgM NOUN B-O
-) PUNCT B-O
-were AUX B-O
-determined VERB B-O
-with SCONJ B-O
-four NUM B-O
-well ADV B-O
-- PUNCT B-O
-established VERB B-O
-immunoassay NOUN B-O
-systems NOUN B-O
-in ADP B-O
-all PRON B-O
-included VERB B-O
-sera NOUN B-O
-: PUNCT B-O
-ALE PROPN B-AC
-, PUNCT B-O
-ACU PROPN B-AC
-, PUNCT B-O
-UniCAP PROPN B-LF
-250 NUM I-LF
-( PUNCT B-O
-UNI PROPN B-AC
-) PUNCT B-O
-from ADP B-O
-Thermo PROPN B-O
-Fisher PROPN B-O
-Scientific PROPN B-O
-( PUNCT B-O
-Freiburg PROPN B-O
-, PUNCT B-O
-Germany PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-AESKULISA PROPN B-LF
-( PUNCT B-O
-AES PROPN B-AC
-) PUNCT B-O
-from ADP B-O
-Aesku.diagnostics PROPN B-O
-( PUNCT B-O
-Wendelsheim PROPN B-O
-, PUNCT B-O
-Germany PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-First ADV B-O
-, PUNCT B-O
-during ADP B-O
-data NOUN B-O
-preprocessing NOUN B-O
-, PUNCT B-O
-we PRON B-O
-removed VERB B-O
-oculomotor NOUN B-O
-artefacts NOUN B-O
-via ADP B-O
-independent ADJ B-LF
-component NOUN I-LF
-analysis NOUN I-LF
-( PUNCT B-O
-ICA PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-see VERB B-O
-S1 PROPN B-O
-Text NOUN B-O
-) PUNCT B-O
-; PUNCT B-O
-second X B-O
-, PUNCT B-O
-we PRON B-O
-have AUX B-O
-only ADV B-O
-reported VERB B-O
-data NOUN B-O
-in ADP B-O
-this DET B-O
-paper NOUN B-O
-from ADP B-O
-two NUM B-O
-channels NOUN B-O
-near ADP B-O
-the DET B-O
-vertex NOUN B-O
-— PUNCT B-O
-C3 NOUN B-O
-and CCONJ B-O
-C4 NOUN B-O
-, PUNCT B-O
-which PRON B-O
-show VERB B-O
-the DET B-O
-least ADJ B-O
-contamination NOUN B-O
-by ADP B-O
-muscle NOUN B-O
-and CCONJ B-O
-motion NOUN B-O
-artefacts NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-See VERB B-O
-S5 PROPN B-O
-and CCONJ B-O
-S6 PROPN B-O
-Figs NOUN B-O
-for ADP B-O
-comparable ADJ B-O
-plots NOUN B-O
-of ADP B-O
-anterior ADJ B-O
-and CCONJ B-O
-posterior ADJ B-O
-midline NOUN B-O
-groups NOUN B-O
-. PUNCT B-O
-
-) PUNCT B-O
-Third X B-O
-, PUNCT B-O
-the DET B-O
-cross ADJ B-O
-- NOUN B-O
-correlation NOUN B-O
-analysis NOUN B-O
-across ADP B-O
-different ADJ B-O
-frequencies NOUN B-O
-( PUNCT B-O
-Fig NOUN B-O
-2A NUM B-O
-) PUNCT B-O
-indicated VERB B-O
-that SCONJ B-O
-relationships NOUN B-O
-were AUX B-O
-specific ADJ B-O
-to ADP B-O
-the DET B-O
-theta NOUN B-O
-band NOUN B-O
-. PUNCT B-O
-
-Prostate ADJ B-LF
-- PUNCT I-LF
-Specific ADJ I-LF
-Antigen NOUN I-LF
-( PUNCT I-LF
-PSA PROPN I-LF
-In ADP B-O
-principle NOUN B-O
-, PUNCT B-O
-it PRON B-O
-can AUX B-O
-occur VERB B-O
-via ADP B-O
-any DET B-O
-1 NUM B-O
-of ADP B-O
-3 NUM B-O
-mechanisms NOUN B-O
-of ADP B-O
-homologous ADJ B-LF
-recombination NOUN I-LF
-( PUNCT B-O
-HR PROPN B-AC
-): PUNCT B-O
-canonical ADJ B-O
-DSB PROPN B-LF
-repair NOUN I-LF
-DSB PROPN B-AC
-( PUNCT B-O
-DSBR PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-synthesis NOUN B-LF
-- PUNCT I-LF
-dependent ADJ I-LF
-strand NOUN I-LF
-annealing NOUN I-LF
-( PUNCT B-O
-SDSA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-break NOUN B-LF
-- PUNCT I-LF
-induced VERB I-LF
-replication NOUN I-LF
-( PUNCT B-O
-BIR PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-reviewed VERB B-O
-in ADP B-O
-[ X B-O
-21,22 NUM B-O
-] PUNCT B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Coverage NOUN B-O
-estimates NOUN B-O
-are AUX B-O
-generally ADV B-O
-obtained VERB B-O
-from ADP B-O
-routine ADJ B-O
-population NOUN B-O
-- PUNCT B-O
-based VERB B-O
-household NOUN B-O
-surveys NOUN B-O
-, PUNCT B-O
-such ADJ B-O
-as ADP B-O
-the DET B-O
-Demographic PROPN B-O
-and CCONJ B-O
-Health PROPN B-O
-Surveys PROPN B-O
-( PUNCT B-O
-DHS PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-the DET B-O
-Multiple PROPN B-LF
-Indicator PROPN I-LF
-Cluster PROPN I-LF
-Surveys PROPN I-LF
-( PUNCT B-O
-MICS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-primarily ADV B-O
-through ADP B-O
-self NOUN B-O
-- PUNCT B-O
-reporting NOUN B-O
-[ PUNCT B-O
-3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-We PRON B-O
-named VERB B-O
-these PRON B-O
-long ADJ B-O
-expressed VERB B-LF
-noncoding NOUN I-LF
-regions NOUN I-LF
-( PUNCT B-O
-ENORs PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-clinical ADJ B-O
-implication NOUN B-O
-of ADP B-O
-AF PROPN B-AC
-is AUX B-O
-that SCONJ B-O
-it PRON B-O
-is AUX B-O
-associated VERB B-O
-with ADP B-O
-an DET B-O
-increased VERB B-O
-risk NOUN B-O
-of ADP B-O
-stroke NOUN B-O
-, PUNCT B-O
-heart NOUN B-LF
-failure NOUN I-LF
-( PUNCT B-O
-HF PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-myocardial ADJ B-LF
-infarction NOUN I-LF
-( PUNCT B-O
-MI PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-death NOUN B-O
-[ X B-O
-2,4 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-primary ADJ B-O
-endpoint NOUN B-O
-was AUX B-O
-clinical ADJ B-O
-benefit NOUN B-O
-( PUNCT B-O
-defined VERB B-O
-as ADP B-O
-stable ADJ B-LF
-disease NOUN I-LF
-[ PUNCT B-O
-SD PROPN B-AC
-] PUNCT B-O
-for ADP B-O
-≥6 NUM B-O
-mo NOUN B-O
-, PUNCT B-O
-partial ADJ B-LF
-response NOUN I-LF
-[ PUNCT B-O
-PR PROPN B-AC
-] PUNCT B-O
-, PUNCT B-O
-or CCONJ B-O
-complete ADJ B-LF
-response NOUN I-LF
-[ PUNCT B-O
-CR PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-. PUNCT B-O
-
-True ADJ B-LF
-skill NOUN I-LF
-statistic NOUN I-LF
-( PUNCT B-O
-TSS PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-used VERB B-O
-as ADP B-O
-a DET B-O
-measure NOUN B-O
-of ADP B-O
-the DET B-O
-model NOUN B-O
-quality NOUN B-O
-, PUNCT B-O
-since SCONJ B-O
-it PRON B-O
-was AUX B-O
-a DET B-O
-default ADJ B-O
-measure NOUN B-O
-in ADP B-O
-BIOMOD PROPN B-O
-2.1.37 NUM B-O
-[ PUNCT B-O
-52 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-A DET B-O
-971 NUM B-O
-- PUNCT B-O
-bp PROPN B-AC
-probe NOUN B-O
-revealed VERB B-O
-DNA NOUN B-O
-rearrangements NOUN B-O
-, PUNCT B-O
-refining VERB B-O
-the DET B-O
-breakpoint NOUN B-O
-to ADP B-O
-a DET B-O
-4.7 NUM B-O
-- PUNCT B-O
-kilobase NOUN B-LF
-( PUNCT B-O
-kb PROPN B-AC
-) PUNCT B-O
-interval NOUN B-O
-on ADP B-O
-the DET B-O
-Celera PROPN B-O
-scaffold NOUN B-O
-sequence NOUN B-O
-or CCONJ B-O
-a DET B-O
-4.0 NUM B-O
-- PUNCT B-O
-kb PROPN B-AC
-interval NOUN B-O
-corresponding VERB B-O
-to ADP B-O
-nucleotides NOUN B-O
-57269–61233 NUM B-O
-of ADP B-O
-BAC PROPN B-AC
-AC117479 NUM B-O
-( PUNCT B-O
-Figure NOUN B-O
-1B NUM B-O
-and CCONJ B-O
-1D NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Surprisingly ADV B-O
-, PUNCT B-O
-the DET B-O
-translocation NOUN B-O
-breakpoint NOUN B-O
-localized VERB B-O
-within ADP B-O
-the DET B-O
-ortholog NOUN B-O
-of ADP B-O
-the DET B-O
-Drosophila PROPN B-O
-roundabout NOUN B-O
-( PUNCT B-O
-robo NOUN B-O
-) PUNCT B-O
-gene NOUN B-O
-, PUNCT B-O
-ROBO1 NOUN B-O
-, PUNCT B-O
-alternatively ADV B-O
-spliced VERB B-O
-and CCONJ B-O
-also ADV B-O
-named VERB B-O
-DUTT1 PROPN B-O
-( PUNCT B-O
-Deleted VERB B-O
-in ADP B-O
-U PROPN B-O
-Twenty PROPN B-O
-Twenty PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-disrupts VERB B-O
-ROBO1 NOUN B-O
-between ADP B-O
-exons NOUN B-O
-1 NUM B-O
-and CCONJ B-O
-2 NUM B-O
-. PUNCT B-O
-
-Known VERB B-O
-risk NOUN B-O
-factors NOUN B-O
-for ADP B-O
-mild ADJ B-O
-CI PROPN B-AC
-include VERB B-O
-increased VERB B-O
-age NOUN B-O
-and CCONJ B-O
-genetic ADJ B-O
-susceptibility NOUN B-O
-[ X B-O
-1 NUM B-O
-, PUNCT B-O
-17 NUM B-O
-] X B-O
-while SCONJ B-O
-cardiovascular ADJ B-O
-disease NOUN B-O
-( PUNCT B-O
-high ADJ B-O
-blood NOUN B-O
-pressure NOUN B-O
-and CCONJ B-O
-stroke NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-diabetes NOUN B-O
-, PUNCT B-O
-depression NOUN B-O
-/ SYM B-O
-anxiety NOUN B-O
-, PUNCT B-O
-tobacco NOUN B-O
-smoking NOUN B-O
-and CCONJ B-O
-social ADJ B-O
-factors NOUN B-O
-( PUNCT B-O
-e.g. X B-O
-, PUNCT B-O
-lack NOUN B-O
-of ADP B-O
-relationships NOUN B-O
-with ADP B-O
-others NOUN B-O
-and CCONJ B-O
-a DET B-O
-community NOUN B-O
-, PUNCT B-O
-lack NOUN B-O
-of ADP B-O
-physical ADJ B-O
-activity NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-low ADJ B-O
-socio ADJ B-LF
-- ADJ I-LF
-economic ADJ I-LF
-status NOUN I-LF
-( PUNCT B-O
-SES PROPN B-AC
-) PUNCT B-O
-) PUNCT B-O
-[ X B-O
-1 NUM B-O
-, PUNCT B-O
-17 NUM B-O
-, PUNCT B-O
-18 NUM B-O
-] X B-O
-are AUX B-O
-reported VERB B-O
-as ADP B-O
-possible ADJ B-O
-risk NOUN B-O
-factors NOUN B-O
-. PUNCT B-O
-
-DN PROPN B-AC
-, PUNCT B-O
-dominant NOUN B-LF
-- PUNCT I-LF
-negative ADJ I-LF
-; PUNCT B-O
-EC PROPN B-AC
-, PUNCT B-O
-endothelial ADJ B-LF
-cell NOUN I-LF
-; PUNCT B-O
-GFP PROPN B-AC
-, PUNCT B-O
-green ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-; PUNCT B-O
-hpf PROPN B-AC
-, PUNCT B-O
-hours NOUN B-LF
-post ADP I-LF
-fertilization NOUN I-LF
-; PUNCT B-O
-HS PROPN B-AC
-, PUNCT B-O
-heat NOUN B-LF
-shock NOUN I-LF
-; PUNCT B-O
-HSPC PROPN B-AC
-, PUNCT B-O
-hematopoietic ADJ B-LF
-stem NOUN I-LF
-and CCONJ I-LF
-progenitor NOUN I-LF
-cell NOUN I-LF
-; PUNCT B-O
-NICD PROPN B-AC
-, PUNCT B-O
-Notch PROPN B-LF
-intracellular ADJ I-LF
-domain NOUN I-LF
-; PUNCT B-O
-n.s NOUN B-O
-. PUNCT B-O
-
-, PUNCT B-O
-nonsignificant ADJ B-O
-; PUNCT B-O
-qRT PROPN B-AC
-, PUNCT B-O
-quantitative ADJ B-LF
-reverse ADJ I-LF
-- PUNCT I-LF
-transcription ADJ I-LF
-PCR NOUN I-LF
-; PUNCT B-O
-WB PROPN B-O
-, PUNCT B-O
-western ADJ B-O
-blot NOUN B-O
-; PUNCT B-O
--PCRWISH PROPN B-AC
-, PUNCT B-O
-whole ADJ B-LF
-- PUNCT I-LF
-mount NOUN I-LF
-in ADP I-LF
-situ NOUN I-LF
-hybridization NOUN I-LF
-When SCONJ B-O
-we PRON B-O
-assessed VERB B-O
-the DET B-O
-presence NOUN B-O
-of ADP B-O
-inflammation NOUN B-O
-in ADP B-O
-the DET B-O
-CNS PROPN B-AC
-of ADP B-O
-Nlrx1−/− PROPN B-O
-2D2 PROPN B-O
-spEAE PROPN B-AC
-mice NOUN B-O
-, PUNCT B-O
-we PRON B-O
-found VERB B-O
-that SCONJ B-O
-the DET B-O
-lack NOUN B-O
-of ADP B-O
-NLRX1 PROPN B-AC
-did AUX B-O
-not PART B-O
-affect VERB B-O
-the DET B-O
-expression NOUN B-O
-of ADP B-O
-glial ADJ B-LF
-fibrillary NOUN I-LF
-acidic ADJ I-LF
-protein NOUN I-LF
-( PUNCT B-O
-GFAP PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-ionized VERB B-LF
-calcium NOUN I-LF
-binding VERB I-LF
-adaptor NOUN I-LF
-molecule NOUN I-LF
-1(Iba1 PROPN I-LF
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-myelin NOUN B-LF
-basic ADJ I-LF
-protein NOUN I-LF
-( PUNCT B-O
-MBP PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-spinal ADJ B-O
-cords NOUN B-O
-of ADP B-O
-healthy ADJ B-O
-Nlrx1−/− PROPN B-O
-2D2 PROPN B-O
-mice NOUN B-O
-( PUNCT B-O
-S1A PROPN B-O
-Fig PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Our PRON B-O
-method NOUN B-O
-was AUX B-O
-highly ADV B-O
-predictive ADJ B-O
-of ADP B-O
-transcription NOUN B-LF
-start NOUN I-LF
-sites NOUN I-LF
-( PUNCT B-O
-TSSs PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-S. PROPN B-O
-cerevisiae NOUN B-O
-[ X B-O
-50]—the X B-O
-NFR PROPN B-O
-boundary NOUN B-O
-closest ADJ B-O
-to PART B-O
-the DET B-O
-5′ NUM B-O
-end NOUN B-O
-of ADP B-O
-the DET B-O
-gene NOUN B-O
-was AUX B-O
-able ADJ B-O
-to PART B-O
-predict VERB B-O
-84 NUM B-O
-% NOUN B-O
-of ADP B-O
-TSSs PROPN B-AC
-within ADP B-O
-50 NUM B-O
-bp NOUN B-O
-. PUNCT B-O
-
-Several ADJ B-O
-lines NOUN B-O
-of ADP B-O
-evidence NOUN B-O
-suggest VERB B-O
-that SCONJ B-O
-histone NOUN B-O
-variants NOUN B-O
-and CCONJ B-O
-their PRON B-O
-covalent ADJ B-O
-post ADJ B-LF
-- ADJ I-LF
-translational ADJ I-LF
-modifications NOUN I-LF
-( PUNCT B-O
-PTMs PROPN B-AC
-) PUNCT B-O
-play VERB B-O
-a DET B-O
-key ADJ B-O
-role NOUN B-O
-in ADP B-O
-developmental ADJ B-O
-processes NOUN B-O
-such ADJ B-O
-as ADP B-O
-the DET B-O
-initiation NOUN B-O
-and CCONJ B-O
-maintenance NOUN B-O
-of ADP B-O
-pericentric ADJ B-O
-heterochromatin NOUN B-O
-, PUNCT B-O
-X NOUN B-O
-chromosome NOUN B-O
-inactivation NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-germ NOUN B-O
-cell NOUN B-O
-differentiation NOUN B-O
-[ PUNCT B-O
-4 NUM B-O
-, PUNCT B-O
-11 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Regarding VERB B-O
-the DET B-O
-biological ADJ B-O
-aspect NOUN B-O
-, PUNCT B-O
-carbon NOUN B-O
-ion NOUN B-O
-beams NOUN B-O
-have VERB B-O
-an DET B-O
-estimated VERB B-O
-2–3 NUM B-O
-- NOUN B-O
-fold ADJ B-O
-higher ADJ B-O
-relative ADJ B-LF
-biological ADJ I-LF
-effectiveness NOUN I-LF
-( PUNCT B-O
-RBE PROPN B-AC
-) PUNCT B-O
-than ADP B-O
-X NOUN B-O
-- NOUN B-O
-rays NOUN B-O
-[ PUNCT B-O
-8 NUM B-O
-, PUNCT B-O
-9 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-order NOUN B-O
-to PART B-O
-determine VERB B-O
-the DET B-O
-mechanical ADJ B-O
-properties NOUN B-O
-of ADP B-O
-the DET B-O
-bone NOUN B-O
-material NOUN B-O
-, PUNCT B-O
-the DET B-O
-fourth ADJ B-O
-caudal ADJ B-O
-vertebrae NOUN B-O
-of ADP B-O
-6 NUM B-O
-medaka NOUN B-O
-( PUNCT B-O
-3 NUM B-O
-controls NOUN B-O
-and CCONJ B-O
-3 NUM B-O
-swim NOUN B-O
-- PUNCT B-O
-trained VERB B-O
-fish NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-6 NUM B-O
-zebrafish NOUN B-O
-( PUNCT B-O
-3 NUM B-O
-controls NOUN B-O
-and CCONJ B-O
-3 NUM B-O
-swim NOUN B-O
-- PUNCT B-O
-trained VERB B-O
-fish NOUN B-O
-) PUNCT B-O
-were AUX B-O
-dehydrated VERB B-O
-with ADP B-O
-increasing VERB B-O
-concentrations NOUN B-O
-of ADP B-O
-ethanol NOUN B-O
-and CCONJ B-O
-embedded VERB B-O
-for ADP B-O
-8 NUM B-O
-hours NOUN B-O
-in ADP B-O
-polymethylmethacrylate NOUN B-LF
-( PUNCT B-O
-PMMA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-was AUX B-O
-polymerized VERB B-O
-in ADP B-O
-an DET B-O
-oven NOUN B-O
-at ADP B-O
-60 NUM B-O
-° NOUN B-O
-C NOUN B-O
-. PUNCT B-O
-
-As SCONJ B-O
-earlier ADV B-O
-reported VERB B-O
-, PUNCT B-O
-Ace PROPN B-AC
-protein NOUN B-O
-had AUX B-O
-been AUX B-O
-modelled VERB B-O
-using VERB B-O
-a DET B-O
-template NOUN B-O
-structure NOUN B-O
-, PUNCT B-O
-zhaoermiatoxin NOUN B-O
-from ADP B-O
-Zhaoermia PROPN B-O
-mangshanensis NOUN B-O
-[ PUNCT B-O
-Protein PROPN B-LF
-Data PROPN I-LF
-Bank PROPN I-LF
-( PUNCT B-O
-PDB PROPN B-AC
-) NOUN B-O
-entry NOUN B-O
-2PH4 NOUN B-O
-] PUNCT B-O
-, PUNCT B-O
-a DET B-O
-dimeric ADJ B-O
-toxin NOUN B-O
-which PRON B-O
-showed VERB B-O
-reasonable ADJ B-O
-sequence NOUN B-O
-similarity NOUN B-O
-( PUNCT B-O
-45 NUM B-O
-% NOUN B-O
-) NOUN B-O
-with ADP B-O
-the DET B-O
-target NOUN B-O
-[ PUNCT B-O
-7 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Both DET B-O
-trials NOUN B-O
-recruited VERB B-O
-postally ADV B-O
-from ADP B-O
-primary ADJ B-O
-care NOUN B-O
-and CCONJ B-O
-delivered VERB B-O
-12 NUM B-O
-- PUNCT B-O
-week NOUN B-O
-pedometer NOUN B-O
-- PUNCT B-O
-based VERB B-O
-walking NOUN B-O
-interventions NOUN B-O
-incorporating VERB B-O
-behaviour NOUN B-LF
-change NOUN I-LF
-techniques NOUN I-LF
-( PUNCT B-O
-BCTs PROPN B-AC
-) PUNCT B-O
-through ADP B-O
-dedicated ADJ B-O
-practice NOUN B-O
-nurse NOUN B-O
-PA PROPN B-AC
-consultations NOUN B-O
-( PUNCT B-O
-3 NUM B-O
-in ADP B-O
-PACE PROPN B-AC
-, PUNCT B-O
-4 NUM B-O
-in ADP B-O
--UPPACE PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
-by ADP B-O
-post NOUN B-O
-( PUNCT B-O
--LiftPACE PROPN B-AC
-only ADV B-O
-) PUNCT B-O
-. PUNCT B-O
-
-DAS28-ESR PROPN B-AC
-, PUNCT B-O
-Disease PROPN B-LF
-Activity PROPN I-LF
-Score–28 NUM I-LF
-with ADP I-LF
-erythrocyte NOUN I-LF
-sedimentation NOUN I-LF
-rate NOUN I-LF
-; PUNCT B-O
-Early ADJ B-O
-, PUNCT B-O
-early ADJ B-O
-treatment NOUN B-O
-; PUNCT B-O
-HAQ PROPN B-AC
-, PUNCT B-O
-Health PROPN B-LF
-Assessment PROPN I-LF
-Questionnaire NOUN I-LF
-; PUNCT B-O
-NSAID PROPN B-O
-, PUNCT B-O
-nonsteroidal ADJ B-O
-anti ADJ B-O
-- PUNCT B-O
-inflammatory ADJ B-O
-drug NOUN B-O
-; PUNCT B-O
-MTX PROPN B-O
-, PUNCT B-O
-methotrexate NOUN B-O
-; PUNCT B-O
-noMTX PROPN B-O
-, PUNCT B-O
-no DET B-O
-methotrexate NOUN B-O
-; PUNCT B-O
-RA PROPN B-AC
-, PUNCT B-O
-rheumatoid ADJ B-LF
-arthritis NOUN I-LF
-; PUNCT B-O
-SDFR PROPN B-AC
-, PUNCT B-O
-sustained VERB B-LF
-DMARD NOUN I-LF
-- PUNCT I-LF
-DMARD PROPN B-AC
-free ADJ I-LF
-remission NOUN I-LF
-; PUNCT B-O
-T2 PROPN B-O
-T PROPN B-O
-, PUNCT B-O
-treat VERB B-O
-- PUNCT B-O
-to ADP B-O
-- PUNCT B-O
-target NOUN B-O
-. PUNCT B-O
-
-Behavioral ADJ B-O
-factors NOUN B-O
-defined VERB B-O
-by ADP B-O
-the DET B-O
-Kenya PROPN B-O
-PrEP PROPN B-AC
-guidelines NOUN B-O
-to PART B-O
-indicate VERB B-O
-a DET B-O
-substantial ADJ B-O
-ongoing ADJ B-O
-risk NOUN B-O
-of ADP B-O
-acquiring VERB B-O
-HIV PROPN B-O
-include VERB B-O
-the DET B-O
-following VERB B-O
-: PUNCT B-O
-( PUNCT B-O
-a DET B-O
-) PUNCT B-O
-inconsistent ADJ B-O
-or CCONJ B-O
-no PRON B-O
-condom NOUN B-O
-use NOUN B-O
-in ADP B-O
-the DET B-O
-last ADJ B-O
-6 NUM B-O
-months NOUN B-O
-; PUNCT B-O
-( PUNCT B-O
-b X B-O
-) PUNCT B-O
-having VERB B-O
-a DET B-O
-high ADJ B-O
-- PUNCT B-O
-risk NOUN B-O
-sex NOUN B-O
-partner(s NOUN B-O
-) PUNCT B-O
-of ADP B-O
-unknown ADJ B-O
-HIV PROPN B-O
-status NOUN B-O
-; PUNCT B-O
-( PUNCT B-O
-c X B-O
-) PUNCT B-O
-engaging VERB B-O
-in ADP B-O
-transactional ADJ B-O
-sex NOUN B-O
-; PUNCT B-O
-( PUNCT B-O
-d X B-O
-) PUNCT B-O
-history NOUN B-O
-of ADP B-O
-ongoing ADJ B-O
-intimate ADJ B-LF
-partner NOUN I-LF
-violence NOUN I-LF
-( PUNCT B-O
-IPV PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-gender NOUN B-LF
-- PUNCT I-LF
-based VERB I-LF
-violence NOUN I-LF
-( PUNCT B-O
-GBV PROPN B-AC
-) PUNCT B-O
-; PUNCT B-O
-( PUNCT B-O
-e X B-O
-) PUNCT B-O
-recent ADJ B-O
-bacterial ADJ B-O
-STIs PROPN B-AC
-, PUNCT B-O
-self NOUN B-O
-- PUNCT B-O
-reported VERB B-O
-or CCONJ B-O
-etiologically ADV B-O
-diagnosed VERB B-O
-; PUNCT B-O
-( PUNCT B-O
-f X B-O
-) PUNCT B-O
-recurrent ADJ B-O
-use NOUN B-O
-of ADP B-O
-postexposure ADJ B-O
-prophylaxis NOUN B-O
-; PUNCT B-O
-( PUNCT B-O
-g X B-O
-) PUNCT B-O
-recurrent ADJ B-O
-sex NOUN B-O
-under ADP B-O
-the DET B-O
-influence NOUN B-O
-of ADP B-O
-alcohol NOUN B-O
-and/or CCONJ B-O
-recreational ADJ B-O
-drugs NOUN B-O
-; PUNCT B-O
-( PUNCT B-O
-h X B-O
-) PUNCT B-O
-injection NOUN B-O
-drug NOUN B-O
-use NOUN B-O
-with ADP B-O
-shared VERB B-O
-needles NOUN B-O
-and/or CCONJ B-O
-syringes NOUN B-O
-; PUNCT B-O
-and CCONJ B-O
-( PUNCT B-O
-i X B-O
-) PUNCT B-O
-having VERB B-O
-an DET B-O
-HIV PROPN B-O
-- PUNCT B-O
-positive ADJ B-O
-partner NOUN B-O
-[ PUNCT B-O
-9 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-One NUM B-O
-recent ADJ B-O
-study NOUN B-O
-found VERB B-O
-that SCONJ B-O
-healthy ADJ B-O
-lifestyle NOUN B-O
-profiles NOUN B-O
-were AUX B-O
-associated VERB B-O
-with ADP B-O
-lower ADJ B-O
-risks NOUN B-O
-of ADP B-O
-dementia NOUN B-O
-only ADV B-O
-among ADP B-O
-apolipoprotein NOUN B-LF
-E PROPN I-LF
-( PUNCT B-O
-APOE PROPN B-AC
-) PUNCT B-O
-ε4 NUM B-O
-noncarriers NOUN B-O
-, PUNCT B-O
-but CCONJ B-O
-not PART B-O
-among ADP B-O
-carriers NOUN B-O
-. PUNCT B-O
-
-HIV PROPN B-AC
-/ SYM B-O
-AIDS PROPN B-AC
-predisposes VERB B-O
-for ADP B-O
-Mycobacterium NOUN B-O
-tuberculosis NOUN B-LF
-( PUNCT B-O
-MTB NOUN B-O
-) PUNCT B-O
-infection NOUN B-O
-and CCONJ B-O
-increases VERB B-O
-the DET B-O
-rate NOUN B-O
-of ADP B-O
-recurrent ADJ B-O
-TB PROPN B-AC
-as ADP B-O
-well ADV B-O
-as ADP B-O
-of ADP B-O
-rapid ADJ B-O
-progress NOUN B-O
-to ADP B-O
-active ADJ B-O
-TB PROPN B-AC
-among ADP B-O
-individuals NOUN B-O
-with ADP B-O
-recently ADV B-O
-acquired VERB B-O
-infection NOUN B-O
-[ PUNCT B-O
-2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-These DET B-O
-properties NOUN B-O
-of ADP B-O
-the DET B-O
-IVs PROPN B-AC
-are AUX B-O
-discussed VERB B-O
-in ADP B-O
-more ADJ B-O
-detail NOUN B-O
-in ADP B-O
-the DET B-O
-section NOUN B-O
-, PUNCT B-O
-Assumptions NOUN B-O
-and CCONJ B-O
-Limitations NOUN B-O
-of ADP B-O
-Instrumental ADJ B-LF
-Variables NOUN I-LF
-in ADP B-O
-Text PROPN B-O
-S1 NUM B-O
-. PUNCT B-O
-
-CDS PROPN B-AC
-, PUNCT B-O
-coding NOUN B-LF
-sequence NOUN I-LF
-; PUNCT B-O
-TE PROPN B-AC
-, PUNCT B-O
-transposable ADJ B-LF
-element NOUN I-LF
-. PUNCT B-O
-
-On ADP B-O
-exposure NOUN B-O
-to ADP B-O
-stress NOUN B-O
-condition NOUN B-O
-these DET B-O
-defence NOUN B-O
-systems NOUN B-O
-are AUX B-O
-activated VERB B-O
-both CCONJ B-O
-enzymatically ADV B-O
-( PUNCT B-O
-ascorbate NOUN B-O
-peroxidase NOUN B-O
-, PUNCT B-O
-catalase NOUN B-O
-, PUNCT B-O
-superoxide NOUN B-O
-dismutase NOUN B-O
-and CCONJ B-O
-peroxidase NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-non ADV B-O
-- ADV B-O
-enzymatically ADV B-O
-( PUNCT B-O
-secondary ADJ B-O
-metabolites NOUN B-O
-) PUNCT B-O
-scavenging VERB B-O
-the DET B-O
-reactive ADJ B-LF
-oxygen NOUN I-LF
-species NOUN I-LF
-( PUNCT B-O
-ROS PROPN B-AC
-) PUNCT B-O
-formed VERB B-O
-as ADP B-O
-result NOUN B-O
-of ADP B-O
-stress NOUN B-O
-condition NOUN B-O
-[ PUNCT B-O
-76 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-EV PROPN B-AC
-, PUNCT B-O
-extracellular ADJ B-LF
-vesicle NOUN I-LF
-; PUNCT B-O
-LPS PROPN B-AC
-, PUNCT B-O
-lipopolysaccharide NOUN B-LF
-. PUNCT B-O
-
-Pseudohyphal ADJ B-O
-growth NOUN B-O
-requires VERB B-O
-the DET B-O
-initiation NOUN B-O
-of ADP B-O
-polarised ADJ B-O
-growth NOUN B-O
-for ADP B-O
-cellular ADJ B-O
-elongation NOUN B-O
-and CCONJ B-O
-is AUX B-O
-under ADP B-O
-the DET B-O
-control NOUN B-O
-of ADP B-O
-two NUM B-O
-signaling NOUN B-O
-pathways NOUN B-O
-: PUNCT B-O
-a DET B-O
-cyclic ADJ B-LF
-adenosine NOUN I-LF
-monophosphate NOUN I-LF
-( PUNCT B-O
-kinase NOUN I-LF
-cAMP)/protein PROPN B-AC
-A NOUN I-LF
-( PUNCT B-O
-PKA PROPN B-AC
-) PUNCT B-O
-pathway NOUN B-O
-and CCONJ B-O
-a DET B-O
-mitogen NOUN B-LF
-- PUNCT I-LF
-activated VERB I-LF
-protein NOUN I-LF
-kinase NOUN I-LF
-( PUNCT B-O
-MAPK PROPN B-AC
-) PUNCT B-O
-cascade NOUN B-O
-. PUNCT B-O
-
-Half NOUN B-O
-of ADP B-O
-the DET B-O
-digest NOUN B-O
-( PUNCT B-O
-500 NUM B-O
-µl NOUN B-O
-) PUNCT B-O
-was AUX B-O
-loaded VERB B-O
-on ADP B-O
-a DET B-O
-strong ADJ B-LF
-anion NOUN I-LF
-exchange NOUN I-LF
-( PUNCT B-O
-SAX PROPN B-AC
-) PUNCT B-O
-column NOUN B-O
-( PUNCT B-O
-SAX PROPN B-AC
-- PUNCT B-O
-Zirchrom PROPN B-O
-2.1 NUM B-O
-mm NOUN B-O
-I.D.×150 NOUN B-O
-mm NOUN B-O
-length NOUN B-O
-; PUNCT B-O
-3 NUM B-O
-µm NOUN B-O
-particles NOUN B-O
-, PUNCT B-O
-ZirChrom PROPN B-O
-Separations PROPN B-O
-, PUNCT B-O
-Anoka PROPN B-O
-, PUNCT B-O
-MN PROPN B-O
-, PUNCT B-O
-USA PROPN B-O
-) PUNCT B-O
-after ADP B-O
-which PRON B-O
-a DET B-O
-binary ADJ B-O
-solvent NOUN B-O
-gradient NOUN B-O
-was AUX B-O
-applied VERB B-O
-to ADP B-O
-fractionate NOUN B-O
-peptides NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-host NOUN B-O
-- PUNCT B-O
-encoded VERB B-O
-glycophosphatidylinositol NOUN B-O
-anchored VERB B-O
-prion NOUN B-O
-protein NOUN B-O
-, PUNCT B-O
-PrPC PROPN B-O
-, PUNCT B-O
-is AUX B-O
-essential ADJ B-O
-for ADP B-O
-the DET B-O
-development NOUN B-O
-of ADP B-O
-TSE PROPN B-AC
-disease NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-a DET B-O
-common ADJ B-O
-feature NOUN B-O
-of ADP B-O
-these DET B-O
-diseases NOUN B-O
-is AUX B-O
-the DET B-O
-accumulation NOUN B-O
-of ADP B-O
-PrPSc PROPN B-O
-in ADP B-O
-the DET B-O
-brain NOUN B-O
-, PUNCT B-O
-an DET B-O
-abnormal ADJ B-O
-form NOUN B-O
-of ADP B-O
-PrPC PROPN B-O
-, PUNCT B-O
-which PRON B-O
-displays VERB B-O
-partial ADJ B-O
-resistance NOUN B-O
-to ADP B-O
-proteinase NOUN B-LF
-K PROPN I-LF
-( PUNCT B-O
-PK PROPN B-AC
-) PUNCT B-O
-digestion NOUN B-O
-. PUNCT B-O
-
-Lung NOUN B-O
-adenocarcinomas NOUN B-O
-from ADP B-O
-patients NOUN B-O
-who PRON B-O
-respond VERB B-O
-to ADP B-O
-the DET B-O
-tyrosine NOUN B-O
-kinase NOUN B-O
-inhibitors NOUN B-O
-gefitinib PROPN B-O
-( PUNCT B-O
-Iressa PROPN B-O
-) PUNCT B-O
-or CCONJ B-O
-erlotinib PROPN B-O
-( PUNCT B-O
-Tarceva PROPN B-O
-) PUNCT B-O
-usually ADV B-O
-harbor VERB B-O
-somatic ADJ B-O
-gain NOUN B-O
-- PUNCT B-O
-of ADP B-O
-- PUNCT B-O
-function NOUN B-O
-mutations NOUN B-O
-in ADP B-O
-exons NOUN B-O
-encoding VERB B-O
-the DET B-O
-kinase NOUN B-O
-domain NOUN B-O
-of ADP B-O
-the DET B-O
-epidermal ADJ B-LF
-growth NOUN I-LF
-factor NOUN I-LF
-receptor NOUN I-LF
-( PUNCT B-O
-EGFR PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Despite SCONJ B-O
-initial ADJ B-O
-responses NOUN B-O
-, PUNCT B-O
-patients NOUN B-O
-eventually ADV B-O
-progress VERB B-O
-by ADP B-O
-unknown ADJ B-O
-mechanisms NOUN B-O
-of ADP B-O
-“ PUNCT B-O
-acquired VERB B-O
-” PUNCT B-O
-resistance NOUN B-O
-. PUNCT B-O
-
-A DET B-O
-total NOUN B-O
-of ADP B-O
-1,045 NUM B-O
-genes NOUN B-O
-( PUNCT B-O
-551 NUM B-O
-up ADV B-O
-- PUNCT B-O
-regulated VERB B-O
-and CCONJ B-O
-494 NUM B-O
-down ADV B-O
-- PUNCT B-O
-regulated VERB B-O
-) PUNCT B-O
-were AUX B-O
-DE PROPN B-AC
-in ADP B-O
-the DET B-O
-FPC PROPN B-AC
-/ SYM B-O
-CC PROPN B-AC
-( PUNCT B-O
-region NOUN B-O
-1 NUM B-O
-, PUNCT B-O
-S1 NUM B-O
-Table PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-644 NUM B-O
-genes NOUN B-O
-( PUNCT B-O
-492 NUM B-O
-up ADV B-O
-- PUNCT B-O
-regulated VERB B-O
-and CCONJ B-O
-152 NUM B-O
-down ADV B-O
-- PUNCT B-O
-regulated VERB B-O
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-HP PROPN B-AC
-( PUNCT B-O
-region NOUN B-O
-2 NUM B-O
-, PUNCT B-O
-S2 NUM B-O
-Table PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-1,137 NUM B-O
-( PUNCT B-O
-526 NUM B-O
-up ADV B-O
-- PUNCT B-O
-regulated VERB B-O
-and CCONJ B-O
-611 NUM B-O
-downregulated ADJ B-O
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-RB PROPN B-AC
-( PUNCT B-O
-region NOUN B-O
-3 NUM B-O
-, PUNCT B-O
-S3 PROPN B-O
-Table PROPN B-O
-) PUNCT B-O
-( PUNCT B-O
-Fig NOUN B-O
-1A NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Gene NOUN B-O
-set NOUN B-O
-enrichment NOUN B-O
-analysis NOUN B-O
-( PUNCT B-O
-using VERB B-O
-DAVID PROPN B-O
-, PUNCT B-O
-see VERB B-O
-Methods NOUN B-O
-) PUNCT B-O
-showed VERB B-O
-significant ADJ B-O
-differences NOUN B-O
-between ADP B-O
-the DET B-O
-regions NOUN B-O
-, PUNCT B-O
-i.e. X B-O
-, PUNCT B-O
-DE PROPN B-AC
-genes NOUN B-O
-from ADP B-O
-each PRON B-O
-of ADP B-O
-the DET B-O
-three NUM B-O
-regions NOUN B-O
-were AUX B-O
-present ADJ B-O
-in ADP B-O
-overlapping VERB B-O
-but CCONJ B-O
-not PART B-O
-identical ADJ B-O
-Kyoto PROPN B-LF
-Encyclopedia PROPN I-LF
-of ADP I-LF
-genes NOUN I-LF
-and CCONJ I-LF
-genomes NOUN I-LF
-( PUNCT B-O
-KEGG PROPN B-AC
-) PUNCT B-O
-pathways NOUN B-O
-( PUNCT B-O
-S4 PROPN B-O
-Table PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-NSE PROPN B-AC
-, PUNCT B-O
-neuron NOUN B-LF
-specific ADJ I-LF
-enolase NOUN I-LF
-. PUNCT B-O
-
-In ADP B-O
-a DET B-O
-next ADJ B-O
-step NOUN B-O
-we PRON B-O
-further ADV B-O
-quantified VERB B-O
-the DET B-O
-voltage NOUN B-O
-firing NOUN B-O
-threshold NOUN B-O
-( PUNCT B-O
--28 NUM B-O
-– PUNCT B-O
--49 NUM B-O
-mV NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-maximum ADJ B-O
-firing NOUN B-O
-frequency NOUN B-O
-( PUNCT B-O
-10–202 NUM B-O
-Hz NOUN B-O
-) PUNCT B-O
-in ADP B-O
-response NOUN B-O
-to ADP B-O
-a DET B-O
-100 NUM B-O
-pA NOUN B-O
-step NOUN B-O
-, PUNCT B-O
-the DET B-O
-amplitude NOUN B-O
-of ADP B-O
-both CCONJ B-O
-spontaneous ADJ B-O
-( PUNCT B-O
-18–80 NUM B-O
-mV NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-evoked VERB B-O
-action NOUN B-O
-potentials NOUN B-O
-( PUNCT B-O
-17–76 NUM B-O
-mV NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-amplitude NOUN B-O
-( PUNCT B-O
-0–18 NUM B-O
-mV NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-time NOUN B-O
-point NOUN B-O
-of ADP B-O
-the DET B-O
-fast ADJ B-LF
-after ADP I-LF
-- PUNCT I-LF
-hyperpolarization NOUN I-LF
-peak NOUN I-LF
-( PUNCT B-O
-fAHP PROPN B-AC
-) PUNCT B-O
-following VERB B-O
-a DET B-O
-spike NOUN B-O
-( PUNCT B-O
-0,2–3,8 NUM B-O
-ms NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Fluorescence NOUN B-LF
-correlation NOUN I-LF
-spectroscopy NOUN I-LF
-( PUNCT B-O
-FCS PROPN B-AC
-) PUNCT B-O
-measurements NOUN B-O
-were AUX B-O
-carried VERB B-O
-out ADP B-O
-with ADP B-O
-a DET B-O
-home NOUN B-O
-- PUNCT B-O
-made VERB B-O
-FCS PROPN B-AC
-setup NOUN B-O
-[ X B-O
-56,57 X B-O
-] X B-O
-including VERB B-O
-an DET B-O
-Olympus PROPN B-O
-IMT-2 PROPN B-O
-inverted ADJ B-O
-microscope NOUN B-O
-with ADP B-O
-a DET B-O
-40x NUM B-O
-, PUNCT B-O
-NA NOUN B-O
-1.2 NUM B-O
-water NOUN B-O
-immersion NOUN B-O
-objective NOUN B-O
-( PUNCT B-O
-Carl PROPN B-O
-Zeiss PROPN B-O
-, PUNCT B-O
-Jena PROPN B-O
-, PUNCT B-O
-Germany PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Given VERB B-O
-clinicians NOUN B-O
-’ PUNCT B-O
-frequent ADJ B-O
-concerns NOUN B-O
-about ADP B-O
-unfavourable ADJ B-O
-outcomes NOUN B-O
-, PUNCT B-O
-Intensive PROPN B-LF
-Care PROPN I-LF
-Unit PROPN I-LF
-( PUNCT B-O
-ICU PROPN B-AC
-) PUNCT B-O
-triage NOUN B-O
-decisions NOUN B-O
-in ADP B-O
-acutely ADV B-O
-ill ADJ B-O
-cancer NOUN B-O
-patients NOUN B-O
-can AUX B-O
-be AUX B-O
-difficult ADJ B-O
-, PUNCT B-O
-as SCONJ B-O
-clinicians NOUN B-O
-may AUX B-O
-have VERB B-O
-doubts NOUN B-O
-about ADP B-O
-the DET B-O
-appropriateness NOUN B-O
-of ADP B-O
-an DET B-O
-ICU PROPN B-AC
-admission NOUN B-O
-. PUNCT B-O
-
-While SCONJ B-O
-Categories NOUN B-O
-I NUM B-O
-and CCONJ B-O
-II NUM B-O
-are AUX B-O
-integrated VERB B-O
-in ADP B-O
-the DET B-O
-swing NOUN B-O
-equation NOUN B-O
-, PUNCT B-O
-the DET B-O
-admittance NOUN B-LF
-matrix NOUN I-LF
-Y PROPN B-AC
-is AUX B-O
-modified VERB B-O
-to PART B-O
-incorporate VERB B-O
-Categories NOUN B-O
-III NUM B-O
-and CCONJ B-O
-IV NUM B-O
-in ADP B-O
-terms NOUN B-O
-of ADP B-O
-the DET B-O
-voltage NOUN B-O
-– PUNCT B-O
-current NOUN B-O
-relationship NOUN B-O
-. PUNCT B-O
-
-Further ADJ B-O
-cryogenic ADJ B-LF
-electron NOUN I-LF
-microscopy NOUN I-LF
-( PUNCT B-O
-cryo-EM PROPN B-AC
-) PUNCT B-O
-maps NOUN B-O
-of ADP B-O
-the DET B-O
-CsgG PROPN B-O
-- PUNCT B-O
-CsgE PROPN B-O
-complex NOUN B-O
-indicate VERB B-O
-that SCONJ B-O
-CsgE PROPN B-O
-could AUX B-O
-oligomerize VERB B-O
-to PART B-O
-form VERB B-O
-nonamers NOUN B-O
-in ADP B-O
-the DET B-O
-periplasm NOUN B-O
-, PUNCT B-O
-“ PUNCT B-O
-capping VERB B-O
-” PUNCT B-O
-the DET B-O
-periplasmic ADJ B-O
-side NOUN B-O
-of ADP B-O
-the DET B-O
-CsgG PROPN B-O
-channel NOUN B-O
-[ PUNCT B-O
-26,27 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-To PART B-O
-produce VERB B-O
-LEGO PROPN B-AC
-libraries NOUN B-O
-, PUNCT B-O
-we PRON B-O
-designed VERB B-O
-a DET B-O
-set NOUN B-O
-of ADP B-O
-oligonucleotide NOUN B-O
-adapters NOUN B-O
-A NOUN B-O
-, PUNCT B-O
-B NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-C NOUN B-O
-( PUNCT B-O
-Figures NOUN B-O
-A NOUN B-O
-, PUNCT B-O
-B NOUN B-O
-in ADP B-O
-S1 NUM B-O
-Fig NOUN B-O
-) PUNCT B-O
-that PRON B-O
-allow VERB B-O
-( PUNCT B-O
-1 X B-O
-) PUNCT B-O
-highly ADV B-O
-optimized VERB B-O
-PCR NOUN B-O
-- PUNCT B-O
-based VERB B-O
-Suppression PROPN B-LF
-Subtractive PROPN I-LF
-Hybridization PROPN I-LF
-( PUNCT B-O
-SSH PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-two NUM B-O
-transcriptomes NOUN B-O
-[ X B-O
-7 X B-O
-] X B-O
-to PART B-O
-selectively ADV B-O
-amplify VERB B-O
-cDNA NOUN B-O
-sequences NOUN B-O
-from ADP B-O
-repressed VERB B-O
-polyadenylated VERB B-O
-transcripts NOUN B-O
-( PUNCT B-O
-see VERB B-O
-for ADP B-O
-schematic ADJ B-O
-design NOUN B-O
-Figures NOUN B-O
-C NOUN B-O
-, PUNCT B-O
-D NOUN B-O
-in ADP B-O
-S1 NUM B-O
-Fig NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-( PUNCT B-O
-2 X B-O
-) PUNCT B-O
-subsequent ADJ B-O
-enzymatic ADJ B-O
-processing NOUN B-O
-of ADP B-O
-selected VERB B-O
-cDNA NOUN B-O
-sequences NOUN B-O
-into ADP B-O
-a DET B-O
-library NOUN B-O
-of ADP B-O
-pRETRO PROPN B-O
-Super PROPN B-O
-shRNA NOUN B-O
-vectors NOUN B-O
-for ADP B-O
-screening NOUN B-O
-( PUNCT B-O
-Figure PROPN B-O
-I NUM B-O
-in ADP B-O
-S1 NUM B-O
-Fig NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-* PUNCT B-O
-As ADP B-O
-compared VERB B-O
-with ADP B-O
-female NOUN B-O
-; PUNCT B-O
-Ref NOUN B-O
-: PUNCT B-O
-reference NOUN B-O
-category NOUN B-O
-; PUNCT B-O
-reduced VERB B-O
-staff NOUN B-O
-: PUNCT B-O
-weekend NOUN B-O
-and CCONJ B-O
-public ADJ B-O
-holydays NOUN B-O
-admissions NOUN B-O
-; PUNCT B-O
-RRT PROPN B-AC
-: PUNCT B-O
-renal ADJ B-LF
-replacement NOUN I-LF
-therapy NOUN I-LF
-; PUNCT B-O
-“ PUNCT B-O
-SAMU PROPN B-O
-” PUNCT B-O
-: PUNCT B-O
-Service PROPN B-O
-d’Aide PROPN B-O
-Médicale PROPN B-O
-Urgente PROPN B-O
-: PUNCT B-O
-mobile ADJ B-O
-emergency NOUN B-O
-team NOUN B-O
-. PUNCT B-O
-
-CTRL PROPN B-O
-, PUNCT B-O
-control NOUN B-O
-group NOUN B-O
-; PUNCT B-O
-ECD PROPN B-AC
-, PUNCT B-O
-early ADJ B-LF
-child NOUN I-LF
-development NOUN I-LF
-; PUNCT B-O
-EI PROPN B-O
-, PUNCT B-O
-Educación PROPN B-O
-Inicial PROPN B-O
-; PUNCT B-O
-ICDS PROPN B-O
-, PUNCT B-O
-Integrated PROPN B-O
-Child PROPN B-O
-Development PROPN B-O
-Services PROPN B-O
-; PUNCT B-O
-INT PROPN B-O
-, PUNCT B-O
-intervention NOUN B-O
-group NOUN B-O
-; PUNCT B-O
-RCT PROPN B-O
-, PUNCT B-O
-randomized VERB B-O
-controlled ADJ B-O
-trial NOUN B-O
-; PUNCT B-O
-RFS PROPN B-O
-, PUNCT B-O
-Responsive PROPN B-O
-Feeding PROPN B-O
-and CCONJ B-O
-Stimulation PROPN B-O
-; PUNCT B-O
-VIP PROPN B-O
-, PUNCT B-O
-Video PROPN B-O
-Interaction PROPN B-O
-Project PROPN B-O
-; PUNCT B-O
-VIPP PROPN B-O
-, PUNCT B-O
-video NOUN B-O
-- PUNCT B-O
-feedback NOUN B-O
-intervention NOUN B-O
-to PART B-O
-promote VERB B-O
-positive ADJ B-O
-parenting NOUN B-O
-; PUNCT B-O
-Of ADP B-O
-the DET B-O
-49,717 NUM B-O
-individuals NOUN B-O
-enrolled VERB B-O
-in ADP B-O
-the DET B-O
-D:A:D PROPN B-AC
-study NOUN B-O
-, PUNCT B-O
-27,215 NUM B-O
-( PUNCT B-O
-55 NUM B-O
-% PUNCT B-O
-) PUNCT B-O
-had VERB B-O
-the DET B-O
-required VERB B-O
-complete ADJ B-O
-covariate NOUN B-O
-data NOUN B-O
-after ADP B-O
-1 NUM B-O
-January PROPN B-O
-2004 NUM B-O
-and CCONJ B-O
-were AUX B-O
-included VERB B-O
-in ADP B-O
-this DET B-O
-analysis NOUN B-O
-, PUNCT B-O
-contributing VERB B-O
-202,034 NUM B-O
-person NOUN B-LF
-- PUNCT I-LF
-years NOUN I-LF
-( PUNCT B-O
-pyrs PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-follow NOUN B-O
-- PUNCT B-O
-up NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-calculated VERB B-O
-the DET B-O
-sensitivity NOUN B-O
-, PUNCT B-O
-specificity NOUN B-O
-and CCONJ B-O
-accuracy NOUN B-O
-of ADP B-O
-our PRON B-O
-algorithm NOUN B-O
-to PART B-O
-detect VERB B-O
-VVA PROPN B-AC
-after ADP B-O
-finding VERB B-O
-an DET B-O
-optimal ADJ B-O
-DCVV PROPN B-AC
-cut NOUN B-O
-- PUNCT B-O
-off NOUN B-O
-using VERB B-O
-Receiver PROPN B-LF
-Operating PROPN I-LF
-Characteristics NOUN I-LF
-( PUNCT B-O
-ROC PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-Youden PROPN B-O
-- PUNCT B-O
-Index PROPN B-O
-( PUNCT B-O
-J NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-A DET B-O
-ROC PROPN B-AC
-curve NOUN B-O
-was AUX B-O
-generated VERB B-O
-using VERB B-O
-SPSS PROPN B-O
-. PUNCT B-O
-
-For ADP B-O
-all DET B-O
-statistical ADJ B-O
-analyses NOUN B-O
-, PUNCT B-O
-the DET B-O
-level NOUN B-O
-of ADP B-O
-significance NOUN B-O
-was AUX B-O
-set VERB B-O
-at ADP B-O
-p NOUN B-O
-< ADP B-O
-0.05 NUM B-O
-( PUNCT B-O
-two NUM B-O
-- PUNCT B-O
-tailed VERB B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Deletion NOUN B-O
-of ADP B-O
-kinases NOUN B-O
-regulated VERB B-O
-by ADP B-O
-Ras PROPN B-O
-such ADJ B-O
-as ADP B-O
-extracellular ADJ B-LF
-signal NOUN I-LF
-regulated VERB I-LF
-kinase NOUN I-LF
-( PUNCT B-O
-ERK PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-glycogen NOUN B-O
-synthase NOUN B-O
-kinase NOUN B-O
-( PUNCT B-O
-GSK-3 PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-mammalian ADJ B-LF
-target NOUN I-LF
-of ADP I-LF
-rapamycin NOUN I-LF
-( PUNCT B-O
-mTOR PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-discrete ADJ B-O
-populations NOUN B-O
-of ADP B-O
-MSNs PROPN B-AC
-also ADV B-O
-affects VERB B-O
-motor NOUN B-O
-activity NOUN B-O
-and/or CCONJ B-O
-responses NOUN B-O
-to ADP B-O
-psychostimulants NOUN B-O
-[ PUNCT B-O
-28–30 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-similar ADJ B-O
-effects NOUN B-O
-are AUX B-O
-observed VERB B-O
-upon SCONJ B-O
-changes NOUN B-O
-in ADP B-O
-Ras PROPN B-O
-activity NOUN B-O
-[ PUNCT B-O
-31,32 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-some DET B-O
-organisms NOUN B-O
-, PUNCT B-O
-additional ADJ B-O
-γ PUNCT B-LF
-- PUNCT I-LF
-tubulin NOUN I-LF
-complex NOUN I-LF
-proteins NOUN I-LF
-( PUNCT B-O
-GCPs PROPN B-AC
-) PUNCT B-O
-combine VERB B-O
-with ADP B-O
-the DET B-O
-γ PROPN B-AC
-to PART B-O
-form VERB B-O
-the DET B-O
-larger ADJ B-O
-γ PUNCT B-LF
-- PUNCT I-LF
-tubulin NOUN I-LF
-ring NOUN I-LF
-complex NOUN I-LF
-( PUNCT B-O
--TuSCγ PROPN B-AC
-) PUNCT B-O
-; PUNCT B-O
-organisms NOUN B-O
-lacking VERB B-O
-these DET B-O
-additional ADJ B-O
--TuRCGCPs PROPN B-AC
-are AUX B-O
-thought VERB B-O
-to PART B-O
-oligomerize VERB B-O
-γ PROPN B-AC
-into ADP B-O
-similar ADJ B-O
-ring NOUN B-O
-complexes NOUN B-O
-[ PUNCT B-O
-12,13 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-data NOUN B-O
-was AUX B-O
-normalized VERB B-O
-to ADP B-O
-the DET B-O
-H/L PROPN B-AC
-( PUNCT B-O
-Heavy ADJ B-LF
-/ SYM I-LF
-Light NOUN I-LF
-) PUNCT B-O
-ratio NOUN B-O
-of ADP B-O
-the DET B-O
-Pwp2p NOUN B-O
-bait NOUN B-O
-to ADP B-O
-correct VERB B-O
-for ADP B-O
-the DET B-O
-reduced VERB B-O
-purification NOUN B-O
-( PUNCT B-O
-the DET B-O
-H PROPN B-AC
-ratio NOUN B-O
-of ADP B-O
-Pwp2p NOUN B-O
-was AUX B-O
-set VERB B-O
-to ADP B-O
-1 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Weight NOUN B-O
-and CCONJ B-O
-height NOUN B-O
-were AUX B-O
-measured VERB B-O
-by ADP B-O
-trained VERB B-O
-professionals NOUN B-O
-to ADP B-O
-standardised ADJ B-O
-protocols NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-( PUNCT B-O
-BMI PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-calculated VERB B-O
-as ADP B-O
-weight NOUN B-O
-divided VERB B-O
-by ADP B-O
-squared VERB B-O
-height NOUN B-O
-( PUNCT B-O
-kg NOUN B-O
-/ SYM B-O
-m2 NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-95 NUM B-O
-% NOUN B-O
-CI NOUN B-O
-, PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-O
-interval NOUN B-O
-; PUNCT B-O
-HR PROPN B-AC
-, PUNCT B-O
-hazard NOUN B-LF
-ratio NOUN I-LF
-; PUNCT B-O
-PSA PROPN B-AC
-, PUNCT B-O
-prostate NOUN B-LF
-- PUNCT I-LF
-specific ADJ I-LF
-antigen NOUN I-LF
-; PUNCT B-O
-pT NOUN B-O
-, PUNCT B-O
-pathological ADJ B-O
-staging NOUN B-O
-of ADP B-O
-the DET B-O
-primary ADJ B-O
-tumor NOUN B-O
-; PUNCT B-O
-RP PROPN B-AC
-, PUNCT B-O
-radical ADJ B-LF
-prostatectomy NOUN I-LF
-. PUNCT B-O
-
-Recent ADJ B-O
-studies NOUN B-O
-suggest VERB B-O
-that SCONJ B-O
-necroptosis NOUN B-O
-is AUX B-O
-mediated VERB B-O
-by ADP B-O
-receptor NOUN B-LF
-interacting VERB I-LF
-protein NOUN I-LF
-3 NUM I-LF
-( PUNCT B-O
-RIP3)[7 PROPN B-AC
-, PUNCT B-O
-8 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-SNP PROPN B-AC
-: PUNCT B-O
-single ADJ B-LF
-nucleotide NOUN I-LF
-polymorphism NOUN I-LF
-; PUNCT B-O
-CTEPH PROPN B-AC
-: PUNCT B-O
-chronic ADJ B-LF
-thromboembolic ADJ I-LF
-pulmonary ADJ I-LF
-hypertension NOUN I-LF
-; PUNCT B-O
-PE PROPN B-AC
-: PUNCT B-O
-pulmonary ADJ B-O
-embolism NOUN B-O
-; PUNCT B-O
-PAH PROPN B-AC
-: PUNCT B-O
-pulmonary ADJ B-LF
-arterial ADJ I-LF
-hypertension NOUN I-LF
-. PUNCT B-O
-
-We PRON B-O
-simulated VERB B-O
-populations NOUN B-O
-using VERB B-O
-an DET B-O
-agent NOUN B-LF
-- PUNCT I-LF
-based VERB I-LF
-model NOUN I-LF
-( PUNCT B-O
-ABM PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-sampled VERB B-O
-them PRON B-O
-monthly ADV B-O
-for ADP B-O
-25 NUM B-O
-years NOUN B-O
-with ADP B-O
-a DET B-O
-total NOUN B-O
-of ADP B-O
-300 NUM B-O
-time NOUN B-O
-points NOUN B-O
-, PUNCT B-O
-where SCONJ B-O
-each DET B-O
-time NOUN B-O
-point NOUN B-O
-is AUX B-O
-a DET B-O
-snapshot NOUN B-O
-of ADP B-O
-changes NOUN B-O
-accumulated VERB B-O
-in ADP B-O
-the DET B-O
-parasite NOUN B-O
-population NOUN B-O
-during ADP B-O
-a DET B-O
-30 NUM B-O
-- PUNCT B-O
-day NOUN B-O
-period NOUN B-O
-. PUNCT B-O
-
-An DET B-O
-analysis NOUN B-O
-of ADP B-O
-the DET B-O
-putative ADJ B-O
-cis ADJ B-O
-- ADJ B-O
-regulatory ADJ B-O
-elements NOUN B-O
-that SCONJ B-O
-were AUX B-O
-present ADJ B-O
-in ADP B-O
-the DET B-O
-promoter NOUN B-O
-sequences NOUN B-O
-of ADP B-O
-aquaporin NOUN B-O
-genes NOUN B-O
-belonging VERB B-O
-to ADP B-O
-TIP PROPN B-AC
-subfamily NOUN B-O
-led VERB B-O
-to ADP B-O
-the DET B-O
-conclusion NOUN B-O
-that SCONJ B-O
-their PRON B-O
-expression NOUN B-O
-may AUX B-O
-be AUX B-O
-regulated VERB B-O
-in ADP B-O
-response NOUN B-O
-to ADP B-O
-hormones NOUN B-O
-such ADJ B-O
-as SCONJ B-O
-abscisic NOUN B-LF
-acid NOUN I-LF
-( PUNCT B-O
-ABA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-methyl NOUN B-LF
-jasmonate NOUN I-LF
-( PUNCT B-O
-MeJA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-auxin NOUN B-O
-and CCONJ B-O
-gibberellin NOUN B-O
-( PUNCT B-O
-GA PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-presence NOUN B-O
-of ADP B-O
-ABRE PROPN B-O
-in ADP B-O
-the DET B-O
-investigated VERB B-O
-promoters NOUN B-O
-suggests VERB B-O
-a DET B-O
-possible ADJ B-O
-role NOUN B-O
-of ADP B-O
-ABA PROPN B-AC
-in ADP B-O
-the DET B-O
-control NOUN B-O
-of ADP B-O
-HvTIP PROPN B-O
-expression NOUN B-O
-as SCONJ B-O
-has AUX B-O
-already ADV B-O
-been AUX B-O
-reported VERB B-O
-for ADP B-O
-some DET B-O
-TIP PROPN B-AC
-genes NOUN B-O
-in ADP B-O
-barley NOUN B-O
-. PUNCT B-O
-
-CS PROPN B-AC
-, PUNCT B-O
-cesarean ADJ B-LF
-section NOUN I-LF
-; PUNCT B-O
-HELLP PROPN B-AC
-, PUNCT B-O
-hemolysis NOUN B-O
-, PUNCT B-O
-elevated ADJ B-O
-liver NOUN B-O
-enzymes NOUN B-O
-, PUNCT B-O
-low ADJ B-O
-platelet NOUN B-O
-count NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-assessed VERB B-O
-the DET B-O
-efficiency NOUN B-O
-of ADP B-O
-gene NOUN B-O
-discovery NOUN B-O
-by ADP B-O
-calculating VERB B-O
-the DET B-O
-percentage NOUN B-O
-of ADP B-O
-known VERB B-O
-genes NOUN B-O
-tagged VERB B-O
-as ADP B-O
-a DET B-O
-function NOUN B-O
-of ADP B-O
-read VERB B-O
-number NOUN B-O
-for ADP B-O
-MF PROPN B-AC
-and CCONJ B-O
-compared VERB B-O
-this DET B-O
-value NOUN B-O
-to ADP B-O
-the DET B-O
-rate NOUN B-O
-of ADP B-O
-gene NOUN B-O
-discovery NOUN B-O
-obtained VERB B-O
-by ADP B-O
-expressed VERB B-LF
-sequence NOUN I-LF
-tags NOUN I-LF
-( PUNCT B-O
-ESTs PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-sorghum NOUN B-O
-( PUNCT B-O
-Figure PROPN B-O
-2 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Alternative ADJ B-O
-, PUNCT B-O
-community NOUN B-O
-- PUNCT B-O
-based VERB B-O
-approaches NOUN B-O
-are AUX B-O
-required VERB B-O
-to PART B-O
-meet VERB B-O
-the DET B-O
-Joint PROPN B-LF
-United PROPN I-LF
-Nations PROPN I-LF
-Programme PROPN I-LF
-on ADP I-LF
-HIV PROPN I-LF
-/ SYM I-LF
-AIDS PROPN I-LF
-( PUNCT B-O
-UNAIDS PROPN B-AC
-) PUNCT B-O
-target NOUN B-O
-of ADP B-O
-diagnosing VERB B-O
-90 NUM B-O
-% NOUN B-O
-of ADP B-O
-those PRON B-O
-living VERB B-O
-with ADP B-O
-HIV PROPN B-O
-by ADP B-O
-2020 NUM B-O
-in ADP B-O
-this DET B-O
-age NOUN B-O
-group NOUN B-O
-. PUNCT B-O
-
-Baht PROPN B-O
-can AUX B-O
-be AUX B-O
-converted VERB B-O
-to ADP B-O
-$ SYM B-O
-US PROPN B-O
-by ADP B-O
-dividing VERB B-O
-by ADP B-O
-31.16 NUM B-O
-; PUNCT B-O
-T1MI PROPN B-AC
-, PUNCT B-O
-type NOUN B-O
-1 NUM B-O
-myocardial ADJ B-LF
-infarction NOUN I-LF
-; PUNCT B-O
-ASCVD PROPN B-AC
-, PUNCT B-O
-atherosclerotic ADJ B-LF
-cardiovascular ADJ I-LF
-disease NOUN I-LF
-; PUNCT B-O
-QALY PROPN B-AC
-, PUNCT B-O
-quality NOUN B-LF
-- PUNCT I-LF
-adjusted VERB I-LF
-life NOUN I-LF
-- PUNCT I-LF
-year NOUN I-LF
-; PUNCT B-O
-ICER PROPN B-AC
-, PUNCT B-O
-incremental ADJ B-LF
-cost NOUN I-LF
-- PUNCT I-LF
-effectiveness NOUN I-LF
-ratio NOUN I-LF
-; PUNCT B-O
-Rama PROPN B-AC
-, PUNCT B-O
-Ramathibodi PROPN B-LF
-- PUNCT I-LF
-Electricity PROPN I-LF
-Generating PROPN I-LF
-Authority PROPN I-LF
-of ADP I-LF
-Thailand PROPN I-LF
-. PUNCT B-O
-
-Since SCONJ B-O
-histone NOUN B-O
-acetylation NOUN B-O
-is AUX B-O
-controlled VERB B-O
-by ADP B-O
-the DET B-O
-balance NOUN B-O
-of ADP B-O
-histone NOUN B-LF
-acetyltransferases NOUN I-LF
-( PUNCT B-O
-HATs PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-deacetylases NOUN B-O
-( PUNCT B-O
-HDACs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-we PRON B-O
-next ADV B-O
-asked VERB B-O
-whether SCONJ B-O
-blocking VERB B-O
-HDAC PROPN B-AC
-function NOUN B-O
-would AUX B-O
-reactivate VERB B-O
-IFN PROPN B-AC
-- PUNCT B-O
-λ PUNCT B-O
-receptor NOUN B-O
-expression NOUN B-O
-in ADP B-O
-nonresponsive ADJ B-O
-cells NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-the DET B-O
-present ADJ B-O
-study NOUN B-O
-, PUNCT B-O
-we PRON B-O
-investigated VERB B-O
-the DET B-O
-effect NOUN B-O
-of ADP B-O
-a DET B-O
-sub ADJ B-O
-- PUNCT B-O
-chronic ADJ B-O
-treatment NOUN B-O
-with ADP B-O
-local ADJ B-LF
-cryotherapy NOUN I-LF
-( PUNCT B-O
-LC PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-widely ADV B-O
-- PUNCT B-O
-used VERB B-O
-rat NOUN B-O
-model NOUN B-O
-of ADP B-O
-adjuvant NOUN B-LF
-- PUNCT I-LF
-induced VERB I-LF
-arthritis NOUN I-LF
-( PUNCT B-O
-AIA PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Two NUM B-O
-modalities NOUN B-O
-of ADP B-O
-cryotherapy NOUN B-O
-were AUX B-O
-compared VERB B-O
-: PUNCT B-O
-local ADJ B-O
-ice NOUN B-O
-and CCONJ B-O
-cold ADJ B-O
-spray NOUN B-O
-application NOUN B-O
-. PUNCT B-O
-
-HRs PROPN B-AC
-were AUX B-O
-adjusted VERB B-O
-for ADP B-O
-age NOUN B-O
-, PUNCT B-O
-sex NOUN B-O
-, PUNCT B-O
-total ADJ B-O
-energy NOUN B-O
-intake NOUN B-O
-, PUNCT B-O
-education NOUN B-O
-, PUNCT B-O
-physical ADJ B-O
-activity NOUN B-O
-, PUNCT B-O
-smoking NOUN B-O
-status NOUN B-O
-, PUNCT B-O
-alcohol NOUN B-O
-intake NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-BMI PROPN B-AC
-. PUNCT B-O
-
-BMI PROPN B-AC
-, PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-; PUNCT B-O
-HR PROPN B-AC
-, PUNCT B-O
-hazard NOUN B-LF
-ratio NOUN I-LF
-; PUNCT B-O
-MetS PROPN B-AC
-, PUNCT B-O
-metabolic ADJ B-LF
-syndrome NOUN I-LF
-; PUNCT B-O
-uPDI PROPN B-AC
-, PUNCT B-O
-unhealthful ADJ B-LF
-plant NOUN I-LF
-- PUNCT I-LF
-based VERB I-LF
-diet NOUN I-LF
-index NOUN I-LF
-. PUNCT B-O
-
-CHW PROPN B-AC
-, PUNCT B-O
-community NOUN B-LF
-health NOUN I-LF
-worker NOUN I-LF
-; PUNCT B-O
-DV PROPN B-O
-, PUNCT B-O
-drug NOUN B-O
-vendor NOUN B-O
-/ SYM B-O
-shop NOUN B-O
-; PUNCT B-O
-HP PROPN B-O
-, PUNCT B-O
-healthcare NOUN B-O
-provider NOUN B-O
-; PUNCT B-O
-MA PROPN B-O
-, PUNCT B-O
-medical ADJ B-O
-assistant NOUN B-O
-; PUNCT B-O
-MD PROPN B-O
-, PUNCT B-O
-medical ADJ B-O
-doctor NOUN B-O
-; PUNCT B-O
-NA PROPN B-O
-, PUNCT B-O
-not PART B-O
-reported VERB B-O
-by ADP B-O
-study NOUN B-O
-authors NOUN B-O
-; PUNCT B-O
-pharm NOUN B-O
-, PUNCT B-O
-pharmacist NOUN B-O
-( PUNCT B-O
-trained VERB B-O
-) PUNCT B-O
-; PUNCT B-O
-PSI PROPN B-O
-, PUNCT B-O
-Population PROPN B-O
-Services PROPN B-O
-International PROPN B-O
-Research PROPN B-O
-and CCONJ B-O
-Metrics PROPN B-O
-; PUNCT B-O
-PW PROPN B-O
-, PUNCT B-O
-pregnant ADJ B-O
-women NOUN B-O
-. PUNCT B-O
-
-This DET B-O
-study NOUN B-O
-was AUX B-O
-undertaken VERB B-O
-in ADP B-O
-Kenyatta PROPN B-LF
-National PROPN I-LF
-Hospital PROPN I-LF
-( PUNCT B-O
-KNH PROPN B-AC
-) PUNCT B-O
--the DET B-O
-largest ADJ B-O
-public ADJ B-O
-tertiary ADJ B-O
-referral NOUN B-O
-centre NOUN B-O
-in ADP B-O
-East PROPN B-O
-& CCONJ B-O
-Central PROPN B-O
-Africa PROPN B-O
-— PUNCT B-O
-to PART B-O
-help AUX B-O
-bridge VERB B-O
-existing VERB B-O
-AMR PROPN B-AC
-knowledge NOUN B-O
-and CCONJ B-O
-practice NOUN B-O
-gaps NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-extracted VERB B-O
-individuals NOUN B-O
-’ PUNCT B-O
-demographic ADJ B-O
-and CCONJ B-O
-residential ADJ B-O
-information NOUN B-O
-, PUNCT B-O
-including VERB B-O
-age NOUN B-O
-, PUNCT B-O
-sex NOUN B-O
-, PUNCT B-O
-residence NOUN B-O
-, PUNCT B-O
-income NOUN B-O
-quintile NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-whether SCONJ B-O
-the DET B-O
-individual NOUN B-O
-was AUX B-O
-resident NOUN B-O
-of ADP B-O
-a DET B-O
-long ADJ B-LF
-- PUNCT I-LF
-term NOUN I-LF
-care NOUN I-LF
-( PUNCT B-O
-LTC PROPN B-AC
-) PUNCT B-O
-facility NOUN B-O
-90 NUM B-O
-days NOUN B-O
-prior ADV B-O
-to ADP B-O
-the DET B-O
-testing NOUN B-O
-date NOUN B-O
-from ADP B-O
-the DET B-O
-database NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-studied VERB B-O
-responses NOUN B-O
-( PUNCT B-O
-dependent ADJ B-O
-variables NOUN B-O
-) PUNCT B-O
-were AUX B-O
-the DET B-O
-dissolution NOUN B-LF
-efficiency NOUN I-LF
-% NOUN B-O
-at ADP B-O
-10 NUM B-O
-min PROPN B-AC
-( PUNCT B-O
-Y1 PROPN B-O
-: PUNCT B-O
-DE PROPN B-AC
-( PUNCT B-O
-10 NUM B-O
-min PROPN B-AC
-) PUNCT B-O
-% NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-dissolution NOUN B-LF
-efficiency NOUN I-LF
-% NOUN B-O
-at ADP B-O
-30 NUM B-O
-min PROPN B-AC
-( PUNCT B-O
-Y2 PROPN B-O
-: PUNCT B-O
-DE PROPN B-AC
-( PUNCT B-O
-30 NUM B-O
-min PROPN B-AC
-) PUNCT B-O
-% NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-mean ADJ B-LF
-dissolution NOUN I-LF
-time NOUN I-LF
-( PUNCT B-O
-Y3 NOUN B-O
-: PUNCT B-O
-MDT PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-disintegration NOUN B-LF
-time NOUN I-LF
-( PUNCT B-O
-Y4 PROPN B-O
-: PUNCT B-O
-DT PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-the DET B-O
-wetting NOUN B-LF
-time NOUN I-LF
-( PUNCT B-O
-Y5 NOUN B-O
-: PUNCT B-O
-WT PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Responses NOUN B-O
-of ADP B-O
-the DET B-O
-prepared VERB B-O
-ODTs PROPN B-AC
-are AUX B-O
-listed VERB B-O
-in ADP B-O
-Table NOUN B-O
-( PUNCT B-O
-2 NUM B-O
-) PUNCT B-O
-in ADP B-O
-S1 PROPN B-O
-File PROPN B-O
-. PUNCT B-O
-
-This PRON B-O
-is AUX B-O
-in ADP B-O
-contrast NOUN B-O
-to ADP B-O
-the DET B-O
-traditional ADJ B-O
-physician NOUN B-O
-- PUNCT B-O
-assessed VERB B-O
-Expanded PROPN B-LF
-Disability PROPN I-LF
-Status PROPN I-LF
-Scale PROPN I-LF
-( PUNCT B-O
-EDSS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-is AUX B-O
-the DET B-O
-primary ADJ B-O
-outcome NOUN B-O
-favoured VERB B-O
-in ADP B-O
-most ADJ B-O
-MS PROPN B-AC
-trials NOUN B-O
-despite SCONJ B-O
-several ADJ B-O
-well ADV B-O
-- PUNCT B-O
-documented VERB B-O
-limitations NOUN B-O
-, PUNCT B-O
-including VERB B-O
-poor ADJ B-O
-interrater NOUN B-O
-and CCONJ B-O
-intrarater ADJ B-O
-reliability NOUN B-O
-and CCONJ B-O
-a DET B-O
-limited ADJ B-O
-sensitivity NOUN B-O
-to ADP B-O
-change NOUN B-O
-over ADP B-O
-the DET B-O
-time NOUN B-O
-frame NOUN B-O
-of ADP B-O
-2–3 NUM B-O
-years NOUN B-O
-, PUNCT B-O
-especially ADV B-O
-in ADP B-O
-progressive ADJ B-O
-MS PROPN B-AC
-[ PUNCT B-O
-16–20 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Compared VERB B-O
-with ADP B-O
-LPS PROPN B-AC
-alone ADV B-O
-, PUNCT B-O
-at ADP B-O
-Vm PROPN B-AC
-values NOUN B-O
-negative ADJ B-O
-from ADP B-O
-the DET B-O
-reversal NOUN B-LF
-NCX PROPN B-AC
-potential NOUN I-LF
-( PUNCT B-O
-Erev PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-additional ADJ B-O
-HS PROPN B-AC
-exposure NOUN B-O
-enhanced VERB B-O
-NCX PROPN B-AC
-inward ADJ B-O
-current NOUN B-O
-( PUNCT B-O
-Fig PROPN B-O
-4C NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Altogether ADV B-O
-, PUNCT B-O
-this PRON B-O
-suggests VERB B-O
-that SCONJ B-O
-NCX PROPN B-AC
-mediates VERB B-O
-Na+ NOUN B-O
-entry NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-location NOUN B-O
-of ADP B-O
-weaker ADJ B-O
-lipid NOUN B-O
-binding VERB B-O
-sites NOUN B-O
-is AUX B-O
-therefore ADV B-O
-usually ADV B-O
-observed VERB B-O
-using VERB B-O
-classical ADJ B-O
-molecular ADJ B-LF
-dynamics NOUN I-LF
-( PUNCT B-O
-MD PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-A DET B-O
-planned VERB B-O
-individual ADJ B-LF
-participant NOUN I-LF
-data NOUN I-LF
-( PUNCT B-O
-IPD PROPN B-AC
-) PUNCT B-O
-meta NOUN B-O
-- NOUN B-O
-analysis NOUN B-O
-( PUNCT B-O
-PROSPERO PROPN B-O
-CRD42017072683 NUM B-O
-) PUNCT B-O
-may AUX B-O
-prove VERB B-O
-helpful ADJ B-O
-to PART B-O
-further ADV B-O
-explore VERB B-O
-possible ADJ B-O
-sex NOUN B-O
-differences NOUN B-O
-in ADP B-O
-the DET B-O
-effects NOUN B-O
-of ADP B-O
-macronutrient NOUN B-O
-supplements NOUN B-O
-in ADP B-O
-human ADJ B-O
-infants NOUN B-O
-born VERB B-O
-small ADJ B-O
-. PUNCT B-O
-
-We PRON B-O
-used VERB B-O
-a DET B-O
-novel ADJ B-O
-in ADP B-O
-vitro X B-O
-assay NOUN B-O
-( PUNCT B-O
-for ADP B-O
-gamma NOUN B-LF
-- NOUN I-LF
-interferon NOUN I-LF
-[ PUNCT B-O
-IFN-γ PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-release NOUN B-O
-to PART B-O
-establish VERB B-O
-LTBI PROPN B-AC
-and CCONJ B-O
-a DET B-O
-questionnaire NOUN B-O
-to PART B-O
-address VERB B-O
-risk NOUN B-O
-factors NOUN B-O
-. PUNCT B-O
-
-Fenland PROPN B-O
-Study PROPN B-O
-participants NOUN B-O
-undergo VERB B-O
-a DET B-O
-health NOUN B-O
-assessment NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-blood NOUN B-O
-samples NOUN B-O
-are AUX B-O
-collected VERB B-O
-for ADP B-O
-the DET B-O
-genotyping NOUN B-O
-of ADP B-O
-single ADJ B-LF
-nucleotide NOUN I-LF
-polymorphisms NOUN I-LF
-( PUNCT B-O
-SNPs PROPN B-AC
-) PUNCT B-O
-associated VERB B-O
-with ADP B-O
-type NOUN B-O
-2 NUM B-O
-diabetes NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-ratio NOUN B-LF
-of ADP I-LF
-nonsynonymous ADJ I-LF
-to PART I-LF
-synonymous ADJ I-LF
-substitutions NOUN I-LF
-( PUNCT B-O
-dN/dS PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-calculated VERB B-O
-in ADP B-O
-phylogenetic ADJ B-LF
-analysis NOUN I-LF
-by ADP I-LF
-maximum ADJ I-LF
-likelihood NOUN I-LF
-( PUNCT B-O
-PAML PROPN B-AC
-) PUNCT B-O
-software NOUN B-O
-[ X B-O
-39 X B-O
-] X B-O
-using VERB B-O
-a DET B-O
-two NUM B-O
-- PUNCT B-O
-ratio NOUN B-O
-maximum ADJ B-O
-- PUNCT B-O
-likelihood NOUN B-O
-analysis NOUN B-O
-between ADP B-O
-the DET B-O
-human ADJ B-LF
-haplotype NOUN I-LF
-'s PART I-LF
-most ADV I-LF
-recent ADJ I-LF
-common ADJ I-LF
-ancestor NOUN I-LF
-( PUNCT B-O
-HH PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-the DET B-O
-human ADJ B-O
-- PUNCT B-O
-chimpanzee NOUN B-O
--MRCAMRCA PROPN B-AC
-( PUNCT B-O
-Figure PROPN B-O
-5B NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-This DET B-O
-measurement NOUN B-O
-, PUNCT B-O
-which PRON B-O
-only ADV B-O
-evaluates VERB B-O
-fixed VERB B-O
-changes NOUN B-O
-, PUNCT B-O
-is AUX B-O
-used VERB B-O
-to PART B-O
-determine VERB B-O
-selective ADJ B-O
-pressures NOUN B-O
-in ADP B-O
-a DET B-O
-coding VERB B-O
-region NOUN B-O
-, PUNCT B-O
-where SCONJ B-O
-values NOUN B-O
-> ADP B-O
-1 NUM B-O
-suggest VERB B-O
-positive ADJ B-O
-selection NOUN B-O
-, PUNCT B-O
-while SCONJ B-O
-values NOUN B-O
-< ADP B-O
-1 NUM B-O
-indicate VERB B-O
-purifying VERB B-O
-selection NOUN B-O
-. PUNCT B-O
-
-Fig NOUN B-O
-5 NUM B-O
-shows VERB B-O
-immunohistochemistry NOUN B-LF
-( PUNCT B-O
-IHC PROPN B-AC
-) PUNCT B-O
-results NOUN B-O
-in ADP B-O
-benign ADJ B-O
-prostate NOUN B-O
-tissue NOUN B-O
-and CCONJ B-O
-prostate NOUN B-O
-adenocarcinoma NOUN B-O
-according VERB B-O
-to ADP B-O
-pT NOUN B-O
-stage NOUN B-O
-and CCONJ B-O
-Gleason PROPN B-O
-score NOUN B-O
-. PUNCT B-O
-
-Among ADP B-O
-the DET B-O
-approximately ADV B-O
-70 NUM B-O
-members NOUN B-O
-in ADP B-O
-the DET B-O
-TRIM PROPN B-AC
-family NOUN B-O
-, PUNCT B-O
-TRIM59 PROPN B-O
-stood VERB B-O
-out ADP B-O
-as ADP B-O
-one NUM B-O
-of ADP B-O
-the DET B-O
-most ADV B-O
-differentially ADV B-O
-expressed VERB B-O
-genes NOUN B-O
-, PUNCT B-O
-with ADP B-O
-its PRON B-O
-expression NOUN B-O
-ubiquitously ADV B-O
-up ADV B-O
-- ADJ B-O
-regulated VERB B-O
-by ADP B-O
-1.6- NUM B-O
-to PART B-O
-6.3 NUM B-O
-- ADJ B-O
-fold NOUN B-O
-in ADP B-O
-12 NUM B-O
-analyzed VERB B-O
-cancer NOUN B-O
-types NOUN B-O
-compared VERB B-O
-with ADP B-O
-the DET B-O
-adjacent ADJ B-O
-normal ADJ B-O
-tissues NOUN B-O
-( PUNCT B-O
-Figs PROPN B-O
-1A NOUN B-O
-and CCONJ B-O
-S1A PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Particularly ADV B-O
-, PUNCT B-O
-in ADP B-O
-breast NOUN B-LF
-invasive ADJ I-LF
-carcinoma NOUN I-LF
-( PUNCT B-O
-BRCA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-TRIM59 PROPN B-O
-mRNA NOUN B-O
-level NOUN B-O
-was AUX B-O
-significantly ADV B-O
-increased VERB B-O
-in ADP B-O
-tumor NOUN B-O
-sites NOUN B-O
-( PUNCT B-O
-red ADJ B-O
-plot NOUN B-O
-) PUNCT B-O
-compared VERB B-O
-with ADP B-O
-its PRON B-O
-expression NOUN B-O
-in ADP B-O
-normal ADJ B-O
-adjacent ADJ B-O
-tissues NOUN B-O
-( PUNCT B-O
-blue ADJ B-O
-plot NOUN B-O
-; PUNCT B-O
-fold NOUN B-O
-change NOUN B-O
-= SYM B-O
-4.03 NUM B-O
-, PUNCT B-O
-P NOUN B-O
-value NOUN B-O
-= SYM B-O
-2.9 NUM B-O
-× PUNCT B-O
-10−28 NUM B-O
-; PUNCT B-O
-S1A PROPN B-O
-Fig PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-analyses NOUN B-O
-of ADP B-O
-frailty NOUN B-O
-categories NOUN B-O
-, PUNCT B-O
-only ADV B-O
-the DET B-O
-G-8 PROPN B-LF
-Geriatric PROPN I-LF
-Screening PROPN I-LF
-Tool PROPN I-LF
-( PUNCT B-O
-G8 PROPN B-AC
-) PUNCT B-O
-score NOUN B-O
-added VERB B-O
-statistically ADV B-O
-significant ADJ B-O
-predictive ADJ B-O
-value NOUN B-O
-( PUNCT B-O
-delta NOUN B-O
-C NOUN B-O
-: PUNCT B-O
-1.6 NUM B-O
-[ PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI NOUN B-O
-: PUNCT B-O
-0.4–2.8 NUM B-O
-] PUNCT B-O
-) PUNCT B-O
-( PUNCT B-O
-S10 PROPN B-O
-Table PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-March PROPN B-O
-2016 NUM B-O
-, PUNCT B-O
-HRSA PROPN B-AC
-awarded VERB B-O
-$ SYM B-O
-94 NUM B-O
-million NUM B-O
-through ADP B-O
-the DET B-O
-Substance PROPN B-LF
-Abuse PROPN I-LF
-Service PROPN I-LF
-Expansion PROPN I-LF
-( PUNCT B-O
-SASE PROPN B-AC
-) PUNCT B-O
-supplemental ADJ B-O
-grants NOUN B-O
-to ADP B-O
-271 NUM B-O
-or CCONJ B-O
-20 NUM B-O
-% NOUN B-O
-of ADP B-O
-HCs PROPN B-AC
-, PUNCT B-O
-with ADP B-O
-supplementary ADJ B-O
-funding NOUN B-O
-ranging VERB B-O
-from ADP B-O
-$ SYM B-O
-217,000 NUM B-O
-to ADP B-O
-$ SYM B-O
-406,000 NUM B-O
-. PUNCT B-O
-
-FisB PROPN B-AC
-, PUNCT B-O
-fission NOUN B-LF
-protein NOUN I-LF
-B. NOUN I-LF
-Consistent ADJ B-O
-with ADP B-O
-this PRON B-O
-, PUNCT B-O
-ICP47 PROPN B-O
-protects VERB B-O
-HSV PROPN B-AC
-- PUNCT B-O
-infected VERB B-O
-human ADJ B-O
-fibroblasts NOUN B-O
-from ADP B-O
-destruction NOUN B-O
-by ADP B-O
-cytotoxic ADJ B-LF
-T PROPN I-LF
-lymphocytes NOUN I-LF
-( PUNCT B-O
-CTLs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-while SCONJ B-O
-murine ADJ B-O
-fibroblasts NOUN B-O
-are AUX B-O
-not PART B-O
-protected VERB B-O
-[ PUNCT B-O
-22 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-These DET B-O
-data NOUN B-O
-were AUX B-O
-then ADV B-O
-analyzed VERB B-O
-via ADP B-O
-a DET B-O
-one NUM B-O
-- PUNCT B-O
-way NOUN B-O
-repeated VERB B-O
-measures NOUN B-O
-analysis NOUN B-LF
-of ADP I-LF
-variance NOUN I-LF
-( PUNCT B-O
-ANOVA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-with ADP B-O
-Fisher PROPN B-O
-’s PART B-O
-post X B-O
-hoc X B-O
-analysis NOUN B-O
-of ADP B-O
-each DET B-O
-experimental ADJ B-O
-treatment NOUN B-O
-group NOUN B-O
-compared VERB B-O
-to ADP B-O
-vehicle NOUN B-O
-following VERB B-O
-a DET B-O
-significant ADJ B-O
-ANOVA PROPN B-AC
-( PUNCT B-O
-P NOUN B-O
-< ADP B-O
-0.05 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-plotted VERB B-O
-as ADP B-O
-a DET B-O
-mean NOUN B-O
-± ADJ B-O
-S.E.M. NOUN B-O
-for ADP B-O
-the DET B-O
-group NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-have AUX B-O
-also ADV B-O
-challenged VERB B-O
-our PRON B-O
-whole ADJ B-O
-blood NOUN B-O
-samples NOUN B-O
-with ADP B-O
-either CCONJ B-O
-intact ADJ B-O
-bacterial ADJ B-O
-( PUNCT B-O
-E.coli PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-or CCONJ B-O
-virus NOUN B-O
-( PUNCT B-O
-HSV-1 PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-rather ADV B-O
-than ADP B-O
-specific ADJ B-O
-Toll NOUN B-LF
-like ADP I-LF
-receptor NOUN I-LF
-( PUNCT B-O
-TLR PROPN B-AC
-) PUNCT B-O
-agonists NOUN B-O
-like ADP B-O
-lipopolysaccharide NOUN B-LF
-( PUNCT B-O
-LPS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-since SCONJ B-O
-we PRON B-O
-considered VERB B-O
-intact ADJ B-O
-pathogens NOUN B-O
-more ADV B-O
-representative ADJ B-O
-of ADP B-O
-in X B-O
-vivo X B-O
-infections NOUN B-O
-. PUNCT B-O
-
-* PUNCT B-O
-Value NOUN B-O
-of ADP B-O
-% NOUN B-O
-DNA NOUN B-LF
-repair NOUN I-LF
-capacity NOUN I-LF
-( PUNCT B-O
-DRC PROPN B-AC
-) PUNCT B-O
-measured VERB B-O
-in ADP B-O
-lymphocytes NOUN B-O
-expressed VERB B-O
-as ADP B-O
-mean NOUN B-O
-( PUNCT B-O
-X NOUN B-O
-¯ NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-± NOUN B-O
-1 NUM B-O
-standard ADJ B-O
-deviation NOUN B-O
-( PUNCT B-O
-SD NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-median ADJ B-O
-values NOUN B-O
-including VERB B-O
-percentile NOUN B-O
-25 NUM B-O
-( PUNCT B-O
-P25 NUM B-O
-) PUNCT B-O
-and CCONJ B-O
-percentile NOUN B-O
-75 NUM B-O
-( PUNCT B-O
-P75 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Those DET B-O
-incident NOUN B-O
-cases NOUN B-O
-with ADP B-O
-sequelae NOUN B-O
-( PUNCT B-O
-or CCONJ B-O
-diseased ADJ B-O
-individuals NOUN B-O
-) PUNCT B-O
-were AUX B-O
-assigned VERB B-O
-years NOUN B-LF
-of ADP I-LF
-life NOUN I-LF
-lost VERB I-LF
-( PUNCT B-O
-YLLs PROPN B-AC
-) PUNCT B-O
-if SCONJ B-O
-fatal ADJ B-O
-or CCONJ B-O
-years NOUN B-LF
-lived VERB I-LF
-with ADP I-LF
-disability NOUN I-LF
-( PUNCT B-O
-YLDs PROPN B-AC
-) PUNCT B-O
-with ADP B-O
-a DET B-O
-disability NOUN B-LF
-weight NOUN I-LF
-( PUNCT B-O
-DW PROPN B-AC
-) PUNCT B-O
-that PRON B-O
-depended VERB B-O
-on ADP B-O
-the DET B-O
-severity NOUN B-O
-of ADP B-O
-the DET B-O
-disease NOUN B-O
-. PUNCT B-O
-
-Nutrient NOUN B-O
-intake NOUN B-O
-stimulates VERB B-O
-production NOUN B-O
-of ADP B-O
-circulating VERB B-O
-Drosophila PROPN B-LF
-insulin NOUN I-LF
-- PUNCT I-LF
-like ADJ I-LF
-peptides NOUN I-LF
-( PUNCT B-O
-Dilps PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-activate VERB B-O
-the DET B-O
-insulin NOUN B-O
-/ SYM B-O
-IGF-1 PROPN B-AC
-receptor NOUN B-O
-( PUNCT B-O
-InR PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-leading VERB B-O
-to ADP B-O
-the DET B-O
-recruitment NOUN B-O
-of ADP B-O
-the DET B-O
-phosphatidyl NOUN B-LF
-inositol-3 NOUN I-LF
-- PUNCT I-LF
-kinase NOUN I-LF
-( PUNCT B-O
-PI3K PROPN B-AC
-— PUNCT B-O
-composed VERB B-O
-of ADP B-O
-two NUM B-O
-subunits NOUN B-O
-, PUNCT B-O
-p60 NOUN B-O
-and CCONJ B-O
-p110 NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-coverts VERB B-O
-phosphatidyl NOUN B-LF
-inositol NOUN I-LF
-phosphate NOUN I-LF
-( PUNCT B-O
-PIP)2 PROPN B-AC
-to ADP B-O
-PIP3 PROPN B-O
-at ADP B-O
-the DET B-O
-plasma NOUN B-O
-membrane NOUN B-O
-of ADP B-O
-signal NOUN B-O
-- PUNCT B-O
-receiving VERB B-O
-cells NOUN B-O
-( PUNCT B-O
-a DET B-O
-process NOUN B-O
-antagonised VERB B-O
-by ADP B-O
-the DET B-O
-phosphatase NOUN B-LF
-and CCONJ I-LF
-tensin NOUN I-LF
-homolog NOUN I-LF
-PTEN PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-3 NUM B-O
-, PUNCT B-O
-20–30 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-AMR PROPN B-AC
-, PUNCT B-O
-asthma NOUN B-LF
-medication NOUN I-LF
-ratio NOUN I-LF
-; PUNCT B-O
-CI PROPN B-O
-, PUNCT B-O
-confidence NOUN B-O
-interval NOUN B-O
-; PUNCT B-O
-GAM PROPN B-AC
-, PUNCT B-O
-generalised ADJ B-LF
-additive ADJ I-LF
-model NOUN I-LF
-; PUNCT B-O
-WIMD PROPN B-AC
-, PUNCT B-O
-Welsh PROPN B-LF
-Index PROPN I-LF
-of ADP I-LF
-Multiple PROPN I-LF
-Deprivation PROPN I-LF
-. PUNCT B-O
-
-ALT PROPN B-AC
-serum NOUN B-O
-concentration NOUN B-O
-was AUX B-O
-analyzed VERB B-O
-as SCONJ B-O
-categorical ADJ B-O
-variable NOUN B-O
-in ADP B-O
-this DET B-O
-model NOUN B-O
-, PUNCT B-O
-as SCONJ B-O
-indicated VERB B-O
-. PUNCT B-O
-
-w PROPN B-O
-, PUNCT B-O
-women NOUN B-O
-; PUNCT B-O
-m PROPN B-O
-, PUNCT B-O
-men NOUN B-O
-; PUNCT B-O
-ALT PROPN B-AC
-, PUNCT B-O
-alanine NOUN B-LF
-aminotransferase NOUN I-LF
-; PUNCT B-O
-BMI PROPN B-AC
-, PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-; PUNCT B-O
-γGT PROPN B-O
-, PUNCT B-O
-γ PUNCT B-O
-- PUNCT B-O
-glutamyl NOUN B-O
-transferase NOUN B-O
-; PUNCT B-O
-IFN PROPN B-AC
-, PUNCT B-O
-interferon NOUN B-LF
-; PUNCT B-O
-INR PROPN B-AC
-, PUNCT B-O
-international ADJ B-LF
-normalized ADJ I-LF
-ratio NOUN I-LF
-; PUNCT B-O
-IFN PROPN B-AC
-, PUNCT B-O
-interferon NOUN B-LF
-; PUNCT B-O
-ULN PROPN B-AC
-, PUNCT B-O
-upper ADJ B-LF
-limit NOUN I-LF
-of ADP I-LF
-normal ADJ I-LF
-. PUNCT B-O
-
-In ADP B-O
-spite NOUN B-O
-of ADP B-O
-the DET B-O
-considerable ADJ B-O
-body NOUN B-O
-of ADP B-O
-research NOUN B-O
-on ADP B-O
-NDDs PROPN B-AC
-such ADJ B-O
-as ADP B-O
-Alzheimer PROPN B-LF
-’s PART I-LF
-disease NOUN I-LF
-( PUNCT B-O
-AD PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-amyotrophic ADJ B-LF
-lateral ADJ I-LF
-sclerosis NOUN I-LF
-( PUNCT B-O
-ALS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Huntington PROPN B-LF
-’s PART I-LF
-disease NOUN I-LF
-( PUNCT B-O
-HD PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-multiple ADJ B-LF
-sclerosis NOUN I-LF
-( PUNCT B-O
-MS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Parkinson PROPN B-LF
-’s PART I-LF
-disease NOUN I-LF
-( PUNCT B-O
-PD PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-schizophrenia NOUN B-LF
-( PUNCT B-O
-SCHIZ PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-effective ADJ B-O
-treatment NOUN B-O
-for ADP B-O
-preventing VERB B-O
-the DET B-O
-progressive ADJ B-O
-neuronal ADJ B-O
-loss NOUN B-O
-is AUX B-O
-yet ADV B-O
-to PART B-O
-be AUX B-O
-available ADJ B-O
-[ PUNCT B-O
-2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-LAM PROPN B-AC
-, PUNCT B-O
-lipoarabinomannan NOUN B-LF
-assay NOUN I-LF
-; PUNCT B-O
-TB PROPN B-AC
-, PUNCT B-O
-tuberculosis NOUN B-LF
-; PUNCT B-O
-Xpert PROPN B-AC
-, PUNCT B-O
-Xpert PROPN B-LF
-MTB PROPN I-LF
-Xpert PROPN B-AC
-/ SYM I-LF
-MTB PROPN B-AC
-RIF PROPN I-LF
-assay NOUN I-LF
-. PUNCT B-O
-
-“ PUNCT B-O
-… PUNCT B-O
-any DET B-O
-work NOUN B-O
-[ X B-O
-done VERB B-O
-] X B-O
-PA PROPN B-AC
-[ X B-O
-posteroanterior ADJ B-LF
-] X B-O
-, PUNCT B-O
-especially ADV B-O
-chests NOUN B-O
-, PUNCT B-O
-I PRON B-O
-always ADV B-O
-like ADP B-O
-to PART B-O
-have AUX B-O
-a DET B-O
-[ X B-O
-radiopaque ADJ B-O
-] X B-O
-marker NOUN B-O
-on ADP B-O
-, PUNCT B-O
-or CCONJ B-O
-sinuses NOUN B-O
-or CCONJ B-O
-skulls NOUN B-O
-because SCONJ B-O
-if SCONJ B-O
-you PRON B-O
-do AUX B-O
-get VERB B-O
-dextrocardia NOUN B-O
-or CCONJ B-O
-something PRON B-O
-like ADP B-O
-that SCONJ B-O
-… PUNCT B-O
-you PRON B-O
-can AUX B-O
-stand VERB B-O
-in ADP B-O
-front NOUN B-O
-of ADP B-O
-the DET B-O
-… PUNCT B-O
-film NOUN B-O
-[ X B-O
-detector NOUN B-O
-] X B-O
-where SCONJ B-O
-your PRON B-O
-marker NOUN B-O
-was AUX B-O
-and CCONJ B-O
-check VERB B-O
-, PUNCT B-O
-was AUX B-O
-it PRON B-O
-a DET B-O
-left NOUN B-O
-or CCONJ B-O
-right NOUN B-O
-and CCONJ B-O
-then ADV B-O
-double ADV B-O
-check VERB B-O
-yourself PRON B-O
-that SCONJ B-O
-you PRON B-O
-have AUX B-O
-actually ADV B-O
-labelled VERB B-O
-it PRON B-O
-correctly ADV B-O
-. PUNCT B-O
-
-Fluorescence NOUN B-LF
-- PUNCT I-LF
-activated VERB I-LF
-cell NOUN I-LF
-sorting NOUN I-LF
-( PUNCT B-O
-FACS PROPN B-AC
-) PUNCT B-O
-sorting NOUN B-O
-to PART B-O
-enrich VERB B-O
-for ADP B-O
-glioma NOUN B-O
-stem NOUN B-O
-cells NOUN B-O
-has AUX B-O
-relied VERB B-O
-on ADP B-O
-the DET B-O
-presence NOUN B-O
-of ADP B-O
-the DET B-O
-glycosylated VERB B-O
-form NOUN B-O
-of ADP B-O
-the DET B-O
-cell NOUN B-O
-surface NOUN B-O
-marker NOUN B-O
-CD133 NOUN B-O
-( PUNCT B-O
-Prominin-1 NOUN B-O
-): PUNCT B-O
-a DET B-O
-protein NOUN B-O
-whose DET B-O
-role NOUN B-O
-in ADP B-O
-tumorigenesis NOUN B-O
-and CCONJ B-O
-glioma NOUN B-O
-biology NOUN B-O
-remains VERB B-O
-unclear ADJ B-O
-[ PUNCT B-O
-27 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Among ADP B-O
-the DET B-O
-methodologies NOUN B-O
-used VERB B-O
-to ADP B-O
-ascertain VERB B-O
-cause NOUN B-LF
-of ADP I-LF
-death NOUN I-LF
-( PUNCT B-O
-CoD PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-those PRON B-O
-derived VERB B-O
-from ADP B-O
-the DET B-O
-verbal ADJ B-O
-autopsy NOUN B-O
-lack VERB B-O
-specificity NOUN B-O
-with ADP B-O
-regard NOUN B-O
-to ADP B-O
-most ADJ B-O
-biological ADJ B-O
-causes NOUN B-O
-of ADP B-O
-death NOUN B-O
-. PUNCT B-O
-
-EASI PROPN B-AC
-, PUNCT B-O
-Eczema PROPN B-LF
-Area PROPN I-LF
-and CCONJ I-LF
-Severity PROPN I-LF
-Index PROPN I-LF
-. PUNCT B-O
-
-We PRON B-O
-found VERB B-O
-biological ADJ B-O
-factors NOUN B-O
-including VERB B-O
-girls NOUN B-O
-experiencing VERB B-O
-early ADJ B-O
-menarche NOUN B-O
-, PUNCT B-O
-having VERB B-O
-lighter ADJ B-O
-periods NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-( PUNCT B-O
-BMI PROPN B-AC
-) PUNCT B-O
-; PUNCT B-O
-household NOUN B-O
-level NOUN B-O
-factors NOUN B-O
-including VERB B-O
-being AUX B-O
-unhappy ADJ B-O
-at ADP B-O
-home NOUN B-O
-, PUNCT B-O
-being AUX B-O
-orphaned VERB B-O
-, PUNCT B-O
-and CCONJ B-O
-coming VERB B-O
-from ADP B-O
-poorer ADJ B-O
-households NOUN B-O
-; PUNCT B-O
-and CCONJ B-O
-social ADJ B-O
-factors NOUN B-O
-including VERB B-O
-experiencing VERB B-O
-harassment NOUN B-O
-for ADP B-O
-sex NOUN B-O
-both PRON B-O
-in ADP B-O
-and CCONJ B-O
-out ADP B-O
-of ADP B-O
-school NOUN B-O
-or CCONJ B-O
-being AUX B-O
-touched VERB B-O
-indecently ADV B-O
-were AUX B-O
-significantly ADV B-O
-associated VERB B-O
-with ADP B-O
-girls NOUN B-O
-’ PUNCT B-O
-sexual ADJ B-O
-and CCONJ B-O
-reproductive ADJ B-O
-harms NOUN B-O
-, PUNCT B-O
-such ADJ B-O
-as ADP B-O
-pregnancy NOUN B-O
-, PUNCT B-O
-HSV-2 PROPN B-AC
-, PUNCT B-O
-and/or CCONJ B-O
-HIV PROPN B-O
-. PUNCT B-O
-
-L1 PROPN B-O
-, PUNCT B-O
-L2 PROPN B-O
-, PUNCT B-O
-L3 PROPN B-O
-= PUNCT B-O
-Languages NOUN B-O
-1–3 NUM B-O
-. PUNCT B-O
-
-fMRI PROPN B-AC
-, PUNCT B-O
-functional ADJ B-LF
-MRI NOUN I-LF
-; PUNCT B-O
-lPL PROPN B-AC
-, PUNCT B-O
-left ADJ B-LF
-parietal ADJ I-LF
-lobe NOUN I-LF
-; PUNCT B-O
-POz PROPN B-AC
-, PUNCT B-O
-midline ADJ B-LF
-posterior ADJ I-LF
-location NOUN I-LF
-according VERB I-LF
-to ADP I-LF
-the DET I-LF
-10–20 NUM I-LF
-system NOUN I-LF
-electrode NOUN I-LF
-location NOUN I-LF
-; PUNCT B-O
-rTMS PROPN B-AC
-, PUNCT B-O
-repetitive ADJ B-LF
-transcranial ADJ I-LF
-magnetic ADJ I-LF
-stimulation NOUN I-LF
-. PUNCT B-O
-
-SFM PROPN B-AC
-shows VERB B-O
-result NOUN B-O
-of ADP B-O
-serum NOUN B-LF
-free ADJ I-LF
-medium NOUN I-LF
-alone ADV B-O
-( PUNCT B-O
-baseline NOUN B-O
-control NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-thalamus NOUN B-O
-expression NOUN B-O
-domain NOUN B-O
-of ADP B-O
-lhx9 NOUN B-O
-overlaps VERB B-O
-with ADP B-O
-the DET B-O
-pattern NOUN B-O
-of ADP B-O
-id2a NOUN B-O
-in ADP B-O
-the DET B-O
-medial ADJ B-O
-part NOUN B-O
-of ADP B-O
-the DET B-O
-mantle NOUN B-LF
-zone NOUN I-LF
-( PUNCT B-O
-g NOUN B-O
-, PUNCT B-O
-g′ NOUN B-O
-, PUNCT B-O
-black ADJ B-O
-bar NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-lef1 NOUN B-O
-as ADP B-O
-a DET B-O
-marker NOUN B-O
-of ADP B-O
-post ADJ B-O
-- NOUN B-O
-mitotic ADJ B-O
-thalamic ADJ B-O
-neurons NOUN B-O
-shows VERB B-O
-co NOUN B-O
-- NOUN B-O
-expression NOUN B-O
-with ADP B-O
-lhx9 NOUN B-O
-in ADP B-O
-the DET B-O
-MZ PROPN B-AC
-( PUNCT B-O
-i NOUN B-O
-, PUNCT B-O
-i′ NOUN B-O
-; PUNCT B-O
-black ADJ B-O
-bar NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Two NUM B-O
-- PUNCT B-O
-month NOUN B-O
-- PUNCT B-O
-old ADJ B-O
-Thy1 PROPN B-O
-- PUNCT B-O
-YFP PROPN B-AC
-transgenic VERB B-O
-mice NOUN B-O
-expressing VERB B-O
-yellow ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-( PUNCT B-O
-YFP PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-layer NOUN B-LF
-5 NUM I-LF
-( PUNCT B-O
-L5 PROPN B-AC
-) PUNCT B-O
-pyramidal ADJ B-O
-neurons NOUN B-O
-were AUX B-O
-repeatedly ADV B-O
-imaged VERB B-O
-before ADP B-O
-and CCONJ B-O
-1 NUM B-O
-to ADP B-O
-4 NUM B-O
-weeks NOUN B-O
-after ADP B-O
-peripheral ADJ B-O
-nerve NOUN B-O
-injury NOUN B-O
-( PUNCT B-O
-Fig NOUN B-O
-3A NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-the DET B-O
-region NOUN B-O
-of ADP B-O
-S1 PROPN B-AC
-corresponding VERB B-O
-to ADP B-O
-the DET B-O
-SNI PROPN B-AC
-surgery NOUN B-O
-side NOUN B-O
-, PUNCT B-O
-we PRON B-O
-found VERB B-O
-a DET B-O
-significant ADJ B-O
-increase NOUN B-O
-in ADP B-O
-the DET B-O
-elimination NOUN B-O
-and CCONJ B-O
-formation NOUN B-O
-rates NOUN B-O
-of ADP B-O
-dendritic ADJ B-O
-spines NOUN B-O
-( PUNCT B-O
-Fig NOUN B-O
-3B NUM B-O
-and CCONJ B-O
-3C NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Within ADP B-O
-the DET B-O
-first ADJ B-O
-week NOUN B-O
-after ADP B-O
-surgery NOUN B-O
-, PUNCT B-O
-7.7 NUM B-O
-± SYM B-O
-0.6 NUM B-O
-% NOUN B-O
-of ADP B-O
-dendritic ADJ B-O
-spines NOUN B-O
-were AUX B-O
-eliminated VERB B-O
-and CCONJ B-O
-8.1 NUM B-O
-± SYM B-O
-0.5 NUM B-O
-% NOUN B-O
-were AUX B-O
-formed VERB B-O
-in ADP B-O
-sham ADJ B-O
-mice NOUN B-O
-, PUNCT B-O
-whereas SCONJ B-O
-11.4 NUM B-O
-± SYM B-O
-1.1 NUM B-O
-% NOUN B-O
-and CCONJ B-O
-11.9 NUM B-O
-± SYM B-O
-1.1 NUM B-O
-% NOUN B-O
-of ADP B-O
-dendritic ADJ B-O
-spines NOUN B-O
-were AUX B-O
-eliminated VERB B-O
-and CCONJ B-O
-formed VERB B-O
-in ADP B-O
-SNI PROPN B-AC
-mice NOUN B-O
-, PUNCT B-O
-respectively ADV B-O
-. PUNCT B-O
-
-Inhibitor-2 NOUN B-LF
-( PUNCT B-O
-I-2 PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-highly ADV B-O
-conserved ADJ B-O
-protein NOUN B-O
-, PUNCT B-O
-interacts VERB B-O
-with ADP B-O
-the DET B-O
-catalytic ADJ B-O
-subunit NOUN B-O
-of ADP B-O
-protein NOUN B-LF
-phosphatase NOUN I-LF
-1 NUM I-LF
-( PUNCT B-O
-PP1 PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-inhibits VERB B-O
-its PRON B-O
-catalytic ADJ B-O
-activity NOUN B-O
-in ADP B-O
-vitro ADV B-O
-[ PUNCT B-O
-33 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-HR NOUN B-O
-, PUNCT B-O
-Heart NOUN B-O
-Rate NOUN B-O
-; PUNCT B-O
-SBP PROPN B-O
-, PUNCT B-O
-Systolic ADJ B-O
-Blood NOUN B-O
-Pressure NOUN B-O
-; PUNCT B-O
-DBP NOUN B-O
-, PUNCT B-O
-Diastolic ADJ B-O
-Blood NOUN B-O
-Pressure NOUN B-O
-; PUNCT B-O
-PP NOUN B-O
-, PUNCT B-O
-Pulse NOUN B-O
-Pressure NOUN B-O
-; PUNCT B-O
-FFR PROPN B-AC
-, PUNCT B-O
-Fractional ADJ B-LF
-Flow PROPN I-LF
-reserve NOUN I-LF
-; PUNCT B-O
-CFVR PROPN B-AC
-, PUNCT B-O
-Coronary ADJ B-LF
-Flow PROPN I-LF
-Velocity PROPN I-LF
-Reserve PROPN I-LF
-; PUNCT B-O
-sFCW PROPN B-AC
-, PUNCT B-O
-systolic ADJ B-LF
-Forward ADJ I-LF
-travelling VERB I-LF
-Compression NOUN I-LF
-Wave PROPN I-LF
-; PUNCT B-O
-dBEW PROPN B-AC
-, PUNCT B-O
-diastolic ADJ B-LF
-Backward ADJ I-LF
-travelling VERB I-LF
-Expansion NOUN I-LF
-Wave PROPN I-LF
-( PUNCT B-O
-Table PROPN B-O
-C PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Univariate ADJ B-O
-linear ADJ B-O
-regression NOUN B-O
-analyses NOUN B-O
-of ADP B-O
-baseline ADJ B-O
-( PUNCT B-O
-pre ADJ B-O
-- ADJ B-O
-PCI PROPN B-AC
-) PUNCT B-O
-sFCW PROPN B-AC
-and CCONJ B-O
-dBEW PROPN B-AC
-cumulative ADJ B-O
-intensity NOUN B-O
-with ADP B-O
-baseline ADJ B-O
-haemodynamic ADJ B-O
-and CCONJ B-O
-patient ADJ B-O
-variables NOUN B-O
-. PUNCT B-O
-
-FRET PROPN B-AC
-, PUNCT B-O
-Förster PROPN B-LF
-resonance NOUN I-LF
-energy NOUN I-LF
-transfer NOUN I-LF
-; PUNCT B-O
-GP PROPN B-AC
-, PUNCT B-O
-EBOV NOUN B-LF
-envelope NOUN I-LF
-EBOV PROPN B-AC
-glycoprotein NOUN I-LF
-; PUNCT B-O
-GPΔmuc PROPN B-AC
-, PUNCT B-O
-GP PROPN B-LF
-with ADP I-LF
-GP PROPN B-AC
-the DET I-LF
-mucin NOUN I-LF
-- PUNCT I-LF
-like ADJ I-LF
-domain NOUN I-LF
-deleted VERB I-LF
-; PUNCT B-O
-MD PROPN B-AC
-, PUNCT B-O
-molecular ADJ B-LF
-dynamics NOUN I-LF
-. PUNCT B-O
-
-The DET B-O
-apparent ADJ B-LF
-digestibility NOUN I-LF
-coefficients NOUN I-LF
-( PUNCT B-O
-ADCs PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-DM PROPN B-AC
-, PUNCT B-O
-protein NOUN B-O
-, PUNCT B-O
-lipid NOUN B-O
-, PUNCT B-O
-ash NOUN B-O
-and CCONJ B-O
-energy NOUN B-O
-were AUX B-O
-calculated VERB B-O
-using VERB B-O
-the DET B-O
-following VERB B-O
-equation NOUN B-O
-[ X B-O
-25 NUM B-O
-] PUNCT B-O
-: PUNCT B-O
-ADCnutrientorenergy=[1−(Markerfeed×NutrientfaecesMarkerfaeces×Nutrientfeed)]×100(1 X B-O
-) PUNCT B-O
-ADCdry ADJ B-O
-matter=[1−(MarkerfeedMarkerfaeces)]×100(2 X B-O
-) PUNCT B-O
-where SCONJ B-O
-Markerfeed PROPN B-O
-and CCONJ B-O
-Markerfaeces NOUN B-O
-are AUX B-O
-the DET B-O
-contents NOUN B-O
-of ADP B-O
-the DET B-O
-marker NOUN B-O
-( PUNCT B-O
-% PUNCT B-O
-dry ADJ B-LF
-matter NOUN I-LF
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-feed NOUN B-O
-and CCONJ B-O
-faeces NOUN B-O
-, PUNCT B-O
-respectively ADV B-O
-, PUNCT B-O
-and CCONJ B-O
-Nutrientfeed PROPN B-O
-and CCONJ B-O
-Nutrientfaeces PROPN B-O
-are AUX B-O
-the DET B-O
-nutrient NOUN B-O
-contents NOUN B-O
-( PUNCT B-O
-% PUNCT B-O
-dry ADJ B-LF
-matter NOUN I-LF
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-feed NOUN B-O
-and CCONJ B-O
-faeces NOUN B-O
-. PUNCT B-O
-
-Excess ADJ B-LF
-lung NOUN I-LF
-weight NOUN I-LF
-( PUNCT B-O
-ELW PROPN B-AC
-) PUNCT B-O
-showed VERB B-O
-highly ADV B-O
-significant ADJ B-O
-correlation NOUN B-O
-with ADP B-O
-parameters NOUN B-O
-describing VERB B-O
-inflation NOUN B-O
-( PUNCT B-O
-inflated VERB B-O
-lung NOUN B-O
-tissue NOUN B-O
-[ X B-O
-% X B-O
-] X B-O
-p NOUN B-O
-= SYM B-O
-0.0001 NUM B-O
-r NOUN B-O
-= SYM B-O
--0.65 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-haemodynamics NOUN B-O
-( PUNCT B-O
-SOFA_cv NOUN B-O
-mean NOUN B-O
-p NOUN B-O
-= SYM B-O
-0.03 NUM B-O
-r NOUN B-O
-= SYM B-O
-0.41 NUM B-O
-) PUNCT B-O
-and CCONJ B-O
-applied VERB B-O
-ventilation NOUN B-O
-pressures NOUN B-O
-( PUNCT B-O
-PEEP PROPN B-AC
-[ X B-O
-mmHg X B-O
-] X B-O
-p NOUN B-O
-= SYM B-O
-0.05 NUM B-O
-r NOUN B-O
-= SYM B-O
-0.37 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-To PART B-O
-do VERB B-O
-so ADV B-O
-we PRON B-O
-apply VERB B-O
-descriptive ADJ B-O
-statistics NOUN B-O
-and CCONJ B-O
-conduct VERB B-O
-logistic ADJ B-O
-and CCONJ B-O
-multinomial ADJ B-O
-regressions NOUN B-O
-using VERB B-O
-data NOUN B-O
-from ADP B-O
-the DET B-O
-Service PROPN B-LF
-Provision PROPN I-LF
-Assessment PROPN I-LF
-( PUNCT B-O
-SPA PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-the DET B-O
-Demographic PROPN B-LF
-and CCONJ I-LF
-Health PROPN I-LF
-Surveys PROPN I-LF
-( PUNCT B-O
-DHS PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-all DET B-O
-health NOUN B-O
-facilities NOUN B-O
-in ADP B-O
-Malawi PROPN B-O
-in ADP B-O
-2013/2014 NUM B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-CABG PROPN B-AC
-, PUNCT B-O
-coronary ADJ B-LF
-artery NOUN I-LF
-bypass NOUN I-LF
-grift NOUN I-LF
-; PUNCT B-O
-PTCA PROPN B-AC
-, PUNCT B-O
-percutaneous ADJ B-LF
-transluminal ADJ I-LF
-coronary ADJ I-LF
-angioplasty NOUN I-LF
-; PUNCT B-O
-ACE PROPN B-AC
-: PUNCT B-O
-Angiotensin NOUN B-LF
-converting VERB I-LF
-enzyme NOUN I-LF
-. PUNCT B-O
-
-Consignments NOUN B-O
-with ADP B-O
-one NUM B-O
-or CCONJ B-O
-more ADJ B-O
-“ PUNCT B-O
-POS PROPN B-AC
-” PUNCT B-O
-samples NOUN B-O
-were AUX B-O
-classified VERB B-O
-as ADP B-O
-OJD PROPN B-AC
-“ PUNCT B-O
-Positive ADJ B-LF
-” PUNCT B-O
-. PUNCT B-O
-
-GFP PROPN B-AC
-, PUNCT B-O
-green ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-; PUNCT B-O
-RNAi PROPN B-AC
-, PUNCT B-O
-RNA NOUN B-LF
-interference NOUN I-LF
-; PUNCT B-O
-TOR PROPN B-AC
-, PUNCT B-O
-Target NOUN B-LF
-of ADP I-LF
-Rapamycin PROPN I-LF
-; PUNCT B-O
-tub NOUN B-O
-. PUNCT B-O
-
-Gal4 NOUN B-O
-, PUNCT B-O
-tubulin NOUN B-O
-. PUNCT B-O
-
-Gal4 NOUN B-O
-; PUNCT B-O
-UAS PROPN B-AC
-, PUNCT B-O
-Upstream PROPN B-LF
-activator NOUN I-LF
-sequence NOUN I-LF
-; PUNCT B-O
-Yki PROPN B-AC
-, PUNCT B-O
-Yorkie PROPN B-LF
-. PUNCT B-O
-
-The DET B-O
-Italian ADJ B-LF
-Liver PROPN I-LF
-Cancer PROPN I-LF
-( PUNCT B-O
-ITA.LI.CA PROPN B-AC
-) PUNCT B-O
-dataset NOUN B-O
-, PUNCT B-O
-including VERB B-O
-more ADJ B-O
-than ADP B-O
-5,000 NUM B-O
-Italian ADJ B-O
-HCC PROPN B-AC
-patients NOUN B-O
-prospectively ADV B-O
-enrolled VERB B-O
-from ADP B-O
-1 NUM B-O
-January PROPN B-O
-1987 NUM B-O
-to ADP B-O
-31 NUM B-O
-March PROPN B-O
-2012 NUM B-O
-, PUNCT B-O
-was AUX B-O
-used VERB B-O
-for ADP B-O
-the DET B-O
-training NOUN B-O
-and CCONJ B-O
-internal ADJ B-O
-validation NOUN B-O
-sets NOUN B-O
-. PUNCT B-O
-
-Schisandra PROPN B-LF
-chinensis PROPN I-LF
-( PUNCT B-O
-SC PROPN B-AC
-) PUNCT B-O
-has VERB B-O
-a DET B-O
-long ADJ B-O
-history NOUN B-O
-as ADP B-O
-a DET B-O
-medicinal ADJ B-O
-herb NOUN B-O
-and CCONJ B-O
-is AUX B-O
-a DET B-O
-traditional ADJ B-O
-component NOUN B-O
-in ADP B-O
-oriental ADJ B-O
-medicines NOUN B-O
-[ PUNCT B-O
-19,20 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Astrocytes NOUN B-LF
-aged VERB I-LF
-seven NUM I-LF
-days NOUN I-LF
-( PUNCT B-O
-E7 PROPN B-AC
-) PUNCT B-O
-showed VERB B-O
-increased VERB B-O
-proliferation NOUN B-O
-and CCONJ B-O
-diminished ADJ B-O
-differentiation NOUN B-O
-, PUNCT B-O
-while SCONJ B-O
-21 NUM B-O
-- PUNCT B-O
-day NOUN B-O
-- PUNCT B-O
-old ADJ B-O
-( PUNCT B-O
-E21 PROPN B-AC
-) PUNCT B-O
-astrocytes NOUN B-O
-depicted VERB B-O
-reversed VERB B-O
-effects NOUN B-O
-. PUNCT B-O
-
-ARE PROPN B-AC
-, PUNCT B-O
-antioxidant ADJ B-LF
-response NOUN I-LF
-element NOUN I-LF
-; PUNCT B-O
-IHC PROPN B-O
-, PUNCT B-O
-immunohistochemical NOUN B-O
-; PUNCT B-O
-MEF PROPN B-AC
-, PUNCT B-O
-mouse NOUN B-LF
-embryonic ADJ I-LF
-fibroblast NOUN I-LF
-; PUNCT B-O
-NRF2 PROPN B-AC
-, PUNCT B-O
-nuclear ADJ B-LF
-factor NOUN I-LF
-- PUNCT I-LF
-erythroid NOUN I-LF
-2 NUM I-LF
-- PUNCT I-LF
-like ADJ I-LF
-2 NUM I-LF
-; PUNCT B-O
-PTCH1 PROPN B-AC
-, PUNCT B-O
-Patched VERB B-LF
-1 NUM I-LF
-Reviewer NOUN B-O
-# NOUN B-O
-3 NUM B-O
-: PUNCT B-O
-In ADP B-O
-this DET B-O
-randomized ADJ B-O
-controlled VERB B-O
-trial NOUN B-O
-, PUNCT B-O
-the DET B-O
-Vienna PROPN B-LF
-Prediction PROPN I-LF
-Model PROPN I-LF
-( PUNCT B-O
-VPM PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-tested VERB B-O
-to ADP B-O
-determine VERB B-O
-whether SCONJ B-O
-implementing VERB B-O
-the DET B-O
-model NOUN B-O
-would AUX B-O
-reduce VERB B-O
-recurrence NOUN B-O
-risk NOUN B-O
-. PUNCT B-O
-
-883 NUM B-O
-patients NOUN B-O
-were AUX B-O
-randomised VERB B-O
-to ADP B-O
-using VERB B-O
-the DET B-O
-VPM PROPN B-AC
-compared VERB B-O
-with ADP B-O
-usual ADJ B-O
-care NOUN B-O
-. PUNCT B-O
-
-While SCONJ B-O
-various ADJ B-O
-cytokines NOUN B-O
-and CCONJ B-O
-growth NOUN B-O
-factors NOUN B-O
-are AUX B-O
-considered VERB B-O
-to ADP B-O
-contribute VERB B-O
-to ADP B-O
-skin NOUN B-O
-fibroblast NOUN B-O
-activation NOUN B-O
-in ADP B-O
-scleroderma NOUN B-O
-, PUNCT B-O
-transforming VERB B-LF
-growth NOUN I-LF
-factor NOUN I-LF
-- PUNCT I-LF
-β PUNCT I-LF
-( PUNCT B-O
-TGF-β PROPN B-AC
-) PUNCT B-O
-plays VERB B-O
-an DET B-O
-important ADJ B-O
-role NOUN B-O
-in ADP B-O
-the DET B-O
-fibrotic ADJ B-O
-reaction NOUN B-O
-of ADP B-O
-scleroderma NOUN B-O
-pathology NOUN B-O
-[ X B-O
-5 NUM B-O
-, PUNCT B-O
-6 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Additionally ADV B-O
-, PUNCT B-O
-the DET B-O
-latest ADJ B-O
-2020 NUM B-O
-ESC PROPN B-O
-Acute ADJ B-O
-Coronary ADJ B-O
-Syndromes PROPN B-O
-( PUNCT B-O
-ACS PROPN B-O
-) PUNCT B-O
-in ADP B-O
-Patients NOUN B-O
-Presenting VERB B-O
-without ADP B-O
-Persistent ADJ B-O
-ST ADJ B-O
-- PUNCT B-O
-Segment PROPN B-O
-Elevation PROPN B-O
-( PUNCT B-O
-Management NOUN B-O
-of ADP B-O
-) PUNCT B-O
-Guidelines PROPN B-O
-recommend VERB B-O
-complete ADJ B-O
-revascularization NOUN B-O
-in ADP B-O
-non ADJ B-O
-- PUNCT B-O
-ST ADJ B-O
-- PUNCT B-O
-elevation ADJ B-O
-acute ADJ B-O
-coronary ADJ B-O
-syndrome NOUN B-O
-( PUNCT B-O
-NSTE PROPN B-O
-- PUNCT B-O
-ACS PROPN B-O
-) PUNCT B-O
-patients NOUN B-O
-without ADP B-O
-cardiogenic ADJ B-O
-shock NOUN B-O
-and CCONJ B-O
-with ADP B-O
-MV PROPN B-O
-coronary ADJ B-LF
-artery NOUN I-LF
-disease NOUN I-LF
-( PUNCT B-O
-CAD PROPN B-AC
-) PUNCT B-O
-but CCONJ B-O
-offer VERB B-O
-no DET B-O
-recommendations NOUN B-O
-for ADP B-O
-patients NOUN B-O
-with ADP B-O
-severe ADJ B-O
-LVSD NOUN B-O
-[ PUNCT B-O
-12 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-We PRON B-O
-have AUX B-O
-previously ADV B-O
-described VERB B-O
-the DET B-O
-presence NOUN B-O
-of ADP B-O
-the DET B-O
-complement NOUN B-O
-- PUNCT B-O
-regulating VERB B-O
-protein NOUN B-O
-salivary ADJ B-LF
-scavenger NOUN I-LF
-and CCONJ I-LF
-agglutinin NOUN I-LF
-( PUNCT B-O
-SALSA PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-amniotic ADJ B-O
-fluid NOUN B-O
-. PUNCT B-O
-
-Their PRON B-O
-serum NOUN B-O
-samples NOUN B-O
-were AUX B-O
-extracted VERB B-O
-from ADP B-O
-a DET B-O
-population NOUN B-O
-- PUNCT B-O
-representative ADJ B-O
-biobank NOUN B-O
-, PUNCT B-O
-the DET B-O
-Finnish PROPN B-LF
-Maternity PROPN I-LF
-Cohort PROPN I-LF
-( PUNCT B-O
-FMC PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-18,21 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Previous ADJ B-O
-studies NOUN B-O
-of ADP B-O
-ischemia NOUN B-LF
-- ADJ I-LF
-reperfusion NOUN I-LF
-injury NOUN I-LF
-( PUNCT B-O
-IRI PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-hearts NOUN B-O
-from ADP B-O
-mice NOUN B-O
-with ADP B-O
-cardiac NOUN B-O
-- ADJ B-O
-restricted VERB B-O
-overexpression NOUN B-O
-of ADP B-O
-CCN2 PROPN B-O
-have AUX B-O
-shown VERB B-O
-that SCONJ B-O
-CCN2 PROPN B-O
-increases VERB B-O
-tolerance NOUN B-O
-towards ADP B-O
-IRI PROPN B-AC
-. PUNCT B-O
-
-The DET B-O
-objectives NOUN B-O
-of ADP B-O
-this DET B-O
-study NOUN B-O
-were AUX B-O
-to PART B-O
-investigate VERB B-O
-to PART B-O
-what DET B-O
-extent NOUN B-O
-post ADJ B-O
-- ADJ B-O
-ischemic ADJ B-O
-administration NOUN B-O
-of ADP B-O
-recombinant ADJ B-O
-human ADJ B-O
-CCN2 PROPN B-O
-( PUNCT B-O
-rhCCN2 PROPN B-AC
-) PUNCT B-O
-would AUX B-O
-limit VERB B-O
-infarct ADJ B-O
-size NOUN B-O
-and CCONJ B-O
-improve VERB B-O
-functional ADJ B-O
-recovery NOUN B-O
-and CCONJ B-O
-what DET B-O
-signaling NOUN B-O
-pathways NOUN B-O
-are AUX B-O
-involved VERB B-O
-. PUNCT B-O
-
-Type NOUN B-O
-I NUM B-O
-methanotrophs NOUN B-O
-( PUNCT B-O
-including VERB B-O
-Methylococcus PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-are AUX B-O
-all PRON B-O
-members NOUN B-O
-of ADP B-O
-the DET B-O
-Gammaproteobacteria NOUN B-O
-, PUNCT B-O
-utilize VERB B-O
-ribulose NOUN B-LF
-monophosphate NOUN I-LF
-( PUNCT B-O
-RuMP PROPN B-AC
-) PUNCT B-O
-as ADP B-O
-the DET B-O
-primary ADJ B-O
-pathway NOUN B-O
-for ADP B-O
-formaldehyde NOUN B-O
-assimilation NOUN B-O
-, PUNCT B-O
-whereas SCONJ B-O
-those PRON B-O
-of ADP B-O
-type NOUN B-O
-II NUM B-O
-, PUNCT B-O
-which PRON B-O
-are AUX B-O
-all PRON B-O
-Alphaproteobacteria NOUN B-O
-, PUNCT B-O
-use VERB B-O
-the DET B-O
-serine ADJ B-O
-pathway NOUN B-O
-( PUNCT B-O
-Hanson PROPN B-O
-and CCONJ B-O
-Hanson PROPN B-O
-1996 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-For ADP B-O
-SNP PROPN B-AC
-validation NOUN B-O
-statistics NOUN B-O
-using VERB B-O
-a DET B-O
-Markov PROPN B-O
-chain NOUN B-O
-method NOUN B-O
-, PUNCT B-O
-the DET B-O
-selected VERB B-O
-SNP PROPN B-AC
-markers NOUN B-O
-were AUX B-O
-further ADV B-O
-examined VERB B-O
-by ADP B-O
-testing VERB B-O
-the DET B-O
-deviation NOUN B-O
-from ADP B-O
-Hardy PROPN B-LF
-Weinberg PROPN I-LF
-equilibrium NOUN I-LF
-( PUNCT B-O
-HWE PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-each DET B-O
-SNP PROPN B-AC
-locus NOUN B-O
-( PUNCT B-O
-S62 PROPN B-O
-Table NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-for ADP B-O
-each DET B-O
-breed NOUN B-O
-population NOUN B-O
-( PUNCT B-O
-S63 PROPN B-O
-Table NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Those DET B-O
-individuals NOUN B-O
-who PRON B-O
-participated VERB B-O
-in ADP B-O
-an DET B-O
-external ADJ B-LF
-quality NOUN I-LF
-assurance NOUN I-LF
-( PUNCT B-O
-EQA PROPN B-AC
-) PUNCT B-O
-program NOUN B-O
-accounted VERB B-O
-for ADP B-O
-36(60 NUM B-O
-% NOUN B-O
-) PUNCT B-O
-( PUNCT B-O
-Table NOUN B-O
-1 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-However ADV B-O
-, PUNCT B-O
-the DET B-O
-Swedish ADJ B-O
-study NOUN B-O
-of ADP B-O
-Rai PROPN B-O
-et PROPN B-O
-al.[11 X B-O
-] X B-O
-reported VERB B-O
-a DET B-O
-clear ADJ B-O
-increase NOUN B-O
-in ADP B-O
-prevalence NOUN B-O
-in ADP B-O
-the DET B-O
-most ADV B-O
-deprived ADJ B-O
-backgrounds NOUN B-O
-even ADV B-O
-after ADP B-O
-taking VERB B-O
-into ADP B-O
-account NOUN B-O
-other ADJ B-O
-associated VERB B-O
-factors NOUN B-O
-and CCONJ B-O
-for ADP B-O
-all DET B-O
-cases NOUN B-O
-of ADP B-O
-ASD PROPN B-AC
-studied VERB B-O
-i.e. X B-O
-with ADP B-O
-or CCONJ B-O
-without ADP B-O
-associated VERB B-O
-intellectual ADJ B-LF
-disability NOUN I-LF
-( PUNCT B-O
-ID PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-A DET B-O
-comparison NOUN B-O
-of ADP B-O
-comorbidities NOUN B-O
-recorded VERB B-O
-through ADP B-O
-HES PROPN B-AC
-with ADP B-O
-those PRON B-O
-from ADP B-O
-primary ADJ B-O
-care NOUN B-O
-records NOUN B-O
-( PUNCT B-O
-clinical ADJ B-LF
-practice NOUN I-LF
-research NOUN I-LF
-database NOUN I-LF
-, PUNCT B-O
-CPRD PROPN B-AC
-) PUNCT B-O
-found VERB B-O
-that SCONJ B-O
-CPRD PROPN B-AC
-recorded VERB B-O
-more ADJ B-O
-comorbidity NOUN B-O
-than ADP B-O
-HES PROPN B-AC
-, PUNCT B-O
-but CCONJ B-O
-this PRON B-O
-did AUX B-O
-not PART B-O
-adversely ADV B-O
-affect VERB B-O
-their PRON B-O
-models NOUN B-O
-of ADP B-O
-mortality NOUN B-O
-risk NOUN B-O
-after ADP B-O
-gastrointestinal ADJ B-O
-bleeding NOUN B-O
-or CCONJ B-O
-diabetes NOUN B-O
-[ PUNCT B-O
-24 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-In SCONJ B-O
-order NOUN B-O
-to PART B-O
-examine VERB B-O
-whether SCONJ B-O
-ID PROPN B-AC
-is AUX B-O
-related VERB B-O
-with ADP B-O
-children NOUN B-O
-with ADP B-O
-hypothyroidism NOUN B-O
-or CCONJ B-O
-with ADP B-O
-low ADJ B-O
-income NOUN B-O
-, PUNCT B-O
-multivariable ADJ B-O
-analyses NOUN B-O
-were AUX B-O
-performed VERB B-O
-using VERB B-O
-Cox PROPN B-O
-proportional ADJ B-O
-hazards NOUN B-O
-models NOUN B-O
-to PART B-O
-calculate VERB B-O
-adjusted VERB B-O
-hazard NOUN B-LF
-ratios NOUN I-LF
-( PUNCT B-O
-HRs PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-LF
-intervals NOUN I-LF
-[ PUNCT B-O
-CIs PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-as ADP B-O
-an DET B-O
-estimate NOUN B-O
-of ADP B-O
-the DET B-O
-relative ADJ B-O
-rate NOUN B-O
-of ADP B-O
-ID PROPN B-AC
-. PUNCT B-O
-
-The DET B-O
-proportionality NOUN B-O
-assumption NOUN B-O
-was AUX B-O
-tested VERB B-O
-by ADP B-O
-plotting VERB B-O
-Schoenfeld PROPN B-O
-- PUNCT B-O
-like ADJ B-O
-residuals NOUN B-O
-. PUNCT B-O
-
-This DET B-O
-pathway NOUN B-O
-directly ADV B-O
-controls VERB B-O
-the DET B-O
-expression NOUN B-O
-of ADP B-O
-many ADJ B-O
-cell NOUN B-O
-- PUNCT B-O
-cycle NOUN B-O
-genes NOUN B-O
-and CCONJ B-O
-plays VERB B-O
-a DET B-O
-key ADJ B-O
-role NOUN B-O
-in ADP B-O
-embryonic ADJ B-LF
-stem NOUN I-LF
-cell NOUN I-LF
-( PUNCT B-O
-ESC PROPN B-AC
-) PUNCT B-O
-self NOUN B-O
-- PUNCT B-O
-renewal NOUN B-O
-[ PUNCT B-O
-37–39,54,55 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Data NOUN B-O
-are AUX B-O
-presented VERB B-O
-as ADP B-O
-mean ADJ B-LF
-fluorescence NOUN I-LF
-intensity NOUN I-LF
-( PUNCT B-O
-MFI PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-MFI PROPN B-AC
-was AUX B-O
-determined VERB B-O
-by ADP B-O
-FlowJo PROPN B-O
-Software PROPN B-O
-( PUNCT B-O
-TreeStar PROPN B-O
-, PUNCT B-O
-Ashland PROPN B-O
-, PUNCT B-O
-OR PROPN B-O
-, PUNCT B-O
-USA PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-line NOUN B-O
-in ADP B-O
-the DET B-O
-middle NOUN B-O
-represents VERB B-O
-the DET B-O
-median ADJ B-O
-value NOUN B-O
-. PUNCT B-O
-
-One NUM B-O
-such ADJ B-O
-insecticide NOUN B-O
-is AUX B-O
-pyriproxyfen NOUN B-LF
-( PUNCT B-O
-PPF PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-an DET B-O
-insect NOUN B-O
-juvenile ADJ B-O
-hormone NOUN B-O
-analogue NOUN B-O
-that PRON B-O
-kills VERB B-O
-mosquito NOUN B-O
-juveniles NOUN B-O
-at ADP B-O
-minute ADJ B-O
-doses NOUN B-O
-and CCONJ B-O
-can AUX B-O
-safely ADV B-O
-be AUX B-O
-used VERB B-O
-even ADV B-O
-in ADP B-O
-drinking NOUN B-O
-water NOUN B-O
-[ PUNCT B-O
-3,27,28 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Of ADP B-O
-the DET B-O
-22 NUM B-O
-studies NOUN B-O
-providing VERB B-O
-results NOUN B-O
-from ADP B-O
-human ADJ B-LF
-immunodeficiency NOUN I-LF
-virus NOUN I-LF
-( PUNCT B-O
-HIV)-testing PROPN B-AC
-, PUNCT B-O
-12 NUM B-O
-( PUNCT B-O
-55 NUM B-O
-% PUNCT B-O
-) PUNCT B-O
-reported VERB B-O
-HIV PROPN B-AC
-prevalence NOUN B-O
-greater ADJ B-O
-than ADP B-O
-50%[39,40,42,43,45–49,55,59 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-To PART B-O
-investigate VERB B-O
-whether SCONJ B-O
-spz5 PROPN B-O
-has VERB B-O
-neurotrophic ADJ B-O
-function NOUN B-O
-we PRON B-O
-first ADV B-O
-visualised VERB B-O
-its PRON B-O
-expression NOUN B-O
-pattern NOUN B-O
-. PUNCT B-O
-
-spz5 PROPN B-O
-is AUX B-O
-expressed VERB B-O
-at ADP B-O
-the DET B-O
-embryonic ADJ B-O
-CNS PROPN B-AC
-midline NOUN B-O
-( PUNCT B-O
-Figure PROPN B-O
-8C NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-in ADP B-O
-muscles NOUN B-O
-( PUNCT B-O
-Figure PROPN B-O
-9A NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-in ADP B-O
-the DET B-O
-epidermis NOUN B-O
-( PUNCT B-O
-unpublished ADJ B-O
-data NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-in ADP B-O
-the DET B-O
-embryonic ADJ B-O
-head NOUN B-O
-peripheral ADJ B-LF
-nervous ADJ I-LF
-system NOUN I-LF
-( PUNCT B-O
-PNS PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-unpublished ADJ B-O
-data NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-drug NOUN B-O
-was AUX B-O
-applied VERB B-O
-to ADP B-O
-the DET B-O
-skin NOUN B-O
-daily ADV B-O
-for ADP B-O
-5 NUM B-O
-days NOUN B-LF
-( PUNCT B-O
-5 NUM B-O
-d PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
-for ADP B-O
-12 NUM B-O
-days NOUN B-LF
-( PUNCT B-O
-1 NUM B-O
-, PUNCT B-O
-2 NUM B-O
-, PUNCT B-O
-3 NUM B-O
-, PUNCT B-O
-4 NUM B-O
-, PUNCT B-O
-5 NUM B-O
-, PUNCT B-O
-8 NUM B-O
-, PUNCT B-O
-9 NUM B-O
-, PUNCT B-O
-10 NUM B-O
-, PUNCT B-O
-11 NUM B-O
-, PUNCT B-O
-12th ADJ B-O
-day NOUN B-LF
-) PUNCT B-O
-( PUNCT B-O
-12d NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-routing NOUN B-O
-of ADP B-O
-DNA NOUN B-O
-through ADP B-O
-the DET B-O
-double ADJ B-O
-hexamers NOUN B-O
-is AUX B-O
-unclear ADJ B-O
-, PUNCT B-O
-and CCONJ B-O
-none NOUN B-O
-of ADP B-O
-the DET B-O
-high ADJ B-O
-- PUNCT B-O
-resolution NOUN B-O
-structures NOUN B-O
-of ADP B-O
-T-ag PROPN B-AC
-to ADP B-O
-date NOUN B-O
-have AUX B-O
-included VERB B-O
-DNA NOUN B-O
-. PUNCT B-O
-
-However ADV B-O
-, PUNCT B-O
-the DET B-O
-recent ADJ B-O
-structure NOUN B-O
-of ADP B-O
-the DET B-O
-BPV PROPN B-AC
-initiator NOUN B-O
-E1 NOUN B-O
-helicase NOUN B-O
-domain NOUN B-O
-shows VERB B-O
-that SCONJ B-O
-E1 NOUN B-O
-forms VERB B-O
-a DET B-O
-hexameric ADJ B-O
-ring NOUN B-O
-which PRON B-O
-contains VERB B-O
-single ADJ B-LF
-- PUNCT I-LF
-stranded ADJ I-LF
-DNA NOUN I-LF
-( PUNCT B-O
-ssDNA PROPN B-AC
-) PUNCT B-O
-within ADP B-O
-its PRON B-O
-central ADJ B-O
-channel NOUN B-O
-[ PUNCT B-O
-20 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-“ PUNCT B-O
-Rabbit PROPN B-O
-ear NOUN B-O
-” PUNCT B-O
-protrusions NOUN B-O
-emanating VERB B-O
-from ADP B-O
-the DET B-O
-dodecameric ADJ B-O
-T PROPN B-AC
-complex NOUN B-O
-have AUX B-O
-been AUX B-O
-observed VERB B-O
-on ADP B-O
-electron NOUN B-O
-microscopy NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-these DET B-O
-protrusions NOUN B-O
-have AUX B-O
-been AUX B-O
-attributed VERB B-O
-to ADP B-O
--agssDNA PROPN B-AC
-coated VERB B-O
-by ADP B-O
-RPA PROPN B-AC
-[ PUNCT B-O
-21 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-We PRON B-O
-tested VERB B-O
-nonactivated ADJ B-O
-and CCONJ B-O
-PHA PROPN B-O
-- PUNCT B-O
-activated VERB B-O
-peripheral ADJ B-LF
-blood NOUN I-LF
-mononuclear ADJ I-LF
-cells NOUN I-LF
-( PUNCT B-O
-PBMCs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-as ADP B-O
-well ADV B-O
-as ADP B-O
-purified VERB B-O
-cell NOUN B-O
-subsets NOUN B-O
-, PUNCT B-O
-including VERB B-O
-CD14 NOUN B-O
-+ NOUN B-O
-monocytes NOUN B-O
-, PUNCT B-O
-activated VERB B-O
-CD4 NOUN B-O
-+ NOUN B-O
-T NOUN B-O
-cells NOUN B-O
-, PUNCT B-O
-immature ADJ B-O
-and CCONJ B-O
-mature ADJ B-O
-monocyte NOUN B-O
-- PUNCT B-O
-derived VERB B-O
-dendritic ADJ B-LF
-cells NOUN I-LF
-( PUNCT B-O
-DCs PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-LASSO PROPN B-AC
-= PUNCT B-O
-least ADJ B-LF
-absolute ADJ I-LF
-shrinkage NOUN I-LF
-and CCONJ I-LF
-selection NOUN I-LF
-operator NOUN I-LF
-. PUNCT B-O
-
-Parent(s)/legal NOUN B-O
-authorized ADJ B-O
-representatives NOUN B-O
-also ADV B-O
-provided VERB B-O
-current ADJ B-O
-inhaled VERB B-LF
-corticosteroid NOUN I-LF
-( PUNCT B-O
-ICS PROPN B-AC
-) PUNCT B-O
-controller NOUN B-O
-medication NOUN B-O
-( PUNCT B-O
-Asmanex PROPN B-O
-® PUNCT B-O
-, PUNCT B-O
-Flovent PROPN B-O
-® PUNCT B-O
-, PUNCT B-O
-Qvar PROPN B-O
-® PUNCT B-O
-, PUNCT B-O
-Pulmicort PROPN B-O
-® PUNCT B-O
-, PUNCT B-O
-Advair PROPN B-O
-® PUNCT B-O
-, PUNCT B-O
-Dulera PROPN B-O
-® PUNCT B-O
-, PUNCT B-O
-Symbicort PROPN B-O
-® PUNCT B-O
-, PUNCT B-O
-etc X B-O
-. PUNCT B-O
-
-) PUNCT B-O
-. PUNCT B-O
-
-For ADP B-O
-transmission NOUN B-LF
-electron NOUN I-LF
-microscopy NOUN I-LF
-( PUNCT B-O
-TEM PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-specimens NOUN B-O
-were AUX B-O
-then ADV B-O
-washed VERB B-O
-3×20 NUM B-O
-min NOUN B-O
-in ADP B-O
-the DET B-O
-same ADJ B-O
-buffer NOUN B-O
-as SCONJ B-O
-used VERB B-O
-for ADP B-O
-fixation NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-post VERB B-O
-- VERB B-O
-fixed VERB B-O
-in ADP B-O
-1–2 NUM B-O
-% NOUN B-O
-osmium NOUN B-O
-tetroxide NOUN B-O
-( PUNCT B-O
-OsO4 NOUN B-O
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-same ADJ B-O
-buffer NOUN B-O
-for ADP B-O
-1–3 NUM B-O
-h. NOUN B-O
-According VERB B-O
-to ADP B-O
-projection NOUN B-O
-of ADP B-O
-Central PROPN B-LF
-Statistics PROPN I-LF
-Agency PROPN I-LF
-( PUNCT B-O
-CSA PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-Ethiopia PROPN B-O
-, PUNCT B-O
-in ADP B-O
-the DET B-O
-year NOUN B-O
-2014 NUM B-O
-its PRON B-O
-population NOUN B-O
-was AUX B-O
-about ADP B-O
-3.2 NUM B-O
-million NUM B-O
-[ PUNCT B-O
-17 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-Major ADJ B-O
-Adverse PROPN B-O
-Cardiovascular PROPN B-O
-Events PROPN B-O
-calculator NOUN B-O
-( PUNCT B-O
-CRCRTR-MACE PROPN B-AC
-) PUNCT B-O
-estimates VERB B-O
-the DET B-O
-burden NOUN B-O
-of ADP B-O
-cardiovascular ADJ B-O
-risk NOUN B-O
-in ADP B-O
-renal ADJ B-LF
-transplant NOUN I-LF
-recipients NOUN I-LF
-( PUNCT B-O
-RTR PROPN B-AC
-) PUNCT B-O
-. NOUN B-O
-Our PRON B-O
-recent ADJ B-O
-study NOUN B-O
-of ADP B-O
-95 NUM B-O
-RTR PROPN B-AC
-reported VERB B-O
-the DET B-O
-7 NUM B-O
-- PUNCT B-O
-year NOUN B-O
-median ADJ B-O
-risk NOUN B-O
-of ADP B-O
-cardiovascular ADJ B-O
-events NOUN B-O
-( PUNCT B-O
-CVE PROPN B-O
-) PUNCT B-O
-to ADP B-O
-be AUX B-O
-9.97 NUM B-O
-% NOUN B-O
-, PUNCT B-O
-ranging VERB B-O
-from ADP B-O
-1.93 NUM B-O
-to ADP B-O
-84.27 NUM B-O
-% NOUN B-O
-. NOUN B-O
-BMI PROPN B-AC
-, PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-; PUNCT B-O
-DHQ PROPN B-AC
-, PUNCT B-O
-Diet PROPN B-LF
-History PROPN I-LF
-Questionnaire PROPN I-LF
-. PUNCT B-O
-
-The DET B-O
-main ADJ B-O
-outcome NOUN B-O
-variable NOUN B-O
-was AUX B-O
-the DET B-O
-nutritional ADJ B-O
-status NOUN B-O
-of ADP B-O
-reproductive ADJ B-O
-age NOUN B-O
-women NOUN B-O
-, PUNCT B-O
-measured VERB B-O
-using VERB B-O
-the DET B-O
-WHO PROPN B-AC
-adult NOUN B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-( PUNCT B-O
-BMI PROPN B-AC
-) PUNCT B-O
-classification NOUN B-O
-[ PUNCT B-O
-13 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-used VERB B-O
-by ADP B-O
-the DET B-O
-Tanzanian PROPN B-O
-National PROPN B-O
-Bureau PROPN B-O
-of ADP B-O
-Statistics PROPN B-O
-and CCONJ B-O
-ICF PROPN B-AC
-International PROPN B-O
-[ PUNCT B-O
-24 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Using VERB B-O
-rat ADJ B-O
-insulinoma NOUN B-O
-INS-1 NOUN B-O
-832/3 NUM B-O
-cells NOUN B-O
-engineered VERB B-O
-by ADP B-O
-clustered VERB B-LF
-regularly ADV I-LF
-interspaced VERB I-LF
-short ADJ I-LF
-palindromic ADJ I-LF
-repeat NOUN I-LF
-( PUNCT B-O
-- PUNCT I-LF
-CRISPR)/CRISPR PROPN B-AC
-associated VERB I-LF
-9 NUM I-LF
-( PUNCT B-O
-Cas9 PROPN B-AC
-) PUNCT B-O
-to PART B-O
-delete VERB B-O
-endogenous ADJ B-O
-GLP-1R PROPN B-AC
-[ X B-O
-40 X B-O
-] X B-O
-stably ADV B-O
-expressing VERB B-O
-human ADJ B-O
-SNAP PROPN B-O
-- PUNCT B-O
-GLP-1R PROPN B-AC
-( PUNCT B-O
-INS-1 NOUN B-O
-832/3 NUM B-O
-GLP-1R−/− PROPN B-AC
-SNAP PROPN B-O
-- PUNCT B-O
-GLP-1R PROPN B-AC
-cells NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-we PRON B-O
-detected VERB B-O
-a DET B-O
-rapid ADJ B-O
-increase NOUN B-O
-in ADP B-O
-TR PROPN B-AC
--FRET PROPN B-AC
-with ADP B-O
-exendin-4 NOUN B-O
-, PUNCT B-O
-which PRON B-O
-reached VERB B-O
-a DET B-O
-maximum NOUN B-O
-within ADP B-O
-10 NUM B-O
-min NOUN B-O
-( PUNCT B-O
-Fig NOUN B-O
-1D NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-IRR PROPN B-AC
-, PUNCT B-O
-incidence NOUN B-LF
-rate NOUN I-LF
-ratio NOUN I-LF
-To PART B-O
-cytologically ADV B-O
-characterize VERB B-O
-the DET B-O
-genetic ADJ B-O
-constitution NOUN B-O
-of ADP B-O
-5113 NUM B-O
-, PUNCT B-O
-root NOUN B-O
-cells NOUN B-O
-and CCONJ B-O
-pollen NOUN B-LF
-mother NOUN I-LF
-cells NOUN I-LF
-( PUNCT B-O
-PMCs PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-used VERB B-O
-( PUNCT B-O
-Fig NUM B-O
-1 NUM B-O
-and CCONJ B-O
-Table PROPN B-O
-1 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Two NUM B-O
-tissue NOUN B-O
-- PUNCT B-O
-specific ADJ B-O
-DNase NOUN B-LF
-l NOUN I-LF
-hypersensitive ADJ I-LF
-sites NOUN I-LF
-( PUNCT B-O
-DHS PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-this DET B-O
-part NOUN B-O
-of ADP B-O
-the DET B-O
-locus NOUN B-O
-correspond VERB B-O
-to ADP B-O
-a DET B-O
-promoter NOUN B-O
-associated VERB B-O
-with ADP B-O
-DQ52 PROPN B-O
-and CCONJ B-O
-the DET B-O
-intronic ADJ B-O
-enhancer NOUN B-O
-Eμ PROPN B-O
-. PUNCT B-O
-
-A DET B-O
-cluster NOUN B-O
-of ADP B-O
-three NUM B-O
-DHSs PROPN B-AC
-was AUX B-O
-recently ADV B-O
-identified VERB B-O
-just ADV B-O
-5′ NUM B-O
-of ADP B-O
-DFL16.1 NUM B-O
-[ PUNCT B-O
-22 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-addition NOUN B-O
-to PART B-O
-diabetes NOUN B-LF
-mellitus NOUN I-LF
-( PUNCT B-O
-DM PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-is AUX B-O
-established VERB B-O
-as ADP B-O
-one NUM B-O
-of ADP B-O
-the DET B-O
-most ADV B-O
-significant ADJ B-O
-risk NOUN B-O
-factors NOUN B-O
-of ADP B-O
-coronary ADJ B-LF
-artery NOUN I-LF
-disease NOUN I-LF
-( PUNCT B-O
-CAD PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-prediabetic ADJ B-O
-conditions NOUN B-O
-such ADJ B-O
-as ADP B-O
-impaired ADJ B-LF
-glucose NOUN I-LF
-tolerance NOUN I-LF
-( PUNCT B-O
-IGT PROPN B-AC
-) PUNCT B-O
-have AUX B-O
-been AUX B-O
-also ADV B-O
-reported VERB B-O
-to PART B-O
-increase VERB B-O
-the DET B-O
-risk NOUN B-O
-of ADP B-O
-cardiovascular ADJ B-O
-events NOUN B-O
-and CCONJ B-O
-affect VERB B-O
-mortality NOUN B-O
-rates NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-, PUNCT B-O
-2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-GLM PROPN B-O
-, PUNCT B-O
-generalized ADJ B-O
-linear ADJ B-O
-model NOUN B-O
-; PUNCT B-O
-HCV PROPN B-AC
-, PUNCT B-O
-hepatitis NOUN B-LF
-C PROPN I-LF
-virus NOUN I-LF
-; PUNCT B-O
-HR PROPN B-AC
-, PUNCT B-O
-hazard NOUN B-LF
-ratio NOUN I-LF
-; PUNCT B-O
-ITT PROPN B-AC
-, PUNCT B-O
-intention NOUN B-LF
-- PUNCT I-LF
-to PART I-LF
-- PUNCT I-LF
-treat VERB I-LF
-; PUNCT B-O
-OR PROPN B-AC
-, PUNCT B-O
-odds NOUN B-LF
-ratio NOUN I-LF
-; PUNCT B-O
-PP NOUN B-O
-, PUNCT B-O
-per ADP B-O
-protocol NOUN B-O
-; PUNCT B-O
-SAE NOUN B-O
-, PUNCT B-O
-severe ADJ B-O
-adverse ADJ B-O
-event NOUN B-O
-; PUNCT B-O
-SVR PROPN B-AC
-, PUNCT B-O
-sustained ADJ B-LF
-virologic ADJ I-LF
-response NOUN I-LF
-. PUNCT B-O
-
-AC PROPN B-AC
-, PUNCT B-O
-adenylate NOUN B-LF
-cyclase NOUN I-LF
-catalytic ADJ I-LF
-domain NOUN I-LF
-; PUNCT B-O
-CaM PROPN B-AC
-, PUNCT B-O
-calmodulin NOUN B-LF
-. PUNCT B-O
-
-ASE PROPN B-AC
-, PUNCT B-O
-allele NOUN B-LF
-- PUNCT I-LF
-specific ADJ I-LF
-expression NOUN I-LF
-; PUNCT B-O
-BDNF PROPN B-AC
-, PUNCT B-O
-brain NOUN B-LF
-- PUNCT I-LF
-derived VERB I-LF
-neurotrophic ADJ I-LF
-factor NOUN I-LF
-; PUNCT B-O
-F1 PROPN B-AC
-, PUNCT B-O
-first ADJ B-LF
-- PUNCT I-LF
-generation NOUN I-LF
-; PUNCT B-O
-OF PROPN B-AC
-, PUNCT B-O
-owl NOUN B-LF
-finch NOUN I-LF
-; PUNCT B-O
-OZ PROPN B-AC
-, PUNCT B-O
-F1 PROPN B-AC
-hybrid ADJ B-O
-offspring NOUN B-O
-between ADP B-O
-OF PROPN B-AC
-♀ PUNCT B-O
-and CCONJ B-O
-ZF PROPN B-AC
-♂ PUNCT B-O
-; PUNCT B-O
-RA PROPN B-AC
-, PUNCT B-O
-robust ADJ B-LF
-nucleus NOUN I-LF
-of ADP I-LF
-the DET I-LF
-arcopallium NOUN I-LF
-; PUNCT B-O
-RPKM PROPN B-AC
-, PUNCT B-O
-reads NOUN B-LF
-per ADP I-LF
-kilobase NOUN I-LF
-of ADP I-LF
-transcript NOUN I-LF
-per ADP I-LF
-million NUM I-LF
-reads NOUN I-LF
-mapped VERB I-LF
-; PUNCT B-O
-ZF PROPN B-AC
-, PUNCT B-O
-zebra NOUN B-LF
-finch NOUN I-LF
-; PUNCT B-O
-ZO PROPN B-AC
-, PUNCT B-O
-F1 PROPN B-AC
-hybrid ADJ B-O
-offspring NOUN B-O
-between ADP B-O
-ZF PROPN B-AC
-♀ PUNCT B-O
-and CCONJ B-O
-OF PROPN B-AC
-♂ PUNCT B-O
-. PUNCT B-O
-
-Recently ADV B-O
-, PUNCT B-O
-data NOUN B-O
-from ADP B-O
-the DET B-O
-British PROPN B-O
-Cardiac PROPN B-O
-Intervention PROPN B-O
-Society PROPN B-O
-( PUNCT B-O
-BCIS PROPN B-O
-) PUNCT B-O
-PCI PROPN B-AC
-database NOUN B-O
-[ X B-O
-9 NUM B-O
-] X B-O
-and CCONJ B-O
-Korea PROPN B-O
-Acute PROPN B-O
-Myocardial PROPN B-O
-Infarction PROPN B-O
-Registry PROPN B-O
-[ X B-O
-10 NUM B-O
-, PUNCT B-O
-11 NUM B-O
-] X B-O
-showed VERB B-O
-significantly ADV B-O
-lower ADJ B-O
-cumulative ADJ B-O
-mortality NOUN B-O
-rates NOUN B-O
-in ADP B-O
-patients NOUN B-O
-who PRON B-O
-underwent VERB B-O
-multivessel NOUN B-O
-( PUNCT B-O
-MV)-PCI NOUN B-O
-than ADP B-O
-in ADP B-O
-those PRON B-O
-who PRON B-O
-underwent VERB B-O
-infarct NOUN B-LF
-- PUNCT I-LF
-related VERB I-LF
-artery NOUN I-LF
-( PUNCT B-O
-IRA)-only PROPN B-AC
-PCI PROPN B-AC
-, PUNCT B-O
-demonstrating VERB B-O
-that SCONJ B-O
-LVSD PROPN B-O
-is AUX B-O
-a DET B-O
-strong ADJ B-O
-predictor NOUN B-O
-of ADP B-O
-all DET B-O
-- PUNCT B-O
-cause NOUN B-O
-mortality NOUN B-O
-. PUNCT B-O
-
-Phosphoglycerate NOUN B-LF
-kinase NOUN I-LF
-( PUNCT B-O
-PGK1 PROPN B-AC
-) PUNCT B-O
-catalyzes VERB B-O
-the DET B-O
-reversible ADJ B-O
-phosphotransfer NOUN B-O
-reaction NOUN B-O
-from ADP B-O
-1 NUM B-LF
-, PUNCT I-LF
-3 NUM I-LF
-- PUNCT I-LF
-bisphosphoglycerate NOUN I-LF
-( PUNCT B-O
-1,3-BPG PROPN B-AC
-) PUNCT B-O
-to PART B-O
-ADP PROPN B-O
-to PART B-O
-form VERB B-O
-3 NUM B-LF
-- PUNCT I-LF
-phosphoglycerate NOUN I-LF
-( PUNCT B-O
-3 PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-ATP NOUN B-O
-. PUNCT B-O
-
-By ADP B-O
-controlling VERB B-O
-ATP NOUN B-O
-and CCONJ B-O
--PG3 PROPN B-AC
-levels NOUN B-O
-, PUNCT B-O
--PGPGK1 PROPN B-AC
-plays VERB B-O
-an DET B-O
-important ADJ B-O
-role NOUN B-O
-in ADP B-O
-coordinating VERB B-O
-energy NOUN B-O
-production NOUN B-O
-with ADP B-O
-biosynthesis NOUN B-O
-and CCONJ B-O
-redox NOUN B-O
-balance NOUN B-O
-. PUNCT B-O
-
-CeMM PROPN B-AC
-, PUNCT B-O
-C. PROPN B-O
-elegans PROPN B-O
-maintenance NOUN B-O
-medium NOUN B-O
-; PUNCT B-O
-hlh-30 PROPN B-AC
-, PUNCT B-O
-basic ADJ B-LF
-helix NOUN I-LF
-– PUNCT I-LF
-loop NOUN I-LF
-– PUNCT I-LF
-helix NOUN I-LF
-transcription NOUN I-LF
-factor NOUN I-LF
-30 NUM I-LF
-; PUNCT B-O
-hlh-30(lf PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-loss NOUN B-O
-- PUNCT B-O
-of ADP B-O
-- PUNCT B-O
-function NOUN B-O
-tm1978 PROPN B-AC
-mutation NOUN B-O
-hlh-30 PROPN B-AC
-; PUNCT B-O
-nhr-31 NOUN B-O
-, PUNCT B-O
-nuclear ADJ B-O
-hormone NOUN B-O
-receptor NOUN B-O
-31 NUM B-O
-; PUNCT B-O
-nhr-31(oe NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-overexpressed VERB B-O
-nhr-31 NOUN B-O
-; PUNCT B-O
-SEM PROPN B-AC
-, PUNCT B-O
-standard ADJ B-LF
-error NOUN I-LF
-of ADP I-LF
-the DET I-LF
-mean NOUN I-LF
-. PUNCT B-O
-
-Nucleotide NOUN B-LF
-- NOUN I-LF
-binding VERB I-LF
-leucine NOUN I-LF
-- NOUN I-LF
-rich ADJ I-LF
-repeat NOUN I-LF
-receptors NOUN I-LF
-( PUNCT B-O
-NLRs PROPN B-AC
-) PUNCT B-O
-are AUX B-O
-key ADJ B-O
-players NOUN B-O
-in ADP B-O
-this DET B-O
-process NOUN B-O
-and CCONJ B-O
-perceive VERB B-O
-the DET B-O
-occurrence NOUN B-O
-of ADP B-O
-nonself NOUN B-O
-- NOUN B-O
-activities NOUN B-O
-or CCONJ B-O
-foreign ADJ B-O
-molecules NOUN B-O
-. PUNCT B-O
-
-All DET B-O
-imaging NOUN B-O
-experiments NOUN B-O
-with ADP B-O
-the DET B-O
-exception NOUN B-O
-of ADP B-O
-those PRON B-O
-depicted VERB B-O
-in ADP B-O
-Fig NOUN B-O
-1B–1E NUM B-O
-and CCONJ B-O
-Fig NOUN B-O
-B NOUN B-O
-in ADP B-O
-S1 NOUN B-O
-Fig NOUN B-O
-were AUX B-O
-performed VERB B-O
-at ADP B-O
-30 NUM B-O
-° NOUN B-O
-C NOUN B-O
-on ADP B-O
-a DET B-O
-Nikon PROPN B-O
-Eclipse PROPN B-O
-Ti PROPN B-O
-inverted ADJ B-O
-microscope NOUN B-O
-equipped VERB B-O
-with ADP B-O
-a DET B-O
-motorized VERB B-O
-laser NOUN B-O
-total ADJ B-LF
-internal ADJ I-LF
-reflection NOUN I-LF
-fluorescence NOUN I-LF
-( PUNCT B-O
-TIRF PROPN B-AC
-) PUNCT B-O
-illumination NOUN B-O
-unit NOUN B-O
-, PUNCT B-O
-a DET B-O
-Borealis PROPN B-O
-beam NOUN B-O
-conditioning NOUN B-O
-unit NOUN B-O
-( PUNCT B-O
-Andor PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-CSU PROPN B-O
-- PUNCT B-O
-W1 PROPN B-O
-Yokugawa PROPN B-O
-spinning VERB B-O
-disk NOUN B-O
-( PUNCT B-O
-Andor PROPN B-O
-; PUNCT B-O
-Belfast PROPN B-O
-, PUNCT B-O
-Northern PROPN B-O
-Ireland PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-60X PROPN B-O
-PlanApo PROPN B-O
-TIRF PROPN B-AC
-1.49 NUM B-O
-numerical ADJ B-LF
-aperture NOUN I-LF
-( PUNCT B-O
-NA PROPN B-AC
-) PUNCT B-O
-objective NOUN B-O
-( PUNCT B-O
-Nikon PROPN B-O
-; PUNCT B-O
-Toyko PROPN B-O
-, PUNCT B-O
-Japan PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-an DET B-O
-iXon PROPN B-O
-Ultra PROPN B-O
-EMCCD PROPN B-O
-camera NOUN B-O
-( PUNCT B-O
-Andor PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-a DET B-O
-laser NOUN B-O
-merge NOUN B-O
-module NOUN B-O
-( PUNCT B-O
-LMM5 PROPN B-O
-, PUNCT B-O
-Spectral PROPN B-O
-Applied PROPN B-O
-Research PROPN B-O
-; PUNCT B-O
-Exton PROPN B-O
-, PUNCT B-O
-PA PROPN B-O
-) PUNCT B-O
-equipped VERB B-O
-with ADP B-O
-405 NUM B-O
-, PUNCT B-O
-440 NUM B-O
-, PUNCT B-O
-488 NUM B-O
-, PUNCT B-O
-and CCONJ B-O
-561 NUM B-O
-- PUNCT B-O
-nm NOUN B-O
-laser NOUN B-O
-lines NOUN B-O
-. PUNCT B-O
-
-Four NUM B-O
-irrigation NOUN B-O
-systems NOUN B-O
-were AUX B-O
-examined VERB B-O
-in ADP B-O
-this DET B-O
-study NOUN B-O
-: PUNCT B-O
-furrow NOUN B-LF
-irrigation NOUN I-LF
-( PUNCT B-O
-FI PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-micro NOUN B-LF
-- NOUN I-LF
-sprinkler NOUN I-LF
-irrigation NOUN I-LF
-( PUNCT B-O
-MS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-plastic NOUN B-O
-film NOUN B-O
-mulching NOUN B-O
-( PUNCT B-O
-PF PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-plastic NOUN B-O
-film NOUN B-O
-mulching NOUN B-O
-combined VERB B-O
-with ADP B-O
-micro NOUN B-LF
-- NOUN I-LF
-sprinkler NOUN I-LF
-irrigation NOUN I-LF
-( PUNCT B-O
-PF+MS PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Of ADP B-O
-these PRON B-O
-, PUNCT B-O
-FI PROPN B-AC
-is AUX B-O
-the DET B-O
-local ADJ B-O
-irrigation NOUN B-O
-method NOUN B-O
-widely ADV B-O
-used VERB B-O
-by ADP B-O
-the DET B-O
-local ADJ B-O
-farmers NOUN B-O
-and CCONJ B-O
-thus ADV B-O
-we PRON B-O
-treated VERB B-O
-FI PROPN B-AC
-as ADP B-O
-the DET B-O
-control NOUN B-O
-. PUNCT B-O
-
-ADC PROPN B-AC
-, PUNCT B-O
-Apparent ADJ B-LF
-Diffusion NOUN I-LF
-Coefficient PROPN I-LF
-; PUNCT B-O
-IPca PROPN B-AC
-, PUNCT B-O
-insignificant ADJ B-LF
-prostate NOUN I-LF
-cancer NOUN I-LF
-; PUNCT B-O
-CSPca PROPN B-AC
-, PUNCT B-O
-clinically ADV B-LF
-significant ADJ I-LF
-prostate NOUN I-LF
-cancer NOUN I-LF
-. PUNCT B-O
-
-We PRON B-O
-investigated VERB B-O
-557 NUM B-O
-women NOUN B-O
-, PUNCT B-O
-recruited VERB B-O
-between ADP B-O
-2009 NUM B-O
-and CCONJ B-O
-2014 NUM B-O
-from ADP B-O
-the DET B-O
-UK PROPN B-LF
-Pregnancies PROPN I-LF
-Better PROPN I-LF
-Eating PROPN I-LF
-and CCONJ I-LF
-Activity PROPN I-LF
-Trial PROPN I-LF
-( PUNCT B-O
-UPBEAT PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-randomised ADJ B-LF
-controlled VERB I-LF
-trial NOUN I-LF
-( PUNCT B-O
-RCT PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-of ADP B-O
-a DET B-O
-lifestyle NOUN B-O
-intervention NOUN B-O
-( PUNCT B-O
-low ADJ B-O
-glycaemic ADJ B-LF
-index NOUN I-LF
-( PUNCT B-O
-GI PROPN B-AC
-) PUNCT B-O
-diet NOUN B-O
-plus CCONJ B-O
-physical ADJ B-O
-activity NOUN B-O
-) PUNCT B-O
-in ADP B-O
-pregnant ADJ B-O
-women NOUN B-O
-with ADP B-O
-obesity NOUN B-O
-( PUNCT B-O
-294 NUM B-O
-contol NOUN B-O
-, PUNCT B-O
-263 NUM B-O
-intervention NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Epidemiological ADJ B-O
-studies NOUN B-O
-that PRON B-O
-were AUX B-O
-to PART B-O
-be AUX B-O
-included VERB B-O
-in ADP B-O
-the DET B-O
-current ADJ B-O
-meta NOUN B-O
-- PUNCT B-O
-analysis NOUN B-O
-studies NOUN B-O
-should AUX B-O
-meet VERB B-O
-the DET B-O
-following ADJ B-O
-criteria NOUN B-O
-: PUNCT B-O
-1 X B-O
-) PUNCT B-O
-was AUX B-O
-a DET B-O
-population- NOUN B-O
-or CCONJ B-O
-hospital NOUN B-O
-- PUNCT B-O
-based VERB B-O
-, PUNCT B-O
-case NOUN B-O
-- PUNCT B-O
-control NOUN B-O
-study NOUN B-O
-or CCONJ B-O
-a DET B-O
-prospective ADJ B-O
-or CCONJ B-O
-retrospective ADJ B-O
-cohort NOUN B-O
-study NOUN B-O
-; PUNCT B-O
-2 X B-O
-) PUNCT B-O
-provided VERB B-O
-the DET B-O
-coffee NOUN B-O
-intake NOUN B-O
-level NOUN B-O
-category NOUN B-O
-and CCONJ B-O
-the DET B-O
-corresponding ADJ B-O
-relative ADJ B-LF
-risk NOUN I-LF
-( PUNCT B-O
-RR PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
-the DET B-O
-odds NOUN B-LF
-ratio NOUN I-LF
-( PUNCT B-O
-OR PROPN B-AC
-) PUNCT B-O
-estimates NOUN B-O
-and CCONJ B-O
-their PRON B-O
-confidential ADJ B-O
-intervals NOUN B-O
-( PUNCT B-O
-95%CIs PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-MM PROPN B-AC
-; PUNCT B-O
-3 X B-O
-) PUNCT B-O
-not PART B-O
-overlapped VERB B-O
-participants NOUN B-O
-with ADP B-O
-other ADJ B-O
-included VERB B-O
-studies NOUN B-O
-. PUNCT B-O
-
-Univariate ADJ B-O
-and CCONJ B-O
-multivariate ADJ B-O
-Cox PROPN B-O
-proportion NOUN B-O
-hazard NOUN B-O
-regression NOUN B-O
-models NOUN B-O
-were AUX B-O
-used VERB B-O
-to PART B-O
-examine VERB B-O
-the DET B-O
-effect NOUN B-O
-of ADP B-O
-HCV PROPN B-AC
-infection NOUN B-O
-on ADP B-O
-cataract NOUN B-O
-risk NOUN B-O
-through ADP B-O
-hazard NOUN B-LF
-ratios NOUN I-LF
-( PUNCT B-O
-HRs PROPN B-AC
-) PUNCT B-O
-with ADP B-O
-their PRON B-O
-respective ADJ B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-LF
-intervals NOUN I-LF
-( PUNCT B-O
-CIs PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-HI PROPN B-AC
-, PUNCT B-O
-haemagglutination NOUN B-LF
-inhibition NOUN I-LF
-; PUNCT B-O
-MCMC PROPN B-AC
-, PUNCT B-O
-Markov PROPN B-LF
-chain NOUN I-LF
-Monte PROPN I-LF
-Carlo PROPN I-LF
-. PUNCT B-O
-
-Cav3 PROPN B-AC
-, PUNCT B-O
-Caveolin-3 PROPN B-LF
-; PUNCT B-O
-CM PROPN B-AC
-, PUNCT B-O
-cardiomyocyte NOUN B-LF
-; PUNCT B-O
-Ct PROPN B-AC
-, PUNCT B-O
-cycle NOUN B-LF
-threshold NOUN I-LF
-value NOUN I-LF
-; PUNCT B-O
-HSA PROPN B-AC
-, PUNCT B-O
-heat NOUN B-LF
-stable ADJ I-LF
-antigen NOUN I-LF
-; PUNCT B-O
-P PROPN B-AC
-, PUNCT B-O
-postnatal ADJ B-LF
-day NOUN I-LF
-; PUNCT B-O
-qRT PROPN B-AC
-, PUNCT B-O
-quantitative ADJ B-LF
-real ADJ I-LF
-time NOUN I-LF
-polymerase NOUN I-LF
-chain NOUN I-LF
-reaction NOUN I-LF
-. PUNCT B-O
-
-In ADP B-O
-addition NOUN B-O
-, PUNCT B-O
-fluorescence NOUN B-LF
-- PUNCT I-LF
-activated VERB I-LF
-cell NOUN I-LF
-sorting NOUN I-LF
-( PUNCT B-O
-FACS PROPN B-AC
-) PUNCT B-O
-analysis NOUN B-O
-of ADP B-O
-cell NOUN B-O
-cycle NOUN B-O
-showed VERB B-O
-that SCONJ B-O
-ATX-3 PROPN B-AC
-deletion NOUN B-O
-resulted VERB B-O
-in ADP B-O
-an DET B-O
-increased VERB B-O
-proportion NOUN B-O
-of ADP B-O
-cells NOUN B-O
-in ADP B-O
-G2 NOUN B-O
-/ SYM B-O
-M NOUN B-O
-phase NOUN B-O
-( PUNCT B-O
-Fig PROPN B-O
-4F NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Without ADP B-O
-p53 NOUN B-O
-and CCONJ B-O
-ATX-3 PROPN B-AC
-double ADJ B-O
-KO PROPN B-AC
-MEF PROPN B-AC
-cells NOUN B-O
-in ADP B-O
-hand NOUN B-O
-, PUNCT B-O
-we PRON B-O
-examined VERB B-O
-the DET B-O
-p53 NOUN B-O
-- PUNCT B-O
-dependence NOUN B-O
-of ADP B-O
-this DET B-O
-effect NOUN B-O
-by ADP B-O
-using VERB B-O
-ATX-3 PROPN B-AC
-stably ADV B-O
-knocked VERB B-O
-down ADP B-O
-HCT116 NOUN B-O
-p53+/+ NOUN B-O
-and CCONJ B-O
-HCT116 NOUN B-O
-p53-/- NOUN B-O
-cells NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-Latin PROPN B-LF
-America PROPN I-LF
-( PUNCT B-O
-LA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-proportion NOUN B-O
-of ADP B-O
-BC PROPN B-AC
-in ADP B-O
-women NOUN B-O
-younger ADJ B-O
-than ADP B-O
-45 NUM B-O
-years NOUN B-O
-is AUX B-O
-nearly ADV B-O
-twice DET B-O
-the DET B-O
-proportion NOUN B-O
-in ADP B-O
-developed VERB B-O
-countries NOUN B-O
-, PUNCT B-O
-a DET B-O
-difference NOUN B-O
-that PRON B-O
-is AUX B-O
-only ADV B-O
-partly ADV B-O
-explained VERB B-O
-by ADP B-O
-population NOUN B-O
-age NOUN B-O
-structure NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-mHAI PROPN B-AC
-, PUNCT B-O
-modified ADJ B-LF
-hepatic ADJ I-LF
-activity NOUN I-LF
-index NOUN I-LF
-; PUNCT B-O
-T2 NOUN B-O
-, PUNCT B-O
-T2 NOUN B-O
-- PUNCT B-O
-weighted VERB B-O
-image NOUN B-O
-; PUNCT B-O
-CE PROPN B-AC
-, PUNCT B-O
-contrast NOUN B-O
-- PUNCT B-O
-enhancement NOUN B-O
-; PUNCT B-O
-RLE PROPN B-AC
-, PUNCT B-O
-relative ADJ B-LF
-liver NOUN I-LF
-enhancement NOUN I-LF
-, PUNCT B-O
-OR PROPN B-AC
-, PUNCT B-O
-Odds NOUN B-LF
-ratio NOUN I-LF
-; PUNCT B-O
-β PUNCT B-O
-, PUNCT B-O
-regression NOUN B-O
-coefficient NOUN B-O
-; PUNCT B-O
-pvp NOUN B-O
-, PUNCT B-O
-portal NOUN B-O
-venous ADJ B-O
-phase NOUN B-O
-; PUNCT B-O
-dp NOUN B-O
-, PUNCT B-O
-delayed VERB B-O
-- PUNCT B-O
-phase NOUN B-O
-. PUNCT B-O
-
-Although SCONJ B-O
-patients NOUN B-O
-supported VERB B-O
-with ADP B-O
-a DET B-O
-Continuous PROPN B-O
-- PUNCT B-O
-Flow PROPN B-O
-Left PROPN B-LF
-Ventricular PROPN I-LF
-Assist PROPN I-LF
-Device PROPN I-LF
-( PUNCT B-O
-CF-LVAD PROPN B-AC
-) PUNCT B-O
-are AUX B-O
-hemodynamically ADV B-O
-stable ADJ B-O
-, PUNCT B-O
-their PRON B-O
-exercise NOUN B-O
-capacity NOUN B-O
-is AUX B-O
-limited ADJ B-O
-. PUNCT B-O
-
-MAD PROPN B-AC
-: PUNCT B-O
-median ADJ B-LF
-absolute ADJ I-LF
-deviation NOUN I-LF
-, PUNCT B-O
-NOTFront PROPN B-AC
-: PUNCT B-O
-percentage NOUN B-O
-of ADP B-O
-misclassified VERB B-O
-DMUs PROPN B-AC
-, PUNCT B-O
-PU20 NUM B-O
-% NOUN B-O
-: PUNCT B-O
-percentage NOUN B-O
-of ADP B-O
-underestimation NOUN B-O
-, PUNCT B-O
-PO20 NUM B-O
-% NOUN B-O
-: PUNCT B-O
-percentage NOUN B-O
-of ADP B-O
-overestimation NOUN B-O
-, PUNCT B-O
-rs NOUN B-O
-: PUNCT B-O
-Spearman PROPN B-O
-’s PART B-O
-rank NOUN B-O
-correlation NOUN B-O
-. PUNCT B-O
-
-CLANS PROPN B-AC
-, PUNCT B-O
-cluster NOUN B-LF
-analysis NOUN I-LF
-of ADP I-LF
-sequences NOUN I-LF
-; PUNCT B-O
-MPP PROPN B-AC
-, PUNCT B-O
-mitochondrial ADJ B-O
-processing NOUN B-O
-peptide NOUN B-O
-; PUNCT B-O
-PreP PROPN B-AC
-, PUNCT B-O
-presequence NOUN B-LF
-protease NOUN I-LF
-; PUNCT B-O
-SPP PROPN B-AC
-, PUNCT B-O
-stromal NOUN B-LF
-processing NOUN I-LF
-peptidase NOUN I-LF
-. PUNCT B-O
-
-Washed VERB B-O
-rod NOUN B-O
-outer ADJ B-O
-segment NOUN B-O
-membranes NOUN B-O
-prepared VERB B-O
-from ADP B-O
-fresh ADJ B-O
-bovine ADJ B-O
-retinas NOUN B-O
-[ X B-O
-36 X B-O
-] PUNCT B-O
-and CCONJ B-O
-cell NOUN B-O
-membranes NOUN B-O
-of ADP B-O
-TE671 PROPN B-O
-cells NOUN B-O
-infected VERB B-O
-with ADP B-O
-either CCONJ B-O
-EF1α NOUN B-O
-- PUNCT B-O
-GC1 PROPN B-AC
-- PUNCT B-O
-IRES PROPN B-AC
-- PUNCT B-O
-eGFP NOUN B-O
-or CCONJ B-O
-EF1α NOUN B-O
-- PUNCT B-O
-eGFP NOUN B-O
-virus NOUN B-O
-were AUX B-O
-reconstituted VERB B-O
-with ADP B-O
-recombinant ADJ B-O
-guanylate NOUN B-LF
-cyclase NOUN I-LF
-activating VERB I-LF
-protein–1 NOUN I-LF
-( PUNCT B-O
-GCAP1 PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-assayed VERB B-O
-for ADP B-O
-GC1 PROPN B-AC
-activity NOUN B-O
-as SCONJ B-O
-previously ADV B-O
-described VERB B-O
-[ X B-O
-37 X B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-Multiple PROPN B-LF
-Sclerosis PROPN I-LF
-Impact PROPN I-LF
-Scale–29 PROPN I-LF
-( PUNCT B-O
-MSIS-29 PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-a DET B-O
-PRO PROPN B-AC
-that PRON B-O
-attempts VERB B-O
-to PART B-O
-assess VERB B-O
-both CCONJ B-O
-physical ADJ B-O
-and CCONJ B-O
-psychological ADJ B-O
-quality NOUN B-O
-of ADP B-O
-life NOUN B-O
-in ADP B-O
-multiple ADJ B-LF
-sclerosis NOUN I-LF
-( PUNCT B-O
-MS PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-14 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-By ADP B-O
-comparing VERB B-O
-the DET B-O
-gene NOUN B-O
-expression NOUN B-O
-ratio NOUN B-O
-between ADP B-O
-the DET B-O
-two NUM B-O
-species NOUN B-O
-and CCONJ B-O
-the DET B-O
-allele NOUN B-LF
-- ADJ I-LF
-specific ADJ I-LF
-expression NOUN I-LF
-( PUNCT B-O
-ASE PROPN B-AC
-) PUNCT B-O
-ratio NOUN B-O
-in ADP B-O
-the DET B-O
-F1 PROPN B-AC
-hybrids NOUN B-O
-( PUNCT B-O
-Fig PROPN B-O
-1D NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-we PRON B-O
-assessed VERB B-O
-the DET B-O
-total ADJ B-O
-number NOUN B-O
-of ADP B-O
-genes NOUN B-O
-whose DET B-O
-expression NOUN B-O
-differs VERB B-O
-by ADP B-O
-divergence NOUN B-O
-in ADP B-O
-cis- ADJ B-O
-versus ADP B-O
-trans ADJ B-O
-- ADJ B-O
-transcriptional ADJ B-O
-regulation NOUN B-O
-between ADP B-O
-the DET B-O
-two NUM B-O
-species NOUN B-O
-. PUNCT B-O
-
-Ins PROPN B-O
-= PUNCT B-O
-inositol NOUN B-O
-peak NOUN B-O
-, PUNCT B-O
-Cho PROPN B-AC
-= PUNCT B-O
-choline NOUN B-LF
-peak NOUN B-O
-, PUNCT B-O
-Cr PROPN B-AC
-= PUNCT B-O
-creatine NOUN B-LF
-/ SYM I-LF
-phosphocreatine NOUN I-LF
-peak NOUN B-O
-, PUNCT B-O
-Glx PROPN B-AC
-= PUNCT B-O
-glutamate NOUN B-O
-/ SYM B-O
-glutamine NOUN B-O
-peaks NOUN B-O
-, PUNCT B-O
-NAA PROPN B-AC
-= PUNCT B-O
-N NOUN B-O
-- PUNCT B-O
-acetyl NOUN B-O
-- PUNCT B-O
-aspartate NOUN B-O
-peak NOUN B-O
-. PUNCT B-O
-
-In ADP B-O
-model NOUN B-O
-A NOUN B-O
-, PUNCT B-O
-participants NOUN B-O
-< ADP B-O
-30 NUM B-O
-years NOUN B-O
-old ADJ B-O
-were AUX B-O
-more ADV B-O
-likely ADJ B-O
-to PART B-O
-have VERB B-O
-good ADJ B-O
-SRH PROPN B-AC
-( PUNCT B-O
-Odds NOUN B-LF
-Ratio NOUN I-LF
-( PUNCT B-O
-OR PROPN B-AC
-) PUNCT B-O
-= SYM B-O
-2.022 NUM B-O
-) PUNCT B-O
-than ADP B-O
-participants NOUN B-O
-> ADP B-O
-50 NUM B-O
-. PUNCT B-O
-
-AbSensitivity PROPN B-O
-( PUNCT B-O
-Antibiotic ADJ B-O
-sensitivity NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-Ca PROPN B-AC
-- PUNCT B-O
-Solub PROPN B-O
-( PUNCT B-O
-Calcium NOUN B-LF
-solubilization NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-Zn PROPN B-AC
-- PUNCT B-O
-Solub PROPN B-O
-( PUNCT B-O
-Zinc NOUN B-LF
-solubilization NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-K PROPN B-AC
-- PUNCT B-O
-Solub PROPN B-O
-( PUNCT B-O
-potassium NOUN B-LF
-solubilization NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-Mg PROPN B-AC
-- PUNCT B-O
-Solub PROPN B-O
-( PUNCT B-O
-magnesium NOUN B-LF
-solubilization NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-P PROPN B-AC
-- PUNCT B-O
-Solub PROPN B-O
-( PUNCT B-O
-phosphorus NOUN B-LF
-solubilization NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-During ADP B-O
-the DET B-O
-consultation NOUN B-O
-, PUNCT B-O
-clinical ADJ B-O
-signs NOUN B-O
-of ADP B-O
-a DET B-O
-relevant ADJ B-O
-focused ADJ B-O
-examination NOUN B-O
-were AUX B-O
-also ADV B-O
-recorded VERB B-O
-( PUNCT B-O
-vital ADJ B-O
-and CCONJ B-O
-danger NOUN B-O
-signs NOUN B-O
-, PUNCT B-O
-temperature NOUN B-O
-, PUNCT B-O
-respiratory ADJ B-O
-rate NOUN B-O
-, PUNCT B-O
-malnutrition NOUN B-O
-assessment NOUN B-O
-, PUNCT B-O
-etc X B-O
-. PUNCT B-O
-
-) PUNCT B-O
-along ADP B-O
-with ADP B-O
-laboratory NOUN B-O
-tests NOUN B-O
-recommended VERB B-O
-by ADP B-O
-the DET B-O
-app NOUN B-O
-( PUNCT B-O
-mRDT PROPN B-AC
-, PUNCT B-O
-C NOUN B-LF
-- PUNCT I-LF
-reactive ADJ I-LF
-protein NOUN I-LF
-[ PUNCT B-O
-CRP PROPN B-AC
-] PUNCT B-O
-, PUNCT B-O
-hemoglobin NOUN B-O
-, PUNCT B-O
-urinary ADJ B-O
-dipstick NOUN B-O
-, PUNCT B-O
-etc X B-O
-. PUNCT B-O
-
-) PUNCT B-O
-. PUNCT B-O
-
-Pre NOUN B-LF
-- PUNCT I-LF
-eclampsia NOUN I-LF
-( PUNCT B-O
-PE PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-a DET B-O
-common ADJ B-O
-pregnancy NOUN B-O
-- PUNCT B-O
-related VERB B-O
-complication NOUN B-O
-affecting VERB B-O
-3 NUM B-O
-% NOUN B-O
-of ADP B-O
-all DET B-O
-pregnancies NOUN B-O
-. PUNCT B-O
-
-Other ADJ B-O
-liver NOUN B-O
-reserve NOUN B-O
-markers NOUN B-O
-, PUNCT B-O
-fibrosis NOUN B-LF
-index NOUN I-LF
-based VERB I-LF
-on ADP I-LF
-4 NUM I-LF
-factors NOUN I-LF
-( PUNCT B-O
-FIB-4 PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-aspartate NOUN B-LF
-aminotransferase NOUN I-LF
-- PUNCT I-LF
-to PART I-LF
-- PUNCT I-LF
-platelet NOUN I-LF
-ratio NOUN I-LF
-( PUNCT B-O
-APRI PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-have AUX B-O
-also ADV B-O
-been AUX B-O
-proposed VERB B-O
-to PART B-O
-assess VERB B-O
-liver NOUN B-O
-dysfunction NOUN B-O
-[ PUNCT B-O
-16 NUM B-O
-, PUNCT B-O
-17 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-District NOUN B-O
-and CCONJ B-O
-health NOUN B-O
-centre NOUN B-O
-heads NOUN B-O
-, PUNCT B-O
-neglected VERB B-O
-tropical ADJ B-O
-diseases NOUN B-O
-( PUNCT B-O
-NTD NOUN B-O
-) PUNCT B-O
-focal ADJ B-O
-persons NOUN B-O
-and CCONJ B-O
-integrated VERB B-LF
-eye NOUN I-LF
-care NOUN I-LF
-workers NOUN I-LF
-( PUNCT B-O
-IECWs PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-involved VERB B-O
-in ADP B-O
-the DET B-O
-key ADJ B-O
-informant NOUN B-O
-in ADP B-O
-- PUNCT B-O
-depth NOUN B-O
-interview NOUN B-O
-. PUNCT B-O
-
-ART PROPN B-AC
-, PUNCT B-O
-artemisinin PROPN B-LF
-; PUNCT B-O
-IC50 PROPN B-AC
-, PUNCT B-O
-concentration NOUN B-O
-of ADP B-O
-half ADJ B-O
-- PUNCT B-O
-maximal ADJ B-O
-inhibition NOUN B-O
-. PUNCT B-O
-
-n NOUN B-O
-= VERB B-O
-number NOUN B-O
-of ADP B-O
-cases NOUN B-O
-; PUNCT B-O
-OR PROPN B-AC
-= VERB B-O
-odds NOUN B-LF
-ratio NOUN I-LF
-; PUNCT B-O
-CI PROPN B-AC
-= VERB B-O
-confidence NOUN B-LF
-interval NOUN I-LF
-; PUNCT B-O
-IQR PROPN B-AC
-= VERB B-O
-interquartile ADJ B-LF
-range NOUN I-LF
-; PUNCT B-O
-HIV PROPN B-AC
-= VERB B-O
-human ADJ B-LF
-immunodeficiency NOUN I-LF
-virus NOUN I-LF
-; PUNCT B-O
-TB PROPN B-AC
-= VERB B-O
-tuberculosis NOUN B-LF
-; PUNCT B-O
-pre PROPN B-AC
-= VERB B-O
-resistance NOUN B-O
-to ADP B-O
-one NUM B-O
-or CCONJ B-O
-more ADJ B-O
-second ADJ B-O
-- PUNCT B-O
-line NOUN B-O
-injectable ADJ B-O
-drugs NOUN B-O
-; PUNCT B-O
--XDRSLID-TBpre PROPN B-AC
-= VERB B-O
-resistance NOUN B-O
-to ADP B-O
-one NUM B-O
-or CCONJ B-O
-more ADJ B-O
-fluoroquinolones NOUN B-O
-. PUNCT B-O
-
-SMC PROPN B-AC
-, PUNCT B-O
-seasonal ADJ B-LF
-malaria NOUN I-LF
-chemoprevention NOUN I-LF
-. PUNCT B-O
-
-In ADP B-O
-the DET B-O
-present ADJ B-O
-experimental ADJ B-O
-setting NOUN B-O
-, PUNCT B-O
-adult ADJ B-O
-male ADJ B-O
-C57BL PROPN B-O
-/ SYM B-O
-N6 NUM B-O
-mice NOUN B-O
-were AUX B-O
-either CCONJ B-O
-flown VERB B-O
-aboard ADV B-O
-the DET B-O
-BION PROPN B-O
-- PUNCT B-O
-M1 PROPN B-O
-biosatellite NOUN B-O
-for ADP B-O
-30 NUM B-O
-days NOUN B-O
-on ADP B-O
-orbit NOUN B-O
-( PUNCT B-O
-BION PROPN B-O
-- PUNCT B-O
-flown VERB B-O
-= PUNCT B-O
-BF PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
-housed VERB B-O
-as SCONJ B-O
-sex- NOUN B-O
-and CCONJ B-O
-age NOUN B-O
-- PUNCT B-O
-matched VERB B-O
-cohorts NOUN B-O
-( PUNCT B-O
-n NOUN B-O
-= PUNCT B-O
-5 NUM B-O
-each PRON B-O
-) PUNCT B-O
-in ADP B-O
-a DET B-O
-replicate ADJ B-O
-flight NOUN B-O
-habitat NOUN B-O
-on ADP B-O
-Earth PROPN B-O
-( PUNCT B-O
-BION PROPN B-O
-- PUNCT B-O
-ground NOUN B-O
-= PUNCT B-O
-BG PROPN B-AC
-) PUNCT B-O
-as SCONJ B-O
-reference NOUN B-O
-flight NOUN B-LF
-control NOUN I-LF
-, PUNCT B-O
-and CCONJ B-O
-in ADP B-O
-standard ADJ B-O
-animal NOUN B-O
-cages NOUN B-O
-concomitant ADJ B-O
-to ADP B-O
-the DET B-O
-duration NOUN B-O
-of ADP B-O
-the DET B-O
-biosatellite NOUN B-O
-flight NOUN B-O
-( PUNCT B-O
-flight NOUN B-LF
-control NOUN I-LF
-= PUNCT B-O
-FC PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Mice NOUN B-O
-flown VERB B-O
-aboard ADV B-O
-of ADP B-O
-the DET B-O
-biosatellite NOUN B-O
-were AUX B-O
-in ADP B-O
-good ADJ B-O
-condition NOUN B-O
-after ADP B-O
-landing NOUN B-O
-, PUNCT B-O
-as SCONJ B-O
-previously ADV B-O
-reported VERB B-O
-by ADP B-O
-Andreev PROPN B-O
-- PUNCT B-O
-Andrievskiy PROPN B-O
-[ PUNCT B-O
-17 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-this DET B-O
-study NOUN B-O
-, PUNCT B-O
-we PRON B-O
-sought VERB B-O
-to PART B-O
-test VERB B-O
-whether SCONJ B-O
-elevated ADJ B-O
-levels NOUN B-O
-of ADP B-O
-Arc PROPN B-O
-interfere VERB B-O
-with ADP B-O
-brain NOUN B-LF
-- PUNCT I-LF
-derived VERB I-LF
-neurotrophic ADJ I-LF
-factor NOUN I-LF
-( PUNCT B-O
-BDNF PROPN B-AC
-) PUNCT B-O
-TrkB PROPN B-O
-receptor NOUN B-O
-signaling NOUN B-O
-, PUNCT B-O
-which PRON B-O
-is AUX B-O
-known VERB B-O
-to PART B-O
-be AUX B-O
-essential ADJ B-O
-for ADP B-O
-both CCONJ B-O
-the DET B-O
-induction NOUN B-O
-and CCONJ B-O
-maintenance NOUN B-O
-of ADP B-O
-LTP PROPN B-AC
-. PUNCT B-O
-
-We PRON B-O
-report VERB B-O
-that SCONJ B-O
-TrkB PROPN B-O
-signaling NOUN B-O
-in ADP B-O
-the DET B-O
-AS PROPN B-AC
-mouse NOUN B-O
-is AUX B-O
-defective ADJ B-O
-, PUNCT B-O
-and CCONJ B-O
-show VERB B-O
-that SCONJ B-O
-reduction NOUN B-O
-of ADP B-O
-Arc PROPN B-O
-expression NOUN B-O
-to PART B-O
-control VERB B-O
-levels NOUN B-O
-rescues VERB B-O
-the DET B-O
-signaling NOUN B-O
-deficits NOUN B-O
-. PUNCT B-O
-
-One NUM B-O
-key NOUN B-O
-molecule NOUN B-O
-in ADP B-O
-this DET B-O
-process NOUN B-O
-is AUX B-O
-an DET B-O
-enzyme NOUN B-O
-named VERB B-O
-D NOUN B-LF
-- NOUN I-LF
-aminoacyl NOUN I-LF
-- NOUN I-LF
-tRNA NOUN I-LF
-deacylase NOUN I-LF
-( PUNCT B-O
-DTD PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-hydrolyses VERB B-O
-D NOUN B-O
-- NOUN B-O
-amino NOUN B-O
-acids NOUN B-O
-attached VERB B-O
-to ADP B-O
-tRNA NOUN B-O
-molecules NOUN B-O
-( PUNCT B-O
-a DET B-O
-D NOUN B-O
-- NOUN B-O
-aminoacyl NOUN B-O
-- NOUN B-O
-tRNA NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Here ADV B-O
-, PUNCT B-O
-we PRON B-O
-show VERB B-O
-that SCONJ B-O
-besides SCONJ B-O
-acting VERB B-O
-on ADP B-O
-D NOUN B-O
-- NOUN B-O
-aminoacyl NOUN B-O
-- NOUN B-O
-tRNA NOUN B-O
-, PUNCT B-O
-DTD PROPN B-AC
-also ADV B-O
-efficiently ADV B-O
-hydrolyses VERB B-O
-the DET B-O
-achiral ADJ B-O
-glycine NOUN B-O
-attached VERB B-O
-to ADP B-O
-tRNA NOUN B-O
-— PUNCT B-O
-glycyl NOUN B-O
-- NOUN B-O
-tRNA(Gly)—as NOUN B-O
-DTD PROPN B-AC
-’s PART B-O
-active ADJ B-O
-site NOUN B-O
-pocket NOUN B-O
-can AUX B-O
-not PART B-O
-discriminate VERB B-O
-between ADP B-O
-D NOUN B-O
-- NOUN B-O
-amino NOUN B-O
-acids NOUN B-O
-and CCONJ B-O
-glycine NOUN B-O
-. PUNCT B-O
-
-SVR PROPN B-AC
-response NOUN B-O
-rates NOUN B-O
-were AUX B-O
-calculated VERB B-O
-using VERB B-O
-relative ADJ B-LF
-risk NOUN I-LF
-( PUNCT B-O
-RR PROPN B-AC
-) PUNCT B-O
-differences NOUN B-O
-using VERB B-O
-chi NOUN B-O
-- PUNCT B-O
-square ADJ B-O
-test NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-São PROPN B-LF
-Paulo PROPN I-LF
-Autopsy PROPN I-LF
-Service PROPN I-LF
-( PUNCT B-O
-SPAS PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-the DET B-O
-only ADJ B-O
-morgue NOUN B-O
-serving VERB B-O
-the DET B-O
-metropolitan ADJ B-O
-area NOUN B-O
-of ADP B-O
-São PROPN B-O
-Paulo PROPN B-O
-( PUNCT B-O
-Brazil PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Consistent ADJ B-O
-with ADP B-O
-our PRON B-O
-hypothesis NOUN B-O
-, PUNCT B-O
-we PRON B-O
-found VERB B-O
-that SCONJ B-O
-a DET B-O
-strong ADJ B-O
-phospho NOUN B-O
-- PUNCT B-O
-Rb PROPN B-AC
-S249 PROPN B-O
-staining NOUN B-O
-positively ADV B-O
-correlated VERB B-O
-with ADP B-O
-tumor NOUN B-O
-grade NOUN B-O
-exclusively ADV B-O
-in ADP B-O
-squamous ADJ B-LF
-cell NOUN I-LF
-carcinomas NOUN I-LF
-( PUNCT B-O
-SCC PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-not PART B-O
-in ADP B-O
-adenocarcinomas NOUN B-LF
-( PUNCT B-O
-AC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-meaning VERB B-O
-that SCONJ B-O
-most ADJ B-O
-of ADP B-O
-the DET B-O
-SCC PROPN B-AC
-tumors NOUN B-O
-with ADP B-O
-higher ADJ B-O
-grades NOUN B-O
-also ADV B-O
-had VERB B-O
-high ADJ B-O
-scores NOUN B-O
-for ADP B-O
-phospho NOUN B-O
-- PUNCT B-O
-Rb PROPN B-AC
-S249 PROPN B-O
-positive ADJ B-O
-cells NOUN B-O
-. PUNCT B-O
-
-An DET B-O
-observation NOUN B-O
-that PRON B-O
-seems VERB B-O
-to PART B-O
-be AUX B-O
-at ADP B-O
-odds NOUN B-O
-with ADP B-O
-the DET B-O
-findings NOUN B-O
-from ADP B-O
-these DET B-O
-ex X B-O
-vivo X B-O
-studies NOUN B-O
-is AUX B-O
-that PRON B-O
-the DET B-O
-eyeblink NOUN B-O
-conditioned VERB B-LF
-response NOUN I-LF
-( PUNCT B-O
-CR PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-well ADV B-O
-- PUNCT B-O
-predicted VERB B-O
-by ADP B-O
-a DET B-O
-suppression NOUN B-O
-in ADP B-O
-Purkinje PROPN B-O
-cell NOUN B-O
-simple ADJ B-O
-spike NOUN B-O
-firing NOUN B-O
-that PRON B-O
-may AUX B-O
-last VERB B-O
-for ADP B-O
-several ADJ B-O
-hundreds NOUN B-O
-of ADP B-O
-milliseconds NOUN B-O
-[ X B-O
-28–31 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-While SCONJ B-O
-PQ PROPN B-AC
-is AUX B-O
-tolerated VERB B-O
-in ADP B-O
-most ADJ B-O
-patients NOUN B-O
-, PUNCT B-O
-it PRON B-O
-can AUX B-O
-cause VERB B-O
-haemolysis NOUN B-O
-in ADP B-O
-patients NOUN B-O
-with ADP B-O
-glucose-6 NOUN B-LF
-- PUNCT I-LF
-phosphate NOUN I-LF
-dehydrogenase NOUN I-LF
-deficiency NOUN I-LF
-( PUNCT B-O
-G6PDd PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-severity NOUN B-O
-of ADP B-O
-which PRON B-O
-is AUX B-O
-dependent ADJ B-O
-on ADP B-O
-the DET B-O
-underlying VERB B-O
-genetic ADJ B-O
-variant NOUN B-O
-, PUNCT B-O
-the DET B-O
-dose NOUN B-O
-of ADP B-O
-PQ PROPN B-AC
-administered VERB B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-age NOUN B-O
-of ADP B-O
-the DET B-O
-patient NOUN B-O
-’s PART B-O
-red ADJ B-LF
-blood NOUN I-LF
-cell NOUN I-LF
-( PUNCT B-O
-RBC PROPN B-AC
-) PUNCT B-O
-population NOUN B-O
-[ X B-O
-7,8 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-BAC PROPN B-AC
-, PUNCT B-O
-bacterial ADJ B-LF
-artificial ADJ I-LF
-chromosome NOUN I-LF
-; PUNCT B-O
-CENP PROPN B-AC
-, PUNCT B-O
-centromere NOUN B-LF
-protein NOUN I-LF
-A NOUN I-LF
-; PUNCT B-O
--ACenX PROPN B-AC
-, PUNCT B-O
-X NOUN B-LF
-centromere NOUN I-LF
-; PUNCT B-O
-ChIP PROPN B-AC
-, PUNCT B-O
-chromatin NOUN B-LF
-immunoprecipitation NOUN I-LF
-sequencing NOUN B-O
-; PUNCT B-O
--seqCRM PROPN B-AC
-, PUNCT B-O
-centromeric ADJ B-LF
-retrotransposons NOUN I-LF
-of ADP I-LF
-maize NOUN I-LF
-; PUNCT B-O
-CRR PROPN B-AC
-, PUNCT B-O
-centromeric ADJ B-LF
-retrotransposons NOUN I-LF
-of ADP I-LF
-rice NOUN I-LF
-; PUNCT B-O
-CRW PROPN B-AC
-, PUNCT B-O
-centromeric ADJ B-LF
-retrotransposons NOUN I-LF
-of ADP I-LF
-wheat NOUN I-LF
-; PUNCT B-O
-FISH PROPN B-AC
-, PUNCT B-O
-fluorescence NOUN B-LF
-in ADP I-LF
-situ NOUN I-LF
-hybridization NOUN I-LF
-; PUNCT B-O
-LAVA PROPN B-AC
-, PUNCT B-O
-LINE PROPN B-LF
-- PUNCT I-LF
-LINE PROPN B-AC
-Alu PROPN I-LF
-- PUNCT I-LF
-VNTR PROPN I-LF
-- PUNCT I-LF
-Alu PROPN I-LF
-- PUNCT I-LF
-like ADJ I-LF
-; PUNCT B-O
-LINE PROPN B-AC
-, PUNCT B-O
-long ADJ B-LF
-interspersed VERB I-LF
-nuclear ADJ I-LF
-element NOUN I-LF
-; PUNCT B-O
-LTR PROPN B-AC
-, PUNCT B-O
-long ADJ B-LF
-terminal ADJ I-LF
-repeat NOUN I-LF
-; PUNCT B-O
-Mya PROPN B-O
-, PUNCT B-O
-million NUM B-O
-years NOUN B-O
-ago ADV B-O
-. PUNCT B-O
-
-Recently ADV B-O
-, PUNCT B-O
-we PRON B-O
-developed VERB B-O
-a DET B-O
-novel ADJ B-O
-and CCONJ B-O
-sensitive ADJ B-O
-XOR PROPN B-AC
-assay NOUN B-O
-for ADP B-O
-the DET B-O
-measurement NOUN B-O
-of ADP B-O
-human ADJ B-O
-plasma NOUN B-O
-XOR PROPN B-AC
-activity NOUN B-O
-that PRON B-O
-is AUX B-O
-based VERB B-O
-on ADP B-O
-[ X B-O
-13C2,15N2]xanthine NOUN B-O
-coupled VERB B-O
-with ADP B-O
-liquid NOUN B-LF
-chromatography NOUN I-LF
-( PUNCT B-O
-mass NOUN I-LF
-LC)/triplequadrupole PROPN B-AC
-spectrometry NOUN I-LF
-( PUNCT B-O
-TQMS PROPN B-AC
-) PUNCT B-O
-[ X B-O
-18,19 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Cadherins NOUN B-O
-form VERB B-O
-an DET B-O
-adhesive ADJ B-O
-interface NOUN B-O
-all ADV B-O
-along ADP B-O
-the DET B-O
-lateral ADJ B-O
-domain NOUN B-O
-but CCONJ B-O
-are AUX B-O
-also ADV B-O
-organised VERB B-O
-into ADP B-O
-special ADJ B-O
-complexes NOUN B-O
-known VERB B-O
-as ADP B-O
-zonula NOUN B-LF
-adherens NOUN I-LF
-( PUNCT B-O
-ZA PROPN B-AC
-) PUNCT B-O
-that PRON B-O
-are AUX B-O
-localised VERB B-O
-at ADP B-O
-the DET B-O
-apical ADJ B-O
-end NOUN B-O
-. PUNCT B-O
-
-At ADP B-O
-baseline NOUN B-O
-, PUNCT B-O
-mothers NOUN B-O
-had VERB B-O
-weight NOUN B-O
-, PUNCT B-O
-mid ADJ B-LF
-- ADJ I-LF
-upper ADJ I-LF
-arm NOUN I-LF
-circumference NOUN I-LF
-( PUNCT B-O
-MUAC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-hemoglobin NOUN B-O
-( PUNCT B-O
-Hemocue PROPN B-O
-, PUNCT B-O
-Ängelholm PROPN B-O
-, PUNCT B-O
-Sweden PROPN B-O
-) PUNCT B-O
-measured VERB B-O
-, PUNCT B-O
-and CCONJ B-O
-were AUX B-O
-tested VERB B-O
-for ADP B-O
-HIV PROPN B-O
-using VERB B-O
-a DET B-O
-rapid ADJ B-O
-test NOUN B-O
-algorithm NOUN B-O
-. PUNCT B-O
-
-Disease PROPN B-O
-activity NOUN B-O
-reflected VERB B-O
-the DET B-O
-direct ADJ B-O
-results NOUN B-O
-of ADP B-O
-treatment NOUN B-O
-, PUNCT B-O
-as SCONJ B-O
-measured VERB B-O
-with ADP B-O
-the DET B-O
-Disease PROPN B-LF
-Activity PROPN I-LF
-Score–28 NUM I-LF
-with ADP I-LF
-erythrocyte NOUN I-LF
-sedimentation NOUN I-LF
-rate NOUN I-LF
-( PUNCT B-O
-DAS28-ESR PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-33 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-AUC PROPN B-AC
-, PUNCT B-O
-area NOUN B-LF
-under ADP I-LF
-the DET I-LF
-curve NOUN I-LF
-; PUNCT B-O
-CITL PROPN B-O
-, PUNCT B-O
-calibration NOUN B-O
-in ADP B-O
-the DET B-O
-large ADJ B-O
-; PUNCT B-O
-E NOUN B-O
-:O NOUN B-O
-, PUNCT B-O
-ratio NOUN B-O
-of ADP B-O
-expected VERB B-O
-( PUNCT B-O
-predicted VERB B-O
-) PUNCT B-O
-probability NOUN B-O
-vs ADP B-O
-observed ADJ B-O
-frequency NOUN B-O
-of ADP B-O
-the DET B-O
-outcome NOUN B-O
-; PUNCT B-O
-STm PROPN B-AC
-, PUNCT B-O
-symptoms NOUN B-LF
-and CCONJ I-LF
-tests NOUN I-LF
-model NOUN I-LF
-; PUNCT B-O
-Tm PROPN B-AC
-, PUNCT B-O
-tests NOUN B-LF
-- PUNCT I-LF
-only ADV I-LF
-model NOUN I-LF
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-GPi PROPN B-AC
-, PUNCT B-O
-globus NOUN B-LF
-pallidus X I-LF
-- PUNCT I-LF
-internus X I-LF
-; PUNCT B-O
-max NOUN B-O
-, PUNCT B-O
-maximum NOUN B-O
-; PUNCT B-O
-min NOUN B-O
-, PUNCT B-O
-minimum NOUN B-O
-; PUNCT B-O
-Mvt PROPN B-O
-, PUNCT B-O
-movement NOUN B-O
-; PUNCT B-O
-NHP PROPN B-AC
-, PUNCT B-O
-nonhuman ADJ B-LF
-primate NOUN I-LF
-; PUNCT B-O
-sp NOUN B-O
-, PUNCT B-O
-spikes NOUN B-O
-; PUNCT B-O
-VLa PROPN B-AC
-, PUNCT B-O
-ventrolateral ADJ B-LF
-anterior ADJ I-LF
-nucleus NOUN I-LF
-Recently ADV B-O
-, PUNCT B-O
-it PRON B-O
-was AUX B-O
-reported VERB B-O
-that SCONJ B-O
-5 NUM B-LF
-- PUNCT I-LF
-HT2 NOUN I-LF
-receptors NOUN I-LF
-( PUNCT B-O
-5-HT2Rs PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-expressed VERB B-O
-in ADP B-O
-cartilage NOUN B-O
-tissues NOUN B-O
-lacking VERB B-O
-both CCONJ B-O
-vessels NOUN B-O
-and CCONJ B-O
-neurons NOUN B-O
-, PUNCT B-O
-suggesting VERB B-O
-possible ADJ B-O
-novel ADJ B-O
-functions NOUN B-O
-of ADP B-O
-5-HT PROPN B-AC
-during ADP B-O
-cartilage NOUN B-O
-development NOUN B-O
-and CCONJ B-O
-regeneration NOUN B-O
-. PUNCT B-O
-
-MOI PROPN B-AC
-, PUNCT B-O
-multiplicity NOUN B-LF
-of ADP I-LF
-infection NOUN I-LF
-. PUNCT B-O
-
-Changes NOUN B-O
-in ADP B-O
-anthropometric ADJ B-O
-indices NOUN B-O
-[ PUNCT B-O
-Weight NOUN B-O
-, PUNCT B-O
-Body PROPN B-O
-- PUNCT B-O
-Mass NOUN B-O
-- PUNCT B-O
-Index PROPN B-O
-( PUNCT B-O
-BMI PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-waist NOUN B-O
-- PUNCT B-O
-circumference NOUN B-O
-( PUNCT B-O
-WC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-waist NOUN B-O
-- PUNCT B-O
-hip NOUN B-O
-ratio NOUN B-O
-( PUNCT B-O
-WHR PROPN B-AC
-) PUNCT B-O
-] PUNCT B-O
-, PUNCT B-O
-clinical ADJ B-O
-[ PUNCT B-O
-systolic ADJ B-LF
-blood NOUN I-LF
-pressure NOUN I-LF
-( PUNCT B-O
-SBP PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-diastolic ADJ B-LF
-blood NOUN I-LF
-pressure NOUN I-LF
-( PUNCT B-O
-DBP PROPN B-AC
-) PUNCT B-O
-] PUNCT B-O
-and CCONJ B-O
-biochemical ADJ B-O
-measurements NOUN B-O
-[ PUNCT B-O
-Triglycerides NOUN B-LF
-( PUNCT B-O
-TG PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-High ADJ B-LF
-Density NOUN I-LF
-Lipoprotein NOUN I-LF
-( PUNCT B-O
-HDL PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Total PROPN B-LF
-Cholesterol PROPN I-LF
-( PUNCT B-O
-TC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-HbA1c% PROPN B-AC
-] PUNCT B-O
-at ADP B-O
-baseline NOUN B-O
-and CCONJ B-O
-follow NOUN B-O
-- PUNCT B-O
-up ADP B-O
-were AUX B-O
-compared VERB B-O
-. PUNCT B-O
-
-Significance NOUN B-O
-was AUX B-O
-calculated VERB B-O
-by ADP B-O
-a DET B-O
-two NUM B-O
-- PUNCT B-O
-tailed ADJ B-O
-t NOUN B-O
-test NOUN B-O
-. PUNCT B-O
-
-* PUNCT B-O
-p NOUN B-O
-= SYM B-O
-0.03 NUM B-O
-. PUNCT B-O
-
-( PUNCT B-O
-B NOUN B-O
-) PUNCT B-O
-HMWCK PROPN B-AC
-( PUNCT B-O
-high ADJ B-LF
-molecular ADJ I-LF
-weight NOUN I-LF
-cytokeratin NOUN I-LF
-) PUNCT B-O
-staining NOUN B-O
-, PUNCT B-O
-whose DET B-O
-expression NOUN B-O
-in ADP B-O
-upper ADJ B-O
-layers NOUN B-O
-marks VERB B-O
-squamous ADJ B-O
-stratifying VERB B-O
-epithelia NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-C NOUN B-O
-) PUNCT B-O
-Staining NOUN B-O
-for ADP B-O
-TMPRSS11B NOUN B-O
-, PUNCT B-O
-a DET B-O
-marker NOUN B-O
-of ADP B-O
-squamous ADJ B-O
-epithelia NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-D NOUN B-O
-, PUNCT B-O
-E NOUN B-O
-) PUNCT B-O
-Lenti PROPN B-O
-- PUNCT B-O
-SOX2 PROPN B-O
-induces VERB B-O
-hyperplasia NOUN B-O
-. PUNCT B-O
-
-Taiwan PROPN B-O
-’s PART B-O
-National PROPN B-LF
-Health PROPN I-LF
-Insurance PROPN I-LF
-( PUNCT B-O
-NHI PROPN B-AC
-) PUNCT B-O
-program NOUN B-O
-is AUX B-O
-a DET B-O
-universal ADJ B-O
-insurance NOUN B-O
-program NOUN B-O
-that PRON B-O
-was AUX B-O
-launched VERB B-O
-in ADP B-O
-1995 NUM B-O
-. PUNCT B-O
-
-We PRON B-O
-conducted VERB B-O
-a DET B-O
-meta NOUN B-O
-- ADJ B-O
-analysis NOUN B-O
-and CCONJ B-O
-meta NOUN B-O
-- ADJ B-O
-regression NOUN B-O
-of ADP B-O
-randomized ADJ B-LF
-controlled VERB I-LF
-trials NOUN I-LF
-( PUNCT B-O
-RCTs PROPN B-AC
-) PUNCT B-O
-evaluating VERB B-O
-SGLT2i PROPN B-AC
-in ADP B-O
-T1DM PROPN B-AC
-to PART B-O
-assess VERB B-O
-moderators NOUN B-O
-of ADP B-O
-the DET B-O
-relative ADJ B-LF
-risk NOUN I-LF
-( PUNCT B-O
-RR PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-DKA PROPN B-AC
-, PUNCT B-O
-of ADP B-O
-glycemic ADJ B-O
-( PUNCT B-O
-HbA1c NOUN B-O
-, PUNCT B-O
-fasting VERB B-O
-plasma NOUN B-O
-glucose NOUN B-O
-, PUNCT B-O
-continuous ADJ B-O
-glucose NOUN B-O
-monitoring NOUN B-O
-parameters NOUN B-O
-, PUNCT B-O
-insulin NOUN B-O
-dose NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-insulin NOUN B-O
-sensitivity NOUN B-O
-indices NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-non ADJ B-O
-- ADJ B-O
-glycemic ADJ B-O
-( PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-( PUNCT B-O
-BMI PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-systolic ADJ B-O
-BP PROPN B-AC
-, PUNCT B-O
-renal ADJ B-O
-function NOUN B-O
-, PUNCT B-O
-albuminuria NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-diabetic ADJ B-O
-eye NOUN B-O
-disorders NOUN B-O
-) PUNCT B-O
-efficacy NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-of ADP B-O
-other ADJ B-O
-safety NOUN B-O
-outcomes NOUN B-O
-( PUNCT B-O
-including VERB B-O
-hypoglycemia NOUN B-O
-, PUNCT B-O
-infections NOUN B-O
-, PUNCT B-O
-major ADJ B-O
-adverse ADJ B-O
-cardiovascular ADJ B-O
-events NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-death NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Diffusion PROPN B-LF
-Tensor PROPN I-LF
-Imaging PROPN I-LF
-( PUNCT B-O
-DTI PROPN B-AC
-) PUNCT B-O
-studies NOUN B-O
-suggest VERB B-O
-that SCONJ B-O
-at ADP B-O
-birth NOUN B-O
-all DET B-O
-major ADJ B-O
-fiber NOUN B-O
-systems NOUN B-O
-are AUX B-O
-in ADP B-O
-place NOUN B-O
-, PUNCT B-O
-despite SCONJ B-O
-low ADJ B-O
-anisotropy NOUN B-O
-value NOUN B-O
-[ PUNCT B-O
-70 NUM B-O
-] PUNCT B-O
-and CCONJ B-O
-incomplete ADJ B-O
-myelination NOUN B-O
-[ PUNCT B-O
-71 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Increasing VERB B-O
-phytoene NOUN B-O
-concentrations NOUN B-O
-favor VERB B-O
-phytofluene NOUN B-LF
-release NOUN B-O
-, PUNCT B-O
-with ADP B-O
-the DET B-O
-z PROPN B-AC
-: NOUN B-O
-pf PROPN B-AC
-ratio NOUN B-O
-decreasing VERB B-O
-from ADP B-O
-ca X B-O
-. PUNCT B-O
-
-4:1 NUM B-O
-to ADP B-O
-1:1 NUM B-O
-( PUNCT B-O
-Fig NOUN B-O
-6B NUM B-O
-, PUNCT B-O
-dotted ADJ B-O
-line NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-underlying ADJ B-O
-numerical ADJ B-O
-data NOUN B-O
-for ADP B-O
-this DET B-O
-figure NOUN B-O
-can AUX B-O
-be AUX B-O
-found VERB B-O
-in ADP B-O
-S1 PROPN B-O
-Data PROPN B-O
-. PUNCT B-O
-
-dpi PROPN B-AC
-, PUNCT B-O
-days NOUN B-LF
-postinoculation NOUN I-LF
-; PUNCT B-O
-N NOUN B-O
-- PUNCT B-O
-acetylneuraminic NOUN B-O
-acid NOUN B-O
-; PUNCT B-O
-siaT PROPN B-AC
-, PUNCT B-O
-predicted VERB B-LF
-sialic ADJ I-LF
-acid NOUN I-LF
-transporter NOUN I-LF
-; PUNCT B-O
-WT PROPN B-AC
-, PUNCT B-O
-wild ADJ B-LF
-type NOUN I-LF
-. PUNCT B-O
-
-CFA PROPN B-AC
-, PUNCT B-O
-complete ADJ B-LF
-Freund PROPN I-LF
-’s PART I-LF
-adjuvant NOUN I-LF
-; PUNCT B-O
-DAPI PROPN B-AC
-, PUNCT B-O
-4′,6 NUM B-LF
-- PUNCT I-LF
-diamidino-2 NOUN I-LF
-- PUNCT I-LF
-phenylindole NOUN I-LF
-; PUNCT B-O
-DRG PROPN B-AC
-, PUNCT B-O
-dorsal ADJ B-LF
-root NOUN I-LF
-ganglia NOUN I-LF
-; PUNCT B-O
-EV PROPN B-AC
-, PUNCT B-O
-empty ADJ B-LF
-vector NOUN I-LF
-; PUNCT B-O
-GFAP PROPN B-AC
-, PUNCT B-O
-glial ADJ B-LF
-fibrillary ADJ I-LF
-acidic ADJ I-LF
-protein NOUN I-LF
-; PUNCT B-O
-GFP PROPN B-AC
-, PUNCT B-O
-green ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-; PUNCT B-O
-HSV PROPN B-AC
-, PUNCT B-O
-herpes NOUN B-LF
-simplex NOUN I-LF
-virus NOUN I-LF
-; PUNCT B-O
-Iba1 PROPN B-AC
-, PUNCT B-O
-ionized VERB B-LF
-calcium NOUN I-LF
-binding VERB I-LF
-adaptor NOUN I-LF
-molecule NOUN I-LF
-1 NUM I-LF
-; PUNCT B-O
-MM PROPN B-AC
-, PUNCT B-O
-mismatch NOUN B-LF
-ODN PROPN I-LF
--ODNODN PROPN B-AC
-; PUNCT B-O
-NF200 PROPN B-O
-, PUNCT B-O
-neurofilament NOUN B-O
-200 NUM B-O
-; PUNCT B-O
-ODN PROPN B-AC
-, PUNCT B-O
-oligodeoxynucleotide NOUN B-LF
-; PUNCT B-O
-SC PROPN B-AC
-, PUNCT B-O
-spinal ADJ B-LF
-cord NOUN I-LF
-; PUNCT B-O
-SEM PROPN B-AC
-, PUNCT B-O
-standard ADJ B-LF
-error NOUN I-LF
-of ADP I-LF
-the DET I-LF
-mean NOUN I-LF
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-CHD PROPN B-AC
-, PUNCT B-O
-coronary ADJ B-LF
-heart NOUN I-LF
-disease NOUN I-LF
-; PUNCT B-O
-BMI PROPN B-AC
-, PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-; PUNCT B-O
-OR PROPN B-AC
-, PUNCT B-O
-odds NOUN B-LF
-ratio NOUN I-LF
-; PUNCT B-O
-CI PROPN B-AC
-, PUNCT B-O
-confidence NOUN B-LF
-interval NOUN I-LF
-. PUNCT B-O
-
-Primaquine PROPN B-LF
-( PUNCT B-O
-PQ PROPN B-AC
-) PUNCT B-O
-actively ADV B-O
-clears VERB B-O
-mature ADJ B-O
-Plasmodium PROPN B-O
-falciparum NOUN B-O
-gametocytes NOUN B-O
-but CCONJ B-O
-in ADP B-O
-glucose-6 NOUN B-O
-- PUNCT B-O
-phosphate NOUN B-O
-dehydrogenase NOUN B-O
-deficient ADJ B-O
-( PUNCT B-O
-G6PDd NOUN B-O
-) PUNCT B-O
-individuals NOUN B-O
-can AUX B-O
-cause VERB B-O
-hemolysis NOUN B-O
-. PUNCT B-O
-
-Further ADV B-O
-, PUNCT B-O
-how SCONJ B-O
-much ADJ B-O
-effect NOUN B-O
-variations NOUN B-O
-in ADP B-O
-r PROPN B-AC
-have AUX B-O
-on ADP B-O
-the DET B-O
-dynamics NOUN B-O
-of ADP B-O
-free ADJ B-O
-virus NOUN B-O
-depended VERB B-O
-on ADP B-O
-the DET B-O
-magnitude NOUN B-O
-of ADP B-O
-the DET B-O
-minimum ADJ B-LF
-activation NOUN I-LF
-rate NOUN I-LF
-of ADP I-LF
-latently ADV I-LF
-infected VERB I-LF
-cells NOUN I-LF
-( PUNCT B-O
-amin PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Homologous ADJ B-O
-recombination NOUN B-O
-can AUX B-O
-also ADV B-O
-have VERB B-O
-a DET B-O
-mutagenic ADJ B-O
-outcome NOUN B-O
-by ADP B-O
-promoting VERB B-O
-recombination NOUN B-O
-between ADP B-O
-nonallelic ADJ B-O
-repeated VERB B-O
-sequences NOUN B-O
-, PUNCT B-O
-leading VERB B-O
-to PART B-O
-genomic ADJ B-O
-instability NOUN B-O
-, PUNCT B-O
-or CCONJ B-O
-by ADP B-O
-templating VERB B-O
-repair VERB B-O
-from ADP B-O
-a DET B-O
-homolog NOUN B-O
-rather ADV B-O
-than ADP B-O
-a DET B-O
-sister NOUN B-O
-chromatid NOUN B-O
-, PUNCT B-O
-leading VERB B-O
-to PART B-O
-loss NOUN B-LF
-of ADP I-LF
-heterozygosity NOUN I-LF
-( PUNCT B-O
-LOH PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-a DET B-O
-living VERB B-O
-cell NOUN B-O
-, PUNCT B-O
-multiple ADJ B-O
-pathways NOUN B-O
-compete VERB B-O
-to PART B-O
-repair VERB B-O
-the DET B-O
-same ADJ B-O
-kinds NOUN B-O
-of ADP B-O
-damage NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-exact ADJ B-O
-location NOUN B-O
-of ADP B-O
-Swt1 PROPN B-O
-could AUX B-O
-not PART B-O
-be AUX B-O
-determined VERB B-O
-, PUNCT B-O
-however ADV B-O
-, PUNCT B-O
-because SCONJ B-O
-the DET B-O
-abundance NOUN B-O
-of ADP B-O
-green ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-( PUNCT B-O
-GFP)- PROPN B-AC
-or CCONJ B-O
-immuno ADJ B-O
-- PUNCT B-O
-labeled VERB B-O
-Swt1 PROPN B-O
-expressed VERB B-O
-from ADP B-O
-the DET B-O
-endogenous ADJ B-O
-promoter NOUN B-O
-was AUX B-O
-too ADV B-O
-low ADJ B-O
-to PART B-O
-be AUX B-O
-visualized VERB B-O
-( PUNCT B-O
-unpublished ADJ B-O
-data NOUN B-O
-and CCONJ B-O
-[ X B-O
-18 NUM B-O
-] PUNCT B-O
-) PUNCT B-O
-. PUNCT B-O
-
-While SCONJ B-O
-initiation NOUN B-O
-requires VERB B-O
-a DET B-O
-rapid ADJ B-O
-but CCONJ B-O
-temporary ADJ B-O
-disappearance NOUN B-O
-of ADP B-O
-Nrg1 PROPN B-O
-via ADP B-O
-activation NOUN B-O
-of ADP B-O
-the DET B-O
-cAMP NOUN B-O
-- PUNCT B-O
-dependent ADJ B-O
-protein NOUN B-O
-kinase NOUN B-O
-A NOUN B-O
-pathway NOUN B-O
-, PUNCT B-O
-maintenance NOUN B-O
-requires VERB B-O
-the DET B-O
-recruitment NOUN B-O
-to ADP B-O
-promoters NOUN B-O
-of ADP B-O
-the DET B-O
-Hda1 NOUN B-O
-histone NOUN B-O
-deacetylase NOUN B-O
-under ADP B-O
-conditions NOUN B-O
-of ADP B-O
-reduced VERB B-O
-signaling NOUN B-O
-by ADP B-O
-the DET B-O
-target NOUN B-LF
-of ADP I-LF
-rapamycin NOUN I-LF
-( PUNCT B-O
-TOR PROPN B-AC
-) PUNCT B-O
-kinase NOUN B-O
-, PUNCT B-O
-leading VERB B-O
-to ADP B-O
-chromatin NOUN B-O
-remodeling NOUN B-O
-that PRON B-O
-blocks VERB B-O
-Nrg1 PROPN B-O
-access NOUN B-O
-to ADP B-O
-the DET B-O
-promoters NOUN B-O
-of ADP B-O
-hypha NOUN B-O
-- PUNCT B-O
-specific ADJ B-O
-genes NOUN B-O
-. PUNCT B-O
-
-Recent ADJ B-O
-studies NOUN B-O
-have AUX B-O
-suggested VERB B-O
-that SCONJ B-O
-these DET B-O
-diseases NOUN B-O
-are AUX B-O
-but ADV B-O
-one NUM B-O
-unique ADJ B-O
-set NOUN B-O
-of ADP B-O
-immunoglobulin NOUN B-LF
-- PUNCT I-LF
-E NOUN I-LF
-( PUNCT B-O
-IgE)-mediated PROPN B-AC
-allergic ADJ B-O
-conditions NOUN B-O
-, PUNCT B-O
-linked VERB B-O
-by ADP B-O
-the DET B-O
-common ADJ B-O
-thread NOUN B-O
-of ADP B-O
-“ PUNCT B-O
-atopic PROPN B-O
-march PROPN B-O
-” PUNCT B-O
-[ PUNCT B-O
-9 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Abbr PROPN B-O
-. PUNCT B-O
-
-: PUNCT B-O
-AN PROPN B-AC
-– PUNCT B-O
-antennal ADJ B-LF
-nerve NOUN I-LF
-; PUNCT B-O
-CDM PROPN B-AC
-– PUNCT B-O
-cibarial NOUN B-O
-dilator NOUN B-O
-muscle NOUN B-O
-; PUNCT B-O
-CNS PROPN B-AC
-– PUNCT B-O
-central ADJ B-LF
-nervous ADJ I-LF
-system NOUN I-LF
-. PUNCT B-O
-
-Strains NOUN B-O
-: PUNCT B-O
-DLY12943 PROPN B-O
-, PUNCT B-O
-DLY7593 PROPN B-O
-( PUNCT B-O
-B NOUN B-O
-- NOUN B-O
-D NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-DLY22883 PROPN B-O
-( PUNCT B-O
-E NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-DLY22928 PROPN B-O
-( PUNCT B-O
-F NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-GFP PROPN B-AC
-, PUNCT B-O
-green ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-; PUNCT B-O
-KS PROPN B-O
-, PUNCT B-O
-Kolmogorov PROPN B-O
-– PUNCT B-O
-Smirnov PROPN B-O
-; PUNCT B-O
-MAT PROPN B-AC
-, PUNCT B-O
-mating NOUN B-LF
-type NOUN I-LF
-; PUNCT B-O
-MFα1 PROPN B-AC
-, PUNCT B-O
-major ADJ B-LF
-α PUNCT I-LF
-- NOUN I-LF
-factor NOUN I-LF
-gene NOUN I-LF
-1 NUM I-LF
-; PUNCT B-O
-sf PROPN B-AC
-, PUNCT B-O
-superfolder NOUN B-LF
-; PUNCT B-O
-TEF1 PROPN B-AC
-, PUNCT B-O
-translation NOUN B-LF
-elongation NOUN I-LF
-factor NOUN I-LF
-1 NUM I-LF
-. PUNCT B-O
-
-The DET B-O
-Hopkins PROPN B-LF
-Symptom PROPN I-LF
-Checklist-37 PROPN I-LF
-for ADP I-LF
-Adolescents PROPN I-LF
-( PUNCT B-O
-HSCL-37A PROPN B-AC
-; PUNCT B-O
-[ PUNCT B-O
-48 NUM B-O
-] PUNCT B-O
-) PUNCT B-O
-examines VERB B-O
-both CCONJ B-O
-internalizing VERB B-O
-symptoms NOUN B-O
-such ADJ B-O
-as ADP B-O
-depression NOUN B-O
-and CCONJ B-O
-anxiety NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-externalizing VERB B-O
-symptoms NOUN B-O
-. PUNCT B-O
-
-These DET B-O
-studies NOUN B-O
-also ADV B-O
-demonstrated VERB B-O
-variation NOUN B-O
-in ADP B-O
-transmission NOUN B-O
-potential NOUN B-O
-after ADP B-O
-different ADJ B-O
-ACTs PROPN B-AC
-, PUNCT B-O
-with ADP B-O
-artemether NOUN B-LF
-- PUNCT I-LF
-lumefantrine NOUN I-LF
-( PUNCT B-O
-AL PROPN B-AC
-) PUNCT B-O
-being AUX B-O
-associated VERB B-O
-with ADP B-O
-lower ADJ B-O
-post ADJ B-O
-- PUNCT B-O
-treatment ADJ B-O
-gametocyte ADJ B-O
-carriage NOUN B-O
-and CCONJ B-O
-transmission NOUN B-O
-potential NOUN B-O
-compared VERB B-O
-to ADP B-O
-dihydroartemisinin NOUN B-LF
-- PUNCT I-LF
-piperaquine NOUN I-LF
-( PUNCT B-O
-DP PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-12 NUM B-O
-, PUNCT B-O
-13 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Alternating VERB B-O
-phase NOUN B-O
-radiofrequency NOUN B-LF
-( PUNCT B-O
-RF PROPN B-AC
-) PUNCT B-O
-pulse NOUN B-O
-acquisition NOUN B-O
-technique NOUN B-O
-implying VERB B-O
-the DET B-O
-acquisition NOUN B-O
-of ADP B-O
-multiple ADJ B-O
-images NOUN B-O
-, PUNCT B-O
-has AUX B-O
-been AUX B-O
-combined VERB B-O
-with ADP B-O
-the DET B-O
-maximum ADJ B-O
-- PUNCT B-O
-intensity NOUN B-O
-, PUNCT B-O
-the DET B-O
-complex ADJ B-O
-- PUNCT B-O
-sum NOUN B-O
-, PUNCT B-O
-the DET B-O
-magnitude NOUN B-O
-- PUNCT B-O
-sum NOUN B-O
-combinations NOUN B-O
-to PART B-O
-eliminate VERB B-O
-them PRON B-O
-. PUNCT B-O
-
-Common ADJ B-O
-bacterial ADJ B-O
-pathogens NOUN B-O
-such ADJ B-O
-as ADP B-O
-Salmonella PROPN B-O
-, PUNCT B-O
-Shigella PROPN B-O
-, PUNCT B-O
-and CCONJ B-O
-Yersinia PROPN B-O
-spp NOUN B-O
-. PUNCT B-O
-
-invade VERB B-O
-the DET B-O
-gut NOUN B-O
-epithelial ADJ B-O
-barrier NOUN B-O
-, PUNCT B-O
-preferentially ADV B-O
-by ADP B-O
-targeting VERB B-O
-the DET B-O
-relatively ADV B-O
-small ADJ B-O
-number NOUN B-O
-of ADP B-O
-M NOUN B-O
-cells NOUN B-O
-located VERB B-O
-in ADP B-O
-the DET B-O
-follicle NOUN B-LF
-- PUNCT I-LF
-associated VERB I-LF
-epithelium NOUN I-LF
-( PUNCT B-O
-FAE PROPN B-AC
-) PUNCT B-O
-[ X B-O
-1–3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Data NOUN B-O
-were AUX B-O
-collected VERB B-O
-from ADP B-O
-articles NOUN B-O
-published VERB B-O
-in ADP B-O
-2019 NUM B-O
-in ADP B-O
-the DET B-O
-biomedical ADJ B-O
-sciences NOUN B-O
-journals NOUN B-O
-: PUNCT B-O
-British PROPN B-LF
-Journal PROPN I-LF
-of ADP I-LF
-Pharmacology PROPN I-LF
-( PUNCT B-O
-BJP PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Journal PROPN B-LF
-of ADP I-LF
-Pharmacy PROPN I-LF
-and CCONJ I-LF
-Pharmacology PROPN I-LF
-( PUNCT B-O
-JPP PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Frontiers PROPN B-LF
-in ADP I-LF
-Pharmacology PROPN I-LF
-( PUNCT B-O
-FP PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Journal PROPN B-LF
-of ADP I-LF
-Cell PROPN I-LF
-Biology PROPN I-LF
-( PUNCT B-O
-JCB PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Journal PROPN B-LF
-of ADP I-LF
-Cell PROPN I-LF
-Science PROPN I-LF
-( PUNCT B-O
-JCS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Cells PROPN B-LF
-( PUNCT B-O
-CEL PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-Journal PROPN B-LF
-of ADP I-LF
-Biological PROPN I-LF
-Chemistry PROPN I-LF
-( PUNCT B-O
-JBC PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-Proceedings PROPN B-LF
-of ADP I-LF
-the DET I-LF
-National PROPN I-LF
-Academy PROPN I-LF
-of ADP I-LF
-Sciences PROPN I-LF
-( PUNCT B-O
-PNAS PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-N NOUN B-O
-= SYM B-O
-200 NUM B-O
-articles NOUN B-O
-analyzed VERB B-O
-in ADP B-O
-each DET B-O
-scientific ADJ B-O
-journal NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-24 NUM B-O
-studies NOUN B-O
-that PRON B-O
-contributed VERB B-O
-data NOUN B-O
-on ADP B-O
-the DET B-O
-diagnosis NOUN B-O
-and CCONJ B-O
-treatment NOUN B-O
-practices NOUN B-O
-of ADP B-O
-healthcare NOUN B-O
-providers NOUN B-O
-were AUX B-O
-undertaken VERB B-O
-in ADP B-O
-ten NUM B-O
-countries NOUN B-O
-, PUNCT B-O
-involving VERB B-O
-a DET B-O
-range NOUN B-O
-of ADP B-O
-cadres NOUN B-O
-, PUNCT B-O
-including VERB B-O
-medical ADJ B-O
-doctors NOUN B-O
-and CCONJ B-O
-nurses NOUN B-O
-, PUNCT B-O
-pharmacists NOUN B-O
-, PUNCT B-O
-drug NOUN B-O
-vendors NOUN B-O
-, PUNCT B-O
-traditional ADJ B-LF
-birth NOUN I-LF
-attendants NOUN I-LF
-( PUNCT B-O
-TBAs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-community NOUN B-LF
-health NOUN I-LF
-workers NOUN I-LF
-( PUNCT B-O
-CHWs PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-Tables NOUN B-O
-2 NUM B-O
-and CCONJ B-O
-3 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-fFN PROPN B-AC
-, PUNCT B-O
-fetal ADJ B-LF
-fibronectin NOUN I-LF
-; PUNCT B-O
-IPD PROPN B-AC
-, PUNCT B-O
-individual ADJ B-LF
-participant NOUN I-LF
-data NOUN I-LF
-; PUNCT B-O
-IQR PROPN B-O
-, PUNCT B-O
-interquartile ADJ B-O
-range NOUN B-O
-; PUNCT B-O
-SD NOUN B-O
-, PUNCT B-O
-standard ADJ B-O
-deviation NOUN B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-ITH PROPN B-AC
-, PUNCT B-O
-intra ADJ B-LF
-- ADJ I-LF
-tumour ADJ I-LF
-heterogeneity NOUN I-LF
-; PUNCT B-O
-DNAm PROPN B-AC
-, PUNCT B-O
-DNA NOUN B-LF
-methylation NOUN I-LF
-; PUNCT B-O
-OC PROPN B-AC
-, PUNCT B-O
-ovarian ADJ B-LF
-cancer NOUN I-LF
-; PUNCT B-O
-UCEC PROPN B-AC
-, PUNCT B-O
-uterine ADJ B-LF
-corpus NOUN I-LF
-endometrial ADJ I-LF
-carcinoma NOUN I-LF
-; PUNCT B-O
-BRCA PROPN B-AC
-, PUNCT B-O
-breast NOUN B-LF
-cancer NOUN I-LF
-invasive ADJ I-LF
-carcinoma NOUN I-LF
-. PUNCT B-O
-
-Also ADV B-O
-, PUNCT B-O
-F→ PROPN B-AC
-, PUNCT B-O
-dv1→ NOUN B-O
-, PUNCT B-O
-dΩ PROPN B-AC
-and CCONJ B-O
-σ PROPN B-AC
-are AUX B-O
-external ADJ B-O
-force NOUN B-O
-vector NOUN B-O
-, PUNCT B-O
-molecules NOUN B-O
-of ADP B-O
-class NOUN B-O
-with ADP B-O
-velocity NOUN B-O
-v1 NOUN B-O
-, PUNCT B-O
-elementary ADJ B-LF
-solid ADJ I-LF
-angle NOUN I-LF
-and CCONJ B-O
-collision NOUN B-LF
-cross NOUN I-LF
-section NOUN I-LF
-[ X B-O
-5,6 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-RNA NOUN B-O
-was AUX B-O
-extracted VERB B-O
-from ADP B-O
-liver NOUN B-O
-using VERB B-O
-TRIzol PROPN B-O
-reagent NOUN B-O
-( PUNCT B-O
-Life PROPN B-O
-Technologies PROPN B-O
-, PUNCT B-O
-Carlsbad PROPN B-O
-, PUNCT B-O
-CA PROPN B-O
-) PUNCT B-O
-and CCONJ B-O
-purified VERB B-O
-using VERB B-O
-the DET B-O
-RNeasy PROPN B-O
-kit NOUN B-O
-( PUNCT B-O
-Qiagen PROPN B-O
-, PUNCT B-O
-Valencia PROPN B-O
-, PUNCT B-O
-CA PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-RNA NOUN B-O
-integrity NOUN B-O
-was AUX B-O
-verified VERB B-O
-by ADP B-O
-formaldehyde NOUN B-O
-gel NOUN B-O
-electrophoresis NOUN B-O
-. PUNCT B-O
-
-cDNA NOUN B-O
-was AUX B-O
-synthesized VERB B-O
-using VERB B-O
-iScript PROPN B-O
-( PUNCT B-O
-BioRad PROPN B-O
-, PUNCT B-O
-Hercules PROPN B-O
-, PUNCT B-O
-CA PROPN B-O
-) PUNCT B-O
-; PUNCT B-O
-quantitative ADJ B-LF
-PCR NOUN I-LF
-( PUNCT B-O
-qPCR PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-performed VERB B-O
-with ADP B-O
-TaqMan PROPN B-O
-® PROPN B-O
-assay NOUN B-O
-kits NOUN B-O
-( PUNCT B-O
-Life PROPN B-O
-Technologies PROPN B-O
-, PUNCT B-O
-Carlsbad PROPN B-O
-, PUNCT B-O
-CA PROPN B-O
-) PUNCT B-O
-using VERB B-O
-β PUNCT B-O
-- NOUN B-O
-glucuronidase NOUN B-O
-as ADP B-O
-the DET B-O
-internal ADJ B-O
-control NOUN B-O
-gene NOUN B-O
-. PUNCT B-O
-
-Previous ADJ B-O
-studies NOUN B-O
-have AUX B-O
-implicated VERB B-O
-that SCONJ B-O
-prolonged VERB B-O
-activation NOUN B-O
-( PUNCT B-O
-> PUNCT B-O
-10 NUM B-O
-min NOUN B-O
-) PUNCT B-O
-of ADP B-O
-mGluR1/5 NOUN B-O
-by ADP B-O
-DHPG PROPN B-AC
-can AUX B-O
-stimulate VERB B-O
-spinal ADJ B-O
-excitatory ADJ B-O
-interneurons NOUN B-O
-to PART B-O
-produce VERB B-O
-endocannabinoids NOUN B-O
-, PUNCT B-O
-which PRON B-O
-act VERB B-O
-as ADP B-O
-retrograde ADJ B-O
-messengers NOUN B-O
-to PART B-O
-stimulate VERB B-O
-Type-1 NOUN B-LF
-cannabinoid NOUN I-LF
-( PUNCT B-O
-CB1 PROPN B-AC
-) PUNCT B-O
-receptors NOUN B-O
-expressed VERB B-O
-at ADP B-O
-inhibitory ADJ B-O
-nerve NOUN B-O
-terminals NOUN B-O
-[ PUNCT B-O
-18 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Some DET B-O
-TUNEL+ NOUN B-O
-cells NOUN B-O
-are AUX B-O
-also ADV B-O
-detected VERB B-O
-in ADP B-O
-the DET B-O
-mantle NOUN B-O
-zone NOUN B-O
-of ADP B-O
-the DET B-O
-PSB PROPN B-AC
-in ADP B-O
-mutant ADJ B-O
-embryos NOUN B-O
-( PUNCT B-O
-Div PROPN B-O
-) PUNCT B-O
-but CCONJ B-O
-do AUX B-O
-not PART B-O
-correspond VERB B-O
-to ADP B-O
-CR PROPN B-AC
-cells NOUN B-O
-since SCONJ B-O
-no DET B-O
-loss NOUN B-O
-of ADP B-O
-Reln PROPN B-O
-was AUX B-O
-observed VERB B-O
-in ADP B-O
-the DET B-O
-lateral ADJ B-LF
-pallium NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-E NOUN B-O
-– PUNCT B-O
-H NOUN B-O
-) PUNCT B-O
-Immunofluorescence NOUN B-O
-using VERB B-O
-Dbx1 NOUN B-O
-antisera NOUN B-O
-showing VERB B-O
-that SCONJ B-O
-at ADP B-O
-the DET B-O
-septum ADJ B-O
-dorsal ADJ B-O
-Dbx1 NOUN B-O
-+ NOUN B-O
-cells NOUN B-O
-are AUX B-O
-deleted VERB B-O
-in ADP B-O
-mutant ADJ B-O
-embryos NOUN B-O
-( PUNCT B-O
-F NOUN B-O
-) PUNCT B-O
-compared VERB B-O
-to ADP B-O
-control NOUN B-O
-animals NOUN B-O
-( PUNCT B-O
-E NOUN B-O
-) PUNCT B-O
-whereas SCONJ B-O
-ventral ADJ B-O
-Dbx1 NOUN B-O
-+ NOUN B-O
-cells NOUN B-O
-are AUX B-O
-not PART B-O
-( PUNCT B-O
-compare VERB B-O
-G PROPN B-O
-and CCONJ B-O
-H NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-situ ADJ B-O
-hybridization NOUN B-O
-for ADP B-O
-Reln PROPN B-O
-( PUNCT B-O
-I NOUN B-O
-, PUNCT B-O
-K NOUN B-O
-, PUNCT B-O
-quantified VERB B-O
-in ADP B-O
-M PROPN B-O
-) PUNCT B-O
-and CCONJ B-O
-p73 NOUN B-O
-( PUNCT B-O
-J PROPN B-O
-, PUNCT B-O
-L PROPN B-AC
-, PUNCT B-O
-quantified VERB B-O
-in ADP B-O
-N PROPN B-O
-) PUNCT B-O
-at ADP B-O
-caudal ADJ B-O
-levels NOUN B-O
-shows VERB B-O
-that SCONJ B-O
-there PRON B-O
-is VERB B-O
-no DET B-O
-significant ADJ B-O
-difference NOUN B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-6 NUM B-O
-) PUNCT B-O
-in ADP B-O
-the DET B-O
-numbers NOUN B-O
-of ADP B-O
-Reln+ NOUN B-O
-and CCONJ B-O
-p73 NOUN B-O
-+ NOUN B-O
-cells NOUN B-O
-between ADP B-O
-E11.5 NUM B-O
-control NOUN B-O
-( PUNCT B-O
-I NOUN B-O
-and CCONJ B-O
-J PROPN B-O
-) PUNCT B-O
-and CCONJ B-O
-Dbx1DTA;Emx1iresCre PROPN B-O
-embryos NOUN B-O
-( PUNCT B-O
-K NOUN B-O
-and CCONJ B-O
-L PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Quantifications NOUN B-O
-of ADP B-O
-the DET B-O
-numbers NOUN B-O
-of ADP B-O
-Reln+ NOUN B-O
-and CCONJ B-O
-p73 NOUN B-O
-+ NOUN B-O
-cells NOUN B-O
-in ADP B-O
-L1 NOUN B-O
-( PUNCT B-O
-O NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-L2 NOUN B-O
-( PUNCT B-O
-P NOUN B-O
-) PUNCT B-O
-DM PROPN B-AC
-regions NOUN B-O
-of ADP B-O
-E12.5 NUM B-O
-control NOUN B-O
-( PUNCT B-O
-white ADJ B-O
-bars NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-Dbx1DTA;Emx1iresCre PROPN B-O
-embryos NOUN B-O
-( PUNCT B-O
-black ADJ B-O
-bars NOUN B-O
-) PUNCT B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-3 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-* PUNCT B-O
-P<0.05 NUM B-O
-. PUNCT B-O
-
-CoSMO PROPN B-AC
-, PUNCT B-O
-Cooperation NOUN B-LF
-that PRON I-LF
-is AUX I-LF
-Synthetic ADJ I-LF
-and CCONJ I-LF
-Mutually ADV I-LF
-Obligatory ADJ I-LF
-. PUNCT B-O
-
-Propensity NOUN B-O
-- PUNCT B-O
-score NOUN B-O
-- PUNCT B-O
-matched VERB B-O
-controls NOUN B-O
-were AUX B-O
-selected VERB B-O
-from ADP B-O
-9,246 NUM B-O
-non ADJ B-O
-- PUNCT B-O
-SAMI PROPN B-AC
-patients NOUN B-O
-( PUNCT B-O
-non ADJ B-O
-- PUNCT B-O
-SA PROPN B-AC
-- PUNCT B-O
-MI PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-association NOUN B-O
-of ADP B-O
-SA PROPN B-AC
-and CCONJ B-O
-outcomes NOUN B-O
-including VERB B-O
-all DET B-O
-- PUNCT B-O
-cause NOUN B-O
-mortality NOUN B-O
-and CCONJ B-O
-major ADJ B-LF
-adverse ADJ I-LF
-cardiac ADJ I-LF
-and CCONJ I-LF
-cerebrovascular ADJ I-LF
-events NOUN I-LF
-( PUNCT B-O
-MACCEs PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-analyzed VERB B-O
-by ADP B-O
-a DET B-O
-Cox PROPN B-O
-proportional ADJ B-O
-hazards NOUN B-O
-model NOUN B-O
-. PUNCT B-O
-
-AMBA PROPN B-O
-, PUNCT B-O
-Allen PROPN B-O
-Mouse PROPN B-O
-Brain PROPN B-O
-Atlas PROPN B-O
-; PUNCT B-O
-CE PROPN B-O
-, PUNCT B-O
-cerebellum NOUN B-O
-; PUNCT B-O
-Fndc5 PROPN B-O
-, PUNCT B-O
-fibronectin NOUN B-O
-type NOUN B-O
-III NUM B-O
-domain NOUN B-O
-containing VERB B-O
-5 NUM B-O
-; PUNCT B-O
-HB PROPN B-O
-, PUNCT B-O
-hindbrain NOUN B-O
-; PUNCT B-O
-LAV PROPN B-O
-, PUNCT B-O
-lateral ADJ B-O
-vestibular ADJ B-O
-nucleus NOUN B-O
-; PUNCT B-O
-LC PROPN B-O
-, PUNCT B-O
-locus NOUN B-O
-coeruleus NOUN B-O
-; PUNCT B-O
-MV PROPN B-O
-, PUNCT B-O
-medial ADJ B-O
-vestibular ADJ B-O
-nucleus NOUN B-O
-; PUNCT B-O
-OT PROPN B-O
-, PUNCT B-O
-optic ADJ B-O
-tectum NOUN B-O
-; PUNCT B-O
-P56 PROPN B-O
-, PUNCT B-O
-postnatal ADJ B-O
-day NOUN B-O
-56 NUM B-O
-; PUNCT B-O
-Pp NOUN B-O
-, PUNCT B-O
-prepontine ADJ B-O
-area NOUN B-O
-; PUNCT B-O
-SUV PROPN B-AC
-, PUNCT B-O
-superior ADJ B-LF
-vestibular ADJ I-LF
-nucleus NOUN I-LF
-; PUNCT B-O
-TH NOUN B-O
-, PUNCT B-O
-tyrosine NOUN B-O
-hydroxylase NOUN B-O
-; PUNCT B-O
-ZBB PROPN B-AC
-, PUNCT B-O
-Zebrafish PROPN B-LF
-Brain PROPN I-LF
-Browser PROPN I-LF
-. PUNCT B-O
-
-Descending VERB B-LF
-DAD- PROPN B-AC
-aortic ADJ I-LF
-distensibility NOUN I-LF
-. PUNCT B-O
-
-The DET B-O
-present ADJ B-O
-findings NOUN B-O
-of ADP B-O
-an DET B-O
-association NOUN B-O
-between ADP B-O
-recent ADJ B-O
-cannabis NOUN B-O
-use NOUN B-O
-and CCONJ B-O
-psychotic ADJ B-O
-features NOUN B-O
-are AUX B-O
-consistent ADJ B-O
-with ADP B-O
-reports NOUN B-O
-of ADP B-O
-cannabis NOUN B-O
-creating VERB B-O
-an DET B-O
-acute ADJ B-O
-toxic ADJ B-O
-psychosis NOUN B-O
-and CCONJ B-O
-with ADP B-O
-short ADJ B-O
-- PUNCT B-O
-duration NOUN B-O
-effects NOUN B-O
-in ADP B-O
-laboratory NOUN B-O
-studies NOUN B-O
-of ADP B-O
-high ADJ B-O
-doses NOUN B-O
-of ADP B-O
-intravenous ADJ B-O
-tetrahydrocannabinol NOUN B-LF
-( PUNCT B-O
-THC PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-35%–50 NUM B-O
-% NOUN B-O
-of ADP B-O
-healthy ADJ B-O
-participants NOUN B-O
-[ PUNCT B-O
-17,60,61 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-This PRON B-O
-overlaps VERB B-O
-the DET B-O
-values NOUN B-O
-for ADP B-O
-the DET B-O
-mammalian ADJ B-O
-stratum NOUN B-O
-4 NUM B-O
-and CCONJ B-O
-3 NUM B-O
-genes NOUN B-O
-( PUNCT B-O
-mean ADJ B-O
-K NOUN B-O
-s NOUN B-O
-values NOUN B-O
-8 NUM B-O
-% NOUN B-O
-and CCONJ B-O
-30 NUM B-O
-% NOUN B-O
-, PUNCT B-O
-respectively ADV B-O
-) PUNCT B-O
-; PUNCT B-O
-these DET B-O
-strata NOUN B-O
-are AUX B-O
-inferred VERB B-O
-to PART B-O
-have AUX B-O
-ceased VERB B-O
-recombining VERB B-O
-between ADP B-O
-the DET B-O
-X NOUN B-O
-and CCONJ B-O
-Y NOUN B-O
-30–50 NUM B-O
-million NUM B-LF
-years NOUN I-LF
-ago ADV I-LF
-( PUNCT B-O
-MYA PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-stratum NOUN B-O
-4 NUM B-O
-, PUNCT B-O
-and CCONJ B-O
-80–130 NUM B-O
-MYA PROPN B-AC
-for ADP B-O
-stratum NOUN B-O
-3 NUM B-O
-, PUNCT B-O
-whereas SCONJ B-O
-strata NOUN B-O
-1 NUM B-O
-and CCONJ B-O
-2 NUM B-O
-diverged VERB B-O
-130–320 NUM B-O
-MYA PROPN B-AC
-[ PUNCT B-O
-9,11 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-ChIP PROPN B-AC
-, PUNCT B-O
-chromatin NOUN B-LF
-immunoprecipitation NOUN I-LF
-and CCONJ I-LF
-sequencing NOUN I-LF
-; PUNCT B-O
--SeqdnIκBα PROPN B-AC
-, PUNCT B-O
-dominant ADJ B-O
-negative ADJ B-O
-mutated VERB B-O
-IκBα PROPN B-O
-; PUNCT B-O
-FDR PROPN B-AC
-, PUNCT B-O
-false ADJ B-LF
-discovery NOUN I-LF
-rate NOUN I-LF
-; PUNCT B-O
-GEO PROPN B-O
-, PUNCT B-O
-Gene PROPN B-O
-Expression PROPN B-O
-Omnibus PROPN B-O
-; PUNCT B-O
-hnRNP NOUN B-O
-, PUNCT B-O
-heterogeneous ADJ B-O
-nuclear ADJ B-O
-ribonucleoprotein NOUN B-O
-; PUNCT B-O
-IκBα PROPN B-O
-, PUNCT B-O
-NFKB PROPN B-O
-inhibitor NOUN B-O
-alpha NOUN B-O
-; PUNCT B-O
-NC PROPN B-O
-, PUNCT B-O
-nitrocellulose NOUN B-O
-; PUNCT B-O
-NF PROPN B-AC
-, PUNCT B-O
-nuclear ADJ B-LF
-factor NOUN I-LF
-kappa NOUN I-LF
-B NOUN I-LF
-; PUNCT B-O
--κBP+I PROPN B-AC
-, PUNCT B-O
-phorbol NOUN B-O
-12 NUM B-O
-- PUNCT B-O
-myristate NOUN B-O
-13 NUM B-O
-- PUNCT B-O
-acetate NOUN B-O
-and CCONJ B-O
-ionomycin NOUN B-O
-; PUNCT B-O
-RNA PROPN B-AC
-, PUNCT B-O
-RNA NOUN B-LF
-sequencing NOUN I-LF
-; PUNCT B-O
--SeqTet PROPN B-AC
-, PUNCT B-O
-tetracycline NOUN B-LF
-. PUNCT B-O
-
-The DET B-O
-concerted ADJ B-O
-action NOUN B-O
-of ADP B-O
-the DET B-O
-three NUM B-O
-HIV-1 PROPN B-O
-proteins NOUN B-O
-Nef PROPN B-O
-, PUNCT B-O
-Env PROPN B-O
-, PUNCT B-O
-and CCONJ B-O
-Vpu PROPN B-O
-results VERB B-O
-in ADP B-O
-a DET B-O
-complete ADJ B-O
-removal NOUN B-O
-of ADP B-O
-CD4 NOUN B-O
-from ADP B-O
-the DET B-O
-surface NOUN B-O
-of ADP B-O
-HIV PROPN B-O
-infected VERB B-O
-cells NOUN B-O
-through ADP B-O
-( PUNCT B-O
-i X B-O
-) PUNCT B-O
-enhanced VERB B-O
-routing NOUN B-O
-of ADP B-O
-CD4 NOUN B-O
-to ADP B-O
-the DET B-O
-endoplasmic ADJ B-LF
-reticulum NOUN I-LF
-( PUNCT B-O
-ER PROPN B-AC
-) PUNCT B-O
-degradation NOUN B-O
-pathway NOUN B-O
-[ PUNCT B-O
-12],[13 X B-O
-] PUNCT B-O
-and CCONJ B-O
-( PUNCT B-O
-ii X B-O
-) PUNCT B-O
-activated VERB B-O
-endocytosis NOUN B-O
-and CCONJ B-O
-lysosomal ADJ B-O
-degradation NOUN B-O
-[ PUNCT B-O
-14],[15 X B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Morphologic ADJ B-O
-parameters NOUN B-O
-collected VERB B-O
-by ADP B-O
-USG PROPN B-AC
-, PUNCT B-O
-such ADJ B-O
-as ADP B-O
-cross ADJ B-LF
-- ADJ I-LF
-sectional ADJ I-LF
-area NOUN I-LF
-( PUNCT B-O
-CSA PROPN B-AC
-) PUNCT B-O
-obtained VERB B-O
-from ADP B-O
-transverse ADJ B-O
-scans NOUN B-O
-, PUNCT B-O
-provide VERB B-O
-useful ADJ B-O
-information NOUN B-O
-complementary ADJ B-O
-to ADP B-O
-electrophysiological ADJ B-O
-data NOUN B-O
-[ PUNCT B-O
-11–13 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-TNAP PROPN B-AC
-dephosphorylates VERB B-O
-poly NOUN B-O
-- PUNCT B-O
-inosine NOUN B-O
-: PUNCT B-O
-cytosine NOUN B-O
-( PUNCT B-O
-Toll PROPN B-LF
-- PUNCT I-LF
-like ADJ I-LF
-receptor NOUN I-LF
-( PUNCT B-O
-TLR PROPN B-AC
-) PUNCT B-O
-3 NUM B-O
-agonist NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-LPS PROPN B-AC
-from ADP B-O
-Klebsiella PROPN B-O
-pneumoniae NOUN B-O
-and CCONJ B-O
-Salmonella PROPN B-O
-minnesota PROPN B-O
-( PUNCT B-O
-TLR4 PROPN B-O
-agonists NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-HPLC PROPN B-AC
-analysis NOUN B-O
-was AUX B-O
-carried VERB B-O
-out ADP B-O
-using VERB B-O
-an DET B-O
-Agilent PROPN B-O
-1260 NUM B-O
-Infinity PROPN B-O
-system NOUN B-O
-( PUNCT B-O
-Agilent PROPN B-O
-Technologies PROPN B-O
-) PUNCT B-O
-with ADP B-O
-ultraviolet NOUN B-LF
-( PUNCT B-O
-UV PROPN B-AC
-) PUNCT B-O
-detection NOUN B-O
-at ADP B-O
-278 NUM B-O
-nm NOUN B-O
-( PUNCT B-O
-maximum ADJ B-O
-absorbance NOUN B-O
-of ADP B-O
-Cm PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-44 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-GFP PROPN B-AC
-, PUNCT B-O
-green ADJ B-LF
-fluorescent ADJ I-LF
-protein NOUN I-LF
-; PUNCT B-O
-PS PROPN B-AC
-, PUNCT B-O
-phosphatidylserine NOUN B-LF
-; PUNCT B-O
-UAS PROPN B-AC
-, PUNCT B-O
-upstream ADJ B-LF
-activating VERB I-LF
-sequence NOUN I-LF
-. PUNCT B-O
-
-Among ADP B-O
-urban ADJ B-O
-, PUNCT B-O
-migrant NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-rural ADJ B-O
-men NOUN B-O
-the DET B-O
-age- NOUN B-O
-and CCONJ B-O
-factory NOUN B-O
-- PUNCT B-O
-adjusted VERB B-O
-percentages NOUN B-O
-classified VERB B-O
-as ADP B-O
-obese ADJ B-O
-( PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-[ X B-O
-BMI PROPN B-AC
-] X B-O
-> NUM B-O
-25 NUM B-O
-kg NOUN B-O
-/ SYM B-O
-m2 NOUN B-O
-) PUNCT B-O
-were AUX B-O
-41.9 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-LF
-interval NOUN I-LF
-[ X B-O
-CI PROPN B-AC
-] X B-O
-39.1–44.7 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-37.8 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-35.0–40.6 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-19.0 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-17.0–21.0 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-respectively ADV B-O
-, PUNCT B-O
-and CCONJ B-O
-as ADP B-O
-diabetic ADJ B-O
-were AUX B-O
-13.5 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-11.6–15.4 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-14.3 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-12.2–16.4 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-6.2 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-5.0–7.4 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-respectively ADV B-O
-. PUNCT B-O
-
-Viruses NOUN B-O
-cause VERB B-O
-respiratory ADJ B-LF
-tract NOUN I-LF
-infections NOUN I-LF
-( PUNCT B-O
-RTIs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-if SCONJ B-O
-severe ADJ B-O
-, PUNCT B-O
-can AUX B-O
-lead VERB B-O
-to ADP B-O
-a DET B-O
-visit NOUN B-O
-to ADP B-O
-the DET B-O
-Emergency PROPN B-LF
-Department PROPN I-LF
-( PUNCT B-O
-ED PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-hospitalization NOUN B-O
-. PUNCT B-O
-
-MDA PROPN B-AC
-, PUNCT B-O
-mass PROPN B-LF
-drug PROPN I-LF
-administration NOUN I-LF
-; PUNCT B-O
-IRS PROPN B-AC
-, PUNCT B-O
-indoor ADJ B-LF
-residual NOUN I-LF
-spraying NOUN I-LF
-; PUNCT B-O
-rfMDA PROPN B-AC
-, PUNCT B-O
-reactive ADJ B-LF
-focal ADJ I-LF
-mass PROPN B-LF
-drug PROPN I-LF
-administration NOUN I-LF
-; PUNCT B-O
-LLIN PROPN B-AC
-, PUNCT B-O
-long ADJ B-LF
-lasting ADJ I-LF
-insecticidal ADJ I-LF
-nets NOUN I-LF
-; PUNCT B-O
-NMCP PROPN B-AC
-, PUNCT B-O
-national ADJ B-O
-malaria NOUN B-O
-control NOUN B-O
-programme NOUN B-O
-; PUNCT B-O
-Contr PROPN B-O
-, PUNCT B-O
-contribution NOUN B-O
-; PUNCT B-O
-Ref PROPN B-O
-, PUNCT B-O
-reference NOUN B-O
-. PUNCT B-O
-
-Exploring VERB B-O
-potential ADJ B-O
-subgroup NOUN B-O
-effects NOUN B-O
-of ADP B-O
-maternal ADJ B-O
-age NOUN B-O
-, PUNCT B-O
-parity NOUN B-O
-, PUNCT B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-( PUNCT B-O
-BMI PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-or CCONJ B-O
-fetal ADJ B-O
-sex NOUN B-O
-is AUX B-O
-therefore ADV B-O
-impossible ADJ B-O
-in ADP B-O
-individual ADJ B-O
-trials NOUN B-O
-. PUNCT B-O
-
-This DET B-O
-process NOUN B-O
-can AUX B-O
-be AUX B-O
-accomplished VERB B-O
-by ADP B-O
-alternative ADJ B-O
-precursor NOUN B-LF
-messenger NOUN I-LF
-RNA NOUN I-LF
-( PUNCT B-O
-pre-mRNA PROPN B-AC
-) PUNCT B-O
-splicing NOUN B-O
-. PUNCT B-O
-
-CIN PROPN B-AC
-, PUNCT B-O
-cervical ADJ B-LF
-intraepithelial ADJ I-LF
-neoplasia NOUN I-LF
-. PUNCT B-O
-
-De X B-O
-novo X B-O
-pathogenic ADJ B-O
-variants NOUN B-O
-in ADP B-O
-Histone NOUN B-LF
-- NOUN I-LF
-lysine NOUN I-LF
-N NOUN I-LF
-- NOUN I-LF
-methyltransferase NOUN I-LF
-2D PROPN I-LF
-( PUNCT B-O
-KMT2D PROPN B-AC
-) PUNCT B-O
-are AUX B-O
-causative ADJ B-O
-in ADP B-O
-up ADP B-O
-to PART B-O
-76 NUM B-O
-% NOUN B-O
-of ADP B-O
-KS PROPN B-O
-patients NOUN B-O
-[ PUNCT B-O
-18,19 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-* PUNCT B-O
-Reproductive ADJ B-O
-/ SYM B-O
-antenatal ADJ B-O
-health NOUN B-O
-: PUNCT B-O
-Reproductive ADJ B-O
-/ SYM B-O
-antenatal ADJ B-O
-knowledge NOUN B-O
-, PUNCT B-O
-medical ADJ B-O
-abortion NOUN B-O
-, PUNCT B-O
-facility NOUN B-O
-delivery NOUN B-O
-, PUNCT B-O
-child NOUN B-O
-dietary ADJ B-O
-diversity NOUN B-O
-. PUNCT B-O
-
-†Non ADJ B-O
-- ADJ I-LF
-communicable ADJ I-LF
-diseases NOUN I-LF
-: PUNCT B-O
-Diabetes NOUN B-O
-, PUNCT B-O
-hypertension NOUN B-O
-. PUNCT B-O
-
-‡One NUM B-O
-ongoing ADJ B-O
-NCD PROPN B-AC
-trial NOUN B-O
-is AUX B-O
-a DET B-O
-multicenter NOUN B-O
-study NOUN B-O
-in ADP B-O
-South PROPN B-O
-Africa PROPN B-O
-and CCONJ B-O
-Malawi PROPN B-O
-, PUNCT B-O
-hence ADV B-O
-the DET B-O
-number NOUN B-O
-of ADP B-O
-symbols NOUN B-O
-exceeds VERB B-O
-the DET B-O
-number NOUN B-O
-of ADP B-O
-included VERB B-O
-trials NOUN B-O
-by ADP B-O
-one NUM B-O
-. PUNCT B-O
-
-§ PUNCT B-O
-Map NOUN B-O
-developed VERB B-O
-by ADP B-O
-use NOUN B-O
-of ADP B-O
-mapchart.net NOUN B-O
-. PUNCT B-O
-
-Phase NOUN B-O
-contrast NOUN B-O
-cine NOUN B-O
-gradient NOUN B-O
-echo NOUN B-O
-sequence NOUN B-O
-was AUX B-O
-also ADV B-O
-obtained VERB B-O
-to PART B-O
-evaluate VERB B-O
-aortic ADJ B-O
-stiffness NOUN B-O
-including VERB B-O
-ascending VERB B-O
-and CCONJ B-O
-descending ADJ B-LF
-aortic ADJ I-LF
-distensibility NOUN I-LF
-( PUNCT B-O
-AAD NOUN B-O
-and CCONJ B-O
-DAD PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-pulse NOUN B-LF
-wave NOUN I-LF
-velocity NOUN I-LF
-( PUNCT B-O
-PWV PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-16 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Streptokinase PROPN B-O
-was AUX B-O
-administered VERB B-O
-in ADP B-O
-seven NUM B-O
-( PUNCT B-O
-6.3 NUM B-O
-% NOUN B-O
-) NOUN B-O
-patients NOUN B-O
-with ADP B-O
-STEMI PROPN B-AC
-. PUNCT B-O
-
-Primary ADJ B-O
-percutaneous ADJ B-LF
-coronary ADJ I-LF
-intervention NOUN I-LF
-( PUNCT B-O
-PCI PROPN B-AC
-) NOUN B-O
-was AUX B-O
-done VERB B-O
-in ADP B-O
-six NUM B-O
-( PUNCT B-O
-3.9 NUM B-O
-% NOUN B-O
-) NOUN B-O
-patients NOUN B-O
-with ADP B-O
-STEMI PROPN B-AC
-. PUNCT B-O
-
-Loading VERB B-O
-dose NOUN B-O
-of ADP B-O
-aspirin NOUN B-O
-and CCONJ B-O
-clopidogrel NOUN B-O
-were AUX B-O
-administered VERB B-O
-in ADP B-O
-the DET B-O
-emergency NOUN B-O
-setting NOUN B-O
-in ADP B-O
-about ADV B-O
-63.8 NUM B-O
-% NOUN B-O
-and CCONJ B-O
-62.8 NUM B-O
-% NOUN B-O
-of ADP B-O
-patients NOUN B-O
-, PUNCT B-O
-respectively ADV B-O
-. PUNCT B-O
-
-Overall ADJ B-O
-and CCONJ B-O
-age NOUN B-O
-- ADJ B-O
-specific ADJ B-O
-meta ADJ B-O
-- ADJ B-O
-analytic ADJ B-O
-estimates NOUN B-O
-of ADP B-O
-proportion NOUN B-O
-positive ADJ B-O
-were AUX B-O
-multiplied VERB B-O
-by ADP B-O
-LRI PROPN B-AC
-hospitalization NOUN B-O
-and CCONJ B-O
-LRI PROPN B-AC
-episode NOUN B-O
-estimates NOUN B-O
-for ADP B-O
-adults NOUN B-O
-≥20 NUM B-O
-years NOUN B-O
-, PUNCT B-O
-which PRON B-O
-were AUX B-O
-from ADP B-O
-the DET B-O
-Global PROPN B-LF
-Burden PROPN I-LF
-of ADP I-LF
-Disease PROPN I-LF
-( PUNCT B-O
-GBD PROPN B-AC
-) PUNCT B-O
-2017 NUM B-O
-study NOUN B-O
-[ PUNCT B-O
-10 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-obtained VERB B-O
-for ADP B-O
-calendar NOUN B-O
-year NOUN B-O
-2016 NUM B-O
-for ADP B-O
-this DET B-O
-analysis NOUN B-O
-. PUNCT B-O
-
-cART PROPN B-AC
-, PUNCT B-O
-combined ADJ B-O
-antiretroviral ADJ B-O
-therapy NOUN B-O
-; PUNCT B-O
-CI PROPN B-O
-, PUNCT B-O
-confidence NOUN B-O
-interval NOUN B-O
-; PUNCT B-O
-DTG PROPN B-AC
-, PUNCT B-O
-dolutegravir NOUN B-LF
-; PUNCT B-O
-FTC PROPN B-AC
-, PUNCT B-O
-emtricitabine NOUN B-LF
-; PUNCT B-O
-ITT PROPN B-AC
-, PUNCT B-O
-intention NOUN B-LF
-- PUNCT I-LF
-to PART I-LF
-- PUNCT I-LF
-treat VERB I-LF
-; PUNCT B-O
-PP PROPN B-AC
-, PUNCT B-O
-per ADP B-O
-- PUNCT B-O
-protocol NOUN B-O
-. PUNCT B-O
-
-People NOUN B-O
-with ADP B-O
-mental ADJ B-O
-illnesses NOUN B-O
-: PUNCT B-O
-Patients NOUN B-O
-under ADP B-O
-psychiatric ADJ B-O
-medications NOUN B-O
-for ADP B-O
-mental ADJ B-O
-illnesses NOUN B-O
-whose DET B-O
-identity NOUN B-O
-were AUX B-O
-informed VERB B-O
-by ADP B-O
-Female PROPN B-LF
-Community PROPN I-LF
-Health PROPN I-LF
-Volunteers PROPN I-LF
-( PUNCT B-O
-FCHVs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-PHC PROPN B-AC
-health NOUN B-O
-workers NOUN B-O
-or CCONJ B-O
-secondary ADJ B-O
-health NOUN B-O
-service NOUN B-O
-providers NOUN B-O
-. PUNCT B-O
-
-Wild ADJ B-LF
-- PUNCT I-LF
-type NOUN I-LF
-( PUNCT B-O
-WT PROPN B-AC
-) PUNCT B-O
-CD45.1 NOUN B-O
-and CCONJ B-O
-CD45.2 NOUN B-O
-mice NOUN B-O
-were AUX B-O
-bred VERB B-O
-and CCONJ B-O
-maintained VERB B-O
-in ADP B-O
-conventional ADJ B-O
-pathogen NOUN B-O
-- PUNCT B-O
-free ADJ B-O
-colonies NOUN B-O
-at ADP B-O
-either CCONJ B-O
-the DET B-O
-National PROPN B-O
-Institute PROPN B-O
-for ADP B-O
-Medical PROPN B-O
-Research PROPN B-O
-( PUNCT B-O
-London PROPN B-O
-, PUNCT B-O
-United PROPN B-O
-Kingdom PROPN B-O
-) PUNCT B-O
-or CCONJ B-O
-at ADP B-O
-the DET B-O
-Royal PROPN B-O
-Free PROPN B-O
-Campus PROPN B-O
-of ADP B-O
-University PROPN B-O
-College PROPN B-O
-London PROPN B-O
-. PUNCT B-O
-
-We PRON B-O
-undertook VERB B-O
-meta NOUN B-O
-- PUNCT B-O
-analyses NOUN B-O
-using VERB B-O
-RevMan PROPN B-O
-5.3 NUM B-O
-[ X B-O
-30 NUM B-O
-] X B-O
-using VERB B-O
-random ADJ B-O
-- PUNCT B-O
-effects NOUN B-O
-models NOUN B-O
-and CCONJ B-O
-calculated VERB B-O
-relative ADJ B-LF
-risks NOUN I-LF
-( PUNCT B-O
-RRs PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-mean ADJ B-LF
-differences NOUN I-LF
-( PUNCT B-O
-MDs PROPN B-AC
-) PUNCT B-O
-with ADP B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-LF
-intervals NOUN I-LF
-( PUNCT B-O
-CIs PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-To PART B-O
-quantify VERB B-O
-time NOUN B-O
-- PUNCT B-O
-dependent ADJ B-O
-changes NOUN B-O
-in ADP B-O
-synaptic ADJ B-O
-gain NOUN B-O
-we PRON B-O
-used VERB B-O
-an DET B-O
-“ PUNCT B-O
-Adaptation PROPN B-LF
-Index PROPN I-LF
-” PUNCT B-O
-( PUNCT B-O
-AI PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-calculated VERB B-O
-as ADP B-O
-the DET B-O
-ratio NOUN B-O
-between ADP B-O
-the DET B-O
-peak ADJ B-O
-initial ADJ B-O
-response NOUN B-O
-to ADP B-O
-an DET B-O
-increase NOUN B-O
-in ADP B-O
-contrast NOUN B-O
-and CCONJ B-O
-the DET B-O
-later ADJ B-O
-steady ADJ B-O
-- PUNCT B-O
-state NOUN B-O
-response NOUN B-O
-. PUNCT B-O
-
-During ADP B-O
-the DET B-O
-course NOUN B-O
-of ADP B-O
-this DET B-O
-study NOUN B-O
-, PUNCT B-O
-an DET B-O
-updated VERB B-O
-, PUNCT B-O
-larger ADJ B-O
-GWAS PROPN B-AC
-dataset NOUN B-O
-for ADP B-O
-coronary ADJ B-LF
-artery NOUN I-LF
-disease NOUN I-LF
-( PUNCT B-O
-CAD PROPN B-AC
-) PUNCT B-O
-became VERB B-O
-publicly ADV B-O
-available ADJ B-O
-( PUNCT B-O
-CARDIoGRAMplusC4D PROPN B-O
-Consortium PROPN B-O
-, PUNCT B-O
-release NOUN B-O
-2015 NUM B-O
-[ X B-O
-41 NUM B-O
-] PUNCT B-O
-) PUNCT B-O
-; PUNCT B-O
-we PRON B-O
-therefore ADV B-O
-redid VERB B-O
-the DET B-O
-analysis NOUN B-O
-for ADP B-O
-CAD PROPN B-AC
-using VERB B-O
-the DET B-O
-release NOUN B-O
-2015 NUM B-O
-data NOUN B-O
-. PUNCT B-O
-
-Rate NOUN B-O
-ratio NOUN B-O
-( PUNCT B-O
-RR NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-credible ADJ B-LF
-interval NOUN I-LF
-( PUNCT B-O
-CrI PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-brackets NOUN B-O
-, PUNCT B-O
-significant ADJ B-O
-predictions NOUN B-O
-in ADP B-O
-bold NOUN B-O
-. PUNCT B-O
-
-To PART B-O
-analyze VERB B-O
-the DET B-O
-amount NOUN B-O
-of ADP B-O
-asymmetry NOUN B-O
-between ADP B-O
-the DET B-O
-dominant ADJ B-O
-and CCONJ B-O
-non ADJ B-O
-- ADJ B-O
-dominant ADJ B-O
-lower ADJ B-O
-limbs NOUN B-O
-, PUNCT B-O
-we PRON B-O
-used VERB B-O
-the DET B-O
-absolute ADJ B-LF
-symmetry NOUN I-LF
-index NOUN I-LF
-( PUNCT B-O
-ASI PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-the DET B-O
-symmetry NOUN B-LF
-index NOUN I-LF
-( PUNCT B-O
-SI PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-31–34 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-This DET B-O
-method NOUN B-O
-, PUNCT B-O
-called VERB B-O
-optimal ADJ B-LF
-metabolic ADJ I-LF
-network NOUN I-LF
-identification NOUN I-LF
-( PUNCT B-O
-OMNI PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-allows VERB B-O
-efficient ADJ B-O
-identification NOUN B-O
-of ADP B-O
-the DET B-O
-set NOUN B-O
-of ADP B-O
-reactions NOUN B-O
-that PRON B-O
-results VERB B-O
-in ADP B-O
-the DET B-O
-best ADJ B-O
-agreement NOUN B-O
-between ADP B-O
-in ADP B-O
-silico NOUN B-O
-predicted VERB B-O
-and CCONJ B-O
-experimentally ADV B-O
-measured VERB B-O
-flux NOUN B-O
-distributions NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-then ADV B-O
-removed VERB B-O
-any DET B-O
-variants NOUN B-O
-with ADP B-O
-flags NOUN B-O
-“ PUNCT B-O
-badRead ADJ B-O
-, PUNCT B-O
-” PUNCT B-O
-mapping NOUN B-LF
-quality NOUN I-LF
-( PUNCT B-O
-“ PUNCT B-O
-MQ PROPN B-AC
-” PUNCT B-O
-) PUNCT B-O
-, PUNCT B-O
-or CCONJ B-O
-quality NOUN B-LF
-depth NOUN I-LF
-( PUNCT B-O
-“ PUNCT B-O
-QD PROPN B-AC
-” PUNCT B-O
-) PUNCT B-O
-. PUNCT B-O
-
-After ADP B-O
-fixation NOUN B-O
-and CCONJ B-O
-permeabilization NOUN B-O
-, PUNCT B-O
-the DET B-O
-cells NOUN B-O
-were AUX B-O
-stained VERB B-O
-for ADP B-O
-pSHIP PROPN B-AC
-and CCONJ B-O
-analyzed VERB B-O
-using VERB B-O
-confocal ADJ B-LF
-microscopy NOUN I-LF
-( PUNCT B-O
-CFm PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
-flow NOUN B-O
-cytometry NOUN B-O
-( PUNCT B-O
-A NOUN B-O
-, PUNCT B-O
-B NOUN B-O
-and CCONJ B-O
-D NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-mean ADJ B-LF
-fluorescence NOUN I-LF
-intensity NOUN I-LF
-( PUNCT B-O
-MFI PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-pSHIP PROPN B-AC
-was AUX B-O
-generated VERB B-O
-using VERB B-O
-NIS PROPN B-O
-- PUNCT B-O
-Elements PROPN B-O
-AR PROPN B-O
-3.2 NUM B-O
-software NOUN B-O
-( PUNCT B-O
-C NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Flow NOUN B-O
-cytometry NOUN B-O
-analysis NOUN B-O
-of ADP B-O
-the DET B-O
-MFI PROPN B-AC
-of ADP B-O
-pSHIP PROPN B-AC
-after ADP B-O
-stimulation NOUN B-O
-with ADP B-O
-sAgs PROPN B-AC
-( PUNCT B-O
-D NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-Pearson PROPN B-O
-’s PART B-O
-correlation NOUN B-O
-coefficients NOUN B-O
-between ADP B-O
-BCR PROPN B-AC
-and CCONJ B-O
-pSHIP PROPN B-AC
-staining NOUN B-O
-in ADP B-O
-sAg PROPN B-AC
-- PUNCT B-O
-stimulated VERB B-O
-cells NOUN B-O
-were AUX B-O
-determined VERB B-O
-using VERB B-O
-NIS PROPN B-O
-- PUNCT B-O
-Elements PROPN B-O
-AR PROPN B-O
-3.2 NUM B-O
-software NOUN B-O
-( PUNCT B-O
-E NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Shown VERB B-O
-are AUX B-O
-representative ADJ B-O
-images NOUN B-O
-at ADP B-O
-indicated VERB B-O
-times NOUN B-O
-and CCONJ B-O
-the DET B-O
-average ADJ B-O
-values NOUN B-O
-( PUNCT B-O
-±SD NOUN B-O
-) PUNCT B-O
-of ADP B-O
-about ADV B-O
-50 NUM B-O
-cells NOUN B-O
-from ADP B-O
-3 NUM B-O
-independent ADJ B-O
-experiments NOUN B-O
-. PUNCT B-O
-
-Furthermore ADV B-O
-, PUNCT B-O
-higher ADJ B-O
-prevalence NOUN B-O
-of ADP B-O
-tumor NOUN B-LF
-- PUNCT I-LF
-infiltrating VERB I-LF
-lymphocytes NOUN I-LF
-( PUNCT B-O
-TILs PROPN B-AC
-) PUNCT B-O
-has AUX B-O
-been AUX B-O
-associated VERB B-O
-with ADP B-O
-better ADJ B-O
-prognosis NOUN B-O
-[ PUNCT B-O
-19–22 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-irrespective ADV B-O
-of ADP B-O
-the DET B-O
-chemotherapy NOUN B-O
-administered VERB B-O
-, PUNCT B-O
-and CCONJ B-O
-also ADV B-O
-with ADP B-O
-a DET B-O
-higher ADJ B-O
-rate NOUN B-O
-of ADP B-O
-pCR PROPN B-AC
-to ADP B-O
-neoadjuvant ADJ B-O
-anthracycline NOUN B-O
-- PUNCT B-O
-based VERB B-O
-chemotherapy NOUN B-O
-in ADP B-O
-TNBC PROPN B-AC
-[ PUNCT B-O
-23 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-To PART B-O
-address VERB B-O
-this DET B-O
-question NOUN B-O
-, PUNCT B-O
-hairpin NOUN B-O
-RNA NOUN B-LF
-- PUNCT I-LF
-induced VERB I-LF
-gene NOUN I-LF
-silencing NOUN I-LF
-( PUNCT B-O
-RNAi PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-adopted VERB B-O
-. PUNCT B-O
-
-The DET B-O
-first ADJ B-O
-antimetabolite NOUN B-O
-drug NOUN B-O
-that PRON B-O
-was AUX B-O
-developed VERB B-O
-to PART B-O
-specifically ADV B-O
-target VERB B-O
-cancer NOUN B-O
-cells NOUN B-O
-was AUX B-O
-the DET B-O
-pyrimidine NOUN B-O
-analogue NOUN B-O
-5 NUM B-LF
-- PUNCT I-LF
-fluorouracil NOUN I-LF
-, PUNCT B-O
-5-FU PROPN B-AC
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-5 PROPN B-AC
-targets VERB B-O
-several ADJ B-O
-cellular ADJ B-O
-mechanisms NOUN B-O
-through ADP B-O
-its PRON B-O
-activated VERB B-O
-metabolites NOUN B-O
-FdUMP NOUN B-O
-, PUNCT B-O
-FUTP PROPN B-O
-and CCONJ B-O
-FdUTP NOUN B-O
-[ PUNCT B-O
-2–3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Cb PROPN B-O
-, PUNCT B-O
-Coxiella PROPN B-O
-burnetii NOUN B-O
-; PUNCT B-O
-GO PROPN B-AC
-, PUNCT B-O
-Gene PROPN B-LF
-Ontology NOUN I-LF
-; PUNCT B-O
-praw NOUN B-O
-, PUNCT B-O
-original ADJ B-O
-p NOUN B-O
-- PUNCT B-O
-value NOUN B-O
-; PUNCT B-O
-padj NOUN B-O
-, PUNCT B-O
-adjusted VERB B-O
-p NOUN B-O
-- PUNCT B-O
-value NOUN B-O
-according VERB B-O
-to ADP B-O
-the DET B-O
-Benjamini PROPN B-O
-- PUNCT B-O
-Hochberg PROPN B-O
-multiple ADJ B-O
-test NOUN B-O
-correction NOUN B-O
-[ PUNCT B-O
-43 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-conceptus NOUN B-O
-was AUX B-O
-dissected VERB B-O
-, PUNCT B-O
-and CCONJ B-O
-transcriptome NOUN B-O
-data NOUN B-O
-were AUX B-O
-generated VERB B-O
-for ADP B-O
-extraembryonic ADJ B-O
-tissue NOUN B-O
-, PUNCT B-O
-whereas SCONJ B-O
-the DET B-O
-endometrium NOUN B-O
-was AUX B-O
-dissected VERB B-O
-into ADP B-O
-caruncular ADJ B-O
-( PUNCT B-O
-gland NOUN B-O
-- PUNCT B-O
-free ADJ B-O
-) PUNCT B-O
-and CCONJ B-O
-intercaruncular ADJ B-O
-( PUNCT B-O
-containing VERB B-O
-endometrial ADJ B-O
-glands NOUN B-O
-) PUNCT B-O
-areas NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-transcriptome NOUN B-O
-data NOUN B-O
-were AUX B-O
-generated VERB B-O
-from ADP B-O
-both DET B-O
-regions NOUN B-O
-of ADP B-O
-the DET B-O
-endometrium NOUN B-O
-( PUNCT B-O
-Fig NOUN B-O
-1A NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Therefore ADV B-O
-, PUNCT B-O
-the DET B-O
-data NOUN B-O
-set NOUN B-O
-analyzed VERB B-O
-was AUX B-O
-comprised VERB B-O
-of ADP B-O
-three NUM B-O
-sample NOUN B-O
-types NOUN B-O
-collected VERB B-O
-from ADP B-O
-each DET B-O
-pregnancy NOUN B-O
-: PUNCT B-O
-extraembryonic ADJ B-O
-, PUNCT B-O
-caruncular ADJ B-O
-, PUNCT B-O
-and CCONJ B-O
-intercaruncular ADJ B-O
-tissues NOUN B-O
-( PUNCT B-O
-Fig NOUN B-O
-1B NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Alignment NOUN B-O
-of ADP B-O
-the DET B-O
-sequences NOUN B-O
-to ADP B-O
-the DET B-O
-B. PROPN B-O
-taurus PROPN B-O
-genome NOUN B-O
-( PUNCT B-O
-University PROPN B-LF
-of ADP I-LF
-Maryland PROPN I-LF
-[ X B-O
-UMD PROPN B-AC
-] X B-O
-assembly NOUN B-O
-3.1 NUM B-O
-) PUNCT B-O
-resulted VERB B-O
-into ADP B-O
-an DET B-O
-average NOUN B-O
-of ADP B-O
-22 NUM B-O
-, PUNCT B-O
-31.4 NUM B-O
-, PUNCT B-O
-and CCONJ B-O
-34.6 NUM B-O
-million NUM B-O
-uniquely ADV B-O
-mapped VERB B-O
-reads NOUN B-O
-for ADP B-O
-extraembryonic ADJ B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-5 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-caruncular ADJ B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-5 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-intercaruncular ADJ B-O
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-5 NUM B-O
-) PUNCT B-O
-tissues NOUN B-O
-, PUNCT B-O
-respectively ADV B-O
-. PUNCT B-O
-
-Hormone NOUN B-LF
-therapy NOUN I-LF
-( PUNCT B-O
-HT PROPN B-AC
-) PUNCT B-O
-may AUX B-O
-decrease VERB B-O
-the DET B-O
-risk NOUN B-O
-of ADP B-O
-osteoporosis NOUN B-O
-and CCONJ B-O
-bone NOUN B-O
-fracture NOUN B-O
-[ PUNCT B-O
-31 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-review NOUN B-O
-is AUX B-O
-reported VERB B-O
-according VERB B-O
-to ADP B-O
-the DET B-O
-Preferred ADJ B-LF
-Reporting PROPN I-LF
-Items PROPN I-LF
-for ADP I-LF
-Systematic PROPN I-LF
-Reviews PROPN I-LF
-and CCONJ I-LF
-Meta PROPN I-LF
-- PROPN I-LF
-Analyses PROPN I-LF
-( PUNCT B-O
-PRISMA PROPN B-AC
-) PUNCT B-O
-[ X B-O
-19 X B-O
-] PUNCT B-O
-( PUNCT B-O
-see VERB B-O
-S1 PROPN B-O
-Checklist PROPN B-O
-) PUNCT B-O
-and CCONJ B-O
-the DET B-O
-Guidelines PROPN B-O
-for ADP B-O
-Meta PROPN B-O
-- PROPN B-O
-Analyses PROPN B-O
-and CCONJ B-O
-Systematic PROPN B-O
-Reviews PROPN B-O
-of ADP B-O
-Observational PROPN B-O
-Studies.[20 PROPN B-O
-] PUNCT B-O
-The DET B-O
-protocol NOUN B-O
-was AUX B-O
-published VERB B-O
-in ADP B-O
-advance NOUN B-O
-( PUNCT B-O
-ID NOUN B-O
-= X B-O
-CRD42015025488).[21 NUM B-O
-] PUNCT B-O
-Eligibility NOUN B-O
-criteria NOUN B-O
-were AUX B-O
-defined VERB B-O
-in ADP B-O
-relation NOUN B-O
-to ADP B-O
-PICOS PROPN B-AC
-( PUNCT B-O
-participants NOUN B-LF
-, PUNCT I-LF
-interventions NOUN I-LF
-, PUNCT I-LF
-comparisons NOUN I-LF
-, PUNCT I-LF
-outcomes NOUN I-LF
-, PUNCT I-LF
-and CCONJ I-LF
-study NOUN I-LF
-design NOUN I-LF
-) PUNCT B-O
-as SCONJ B-O
-recommended VERB B-O
-by ADP B-O
-PRISMA PROPN B-AC
-. PUNCT B-O
-
-In ADP B-O
-this DET B-O
-study NOUN B-O
-, PUNCT B-O
-we PRON B-O
-assembled VERB B-O
-a DET B-O
-large ADJ B-O
-array NOUN B-O
-of ADP B-O
-variables NOUN B-O
-from ADP B-O
-4 NUM B-O
-components NOUN B-O
-within ADP B-O
-HRS PROPN B-AC
-, PUNCT B-O
-including VERB B-O
-the DET B-O
-core NOUN B-O
-survey NOUN B-O
-( PUNCT B-O
-1996–2016 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-newly ADV B-O
-released VERB B-O
-2015 NUM B-O
-Life PROPN B-LF
-History PROPN I-LF
-Mail PROPN I-LF
-Survey PROPN I-LF
-( PUNCT B-O
-LHMS PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-Enhanced PROPN B-LF
-Face PROPN I-LF
-- PUNCT I-LF
-To ADP I-LF
-- PUNCT I-LF
-Face PROPN I-LF
-( PUNCT B-O
-EFTF PROPN B-AC
-) PUNCT B-O
-interview NOUN B-O
-( PUNCT B-O
-2006–2016 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-2016 NUM B-O
-Venous PROPN B-LF
-Blood PROPN I-LF
-Study PROPN I-LF
-( PUNCT B-O
-VBS PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-A DET B-O
-description NOUN B-O
-of ADP B-O
-the DET B-O
-4 NUM B-O
-data NOUN B-O
-sources NOUN B-O
-can AUX B-O
-be AUX B-O
-found VERB B-O
-in ADP B-O
-S1 PROPN B-O
-Appendix PROPN B-O
-and CCONJ B-O
-elsewhere ADV B-O
-[ PUNCT B-O
-31 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-A DET B-O
-plot NOUN B-O
-of ADP B-O
-the DET B-O
-total ADJ B-O
-median ADJ B-LF
-p-Stat5 PROPN B-AC
-fluorescence NOUN I-LF
-intensity NOUN I-LF
-( PUNCT B-O
-MFI PROPN B-AC
-) PUNCT B-O
-versus ADP B-O
-Epo PROPN B-AC
-concentration NOUN B-O
-has VERB B-O
-Michaelian ADJ B-O
-kinetics NOUN B-O
-with ADP B-O
-a DET B-O
-Hill PROPN B-LF
-coefficient NOUN I-LF
-( PUNCT B-O
-nH PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-1 NUM B-O
-( PUNCT B-O
-lower ADJ B-O
-left ADJ B-O
-panel NOUN B-O
-, PUNCT B-O
-please INTJ B-O
-note VERB B-O
-a DET B-O
-log NOUN B-O
-scale NOUN B-O
-was AUX B-O
-used VERB B-O
-for ADP B-O
-the DET B-O
-x NOUN B-O
-- NOUN B-O
-axis NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-A X B-O
-: PUNCT B-O
-Flow NOUN B-O
-cytometry NOUN B-O
-of ADP B-O
-patient ADJ B-O
-P3 NOUN B-O
-peripheral ADJ B-LF
-blood NOUN I-LF
-mononuclear ADJ I-LF
-cells NOUN I-LF
-( PUNCT B-O
-PBMC PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-left ADJ B-O
-column NOUN B-O
-) PUNCT B-O
-followed VERB B-O
-by ADP B-O
-cell NOUN B-O
-sorting NOUN B-O
-of ADP B-O
-TCRVβ22 NOUN B-O
-+ ADJ B-O
-tumor NOUN B-O
-cells NOUN B-O
-( PUNCT B-O
-median ADJ B-O
-column NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-non ADJ B-O
-- ADJ B-O
-TCRVβ22 NOUN B-O
-+ ADJ B-O
-cells NOUN B-O
-( PUNCT B-O
-right ADJ B-O
-column NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-STAT2 PROPN B-O
-is AUX B-O
-the DET B-O
-quintessential ADJ B-O
-transcription NOUN B-O
-factor NOUN B-O
-for ADP B-O
-type NOUN B-O
-1 NUM B-O
-interferons NOUN B-LF
-( PUNCT B-O
-IFNs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-where SCONJ B-O
-it PRON B-O
-functions VERB B-O
-as ADP B-O
-a DET B-O
-heterodimer NOUN B-O
-with ADP B-O
-STAT1 PROPN B-O
-. PUNCT B-O
-
-However ADV B-O
-, PUNCT B-O
-the DET B-O
-human ADJ B-O
-and CCONJ B-O
-murine ADJ B-O
-STAT2 PROPN B-O
-- PUNCT B-O
-deficient ADJ B-O
-phenotypes NOUN B-O
-suggest VERB B-O
-important ADJ B-O
-additional ADJ B-O
-and CCONJ B-O
-currently ADV B-O
-unidentified ADJ B-O
-type NOUN B-O
-1 NUM B-O
-IFN PROPN B-AC
-- PUNCT B-O
-independent ADJ B-O
-activities NOUN B-O
-. PUNCT B-O
-
-We PRON B-O
-performed VERB B-O
-the DET B-O
-present ADJ B-O
-exclusive ADJ B-O
-study NOUN B-O
-to PART B-O
-investigate VERB B-O
-the DET B-O
-associations NOUN B-O
-between ADP B-O
-a DET B-O
-total NOUN B-O
-of ADP B-O
-9 NUM B-O
-static ADJ B-O
-and CCONJ B-O
-14 NUM B-O
-dynamic ADJ B-O
-lactate NOUN B-O
-indices NOUN B-O
-during ADP B-O
-the DET B-O
-first ADJ B-O
-24h NUM B-O
-of ADP B-O
-an DET B-O
-intensive ADJ B-LF
-care NOUN I-LF
-unit NOUN I-LF
-( PUNCT B-O
-ICU PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-in ADP B-O
-- PUNCT B-O
-hospital NOUN B-O
-mortality NOUN B-O
-in ADP B-O
-unselected ADJ B-O
-ICU PROPN B-AC
-patients NOUN B-O
-. PUNCT B-O
-
-Since SCONJ B-O
-selective ADJ B-O
-serotonin NOUN B-O
-reuptake NOUN B-O
-inhibitors NOUN B-O
-( PUNCT B-O
-SSRIs PROPN B-O
-) PUNCT B-O
-such ADJ B-O
-as ADP B-O
-fluvoxamine NOUN B-O
-and CCONJ B-O
-sertraline NOUN B-O
-are AUX B-O
-potent ADJ B-O
-σ1R NOUN B-O
-ligands NOUN B-O
-, PUNCT B-O
-we PRON B-O
-recently ADV B-O
-focused VERB B-O
-on ADP B-O
-cardioprotective ADJ B-O
-mechanisms NOUN B-O
-of ADP B-O
-SSRI PROPN B-O
-through ADP B-O
-the DET B-O
-σ1R NOUN B-O
-in ADP B-O
-heart NOUN B-O
-failure NOUN B-O
-models NOUN B-O
-using VERB B-O
-transverse ADJ B-LF
-aortic ADJ I-LF
-constriction NOUN I-LF
-( PUNCT B-O
-TAC PROPN B-AC
-) PUNCT B-O
-mice NOUN B-O
-and CCONJ B-O
-ovariectomised ADJ B-O
-rats NOUN B-O
-[ PUNCT B-O
-5–7 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Here ADV B-O
-, PUNCT B-O
-we PRON B-O
-used VERB B-O
-unilateral ADJ B-O
-and CCONJ B-O
-bilateral ADJ B-O
-reversible ADJ B-O
-inactivation NOUN B-O
-of ADP B-O
-the DET B-O
-frontal ADJ B-LF
-eye NOUN I-LF
-fields NOUN I-LF
-( PUNCT B-O
-FEF PROPN B-AC
-) PUNCT B-O
-to PART B-O
-identify VERB B-O
-a DET B-O
-cortical ADJ B-O
-drive NOUN B-O
-for ADP B-O
-microsaccades NOUN B-O
-. PUNCT B-O
-
-Ten NUM B-O
-- PUNCT B-O
-week NOUN B-O
-- PUNCT B-O
-old ADJ B-O
-C57BL/6 PROPN B-O
-male ADJ B-O
-mice NOUN B-O
-( PUNCT B-O
-purchased VERB B-O
-from ADP B-O
-Taconic PROPN B-O
-, PUNCT B-O
-Ry PROPN B-O
-, PUNCT B-O
-Denmark PROPN B-O
-, PUNCT B-O
-and CCONJ B-O
-allowed VERB B-O
-one NUM B-O
-week NOUN B-O
-of ADP B-O
-acclimatization NOUN B-O
-on ADP B-O
-chow NOUN B-O
-diet NOUN B-O
-before ADP B-O
-study NOUN B-O
-start NOUN B-O
-) PUNCT B-O
-were AUX B-O
-fed VERB B-O
-either CCONJ B-O
-a DET B-O
-high ADJ B-O
-fat NOUN B-O
-control NOUN B-O
-diet NOUN B-O
-( PUNCT B-O
-HFD PROPN B-AC
-, PUNCT B-O
-n NOUN B-O
-= SYM B-O
-9 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-or CCONJ B-O
-a DET B-O
-high ADJ B-LF
-fat NOUN I-LF
-diet NOUN I-LF
-containing VERB B-O
-0.75 NUM B-O
-% NOUN B-O
-TTA PROPN B-AC
-( PUNCT B-O
-n NOUN B-O
-= SYM B-O
-9 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-water NOUN B-O
-ad X B-O
-libitum X B-O
-for ADP B-O
-6 NUM B-O
-weeks NOUN B-O
-. PUNCT B-O
-
-Furthermore ADV B-O
-, PUNCT B-O
-rates NOUN B-O
-of ADP B-O
-new ADJ B-O
-hepatitis NOUN B-LF
-C PROPN I-LF
-virus NOUN I-LF
-( PUNCT B-O
-HCV PROPN B-AC
-) PUNCT B-O
-infection NOUN B-O
-are AUX B-O
-on ADP B-O
-the DET B-O
-rise NOUN B-O
-due ADP B-O
-to ADP B-O
-the DET B-O
-ongoing ADJ B-O
-epidemic NOUN B-O
-of ADP B-O
-injection NOUN B-O
-drug NOUN B-O
-use NOUN B-O
-. PUNCT B-O
-
-It PRON B-O
-was AUX B-O
-found VERB B-O
-that SCONJ B-O
-an DET B-O
-increase NOUN B-O
-in ADP B-O
-the DET B-O
-optical ADJ B-LF
-density NOUN I-LF
-( PUNCT B-O
-OD PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-the DET B-O
-formazan NOUN B-O
-dye NOUN B-O
-directly ADV B-O
-correlates VERB B-O
-with ADP B-O
-the DET B-O
-metabolic ADJ B-O
-activity NOUN B-O
-of ADP B-O
-the DET B-O
-cells NOUN B-O
-following VERB B-O
-exposure NOUN B-O
-to ADP B-O
-either CCONJ B-O
-Pt PROPN B-AC
-or CCONJ B-O
--DissPt PROPN B-AC
-. PUNCT B-O
-
-For ADP B-O
-measurement NOUN B-O
-of ADP B-O
-the DET B-O
-formazan NOUN B-O
-dye NOUN B-O
-intensities NOUN B-O
-, PUNCT B-O
-the DET B-O
-cell NOUN B-O
-culture NOUN B-O
-medium NOUN B-O
-was AUX B-O
-exchanged VERB B-O
-with ADP B-O
-those PRON B-O
-containing VERB B-O
-WST-1 NOUN B-O
-solution NOUN B-O
-at ADP B-O
-the DET B-O
-final ADJ B-O
-concentration NOUN B-O
-of ADP B-O
-1 NUM B-O
-mg NOUN B-O
-/ SYM B-O
-ml NOUN B-O
-. PUNCT B-O
-
-Further ADV B-O
-, PUNCT B-O
-1,377 NUM B-O
-of ADP B-O
-these DET B-O
-windows NOUN B-O
-overlapped VERB B-O
-with ADP B-O
-the DET B-O
-transcription NOUN B-O
-start NOUN B-O
-site NOUN B-O
-or CCONJ B-O
-gene NOUN B-O
-body NOUN B-O
-of ADP B-O
-766 NUM B-O
-independent ADJ B-O
-genes NOUN B-O
-in ADP B-O
-Suz12 PROPN B-AC
-- PUNCT B-O
-deleted VERB B-O
-basal ADJ B-O
-organoids NOUN B-O
-( PUNCT B-O
-referred VERB B-O
-to ADP B-O
-as ADP B-O
-differentially ADV B-LF
-accessible ADJ I-LF
-[ X B-O
-DA PROPN B-AC
-] X B-O
-genes NOUN B-O
-from ADP B-O
-hereon ADV B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Biopharmaceutical ADJ B-LF
-products NOUN I-LF
-( PUNCT B-O
-BPs PROPN B-AC
-) PUNCT B-O
-are AUX B-O
-widely ADV B-O
-used VERB B-O
-to PART B-O
-treat VERB B-O
-autoimmune ADJ B-O
-diseases NOUN B-O
-, PUNCT B-O
-but CCONJ B-O
-immunogenicity NOUN B-O
-limits VERB B-O
-their PRON B-O
-efficacy NOUN B-O
-for ADP B-O
-an DET B-O
-important ADJ B-O
-proportion NOUN B-O
-of ADP B-O
-patients NOUN B-O
-. PUNCT B-O
-
-ATc PROPN B-AC
-, PUNCT B-O
-anhydrotetracycline NOUN B-LF
-; PUNCT B-O
-GCaMP6 PROPN B-AC
-, PUNCT B-O
-GFP NOUN B-LF
-- PUNCT I-LF
-GFP PROPN B-AC
-Calmodulin NOUN I-LF
-- PUNCT I-LF
-M13 NOUN I-LF
-- PUNCT I-LF
-peptide-6 NOUN I-LF
-. PUNCT B-O
-
-To ADP B-O
-this DET B-O
-day NOUN B-O
-, PUNCT B-O
-vertebrate ADJ B-O
-prion NOUN B-LF
-proteins NOUN I-LF
-exhibit VERB B-O
-profound ADJ B-O
-sequence NOUN B-O
-similarities NOUN B-O
-to ADP B-O
-the DET B-O
-subbranch NOUN B-O
-of ADP B-O
-ZIP PROPN B-O
-zinc NOUN B-O
-transporters NOUN B-O
-comprising VERB B-O
-ZIP5 NUM B-O
-, PUNCT B-O
-ZIP6 PROPN B-O
-and CCONJ B-O
-ZIP10 NOUN B-O
-[ PUNCT B-O
-2 NUM B-O
-, PUNCT B-O
-3 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-highly ADV B-O
-similar ADJ B-O
-defects NOUN B-O
-in ADP B-O
-the DET B-O
-execution NOUN B-O
-of ADP B-O
-a DET B-O
-morphogenetic ADJ B-O
-program NOUN B-O
-, PUNCT B-O
-known VERB B-O
-as ADP B-O
-epithelial ADJ B-LF
-- PUNCT I-LF
-to ADP I-LF
-- PUNCT I-LF
-mesenchymal ADJ I-LF
-transition NOUN I-LF
-( PUNCT B-O
-EMT PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-4 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-have AUX B-O
-been AUX B-O
-reported VERB B-O
-for ADP B-O
-zebrafish NOUN B-O
-embryos NOUN B-O
-deficient ADJ B-O
-in ADP B-O
-ZIP6 PROPN B-O
-[ PUNCT B-O
-5 NUM B-O
-] PUNCT B-O
-or CCONJ B-O
-PrP PROPN B-AC
-[ PUNCT B-O
-6 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-On ADP B-O
-17 NUM B-O
-days NOUN B-LF
-of ADP I-LF
-gestation NOUN I-LF
-( PUNCT B-O
-17-DG PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-dams NOUN B-O
-were AUX B-O
-anesthetized VERB B-O
-by ADP B-O
-ketamine NOUN B-O
-( PUNCT B-O
-75mg NUM B-O
-/ SYM B-O
-kg NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-xylazine NOUN B-O
-( PUNCT B-O
-10mg NUM B-O
-/ SYM B-O
-kg NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-uterus NOUN B-O
-was AUX B-O
-exposed VERB B-O
-. PUNCT B-O
-
-All DET B-O
-patients NOUN B-O
-with ADP B-O
-IVF PROPN B-AC
-received VERB B-O
-an DET B-O
-implantable ADJ B-LF
-cardioverter ADJ I-LF
-defibrillator NOUN I-LF
-( PUNCT B-O
-ICD PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Patients NOUN B-O
-took VERB B-O
-oral ADJ B-O
-antiarrhythmic ADJ B-O
-agents NOUN B-O
-during ADP B-O
-the DET B-O
-follow NOUN B-O
-- ADJ B-O
-up ADP B-O
-period NOUN B-O
-, PUNCT B-O
-including VERB B-O
-amiodarone NOUN B-O
-, PUNCT B-O
-flecainide NOUN B-O
-, PUNCT B-O
-propafenone NOUN B-O
-, PUNCT B-O
-beta NOUN B-O
-- ADJ B-O
-blockers NOUN B-O
-( PUNCT B-O
-BB PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-calcium NOUN B-O
-channel NOUN B-O
-blocker NOUN B-O
-( PUNCT B-O
-CCB PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Many ADJ B-O
-patients NOUN B-O
-did AUX B-O
-n’t PART B-O
-take VERB B-O
-medications NOUN B-O
-and CCONJ B-O
-the DET B-O
-patients NOUN B-O
-who PRON B-O
-had AUX B-O
-received VERB B-O
-medication NOUN B-O
-mostly ADV B-O
-took VERB B-O
-beta NOUN B-O
-- ADJ B-O
-blockers NOUN B-O
-: PUNCT B-O
-20 NUM B-O
-patients NOUN B-O
-in ADP B-O
-the DET B-O
-f PROPN B-AC
-group NOUN B-O
-[ PUNCT B-O
-no DET B-O
-medications NOUN B-O
-( PUNCT B-O
-7 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-BB PROPN B-O
-( PUNCT B-O
-5 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-CCB PROPN B-O
-( PUNCT B-O
-2 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-amiodarone NOUN B-O
-( PUNCT B-O
-1 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-CCB PROPN B-O
-+ CCONJ B-O
-BB PROPN B-O
-( PUNCT B-O
-2 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-amiodarone NOUN B-O
-+ CCONJ B-O
-BB PROPN B-O
-( PUNCT B-O
-2 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-flecanide NOUN B-O
-+ CCONJ B-O
-BB PROPN B-O
-( PUNCT B-O
-1 NUM B-O
-) PUNCT B-O
-] PUNCT B-O
-, PUNCT B-O
-35 NUM B-O
-patients NOUN B-O
-in ADP B-O
-the DET B-O
-J PROPN B-O
-wave PROPN B-O
-group NOUN B-O
-[ PUNCT B-O
-no DET B-O
-medications NOUN B-O
-( PUNCT B-O
-15 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-BB PROPN B-O
-( PUNCT B-O
-13 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-CCB PROPN B-O
-( PUNCT B-O
-2 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-amiodarone NOUN B-O
-( PUNCT B-O
-2 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-CCB PROPN B-O
-+ CCONJ B-O
-BB PROPN B-O
-( PUNCT B-O
-1 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-propafenone NOUN B-O
-( PUNCT B-O
-1 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-propafenone NOUN B-O
-+ CCONJ B-O
-BB PROPN B-O
-( PUNCT B-O
-1 NUM B-O
-) PUNCT B-O
-] PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-26 NUM B-O
-patients NOUN B-O
-in ADP B-O
-the DET B-O
-normal ADJ B-O
--QRSECG PROPN B-AC
-group NOUN B-O
-[ PUNCT B-O
-no DET B-O
-medications NOUN B-O
-( PUNCT B-O
-16 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-BB PROPN B-O
-( PUNCT B-O
-9 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-amiodarone NOUN B-O
-( PUNCT B-O
-1 NUM B-O
-) PUNCT B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Although SCONJ B-O
-adjuvant ADJ B-LF
-platinum NOUN I-LF
-- ADJ I-LF
-based VERB I-LF
-chemotherapy NOUN I-LF
-( PUNCT B-O
-AC PROPN B-AC
-) PUNCT B-O
-has AUX B-O
-been AUX B-O
-shown VERB B-O
-to PART B-O
-improve VERB B-O
-survival NOUN B-O
-of ADP B-O
-patients NOUN B-O
-with ADP B-O
-completely ADV B-O
-resected VERB B-O
-stage NOUN B-O
-II NUM B-O
-and CCONJ B-O
-stage NOUN B-O
-IIIA NUM B-O
-non ADJ B-LF
-- ADJ I-LF
-small ADJ I-LF
-cell NOUN I-LF
-lung NOUN I-LF
-cancer NOUN I-LF
-( PUNCT B-O
-NSCLC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-its PRON B-O
-effect NOUN B-O
-is AUX B-O
-limited ADJ B-O
-. PUNCT B-O
-
-The DET B-O
-DSX PROPN B-O
-transgenic ADJ B-O
-line NOUN B-O
-[ X B-O
-12 X B-O
-] X B-O
-that PRON B-O
-expresses VERB B-O
-GFP PROPN B-AC
-( PUNCT B-O
-green NOUN B-O
-) PUNCT B-O
-under ADP B-O
-the DET B-O
-β PUNCT B-O
-- NOUN B-O
-tubulin NOUN B-O
-promoter NOUN B-O
-in ADP B-O
-the DET B-O
-meiotic ADJ B-O
-stages NOUN B-O
-starting VERB B-O
-from ADP B-O
-spermatocytes NOUN B-O
-but CCONJ B-O
-not PART B-O
-in ADP B-O
-the DET B-O
-mitotic ADJ B-O
-germline NOUN B-LF
-stem NOUN I-LF
-cells NOUN I-LF
-( PUNCT B-O
-GSC PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-spermatogonia NOUN B-O
-. PUNCT B-O
-
-MS PROPN B-AC
-, PUNCT B-O
-multiple ADJ B-LF
-sclerosis NOUN I-LF
-; PUNCT B-O
-PMD PROPN B-AC
-, PUNCT B-O
-postmortem ADJ B-LF
-delay NOUN I-LF
-. PUNCT B-O
-
-A DET B-O
-common ADJ B-O
-limitation NOUN B-O
-of ADP B-O
-SE PROPN B-AC
-recording NOUN B-O
-is AUX B-O
-the DET B-O
-lack NOUN B-O
-of ADP B-O
-true ADJ B-O
-monophasic ADJ B-O
-shapes NOUN B-O
-of ADP B-O
-recorded VERB B-O
-CAPs PROPN B-AC
-due ADJ B-O
-to ADP B-O
-propagation NOUN B-O
-of ADP B-O
-action NOUN B-O
-potentials NOUN B-O
-within ADP B-O
-the DET B-O
-SE PROPN B-AC
-portion NOUN B-O
-of ADP B-O
-axons NOUN B-O
-, PUNCT B-O
-resulting VERB B-O
-in ADP B-O
-different ADJ B-O
-degrees NOUN B-O
-of ADP B-O
-biphasicity NOUN B-O
-depending VERB B-O
-on ADP B-O
-preservation NOUN B-O
-of ADP B-O
-conduction NOUN B-O
-properties NOUN B-O
-of ADP B-O
-distinct ADJ B-O
-types NOUN B-O
-of ADP B-O
-axons NOUN B-O
-within ADP B-O
-the DET B-O
-SE PROPN B-AC
-. PUNCT B-O
-
-As ADP B-O
-in ADP B-O
-any DET B-O
-SE PROPN B-AC
-- PUNCT B-O
-recorded VERB B-O
-CAPs PROPN B-AC
-, PUNCT B-O
-the DET B-O
-signals NOUN B-O
-propagating VERB B-O
-within ADP B-O
-the DET B-O
-suction NOUN B-LF
-electrode NOUN I-LF
-portion NOUN B-O
-of ADP B-O
-axons NOUN B-O
-may AUX B-O
-create VERB B-O
-a DET B-O
-time NOUN B-O
-- PUNCT B-O
-shifted VERB B-O
-signal NOUN B-O
-of ADP B-O
-opposite ADJ B-O
-polarity NOUN B-O
-affecting VERB B-O
-the DET B-O
-peaks NOUN B-O
-and CCONJ B-O
-valleys NOUN B-O
-of ADP B-O
-recorded VERB B-O
-signals NOUN B-O
-, PUNCT B-O
-being AUX B-O
-more ADV B-O
-pronounced ADJ B-O
-in ADP B-O
-slower ADV B-O
-conducting VERB B-O
-components NOUN B-O
-( PUNCT B-O
-seen VERB B-O
-to ADP B-O
-different ADJ B-O
-extent NOUN B-O
-in ADP B-O
-Figs NOUN B-O
-2–9 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Healthcare NOUN B-LF
-- PUNCT I-LF
-associated VERB I-LF
-infections NOUN I-LF
-( PUNCT B-O
-HAIs PROPN B-AC
-) PUNCT B-O
-are AUX B-O
-associated VERB B-O
-with ADP B-O
-increased VERB B-O
-morbidity NOUN B-O
-and CCONJ B-O
-mortality NOUN B-O
-and CCONJ B-O
-excess ADJ B-O
-costs NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-because SCONJ B-O
-a DET B-O
-significant ADJ B-O
-proportion NOUN B-O
-of ADP B-O
-them PRON B-O
-are AUX B-O
-preventable ADJ B-O
-, PUNCT B-O
-they PRON B-O
-are AUX B-O
-considered VERB B-O
-to PART B-O
-be AUX B-O
-a DET B-O
-marker NOUN B-O
-of ADP B-O
-quality NOUN B-O
-of ADP B-O
-patient NOUN B-O
-care NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Randomised ADJ B-LF
-controlled VERB I-LF
-trials NOUN I-LF
-( PUNCT B-O
-RCTs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-longitudinal ADJ B-O
-cohort NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-cross ADJ B-O
-- ADJ B-O
-sectional ADJ B-O
-studies NOUN B-O
-were AUX B-O
-considered VERB B-O
-for ADP B-O
-inclusion NOUN B-O
-, PUNCT B-O
-whereas SCONJ B-O
-retrospective ADJ B-O
-registry NOUN B-O
-reviews NOUN B-O
-, PUNCT B-O
-medical ADJ B-O
-records NOUN B-O
-audits NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-qualitative ADJ B-O
-studies NOUN B-O
-were AUX B-O
-excluded VERB B-O
-. PUNCT B-O
-
-These DET B-O
-results NOUN B-O
-are AUX B-O
-not PART B-O
-from ADP B-O
-data NOUN B-O
-collected VERB B-O
-in ADP B-O
-a DET B-O
-centralised ADJ B-O
-laboratory NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-different ADJ B-O
-multiplex NOUN B-O
-polymerase NOUN B-LF
-chain NOUN I-LF
-reaction NOUN I-LF
-( PUNCT B-O
-PCR PROPN B-AC
-) PUNCT B-O
-panels NOUN B-O
-for ADP B-O
-detecting VERB B-O
-viruses NOUN B-O
-were AUX B-O
-used VERB B-O
-in ADP B-O
-the DET B-O
-respective ADJ B-O
-laboratories NOUN B-O
-[ PUNCT B-O
-19 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Open ADJ B-LF
-access NOUN I-LF
-( PUNCT B-O
-OA PROPN B-AC
-) PUNCT B-O
-to ADP B-O
-the DET B-O
-scientific ADJ B-O
-literature NOUN B-O
-means VERB B-O
-the DET B-O
-removal NOUN B-O
-of ADP B-O
-barriers NOUN B-O
-( PUNCT B-O
-including VERB B-O
-price NOUN B-O
-barriers NOUN B-O
-) PUNCT B-O
-from ADP B-O
-accessing VERB B-O
-scholarly ADJ B-O
-work NOUN B-O
-. PUNCT B-O
-
-f X B-O
-- X B-O
-forward NOUN B-O
-; PUNCT B-O
-r NOUN B-O
-- X B-O
-reverse NOUN B-O
-; PUNCT B-O
-Ta NOUN B-O
-– PUNCT B-O
-Annealing NOUN B-O
-temperature NOUN B-O
-, PUNCT B-O
-RE- NOUN B-O
-restriction NOUN B-O
-Enzyme PROPN B-O
-, PUNCT B-O
-AS PROPN B-AC
-- X B-O
-Allele PROPN B-LF
-Specific PROPN I-LF
-Ref PROPN B-O
-- X B-O
-reference NOUN B-O
-We PRON B-O
-also ADV B-O
-collected VERB B-O
-measures NOUN B-O
-of ADP B-O
-inhibitory ADJ B-O
-control NOUN B-O
-and CCONJ B-O
-working VERB B-O
-memory NOUN B-O
-using VERB B-O
-the DET B-O
-pencil NOUN B-LF
-tapping NOUN I-LF
-task NOUN I-LF
-( PUNCT B-O
-PTT PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-29 X B-O
-] PUNCT B-O
-and CCONJ B-O
-of ADP B-O
-pre ADJ B-O
-- PUNCT B-O
-academic ADJ B-O
-skills NOUN B-O
-using VERB B-O
-a DET B-O
-subset NOUN B-O
-of ADP B-O
-age NOUN B-O
-- PUNCT B-O
-appropriate ADJ B-O
-items NOUN B-O
-from ADP B-O
-the DET B-O
-Daberon PROPN B-LF
-Screening PROPN I-LF
-for ADP I-LF
-School PROPN I-LF
-Readiness PROPN I-LF
-– PUNCT I-LF
-Second PROPN I-LF
-Edition PROPN I-LF
-( PUNCT B-O
-Daberon-2 PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-30 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Acute ADJ B-LF
-respiratory ADJ I-LF
-infection NOUN I-LF
-( PUNCT B-O
-ARI PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-diarrhoea NOUN B-O
-are AUX B-O
-the DET B-O
-leading VERB B-O
-causes NOUN B-O
-of ADP B-O
-childhood NOUN B-O
-morbidity NOUN B-O
-and CCONJ B-O
-mortality NOUN B-O
-in ADP B-O
-Ethiopia PROPN B-O
-. PUNCT B-O
-
-Clinical ADJ B-O
-outcomes NOUN B-O
-and CCONJ B-O
-the DET B-O
-proportion NOUN B-O
-of ADP B-O
-justified ADJ B-O
-use NOUN B-O
-of ADP B-O
-personal ADJ B-O
-nursing NOUN B-O
-care NOUN B-O
-were AUX B-O
-evaluated VERB B-O
-using VERB B-O
-a DET B-O
-statistical ADJ B-O
-technique NOUN B-O
-known VERB B-O
-as ADP B-O
-Generalized PROPN B-LF
-Pairwise PROPN I-LF
-Comparisons PROPN I-LF
-( PUNCT B-O
-GPC PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-46 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Within ADP B-O
-the DET B-O
-control NOUN B-O
-group NOUN B-O
-CRMP-5 PROPN B-AC
-was AUX B-O
-verified VERB B-O
-with ADP B-O
-a DET B-O
-label NOUN B-LF
-- PUNCT I-LF
-free ADJ I-LF
-quantification NOUN I-LF
-intensity NOUN I-LF
-( PUNCT B-O
-LFQI PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-1.93x109 NUM B-O
-. PUNCT B-O
-
-Notably ADV B-O
-, PUNCT B-O
-although SCONJ B-O
-it PRON B-O
-has AUX B-O
-previously ADV B-O
-been AUX B-O
-hypothesized VERB B-O
-that SCONJ B-O
-the DET B-O
-hormonal ADJ B-O
-drivers NOUN B-O
-of ADP B-O
-PD PROPN B-AC
-would AUX B-O
-result VERB B-O
-in ADP B-O
-it PRON B-O
-being AUX B-O
-a DET B-O
-stronger ADJ B-O
-risk NOUN B-O
-marker NOUN B-O
-for ADP B-O
-oestrogen NOUN B-LF
-receptor NOUN I-LF
-( PUNCT B-O
-ER)–positive PROPN B-AC
-than ADP B-O
-ER PROPN B-AC
-- PUNCT B-O
-negative ADJ B-O
-breast NOUN B-O
-cancer NOUN B-O
-, PUNCT B-O
-a DET B-O
-large ADJ B-O
-differential NOUN B-O
-in ADP B-O
-the DET B-O
-MD PROPN B-AC
-- PUNCT B-O
-breast NOUN B-O
-cancer NOUN B-O
-association NOUN B-O
-by ADP B-O
-tumour NOUN B-O
-subtype NOUN B-O
-does AUX B-O
-not PART B-O
-appear VERB B-O
-to PART B-O
-be AUX B-O
-present ADJ B-O
-[ PUNCT B-O
-23 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Interleukins NOUN B-LF
-( PUNCT B-O
-ILs PROPN B-AC
-) PUNCT B-O
-are AUX B-O
-a DET B-O
-group NOUN B-O
-of ADP B-O
-cytokines NOUN B-O
-that PRON B-O
-are AUX B-O
-involved VERB B-O
-in ADP B-O
-the DET B-O
-communication NOUN B-O
-between ADP B-O
-immune ADJ B-O
-and CCONJ B-O
-inflammatory ADJ B-O
-cells NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-38 NUM B-O
-ILs PROPN B-AC
-have AUX B-O
-been AUX B-O
-identified VERB B-O
-thus ADV B-O
-far ADV B-O
-. PUNCT B-O
-
-There PRON B-O
-are VERB B-O
-different ADJ B-O
-types NOUN B-O
-of ADP B-O
-medication NOUN B-O
-reviews NOUN B-O
-, PUNCT B-O
-ranging VERB B-O
-from ADP B-O
-a DET B-O
-prescription NOUN B-O
-review NOUN B-O
-( PUNCT B-O
-which PRON B-O
-is AUX B-O
-basically ADV B-O
-an DET B-O
-evaluation NOUN B-O
-of ADP B-O
-the DET B-O
-list NOUN B-O
-of ADP B-O
-prescribed VERB B-O
-medicines NOUN B-O
-) PUNCT B-O
-to ADP B-O
-a DET B-O
-clinical ADJ B-LF
-medication NOUN I-LF
-review NOUN I-LF
-( PUNCT B-O
-CMR PROPN B-AC
-; PUNCT B-O
-with ADP B-O
-the DET B-O
-availability NOUN B-O
-of ADP B-O
-all DET B-O
-clinical ADJ B-O
-data NOUN B-O
-and CCONJ B-O
-an DET B-O
-extensive ADJ B-O
-patient NOUN B-O
-interview NOUN B-O
-) PUNCT B-O
-[ PUNCT B-O
-3 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Sural ADJ B-LF
-sensory ADJ I-LF
-nerve NOUN I-LF
-amplitude NOUN I-LF
-( PUNCT B-O
-SSNamp PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-sural ADJ B-LF
-sensory ADJ I-LF
-nerve NOUN I-LF
-conduction NOUN I-LF
-velocity NOUN I-LF
-( PUNCT B-O
-SSNCV PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-peroneal ADJ B-LF
-motor NOUN I-LF
-nerve NOUN I-LF
-amplitude NOUN I-LF
-( PUNCT B-O
-PMNamp PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-peroneal ADJ B-LF
-motor NOUN I-LF
-nerve NOUN I-LF
-conduction NOUN I-LF
-velocity NOUN I-LF
-( PUNCT B-O
-PMNCV PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-assessed VERB B-O
-using VERB B-O
-a DET B-O
-Dantec PROPN B-O
-“ PUNCT B-O
-Keypoint PROPN B-O
-” PUNCT B-O
-system NOUN B-O
-( PUNCT B-O
-Dantec PROPN B-O
-Dynamics PROPN B-O
-Ltd PROPN B-O
-, PUNCT B-O
-Bristol PROPN B-O
-, PUNCT B-O
-UK PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-DF PROPN B-AC
-, PUNCT B-O
-dorsal ADJ B-LF
-funiculus NOUN I-LF
-; PUNCT B-O
-dVL PROPN B-AC
-, PUNCT B-O
-dorsal ADJ B-LF
-ventricular ADJ I-LF
-layer NOUN I-LF
-; PUNCT B-O
-NKX6.1 NOUN B-O
-, PUNCT B-O
-NK6 NOUN B-O
-homeobox NOUN B-O
-1 NUM B-O
-; PUNCT B-O
-SOX2 PROPN B-O
-, PUNCT B-O
-SRY NOUN B-O
-- PUNCT B-O
-related VERB B-O
-HMG NOUN B-O
-- PUNCT B-O
-box NOUN B-O
-2 NUM B-O
-; PUNCT B-O
-VF PROPN B-AC
-, PUNCT B-O
-ventral ADJ B-LF
-funiculus NOUN I-LF
-; PUNCT B-O
-VL PROPN B-AC
-, PUNCT B-O
-ventricular ADJ B-LF
-layer NOUN I-LF
-; PUNCT B-O
-vVL PROPN B-AC
-, PUNCT B-O
-ventral ADJ B-LF
-ventricular ADJ B-LF
-layer NOUN I-LF
-; PUNCT B-O
-( PUNCT B-O
-+ PUNCT B-O
-) PUNCT B-O
-, PUNCT B-O
-expressing NOUN B-O
-. PUNCT B-O
-
-Powers PROPN B-O
-et PROPN B-O
-al NOUN B-O
-. PUNCT B-O
-
-estimated VERB B-O
-that SCONJ B-O
-the DET B-O
-fraction NOUN B-LF
-of ADP I-LF
-HIV PROPN I-LF
-incidence NOUN I-LF
-attributable ADJ I-LF
-to PART I-LF
-transmission NOUN I-LF
-from ADP I-LF
-acutely ADV I-LF
-infected VERB I-LF
-individuals NOUN I-LF
-( PUNCT B-O
-AFacute PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-40 NUM B-O
-% NOUN B-O
-[ PUNCT B-O
-19 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-while SCONJ B-O
-Williams PROPN B-O
-et PROPN B-O
-al NOUN B-O
-. PUNCT B-O
-
-argued VERB B-O
-that SCONJ B-O
-AFacute PROPN B-AC
-was AUX B-O
-more ADV B-O
-likely ADJ B-O
-to PART B-O
-be AUX B-O
-2%–4 NUM B-O
-% NOUN B-O
-[ PUNCT B-O
-44 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Is AUX B-O
-six NUM B-LF
-- PUNCT I-LF
-minute NOUN I-LF
-- PUNCT I-LF
-walk NOUN I-LF
-distance NOUN I-LF
-" PUNCT B-O
-6MWD PROPN B-AC
-” PUNCT B-O
-? PUNCT B-O
-Is AUX B-O
-six NUM B-LF
-- PUNCT I-LF
-minute NOUN I-LF
-- PUNCT I-LF
-walk NOUN I-LF
-test NOUN I-LF
-" PUNCT B-O
-6MWT PROPN B-AC
-” PUNCT B-O
-? PUNCT B-O
-（ PUNCT B-O
-Line NOUN B-O
-55 NUM B-O
-） PUNCT B-O
-Response NOUN B-O
-: PUNCT B-O
-We PRON B-O
-have AUX B-O
-revised VERB B-O
-the DET B-O
-abbreviations NOUN B-O
-in ADP B-O
-the DET B-O
-manuscript NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-primary ADJ B-O
-trial NOUN B-O
-outcome NOUN B-O
-was AUX B-O
-a DET B-O
-composite ADJ B-O
-endpoint NOUN B-O
-of ADP B-O
-women NOUN B-O
-’s PART B-O
-retention NOUN B-O
-in ADP B-O
-ART PROPN B-AC
-care NOUN B-O
-and CCONJ B-O
-viral ADJ B-LF
-suppression NOUN I-LF
-( PUNCT B-O
-VS PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-viral ADJ B-O
-load NOUN B-O
-< ADP B-O
-50 NUM B-O
-copies NOUN B-O
-/ SYM B-O
-ml NOUN B-O
-) PUNCT B-O
-at ADP B-O
-12 NUM B-O
-months NOUN B-O
-postpartum ADV B-O
-; PUNCT B-O
-secondary ADJ B-O
-outcomes NOUN B-O
-included VERB B-O
-duration NOUN B-O
-of ADP B-O
-any PRON B-O
-and CCONJ B-O
-exclusive ADJ B-O
-breastfeeding NOUN B-O
-, PUNCT B-O
-mother NOUN B-O
-- PUNCT B-O
-to ADP B-O
-- PUNCT B-O
-child NOUN B-O
-HIV PROPN B-O
-transmission NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-infant NOUN B-O
-mortality NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-MSIS-29 PROPN B-AC
-consists VERB B-O
-of ADP B-O
-29 NUM B-O
-questions NOUN B-O
-answered VERB B-O
-on ADP B-O
-a DET B-O
-5 NUM B-O
-- PUNCT B-O
-point NOUN B-O
-Likert PROPN B-O
-scale NOUN B-O
-, PUNCT B-O
-giving VERB B-O
-2 NUM B-O
-scores NOUN B-O
-: PUNCT B-O
-the DET B-O
-MSIS-29 PROPN B-LF
-physical ADJ I-LF
-MSIS-29 PROPN B-AC
-( PUNCT B-O
-MSIS-29 PROPN B-AC
-) PUNCT B-O
-score NOUN B-O
-( PUNCT B-O
-questions NOUN B-O
-1–20 NUM B-O
-; PUNCT B-O
-therefore ADV B-O
-score NOUN B-O
-range NOUN B-O
-20–100 NUM B-O
-) PUNCT B-O
-and CCONJ B-O
-the DET B-O
-MSIS-29 PROPN B-LF
-psychological ADJ I-LF
--PHYSMSIS-29 PROPN B-AC
-( PUNCT B-O
-MSIS-29 PROPN B-AC
-) PUNCT B-O
-score NOUN B-O
-( PUNCT B-O
-questions NOUN B-O
-21–29 NUM B-O
-; PUNCT B-O
-therefore ADV B-O
-score NOUN B-O
-range NOUN B-O
-9–45 NUM B-O
-) PUNCT B-O
-[ PUNCT B-O
-14,26 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Metabolic ADJ B-LF
-syndrome NOUN I-LF
-( PUNCT B-O
-MetS PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-a DET B-O
-cluster NOUN B-O
-of ADP B-O
-risk NOUN B-O
-factors NOUN B-O
-that PRON B-O
-encompasses VERB B-O
-metabolic ADJ B-O
-, PUNCT B-O
-vascular ADJ B-O
-, PUNCT B-O
-and CCONJ B-O
-inflammatory ADJ B-O
-indicators NOUN B-O
-. PUNCT B-O
-
-Portal ADJ B-LF
-Venous ADJ I-LF
-Thrombosis NOUN I-LF
-( PUNCT B-O
-PVT PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-a DET B-O
-common ADJ B-O
-complication NOUN B-O
-of ADP B-O
-Hepatocellular ADJ B-LF
-Carcinoma PROPN I-LF
-( PUNCT B-O
-HCC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-assessed VERB B-O
-as ADP B-O
-adverse ADJ B-O
-prognostic ADJ B-O
-factor NOUN B-O
-and CCONJ B-O
-parameter NOUN B-O
-of ADP B-O
-tumor NOUN B-O
-aggressiveness NOUN B-O
-together ADV B-O
-with ADP B-O
-tumor NOUN B-O
-size NOUN B-O
-, PUNCT B-O
-multifocality NOUN B-O
-and CCONJ B-O
-Alpha NOUN B-LF
-- PUNCT I-LF
-fetoprotein NOUN I-LF
-( PUNCT B-O
-AFP PROPN B-AC
-) PUNCT B-O
-levels NOUN B-O
-[ PUNCT B-O
-1,2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-These DET B-O
-estimates NOUN B-O
-do AUX B-O
-not PART B-O
-account VERB B-O
-for ADP B-O
-immunity NOUN B-O
-resulting VERB B-O
-from ADP B-O
-transmission NOUN B-O
-of ADP B-O
-OPV PROPN B-AC
-among ADP B-O
-contacts NOUN B-O
-of ADP B-O
-vaccinated VERB B-O
-children NOUN B-O
-, PUNCT B-O
-maternally ADV B-O
-derived VERB B-O
-antibodies NOUN B-O
-, PUNCT B-O
-or CCONJ B-O
-naturally ADV B-O
-acquired VERB B-O
-immunity NOUN B-O
-following VERB B-O
-exposure NOUN B-O
-to ADP B-O
-cVDPV2 PROPN B-AC
-. PUNCT B-O
-
-In ADP B-O
-Nigeria PROPN B-O
-, PUNCT B-O
-receipt NOUN B-O
-of ADP B-O
-tOPV PROPN B-AC
-through ADP B-O
-RI PROPN B-AC
-was AUX B-O
-inferred VERB B-O
-from ADP B-O
-district NOUN B-O
-- PUNCT B-O
-level NOUN B-O
-coverage NOUN B-O
-with ADP B-O
-three NUM B-O
-doses NOUN B-O
-of ADP B-O
-diphtheria NOUN B-O
-- PUNCT B-O
-tetanus NOUN B-O
-- PUNCT B-O
-pertussis NOUN B-O
-( PUNCT B-O
-DTP3 PROPN B-O
-) PUNCT B-O
-vaccine NOUN B-O
-at ADP B-O
-the DET B-O
-age NOUN B-O
-of ADP B-O
-12 NUM B-O
-mo NOUN B-O
-or CCONJ B-O
-later ADV B-O
-estimated VERB B-O
-from ADP B-O
-Demographic PROPN B-LF
-and CCONJ I-LF
-Health PROPN I-LF
-Surveys PROPN I-LF
-( PUNCT B-O
-DHS PROPN B-AC
-) PUNCT B-O
-data NOUN B-O
-( PUNCT B-O
-estimates NOUN B-O
-are AUX B-O
-derived VERB B-O
-in ADP B-O
-[ PUNCT B-O
-22 NUM B-O
-] PUNCT B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Coxsackievirus PROPN B-LF
-B PROPN I-LF
-( PUNCT B-O
-CVB PROPN B-AC
-) PUNCT B-O
-belongs VERB B-O
-to ADP B-O
-the DET B-O
-Enterovirus NOUN B-O
-B PROPN B-O
-species NOUN B-O
-of ADP B-O
-the DET B-O
-Picornaviridae PROPN B-O
-family NOUN B-O
-and CCONJ B-O
-has AUX B-O
-been AUX B-O
-associated VERB B-O
-with ADP B-O
-a DET B-O
-wide ADJ B-O
-range NOUN B-O
-of ADP B-O
-diseases NOUN B-O
-from ADP B-O
-mild ADJ B-O
-respiratory ADJ B-O
-infections NOUN B-O
-to ADP B-O
-more ADV B-O
-severe ADJ B-O
-infections NOUN B-O
-of ADP B-O
-the DET B-O
-central ADJ B-O
-nervous ADJ B-O
-system NOUN B-O
-, PUNCT B-O
-heart NOUN B-O
-and CCONJ B-O
-pancreas NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-order NOUN B-O
-to PART B-O
-systematically ADV B-O
-investigate VERB B-O
-the DET B-O
-influence NOUN B-O
-of ADP B-O
-potentially ADV B-O
-functional ADJ B-O
-coding VERB B-O
-polymorphisms NOUN B-O
-in ADP B-O
-the DET B-O
-NLR PROPN B-O
-genes NOUN B-O
-on ADP B-O
-sporadic ADJ B-O
-CRC PROPN B-AC
-risk NOUN B-O
-and CCONJ B-O
-survival NOUN B-O
-, PUNCT B-O
-we PRON B-O
-conducted VERB B-O
-a DET B-O
-case NOUN B-O
-- ADJ B-O
-control NOUN B-O
-study NOUN B-O
-with ADP B-O
-replications NOUN B-O
-in ADP B-O
-2 NUM B-O
-large ADJ B-O
-genome NOUN B-O
-- ADJ B-O
-wide ADJ B-O
-association NOUN B-O
-studies NOUN B-O
-( PUNCT B-O
-GWASs PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-covering VERB B-O
-the DET B-O
-majority NOUN B-O
-of ADP B-O
-known VERB B-O
-non ADJ B-LF
-- ADJ I-LF
-synonymous ADJ I-LF
-single ADJ I-LF
-nucleotide NOUN I-LF
-polymorphisms NOUN I-LF
-( PUNCT B-O
-nsSNPs PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-21 NUM B-O
-genes NOUN B-O
-across ADP B-O
-different ADJ B-O
-NLR PROPN B-O
-signalling NOUN B-O
-pathways NOUN B-O
-. PUNCT B-O
-
-Progress NOUN B-LF
-variables NOUN I-LF
-( PUNCT B-O
-PVs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-akin ADJ B-O
-to ADP B-O
-reaction NOUN B-O
-coordinates NOUN B-O
-, PUNCT B-O
-for ADP B-O
-all DET B-O
-free ADJ B-O
-- PUNCT B-O
-energy NOUN B-O
-molecular ADJ B-O
-dynamics NOUN B-O
-calculations NOUN B-O
-were AUX B-O
-chosen VERB B-O
-as ADP B-O
-the DET B-O
-location NOUN B-O
-on ADP B-O
-the DET B-O
-z NOUN B-O
-axis NOUN B-O
-of ADP B-O
-the DET B-O
-center NOUN B-O
-of ADP B-O
-mass NOUN B-O
-of ADP B-O
-the DET B-O
-small ADJ B-O
-- PUNCT B-O
-molecule(s NOUN B-O
-) PUNCT B-O
-of ADP B-O
-interest NOUN B-O
-. PUNCT B-O
-
-Non ADJ B-LF
-- ADJ I-LF
-alcoholic ADJ I-LF
-fatty ADJ I-LF
-liver NOUN I-LF
-disease NOUN I-LF
-( PUNCT B-O
-NAFLD PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-defined VERB B-O
-as ADP B-O
-the DET B-O
-accumulation NOUN B-O
-of ADP B-O
-excess ADJ B-O
-, PUNCT B-O
-microscopically ADV B-O
-visible ADJ B-O
-lipid NOUN B-O
-in ADP B-O
-hepatocytes NOUN B-O
-in ADP B-O
-the DET B-O
-absence NOUN B-O
-of ADP B-O
-excessive ADJ B-O
-alcohol NOUN B-O
-consumption NOUN B-O
-and CCONJ B-O
-is AUX B-O
-now ADV B-O
-the DET B-O
-most ADV B-O
-common ADJ B-O
-chronic ADJ B-O
-liver NOUN B-O
-disease NOUN B-O
-in ADP B-O
-developed VERB B-O
-countries NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-, PUNCT B-O
-2 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-current ADJ B-O
-prequalified ADJ B-O
-oral ADJ B-LF
-cholera NOUN I-LF
-vaccines NOUN I-LF
-( PUNCT B-O
-OCVs PROPN B-AC
-) PUNCT B-O
-provide VERB B-O
-over ADP B-O
-80 NUM B-O
-% NOUN B-O
-( PUNCT B-O
-direct ADJ B-O
-) PUNCT B-O
-protection NOUN B-O
-in ADP B-O
-the DET B-O
-first ADJ B-O
-6 NUM B-O
-mo NOUN B-O
-after ADP B-O
-vaccination NOUN B-O
-[ PUNCT B-O
-2–4 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-with ADP B-O
-protection NOUN B-O
-of ADP B-O
-up ADP B-O
-to PART B-O
-65 NUM B-O
-% NOUN B-O
-for ADP B-O
-5 NUM B-O
-y NOUN B-O
-estimated VERB B-O
-in ADP B-O
-an DET B-O
-endemic ADJ B-O
-setting NOUN B-O
-[ PUNCT B-O
-5 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-volatile ADJ B-LF
-fatty ADJ I-LF
-acids NOUN I-LF
-( PUNCT B-O
-VFAs PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-HARs PROPN B-AC
-and CCONJ B-O
-BRs PROPN B-AC
-were AUX B-O
-measured VERB B-O
-acetic ADJ B-O
-, PUNCT B-O
-propionate NOUN B-O
-, PUNCT B-O
-iso ADJ B-O
-- PUNCT B-O
-butyric ADJ B-O
-, PUNCT B-O
-butyric ADJ B-O
-, PUNCT B-O
-valeric ADJ B-O
-and CCONJ B-O
-iso ADJ B-O
-- PUNCT B-O
-valeric ADJ B-O
-acid NOUN B-O
-by ADP B-O
-GC PROPN B-O
-( PUNCT B-O
-GC-2001 PROPN B-O
-, PUNCT B-O
-Shimadzu PROPN B-O
-, PUNCT B-O
-Japan PROPN B-O
-) PUNCT B-O
-equipped VERB B-O
-with ADP B-O
-hydrogen NOUN B-O
-flame NOUN B-O
-ionization NOUN B-O
-detector NOUN B-O
-( PUNCT B-O
-FID PROPN B-O
-) PUNCT B-O
-using VERB B-O
-Nitrogen PROPN B-O
-as ADP B-O
-a DET B-O
-carrier NOUN B-O
-gas NOUN B-O
-in ADP B-O
-a DET B-O
-quartz NOUN B-O
-capillary NOUN B-O
-column NOUN B-O
-( PUNCT B-O
-30 NUM B-O
-m×0.32 NUM B-O
-mm×D×0.25 NUM B-O
-μm NOUN B-O
-; PUNCT B-O
-Stabilwax PROPN B-O
-- PUNCT B-O
-DA PROPN B-O
-, PUNCT B-O
-RESTEK PROPN B-O
-, PUNCT B-O
-USA PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-GC PROPN B-O
-was AUX B-O
-operated VERB B-O
-when SCONJ B-O
-the DET B-O
-injection NOUN B-O
-port NOUN B-O
-and CCONJ B-O
-detector NOUN B-O
-temperatures NOUN B-O
-were AUX B-O
-220 NUM B-O
-° NUM B-O
-C NOUN B-O
-and CCONJ B-O
-230 NUM B-O
-° NUM B-O
-C NOUN B-O
-, PUNCT B-O
-respectively ADV B-O
-. PUNCT B-O
-
-Concurrently ADV B-O
-, PUNCT B-O
-Ca2 NOUN B-O
-+ NOUN B-O
-binding VERB B-O
-to ADP B-O
-another DET B-O
-synaptic ADJ B-O
-vesicle NOUN B-O
-associated VERB B-O
-protein NOUN B-O
-, PUNCT B-O
-Synaptotagmin PROPN B-LF
-1 NUM I-LF
-( PUNCT B-O
-Syt1 PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-triggers VERB B-O
-the DET B-O
-migration NOUN B-O
-of ADP B-O
-synaptic ADJ B-O
-vesicles NOUN B-O
-towards ADP B-O
-the DET B-O
-plasma NOUN B-O
-membrane NOUN B-O
-, PUNCT B-O
-with ADP B-O
-Syt1 PROPN B-AC
-mediating VERB B-O
-the DET B-O
-docking NOUN B-O
-, PUNCT B-O
-fusion NOUN B-O
-and CCONJ B-O
-exocytosis NOUN B-O
-of ADP B-O
-the DET B-O
-readily ADV B-O
-releasable ADJ B-O
-synaptic ADJ B-O
-vesicles NOUN B-O
-at ADP B-O
-the DET B-O
-synaptic ADJ B-O
-cleft NOUN B-O
-[ PUNCT B-O
-30–32 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Light NOUN B-O
-induced VERB B-O
-c NOUN B-O
-- PUNCT B-O
-Fos NOUN B-O
-immunoreactivity NOUN B-O
-in ADP B-O
-the DET B-O
-suprachiasmatic ADJ B-O
-nuclei NOUN B-O
-( PUNCT B-O
-SCN PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-in ADP B-O
-sleep NOUN B-O
-- PUNCT B-O
-active ADJ B-O
-ventrolateral ADJ B-LF
-preoptic ADJ I-LF
-( PUNCT B-O
-VLPO PROPN B-AC
-) PUNCT B-O
-neurons NOUN B-O
-was AUX B-O
-importantly ADV B-O
-reduced VERB B-O
-in ADP B-O
-Opn4−/− PROPN B-O
-mice NOUN B-O
-, PUNCT B-O
-implicating VERB B-O
-both DET B-O
-sleep NOUN B-O
-- PUNCT B-O
-regulatory ADJ B-O
-structures NOUN B-O
-in ADP B-O
-the DET B-O
-melanopsin NOUN B-O
-- PUNCT B-O
-mediated VERB B-O
-effects NOUN B-O
-of ADP B-O
-light NOUN B-O
-. PUNCT B-O
-
-SDS PROPN B-O
-- ADJ B-O
-PAGE PROPN B-O
-under ADP B-O
-reducing VERB B-O
-conditions NOUN B-O
-of ADP B-O
-antithrombin ADJ B-O
-in ADP B-O
-complex NOUN B-O
-with ADP B-O
-FXa PROPN B-O
-upon SCONJ B-O
-activation NOUN B-O
-with ADP B-O
-low ADJ B-LF
-molecular ADJ I-LF
-weight NOUN I-LF
-heparin NOUN I-LF
-( PUNCT B-O
-LMWH PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-active ADJ B-O
-heparanase NOUN B-O
-( PUNCT B-O
-HPSE PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-10 NUM B-O
-- ADJ B-O
-fold ADJ B-O
-concentrated ADJ B-O
-medium NOUN B-O
-of ADP B-O
-cells NOUN B-O
-transfected VERB B-O
-with ADP B-O
-proheparanase NOUN B-O
-( PUNCT B-O
-mProHPSE PROPN B-O
-) PUNCT B-O
-; PUNCT B-O
-10 NUM B-O
-- ADJ B-O
-fold ADJ B-O
-concentrated ADJ B-O
-medium NOUN B-O
-of ADP B-O
-cells NOUN B-O
-transfected VERB B-O
-with ADP B-O
-an DET B-O
-empty ADJ B-O
-plasmid NOUN B-O
-but CCONJ B-O
-supplemented VERB B-O
-with ADP B-O
-active ADJ B-O
-heparanase NOUN B-O
-( PUNCT B-O
-mHPSE PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Detection NOUN B-O
-was AUX B-O
-done VERB B-O
-by ADP B-O
-western ADJ B-O
-blot NOUN B-O
-using VERB B-O
-an DET B-O
-anti ADJ B-O
-- ADJ B-O
-antithrombin ADJ B-O
-antibody NOUN B-O
-. PUNCT B-O
-
-Treating VERB B-O
-hyperglycemia NOUN B-O
-in ADP B-O
-previously ADV B-O
-non ADJ B-O
-- PUNCT B-O
-diabetic ADJ B-O
-individuals NOUN B-O
-with ADP B-O
-exogenous ADJ B-O
-insulin NOUN B-O
-immediately ADV B-O
-after ADP B-O
-kidney NOUN B-O
-transplantation NOUN B-O
-reduced VERB B-O
-the DET B-O
-odds NOUN B-O
-of ADP B-O
-developing VERB B-O
-Posttransplantation PROPN B-LF
-Diabetes PROPN I-LF
-Mellitus PROPN I-LF
-( PUNCT B-O
-PTDM PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-our PRON B-O
-previous ADJ B-O
-proof NOUN B-O
-- PUNCT B-O
-of ADP B-O
-- PUNCT B-O
-concept NOUN B-O
-clinical ADJ B-O
-trial NOUN B-O
-. PUNCT B-O
-
-Our PRON B-O
-dataset NOUN B-O
-comprised VERB B-O
-40 NUM B-O
-acylcarnitines NOUN B-O
-, PUNCT B-O
-34 NUM B-O
-lipids NOUN B-O
-( PUNCT B-O
-14 NUM B-O
-lysophospholipids NOUN B-O
-, PUNCT B-O
-10 NUM B-O
-sphingolipids NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-10 NUM B-O
-phosphatidylcholines NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-24 NUM B-O
-amino ADJ B-O
-acids NOUN B-O
-, PUNCT B-O
-16 NUM B-O
-organic ADJ B-O
-acids NOUN B-O
-, PUNCT B-O
-12 NUM B-O
-biogenic ADJ B-O
-amines NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-4 NUM B-O
-metabolites NOUN B-O
-classified VERB B-O
-as ADP B-O
-‘ PUNCT B-O
-other ADJ B-O
-’ PUNCT B-O
-( PUNCT B-O
-creatine NOUN B-O
-, PUNCT B-O
-choline NOUN B-O
-, PUNCT B-O
-trimethylamine NOUN B-LF
-N NOUN I-LF
-- PUNCT I-LF
-oxide NOUN I-LF
-[ PUNCT B-O
-TMAO PROPN B-AC
-] PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-glucose NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Brazil PROPN B-O
-’s PART B-O
-considerable ADJ B-O
-investments NOUN B-O
-in ADP B-O
-social ADJ B-O
-protection NOUN B-O
-policies NOUN B-O
-over ADP B-O
-the DET B-O
-last ADJ B-O
-two NUM B-O
-decades NOUN B-O
-include VERB B-O
-the DET B-O
-rollout NOUN B-O
-of ADP B-O
-conditional ADJ B-O
-cash NOUN B-O
-transfers NOUN B-O
-under ADP B-O
-the DET B-O
-Bolsa PROPN B-O
-Família PROPN B-O
-programme NOUN B-O
-and CCONJ B-O
-a DET B-O
-commitment NOUN B-O
-to ADP B-O
-UHC PROPN B-AC
-with ADP B-O
-the DET B-O
-expansion NOUN B-O
-of ADP B-O
-PHC PROPN B-AC
-through ADP B-O
-the DET B-O
-Estratégia PROPN B-LF
-de ADP I-LF
-Saúde PROPN I-LF
-da PROPN I-LF
-Família PROPN I-LF
-( PUNCT B-O
-ESF PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-family NOUN B-O
-health NOUN B-O
-strategy NOUN B-O
-) PUNCT B-O
-[ PUNCT B-O
-14,15 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-For ADP B-O
-comparison NOUN B-O
-to ADP B-O
-the DET B-O
-Global PROPN B-LF
-Lipids PROPN I-LF
-Genetics PROPN I-LF
-Consortium PROPN I-LF
-( PUNCT B-O
-GLGC PROPN B-AC
-) PUNCT B-O
-lipid NOUN B-O
-panel NOUN B-O
-and CCONJ B-O
-extension NOUN B-O
-to ADP B-O
-other ADJ B-O
-lipoproteins NOUN B-O
-, PUNCT B-O
-we PRON B-O
-also ADV B-O
-included VERB B-O
-the DET B-O
-2019 NUM B-O
-release NOUN B-O
-of ADP B-O
-the DET B-O
-Neale PROPN B-O
-Lab PROPN B-O
-UKB PROPN B-AC
-GWAS PROPN B-AC
-( PUNCT B-O
-automated ADJ B-O
-diastolic ADJ B-O
-and CCONJ B-O
-systolic ADJ B-O
-blood NOUN B-LF
-pressure NOUN I-LF
-( PUNCT B-O
-BP PROPN B-AC
-) PUNCT B-O
-measurement NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-their PRON B-O
-biochemistry NOUN B-O
-panel NOUN B-O
-( PUNCT B-O
-HDL PROPN B-AC
-, PUNCT B-O
--CLDL PROPN B-AC
-direct ADJ B-O
-, PUNCT B-O
--CTRG PROPN B-AC
-, PUNCT B-O
-apolipoprotein NOUN B-LF
-A NOUN I-LF
-( PUNCT B-O
-ApoA PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-ApoB PROPN B-AC
-, PUNCT B-O
-and CCONJ B-O
-lipoprotein NOUN B-O
-A NOUN B-O
-) PUNCT B-O
-[ PUNCT B-O
-36 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-CH PROPN B-AC
-, PUNCT B-O
-chronic ADJ B-LF
-hepatitis NOUN I-LF
-; PUNCT B-O
-LC PROPN B-AC
-, PUNCT B-O
-liver NOUN B-O
-cirrhotic ADJ B-O
-; PUNCT B-O
-HCC PROPN B-AC
-, PUNCT B-O
-hepatocellular ADJ B-LF
-carcinoma NOUN I-LF
-; PUNCT B-O
-SNP PROPN B-AC
-, PUNCT B-O
-single ADJ B-LF
-nucleotide NOUN I-LF
-polymorphism NOUN I-LF
-; PUNCT B-O
-HWE PROPN B-AC
-, PUNCT B-O
-Hardy PROPN B-LF
-- PUNCT I-LF
-Weinberg PROPN I-LF
-Equilibrium PROPN I-LF
-; PUNCT B-O
-Del PROPN B-O
-, PUNCT B-O
-deletion NOUN B-O
-; PUNCT B-O
-ID NOUN B-O
-, PUNCT B-O
-insertion NOUN B-O
-+ SYM B-O
-deletion NOUN B-O
-; PUNCT B-O
-Ht PROPN B-AC
-, PUNCT B-O
-haplotype NOUN B-LF
-. PUNCT B-O
-
-Foam NOUN B-O
-cell NOUN B-O
-formation NOUN B-O
-is AUX B-O
-regulated VERB B-O
-by ADP B-O
-several ADJ B-O
-factors NOUN B-O
-: NOUN B-O
-1 NUM B-O
-) PUNCT B-O
-scavenger NOUN B-O
-receptors NOUN B-O
-, PUNCT B-O
-such ADJ B-O
-as ADP B-O
-CD36 PROPN B-AC
-and CCONJ B-O
-lectin NOUN B-O
-- NOUN B-O
-like ADJ B-O
-ox- NOUN B-O
-low ADJ B-LF
-- NOUN I-LF
-density NOUN I-LF
-lipoprotein NOUN I-LF
-( PUNCT B-O
-LDL PROPN B-AC
-) PUNCT B-O
-receptor-1 NOUN B-O
-( PUNCT B-O
-Lox-1 PROPN B-AC
-) PUNCT B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-2 X B-O
-) PUNCT B-O
-acyl NOUN B-O
-- NOUN B-O
-coenzyme NOUN B-O
-A NOUN B-O
-: NOUN B-O
-cholesterol NOUN B-O
-acyltransferase NOUN B-O
-1 NUM B-O
-( PUNCT B-O
-ACAT1 PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-rate NOUN B-O
-- NOUN B-O
-limiting VERB B-O
-enzyme NOUN B-O
-for ADP B-O
-the DET B-O
-esterification NOUN B-O
-of ADP B-O
-cholesterol NOUN B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-3 X B-O
-) PUNCT B-O
-free ADJ B-O
-- NOUN B-O
-cholesterol NOUN B-O
-efflux NOUN B-O
-mediated VERB B-O
-by ADP B-O
-ATP PROPN B-O
-- NOUN B-O
-binding VERB B-O
-cassette NOUN B-O
-transporter NOUN B-O
-A1 NOUN B-O
-( PUNCT B-O
-ABCA1 PROPN B-O
-) PUNCT B-O
-and CCONJ B-O
-ATP PROPN B-O
-- NOUN B-O
-binding VERB B-O
-cassette NOUN B-O
-sub NOUN B-O
-- NOUN B-O
-family NOUN B-O
-G NOUN B-O
-member NOUN B-O
-1 NUM B-O
-( PUNCT B-O
-ABCG1 PROPN B-O
-) PUNCT B-O
-[ PUNCT B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Events NOUN B-O
-corresponding VERB B-O
-to PART B-O
-γδ PUNCT B-O
-T NOUN B-O
-( PUNCT B-O
-green ADJ B-O
-) PUNCT B-O
-, PUNCT B-O
-invariant ADJ B-O
-natural ADJ B-O
-killer NOUN B-O
-T NOUN B-O
-( PUNCT B-O
-iNKT PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-red ADJ B-O
-) PUNCT B-O
-, PUNCT B-O
-MAIT PROPN B-AC
-( PUNCT B-O
-blue ADJ B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-conventional ADJ B-O
-T NOUN B-O
-( PUNCT B-O
-Tconv PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-cyan NOUN B-O
-) PUNCT B-O
-cells NOUN B-O
-were AUX B-O
-superimposed VERB B-O
-to PART B-O
-generate VERB B-O
-a DET B-O
-dot NOUN B-O
-plot NOUN B-O
-( PUNCT B-O
-B NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-frequency NOUN B-O
-of ADP B-O
-IFN PROPN B-AC
-- NOUN B-O
-γ+ NOUN B-O
-cells NOUN B-O
-and CCONJ B-O
-the DET B-O
-mean ADJ B-LF
-fluorescence NOUN I-LF
-intensity NOUN I-LF
-( PUNCT B-O
-MFI PROPN B-AC
-) PUNCT B-O
-of ADP B-O
-IFN PROPN B-AC
-- NOUN B-O
-γ PUNCT B-O
-staining NOUN B-O
-were AUX B-O
-determined VERB B-O
-in ADP B-O
-7 NUM B-O
-donors NOUN B-O
-, PUNCT B-O
-each PRON B-O
-of ADP B-O
-whom PRON B-O
-is AUX B-O
-represented VERB B-O
-by ADP B-O
-a DET B-O
-circle NOUN B-O
-( PUNCT B-O
-C NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Five NUM B-O
-subpopulations NOUN B-O
-were AUX B-O
-defined VERB B-O
-among ADP B-O
-SEB PROPN B-AC
-- NOUN B-O
-stimulated VERB B-O
-CD3 NOUN B-O
-+ NOUN B-O
-cells NOUN B-O
-based VERB B-O
-on ADP B-O
-their PRON B-O
-co NOUN B-O
-- NOUN B-O
-expression NOUN B-O
-of ADP B-O
-CD161 NOUN B-O
-and CCONJ B-O
-Vα7.2 NOUN B-O
-, PUNCT B-O
-or CCONJ B-O
-lack NOUN B-O
-thereof ADV B-O
-. PUNCT B-O
-
-Receiver NOUN B-O
-- PUNCT B-O
-operating VERB B-O
-characteristic ADJ B-O
-( PUNCT B-O
-ROC PROPN B-AC
-) PUNCT B-O
-curves NOUN B-O
-were AUX B-O
-constructed VERB B-O
-to PART B-O
-calculate VERB B-O
-the DET B-O
-best ADJ B-O
-cutoff NOUN B-O
-values NOUN B-O
-, PUNCT B-O
-including VERB B-O
-the DET B-O
-area NOUN B-O
-under ADP B-O
-the DET B-O
-curve NOUN B-O
-( PUNCT B-O
-AUC PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-positive ADJ B-LF
-predictive ADJ I-LF
-value NOUN I-LF
-( PUNCT B-O
-PPV PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-negative ADJ B-LF
-predictive ADJ I-LF
-value NOUN I-LF
-( PUNCT B-O
-NPV PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-accuracy NOUN B-O
-for ADP B-O
-discriminating VERB B-O
-H. NOUN B-O
-pylori NOUN B-O
-positivity NOUN B-O
-, PUNCT B-O
-chronic ADJ B-O
-gastritis NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-atrophic ADJ B-O
-gastritis NOUN B-O
-. PUNCT B-O
-
-To ADP B-O
-that DET B-O
-end NOUN B-O
-, PUNCT B-O
-the DET B-LF
-Cancer PROPN I-LF
-Genome PROPN I-LF
-Atlas PROPN I-LF
-( PUNCT B-O
-TCGA PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-used VERB B-O
-to PART B-O
-identify VERB B-O
-samples NOUN B-O
-from ADP B-O
-LUSC PROPN B-AC
-( PUNCT B-O
-lung ADJ B-LF
-squamous ADJ I-LF
-cell NOUN I-LF
-carcinoma NOUN I-LF
-) PUNCT B-O
-and CCONJ B-O
-LUAC PROPN B-AC
-( PUNCT B-O
-lung ADJ B-LF
-adenocarcinoma NOUN I-LF
-) PUNCT B-O
-patients NOUN B-O
-for ADP B-O
-which PRON B-O
-clinical ADJ B-O
-follow VERB B-O
-- PUNCT B-O
-up ADP B-O
-data NOUN B-O
-was AUX B-O
-available ADJ B-O
-. PUNCT B-O
-
-STROBE PROPN B-AC
-, PUNCT B-O
-Strengthening VERB B-LF
-the DET I-LF
-Reporting NOUN I-LF
-of ADP I-LF
-Observational ADJ I-LF
-Studies NOUN I-LF
-in ADP I-LF
-Epidemiology NOUN I-LF
-. PUNCT B-O
-
-All DET B-O
-these DET B-O
-13 NUM B-O
-genes NOUN B-O
-are AUX B-O
-co ADJ B-O
-- ADJ B-O
-DE PROPN B-AC
-in ADP B-O
-acute ADJ B-LF
-megakaryoblastic ADJ I-LF
-leukemia NOUN I-LF
-( PUNCT B-O
-AMKL PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-acute ADJ B-LF
-myeloid ADJ I-LF
-leukemia NOUN I-LF
-( PUNCT B-O
-AML PROPN B-AC
-) PUNCT B-O
-mononuclear ADJ B-O
-cells NOUN B-O
-. PUNCT B-O
-
-Gi PROPN B-AC
-, PUNCT B-O
-nucleus NOUN B-LF
-gigantocellularis NOUN I-LF
-; PUNCT B-O
-DR PROPN B-AC
-, PUNCT B-O
-dorsal ADJ B-LF
-raphé NOUN I-LF
-; PUNCT B-O
-LC PROPN B-AC
-, PUNCT B-O
-locus NOUN B-LF
-coeruleus NOUN I-LF
-; PUNCT B-O
-LDT PROPN B-AC
-, PUNCT B-O
-laterodorsal ADJ B-LF
-tegmental ADJ I-LF
-nucleus NOUN I-LF
-; PUNCT B-O
-PC PROPN B-AC
-, PUNCT B-O
-nucleus NOUN B-LF
-pontis NOUN I-LF
-caudalis NOUN I-LF
-; PUNCT B-O
-PO PROPN B-AC
-, PUNCT B-O
-nucleus NOUN B-LF
-pontis NOUN I-LF
-oralis ADJ I-LF
-; PUNCT B-O
-SubLC PROPN B-AC
-, PUNCT B-O
-subcoeruleus NOUN B-LF
-PM2.5 PROPN B-AC
-, PUNCT B-O
-particulate NOUN B-LF
-matter NOUN I-LF
-with ADP I-LF
-an DET I-LF
-aerodynamic ADJ I-LF
-diameter NOUN I-LF
-less ADJ I-LF
-than ADP I-LF
-or CCONJ I-LF
-equal ADJ I-LF
-to ADP I-LF
-2.5 NUM I-LF
-μm NOUN I-LF
-or CCONJ I-LF
-fine ADJ I-LF
-particulate NOUN I-LF
-matter NOUN I-LF
-; PUNCT B-O
-YLL PROPN B-AC
-, PUNCT B-O
-years NOUN B-LF
-of ADP I-LF
-life NOUN I-LF
-lost VERB I-LF
-. PUNCT B-O
-
-Inflammation NOUN B-O
-is AUX B-O
-an DET B-O
-important ADJ B-O
-factor NOUN B-O
-in ADP B-O
-the DET B-O
-pathogenesis NOUN B-O
-of ADP B-O
-calcific ADJ B-O
-aortic ADJ B-LF
-stenosis NOUN I-LF
-( PUNCT B-O
-AS PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-We PRON B-O
-aimed VERB B-O
-to ADP B-O
-evaluate VERB B-O
-the DET B-O
-association NOUN B-O
-between ADP B-O
-an DET B-O
-inflammatory ADJ B-O
-marker NOUN B-O
-, PUNCT B-O
-neutrophil NOUN B-LF
-- PUNCT I-LF
-to ADP I-LF
-- PUNCT I-LF
-lymphocyte NOUN I-LF
-ratio NOUN I-LF
-( PUNCT B-O
-NLR PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-major ADJ B-LF
-adverse ADJ I-LF
-cardiovascular ADJ I-LF
-events NOUN I-LF
-( PUNCT B-O
-MACE PROPN B-AC
-) PUNCT B-O
-in ADP B-O
-patients NOUN B-O
-with ADP B-O
-severe ADJ B-O
-calcific ADJ B-O
-AS PROPN B-AC
-. PUNCT B-O
-
-Nuclei NOUN B-O
-were AUX B-O
-stained VERB B-O
-by ADP B-O
-4',6 NUM B-LF
-- PUNCT I-LF
-diamidino-2 NOUN I-LF
-- PUNCT I-LF
-phenylindole NOUN I-LF
-( PUNCT B-O
-DAPI PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-Sigma PROPN B-O
-- PUNCT B-O
-Aldrich PROPN B-O
-, PUNCT B-O
-Lyon PROPN B-O
-, PUNCT B-O
-France PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-used VERB B-O
-at ADP B-O
-a DET B-O
-1:2000 NUM B-O
-dilution NOUN B-O
-in ADP B-O
-Mowiol PROPN B-O
-mounting NOUN B-O
-medium NOUN B-O
-( PUNCT B-O
-2.4 NUM B-O
-g NOUN B-O
-Mowiol PROPN B-O
-4–88 NUM B-O
-from ADP B-O
-Sigma PROPN B-O
-- PUNCT B-O
-Aldrich PROPN B-O
-, PUNCT B-O
-6 NUM B-O
-g NOUN B-O
-glycerol NOUN B-O
-, PUNCT B-O
-6 NUM B-O
-mL NOUN B-O
-distilled VERB B-O
-water NOUN B-O
-, PUNCT B-O
-12 NUM B-O
-mL NOUN B-O
-0.2 NUM B-O
-M NOUN B-O
-Tris NOUN B-O
-- PUNCT B-O
-Cl NOUN B-O
-buffer NOUN B-O
-· PUNCT B-O
-pH NOUN B-O
-8.5 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Here ADV B-O
-, PUNCT B-O
-we PRON B-O
-use VERB B-O
-cryo NOUN B-LF
-- PUNCT I-LF
-electron NOUN I-LF
-microscopy NOUN I-LF
-( PUNCT B-O
-cryoEM PROPN B-AC
-) PUNCT B-O
-to ADP B-O
-decipher VERB B-O
-the DET B-O
-mechanism NOUN B-O
-of ADP B-O
-action NOUN B-O
-of ADP B-O
-a DET B-O
-potent ADJ B-O
-HA PROPN B-AC
-head NOUN B-O
-- PUNCT B-O
-directed VERB B-O
-monoclonal ADJ B-LF
-antibody NOUN I-LF
-( PUNCT B-O
-mAb PROPN B-AC
-) PUNCT B-O
-bound VERB B-O
-to ADP B-O
-an DET B-O
-influenza NOUN B-O
-H7 PROPN B-O
-HA PROPN B-AC
-. PUNCT B-O
-
-The DET B-O
-epitope NOUN B-O
-of ADP B-O
-the DET B-O
-antibody NOUN B-O
-is AUX B-O
-not PART B-O
-solvent NOUN B-O
-accessible ADJ B-O
-in ADP B-O
-the DET B-O
-compact ADJ B-O
-, PUNCT B-O
-prefusion NOUN B-O
-conformation NOUN B-O
-that PRON B-O
-typifies VERB B-O
-all DET B-O
-HA PROPN B-AC
-structures NOUN B-O
-to ADP B-O
-date NOUN B-O
-. PUNCT B-O
-
-Matrix NOUN B-LF
-effects NOUN I-LF
-( PUNCT B-O
-ME PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-extraction NOUN B-O
-recoveries NOUN B-O
-( PUNCT B-O
-ER PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-process NOUN B-O
-efficiencies NOUN B-O
-( PUNCT B-O
-PE PROPN B-AC
-) PUNCT B-O
-for ADP B-O
-PBTZ169 PROPN B-O
-, PUNCT B-O
-five NUM B-O
-active ADJ B-O
-metabolites NOUN B-O
-and CCONJ B-O
-internal ADJ B-O
-standards NOUN B-O
-were AUX B-O
-quantitatively ADV B-O
-assessed VERB B-O
-according VERB B-O
-to ADP B-O
-Matuszeswski PROPN B-O
-’s PART B-O
-procedures NOUN B-O
-as ADP B-O
-well ADV B-O
-as ADP B-O
-to ADP B-O
-the DET B-O
-recommendations NOUN B-O
-of ADP B-O
-the DET B-O
-EMEA PROPN B-AC
-/ SYM B-O
-FDA PROPN B-AC
-[ X B-O
-27 NUM B-O
-, PUNCT B-O
-28 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Among ADP B-O
-these DET B-O
-measures NOUN B-O
-are AUX B-O
-years NOUN B-O
-of ADP B-O
-life NOUN B-O
-lost VERB B-O
-( PUNCT B-O
-YLLs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-quantifies VERB B-O
-the DET B-O
-number NOUN B-O
-of ADP B-O
-years NOUN B-O
-of ADP B-O
-life NOUN B-O
-lost VERB B-O
-because SCONJ B-O
-the DET B-O
-person NOUN B-O
-dies VERB B-O
-prematurely ADV B-O
-due ADP B-O
-to ADP B-O
-a DET B-O
-disease NOUN B-O
-or CCONJ B-O
-injury NOUN B-O
-; PUNCT B-O
-years NOUN B-O
-lived VERB B-O
-with ADP B-O
-disability NOUN B-O
-( PUNCT B-O
-YLDs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-quantifies VERB B-O
-the DET B-O
-healthy ADJ B-O
-time NOUN B-O
-lost VERB B-O
-by ADP B-O
-a DET B-O
-person NOUN B-O
-living VERB B-O
-with ADP B-O
-a DET B-O
-disability NOUN B-O
-caused VERB B-O
-by ADP B-O
-a DET B-O
-disease NOUN B-O
-or CCONJ B-O
-injury NOUN B-O
-; PUNCT B-O
-and CCONJ B-O
-disability NOUN B-LF
-- PUNCT I-LF
-adjusted VERB I-LF
-life NOUN I-LF
-years NOUN I-LF
-( PUNCT B-O
-DALYs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-a DET B-O
-summary NOUN B-O
-measure NOUN B-O
-that PRON B-O
-is AUX B-O
-the DET B-O
-sum NOUN B-O
-of ADP B-O
-YLLs PROPN B-AC
-and CCONJ B-O
-YLDs PROPN B-AC
-[ PUNCT B-O
-17 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Irrespective ADV B-O
-of ADP B-O
-familial ADJ B-O
-relationship NOUN B-O
-, PUNCT B-O
-adults NOUN B-O
-who PRON B-O
-resided VERB B-O
-with ADP B-O
-another DET B-O
-adult NOUN B-O
-with ADP B-O
-any DET B-O
-chronic ADJ B-O
-condition NOUN B-O
-had VERB B-O
-29 NUM B-O
-% NOUN B-O
-higher ADJ B-O
-adjusted ADJ B-O
-relative ADJ B-O
-odds NOUN B-O
-of ADP B-O
-having VERB B-O
-1 NUM B-O
-or CCONJ B-O
-more ADJ B-O
-chronic ADJ B-O
-conditions NOUN B-O
-themselves PRON B-O
-( PUNCT B-O
-adjusted ADJ B-LF
-odds NOUN I-LF
-ratio NOUN I-LF
-[ X B-O
-aOR PROPN B-AC
-] X B-O
-= SYM B-O
-1.29 NUM B-O
-; PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-LF
-interval NOUN I-LF
-[ X B-O
-95 NUM B-O
-% NOUN B-O
-CI PROPN B-AC
-] X B-O
-1.10–1.50 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-LJD PROPN B-O
-was AUX B-O
-the DET B-O
-Chairman PROPN B-O
-of ADP B-O
-the DET B-O
-National PROPN B-O
-Patient PROPN B-O
-Safety PROPN B-O
-Agency PROPN B-O
-( PUNCT B-O
-NPSA PROPN B-O
-) PUNCT B-O
-( PUNCT B-O
-2010–2012 NUM B-O
-) PUNCT B-O
-and CCONJ B-O
-is AUX B-O
-currently ADV B-O
-involved ADJ B-O
-in ADP B-O
-the DET B-O
-programme NOUN B-O
-of ADP B-O
-research NOUN B-O
-associated VERB B-O
-with ADP B-O
-the DET B-O
-National PROPN B-LF
-Reporting PROPN I-LF
-and CCONJ I-LF
-Learning PROPN I-LF
-System PROPN I-LF
-( PUNCT B-O
-NRLS PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-He PRON B-O
-is AUX B-O
-also ADV B-O
-the DET B-O
-World PROPN B-O
-Health PROPN B-O
-Organization PROPN B-O
-'s PART B-O
-Patient PROPN B-O
-Safety PROPN B-O
-Envoy PROPN B-O
-. PUNCT B-O
-
-Many ADJ B-O
-additional ADJ B-O
-milestones NOUN B-O
-have AUX B-O
-been AUX B-O
-reached VERB B-O
-, PUNCT B-O
-including VERB B-O
-the DET B-O
-last ADJ B-O
-naturally ADV B-O
-occurring VERB B-O
-isolation NOUN B-O
-of ADP B-O
-serotype-2 NOUN B-O
-WPV PROPN B-AC
-in ADP B-O
-1999 NUM B-O
-, PUNCT B-O
-the DET B-O
-last ADJ B-O
-reported VERB B-O
-case NOUN B-O
-of ADP B-O
-poliomyelitis NOUN B-O
-associated VERB B-O
-with ADP B-O
-serotype-3 NOUN B-O
-in ADP B-O
-2012 NUM B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-absence NOUN B-O
-of ADP B-O
-any DET B-O
-reported VERB B-O
-wild ADJ B-LF
-poliovirus NOUN I-LF
-type NOUN I-LF
-1 NUM I-LF
-( PUNCT B-O
-WPV1 PROPN B-AC
-) PUNCT B-O
-cases NOUN B-O
-in ADP B-O
-Africa PROPN B-O
-outside ADP B-O
-of ADP B-O
-Borno PROPN B-O
-, PUNCT B-O
-Nigeria PROPN B-O
-( PUNCT B-O
-which PRON B-O
-reported VERB B-O
-4 NUM B-O
-WPV1 PROPN B-AC
-cases NOUN B-O
-with ADP B-O
-a DET B-O
-date NOUN B-O
-of ADP B-O
-onset NOUN B-O
-in ADP B-O
-July PROPN B-O
-– PUNCT B-O
-August PROPN B-O
-2016 NUM B-O
-and CCONJ B-O
-remains VERB B-O
-a DET B-O
-challenge NOUN B-O
-because SCONJ B-O
-of ADP B-O
-issues NOUN B-O
-with ADP B-O
-security NOUN B-O
-, PUNCT B-O
-inaccessibility NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-weak ADJ B-O
-surveillance NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-since SCONJ B-O
-August PROPN B-O
-2014 NUM B-O
-( PUNCT B-O
-in ADP B-O
-Somalia PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Ex ADJ B-LF
-- ADJ I-LF
-vivo ADJ I-LF
-lung NOUN I-LF
-perfusion NOUN I-LF
-( PUNCT B-O
-EVLP PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-an DET B-O
-emerging VERB B-O
-technique NOUN B-O
-promising VERB B-O
-an DET B-O
-expansion NOUN B-O
-of ADP B-O
-the DET B-O
-donor NOUN B-O
-pool NOUN B-O
-and CCONJ B-O
-improvements NOUN B-O
-in ADP B-O
-the DET B-O
-outcome NOUN B-O
-after ADP B-O
-lung NOUN B-O
-transplantation NOUN B-O
-. PUNCT B-O
-
-These DET B-O
-results NOUN B-O
-contrast VERB B-O
-to ADP B-O
-the DET B-O
-prevalent ADJ B-O
-thought NOUN B-O
-that SCONJ B-O
-oxygen NOUN B-O
-- PUNCT B-O
-reactive ADJ B-O
-Hbs PROPN B-AC
-( PUNCT B-O
-HbII NOUN B-O
-and CCONJ B-O
-HbIII NOUN B-O
-) PUNCT B-O
-are AUX B-O
-widely ADV B-O
-distributed VERB B-O
-and CCONJ B-O
-that SCONJ B-O
-the DET B-O
-sulfide NOUN B-O
-- PUNCT B-O
-reactive ADJ B-O
-hemoglobin NOUN B-LF
-( PUNCT B-O
-HbI NOUN B-O
-) PUNCT B-O
-is AUX B-O
-only ADV B-O
-present ADJ B-O
-in ADP B-O
-the DET B-O
-tissue NOUN B-O
-where SCONJ B-O
-the DET B-O
-endosymbiont NOUN B-O
-is AUX B-O
-located VERB B-O
-[ X B-O
-1 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-CTRL PROPN B-O
-, PUNCT B-O
-control NOUN B-O
-; PUNCT B-O
-EXC PROPN B-O
-, PUNCT B-O
-excised VERB B-O
-; PUNCT B-O
-hpi PROPN B-O
-, PUNCT B-O
-hours NOUN B-O
-post NOUN B-O
-invasion NOUN B-O
-; PUNCT B-O
-INT PROPN B-O
-, PUNCT B-O
-integration NOUN B-O
-; PUNCT B-O
-n.s PROPN B-O
-. PUNCT B-O
-
-, PUNCT B-O
-not PART B-O
-significant ADJ B-O
-by ADP B-O
-unpaired ADJ B-O
-t NOUN B-O
-test NOUN B-O
-( PUNCT B-O
-p NOUN B-O
-- PUNCT B-O
-value NOUN B-O
-= SYM B-O
-0.9895 NUM B-O
-) PUNCT B-O
-; PUNCT B-O
-PDEβ PROPN B-AC
-, PUNCT B-O
-phosphodiesterase NOUN B-LF
-β PUNCT I-LF
-; PUNCT B-O
-PfPDEβ PROPN B-AC
-, PUNCT B-O
-Plasmodium NOUN B-LF
-falciparum NOUN I-LF
-phosphodiesterase NOUN B-LF
-β PUNCT I-LF
-; PUNCT B-O
-RAP PROPN B-AC
-, PUNCT B-O
-rapamycin NOUN B-LF
-; PUNCT B-O
-RFU PROPN B-O
-, PUNCT B-O
-relative ADJ B-O
-fluorescence NOUN B-O
-unit NOUN B-O
-. PUNCT B-O
-
-Additionally ADV B-O
-, PUNCT B-O
-participants NOUN B-O
-reported VERB B-O
-that SCONJ B-O
-most ADJ B-O
-of ADP B-O
-the DET B-O
-current ADJ B-O
-priority NOUN B-O
-initiatives NOUN B-O
-such ADJ B-O
-as ADP B-O
-Clean PROPN B-LF
-and CCONJ I-LF
-Safe PROPN I-LF
-Health PROPN I-LF
-Facility PROPN I-LF
-( PUNCT B-O
-CASH PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-quality NOUN B-O
-movement NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-Compassionate PROPN B-LF
-, PUNCT I-LF
-Respectful PROPN I-LF
-, PUNCT I-LF
-and CCONJ I-LF
-Caring PROPN I-LF
-( PUNCT B-O
-CRC PROPN B-AC
-) PUNCT B-O
-by ADP B-O
-the DET B-O
-Federal PROPN B-O
-Minstry PROPN B-O
-of ADP B-O
-Health PROPN B-O
-( PUNCT B-O
-FMOH PROPN B-O
-) PUNCT B-O
-could AUX B-O
-well ADV B-O
-be AUX B-O
-complemented VERB B-O
-by ADP B-O
-the DET B-O
-intents NOUN B-O
-of ADP B-O
-the DET B-O
-current ADJ B-O
-guideline NOUN B-O
-. PUNCT B-O
-
-These DET B-O
-cases NOUN B-O
-have AUX B-O
-deserved VERB B-O
-the DET B-O
-designation NOUN B-O
-of ADP B-O
-GT PROPN B-AC
-- PUNCT B-O
-like ADJ B-O
-syndrome NOUN B-O
-( PUNCT B-O
-GTLS PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
-ITGA2B PROPN B-LF
-/ SYM I-LF
-ITGA2B PROPN B-AC
-ITGB3 PROPN I-LF
-- PUNCT I-LF
-ITGB3 PROPN B-AC
-related VERB I-LF
-thrombocytopenia NOUN I-LF
-( PUNCT B-O
-ITGA2B PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-first ADJ B-O
-description NOUN B-O
-dates VERB B-O
-to ADP B-O
-the DET B-O
-1990s NOUN B-O
-[ PUNCT B-O
-14,15 NUM B-O
-] PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-, PUNCT B-O
-along ADP B-O
-the DET B-O
-recent ADJ B-O
-years NOUN B-O
-, PUNCT B-O
-the DET B-O
-disease NOUN B-O
-has AUX B-O
-been AUX B-O
-characterized VERB B-O
-, PUNCT B-O
-with ADP B-O
-only ADV B-O
-a DET B-O
-few ADJ B-O
-variants NOUN B-O
-being AUX B-O
-described VERB B-O
-in ADP B-O
-the DET B-O
-/ITGB3-RTITGA2B PROPN B-AC
-and CCONJ B-O
-ITGB3 PROPN B-AC
-genes NOUN B-O
-. PUNCT B-O
-
-Another DET B-O
-well ADV B-O
-- PUNCT B-O
-characterized VERB B-O
-CTL PROPN B-AC
-epitope NOUN B-O
-, PUNCT B-O
-from ADP B-O
-Sendai PROPN B-LF
-virus NOUN I-LF
-nucleoprotein NOUN I-LF
-( PUNCT B-O
-SV PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-was AUX B-O
-investigated VERB B-O
-to PART B-O
-provide VERB B-O
-further ADJ B-O
-evidence NOUN B-O
-that SCONJ B-O
--NPTAP PROPN B-AC
-over NOUN B-O
-- PUNCT B-O
-expression NOUN B-O
-can AUX B-O
-augment VERB B-O
-antiviral ADJ B-O
-responses NOUN B-O
-. PUNCT B-O
-
-Importantly ADV B-O
-, PUNCT B-O
-caspase-4 NOUN B-O
-can AUX B-O
-be AUX B-O
-activated VERB B-O
-by ADP B-O
-increased VERB B-O
-intracellular ADJ B-O
-Ca2 NOUN B-O
-+ NOUN B-O
-level NOUN B-O
-, PUNCT B-O
-for ADP B-O
-example NOUN B-O
-, PUNCT B-O
-ER PROPN B-AC
-Ca2 NOUN B-O
-+ NOUN B-O
-release NOUN B-O
-mediated VERB B-O
-by ADP B-O
-transmembrane NOUN B-LF
-protein NOUN I-LF
-173 NUM I-LF
-( PUNCT B-O
-TMEM173 PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-also ADV B-O
-known VERB B-O
-as ADP B-O
-stimulator NOUN B-LF
-of ADP I-LF
-interferon NOUN I-LF
-genes NOUN I-LF
-( PUNCT B-O
-STING PROPN B-AC
-) PUNCT B-O
-) PUNCT B-O
-[ X B-O
-56 X B-O
-] PUNCT B-O
-or CCONJ B-O
-the DET B-O
-SERCA PROPN B-AC
-inhibitor NOUN B-O
-thapsigargin NOUN B-O
-[ X B-O
-57 X B-O
-] PUNCT B-O
-. PUNCT B-O
-
-KO PROPN B-AC
-, PUNCT B-O
-knockout NOUN B-LF
-; PUNCT B-O
-mDia1 PROPN B-O
-, PUNCT B-O
-mammalian ADJ B-O
-diaphanous ADJ B-O
-homolog1 NOUN B-O
-; PUNCT B-O
-mDia3 PROPN B-O
-, PUNCT B-O
-mammalian ADJ B-O
-diaphanous ADJ B-O
-homolog3 NOUN B-O
-; PUNCT B-O
-WT PROPN B-AC
-, PUNCT B-O
-wild ADJ B-LF
-- PUNCT I-LF
-type NOUN I-LF
-. PUNCT B-O
-
-Detection NOUN B-O
-was AUX B-O
-carried VERB B-O
-out ADP B-O
-in ADP B-O
-multiple ADJ B-LF
-reactions NOUN I-LF
-monitoring NOUN I-LF
-( PUNCT B-O
-MRM PROPN B-AC
-) PUNCT B-O
-mode NOUN B-O
-. PUNCT B-O
-
-A DET B-O
-significant ADJ B-O
-independent ADJ B-O
-association NOUN B-O
-was AUX B-O
-found VERB B-O
-between ADP B-O
-serum ADJ B-O
-CysC PROPN B-AC
-and CCONJ B-O
-GDM PROPN B-AC
-in ADP B-O
-the DET B-O
-binary ADJ B-O
-logistic ADJ B-O
-regression NOUN B-O
-analysis NOUN B-O
-after SCONJ B-O
-adjusted VERB B-O
-for ADP B-O
-age NOUN B-O
-, PUNCT B-O
-BMI PROPN B-AC
-, PUNCT B-O
-SP PROPN B-AC
-, PUNCT B-O
-DP PROPN B-AC
-, PUNCT B-O
-HbA1c PROPN B-AC
-, PUNCT B-O
-UA PROPN B-AC
-, PUNCT B-O
-TG PROPN B-AC
-and CCONJ B-O
-HOMA PROPN B-AC
-ratio NOUN I-LF
-( PUNCT B-O
--IR[oddsOR PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-14.269 NUM B-O
-; PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-LF
-interval(CI NOUN I-LF
-) PUNCT B-O
-, PUNCT B-O
-4.977–40.908 NUM B-O
-, PUNCT B-O
-P<0.001 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-Clinical ADJ B-O
-investigators NOUN B-O
-, PUNCT B-O
-IRBs PROPN B-AC
-, PUNCT B-O
-data NOUN B-O
-safety NOUN B-O
-and CCONJ B-O
-monitoring NOUN B-O
-boards NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-regulatory ADJ B-O
-agencies NOUN B-O
-( PUNCT B-O
-e.g. X B-O
-, PUNCT B-O
-the DET B-O
-European PROPN B-LF
-Medicines PROPN I-LF
-Agency PROPN I-LF
-[ PUNCT B-O
-EMA PROPN B-AC
-] PUNCT B-O
-and CCONJ B-O
-the DET B-O
-Food PROPN B-LF
-and CCONJ I-LF
-Drug PROPN I-LF
-Administration PROPN I-LF
-[ PUNCT B-O
-FDA PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-are AUX B-O
-all PRON B-O
-charged VERB B-O
-with ADP B-O
-risk NOUN B-O
-– PUNCT B-O
-benefit NOUN B-O
-assessment NOUN B-O
-. PUNCT B-O
-
-RNA-seq PROPN B-AC
-, PUNCT B-O
-RNA NOUN B-LF
-sequencing NOUN I-LF
-. PUNCT B-O
-
-Parenteral ADJ B-O
-nutrition NOUN B-O
-can AUX B-O
-be AUX B-O
-provided VERB B-O
-independently ADV B-O
-( PUNCT B-O
-total ADJ B-LF
-parenteral ADJ I-LF
-nutrition NOUN I-LF
-, PUNCT B-O
-TPN PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-or CCONJ B-O
-be AUX B-O
-combined VERB B-O
-with ADP B-O
-enteral ADJ B-O
-nutrition NOUN B-O
-. PUNCT B-O
-
-Studies NOUN B-O
-in ADP B-O
-Drosophila PROPN B-O
-have AUX B-O
-identified VERB B-O
-conserved ADJ B-O
-polarity NOUN B-O
-factors NOUN B-O
-that PRON B-O
-define VERB B-O
-the DET B-O
-apical ADJ B-O
-( PUNCT B-O
-Crumbs PROPN B-O
-, PUNCT B-O
-Stardust PROPN B-O
-, PUNCT B-O
-Par-6 PROPN B-O
-, PUNCT B-O
-atypical ADJ B-LF
-protein NOUN I-LF
-kinase NOUN I-LF
-C PROPN I-LF
-[ X B-O
-aPKC PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-, PUNCT B-O
-junctional ADJ B-O
-( PUNCT B-O
-Bazooka PROPN B-LF
-[ X B-O
-Baz]/Par-3 PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-basolateral ADJ B-O
-( PUNCT B-O
-Scribbled VERB B-LF
-[ X B-O
-Scrib PROPN B-AC
-] PUNCT B-O
-, PUNCT B-O
-Discs NOUN B-LF
-large ADJ I-LF
-[ X B-O
-Dlg PROPN B-AC
-] PUNCT B-O
-, PUNCT B-O
-Lethal ADJ B-O
-[ X B-O
-2 X B-O
-] PUNCT B-O
-giant ADJ B-O
-larvae NOUN B-O
-[ X B-O
-Lgl PROPN B-AC
-] PUNCT B-O
-) PUNCT B-O
-domains NOUN B-O
-of ADP B-O
-epithelial ADJ B-O
-cells NOUN B-O
-. PUNCT B-O
-
-The DET B-O
-prevalence NOUN B-O
-of ADP B-O
-alcohol NOUN B-LF
-use NOUN I-LF
-disorder NOUN I-LF
-( PUNCT B-O
-AUD PROPN B-AC
-) PUNCT B-O
-was AUX B-O
-14.2 NUM B-O
-% PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-addition NOUN B-O
-, PUNCT B-O
-wtBMMΦ PROPN B-AC
-and CCONJ B-O
-wtBMDCs PROPN B-AC
-secrete VERB B-O
-IFNα PROPN B-O
-after ADP B-O
-MNV-1 PROPN B-AC
-- PUNCT B-O
-infection NOUN B-O
-, PUNCT B-O
-as SCONJ B-O
-determined VERB B-O
-by ADP B-O
-IFNα PROPN B-O
-enzyme NOUN B-LF
-- PUNCT I-LF
-linked VERB I-LF
-immunosorbent ADJ I-LF
-assay NOUN I-LF
-( PUNCT B-O
-ELISA PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-data NOUN B-O
-not PART B-O
-shown VERB B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Resource NOUN B-LF
-utilization NOUN I-LF
-groups NOUN I-LF
-( PUNCT B-O
-RUGs PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-introduced VERB B-O
-as ADP B-O
-the DET B-O
-way NOUN B-O
-per X B-O
-diem X B-O
-prospective ADJ B-O
-payments NOUN B-O
-are AUX B-O
-set VERB B-O
-for ADP B-O
-Medicare PROPN B-O
-- PUNCT B-O
-reimbursed VERB B-O
-SNF PROPN B-AC
-care NOUN B-O
-, PUNCT B-O
-classifying VERB B-O
-patients NOUN B-O
-into ADP B-O
-reimbursement NOUN B-O
-categories NOUN B-O
-based VERB B-O
-on ADP B-O
-rehabilitation NOUN B-O
-service NOUN B-O
-use NOUN B-O
-: PUNCT B-O
-ultra ADJ B-O
-( PUNCT B-O
-720 NUM B-O
-+ NUM B-O
-minutes NOUN B-O
-/ SYM B-O
-week NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-very ADV B-O
-high ADJ B-O
-( PUNCT B-O
-500–719 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-high ADJ B-O
-( PUNCT B-O
-325–499 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-medium ADJ B-O
-( PUNCT B-O
-150–324 NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-low ADJ B-O
-( PUNCT B-O
-45–149 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-each DET B-O
-country NOUN B-O
-we PRON B-O
-sought VERB B-O
-published VERB B-O
-and CCONJ B-O
-unpublished ADJ B-O
-documents NOUN B-O
-( PUNCT B-O
-situation NOUN B-O
-reports NOUN B-O
-, PUNCT B-O
-official ADJ B-O
-statistics NOUN B-O
-, PUNCT B-O
-evaluation NOUN B-O
-reports NOUN B-O
-, PUNCT B-O
-technical ADJ B-O
-documents NOUN B-O
-, PUNCT B-O
-guidelines NOUN B-O
-for ADP B-O
-victim NOUN B-O
-identification NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-public ADJ B-O
-health NOUN B-O
-reports NOUN B-O
-) PUNCT B-O
-from ADP B-O
-national ADJ B-O
-ministries NOUN B-O
-of ADP B-O
-health NOUN B-O
-and CCONJ B-O
-government NOUN B-O
-offices NOUN B-O
-, PUNCT B-O
-the DET B-O
-World PROPN B-LF
-Health PROPN I-LF
-Organization PROPN I-LF
-( PUNCT B-O
-WHO PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-non ADJ B-O
-- ADJ B-O
-governmental ADJ B-O
-organisations NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-voluntary ADJ B-O
-groups NOUN B-O
-. PUNCT B-O
-
-Immunofluorescence NOUN B-O
-with ADP B-O
-antibodies NOUN B-O
-to ADP B-O
-the DET B-O
-myelin NOUN B-O
-protein NOUN B-O
-, PUNCT B-O
-myelin NOUN B-LF
-oligodendrocyte NOUN I-LF
-glycoprotein NOUN I-LF
-( PUNCT B-O
-MOG PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-confirmed VERB B-O
-the DET B-O
-myelin NOUN B-O
-integrity NOUN B-O
-( PUNCT B-O
-Fig PROPN B-O
-1A NUM B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-HLA PROPN B-O
-- ADJ B-O
-DR PROPN B-O
-( PUNCT B-O
-MHC PROPN B-O
-class NOUN B-O
-II NUM B-O
-) PUNCT B-O
-antibodies NOUN B-O
-confirmed VERB B-O
-the DET B-O
-presence NOUN B-O
-of ADP B-O
-microglia NOUN B-O
-with ADP B-O
-an DET B-O
-activated VERB B-O
-morphology NOUN B-O
-( PUNCT B-O
-thicker ADJ B-O
-and CCONJ B-O
-shorter ADJ B-O
-processes NOUN B-O
-) PUNCT B-O
-( PUNCT B-O
-Fig PROPN B-O
-1B NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Immunofluorescence NOUN B-O
-for ADP B-O
-Caspr1 PROPN B-O
-localised VERB B-O
-at ADP B-O
-the DET B-O
-paranodes NOUN B-O
-demonstrated VERB B-O
-that SCONJ B-O
-Caspr1 PROPN B-O
-- ADJ B-O
-stained VERB B-O
-paranodes NOUN B-O
-( PUNCT B-O
-2.8 NUM B-O
-± SYM B-O
-1.1 NUM B-O
-μm NOUN B-O
-) PUNCT B-O
-were AUX B-O
-significantly ADV B-O
-21.7 NUM B-O
-% NOUN B-O
-longer ADJ B-O
-on ADP B-O
-average ADJ B-O
-in ADP B-O
-the DET B-O
-MS PROPN B-AC
-NAWM PROPN B-AC
-tissue NOUN B-O
-than ADP B-O
-in ADP B-O
-the DET B-O
-non ADJ B-O
-- ADJ B-O
-neurological ADJ B-O
-control NOUN B-O
-tissue NOUN B-O
-( PUNCT B-O
-2.3 NUM B-O
-± SYM B-O
-0.8μm NUM B-O
-, PUNCT B-O
-Fig PROPN B-O
-1C–1 NUM B-O
-G PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Furthermore ADV B-O
-, PUNCT B-O
-43 NUM B-O
-% NOUN B-O
-of ADP B-O
-the DET B-O
-paranodes NOUN B-O
-in ADP B-O
-the DET B-O
-MS PROPN B-AC
-tissue NOUN B-O
-were AUX B-O
-longer ADJ B-O
-than ADP B-O
-the DET B-O
-75 NUM B-O
-% NOUN B-O
-percentile NOUN B-O
-of ADP B-O
-the DET B-O
-control NOUN B-O
-group NOUN B-O
-( PUNCT B-O
-2.7 NUM B-O
-μm NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-and CCONJ B-O
-11.14 NUM B-O
-% NOUN B-O
-were AUX B-O
-longer ADJ B-O
-than ADP B-O
-4 NUM B-O
-μm NOUN B-O
-, PUNCT B-O
-compared VERB B-O
-to ADP B-O
-the DET B-O
-4.1 NUM B-O
-% NOUN B-O
-in ADP B-O
-the DET B-O
-non ADJ B-O
-- ADJ B-O
-neurological ADJ B-O
-controls NOUN B-O
-( PUNCT B-O
-Fig PROPN B-O
-1 NUM B-O
-G PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-There PRON B-O
-was VERB B-O
-little ADJ B-O
-difference NOUN B-O
-between ADP B-O
-the DET B-O
-2 NUM B-O
-brain NOUN B-O
-areas NOUN B-O
-examined VERB B-O
-; PUNCT B-O
-the DET B-O
-paranodal ADJ B-O
-lengths NOUN B-O
-in ADP B-O
-the DET B-O
-cerebral ADJ B-O
-peduncles NOUN B-O
-of ADP B-O
-the DET B-O
-mesencephalon NOUN B-O
-were AUX B-O
-2.81 NUM B-O
-± SYM B-O
-0.019 NUM B-O
-μm NOUN B-O
-long ADJ B-O
-, PUNCT B-O
-and CCONJ B-O
-12 NUM B-O
-% NOUN B-O
-of ADP B-O
-them PRON B-O
-were AUX B-O
-> ADP B-O
-4 NUM B-O
-μm NOUN B-O
-, PUNCT B-O
-compared VERB B-O
-to ADP B-O
-those PRON B-O
-in ADP B-O
-the DET B-O
-precentral ADJ B-O
-gyrus NOUN B-O
-, PUNCT B-O
-which PRON B-O
-were AUX B-O
-2.79 NUM B-O
-± SYM B-O
-0.017 NUM B-O
-μm NOUN B-O
-long ADJ B-O
-, PUNCT B-O
-and CCONJ B-O
-10 NUM B-O
-% NOUN B-O
-of ADP B-O
-them PRON B-O
-were AUX B-O
-> ADP B-O
-4 NUM B-O
-μm NOUN B-O
-( PUNCT B-O
-S1 PROPN B-O
-Fig PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Class NOUN B-O
-B NOUN B-O
-enzymes NOUN B-O
-are AUX B-O
-zinc NOUN B-O
-dependent ADJ B-O
-metallo NOUN B-LF
-- PUNCT I-LF
-β PUNCT I-LF
-- PUNCT I-LF
-lactamases NOUN I-LF
-( PUNCT B-O
-MBLs PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-which PRON B-O
-require VERB B-O
-one NUM B-O
-or CCONJ B-O
-two NUM B-O
-Zn2 NOUN B-O
-+ NOUN B-O
-in ADP B-O
-their PRON B-O
-active ADJ B-O
-site NOUN B-O
-for ADP B-O
-catalysis NOUN B-O
-[ PUNCT B-O
-3 NUM B-O
-, PUNCT B-O
-4 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-the DET B-O
-present ADJ B-O
-study NOUN B-O
-, PUNCT B-O
-we PRON B-O
-chose VERB B-O
-to PART B-O
-investigate VERB B-O
-this PRON B-O
-using VERB B-O
-two NUM B-O
-different ADJ B-O
-kinds NOUN B-O
-of ADP B-O
-spatial ADJ B-O
-memory NOUN B-O
-tests NOUN B-O
-: PUNCT B-O
-the DET B-O
-spontaneous ADJ B-LF
-place NOUN I-LF
-recognition NOUN I-LF
-( PUNCT B-O
-SPR PROPN B-AC
-) PUNCT B-O
-test NOUN B-O
-and CCONJ B-O
-the DET B-O
-delay NOUN B-LF
-- PUNCT I-LF
-interposed VERB I-LF
-radial ADJ I-LF
-arm NOUN I-LF
-maze NOUN I-LF
-( PUNCT B-O
-dRAM PROPN B-AC
-) PUNCT B-O
-task NOUN B-O
-. PUNCT B-O
-
-For ADP B-O
-EM PROPN B-AC
-studies NOUN B-O
-, PUNCT B-O
-MRC5 PROPN B-O
-cells NOUN B-O
-were AUX B-O
-infected VERB B-O
-at ADP B-O
-an DET B-O
-m.o.i NOUN B-O
-. PUNCT B-O
-
-of ADP B-O
-5 NUM B-O
-as SCONJ B-O
-described VERB B-O
-above ADV B-O
-and CCONJ B-O
-fixed VERB B-O
-in ADP B-O
-situ NOUN B-O
-by ADP B-O
-incubation NOUN B-O
-for ADP B-O
-48 NUM B-O
-h NOUN B-O
-in ADP B-O
-4 NUM B-O
-% NOUN B-O
-PFA NOUN B-O
-and CCONJ B-O
-1 NUM B-O
-% NOUN B-O
-glutaraldehyde NOUN B-O
-in ADP B-O
-0.1 NUM B-O
-M PROPN B-O
-phosphate NOUN B-O
-buffer NOUN B-O
-( PUNCT B-O
-pH NOUN B-O
-7.2 NUM B-O
-) PUNCT B-O
-; PUNCT B-O
-they PRON B-O
-were AUX B-O
-then ADV B-O
-post VERB B-O
-- VERB B-O
-fixed VERB B-O
-by ADP B-O
-incubation NOUN B-O
-for ADP B-O
-1 NUM B-O
-h NOUN B-O
-with ADP B-O
-2 NUM B-O
-% NOUN B-O
-osmium NOUN B-O
-tetroxide NOUN B-O
-( PUNCT B-O
-Electron PROPN B-LF
-Microscopy PROPN I-LF
-Science PROPN B-O
-, PUNCT B-O
-http://www.emsdiasum.com X B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Timely ADV B-O
-and CCONJ B-O
-an PRON B-O
-accurate ADJ B-O
-risk NOUN B-O
-stratification NOUN B-O
-of ADP B-O
-patients NOUN B-O
-in ADP B-O
-the DET B-O
-emergency NOUN B-LF
-department NOUN I-LF
-( PUNCT B-O
-ED PROPN B-AC
-) PUNCT B-O
-supports VERB B-O
-the DET B-O
-clinician NOUN B-O
-in ADP B-O
-reducing VERB B-O
-time NOUN B-O
-to ADP B-O
-effective ADJ B-O
-treatment NOUN B-O
-— PUNCT B-O
-a DET B-O
-key ADJ B-O
-predictor NOUN B-O
-for ADP B-O
-patient NOUN B-O
-outcome NOUN B-O
-. PUNCT B-O
-
-HL PROPN B-AC
-: PUNCT B-O
-hyperlipidemia NOUN B-LF
-Statistical ADJ B-O
-analyses NOUN B-O
-were AUX B-O
-performed VERB B-O
-using VERB B-O
-logistic ADJ B-O
-regression NOUN B-O
-and CCONJ B-O
-results NOUN B-O
-were AUX B-O
-reported VERB B-O
-as ADP B-O
-odds NOUN B-LF
-ratio NOUN I-LF
-( PUNCT B-O
-OR PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-O
-interval NOUN B-O
-( PUNCT B-O
-95 NUM B-O
-% NOUN B-O
-CI NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-HBV PROPN B-AC
-, PUNCT B-O
-hepatitis NOUN B-LF
-B PROPN I-LF
-virus NOUN I-LF
-; PUNCT B-O
-HDV PROPN B-AC
-, PUNCT B-O
-hepatitis NOUN B-LF
-D PROPN I-LF
-virus NOUN I-LF
-. PUNCT B-O
-
-Each DET B-O
-green ADJ B-O
-dot NOUN B-O
-represents VERB B-O
-a DET B-O
-metabolic ADJ B-O
-trait NOUN B-O
-and CCONJ B-O
-the DET B-O
-positions NOUN B-O
-of ADP B-O
-the DET B-O
-dots NOUN B-O
-are AUX B-O
-determined VERB B-O
-by ADP B-O
-difference NOUN B-O
-in ADP B-O
-mean ADJ B-O
-offspring NOUN B-O
-metabolite NOUN B-O
-( PUNCT B-O
-in ADP B-O
-SD NOUN B-O
-units NOUN B-O
-) PUNCT B-O
-for ADP B-O
-each DET B-O
-increase NOUN B-O
-of ADP B-O
-1 NUM B-O
-- NOUN B-O
-SD NOUN B-O
-maternal ADJ B-O
-body NOUN B-LF
-mass NOUN I-LF
-index NOUN I-LF
-( PUNCT B-O
-BMI PROPN B-AC
-) PUNCT B-O
-( PUNCT B-O
-x NOUN B-O
-- NOUN B-O
-axis NOUN B-O
-) PUNCT B-O
-and CCONJ B-O
-difference NOUN B-O
-in ADP B-O
-mean ADJ B-O
-offspring NOUN B-O
-metabolite NOUN B-O
-( PUNCT B-O
-in ADP B-O
-SD NOUN B-O
-units NOUN B-O
-) PUNCT B-O
-for ADP B-O
-each DET B-O
-increase NOUN B-O
-in ADP B-O
-1 NUM B-O
-- NOUN B-O
-SD NOUN B-O
-paternal ADJ B-O
-BMI PROPN B-AC
-( PUNCT B-O
-y NOUN B-O
-- NOUN B-O
-axis NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Acute ADJ B-LF
-gastroenteritis NOUN I-LF
-( PUNCT B-O
-AGE PROPN B-AC
-) PUNCT B-O
-is AUX B-O
-a DET B-O
-common ADJ B-O
-condition NOUN B-O
-that PRON B-O
-imposes VERB B-O
-a DET B-O
-significant ADJ B-O
-burden NOUN B-O
-on ADP B-O
-communities NOUN B-O
-and CCONJ B-O
-healthcare NOUN B-O
-systems NOUN B-O
-worldwide ADV B-O
-. PUNCT B-O
-
-We PRON B-O
-developed VERB B-O
-and CCONJ B-O
-validated VERB B-O
-a DET B-O
-computational ADJ B-O
-model NOUN B-O
-of ADP B-O
-signal NOUN B-LF
-transducer NOUN I-LF
-and CCONJ I-LF
-activator NOUN I-LF
-of ADP I-LF
-transcription-3 NOUN I-LF
-( PUNCT B-O
-Stat3 PROPN B-AC
-) PUNCT B-O
-pathway NOUN B-O
-kinetics NOUN B-O
-, PUNCT B-O
-a DET B-O
-signaling NOUN B-O
-network NOUN B-O
-involved VERB B-O
-in ADP B-O
-embryonic ADJ B-O
-stem NOUN B-O
-cell NOUN B-O
-( PUNCT B-O
-ESC PROPN B-AC
-) PUNCT B-O
-self NOUN B-O
-- PUNCT B-O
-renewal NOUN B-O
-. PUNCT B-O
-
-Electrophoretic ADJ B-LF
-mobility NOUN I-LF
-shift NOUN I-LF
-assays NOUN I-LF
-( PUNCT B-O
-EMSAs PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-performed VERB B-O
-using VERB B-O
-the DET B-O
-Lightshift PROPN B-O
-chemi NOUN B-O
-- PUNCT B-O
-luminescence NOUN B-O
-EMSA PROPN B-AC
-kit NOUN B-O
-( PUNCT B-O
-Pierce PROPN B-O
-) PUNCT B-O
-according VERB B-O
-to ADP B-O
-the DET B-O
-manufacturer NOUN B-O
-’s PART B-O
-instructions NOUN B-O
-described VERB B-O
-in ADP B-O
-[ X B-O
-65 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-The DET B-O
-average NOUN B-O
-of ADP B-O
-3 NUM B-O
-blood NOUN B-LF
-pressures NOUN I-LF
-( PUNCT B-O
-BP PROPN B-AC
-) PUNCT B-O
-taken VERB B-O
-5 NUM B-O
-minutes NOUN B-O
-apart ADV B-O
-were AUX B-O
-used VERB B-O
-. PUNCT B-O
-
-Almost ADV B-O
-all PRON B-O
-women NOUN B-O
-recruited VERB B-O
-in ADP B-O
-both DET B-O
-study NOUN B-O
-groups NOUN B-O
-used VERB B-O
-their PRON B-O
-allocated VERB B-O
-study NOUN B-O
-treatment NOUN B-O
-( PUNCT B-O
-381 NUM B-O
-[ X B-O
-95.7 NUM B-O
-% NOUN B-O
-] PUNCT B-O
-in ADP B-O
-the DET B-O
-progesterone NOUN B-O
-group NOUN B-O
-and CCONJ B-O
-359 NUM B-O
-[ X B-O
-92.3 NUM B-O
-% NOUN B-O
-] PUNCT B-O
-in ADP B-O
-the DET B-O
-placebo NOUN B-O
-group NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-with ADP B-O
-similar ADJ B-O
-median ADJ B-O
-days NOUN B-O
-of ADP B-O
-use NOUN B-O
-in ADP B-O
-both DET B-O
-study NOUN B-O
-groups NOUN B-O
-( PUNCT B-O
-51.0 NUM B-O
-days NOUN B-O
-[ X B-O
-interquartile ADJ B-LF
-range NOUN I-LF
-( PUNCT B-O
-IQR PROPN B-AC
-) PUNCT B-O
-28.0–69.0 NUM B-O
-] PUNCT B-O
-in ADP B-O
-the DET B-O
-progesterone NOUN B-O
-group NOUN B-O
-versus ADP B-O
-52.0 NUM B-O
-days NOUN B-O
-[ X B-O
-IQR PROPN B-AC
-27.0–76.0 NUM B-O
-] PUNCT B-O
-in ADP B-O
-the DET B-O
-placebo NOUN B-O
-group NOUN B-O
-) PUNCT B-O
-( PUNCT B-O
-Table PROPN B-O
-1 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-As SCONJ B-O
-shown VERB B-O
-in ADP B-O
-S5 NUM B-O
-Fig PROPN B-O
-, PUNCT B-O
-and CCONJ B-O
-consistent ADJ B-O
-with ADP B-O
-our PRON B-O
-previous ADJ B-O
-results NOUN B-O
-, PUNCT B-O
-ectopic ADJ B-O
-induction NOUN B-O
-of ADP B-O
-all DET B-O
-three NUM B-O
-Su(H NOUN B-O
-) PUNCT B-O
-mutants NOUN B-O
-in ADP B-O
-the DET B-O
-eye NOUN B-O
-imaginal ADJ B-O
-discs NOUN B-O
-effects VERB B-O
-eye NOUN B-O
-morphology NOUN B-O
-indistinguishable ADJ B-O
-from ADP B-O
-wild ADJ B-O
-- PUNCT B-O
-type NOUN B-O
-Su(H NOUN B-O
-) PUNCT B-O
-, PUNCT B-O
-but CCONJ B-O
-the DET B-O
-triple ADJ B-O
-mutants NOUN B-O
-Su(H)LLL PROPN B-AC
-/ NOUN B-O
-AAA NOUN B-O
-and CCONJ B-O
-Su(H)LLF PROPN B-AC
-/ NOUN B-O
-AAA NOUN B-O
-retain VERB B-O
-little ADJ B-O
-to PART B-O
-no PRON B-O
-binding NOUN B-O
-of ADP B-O
-Hairless PROPN B-LF
-in ADP B-O
-vivo ADJ B-O
-. PUNCT B-O
-
-This PRON B-O
-is AUX B-O
-fully ADV B-O
-restored VERB B-O
-in ADP B-O
-Dble::R6/2 PROPN B-O
-mice NOUN B-O
-at ADP B-O
-12 NUM B-O
-wk NOUN B-O
-of ADP B-O
-age NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-K NOUN B-O
-) PUNCT B-O
-Representative ADJ B-O
-traces NOUN B-O
-of ADP B-O
-miniature ADJ B-LF
-EPSCs NOUN I-LF
-EPSCs PROPN B-AC
-( PUNCT B-O
-mEPSCs PROPN B-AC
-) PUNCT B-O
-at ADP B-O
-8 NUM B-O
-wk NOUN B-O
-. PUNCT B-O
-
-Status NOUN B-O
-of ADP B-O
-promoter NOUN B-O
-region NOUN B-O
-methylation NOUN B-O
-of ADP B-O
-O6 NOUN B-O
-- PUNCT B-O
-methylguanine NOUN B-O
-DNA NOUN B-O
-methyltransferase NOUN B-O
-( PUNCT B-O
-MGMT PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-Isocitrate NOUN B-LF
-dehydrogenase NOUN I-LF
-1 NUM B-O
-and CCONJ B-O
-2 NUM B-O
-( PUNCT B-O
-IDH PROPN B-AC
-1/2 NUM B-O
-) PUNCT B-O
-mutations NOUN B-O
-were AUX B-O
-also ADV B-O
-assessed VERB B-O
-. PUNCT B-O
-
-The DET B-O
-included VERB B-O
-literature NOUN B-O
-fulfilled VERB B-O
-the DET B-O
-following ADJ B-O
-criteria NOUN B-O
-: PUNCT B-O
-( PUNCT B-O
-1 X B-O
-) PUNCT B-O
-The DET B-O
-case NOUN B-O
-- PUNCT B-O
-control NOUN B-O
-studies NOUN B-O
-or CCONJ B-O
-cohort NOUN B-O
-designs NOUN B-O
-on ADP B-O
-the DET B-O
-correlation NOUN B-O
-between ADP B-O
-the DET B-O
-polymorphism NOUN B-O
-of ADP B-O
-ADIPOQ NOUN B-O
-gene NOUN B-O
-rs2241766 NOUN B-O
-or CCONJ B-O
-rs1501299 NOUN B-O
-and CCONJ B-O
-T2DM PROPN B-AC
-. PUNCT B-O
-
-( PUNCT B-O
-2 X B-O
-) PUNCT B-O
-The DET B-O
-genotype NOUN B-O
-distribution NOUN B-O
-conformed VERB B-O
-to ADP B-O
-the DET B-O
-HWE PROPN B-AC
-( PUNCT B-O
-Hardy PROPN B-LF
-- PUNCT I-LF
-Weinberg PROPN I-LF
-Equilibrium PROPN I-LF
-) PUNCT B-O
-balance NOUN B-O
-in ADP B-O
-the DET B-O
-control NOUN B-O
-population NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-3 X B-O
-) PUNCT B-O
-The DET B-O
-genotype NOUN B-O
-frequency NOUN B-O
-, PUNCT B-O
-the DET B-O
-odds NOUN B-LF
-ratio NOUN I-LF
-( PUNCT B-O
-OR PROPN B-AC
-) PUNCT B-O
-value NOUN B-O
-, PUNCT B-O
-or CCONJ B-O
-95 NUM B-O
-% NOUN B-O
-confidence NOUN B-LF
-interval NOUN I-LF
-( PUNCT B-O
-CI PROPN B-AC
-) PUNCT B-O
-were AUX B-O
-directly ADV B-O
-given VERB B-O
-in ADP B-O
-the DET B-O
-literature NOUN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-4 X B-O
-) PUNCT B-O
-The DET B-O
-language NOUN B-O
-of ADP B-O
-the DET B-O
-literature NOUN B-O
-was AUX B-O
-Chinese PROPN B-O
-or CCONJ B-O
-English PROPN B-O
-. PUNCT B-O
-
-( PUNCT B-O
-5 X B-O
-) PUNCT B-O
-For ADP B-O
-multiple ADJ B-O
-studies NOUN B-O
-of ADP B-O
-the DET B-O
-same ADJ B-O
-author NOUN B-O
-, PUNCT B-O
-the DET B-O
-latest ADJ B-O
-study NOUN B-O
-or CCONJ B-O
-that SCONJ B-O
-with ADP B-O
-sufficient ADJ B-O
-data NOUN B-O
-was AUX B-O
-selected VERB B-O
-. PUNCT B-O
-
-The DET B-O
-median ADJ B-O
-age NOUN B-O
-was AUX B-O
-45 NUM B-O
-years NOUN B-O
-( PUNCT B-O
-interquartile ADJ B-LF
-range NOUN I-LF
-( PUNCT B-O
-IQR PROPN B-AC
-) PUNCT B-O
-38–54 NUM B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-MACEs PROPN B-AC
-: PUNCT B-O
-major ADJ B-LF
-adverse ADJ I-LF
-cardiac ADJ I-LF
-events NOUN I-LF
-, PUNCT B-O
-MI PROPN B-O
-: PUNCT B-O
-myocardial ADJ B-O
-infarction NOUN B-O
-, PUNCT B-O
-TLR NOUN B-O
-: PUNCT B-O
-target NOUN B-O
-lesion NOUN B-O
-revascularization NOUN B-O
-, PUNCT B-O
-TVR NOUN B-O
-: PUNCT B-O
-target NOUN B-O
-vessel NOUN B-O
-revascularization NOUN B-O
-, PUNCT B-O
-ST NOUN B-O
-: PUNCT B-O
-stent NOUN B-O
-thrombosis NOUN B-O
-. PUNCT B-O
-
-Abbreviations NOUN B-O
-: PUNCT B-O
-ER PROPN B-AC
-, PUNCT B-O
-estrogen NOUN B-LF
-receptor NOUN I-LF
-; PUNCT B-O
-PR PROPN B-AC
-, PUNCT B-O
-progesterone NOUN B-LF
-receptor NOUN I-LF
-; PUNCT B-O
-HER2 PROPN B-O
-, PUNCT B-O
-Human PROPN B-O
-epidermal ADJ B-O
-growth NOUN B-O
-factor NOUN B-O
-receptor NOUN B-O
-2 NUM B-O
-; PUNCT B-O
-FSH PROPN B-O
-, PUNCT B-O
-follicle NOUN B-O
-stimulating VERB B-O
-hormone NOUN B-O
-; PUNCT B-O
-AST PROPN B-AC
-, PUNCT B-O
-aspartate NOUN B-LF
-aminotransferase NOUN I-LF
-; PUNCT B-O
-ALT PROPN B-AC
-, PUNCT B-O
-alanine NOUN B-LF
-aminotransferase NOUN I-LF
-; PUNCT B-O
-HDL PROPN B-O
-, PUNCT B-O
-high ADJ B-O
-- PUNCT B-O
-density NOUN B-O
-lipoprotein NOUN B-O
-; PUNCT B-O
-LDL NOUN B-O
-, PUNCT B-O
-low ADJ B-O
-- PUNCT B-O
-density NOUN B-O
-lipoprotein NOUN B-O
-; PUNCT B-O
-NFS PROPN B-O
-, PUNCT B-O
-nonalcoholic ADJ B-O
-fatty ADJ B-O
-liver NOUN B-O
-disease NOUN B-O
-fibrosis NOUN B-O
-score NOUN B-O
-; PUNCT B-O
-FIB-4 NOUN B-O
-, PUNCT B-O
-fibrosis-4 NOUN B-O
-; PUNCT B-O
-CT PROPN B-AC
-, PUNCT B-O
-computed VERB B-LF
-tomography NOUN I-LF
-. PUNCT B-O
-
-Worldwide ADV B-O
-, PUNCT B-O
-HPVs PROPN B-AC
-are AUX B-O
-known VERB B-O
-to PART B-O
-be AUX B-O
-one NUM B-O
-of ADP B-O
-the DET B-O
-most ADV B-O
-common ADJ B-O
-Sexually ADV B-LF
-Transmitted VERB I-LF
-Infections NOUN I-LF
-( PUNCT B-O
-STIs PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-Diet NOUN B-O
-was AUX B-O
-assessed VERB B-O
-using VERB B-O
-the DET B-O
-FAST PROPN B-AC
-( PUNCT B-O
-Food PROPN B-LF
-Assessment PROPN I-LF
-in ADP I-LF
-Schools PROPN I-LF
-Tool PROPN I-LF
-) PUNCT B-O
-food NOUN B-O
-diary NOUN B-O
-method NOUN B-O
-, PUNCT B-O
-a DET B-O
-method NOUN B-O
-validated VERB B-O
-for ADP B-O
-use NOUN B-O
-in ADP B-O
-young ADJ B-O
-children NOUN B-O
-[ PUNCT B-O
-14 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-BMI PROPN B-AC
-was AUX B-O
-also ADV B-O
-determined VERB B-O
-according VERB B-O
-to PART B-O
-the DET B-O
-International PROPN B-O
-Obesity PROPN B-O
-Task PROPN B-O
-Force PROPN B-O
-( PUNCT B-O
-IOTF PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-World PROPN B-LF
-Health PROPN I-LF
-Organization PROPN I-LF
-( PUNCT B-O
-WHO PROPN B-AC
-) PUNCT B-O
-criteria NOUN B-O
-: PUNCT B-O
-Thin ADJ B-O
-< NUM B-O
-5th ADJ B-O
-centiles NOUN B-O
-; PUNCT B-O
-normal ADJ B-O
-5th ADJ B-O
-to PART B-O
-< NUM B-O
-85th ADJ B-O
-centiles NOUN B-O
-; PUNCT B-O
-overweight ADJ B-O
-85th ADJ B-O
-to PART B-O
-< NUM B-O
-95th ADJ B-O
-centiles NOUN B-O
-; PUNCT B-O
-obese ADJ B-O
-95th ADJ B-O
-to PART B-O
-< NUM B-O
-98th ADJ B-O
-centiles NOUN B-O
-; PUNCT B-O
-and CCONJ B-O
-extremely ADV B-O
-- ADJ B-O
-obese ADJ B-O
-≥98th ADJ B-O
-centiles NOUN B-O
-[ PUNCT B-O
-13 NUM B-O
-] PUNCT B-O
-. PUNCT B-O
-
-ECRL PROPN B-O
-, PUNCT B-O
-extensor NOUN B-O
-carpi X B-O
-radialis X B-O
-longus X B-O
-; PUNCT B-O
-EEG PROPN B-AC
-, PUNCT B-O
-electroencephalography NOUN B-LF
-; PUNCT B-O
-EMG PROPN B-AC
-, PUNCT B-O
-electromyography NOUN B-LF
-. PUNCT B-O
-
-Plasma NOUN B-O
-interleukin-6 NOUN B-LF
-( PUNCT B-O
-IL-6 PROPN B-AC
-) PUNCT B-O
-levels NOUN B-O
-were AUX B-O
-quantitated VERB B-O
-using VERB B-O
-the DET B-O
-MILLIPLEX PROPN B-O
-® PROPN B-O
-MAP PROPN B-O
-Human PROPN B-O
-High ADJ B-O
-Sensitivity PROPN B-O
-T PROPN B-O
-Cell PROPN B-O
-Magnetic PROPN B-O
-Bead PROPN B-O
-Panel PROPN B-O
-immunoassay NOUN B-O
-( PUNCT B-O
-Merck PROPN B-O
-KGaA PROPN B-O
-, PUNCT B-O
-Darmstadt PROPN B-O
-, PUNCT B-O
-Germany PROPN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-After ADP B-O
-staining VERB B-O
-polytene NOUN B-O
-chromosomes NOUN B-O
-from ADP B-O
-wild ADJ B-O
-- PUNCT B-O
-type NOUN B-O
-larvae NOUN B-O
-with ADP B-O
-antibodies NOUN B-O
-against ADP B-O
-ISWI PROPN B-AC
-and CCONJ B-O
-the DET B-O
-elongating VERB B-O
-form NOUN B-O
-of ADP B-O
-Pol PROPN B-AC
-( PUNCT B-O
-Pol PROPN B-O
-IIoser2 PROPN B-O
-) PUNCT B-O
-, PUNCT B-O
-the DET B-O
-positions NOUN B-O
-of ADP B-O
-potential ADJ B-O
-target NOUN B-O
-genes NOUN B-O
-were AUX B-O
-identified VERB B-O
-by ADP B-O
-fluorescent ADJ B-LF
-in ADP I-LF
-situ NOUN I-LF
-hybridization NOUN I-LF
-( PUNCT B-O
-IIFISH PROPN B-AC
-; PUNCT B-O
-Figure PROPN B-O
-3C NUM B-O
-and CCONJ B-O
-3D NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-For ADP B-O
-these DET B-O
-experiments NOUN B-O
-, PUNCT B-O
-we PRON B-O
-selected VERB B-O
-genes NOUN B-O
-that PRON B-O
-exhibited VERB B-O
-at ADP B-O
-least ADJ B-O
-a DET B-O
-2.5 ADJ B-O
-- PUNCT B-O
-fold ADJ B-O
-change NOUN B-O
-in ADP B-O
-gene NOUN B-O
-expression NOUN B-O
-in ADP B-O
-Iswi PROPN B-O
-mutant ADJ B-O
-versus ADP B-O
-wild ADJ B-O
-- PUNCT B-O
-type NOUN B-O
-male NOUN B-O
-larvae NOUN B-O
-. PUNCT B-O
-
-This PRON B-O
-resulted VERB B-O
-in ADP B-O
-excluding VERB B-O
-an DET B-O
-average ADJ B-O
-number NOUN B-O
-of ADP B-O
-voxels NOUN B-O
-equal ADJ B-O
-to ADP B-O
-16.2 NUM B-O
-% NOUN B-O
-of ADP B-O
-the DET B-O
-region NOUN B-LF
-EVC PROPN B-AC
-of ADP I-LF
-interest NOUN I-LF
-( PUNCT B-O
-ROI PROPN B-AC
-; PUNCT B-O
-range NOUN B-O
-7.23%–31.55 NUM B-O
-% NOUN B-O
-across ADP B-O
-participants NOUN B-O
-) PUNCT B-O
-. PUNCT B-O
-
-Tissue NOUN B-O
-advanced ADJ B-LF
-glycation NOUN I-LF
-end NOUN I-LF
-product NOUN I-LF
-( PUNCT B-O
-AGE PROPN B-AC
-) PUNCT B-O
-accumulation NOUN B-O
-has AUX B-O
-been AUX B-O
-proposed VERB B-O
-as ADP B-O
-a DET B-O
-marker NOUN B-O
-of ADP B-O
-cumulative ADJ B-O
-metabolic ADJ B-O
-stress NOUN B-O
-that PRON B-O
-can AUX B-O
-be AUX B-O
-assessed VERB B-O
-noninvasively ADV B-O
-by ADP B-O
-measurement NOUN B-O
-of ADP B-O
-skin NOUN B-LF
-autofluorescence NOUN I-LF
-( PUNCT B-O
-SAF PROPN B-AC
-) PUNCT B-O
-. PUNCT B-O
-
-In ADP B-O
-persons NOUN B-O
-on ADP B-O
-haemodialysis NOUN B-O
-, PUNCT B-O
-SAF PROPN B-AC
-is AUX B-O
-an DET B-O
-independent ADJ B-O
-risk NOUN B-O
-factor NOUN B-O
-for ADP B-O
-cardiovascular ADJ B-LF
-events NOUN I-LF
-( PUNCT B-O
-CVEs PROPN B-AC
-) PUNCT B-O
-and CCONJ B-O
-all DET B-LF
-- PUNCT I-LF
-cause NOUN I-LF
-mortality NOUN I-LF
-( PUNCT B-O
-ACM PROPN B-AC
-) PUNCT B-O
-, PUNCT B-O
-but CCONJ B-O
-data NOUN B-O
-at ADP B-O
-earlier ADJ B-O
-stages NOUN B-O
-of ADP B-O
-chronic ADJ B-LF
-kidney NOUN I-LF
-disease NOUN I-LF
-( PUNCT B-O
-CKD PROPN B-AC
-) PUNCT B-O
-are AUX B-O
-inconclusive ADJ B-O
-. PUNCT B-O
-
-If SCONJ B-O
-the DET B-O
-systolic ADJ B-LF
-blood NOUN I-LF
-pressure NOUN I-LF
-( PUNCT B-O
-SBP PROPN B-AC
-) PUNCT B-O
-or CCONJ B-O
-diastolic ADJ B-LF
-blood NOUN I-LF
-pressure NOUN I-LF
-( PUNCT B-O
-DBP PROPN B-AC
-) PUNCT B-O
-exceeded VERB B-O
-140 NUM B-O
-mmHg NOUN B-O
-or CCONJ B-O
-90 NUM B-O
-mmHg NOUN B-O
-, PUNCT B-O
-respectively ADV B-O
-, PUNCT B-O
-the DET B-O
-measurement NOUN B-O
-was AUX B-O
-repeated VERB B-O
-after ADP B-O
-5 NUM B-O
-min NOUN B-O
-, PUNCT B-O
-and CCONJ B-O
-the DET B-O
-results NOUN B-O
-were AUX B-O
-averaged VERB B-O
-. PUNCT B-O
-
-The DET B-O
-largest ADJ B-O
-cluster NOUN B-O
-( PUNCT B-O
-# PUNCT B-O
-0 NUM B-O
-) PUNCT B-O
-has VERB B-O
-16 NUM B-O
-members NOUN B-O
-, PUNCT B-O
-a DET B-O
-silhouette NOUN B-O
-value NOUN B-O
-of ADP B-O
-0.789 NUM B-O
-and CCONJ B-O
-is AUX B-O
-labeled VERB B-O
-as ADP B-O
-carcinogenic ADJ B-O
-aristolochic ADJ B-O
-acid NOUN B-O
-by ADP B-O
-LLR PROPN B-AC
-( PUNCT B-O
-log ADJ B-LF
-- PUNCT I-LF
-likelihood NOUN I-LF
-ratio NOUN I-LF
-) PUNCT B-O
-. PUNCT B-O
-
-As SCONJ B-O
-shown VERB B-O
-in ADP B-O
-Figure NOUN B-O
-1B NUM B-O
-, PUNCT B-O
-quantitative ADJ B-O
-PCR NOUN B-O
-experiments NOUN B-O
-demonstrated VERB B-O
-that SCONJ B-O
-β PUNCT B-O